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H. Bentley Glass (1906-2005)
H. Bentley Glass, the distinguished geneticist and educator whose intimate involvement with Cold Spring
Harbor Laboratory spanned more than 50 years, died on January 16, 2005, one day before he would have
celebrated his 99th birthday. Born in Laichoufu, China to Baptist missionary parents, he first came to the
United States as a student at Baylor University in Waco, Texas. After graduation, he taught science and
coached football for 2 years at Timpson High School, near the Louisiana border, before returning to Baylor
for research that led to his master's degree. Already focused on genetics, he moved in 1929 to the University
of Texas at Austin for Ph.D. research under the supervision of already famed Drosophila geneticist Herman J.
Muller, whose 1926 discovery that X rays induce mutations later led to a 1946 Nobel Prize. Because of his
unorthodox social life and left-wing political affiliations, Muller's position as a professor at the University was
increasingly unstable, leading to his 1932 move to the Berlin laboratory of Russian-born geneticist,
N. Timofeev-Ressovsky. Bentley, whose later career was to mark him as the best of Muller's American stu-
dents, used a highly prized National Research Council Postdoctoral Fellowship to also go to Berlin, then the
scientific capital of the world. But just before he was to arrive, his potential mentor, the German-Jewish
geneticist Curt Stern, fearful that the Nazis would come to power, abruptly decided to remain in the United
States. Bentley briefly worked in Timofeev's lab until Hitler's rise to power in March 1933 led to his going on
to Norway and the laboratory of the population geneticist Otto Mohr.
On returning to the United States, Bentley taught for 4 years at Stephens College in Columbia, Missouri
where he married embryology graduate student Suzanne Smith. In 1938, they moved to Baltimore, Maryland
and for the next 9 years Bentley taught at Gaucher College, a women's college located close to Johns
Hopkins University. After World War II, he became a biology professor at Johns Hopkins, there organizing with
Bill McElroy eight Mc Cullum Pratt symposia on biochemistry, each of which led to influential books. Bentley
also long presided over the Quarterly Review of Biology (from 1958 to 1986). His 13 years at Hopkins were
his most productive as a scientist. Although he initially made his reputation as a Drosophila scientist, he later
also left his mark as a human geneticist working on blood group polymorphisms, genetic drift, and the bio-
logical effects of ionizing radiation. Through this involvement in human genetics, Bentley became engaged in
a number of public controversies concerning race relations, Lysenkoism, academic freedom, and nuclear fall-
out. In the late 1940s, he served as a highly active member of the Genetics Society of America's committee
to counter antigenetic opinions, an action group created to stop the spread of Lysenko's influence beyond
Soviet borders. At the same time, he was elected president of the Maryland Chapter of the American Civil
Liberties Union and chaired the American Association of University Professors Special Committee on
Academic Freedom and Tenure. He opposed loyalty oaths and refused an appointment to the Maryland
Radiation Control Advisory Board because doing so would have required him to sign a loyalty oath.
In the late 1950s and 1960s, Bentley was deeply involved with major attempts to reform secondary school
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science curricula. Early on, he chaired the Biological Sciences Curriculum Study, a collaborative project that
produced three highly influential textbooks. Each volume focused not on memorization but on learning as a
process. His other notable effort as an educator involved his membership in the Baltimore County School
Board of Education from 1954 to 1958. In that capacity, he used his authority as a geneticist to argue for
desegregation of the city's schools. Reportedly, he told the school board that until opportunity is equalized,
no one can say what is inherent by natural law (genetic endowment). The New Republic was to describe him
as a unique "triple threat" to defenders of the status quo in Maryland-by training, a scientist; by political affil-
iation, a Democrat; and by religious persuasion, a Baptist.
Bentley was the subject of several postwar FBI investigations, with his views on race relations rather than
his outspoken support of academic freedom landing him on J. Edgar Hoover's security risk list. It was a $5.00
donation to the Communist-tainted American Youth for Democracy that kindled the FBI director's ire. Bentley
paid that sum to attend a 1944 luncheon at which he spoke against segregation in the military. Although he
was officially cleared in 1955, the FBI continued to monitor Bentley's activities throughout the 1960s.
Bentley's close association with Cold Spring Harbor Laboratory began in 1941, the first of four summers
(also '42, '46, and '52) that he spent living in Williams House as a summer investigator. A participant in many
symposia, he was the summarizer of the 1964 June Symposium on "Human Genetics." Long an informal
advisor and confident of Milislav Demerec during the latter's 20-year directorship, Bentley was appointed in
1959 to an ad hoc review committee for advice on the future direction of the Lab. The committee, chaired by
Edward Tatum of The Rockefeller University, deplored the lack of funds for senior staff positions and argued
for continued emphasis on molecular biology and genetics.
Following his appointment as the academic vice president of Stony Brook University, Bentley was in a
position to directly help the science of Cold Spring Harbor Laboratory. Soon joining our Board of Trustees, he
succeeded Ed Tatum as chairman in October 1967-a critical time during which the Lab's existence into the
future was widely doubted. John Cairns no longer wished to continue as director and no funds were avail-
able to pay the stipend of a successor. For the previous 2 years, I had unsuccessfully tried to find such salary
monies. With the board now having a supportive chairman, I had the courage to propose that I become direc-
tor as long as I could remain a full-salaried professor at Harvard. Bentley and Norton Zinder, who succeed-
ed Tatum as Rockefeller's representative on our board, both instantly endorsed my plan for action. Franklin
Ford, the Dean of Arts and Sciences at Harvard, happily gave his okay to proceed. Again, Bentley canvassed
our board members about my taking the Lab's reigns, obtaining their unanimous consent.
During the remaining 5 years of Bentley's chairmanship, he and I, in contrast to John Cairns and Ed Tatum,
never had significant disagreements. I particularly valued his support of a June 1973 meeting of our trustees.
After sustained pressure by Town of Huntington Supervisor Jerome Ambro, the wealthy marina owner Arthur
Knudsen agreed to sell us Whaler's Cove Yacht Club on the eastern edge of Cold Spring Harbor for
$300,000. Were we not to buy it, Knudsen planned to double its size, bastardizing our harbor's still old-fash-
ioned 19th-century atmosphere. John Cairns and I strongly felt that the Lab's long-term future demanded that
the inner harbor remain the same. But our long-valued trustee, Walter Page, temporarily thought otherwise,
citing the Lab's still-limited financial resources. If Walter's views were to hold sway over our trustees, I said, I
would return full-time to Harvard. Wisely, Bentley did not allow the matter to come to a divided vote. Walter
soon graciously dropped his objections, allowing me to breathe easier. By then, going back to Harvard was
not a viable option for either me or the Lab.
After his retirement from Stony Brook at age 70, Bentley and Suzanne continued to live for almost 20 more
years in their charming Setauket home on Long Island Sound. Bentley's retirement was never passive. For a
decade, he commuted weekly from Stony Brook to Philadelphia to serve as director of the Genetics Archive
Project of the American Philosophical Society. They were still nearby when we dedicated our Bentley Glass
cabin in 1989. Six years later, following Suzanne's death, Bentley moved to Boulder, Colorado where his
daughter, Louise Edgar, was living.
Bentley Glass's passion for intellectual excellence and honesty and for human fairness and decency
should never be forgotten.
James D. Watson
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Ernst Mayr (1904-2005)
Ernst Mayr, one of the 20th century's leading evolutionary biologists, died on February 3, 2005 at the age of
100. Born in Kempten, Germany on July 5, 1904, Mayr was early on fascinated by wildlife, particularly birds.
He completed a Ph.D. in zoology from the University of Berlin in 1926 in only 16 months and, upon gradua-
tion, was offered the position of assistant curator of the Zoological Museum at the University of Berlin. The
position offered Mayr the opportunity to travel to New Guinea to begin his work in evolution.
During two trips to New Guinea and the nearby Solomon Islands, Mayr braved much rough terrain and
ghastly heat and humidity to classify and catalog the region's birds of paradise. There, he developed the con-
cept of species still taught today: A group of individuals are capable of breeding with one another but not with
others outside the group. He also pioneered the concept that new species develop when existing groups
divide into populations so different that they are unable to interbreed, solving one of the mysteries to which
Darwin alluded years before.
In 1932, Mayr came to the United States to take the position of associate curator of the Whitney-Roths-
child Collection of the American Museum of Natural History in New York, eventually rising to curator. In 1953,
he was appointed Alexander Agassiz Professor of Zoology at Harvard University, later serving 10 years as
director of its famed Museum of Comparative Zoology. He retained his named chair until his death.
Mayr was one of the most prolific writers in biology. With more than 25 books and countless articles, he
made his first big start through his masterful Systematics and the Origin of Species (1942), the logical suc-
cessor to his close friend Theodosius Dobzhansky's seminal 1937 book Genetics and the Origin of Species.
His writing career only went into full throttle upon his then-mandatory 1975 retirement. He was 76 when his
high-powered The Growth of Biological Thought was published to great acclaim. Equally impressive was his
This Is Life, which revealed that at 90 his writing skills had not diminished. On its jacket cover I endorsed it as
an intellectually masterful overview of the big questions in biology written with clarity and verve. In his 95th year,
What Evolution Is was published, written partially in Florida, where he increasingly went during winters
following the death of his wife Gretel, to whom he was married for more than 60 years. His last book What
Makes Biology Unique came out in his 100th year, when his legendary good health precipitately failed,
depriving the world of the two more books whose outlines were already well-thought through.
He was recognized with many awards and accolades, including memberships in the National Academy of
Sciences, the American Academy of Arts and Sciences, and the Royal Society of London. Throughout his
career, he was awarded more than 16 honorary degrees, including the 2001 honorary Ph.D. bestowed upon
him by his alma mater on the 75th anniversary of his original degree. His research earned the National Medal
of Science, Gregor Mendel Medal, Darwin Medal, and Brewster Medal.
During his time in New York at the Museum of Natural History, Mayr and his family were regular summer
visitors to Cold Spring Harbor Laboratory. He only missed one summer here between 1943 and 1952, one
x
of few researchers on site at the time who maintained active natural history research. In 1950, he joined the
board of directors of the Lab's local governing board-the Long Island Biological Association-serving until
1958, and over a 15-year stretch he attended seven symposia. He is remembered today, not only for his use
of Hooper House, but more importantly be-cause our main dining room in Blackford Hall has borne his name
since 1995.
I first met Ernst, his wife Gretel, and their daughters Christa and Susie during the summer of 1948, my first
at Cold Spring Harbor. My reading of Systematics and the Origin of Species during my senior year at the
University of Chicago had made him my bird-watcher hero. I still then was a keen bird-watcher and
initially disappointed to see Ernst showing little interest in local birds. Watching birds by then for him no longer
meant hard science; it was how evolution occurred that made him jump.
The Mayrs were regular attendees of the Saturday night square dances below Davenport House, and
they were daily seen on Bungtown Road on their way to swimming out to the Lab's raft just off Airs lie, where
Milislav Demerec and his family lived. When I came back to give my first public talk on the double helix at
the June 1953 Symposium on "Viruses," Ernst was among the first acquaintances from my past to greet
me in Blackford Hall. Excitedly, he told me about his impending move to Harvard, adding that I would be
surprised by how much Christa, his eldest daughter, had changed during my 3 years in Europe. To say the
least, she instantly caught my fancy when she and Susie arrived several days later with their mother. For the
next 2 years, I spent increasingly more time at their home near Harvard or at their newly purchased New
England farmhouse just across the New Hampshire state line. When Christa's junior year at Swarthmore led
to her marriage to a German engineering student, I temporarily saw less of Ernst. But by then I was also at
Harvard, with department meetings and lunches at the Faculty Club frequently bringing us together.
Although many of our fellow biology department members did not initially welcome the intrusion of
molecular biologists into their midst, Ernst was never so worried and took pride in Harvard becoming a
world leader in molecular as well as evolutionary biology.
In a 2002 interview, Ernst reflected fondly on his time at the Labor-atory and the fascinating characters he
met there-in particular, Barbara McClintock, Milislav Demerec, and Max Delbruck. He colorfully recalled the
chronic summer housing shortage, fun on the Sandspit, and the memories of a devoted group of scientists
who shared his time. "It was a marvelous atmosphere," he said, "because there were a number of places
where people got together and talked." For those who knew him, though, part of the wonderful atmosphere
was talking to Ernst himself.
He is already sorely missed for the breadth of his strongly felt convictions.
James D. Watson
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PRESIDENT'S REPORT
From the eastern shore of Cold Spring Harbor and many vantage points on our beautiful cam-
pus, the emergence of a cluster of new buildings is now obvious. This exciting expansion of our
research facilities flows naturally from the success of our current research and makes real a long-
held dream.
A decade ago, the village of Laurel Hollow redefined our campus as a scientific and research zone
distinct from its residential areas. Soon thereafter, the Board of Trustees initiated a strategic review of
future use of the Laboratory's 113-acre main campus. This review determined that any future devel-
opment would take place at the south end of the campus, close to existing buildings, to encourage
scientific collaboration. By the fall of 2001, our Connecticut-based architectural firm, Centerbrook, had
completed a vision for campus expansion that made efficient use of available space while retaining the
"village of science" style that has come to define Cold Spring Harbor Laboratory. Now, because of the
ingenuity of the Laboratory's recent science, our need for such expansion is very pressing.
The dramatic success of our Cancer Center offers opportunities to turn our attention to novel
therapeutic and diagnostic approaches for controlling human cancer. In recent years, our research
staff has begun collaborating with clinicians in many cancer centers worldwide. A number of new
technologies developed at the Laboratory offer novel approaches to investigating diagnoses and
treatments. One new technology is the RNAi library developed in Greg Hannon's laboratory, which
makes it possible to turn off the expression of every human gene and thus identify those that, when
inhibited, cause tumor regression or enhance the effects of chemotherapy. This approach will accel-
erate the rate of discovery of new molecular targets for drugs that fight cancer.
A new effort in human genetics by Michael Wigler's research group, in collaboration with Robert
Lucito, uses newly developed, powerful techniques for identifying the number of copies of genes that
exist in each individual. Classical Mendelian genetics have taught us that we all have two copies of
most of our genes, but in 2004, Wig ler, Jonathan Sebat, and colleagues discovered that this idea is
too simplistic. In our individual genomes, we all have either missing genes or extra copies of genes,
and the particular genes affected vary. This new aspect of human genetic variation, referred to as
copy-number polymorphism (CNP), has important implications. One is that CNP may contribute to
an individual's vulnerability to disease, an insight that has given fresh impetus to research on the
genetics of autism, schizophrenia, and neurodegenerative Parkinson's disease. Another is that CNP
may influence cancer cells. Cancer results from accumulated mutations in an individual's DNA and
many of these mutations are copy-number variations. Using the new technology, such variations can
now be quickly detected by scanning DNA taken directly from a tumor itself. This information will help
physicians to identify the cellular origin of a tumor and decide on appropriate therapy, and help sci-
entists to identify potential therapeutic targets.
Identifying potential targets is immensely valuable, but validating them as effective is still a major
challenge. One approach has been to study hard-to-cure cancers in mice, cancers that attempt to
mimic the genetics of human cancer cells and also reflect the clinical experience with human
tumors. Laboratory scientist Scott Lowe has been a leader in this area, pioneering new work on
leukemias, lymphomas, and liver carcinomas. Lowe has developed techniques for creating tumors
in mice that contain combinations of genes that cause human cancers. This approach permits the
discovery of new cancer-causing genes as well as the testing of novel therapeutic strategies. For
example, Lowe and Hannon have collaborated with Scott Powers to block tumor growth using
RNAi molecules directed against cancer-producing genes. Such mouse models are potentially
powerful because anticancer drugs can be tested and validated in many combinations, something
that is very difficult to achieve in human clinical studies.
The Laboratory's development of these technologies, coupled with our strong program in
understanding the biology of cancer, has fashioned a new path for cancer therapy research.
Technology development has also opened additional possibilities in neuroscience.
The current neuroscience program began at CSHL in the early 1990s. From an initial focus on
the genetics of learning and memory in the fruit fly by Tim Tully and colleagues, it expanded to sim-
ilar studies in rodents. Underlying learning and memory are processes that mold and strengthen
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synaptic connections among neurons. These processes are being studied in several laboratories
here at Cold Spring Harbor and the need to observe them at work in living animals led to the con-
struction of the Marks Building to house a new program in innovative, high-resolution brain imag-
ing. The success of this program created the need for computational studies of complex imaging
data and for modelling the way in which neuronal networks in the brain respond to external stimuli.
From this basis, our neuroscience research has grown to embrace investigations at a systems level
into how the brain handles the immensely complex processes of normal cognition, such as deci-
sion-making and attention. This cutting-edge initiative, pioneered by Zach Mainen, Tony Zador, and
Carlos Brody, will, I expect, eventually mesh with the new studies on the genetics of human cogni-
tive dysfunction. Our 15-year-old neuroscience research program has been remarkably successful
and now needs space to grow even further.
A third area of research that has prospered at Cold Spring Harbor and elsewhere over the last
decade is bioinformatics. It is no longer possible to keep track of all the data and information pub-
lished in biology. As a result, new science has emerged that employs practioners with backgrounds
in biology, medicine, physics, computer science, and mathematics who use computers as their
workbench. Scientists at Cold Spring Harbor, such as Lincoln Stein, have been instrumental in this
revolutionary approach, developing, for example, methods to manage and analyze the huge
amounts of data that have emerged from worldwide genome-sequencing. From their work on our
campus have emerged databases revealing new knowledge of human genetic variation and of the
evolutionary history of humanity. But these scientists are housed in converted apartments normal-
ly used to accommodate visitors to our campus; new facilities are required to maintain and expand
this exciting and important area of research.
In addition to new research facilities, we also need permanent housing for our highly successful
Watson School of Biological Sciences, as well as more on-campus accommodation and facilities
for the approximately 8000 yearly visitors to our meetings and courses programs. We also believe
there is an opportunity to establish a unique center for the history of molecular biology and biotech-
nology. Many of the important advances in molecular biology can be traced to the courses, meet-
ings, and research that took place at Cold Spring Harbor from the late 1940s onward, and the
Laboratory is thus a natural location for the archives of the founders of these fields. Mila Pollock,
our energetic, enthusiastic librarian and archivist, has begun a number of new initiatives such as
oral history, Web-based memory boards, and collections of archive materials that have enhanced
our already rich collections. Short- and long-term development of these resources will not only ben-
efit our graduate students, but also provide valuable reference material for scholars pondering the
future of genetics and biotechnology.
The needs, opportunities, and initiatives outlined here have prompted a clever and sensitively
constructed master plan (page 3) that shows how Cold Spring Harbor Laboratory will respond. Our
vision, however, is tempered by the reality of the substantial financial resources required to achieve
it, so the plan will be executed in phases, the first being the completion of research facilities close
to the existing buildings.
Site preparation for the research buildings that is now so visible was approved about 1 year ago by
the Village of Laurel Hollow, and during that process, local residents were informed via a series of meet-
ings and mailings. Installation of the infrastructure for the entire site will be complete by summer 2006
and construction of six new research buildings (100,000 sq. ft.) will proceed shortly thereafter, with the
aim of completion at the close of 2008 or early 2009. Extensive landscaping and some reforestation of
the disrupted areas of the campus will begin in spring 2006.
From the initial planning stages, through discussions with the Village and interactions with the
architects, to the beginning of construction, the huge and complex needs of this unprecedented
project have been addressed with extraordinary efforts from our administration and faculty and, in
particular, the dedication, energy, and attention to detail of Art Brings, our Chief Facilities Officer.
Without his hard work, this project would not be where it is today.
Throughout its history, Cold Spring Harbor Laboratory has expanded in response to significant
advances in biological and biomedical research. This is such a moment. Our long-held dream is
becoming reality and the opportunity to do even more exceptional research is energizing the faculty and
support staff as never before. We have much to discover.
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MASTER PLAN
COLD SPRIBIZIORDLgrORY
Existing conditions of the construction site
The Hillside Campus
The figure above shows the
existing campus buildings.
Route 25A and our southern
boundary is on the left. The fig-
ure at right shows the new
buildings in the master plan,
shaded in light gray. Those
planned as part of phase 1 are
shown in dark gray: a series of
six research buildings and a
supporting mechanical building.
COM SPRING rwagoaLABORATORY
!RASTER PUN
Plan of proposed modifications
ED.
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HIGHLIGHTS OF THE YEAR
Research
Cancer
During the past few years, researchers have discovered that naturally occurring molecular
snippets called "microRNAs" influence normal human growth and development. In 2005,
CSHL scientists Greg Hannon, Scott Lowe, Scott Powers, and their colleagues discovered
that microRNAs can also have an important role in cancer. It is a remarkable example of the
progress that can be made when researchers working from different approachescollaborate
closely on a project (in this case, Hannon, Lowe, and Powers working on microRNAs, ani-
mal models of cancer, and cancer genomics, respectively).
The study focused on a segment of human chromosome 13 that was known to be "ampli-
fied" or present in excess copies in several tumor types including B-cell lymphoma. The
researchers observed that five microRNAs encoded by this DNA segment-referred to as the
"mir-17-92 cluster -are present at abnormally high levels in human B-cell lymphoma cell
lines, as well as in biopsies of human lymphomas and colorectal carcinomas. These discov-
eries indicated that misregulated microRNAs might contribute to human cancer, particularly to
B-cell lymphoma, but also to other forms of the disease. To test whether increased levels of
the microRNAs could indeed contribute to cancer, the researchers engineered mouse cells to
have high levels of the microRNAs. They found that the microRNAs accelerated tumor devel-
opment and decreased survival in a mouse model of B-cell lymphoma. Moreover, lymphomas
engineered to have high levels of the microRNAs consistently invaded organs including liver,
lung, and kidney and lacked the extensive "programmed cell death" that otherwise keeps
tumors in check. The observations suggest that microRNAs promote metastasis.
The Cancer Genome Atlas pilot project recently announced by the National Cancer
Institute (NCI), in response to the recommendations of an NCI advisory committee ofwhich
I was a member, aims to find all of the major human cancer genes in specific types of can-
cers. Now, with the knowledge that genes encoding RNA can be among the set that pro-
mote cancer, the Cancer Genome Atlas has additional challenges to discover how wide-
spread this phenomenon is.
In other work aimed at investigating cancer progression, Alea Mills and her colleagues have
discovered that the loss of a gene called p63 accelerates aging in mice. Similar versions of
the gene are present in many organisms, including humans. The p63 gene is
thus likely to have a fundamental role in aging. Aging and cancer are two sides
of the same coin. In one case, cells stop dividing. In the other, they cannot stop
dividing. Therefore, Alea suspects that having the right amount of the p63 pro-
tein in the right cells at the right time normally creates a balance that enables
organisms to live relatively cancer-free for a reasonably long time.
To study how the p63 gene works, the researchers devised a system for
eliminating it from adult mouse tissues. What struck them right away was that
the p63-deficient mice were aging prematurely. The effects of premature
aging observed in these mice were hair loss, reduced fitness and body
weight, progressive curvature of the spine, and shortened lifespan. The p63
gene has been studied since it was discovered in 1997, but this is the first
time it has been implicated in aging. A related protein called p53 is perhaps
the most commonly mutated gene in human cancers and acts to suppressAlea Mills
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tumor formation. Both p63 and p53 bind to specific sequences in DNA, and thus the inter-
play between them, as well as a third related protein p73, may set up a regulatory network
that creates a balance between aging and cancer progression.
Genomics and Bioinformatics
Bioinformatics researcher Lincoln Stein and his colleagues are part of a pub-
lic-private effort-the International Hap Map Consortium-whose aim is to
chart the patterns of genetic variation that are common in the world's human
population. In 2005, the researchers published the first comprehensive col-
lection of their results called a "haplotype map" or Hap Map. Comprising more
than 1 million unique markers of human genetic variation, this first version of
the Hap Map is already accelerating the search for genes involved in common
diseases including cancer, heart disease, diabetes, asthma, and macular
degeneration. The Hap Map may also be used to identify genetic factors that
contribute to good health, such as those protecting against infectious dis-
eases or other disorders.
In addition to its principal use as a resource for studies of human health
and disease, the Hap Map is yielding intriguing clues about how our species
evolved over time and the evolutionary forces that were important as the human population
spread around the globe. The Hap Map is built on a foundation laid by the completion of the
3-billion-letter human genome sequence in 2003. As was the case with all of the data gener-
ated by the Human Genome Project, the data from the International Hap Map Consortium are
being made freely available to the world's scientists without restrictions.
The Hap Map data are a collection of single-base changes, or SNPs, in the DNA that vary
among individuals. These SNPs are inherited in blocks along chromosomes. They are a source
of human genetic variation, but not the only source. Last year, Jonathan Sebat and Michael
Wig ler and their colleagues reported the discovery of a large number of deletions and amplifi-
cations of segments of the human genome. Called copy-number polymorphisms or CNPs,
these also contribute to human genetic variation and to evolution of our species. Thus, we are
now beginning to have a fairly robust view of how we as individuals differ from each other.
Lincoln Stein
Infectious Disease
By determining the molecular structure of a protein that enables malaria parasites to invade
human red blood cells, structural biologist Leemor Joshua-Tor and her student Niraj Tolia have
uncovered valuable clues for rational antimalarial drug design and vaccine
development. Niraj is a native of Kenya where malaria is endemic and a major
medical problem, so he pursued this project with first-hand knowledge that
something needs to be done about this devastating disease.
Malaria causes approximately 400 million clinical cases and 2 million
deaths annually, with more than 80% of deaths occurring among children.
The disease is caused by mosquito-borne parasites of the genus
Plasmodium. A major pathway through which malaria parasites invade red
blood cells is the binding of a particular protein on the surface of parasites
(EBA-175) to a receptor protein on the surface of red blood cells (glycophorin
A). Consequently, drugs or vaccines that block the binding of EBA-175 to gly-
cophorin A could be effective therapies for controlling malaria.
As a first step toward developing such therapies, Leemor's group used X- Niraj Tolia
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ray crystallography to determine the atomic structure of a key portion of the EBA-175 pro-
tein. The results revealed precisely how the malaria parasite protein is likely to bind to human
glycophorin A. This discovery enables researchers to take rational, structure-based
approaches to designing antimalarial drugs and vaccines.
Cell Biology
David Spector and his colleagues have discovered a new molecular mechanism that is likely to
control the production of many proteins in humans and other organisms. A deeper under-
standing of this rapid response, "cut and run" mechanism is predicted to have broad implica-
tions for biology and biomedical research. A few years ago, members of David's group noticed
that under standard growth conditions, a particular subset of messenger RNA molecules lin-
gered in the nucleus indefinitely (in structures called "speckles") and never reached the cyto-
plasm as they typically do. Spearheaded by the work of Kannanganattu Prasanth in David's
group, a new paradigm of gene regulation was discovered that explains why such atypical
messenger RNAs linger in the nucleus instead of being used immediately to produce protein.
First, they found that a mouse gene called mCAT2 encodes two different kinds of mes-
senger RNAs: a standard protein-coding version that is exported to the cytoplasm soon after
it is produced in the nucleus and an atypical version that lingers in the nucleus. These obser-
vations led David and his colleagues to propose that when cells are stressed (e.g., by viral
infection), perhaps the lingering mCAT2 messenger RNAs are rapidly released from the
nucleus and exported to the cytoplasm, thus circumventing the time-consuming process of
producing new messenger RNA needed for stress response.
Confirming this idea, they discovered that the atypical mCAT2 messenger RNAs in the
nucleus were rapidly cleaved in response to interferon treatment (which mimics the effect of
viral infection) and that the protein-coding portion of the messenger RNAs was indeed then
rapidly exported to the cytoplasm and translated into protein. David has reason to believe
that many genes in humans and other organisms that need to be rapidly induced are regu-
lated in this way.
Because the protein-coding regions of most mammalian genes are interrupted by large
segments of DNA (called introns), a phenomenon discovered at CSHL in 1977, leading to a
Nobel Prize, it can take many hours to copy the DNA into mRNA. The new mechanism of
gene regulation discovered by David and his colleagues may explain how genes can be
rapidly expressed when cells receive an appropriate signal.
Plant Molecular Genetics
Rob Martienssen
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In 1909, while harvesting a typical corn crop (Zea mays) in Illinois, a field
worker noticed a plant so unusual that it was thought to be a new species.
Its "peculiarly shaped ear" was "laid aside as a curiosity." The specimen was
designated Zea ramosa (from the Latin ramosus, "having many branches").
Owing to the natural alteration of a single gene-later dubbed ramosal-
both the ear and the tassel of the Zea ramosa specimen were much more
branched than those of typical corn plants, resulting in loose, crooked cobs
and a far bushier than usual tassel.
Solving this enduring genetic mystery, Rob Martienssen and his colleagues
recently isolated the ramosa 1 gene and discovered how it governs the archi-
tecture of corn plants. The discovery also explains why rice, other cereal crops,
and even popular ornamental grasses look the way they do. The study was a
cover story of the international journal Nature. As part of the study revealed, to produce increas-
ingly larger ears, primitive farmers almost certainly selected corn progenitors that bore special
versions of the ramosa 1 gene: versions that restrained branching in the ear, thus enabling more
rows of kernels to form.
Rob's group found that rice, corn, and other grasses have either none, some, or a com-
paratively large amount of ramosa1 gene activity and that the levels and timing of this activity
have a major impact on the architectural and agricultural yield of plants. It is a prime example
of how selection by humans can influence the evolution of plant species. But importantly, the
study also shows that considerable variation in plant structure can be caused by relatively
small changes in the genomic DNA. Such simple variation in one or a few genes may also
underlie the vast physical differences in domestic dogs that were also selected by man.
Neuroscience
According to a study by neuroscientist Partha Mitra and his colleagues, sleep helps young
birds master the art of song, and it does so in a surprising way. The study revealed that when
young zebra finches first awaken, instead of "picking up where they left off" in their vocal
learning and memory, they are actually dramatically worse singers than they were at the end
of the previous day. However, the quality of the birds' songs was found to improve after
intense morning rehearsal such that by the end of each new day, their vocal performances
are indeed better than the previous day.
More work is needed to explain this "one step back, two steps forward" effect of sleep on
the brain circuits that govern vocal learning and memory consolidation. In the meantime, a
useful analogy is the tempering of steel, in which to gain its ultimate structure and strength,
it is first weakened. Vocal learning in songbirds is similar to speech acquisition in humans:
Young birds go through a period of "screeching" before learning to imitate adult songs accu-
rately, much as babies babble before grasping words. Therefore, to extend the significance
of his discoveries to human development, Partha has begun to study the
vocalizations of infant children in a rigorous, quantitative way. From this work,
he expects to learn, among other things, how sleep affects learning and
memory in humans.
To collect the data used in the zebra finch study, behavioral neuroscientists
Ofer Tchernichovski and Sebastien Deregnaucourt of City College of New
York recorded every sound-approximately 1 million syllables per bird-made
by young zebra finches over several months as the birds learned to imitate
and perfect their own renditions of recorded adult zebra finch songs. To mea-
sure how the vocal learning and memory of the birds changed over time,
Partha developed mathematical algorithms that became the basis of power-
ful software he and Ofer created for analyzing the structure and patterns of
recorded sounds (Sound Analysis Pro). Using this software, the vast amount of Partha Mitra
data was now accessible for interpretation, leading to their surprising discovery. Partha is a
member of the Swartz Center for Computational Neuroscience, which supports research on
development of theory and computational analysis of complex neuroscience data sets.
Another member of the Swartz Center, Mitya Chklovskii has made a significant advance
in understanding the wiring of an entire nervous system of an animal. In the 1960s, Sydney
Brenner started research at Cambridge University on the small worm Caenorhabditis ele-
gans. This early beginning established the worm as one of the major model organisms for
research on genetics, development, genomics, and neurobiology. For example, the entire lin-
eage of cell divisions and cell deaths during development was determined by John Sulston
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and colleagues, leading to the first description of how an animal grows from a fertilized egg
and also led to the discovery of programmed cell death. Electron micrographs of the entire
worm were collected as part of this project. Mitya and his colleagues used these to update
and complete an analysis of the neurons and synaptic connections, thereby creating a wiring
diagram of the worm's nervous system.
Previous research by Mitya and his colleagues had hypothesized that wiring of the nervous
system was guided by placement of the neurons in the animal so that the wiring diagram min-
imized the length of the neuronal projections. This so-called wiring minimalization was pro-
posed to be a strong evolutionary force in development of the worm brain, but also for neu-
rons in our own cortex. Now, they have been able to test their model and, remarkably, find
that their computer model fits the actual wiring of a majority of the worm's nervous system.
Thus, computational predictions of how a nervous system is established can have a major role
in understanding how neuronal networks come into being and how they function.
Cold Spring Harbor Laboratory Board of Trustees
As is customary, there were a number of new additions and departures to our Board of
Trustees this year. We were pleased to appoint Dr. Robert Tjian, Howard Hughes Medical
Institute Investigator and Professor in the Department of Molecular and Cellular Biology at
the University of California, Berkeley, to our Scientific Trustees and Henry Wendt, Ill as our
newest Honorary Trustee. Stephen M. Lessing, Managing Director, Lehman Brothers; David
M. Rubenstein, Managing Director, The Carlyle Group; Alan Seligson, NAK International; and
Andrew Solomon also began their terms as Individual Trustees this year.
Sadly, we said good-bye to Honorary Trustee H. Bentley Glass who passed away in
January 2005 at the age of 98. Dr. Glass, one of the Nation's leading biologists, served as
Chairman of the Board of Trustees in the 1960s, during a period of great expansion at CSHL,
and actually convinced Jim Watson to join the Laboratory as its then new Director.
This year, Trudy Calabrese concluded her term as President of Cold Spring Harbor
Laboratory Association (CSHLA), and therefore, her term as a member of the Board of
Trustees. During her term, we saw the Annual Fund reach-and surpass-the $1 million
mark, and we will always be grateful for her dedication and commitment to our organization.
Stepping in to assume the role as President of the CSHLA, we welcomed Joseph T.
Donohue, Managing Director of Gleacher Partners, LLC, to the Board of Trustees.
Hillside Campus Construction
2005 was a watershed year for construction projects at the Laboratory. After more than three
years of planning and legal groundwork, led by Chief Facilities Officer Art Brings, the
Laboratory's Hillside Campus Project began. Art's fantastic work, particularly with the Trustees
of the Village of Laurel Hollow, has enabled the beginning stages of our construction to run
smoothly. Construction progress for the entire project is on schedule, with a targeted com-
pletion date toward the end of 2008. 2005 saw the installation of much of the infrastructure
for the entire project. This includes new roads, electricity, and water access and the con-
struction of a series of drainage sumps that prevent water from directly running off our cam-
pus into the inner harbor of Cold Spring Harbor. This large drainage project reflects thelong-
time commitment by the Laboratory to protect the beautiful waterway that is our namesake.
Senators Dean Skelos, Kemp Hannon, and Carl Marcel lino, and Charles A. Gargano,
Chairman of Empire State Development, were in attendance at a groundbreaking ceremony
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(Left to right) Henry Mund, Charles Gargano, James Watson, Bruce Stillman, Dean Skelos, Carl
Marcel lino, John Cleary, Dill Ayres, and Harry Anand at the groundbreaking ceremony
on July 14 to begin construction on The Center for Bioinformatics at CSHL, solidifying the
efforts to boost the biotech industry on Long Island and celebrating the economic and
employment opportunities created by this funding for all Long Islanders.
In preparation for our expansion, we have reconstructed our Development Office to prepare
for the task of raising funds to build our new space. Chief Development Officer Charles V Prizzi
has done a remarkable job in directing our new efforts to raise funds, increasing our donor base
and exploring new directions in fund-raising, and the department is now running very efficient-
ly and most effectively.
Cancer Center Renewal
The NCI created a network of NCI-designated "Cancer Centers" to spearhead its efforts as
the nation's leading agency that supports cancer research. In 1987, CSHL was approved to
become an NCI-designated Cancer Center to allow expansion of the highly successful can-
cer research program initiated by Jim Watson when he came to Cold Spring Harbor in 1968.
Since then, the CSHL Cancer Center has been one of the leading cancer research centers in
the United States. The large NCI grant must be renewed every 5 years, and I am happy to
report that the CSHL Cancer Center was reviewed again this year and approved for another
5 years of funding. The review characterized virtually all aspects of our Cancer Center as either
"outstanding" or "excellent" and yielded the grant's highest ever priority score. For their efforts
in this vital grant application process, I wish to acknowledge the enormous amount of effort
from Scott Lowe (Professor and Deputy Director, CSHL Cancer Center), Denise Roberts
(Deputy Director of Administration) and her assistant Denise Moller, together with Program
Leaders Greg Hannon, Nick Tonks, and David Spector. I also thank Peter Sherwood (Director
of Research Communications) who assisted with the writing of the introduction and the many
Cancer Center members and staff who contributed to this successful grant renewal.
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Awards and Honors
Scott Lowe
This year, Gregory Hannon and Scott Lowe were among the 43 biomedical
scientists named Howard Hughes Medical Institute (HHMI) Investigators. The
new Investigators were selected from more than 300 nominations drawn from
31 institutions nationwide, representing traditional biomedical research disci-
plines, as well as engineering, physics, chemistry, and computer science. In
addition, both Greg and Scott were honored elsewhere this year. Scott
received Memorial Sloan-Kettering Cancer Center's 2005 Paul Marks Prize for
Cancer Research. This significant award recognizes researchers under the age
of 45 for their major accomplishments in cancer research. Greg was named
the 2005 recipient of the AACR Award for Outstanding Achievement in Cancer
Research, which is given annually to recognize a young investigator on the
basis of meritorious achievement in cancer research. Esquire Magazine also
listed Greg as one of "America's Best & Brightest" in its year-end cover story.
Tatsuya Hirano and I were elected this year as Fellows of the American
Association for the Advancement of Science.
CSHL neuroscientist and Director of Research Holly Cline was selected as a
recipient of the 2005 NIH (National Institutes of Health) Director's Pioneer Award.
Holly was among only 13 winners chosen from a pool of 840 scientists who
underwent a rigorous selection process.
For the fifth consecutive year, the philanthropic evaluator Charity Navigator
has bestowed their highest four-star rating on CSHL for its sound financial prac-
tices. This distinction ranks CSHL among the most responsible of more than
1.5 million philanthropic organizations that exist
Barbara McClintock, the Nobel laureate who spent 50 years doing research at
CSHL, was one of four scientists honored this year with a stamp from the United
States Post Office. Dr. McClintock's work on transposable elements launched a
new era of genetic discovery and this unique honor was well-deserved.
Dolan DNALC and Cold Spring Harbor High School Launch Partnership Program
This fall, Dolan DNALC Executive Director David Mick los initiated a new yearlong course in
molecular genetics in collaboration with Cold Spring Harbor High School. The course is an
advanced lecture and laboratory program open to high school seniors nominated by Cold
Spring Harbor High School's science faculty. Partnership students learn the theory of mole-
cular biology in the classroom and visit the Dolan DNALC every other day to put what they
have learned into practice in the lab.
Development
Fund-raising this year set new heights, and we gratefully acknowledge the following for their
major support of our campus expansion for research infrastructure and education: The Starr
Foundation; The Frederick & Nancy De Matteis Charitable Trust; Clay Mathematics Institute;
Mrs. Leslie C. Quick, Jr. and family; Jeff Hawkins; Nancy Marks; Laurie J. Landeau; Eduardo
Mestre; The William Stamps Farish Fund; William Randolph Hearst Foundation; Gladys and
Roland Harriman Foundation; Francis Goelet Trust; Mr. and Mrs. Robert D. Lindsay; Mr. and
Mrs. Donald Everett Minn; Mary D. Lindsay; Mr. and Mrs. Gerard Leeds; The Koshland
Foundation; Mr. and Mrs. John P. Cleary; and Edward A. Chernoff.
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Private funding is also essential to maintain our vigorous research programs, enabling suc-
cessful projects that are too innovative for public funding. For this reason, we are especially
appreciative to those supporters who made major gifts in 2005 to our cancer and neuro-
science research programs. We gratefully acknowledge donors of $100,000 or more to our
cancer program: The Simons Foundation; The Karches Foundation for CLL Research;
Fannie E. Rippel Foundation for Ovarian Cancer Research; The Frederick & Nancy De Matteis
Charitable Trust for Colon Cancer Research; Joan's Legacy: The Joan Scarangello
Foundation to Conquer Lung Cancer; and The Miracle Foundation.
We also acknowledge the generous support to our neuroscience program including
$100,000+ gifts from Mr. and Mrs. Theodore R. Stanley for schizophrenia research; The
Swartz Foundation for neuroscience research; The Forrest C. Lattner Foundation for
Schizophrenia Research; The Thomas Hartman Foundation; and Jo-Ellen and Ira Hazen.
President's Council
The President's Council brings together leaders from business, research, and biotechnology
who share an interest in science and CSHL's research. Specifically, Council members sup-
port Cold Spring Harbor Laboratory Fellows-exceptional young and recently graduated
Ph.D. or M.D. students who perform independent research at Cold Spring Harbor for a peri-
od of 3 years. This year, President's Council members raised an impressive $400,000 and
established a new record for the annual contributions to this Fund. On page 426 we grate-
fully acknowledge all of the men and women who made this possible.
Robertson Research Fund
The Robertson Research Fund has been the primary in-house support for our scientists for
more than three decades. During 2005, Robertson Funds supported research in the labs of
Alea Mills, Cordula Schultz, Leemor Joshua-Tor, Rui-Ming Xu, and Wolfgang Lukowitz. In
addition, the Robertson Fund supported the annual CSHL In-House Symposium and our
programs for postdoctoral fellows and graduate students.
Sadly, we lost Carl Schafer this year to cancer. Carl was a long-time financial advisor to
the Robertson family and Chairman of the Robertson Research Fund Committee here at
CSHL. We all appreciated his positive and even-handed approach to various issues that
arose over the years in connection with the management of the Robertson Research and
Maintenance Funds. He represented the Robertson family well while, at the same time, mak-
ing it clear that he also had the best interests of the Laboratory at heart. We are appreciative
of all of his efforts on behalf of CSHL and his years of friendship.
Watson School of Biological Sciences
Support of the Dean's Chair, fellowships, and lectureships enable the Watson School to con-
tinue to grow and influence the field of biological sciences. We appreciate new gifts of
$100,000 or more made this year by The Arnold and Mabel Beckman Foundation; Curt
Englehorn; Bristol-Myers Squibb Foundation; the Lita Annenberg Hazen Foundation; and the
Starr Foundation.
Dolan DNA Learning Center
Thanks to a very generous gift from the William and Flora Hewlett Foundation, progress can
continue to be made on Dolan DNALC's newest addition to their Web portal: Genes to
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Cognition (G2C) Online: A Network-driven Internet Site on Modern Brain Research. In addi-
tion, the Dolan DNALC received significant support from the Amgen Foundation for the
Amgen Leadership Program.
Carnegie Library
In 2005, a grant from the Mellon Foundation provided consultants from two major library firms
to assess our library systems and archival collection and to recommend software and com-
puter systems to facilitate our digitization project. In addition, a 2-year $500,000 grant -
Preserving the Past and Present, Looking to the Future: Preserving and Digitizing the Cold
Spring Harbor Laboratory Archives Collections-from the Macy Foundation will allow us to
create an integrated metadata database to provide worldwide online access to our digitized
collection to scholars, students, and all other users. This year, Mila Pollock, our Librarian and
Archivist, organized with Darwin Stapleton from The Rockefeller University and Jan Witkowski,
Executive Director of our Banbury Center, a very successful international archives meeting.
This meeting discussed approaches to maintaining archives in the modern electronic age and
ways of funding the process. We also plan to establish a center for the history of Molecular
Biology and Biotechnology at Cold Spring Harbor as part of our archives program, housing
some of the most important archives at a place that has had a major role in these fields.
Additional Support
The Laboratory was fortunate to receive support for many ongoing projects in 2005 including
a gift from Herbert J. Siegel for the Weghorn House; a gift from the Francis Goelet Trust for
the Francis Goelet Fellowship in Biomathematics; a gift from the Gerber Foundation for con-
genital heart disease research; and a gift from the estate of Florence Strelkowski. We were
also pleased to host a special concert given in Grace Auditorium by Manhattan School of
Music students Victoria Sbarro and Evan Kory on October 16. "Playing for Parkinson's" ben-
efited the Thomas Hartman Foundation for Parkinson's Research, which funds several of our
neuroscience faculty as they investigate possible causes and cures for Parkinson's disease.
Breast Cancer Research Support
An essential aspect to our very successful breast cancer research program is the support we
receive from local grassroots groups who provide direct research support for our program, in
addition to the wonderful services they provide to the breast cancer community. This year, we
were fortunate to receive support from the Breast Cancer Research Foundation; the Miracle
Foundation; the Pierre and Pamela Omidyar Fund; 1 in 9: The Long Island Breast Cancer
Action Coalition; Breast Cancer Help, Inc.; the Cold Spring Harbor Main Street Association;
Dunkin Brands; Find A Cure Today (EA.C.T.); The Islip Breast Cancer Coalition; The Long
Island 2-Day Walk to Fight Breast Cancer, Inc.; Long Islanders Against Breast Cancer
(L.I.A.B.C.); the Manhasset Women's Coalition Against Breast Cancer; Breast Cancer
Awareness Day in memory of Elizabeth McFarland; the Waldbaum Foundation; the Judi Shesh
Memorial Foundation; and the West Islip Breast Cancer Coalition.
Building Projects
In addition to the planned new construction, the Laboratory has completed several building
projects during 2005. The student and postdoctoral fellow housing units at Uplands Farm
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were completed after 2 years of construction and named in memory of long-time Laboratory
friend and supporter Elisabeth (Betty) Livingston. In addition, two existing houses on
Uplands Farm and another across the harbor from our main campus were named for other
long-time supporters William and Irene Miller, Wendy Vander Poel Russell, and George
Cutting. These residences enable our young scientists to live near the campus in affordable
and attractive housing. The Laboratory also purchased a single-family residence adjoining its
campus, renovated it, and rededicated it as the Garden House for use as faculty housing.
Other ongoing projects made significant progress during the year. At Banbury Center, the
pool was reconstructed and the hostess quarters of the Robertson House were renovated.
More than half of the extensive renovations planned for the James Laboratory have been
completed, with the remainder scheduled to be completed in 2006. The renovation of the
Demerec Tissue Culture Facility was completed. The bluestone patios at the front and rear
of the Grace Auditorium were replaced, improving the spaces for our meetings visitors.
Special Events
Symposium
The 70th Symposium-"Molecular Approaches to Controlling Cancer"-once again includ-
ed the annual Dorcas Cummings lecture. Charles Sawyers' outstanding lecture on "Making
Progress through Molecular Attacks on Cancer" was presented to a mixed audience of sci-
entists and lay friends and neighbors of the Laboratory. Following the lecture, more than 20
of our neighbors graciously opened their homes and hosted dinner parties for Symposium
participants and Laboratory friends alike.
Gavin Borden Visiting Fellows
The 11th Annual Gavin Borden Visiting Fellow Lecture-in memory of the publisher of
Molecular Biology of the Cell-was held on Wednesday, March 9. Dr. Huda Zoghbi, a
Professor of Pediatrics, Neurology, Neuroscience, and Molecular and Human Genetics at the
Huda Zoghbi, Bruce Stillman, Lilian Clark Gann
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Baylor College of Medicine, gave this year's lecture entitled "Cross-species Studies to Unfold
the Pathogenesis of a Neurodegenerative Disease."
Public Lectures
The CSHL Cultural Series is a tradition in which an eclectic mix of artists, writers, and scien-
tists present lectures, concerts, and exhibits that provide compelling glimpses of how we
experience, discover, live in, and make sense of our world. Open to the public, the aim of the
Cultural Series is to stimulate, inspire and entertain.
Rodney Brooks
Sept. 13
Sept. 20
Sept. 27
April 19 Nina Federoff, Evan Pugh Professor at Penn State
University: Mendel in the Kitchen: Myths & Realities
of Genetically Modified Food.
May 16 Don Axinn, author of seven volumes of poetry and
two novels: Discussion & Screening of the Film SPIN.
May 17 Rodney Brooks, director of the MIT Computer
Science and Artificial Intelligence Laboratory and the
Fujitsu Professor of Computer Science at MIT: Flesh
& Machines: How Robots Will Change Us.
May 23 Sherwin Nuland, Clinical Professor of Surgery at the
Yale University School of Medicine and Fellow of the
university's Institution for Social and Policy Studies:
The Artist Looks at the Doctor: A Millennium of
Clinical Observation.
May 31 Cynthia Rosenzweig, Senior Research Scientist at
the Columbia University Earth Institute and a profes-
sor of environmental sciences at Barnard College:
The Heat is On: Present & Future Impacts of Global
Warming.
William Li, President, Medical Director and Cofounder, the Angiogenesis
Foundation: Canines & Cancer: New Therapies from & for Man's Best
Friend.
Stephen S. Hall, contributing writer and editor at The New York Times
Magazine: Short People: Biological, Psychological, and Cultural
Considerations.
Diana Reiss, Director of Marine Mammal Research and Conservation at the
New York Aquarium of the Wildlife Conservation Society: Exploring the
Dolphin Mind.
Oct. 11 Steve Squyres, Professor of Astronomy at Cornell University and the
Principal Investigator on the Mars Exploration Rover Project: Life on Mars:
Lessons from the Rovers Spirit & Opportunity
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Concerts
April 24 Gilles Vonsattel, piano
April 30 Benjamin Loeb and Joseph Lin, piano
and violin
May 7 Jennifer Check and Ken Noda, soprano
and piano
May 21 Jose Franch-Ballester, clarinet
August 27 Anton Barakhovsky and Sonya Ovrutsky,
violin and piano
September 10 Timothy Fain, violin
September 17 Dmitri Berlinsky, Elena Baksht, and Suren
Bagratuni, violin, piano and cello
September 24 Elizabeth Joy Roe and Greg Anderson,
four-hands piano
October 8 Jean-Efflam Bavouzet, piano
October 29 Daxun Zhang, bass
Other Lectures
Laboratory Trustee Jeff Hawkins (creator of the Palm Pilot, the
Treo smart phone, and other handheld devices) presented a
fascinating lecture, The World Is a Song: How Music Led to a
Theory of Human Intelligence, based on his latest book, On
Intelligence. The lecture was held in February at The Juilliard
School in New York City.
A panel discussion on Memory-and How to Keep It/-
featuring Ronald Hedgepath, Ph.D., neuropsychologist at St.
John land Nursing Center; Zach Mainen, Ph.D., Associate
Professor at CSHL; Tracey J. Shors, Ph.D., Professor at
Rutgers University; and Trey Sunderland, M.D., Director,
Litwin-Zucker Alzheimer's Research Center, North Shore-LIJ
Health System was held in Grace Auditorium on July 26.
A Memory Board advisory committee, which included Liz
Watson and several community and library staff members, held an event entitled "Memories
under the Moonlight," on July 28 to promote the Library and Archives' new Memory Board
Web site. After a brief presentation by Tim Tully on the scientific aspects of memory, Mila
Pollock described how to navigate the memory board site. The audience had the opportu-
nity to relate their own humorous or poignant anecdotes of the Laboratory, evoking heartfelt
emotions from both Laboratory and local community members, including Jim Watson and
CSHL Honorary Trustee David Luke.
Joseph Lin and Benjamin Loeb
Jeff Hawkins
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Craig Hinkley ("Gene Recipes: How Much Is a Pinch of RNA"), Partha Mitra ("How the
Song Bird Sings"), Sandra Kulhman ("Rhythms in Nature and Our Body: Why Does Your
Stomach Growl at Noon"), and Wolfgang Lukowitz ("Everything You Wanted to Know About
Flowers [But Were Afraid to Ask] ") all participated in our lecture series for fourth- to sixth-
grade students and their parents, co-hosted with the Cold Spring Harbor School District, at
the Dolan DNALC.
Rounding out our year, Dr. Kanta Subbarao, Senior Investigator in the Laboratory of
Infectious Diseases at the National Institute of Allergy and Infectious Diseases, presented a
timely and relevant public lecture, Bird Flu and the Global Threat of Emerging Respiratory
Diseases on December 3.
Exhibits
The 2004 Photographer-in-Residence Reuben Cox exhibited his works in Bush Auditoriumthroughout the month of July. The large-scale photographs of many CSHL researchers werecaptured during his residency the previous summer.
Laboratory Employees
Chancellor News
CSHL Chancellor Jim Watson spent a great deal of time this year traveling to raise funds forCSHL research. In addition, Jim edited and wrote the foreword to Darwin: The IndelibleStamp; The Evolution of an Idea, a seminal volume on the famous biologist. Jim appearedon The Charlie Rose Show with Edward 0. Wilson, the author of another recently releasedbook about Darwin entitled From So Simple a Beginning: The Four Great Books of CharlesDarwin, to discuss creationism, Darwinism, and science education. It was a riveting and verywell-received program.
Jim Watson
New Staff
Sydney Gary, a neuroscientist who worked with Susan Hockfield at Yale, joined the Laboratory
as Assistant Director of the Banbury Center. Sydney is working on developing the neuroscience
and mental health meetings and courses programs, at Banbury and on the main campus.
Promotions
A number of faculty members were promoted in 2005, including Leemor Joshua-Tor, William
Tansey, and Rui-Ming Xu, to Professor; Carlos Brody, Josh Huang, Alea Mills, and Marja
Timmermans to Associate Professor; and Jonathan Sebat to Assistant Professor. Uwe
Hilgert was also named Assistant Director of the Dolan DNALC.
Departures
As was announced last year, Professors Nouria Hernandez and Winship Herr moved to
Switzerland to become professors at a new institute in Lausanne. During the year, Nouria
was named director of the Center for Integrative Genomics. Assistant Professor Masaaki
Hamaguchi left the Laboratory to assume a position at Fordham University.
This year saw the departure of Katya Davies, the long-term hostess at Robertson House at
our Banbury Center. Katya was at the laboratory for 26 years and was known to many scientists
who visited Banbury to attend meetings and courses. Katya created her own style of welcome
for the numerous visitors that will long be remembered. We wish her well in retirement in Maine.
Community Outreach
CSHL sent a team to the fifth annual Pancreatic Cancer Walk at Old Westbury Gardens on July
31. The walk benefited The Lustgarten Foundation, a generous supporter of CSHL's research.
A group of volunteers manned a rest stop at the Long Island 2-Day Walk to Fight Breast
Cancer, a 35-mile walk to benefit several groups across Long Island including CSHL. Our vol-
unteers passed out water and raised spirits during the last legs of their journey.
Laboratory employees donated 489 pounds of assorted food through a food drive run by
the Hauppauge Industrial Association to benefit Long Island Cares. We continued to support
the Ronald McDonald House at Schneider Children's Hospital in New Hyde Park throughout
the year by collecting empty printer, fax, and copy machine ink and toner cartridges, as well
as old cell phones, for the foundation. Proceeds from the sale of these items went directly to
the Ronald McDonald House at Schneider.
Long-term Service
The following employees celebrated milestone anniversaries in 2005:
35 years Madeline Wisnewski
25 years Bruce Fahlbusch, Michael Riggs, Linda Rodgers, Marlene Rubino,
Andrea Stephenson
20 years Frank Carberry, Lisa Manche, David Spector, Wanda Stolen, Harry Wozniak
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(First row, left to right) Michael Riggs, Danuta Slodkowska, Karen McKeon, Barbara Purcell, Dora Merlino,
Marlene Rubino, Lisa Manche, Linda Rodgers, Holly Cline. (Second row, left to right) David Spector, Harry
Wozniak, James Watson, Madeline Wisnewski, Bruce Stillman, Ronald Romani, Frank Carberry, George
Newell, Bruce Fahlbush
15 years June Blanchford, Clare Bunce, Edward Campodonico, Karen McKeon,
Dora Merlino, George Newell, Natalia Peunova, Barbara Purcell,
Ronald Romani, Danuta Slodkowska, Yew Yeo, Nicholas Tonks
Looking Forward
Our new research buildings at CSHL will be in the elegant style that has established the
Laboratory as one of the most attractive research institutes in the world. Although the next
few years of construction will be partially disruptive of our idyllic life of research and scholar-
ship on the shores of Cold Spring Harbor, we look forward to the new facilities providing
much needed research space for our outstanding research programs. I cannot wait until the
new addition to our campus is completed and landscaped.
Bruce Stillman, Ph.D., F.R.S.
President
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CHIEF OPERATING
OFFICER'S REPORT
We are sure to remember 2005 as the year we broke ground on the largest expansion of
the Laboratory's facilities in its 115-year history. This is an enormous undertaking. Five years
of architectural and engineering planning, municipal and environmental reviews and
approvals, and internal strategic and financial planning culminated in a July groundbreaking
ceremony attended by New York State, Nassau County, and Village of Laurel Hollow
leaders and officials.
The process to date has been challenging but remarkably smooth. It has been facilitated
by a diligent but cooperative Board of Trustees in the Village of Laurel Hollow. Centerbrook
Architects have again put forth beautiful and innovative building designs. Chief Facilities
Officer Art Brings and his staff have worked extremely effectively with the municipalities, gov-
ernment agencies, architects, engineers, and contractors to keep the project on time, on
budget, and orderly. If all goes according to schedule, we will be dedicating and opening six
new research buildings on the southern tip of our main campus in the fall of 2008.
Approximately 100,000 square feet of new space will accommodate the expansion of our
research programs in cancer, cognitive neuroscience, and bioinformatics. Fund-raising for
the project is in full swing. Although the cost of infrastructure and buildings is approximately
$100 million, we must devote substantial additional funds to start-up expenses and endow-
ment. This is an ambitious undertaking, but we are encouraged by the generous gifts
received to date. We are grateful for the support, energy, and generosity of the Laboratory's
friends and Trustees who are so critical to the success of these efforts.
2005 also marked another successful year in our core programs. The research continues
to be innovative and of the very highest quality. It has been recognized as such through dis-
tinguished faculty publications, awards, and honors too numerous to mention. Despite grow-
ing competition around the world, our Meetings and Courses program remains the most
impactful and sought after in the field. The Banbury Center and the Dolan DNA Learning
Center are operating at capacity as they each do their part to fulfill the Laboratory's educa-
tional mission. The Watson School of Biological Sciences has now established itself as one
of the most innovative, popular, and successful graduate programs in biology. The Cold
Spring Harbor Laboratory Press had a banner year, with its journals and books contributing
very positively to our cash flow and bottom line.
For the fiscal year ended 12/31/05, the Laboratory budget reached $103 million-a 7%
increase over the prior year and well ahead of forecast. We had expected an operating deficit
for the year, which did not materialize. This is a fortunate and interesting outcome given the
fact that we were concerned up to the end of the year about the funding for the research
program. As is often the case, fundings from grants and from endowment support were not
going to be sufficient to cover the direct cost of the research in 2005. In such years, we must
rely on royalty and licensing income to make up the difference. Fortunately, at year-end 2005,
we received an unexpectedly large royalty payment on an expired patent that allowed us to
cover the annual research budget in its entirety. We also anticipated a shortfall for the year in
our ability to cover our indirect (or overhead) expenses. Despite rigorous and effective efforts
to contain administrative expenses, it did not appear that there would be sufficient indirect
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Consists of full-time a. part-time technical support, core services, publications, meetings, library, public
affairs, building and grounds, administrative, personnel, Banbury Center, and DNA Learning Center
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cost recovery on grants and income from operations to balance the budget after deprecia-
tion and interest expense. Fortunately, this also proved not to be the case. Indirect cost reim-
bursement was greater than budgeted, and the Cold Spring Harbor Laboratory Press had
an excellent year, exceeding its budgeted operating surplus.
Investment returns on our endowment funds were strong for the third consecutive year.
The total return on the portfolio was 7.5% for the calendar year-well ahead of the bench-
mark indices. Our total equity portfolio was up 9.1% as compared to the 4.9% appreciation
in the S&P. This was a result of excellent performances from both our domestic and interna-
tional equity managers. The fixed-income portfolio returned 3.1%, slightly ahead of the
benchmarks. At year end, the market value of the endowment funds totaled $255 million
after taking our customary annual draw of 4%. The Investment Committee continues to work
diligently, under the leadership of Board Treasurer Ed Travaglianti, to establish a well-diversi-
fied portfolio of investments with proven managers and acceptable levels of risk and return.
During the coming year, the Committee will be evaluating the allocation to alternative invest-
ments and deciding whether to increase the exposure to this asset class. Although invest-
ments in private equity, venture capital, real assets, and hedge funds can generate higher
returns and less correlation, they are not always as accessible to endowments our size as
they are to multibillion dollar funds.
Although it is satisfying to report a "balanced budget" for the year, our challenges going
forward should not be underestimated. The cost of doing cutting-edge research is escalat-
ing at a time when the pool of federal funds for research is no longer growing. Operating
costs that are difficult to control, such as utilities, insurance, and healthcare, are increasing
at double-digit rates. To mount a successful fund-raising campaign, we have doubled the
expense of our development office. And in 2006, we anticipate issuing bonds to support the
building project that will more than double our interest expense. All of these hurdles present
themselves at a time when we are undertaking a 40% expansion of our physical plant.
The good news is that Cold Spring Harbor Laboratory continues to distinguish itself by
doing some of the world's best and most important scientific research. And in our experi-
ence, funding follows good research. In periods when public funding is static, we must
increase our efforts to develop private sources of research support. Fortunately, we are
already having success in this effort with names like Simons, Dart, Starr, Davis, Stanley, and
Swartz funding important research initiatives. We must also continue to be creative in our
efforts to commercialize our technology and intellectual property where possible. Our Office
of Technology Transfer, so ably led over the years by John Maroney, has been very proactive
and innovative in this area, allowing us to support research that would not otherwise have
been possible. The future looks bright and exciting, but we have our work cut out for us.
Dill Ayres
Chief Operating Officer
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See previous page for photos of the following scientific staff:
Row 1: Hysall Oviedo; Md Aftabul Hague; Jody Barditch, Florinda
Chaves; Jonathan Kui; Noah Gray, Takashi Sato
Row 2: Christian Speck; Gidon Felsen; Anna Kloc; Lidia Nascimento;
Hongjae Sunwoo; Dominik Duelli; Michael Hueber
Row 3: Prakash Kumar; Min Yu; Alexis Maizel; Yue (Cindy) Wang;
Tal Nawy; Anne Daulny; Joseph Simorowski
Row 4: Jeanne Wiggins; Z. Josh Huang, Caizhi Wu; Kandasamy Ravi;
Darren Burgess; Inessa Hakker; Allison Blum; Benjamin Boettner
Row 5: Mary Kusenda; Rahul Sinha; Ingrid Ibarra; Rebecca Ewald,
Kasandra Burgos; Taneisha James; Wen Xue, Mona Spector
Row 6: Victoria Aranda Calleja; Martin Bayer; Christopher Johns;
Gilbert Henry; Alexandra Lucs; Byeong Ha Lee
Row 7: Theresa Auletta; Ross Dickins; Yi-Chun (Maria) Chen;
Kathryn Bambino; Wei Wei
Row 8: Ray Onn; Oliver Fregoso; Khalid Siddiqui; Ingrid Ehrlich;
Stephen Hearn; Leopoldo Petreanu
CANCER: GENE EXPRESSION
Sometimes complex processes are best studied by stripping them down to their essential components.
Nouria Hernandez has done just that by biochemically reconstituting the process of RNA transcription with
purified proteins in a test tube. These studies revealed the minimum requirements for transcription and
uncovered two new components in the RNA polymerase III transcription pathway, the structural protein
actin and the enzyme casein kinase II (CK2), which Hernandez has subsequently shown can both posi-
tively and negatively regulate transcription.
This year, Leemor Joshua-Tor determined, in collaboration with Greg Hannon, that an enzyme called
Argonaute2 and a guide RNA are all that are needed to carry out the molecular slicing that cuts messen-
ger RNA in an ultimate gene silencing step mediated by RNA interference. However, the researchers also
found that the sliced messenger RNAs produced by Argonaute2 require another unknown protein to assist
their release from the Argonaute2-guide RNA complex. In other work, Joshua-Tor's group revealed new
clues to antimalarial drug design and vaccine development. These findings are based on the determina-
tion, by X-ray crystallography, of the molecular structure of a protein that enables malaria parasites to
invade human red blood cells.
One of the ways cells adapt to various conditions is to produce different proteins from the same genet-
ic message. This is accomplished by a mechanism called alternative splicing in which a single premes-
senger RNA molecule can be spliced in diverse patterns to produce messenger RNAs that encode differ-
ent proteins. Adrian Krainer studies a family of splicing factors called SR proteins that bind to specific sites
on messenger RNAs and recruit the splicing machinery to those sites. Recently, his group discovered that
when present in excess, certain SR proteins can transform cells into a cancerous state. In collaboration
with Scott Powers, Krainer's group is exploring the possibility that the splicing defects they have observed
in human colon tumors identify novel therapeutic targets.
Rui-Ming Xu studies how proteins known to be involved in cancer are also integral parts of the protein
complexes that maintain chromosome structure. By using X-ray crystallography, a tool for determining the
three-dimensional structure of proteins and protein complexes, his group has determined the structures
of a number of human oncoprotein complexes including Bmi-Ring 1B and EMSY-HP1 (the latter involved
in hereditary breast cancer). These structural studies provide important insights into the functions of these
proteins in normal cells and their roles in cancer.
A collaborative effort between Scott Lowe and William Tansey established how particular mutations in
a potent growth control protein called Myc can lead to cancer. The series of Myc mutants the researchers
studied came from patients who had developed Burkitt's lymphoma. Tansey became interested in the
mutants because the corresponding genetic changes led to greatly increased levels of Myc protein in the
cell, a phenomenon he had previously studied. When the scientists recapitulated the behavior of the
human mutant Myc proteins in mice, they discovered that this class of myc mutations inactivates the "pro-
grammed cell death" pathway that normally acts to rid cancerous cells from the body.
Michael Myers is using the accumulated knowledge of how proteins and protein complexes regulate
cell physiology to create global network maps of all the interacting proteins in a cell. These maps display
how protein-protein interactions contribute to normal cell physiology, and how the interactions are dis-
rupted in cancer. His global protein network map is beginning to reveal why cells can tolerate certain kinds
of errors, whereas other defects lead to cancer. Myers aims to understand how such networks generate
robustness (error tolerance) and adaptability in cells.
Jacek Skowronski studies how the AIDS virus exerts control over protein sorting and signaling
machineries in human cells. He has recently identified several human proteins that associate with the AIDS
viral proteins Nef and VprNpx. Skowronski's group is now working to verify these interactions and to
determine their relevance to previously known roles of the Nef and VprNpx accessory factors in AIDS
pathogenesis.
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MECHANISMS OF TRANSCRIPTION
N. Hernandez F. Emran A. Saxena
B. Ma Y. Sun
S. Mayilvahanan C.-C. Yuan
K. Samudre
RNA polymerase III (pol III) synthesizes a collection
of essential RNA molecules that are themselves com-
ponents of the protein synthetic and RNA processing
machineries, such as the ribosomal 5S RNA genes,
tRNA genes, and other genes including the U6 small
nuclear RNA (snRNA) gene. Because most pol III
transcripts are both abundant and stable, pol III tran-
scription is highly regulated with cell growth and pro-
liferation. In resting cells, only the small number of
pol III transcripts that decay over time must be
replaced, and pol III activity is low. In contrast, in
rapidly dividing cells, an entire complement of the
abundant 5S, tRNA, and other molecules must be syn-
thesized in just one generation time, and pol III tran-
scription is highly active. Indeed, pol III transcription
is invariably up-regulated in malignant cells.
pol III can be recruited to three main classes of
promoters. Classes I and II are present in the 5S RNA
and tRNA genes, respectively, and are gene-internal.
These promoters recruit a multisubunit complex
known as TFIIIC, either directly in the case of the
class II promoters or with the help of another tran-
scription factor known as TFIIIA in the case of class I
promoters. TFIIIC in turn recruits Brfl-TFIIIB, an
activity containing the TATA-box-binding protein
TBP, the TFIIB-related factor Brfl, and the SANT
domain protein Bdpl. The resulting protein/DNA
complex can then specifically recruit pol III. Class III
promoters are present in the human U6 snRNA genes
and other genes and are gene-external. They consist of
two essential elements, a proximal sequence element
(PSE) and a TATA box. Transcription from class III
promoters can be reconstituted in vitro with recombi-
nant snRNA-activating protein complex (SNAP), a
PSE-binding factor composed of five types of sub-
units; recombinant Brf2-TFIIIB, an activity similar to
Brfl-TFIIIB but in which Bfrl is replaced with Brf2;
and a highly purified pol III complex isolated from
He La cells expressing a doubly tagged pol III subunit.
When combined, these factors are sufficient to direct
several rounds of correctly initiated and terminated
transcription from the U6 promoter.
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Class III promoters are remarkable in that they are
highly similar to the promoters of many snRNA genes
such as the human Ul and U2 snRNA genes, which
are recognized by pol II. The Ul and U2 core promot-
ers contain a PSE but they lack the TATA box that
characterizes the pol III class III promoters.
Transcription from the Ul and U2 promoters requires
TBP, TFIIB, and many of the other factors required for
pol II transcription from the classical pol II promoters,
those that direct the transcription of mRNA-encoding
genes. We are interested in understanding the mecha-
nisms that govern the regulation of pol III transcrip-
tion, as well as those that ensure recruitment of the
correct RNA polymerase.
FACTORS IMPLICATED IN THE REGULATION
OF sNRNA GENE TRANSCRIPTION
In an attempt to identify regulators of snRNA gene
transcription, we generated cell lines expressing
tagged SNAP, subunits and used these cell lines to
purify SNAP, and associated polypeptides by tag
affinity chromatography. Our results indicate that
SNAP, is associated with Yin-Yang-1 (YY1), a factor
implicated in both activation and repression of tran-
scription. Recombinant YY1 accelerates the binding
of SNAP, to the PSE. Moreover, it enhances formation
of a complex on the U6 snRNA promoter containing
SNAP TBP, Brf2, and Bdpl, as well as that of a sub-
complex containing TBP, Brf2, and Bdpl. YY1 is
found on both the pol II Ul and pol III U6 promoters
as determined by chromatin immunoprecipitations.
Thus, YY1 represents a new factor that participates in
transcription complexes formed on both pol II and pol
III promoters.
THE DETERMINATION OF RNA POLYMERASE
SPECIFICITY
The transcription factors TFIIB, Brfl, and Brf2 share
related amino-terminal zinc ribbon and core domains;
however, as described above, TFIIB bridges pol II with
the promoter-bound preinitiation complex, whereas
Brfl and Brf2 are involved, as part of Brfl-TFIIIB and
Brf2-TFIIIB, in the recruitment of pol III. Brfl and
Brf2 both have a carboxy-terminal extension absent in
TFIIB, but their carboxy-terminal extensions are unre-
lated. In yeast Brfl, the carboxy-terminal extension
interacts with the TBP/TATA box complex and con-
tributes to the recruitment of Bdpl. The role of the
carboxy-terminal extension of Brf2, if any, was
unknown.
To understand how the U6 promoter can specifi-
cally recruit pol III, we tested truncated Brf2 as well as
Brf2/TFIIB chimeric proteins for U6 transcription and
for assembly of U6 preinitiation complexes. Our
results characterized functions of various human Brf2
domains and revealed that the carboxy-terminal
domain is required for efficient association of the pro-
tein with U6 promoter-bound TBP and SNAP, and for
efficient recruitment of Bdp I. Close inspection of the
carboxy-terminal domain of Brf2 revealed that the car-
boxy-terminal region of Brf2 contains a short region
that can be aligned with conserved region II of Brfl,
the Brfl region required for efficient binding to the
TBP/TATA box complex. The results suggest that a
common feature among TFIIB family members
involved in pol III transcription is the use of their car-
boxy-terminal extension to associate efficiently with a
TBP/TATA box complex and to recruit Bdpl. This in
turn suggests that the carboxy-terminal extensions in
Brfl and Brf2 are key to specific recruitment of pol III
over pol II.
RNA polymerase specificity is, then, determined
at two levels. The first level is the arrangement of the
promoter elements themselves. In the human snRNA
promoters, it is the presence or absence of a TATA box
downstream from the PSE that largely determines pol
III or pol II transcription, respectively. This in turn
somehow results in the specific recruitment of either
TFIIB in the case of poi II snRNA promoters or Brf2
in the case of pol III snRNA promoters. Ironically, we
do not yet understand how the presence of a TATA box
specifies Brf2 recruitment over TFIIB recruitment.
Indeed, we find that it is possible to assemble effi-
ciently a complex containing TBP, SNAP,, and TFIIB
on the U6 promoter. It seems likely that in human
cells, so far unidentified factors associated with either
TFIIB, Brfl, TBP, or SNAP, prevent assembly of
TFIIB and/or favor assembly of Brf2 into the U6 initi-
ation complex.
The second level of RNA polymerase specificity
determination is protein-protein interactions among
factors recruited by the promoter elements. Thus, even
though the U6 promoter is capable of assembling com-
plexes containing either TBP, SNAP,, and TFIIB or
TBP, SNAP and Brf2, only the latter complex is
capable of recruiting Bdp I. Moreover, the carboxy-
terminal domain of Brf2 may also be involved in the
recruitment of pol III. With yeast Brfl, the carboxy-
terminal domain of the protein has been shown to
associate with the yeast pol III subunit C34, which has
no counterpart in pol II. Thus, the carboxy-terminal
extensions present in the TFIIB family members
involved in RNA pol III transcription, i.e., Brfl and
Brf2, are key to favoring recruitment of pol III over
that of pol II because they allow recruitment of Bdpl
and, probably, of pol III itself through pol III-specific
subunits.
PUBLICATIONS
Kim Y.-S., Kim J.-M., Jung D.-L., Kang J.-E., Lee S., Kim J.S.,
Seol W., Shin H.-C., Kwon H.S., Van Lint C., Hernandez N.,
and Hur M.-W. 2005. Artificial zinc-finger fusions targeting
Sp1 binding sites and trans-activator-responsive element
potently repress transcription and replication of HIV-1. J.
Biol. Chem. 280: 21545-21552.
Saxena A., Ma B., Schramm L., and Hernandez N. 2005.
Structure-function analysis of the human TFIIB-related fac-
tor II protein reveals an essential role for the C-terminal
domain in RNA polymerase Ill transcription. Mol. Cell. Biol.
25: 9406-9418.
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STRUCTURAL BIOLOGY OF NUCLEIC ACID REGULATORY
PROCESSES
L. Joshua-Tor D. Chitwood
E. Enemark
H. He
P.R. Kumar
P. O'Farrell
S. Smith
J.-J. Song
T. Takara
N. Tolia
We study the molecular basis of cell regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their interactions
with other molecules. Biochemistry and molecular
biology allow us to study properties that can be corre-
lated with protein structure and function. Our efforts
largely center on protein complexes involved in nucle-
ic acid regulatory processes.
Mechanisms of RNAi
N. Tolia, J.-J. Song, D. Chitwood, S. Smith [in collaboration
with G.J. Hannon, Cold Spring Harbor Laboratory]
The introduction of exogenous double-stranded RNA
(dsRNA) into a cell can trigger the gene-silencing
process called RNA interference or RNAi. An RNase
III family enzyme, Dicer, initiates silencing by releas-
ing about 20 base duplexes, with 2-nucleotide 3' over-
hangs called short interfering RNAs (siRNAs). The
RNAi pathway also mediates the function of endoge-
nous, noncoding regulatory RNAs called microRNAs
(miRNAs). Both miRNAs and siRNAs guide substrate
selection by similar if not identical effector complexes
called RISC (RNA-induced silencing complex). These
contain single-stranded versions of the small RNA and
additional protein components. Of those, the signature
element, which virtually defines a RISC, is a member
of the Argonaute family of proteins. In a central RNAi
pathway, guided by the siRNA, RISC directs the cleav-
age of mRNA substrates. We embarked on structural
and biochemical studies of key proteins in the RNAi
pathway, the protein-RNA and protein-protein interac-
tions involved. Last year, we determined the structure
of a full-length Argonaute protein from Pyrococcus
furiosus and demonstrated its similarity to RNase H.
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This led us to propose that Argonaute functions as the
important "Slicer" in RISC and suggested a mecha-
nism for siRNA-guided mRNA cleavage. This was
tested in the mammalian system, by mutational analy-
sis of hAgo2 as guided by our structure.
This year, we developed an expression system for
hAgo2 in Escherichia coli. This provided an important
opportunity to examine which features of RISC activ-
ity reside in Argonaute itself and which must reside
elsewhere, which we have done in collaboration with
Greg Hannon's lab here at CSHL. First, we learned
that hAgo2 and an siRNA guide are all that is needed
to carry out slicing. The 5' phosphate of the siRNA is
important for enzyme stability as well as RISC fideli-
ty. Single turnover kinetics for this minimal enzyme
are remarkably similar to those determined for RISC
from either flies or human cell extracts, indicating that
other factors are not needed to assist in binding and
cleavage. However, an ATP dependence on turnover,
characteristic of more complete RISC complexes, is
absent from this minimal form, indicating that anoth-
er protein assists in product release using ATP. Such a
factor may trigger domain movement in Argonaute, a
feature that is intimated from the various structures
described above.
The DNA-binding and Assembly
of the Papillomavirus Initiator
Protein El
E. Enemark, H. He [in collaboration with A. Stenlund,
Cold Spring Harbor Laboratory]
Infection with the human papillomavirus (HPV) is the
most common sexually transmitted disease, with an
infection rate of above 40% in the college-aged popu-
lation. Women with persistent infections from certain
types of HPV are at risk for cervical cancer, as 99% of
cervical cancers around the world are associated with
HPV infection. The papillomavirus El protein belongs
to a family of multifunctional viral proteins whose
main function is related to viral DNA replication.
These proteins bind to the origin of DNA replication
(ori), melt the DNA duplex, possess DNA helicase
activity, and recruit other cellular replication proteins.
We are pursuing structural and biochemical studies of
El, its DNA-binding activity, and its assembly on
DNA. The relative simplicity of this system also allows
examination of the general mechanistic features of
DNA replication. Because a single protein encompass-
es all key events in replication initiation through dif-
ferent oligomeric forms, this system provides a great
opportunity to examine these events on a mechanistic
and atomic level. These studies can also provide a basis
for the development of clinical intervention strategies.
The initial binding of an El dimer together with E2
serves to recognize the double-stranded on with high
specificity. The subsequent binding of additional El
molecules leads to ori melting. Ultimately, two hexam-
eric rings are formed on the ori that can unwind the
DNA double helix. Thus, the transition between these
complexes represents a transition from a tethering
function for El to a function that modifies the DNA
structure. In collaboration with Arne Stenlund's group
here at CSHL, we embarked on structural studies to
provide high-resolution structural information about
El, its DNA-binding activity, and its assembly on
DNA. Initially, we solved the structure of the unbound
DNA-binding domain (DBD) of El from BPV-1
(bovine papillomavirus type 1) and characterized the
DNA-binding surfaces. We also suggested a model for
binding of the initial dimer to the origin and found the
dimerization surface to be essential for replication in
vivo. We have also solved the structure of the DBD
from a high-risk papillomavirus, HPV-18, which is
associated with poor prognosis in cervical cancer
patients, and characterized its DNA-binding and
dimerization properties toward further studies in drug
design. These DBDs are now part of a growing family
of viral initiator proteins with similar structures.
More recently, we have captured structural snap-
shots of two sequential steps in the assembly process,
with structures of both the dimeric and tetrameric
forms of the El -DBD bound to the origin DNA. We
found that the mode of DNA binding employed by El
partitions the two individual DNA strands onto dis-
tinct binding surfaces of the protein. This suggests
how El ultimately progresses from a double-stranded
origin recognition complex to a hexameric helicase
where the two strands are fully separated, and each
strand is encircled by a hexameric ring. We are cur-
rently studying the hexameric form of the helicase
itself and its interaction with DNA.
These studies would provide general insight into
the biochemical events that are involved in viral DNA
replication. They can also provide a basis for the devel-
opment of clinical intervention strategies. Second, the
viral DNA replication machinery itself represents an
obvious target for antiviral therapy, and detailed infor-
mation such as high-resolution structures of viral pro-
teins required for replication will greatly facilitate the
development and testing of antiviral agents.
Erythrocyte Invasion by
the Malaria Parasite
N. Tolia [in collaboration with B.K.L. Sim, Protein Potential]
Malaria causes approximately 400 million clinical
cases and two million deaths annually, with more than
80% of deaths occurring among children. The disease
is caused by mosquito-borne parasites of the genus
Plasmodium (primarily Plasmodium falciparum).
Following the initial stages of infection, merozoite-
stage parasites ("merozoites") invade red blood cells,
leading to clinical symptoms and, in many cases, death.
This past year, we reported on a crystal structure
of an important protein from the malaria parasite,
Plasmodium falciparum. All of the pathological and
clinical manifestations of the disease are caused by
the blood (erythrocytic)-stage form of the parasite,
the merozoite. Thus, disruption of the invasion of
erythrocytes by merozoites might help in controlling
this disease. P. falciparum displays a family of pro-
teins that bind to host-cell receptors during invasion
and also sequestration, where the infected blood cells
bind to the capillaries of host tissues, which in turn
may result in particularly severe pathologies such as
cerebral malaria. Our structure, of the erythrocyte-
binding domain (RH) of the erythrocyte-binding
antigen, EBA-175, was solved with and without a
glycan that contains the essential components of the
receptor required for binding (Fig. 1). This is the first
structure of this important family of proteins. The
dimeric organization of RII mimics a handshake and
displays two prominent channels. The RH dimer
appears to grip the glycans that are bound to the
dimer interface and contact both monomers. These
structures provide insight into the mechanism of
erythrocyte invasion by the malaria parasite (Fig. 2)
29
FIGURE 1 Crystal structure of All with sialyllactose. (A) Ribbon representation of the dimeric structure
of RIl. The monomers are shaded in different intensities and are composed of two subdomains, Fl
and F2. Two channels are created in the center of the molecule. Glycan positions are shown in Fo-Fe
electron density. (8) Close-up views of three of the glycan binding sites-1, 3, and 5, from left to right.
Residues from both monomers contact each glycan.
P. falciparum membrane
GpA GpA
Erythrocyte membrane
FIGURE 2 (Top) P falciparum membrane; (bottom) erythrocyte
membrane. The receptor-binding domain of EBA-175, Fill, is
shown as a surface representation. Lines above the surface
represent portions of the EBA-175 backbone not included in
the crystal structure. The receptor glycophorin A (GpA) is
shown at the bottom with the membrane-spanning region in
detail using the nuclear magnetic resonance (NMR) structure
and the extracellular domain drawn as a schematic flexible line.
In the left panel, the All dimer assembles around the GpA dimer,
with GpA binding within the channels. An alternative model is
shown on the right, where the GpA monomers dock on the
outer surface of the protein, feeding glycans into the channels.
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and enable the search for small-molecule inhibitors
that can block the interactions of these types of pro-
teins to their receptors either directly or by blocking
dimerization, as well as more efficient vaccine
design based on these proteins.
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RNA SPLICING
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MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE -MRNA SPLICING
RNA splicing is an essential step in the expression of
most eukaryotic protein-coding genes. The spliceosome
selects and pairs authentic splice sites with extremely
high fidelity, which requires precise interpretation of
limited and dispersed sequence information present
throughout introns and exons. In humans, about 75% of
genes are expressed via alternative splicing, giving rise
to multiple protein isoforms. The choice of alternative
splice sites is commonly regulated to alter gene expres-
sion, either tissue-specifically or in response to a devel-
opmental program or to signaling pathways. The fact
that multiple protein isoforms can be expressed from
individual genes demonstrates that the classical "one
gene-one enzyme" paradigm is no longer valid and
provides an explanation for the unexpectedly small num-
ber of genes uncovered by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well as
RNA components that are part of small nuclear ribonu-
cleoprotein (snRNP) particles. The work in our lab
focuses primarily on the identification and molecular
characterization of protein factors and sequence ele-
ments that are necessary for the catalysis and fidelity of
splicing and/or for the regulation of alternative splice site
selection. We are interested in how the spliceosome cor-
rectly identifies the exons on pre-mRNA, and how cer-
tain point mutations in either exon or intron sequences
cause aberrant splicing, leading to various genetic dis-
eases. Some of the splicing factors we study have addi-
tional cellular functions, e.g., reflecting their nucleic-
acid-binding properties or localization in multiple cellu-
lar compartments, and we are interested in some of these
nonsplicing functions as well. A brief summary of six of
our recently published studies is given below.
NOVEL LKB1 SPLICING MUTATION ASSOCIATED WITH
PEUTZ-JEGHERS SYNDROME
In collaboration with N. Resta, A. Stella, and G.
Guanti (University of Bari, Italy), we characterized a
P. Smith
S. Sun
Z. Zhang
novel splicing mutation associated with Peutz-Jeghers
syndrome (PJS). PJS is an autosomal dominant disor-
der associated with gastrointestinal polyposis and
increased cancer risk. PJS is caused by germ-line
mutations in the tumor suppressor gene LKBI, which
encodes a protein kinase. One familial mutation,
IVS2+1A>G, alters the second intron 5' splice site,
which has sequence features of a U12-type AT-AC
intron. This rare type of intron normally begins with
either A or G. We found that in patients, LKBI RNA
splicing occurs from the mutated 5' splice site to sev-
eral cryptic, noncanonical 3' splice sites immediately
adjacent to the normal 3' splice site. In vitro splicing
analysis demonstrated that this aberrant splicing is
mediated by the U12-dependent spliceosome. These
results indicate that the minor spliceosome can use a
variety of 3' splice site sequences to pair to a given 5'
splice site, albeit with tight constraints for maintaining
the 3' splice site position. The unusual splicing defect
associated with this PJS-causing mutation uncovered
interesting differences in splice site recognition
between the major and minor pre-mRNA splicing
pathways.
REGULATION OF HNRNP Al SHUTTLING BY
PHOSPHORYLATION
Heterogeneous nuclear ribonucleoprotein (hnRNP) Al
is an abundant RNA-binding protein involved in the
regulation of alternative splicing and other cellular
processes. hnRNP Al is mainly nuclear, although it
shuttles rapidly between nuclear and cytoplasmic com-
partments. Genotoxic stress, such as osmotic shock,
activates the MKK3 /6 -p38 signaling pathway, which
in turn results in accumulation of hnRNP Al in the
cytoplasm. This effect modulates alternative splicing
regulation in vivo-by decreasing the level of nuclear
hnRNP Al-and correlates with increased hnRNP Al
phosphorylation. In collaboration with J. Caceres
(Edinburgh), M. Myers (CSHL), and J. Moscat
(Madrid), we have characterized the molecular mech-
anism involved in the cytoplasmic accumulation of
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hnRNP Al in cells subjected to osmotic shock. This
treatment results in serine-specific phosphorylation
within a carboxy-terminal peptide, dubbed the "F pep-
tide," which is adjacent to the M9 motif that mediates
bidirectional transport of hnRNP Al . Analysis of
mutants in which the F-peptide serines were replaced
by aspartic acids or alanines showed that F-peptide
phosphorylation is required for the subcellular redis-
tribution of hnRNP Al in cells subjected to osmotic
shock. Furthermore, we showed that F-peptide phos-
phorylation modulates the interaction of hnRNP Al
with transportin Trnl. These findings suggest that the
phosphorylation of F peptide by signaling pathways
regulates the rate of hnRNP Al nuclear import.
DETERMINANTS OF 5" SPLICE SITE STRENGTH
We previously showed that the authentic 5' splice site
of the first exon in the human 13-globin gene is intrin-
sically stronger than a cryptic 5' splice site located 16
nucleotides upstream. In an ongoing collaboration
with R. Sachidanandam (CSHL) we have now exam-
ined by mutational analysis the contribution of indi-
vidual 5' splice site nucleotides to discrimination
between these two 5' splice sites. On the basis of the
in vitro splicing efficiencies of a large panel of the
wild-type and mutant substrates in two separate 5'
splice site competition assays, we established a hierar-
chy of 5' splice sites and grouped them into three
functional subclasses: strong, intermediate, and weak.
Competition between two 5' splice sites from different
subclasses always results in selection of the 5' splice
site belonging to the stronger subclass. Moreover,
each subclass has different characteristic features.
Strong and intermediate 5' splice sites can be distin-
guished by their predicted free energy of base pairing
to the U 1 small nuclear RNA (snRNA) 5' terminus
(AG). The extent of splicing via the strong 5' splice
sites correlates well with the AG, but this is not the
case for competition between intermediate 5' splice
sites. Weak 5' splice sites were used only when the
competing authentic 5' splice site was inactivated by
mutation. These results indicate that extensive com-
plementarity to Ul snRNA exerts a dominant effect
for 5' splice site selection, but in the case of compet-
ing 5' splice sites with similarly modest complemen-
tarity to Ul, the role of other 5' splice site features is
more prominent. This study reveals the importance of
additional submotifs present in certain 5' splice site
sequences, whose characterization will be critical for
understanding 5' splice site selection in human genes.
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GENOME-WIDE ANALYSIS OF SR PROTEIN EXONIC
SPLICING ENHANCER MOTIFS
Exonic splicing enhancers (ESEs) are pre-mRNA cis-
acting elements required for splice site recognition. In
collaboration with M. Zhang here at CSHL, we previ-
ously developed a Web-based program called
ESEfinder that scores any sequence for the presence
of ESE motifs recognized by the human SR proteins
SF2/ASF, SRp40, SRp55, and SC35 (http://rulai.cshl.
edu/tools/ESE/). Using ESEfinder, we have undertak-
en a large-scale analysis of ESE motif distribution in
human protein-coding genes. Significantly higher fre-
quencies of ESE motifs were observed in constitutive
internal protein-coding exons, compared with both
their flanking intronic regions and with pseudoexons.
Statistical analysis of ESE motif frequency distribu-
tions revealed a complex relationship between splice
site strength and increased or decreased frequencies of
particular SR protein motifs. Comparison of constitu-
tively and alternatively spliced exons demonstrated
slightly weaker splice site scores, as well as signifi-
cantly fewer ESE motifs, in the alternatively spliced
group. Our results underline the importance of ESE-
mediated SR protein function in the process of exon
definition, in the context of both constitutive splicing
and regulated alternative splicing.
MECHANISMS OF EXON RECOGNITION IN THE SPINAL
MUSCULAR ATROPHY GENES
Spinal muscular atrophy is a neurodegenerative genetic
disorder caused by the deletion or mutation of the sur-
vival-of-motor-neuron gene, SMN1. An SMNI paralog,
SMN2, differs by a C-to-T transition in exon 7 that caus-
es substantial skipping of this exon, such that SMN2
expresses only low levels of functional protein. A better
understanding of SMN splicing mechanisms should
facilitate the development of drugs that increase sur-
vival motor neuron (SMN) protein levels by improving
SMN2 exon 7 inclusion. In addition, exonic mutations
that cause defective splicing give rise to many genetic
diseases, and the SMN1/2 system is a useful paradigm
for understanding exon identity determinants and alter-
native splicing mechanisms. Skipping of SMN2 exon 7
was previously attributed either to the loss of an
SF2/ASF-dependent exonic splicing enhancer or to the
creation of an hnRNP A/B-dependent exonic splicing
silencer, as a result of the C-to-T transition. We exten-
sively tested the enhancer-loss and silencer-gain models
by mutagenesis, RNA interference, overexpression,
RNA splicing, and RNA-protein interaction experi-
ments. Our results support the enhancer-loss model but
also demonstrate that hnRNP A/B proteins antagonize
SF2/ASF-dependent ESE activity and promote exon 7
skipping by a mechanism that is independent of the C-
to-T transition and is therefore common to both SMN1
and SMN2. These findings explain the basis of defective
SMN2 splicing, illustrate the fine balance between pos-
itive and negative determinants of exon identity and
alternative splicing, and underscore the importance of
antagonistic splicing factors and exonic elements in a
disease context.
ROLE OF HNRNP Al IN TELOMERE LENGTH
REGULATION
Telomerase is a ribonucleoprotein enzyme complex
that reverse-transcribes an integral RNA template to
add short DNA repeats to the 3' ends of telomeres. G-
quadruplex structure in a DNA substrate can block its
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extension by telomerase. In collaboration with R.-M.
Xu here at CSHL, we found that hnRNP Al -which
was previously implicated in telomere-length regula-
tion-binds to both single-stranded and structured
human telomeric repeats, and in the latter case, it dis-
rupts their higher-order structure, which is probably an
intermolecular dimeric G quadruplex. Using an in
vitro telomerase assay, we observed that depletion of
hnRNP A/B proteins from HEK293 cell extracts dra-
matically reduced telomerase activity, which was fully
recovered upon addition of purified recombinant
hnRNP Al (Fig. 1). This finding suggests that hnRNP
Al functions as an auxiliary, if not essential, factor of
telomerase holoenzyme. We also showed, using chro-
matin immunoprecipitation, that hnRNP Al associates
with human telomeres in vivo. We proposed that
hnRNP Al stimulates telomere elongation through
unwinding of a G quadruplex or G-G hairpin structure
formed at each translocation step, thereby enhancing
the repeat-addition processivity of telomerase.
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FIGURE 1 Effect of depletion and add-back of
hnRNP NB proteins on telomerase activity.
Telomerase extracts prepared from HEK293 cells
were incubated with immobilized, 5"-biotinylated sin-
gle-stranded DNA with three human telomeric
repeats, (TTAGGG)3, to generate extracts depleted
of components that bind tightly to these repeats. (/4)
Western blot showing the successful depletion of
hnRNP Al and A2 from the telomerase extracts.
Monoclonal antibodies were used for detection of
hnRNP Al, hnRNP Al /A2, and hnRNP Cl /C2. (8)
Silver staining of telomerase extracts before and
after depletion of hnRNP NB proteins. M, markers
(sizes indicated at left). (C) RT-PCR detection of
telomerase RNA (hTR) before and after depletion of
hnRNP NB proteins. RNA was purified from the
extracts and from the material bound to the beads,
and hTR and control U6 RNAs were detected by
RT-PCR (lanes 2-4). Control reactions without
reverse transcriptase are also shown (lanes 5-7).
The PCR products corresponding to hTR and U6
snRNA are indicated. The asterisk denotes an
unknown product that was also amplified with the
hTR primers. (D) Telomerase activity in the presence
and absence of hnRNP NB proteins. The indicated
recombinant proteins (5 pmoles) were added to the
depleted extract individually. For every condition,
RNase A was added as a control in the indicated
lanes to destroy the telomerase RNA. Telomerase
activity was measured by TRAP (telomeric repeat
amplification protocol). (M) DNA markers (sizes indi-
cated at left); (IC) internal control PCR product. (E)
Titration of recombinant hnRNP Al to show the
concentration dependence of telomerase stimulato-
ry activity. The amounts of hnRNP Al used for lanes
4-6 were 0.16, 0.63, and 2.5 pmoles, respectively.
U6 RNA
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PROTEOMICS
M. Myers R. Bish L.L. Schmidt
0. Fregoso C. van der Meijden
D. Perkowski
The completion of the human genome has ushered in
a new age of biological discovery. This accomplish-
ment has essentially identified all of the players gov-
erning human biology. The important work of assign-
ing functions to this myriad of proteins has become
one of the principal tasks of modern biology. Although
many functions will be assigned using genetics or
bioinformatics, the majority of this functional charac-
terization will be performed by proteomics.
The goal of our laboratory is to understand how
proteins and protein complexes regulate cellular
behavior. In the environment of a cell, almost all of the
proteins can be found in a highly interactive network.
Our laboratory is focused on understanding the global
architecture of this network and how this network gen-
erates robustness (error tolerance) and adaptability to
the system and how this network is altered to produce
and survive complex diseases, such as cancer.
Optimization of Protein
Identification
D. Perkowski, L.L. Schmidt
Protein identification is the major tool of proteomics.
We have been optimizing mass spectrometry (MS) for
protein identification. MS has many advantages over
other techniques for protein identification, especially
its sensitivity. However, the improved sensitivity
comes at a price, because the sample preparation
becomes increasingly important to ensure success. We
have been optimizing a number of parameters to
increase this success rate.
As part of the optimization, we have found that
nanoscale chromatography gives the best sensitivity.
Using conventional chromatography media (packed
beds of small, functionalized beads), we have been
fabricating our own nanoscale (75-1.tm internal diame-
ter) columns that operate at flow rates of 200-500
nl/min. The sensitivity and resolution of these nano-
scale columns are related to their internal diameter.
However, the internal pressures required for chro-
matography increase dramatically as diameter
decreases, limiting the practical utility of miniaturiz-
ing conventional chromatography media. To overcome
the pressure problem, we have developed a meso-
porous, monolithic chromatography media that is well
suited for miniaturization. Monolithic medium is com-
posed of a single, highly cross-linked entity that is
formed during the polymerization of silicas (sol-gels)
or organic polymers (plastics). Although these meso-
porous materials offer significant advantages when
analyzing relatively simple mixtures (a few hundred
components), we have found them to be unsuitable for
use for the analysis of complex mixtures (greater than
1000 components). This is largely due to the greater
peak capacity of beaded chromatography media. We
are currently trying to imbed beaded media into the
mesoporous material to produce a composite material
that has the benefits of both materials.
In addition to improving the chromatographic sep-
aration, we have been attempting to improve the sam-
ple preparation before chromatographic separation. In
the past, we relied on small reverse-phase columns for
sample cleanup and concentration. However, these
columns are difficult to customize to sample amount,
sample volume, and optimal type of purification
required (ion exchange, reverse phase, normal phase,
HILIC, IMAC, etc.). Therefore, we have focused on
developing a microbead-based sample preparation
strategy. We can customize the amount of microbeads
and the time of binding to suit the scale of purification
needed and we can change the type of purification by
changing the chemistry on the microbeads. We have
found that for most analyses, the microbead format
performs as well as our current microcolumn format.
Importantly, the microbead format also increases the
throughput of sample prep, allowing many more sam-
ples to be processed simultaneously, and we are cur-
rently attempting to place the microbeads directly in
line with nanoscale chromatography. The in-line analy-
sis is expected to result in a significant increase in sen-
sitivity and throughput, especially in cases requiring
complex, multidimensional (i.e., MuDPIT) analysis.
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Monitoring Posttranslational
Modifications
L.L. Schmidt, D. Perkowski
One of the challenges in the postgenomic era is to
understand how proteins are regulated by posttransla-
tional modifications. These modifications are responsi-
ble for controlling the activity of proteins and ultimate-
ly determining how a cell responds to its environment.
Phophorylation is considered to be the most common
posttranslational modification, and its wide use as a
regulatory mechanism has been attributed to its
reversible nature. Alterations in protein phosphorylation
have been shown to be the hallmark of many patholog-
ical conditions including cancer and diabetes.
Therefore, efficient identification of phosphorylated
proteins, as well as mapping the specific phosphoryla-
tion sites, has become one of the primary goals of pro-
teomics. We have been attempting to develop sensitive
and robust MS methods for characterizing this impor-
tant posttranslational modification. Characterization of
phosphorylated residues is complicated by three attrib-
utes of phosphorylation: (1) phosphorylation suppress-
es peptide detection by mass spectrometry, (2) phos-
phorylation is generally substoichiometric, and (3)
phosphorylated residues readily undergo neutral loss of
the phosphoryl group. We have expended a significant
effort exploring why phosphorylation suppresses pep-
tide signals during MS. Conventional wisdom dictates
that the poor signal of phosphopeptides was due solely
to their strong negative charge. Our analysis indicated
that this is not the case. For example, phosphorylated
peptides are equally suppressed regardless of whether
positive or negative ions are detected, and sulfated pep-
tides (which carry a similar strong negative charge) do
not exhibit the same suppression as their phosphorylat-
ed cousins. Our results suggest that the suppression of
phosphopeptides is likely the result of a combination of
the poor volatility of the phosphoryl group and/or insta-
bility of the phosphopeptides in the gas phase. We have
performed an exhaustive search for conditions that alle-
viate this suppression and have found that switching the
MALDI (matrix-assisted laser desorption ionization)
matrix provides a significant improvement in the detec-
tion of phosphorylated peptides. The most commonly
used matrix compounds, CHCA and DHB typically
result in a 10- to 100-fold suppression of signal from
phosphorylated peptides. However, trans-3-indole
acrylic acid only results in an approximately 1.5-fold
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reduction in signal from phosphorylated peptides.
Importantly, 3-indole acrylic acid is typically used for
the analysis of poorly volatile, nonpolar compounds,
which likely accounts for why 3-indole acrylic acid alle-
viates the suppression usually seen in the analysis of
phosphorylated peptides.
"Small World" Proteomics
R. Bish, C. van der Meijden [in collaboration with
R. Sachidanandam, Cold Spring Harbor Laboratory]
We have modeled the data from several high-through-
put protein interaction screens as a network. We have
chosen to model these data as a network because it is
one of the only ways to make sense of these large and
complicated data sets. In this model, each protein is
treated as a node, and the interactions are treated as
links between the nodes. In this way, the yeast protein
network ends up looking very similar to the network
of computers that make up the World Wide Web or the
network of human social interactions that make this a
"small world." On the basis of the network properties
of the yeast protein network, we have been able to
classify the yeast network as a scale-free network, in
which only a fraction of the proteins are responsible
for making the lion's share of the connections. One
prediction from the network model is that these high-
ly connected proteins are essential for yeast viability.
In fact, we find that this is the case, because essential
proteins are highly enriched in the pool of highly con-
nected proteins. Importantly, not all highly connected
genes are essential, and we are focusing on trying to
understand the differences between these proteins and
those that are essential.
The overall goal of this study is to understand how
these protein networks provide adaptability to genetic
alterations, such as loss of a node (gene) that occurs
during tumorigenesis. The large number of essential
genes, 15-20%, depending on the organism, suggests
that the network is very intolerant of gene loss.
Interestingly, we have found that the yeast nonessen-
tial and essential genes differ in their chromosomal
distributions, indicative of a selective pressure exclud-
ing essential genes from some areas and enriching
them in others. In contrast to normal proteome net-
works, the cancer network is expected to be robust to
gene loss, largely because genomic instability is one
of the hallmarks of human cancer.
We were hoping that our analysis of the yeast pro-
teome network would reveal properties of mammalian
networks and perhaps even how these networks
become reprogrammed during tumorigenesis. One of
the lessons from our work in yeast was that even this
relatively small-scale network (6000 genes) was
incredibly complex, suggesting that global approaches
would result in few inroads. Therefore, we have
focused on studying the DNA damage response, par-
tially due to our finding on the distribution of essential
genes in yeast and partially because most tumors are
initially sensitive to therapies based on DNA damag-
ing agents.
DNA damage elicits a signaling cascade that
results in cell cycle arrest and recruitment of the DNA
repair machinery to sites of DNA damage.
Importantly, polyubiquitin chains have an important
role in this recruitment. In fact, BRCA1, a gene identi-
fied in hereditary forms of breast cancer, is a critical
factor for DNA repair and functions as an ubiquitin
ligase. Interestingly, BRCA1 elaborates a specific
form of polyubiquitin, K6-linked chains. However, the
substrates and effectors of this chain are unclear, and
we attempted to identify potential BRCA1 effectors by
identifying proteins that are associated with K6-linked
polyubiquitin chains. This resulted in the identifica-
tion of a WHIP (Werner's helicase interacting protein).
Importantly, WHIP binds to polyubiquitin via a previ-
ously uncharacterized polyubiquitin-binding domain.
The yeast homolog of WHIP, MGS1, has previously
been implicated in DNA repair, and we have found
WHIP to be in a larger network of DNA repair pro-
teins, including Werner's helicase, ERCC1, ERCC4,
and a human RuvB homolog. In addition, we also find
WHIP to be associated with proteins involved in the
unfolded protein response, such as CHIP and Bag2.
These findings suggest that WHIP may function in
both DNA damage repair and as a ubiquitin-dependent
chaperone. Interestingly, RAD23 also has a dual role
in DNA damage repair and as a ubiquitin chaperone,
suggesting a heretofore, unrecognized connection
between these two pathways.
We have also been analyzing mammalian
homologs of the yeast CCR4 protein. Importantly,
yeast CCR4 plays an important cell cycle checkpoint
function in response both to DNA damage and meta-
bolic state. Mammalian systems contain at least three
proteins with significant homology to yCCR4 and
include CCR4, TTRAP, and nocturnin. Importantly,
nocturnin has been implicated in linking the cell cycle
to circadian rhythm. It is likely that this linkage
involves the ability of CCR4 family members to func-
tion as a metabolic checkpoint of the cell cycle.
Importantly, this checkpoint appears to be nonfunc-
tional in most human tumors.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Gierszewska M. Kwofie
K. Hrecka S. Srivastava
L. Kozaczkiewicz Z. Thakkar
Our interest lies in understanding the molecular mech-
anisms underlying the pathogenesis of AIDS and, in
particular, understanding the functional consequences
of interactions between viral proteins and the cellular
regulatory machinery. The main focus of our research
is to understand the functions of accessory proteins
Nef and Vpr of human and simian immunodeficiency
viruses (HIV and SIV). These proteins are important
determinants of virulence. We directed a major effort
toward the identification of mechanisms and down-
stream effectors that mediate the effects of Nef and
Vpr on cell machineries. Our experiments have been
concentrated in four areas: First, we have focused
heavily on the isolation and identification of cellular
proteins that mediate the effects of Nef on signal trans-
duction and endocytic machineries. This has led
recently to the purification and microsequencing of
several cellular factors that associate with Nef in T
lymphocytes. Importantly, we found that Nef targets a
critical molecular switch that regulates Rac GTPases
downstream from chemokine- and antigen-initiated
signaling pathways. This interaction enables Nef to
influence multiple aspects of T-cell function and thus
provides an important mechanism by which Nef
impacts pathogenesis by primate lentiviruses. Second,
we continued to verify selected novel interactions and
to address their relevance to previously known and
possibly novel functions of Nef, as well as to AIDS
pathogenesis. Third, we continued to address the rele-
vance of individual Nef activities in vivo. To this end,
we characterized the impact of Nef interaction with
one of its targets, the AP-2 clathrin adapter complex,
on lentivirus replication and progression to AIDS in an
SIV-infected rhesus monkey model of human AIDS.
Finally, we initiated experiments aimed at purifying
and identifying downstream effectors of the lentiviral
Vpr/Vpx family of accessory proteins. These experi-
ments have led to the identification of several novel
cellular proteins that tightly associate with Vpr/Vpx in
monocytes. Among them are components of protein
complexes involved with DNA damage repair and pro-
teolysis. Current studies are aimed at verifying these
novel interactions and addressing their relevance to
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previously known and possibly novel functions of
Vpr/Vpx lentiviral accessory factors.
NEF AND CHEMOTACTIC MACHINERY IN
T LYMPHOCYTES
In our initial studies, we noticed that CXCR4 levels on
the surface of cells expressing HIV-1 Nef are slightly
decreased. CXCR4 is a receptor for the stroma-
derived factor 1 (SDF-1) chemokine and is essential
for lymphocyte migration to SDF-1. CXCR4 is also an
entry cofactor for HIV-1 but not HIV-2 or SIV virus-
es. These observations suggested that HIV-1 may
down-regulate cell surface expression of CXCR4 and
that this effect could be relevant to HIV-1 entry into
the target cells. Alternatively, down-regulating
CXCR4 expression could provide an additional mech-
anism for Nef to inhibit T-cell migration to the SDF-1
chemokine and have another entry-independent role in
the leniviral life cycle. To address these possibilities,
we examined the effects of Nef proteins from diverse
groups of primate lentiviruses including HIV-1 and
HIV-2 and SIVmac239, SIVsm, and SIVagm on
CXCR4 cell surface expression.
Flow cytometric analysis of T lymphocytes
expressing SIVmac239, SIVsm, and SIVagm Nef pro-
teins revealed that they strongly down-modulate cell
surface expression of CXCR4. Notably, these viruses
generally do not utilize the CXCR4 chemokine recep-
tor for entry into target cells. In contrast, all HIV-1 and
the majority of HIV-2 Nef proteins tested did not have
such strong effects. Nef is known to down-modulate
several cell surface receptors that are crucial for nor-
mal immune function by altering their trafficking in
the cell. Therefore, we asked whether Nef also disrupts
CXCR4 trafficking. The experiments revealed that
low-level cell surface CXCR4 expression correlated
with accelerated CXCR4 internalization from the cell
surface and thus indicated that Nef proteins also
induce CXCR4 endocytosis. Notably, CXCR4 down-
modulation was abolished by mutations that disrupt
the constitutively strong AP-2-binding element locat-
ed in the amino-terminal region of the SIV Nef mole-
cule, suggesting that Nef induces CXCR4 endocytosis
via the AP-2 clathrin adapter pathway. Together, these
results point to CXCR4 having an important role for
SIV persistence in vivo that is unrelated to viral entry
into the target cells. Rather, Nef targets CXCR4 to dis-
rupt ordered trafficking of the infected leukocytes
between local microenvironments. This in turn could
facilitate their dissemination and/or impair antiviral
immune response.
NOVEL DOWNSTREAM EFFECTORS OF
LENTIVIRAL NEF PROTEINS
We completed biochemical/proteomic experiments
designed to purify and identify by mass spectroscopy
cellular proteins to which Nef binds. Specifically, we
produced gram quantities of Jurkat T lymphoblasts
and U937 monocytes expressing hemagglutinin (HA)-
and FLAG-epitope-tagged SIVmac and HIV-1 Nef
proteins and purified Nef and their associated cellular
proteins by two sequential immunoprecipitations with
anti-HA and anti-FLAG monoclonal antibodies, each
followed by competitive elution with the appropriate
peptide. We next collaborated with Drs. M. Washburn
and L. Florens (Stowers Institute for Medical
Research, Kansas City, Kansas) who performed mass
spectroscopic identification of Nef-associated cellular
proteins using multidimensional protein identification
technology (MudPIT). The MudPIT approach identi-
fied several novel and potentially relevant interactions
between Nef and cellular proteins. First, we found that
in U937 cells, Nef binds ELMO2. ELMO2 is an iso-
form of ELMO1, a subunit of the DOCK2-ELMO1
activator of the small Rho family GTPase Rac that we
previously showed to be targeted by Nef in T lympho-
cytes. This observation indicates that Nef targets not
only specifically the DOCK2 and ELMO1 isoforms,
but also other members of these protein families and
furthermore suggests that Nef could deregulate Rac
activity through this mechanism in a wider range of
cell types than previously suspected. This latter possi-
bility will be addressed in more detail in future stud-
ies. Second, we found that both the HIV-1 and
SIVmac Nef bind specifically common cellular pro-
teins such as, for example, PCMT1 and LETM1 in
both Jurkat and U937 cells. PCMT1 is a protein
"repair" enzyme. It initiates the conversion of dam-
aged L-isoaspartyl and D-aspartyl residues to normal
L-aspartyl residues. The "repair" reaction helps to
maintain proper protein conformation by preventing
the accumulation of damaged proteins containing
abnormal amino acid residues. LETM1 is an inner
mitochondrial membrane protein that regulates the
potassium ion gradient and membrane potential across
the mitochondrion membrane and likely has a crucial
role for energy metabolism by mitochondria. Thus,
both LETM1 and PCMT1 could be important and rel-
evant targets for Nef in cells infected by primate
lentiviruses. We are now assessing whether Nef mod-
ulates the normal functions of PCMT1 and/or
LETM1, as well as selected mitochondrial functions.
PURIFICATION AND IDENTIFICATION BY MASS
SPECTROSCOPY OF NOVEL PUTATIVE
EFFECTORS OF LENTIVIRAL V. PROTEINS
Vpr is one of the accessory proteins of HIV-1. One
function of HIV-1 Vpr is to mediate translocation of
viral reverse transcription complexes into the nucleus
in nondividing cells, such as terminally differentiated
macrophages. The other effect is to perturb the cell
cycle progression and proliferation status of the
infected cell. Both functions are thought to be impor-
tant for facilitating the HIV-1 life cycle in the infect-
ed host. Unlike HIV-1, HIV-2/SIVmac viruses encode
in addition to Vpr a closely related protein called Vpx.
Vpr blocks cell cycle progression in the
GyM phase, similar to Vpr proteins from HIV- l
strains, but it does not have the ability to promote
nuclear transport of the preintegration complexes in
nondividing cells. In contrast, Vpx mediates the
nuclear import of the viral reverse transcription com-
plex, but it does not affect cell cycle progression of
the host cell. Thus, two independent functions of the
HIV-1 Vpr protein are encoded by separate accessory
proteins in HIV-2/SIV viruses. We thought that com-
parative studies of Vpr/Vpx would provide a powerful
system with which to analyze the molecular mecha-
nisms mediating the cell cycle and nuclear transport
effects of these proteins.
As a first step toward this goal, we set up to identi-
fy cellular proteins that Vpr and Vpx associate with in
the cell. The unbiased approaches that have been used
so far to identify immediate downstream effectors of
Vpr proteins have relied heavily on the abilities to
reconstruct the relevant interactions in heterologous or
in in vitro systems, such as the yeast two-hybrid (YTH)
interaction screen. These approaches have correctly
identified a subset of Vpr ligands, but they have their
limitations and have been used exhaustively. Therefore,
to bypass the limitations of the previously used meth-
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ods, we purified to near homogeneity HIV-1 Vpr,
SIVmac Vpr, and SIV Vpx and their associated protein
complexes from stably transfected U937 monocyte/
macrophage as well as transiently transfected HEK
293T cells, using an immunoaffinity purification pro-
tocol. With this approach, we detected a series of
polypeptides with apparent molecular masses ranging
from 20 kD to more than 250 kD that copurified with
HIV-1 and SIV VprNpx proteins from both cell lines.
Next, we determined their sequences by mass spectro-
scopic analysis, in collaboration with Dr. M. Washburn
and L. Florens (Stowers Institute for Medical Research,
Kansas City, Kansas). This led to the identification of
several common polypeptides associated with Vpr and
Vpx proteins. We are currently characterizing the
selected interactions and their effects on lentiviral life
cycle and normal cell functions.
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TRANSCRIPTIONAL CONTROL AND THE UBIQUITIN-
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Ubiquitin (Ub)-mediated proteolysis is a process in
which the covalent attachment of Ub to target proteins
signals their destruction by the 26S proteasome. The
controlled destruction of proteins by this system is
used to fine-tune the levels of proteins within the cell,
allows cells to rapidly alter their protein composition
in response to particular signals, and provides rigorous
control and directionality to processes such as the cell
cycle. Our particular interest centers on how Ub-medi-
ated proteolysis regulates gene transcription. In recent
years, a body of evidence has accumulated suggesting
that Ub, the proteasome, and other components of the
Ub system are involved-directly and mechanistical-
ly-in the regulation of gene activity. We are interest-
ed in understanding how the Ub system regulates tran-
scription and the consequences of this regulation for
the control of cell growth in normal and cancer cells.
Research in our laboratory is divided in two areas.
To study the basic processes that connect the tran-
scription and Ub systems, we perform biochemical
and genetic experiments using the brewer's yeast
Saccharomyces cerevisiae as a model. To understand
the biological significance of the intersections
between these systems, we study the human oncopro-
tein transcription factor Myc.
REGULATION OF MYC BY UBIQUITIN-
MEDIATED PROTEOLYSIS
Myc is a basic helix-loop-helix leucine-zipper tran-
scription factor that features prominently in the control
of cell growth. Capable of acting as both a transcrip-
tional activator and repressor, Myc controls the
expression of genes required for cell growth and divi-
sion. Consistent with the type of genes that it regu-
lates, Myc is also is a major human oncoprotein that
features in approximately 70,000 cancer deaths in the
United States each year.
Like many transcription factors, particularly those
involved in the control of cell growth, Myc is an unsta-
ble protein that is destroyed by Ub-mediated proteoly-
sis. Previous work in our laboratory has revealed that
the destruction of transcription factors such as Myc
can be intimately connected to their ability to activate
transcription. Specifically, we have found that the
same domain in these proteins that allows them to acti-
vate transcription is responsible for their destruction.
We have also found that, in some cases, transcription
factors need to engage the Ub system and become
ubiquitylated in order to function. This intimate con-
nection between transcription factor activity and
turnover has two important ramifications. First, it pre-
dicts that components of the ubiquitin-proteasome
system will be directly and intimately involved in the
control of gene expression. Second, it reveals that if
we study the destruction of transcription factors, we
can learn not just about activator proteolysis, but also
about activator function. Thus, we believe that by
probing the mechanisms through which Myc is
destroyed by the Ub system-the elements involved,
the cellular players that control Myc turnover, and the
pathways that govern Myc stability-we can also gain
new insight into how this enigmatic human oncopro-
tein functions.
For example, we and others have found that aden-
ovirus El A can stabilize Myc during the course of
adenovirus infection. E1A is a prototypical viral onco-
protein that functions to regulate the expression of
both viral and cellular genes. The analysis of El A has
been instrumental in revealing critical pathways that
lead to cellular transformation. Although the signifi-
cance of E1A-mediated stabilization of Myc was not
known, the intimate connection between transcription
factor activity and destruction led us to speculate that
this stabilization must have a functional consequence.
In collaboration with the Hannon and Lowe labs here
at CSHL, we therefore investigated the mechanism
through which E1A stabilizes Myc and probed the
relationship of this mechanism to the function of the
El A oncoprotein. We found that 12S E 1 A, when sta-
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bly expressed in U2OS cells or in nontransformed
IMR90 human diploid fibroblasts, promoted the accu-
mulation of Myc protein. We subsequently showed
that E1A expression stabilizes Myc, without affecting
its ubiquitylation, and that it does so via the transcrip-
tional coactivator p400. This was an interesting find-
ing, because although the E1A-p400 interaction was
known to be important for E1A function, the down-
stream target of this interaction was unknown. The
functional significance of the El A-p400-Myc nexus
was demonstrated by (1) the observation that Myc,
like p400, is essential for E1A to induce apoptosis, (2)
the finding that E I A can stimulate expression of Myc
target genes, and (3) the finding that in vitro transfor-
mation defects that arise upon disruption of the p400-
binding site in E1A can be ameliorated by overex-
pression of Myc, arguing that the essential function of
this region of E1A is to increase Myc protein levels.
Taken together, these data reveal that interaction of
E1A with p400 leads to an increase in the levels of
p400, which in turn results in a postubiquitylation sta-
bilization of Myc and a subsequent activation of Myc
target genes. In essence, E1A (via p400) "hijacks"
Myc to perform an important facet of its activities. We
are excited to learn about this novel pathway of E1A
function and keen to explore the mechanism through
which E1A regulates p400 and through which p400
modulates Myc.
In addition to understanding how the factors that
control Myc stability impact Myc activity, we are
interested in learning how the elements within Myc
that signal its destruction participate in transcriptional
regulation. The transcription activation domain (TAD)
of Myc spans the amino-terminal 143 residues and
includes two highly conserved regions known as Myc
Box (MB) I and MBII. Myc boxes have been impli-
cated in both transcriptional regulation and proteoly-
sis, lending support to the concept that proteolytic
control of Myc is tied to both its conservation and its
activity as a transcription factor. Several years ago, we
performed a systematic deletion analysis of Myc and
identified a second destruction element within Myc
we called the "D-element." Interestingly, the D-ele-
ment overlaps with another highly conserved
sequence-Myc Box III (MBIII). MBIII was original-
ly identified about 20 years ago, but it has not been
studied extensively, leaving a considerable gap in our
knowledge about Myc function. Because Myc boxes
have been shown to be involved in both the activity
and destruction of Myc, we revisited the roles of these
conserved elements in various aspects of Myc biolo-
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gy. To accomplish this goal, we have compared the
activities of wild-type versus MB-deleted Myc pro-
teins. One of the most intriguing findings of this work
is that transcriptional repression by Myc is largely
dependent on MBIII. Transcriptional repression by
Myc is an important and understudied topic and is
thought to have a key role in Myc-driven entry into the
S phase of the cell cycle. As such, the transcriptional
regulation of key factors such as p15 and p21 by Myc
could be an important component of Myc's ability to
cause cancer, and we have recently focused on identi-
fying the mechanisms by which Myc, through MBIII,
represses these and other Myc targets. Our studies to
date demonstrate that MBIII can function by altering
the pattern of covalent histone modifications at Myc
target genes, thereby impeding access of the general
transcriptional machinery to sites of Myc target gene
transcription in vivo. Our studies in this area not only
reinforce the concept that proteolysis can be used as a
platform to study transcription factor activity, but pro-
vide novel insight into how Myc, through its con-
served elements and recruitment of transcriptional
regulators, chromatin modifiers, and novel interacting
proteins, controls gene expression.
SYSTEM IN GENE ACTIVITY
Our original observation of the tight relationship
between transcriptional activation and Ub-mediated
destruction of transcriptional activators predicted that,
at some level, components of the Ub-proteasome sys-
tem would be involved in transcriptional regulation.
During the past several years, work from a number of
groups, including our own, has supported this predic-
tion. For example, we have found that Ub ligases can
be recruited to sites of transcription, where they per-
form essential steps in gene activation, including dri-
ving postinitiation changes in the entourage of RNA-
polymerase-interacting proteins. Other groups have
found that Ub ligases can promote coactivator
exchange at promoters in vivo, as well as targeting
stalled RNA polymerases for destruction to clear the
path for successful gene transcription following DNA-
damage-mediated transcriptional arrest. Moreover,
ubiquitylation of histones has been linked to transcrip-
tional repression and shown to participate in the regu-
lation of covalent patterns of histone modifications.
Our ongoing studies in this area continue to focus on
the role of activator ubiquitylation, but we are also
studying ubiquitylation of RNA polymerase, histones,
and the relationship between the Ub system and pre-
mRNA processing.
In addition to our interest in Ub-dependent trans-
actions and how they feature in transcription, we are
also interesting in the role of the proteasome in regu-
lating gene activity. Inspired by work from Stephen
Johnston's laboratory at Arizona State University, we
have also found that components of the proteasome are
recruited to sites of transcription in yeast cells.
Recruitment of proteasome components to chromatin
depends on the monoubiquitylation of histone H2B and
is important for multiple steps in the transcription
process, including the transcription-coupled methyla-
tion of histone H3. Curiously, we have also found that
proteasome subunits associate with gene promoters
before activation, suggesting that these proteins are
involved in either maintaining genes in the inactive
state or in some very early step in transcriptional acti-
vation. In collaboration with the laboratory of Jerry
Workman at Stowers Institute, we demonstrated that at
the GAL genes in yeast, the latter situation is likely. We
found that mutations in ATPase subunits of the 19S
proteasome specifically give rise to defects at the earli-
est stage of transcriptional activation of the GAL10
gene: recruitment of the SAGA chromatin remodeling
complex. In vitro studies supported this observation by
showing that 19S proteins, in the absence of 20S com-
ponents of the proteasome, could facilitate the stable
interaction between a DNA-bound Gal4 activator and
the SAGA complex. This effect was most pronounced
at limiting levels of SAGA and required both intact
ATPase function of the 19S complex and ATP hydroly-
sis. The ability of the 19S complex to stabilize interac-
tions between an activator and its target in the tran-
scriptional machinery is very similar to the role of
loading factors in DNA replication, which use the ener-
gy of ATP hydrolysis to drive chaperone-like activities
that direct the specific and ordered assembly of pre-
replication complexes at origins of replication. By
analogy, we therefore posit that the 19S proteins use
their chaperone functions to act as loading factors for
gene transcription. We suggest that the localization of
19S proteins to promoters prior to activation not only
serves to coordinate early events in the activation
process, but provides a high level of specificity to the
process; if the activator and SAGA can only stably
associate in the presence of 19S proteins, and if 19S
proteins are localized to promoters (which appears to
be the case prior to transcription), then the activator and
SAGA will only come together on promoter DNAs in
response to the correct signals. Ongoing studies in this
area are directed toward understanding exactly how
these 19S proteins function, identifying their targets in
the transcriptional machinery, and probing whether
19S and other subunits of the proteasome are involved
in additional steps in the transcription process.
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STRUCTURAL BIOLOGY
R.-M. Xu H.-C. Hsu Z. Li
Y. Huang P.-C. Lin
We continued to focus our research on structural stud-
ies of proteins involved in mRNA processing and pro-
teins that are important for the assembly and remodel-
ing of higher-order chromatin structures. During 2005,
we have determined the structures of a human Bmi 1 -
Ring1B oncoprotein complex; a complex of EMSY, a
BRCA2-associated protein, and the chromo shadow
domain (CSD) of HP1; and a structure of a methylat-
ed histone H3 peptide in complex with the double-
tudor domain of a Jmjc domain histone demethylase,
JMJD2A. Our structural results provide important
insights into molecular mechanisms by which these
proteins function in modulating higher-order chro-
matin structure and oncogenesis.
BMI1-RING1B POLYCOMB GROUP UBIQUITIN LIGASE
COMPLEX
Polycomb group (PcG) proteins are a set of evolution-
arily conserved transcriptional repressors controlling
homeotic gene expression during development.
Biochemical and genetic characterizations of PcG pro-
teins have revealed that they exist in distinct complex-
es, of which the two best characterized are the PRC1
and PRC2 complexes. Both PcG complexes have been
implicated in diverse biological processes such as epi-
genetic inheritance, stem-cell development, senes-
cence, and tumorigenesis. A human PRC1 complex
composed of Bmi-1, HPH2, PC3, and Ring proteins
(Ring 1 A and Ring1B), which are homologs of
Drosophila Psc, Ph, Pc, and dRing, respectively, is an
E3 ubiquitin ligase complex that mono-ubiquitinates
Lys-119 of nucleosomal histone H2A. The catalytic
subunit of the PRC1 E3 ligase complex is Ring1B. The
E3 ligase activity has been shown to be important for
the involvement of PRC1 in X-chromosome inactiva-
tion and the control of Hox gene expression. Bmi-1, a
Drosophila Psc homolog that was originally discov-
ered through its ability to collaborate with Myc in
lymphomagenesis, has a central role in the assembly
of the PRC1 complex, and although Bmi-1 displays no
detectable ubiquitin ligase activity, the binding of
Bmi-1 greatly stimulates the E3 ligase activity of
Ring1B.
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We have mapped the regions of Bmi-1 and
Ring1B required for efficient ubiquitin transfer and
determined a 2.5-A structure of the Bmi-l-Ring1B
core domain complex. Both proteins contain a canon-
ical RING domain, which is composed of a three-
stranded antiparallel 13-sheet in the 211131 configu-
ration, two zinc-binding loops, and an a helix imme-
diately carboxy-terminal to 132. Ring1B "hugs" Bmi-
1 through extensive RING domain contacts, and its
amino-terminal tail wraps around Bmi- 1 . The two
RING domains are positioned in a manner similar to
that of the only other known heterodimeric RING
domain structure, the BRCA1 -BARD1 RING-RING
complex. We also showed that the two regions of
interaction have a synergistic effect on the E3 ligase
activity. Our analyses suggest a model where the Bmi-
l-Ring1B complex stabilizes the interaction between
the E2 enzyme and the nucleosomal substrate to allow
efficient ubiquitin transfer.
EMSY-HP1 INTERACTION
Heterochromatin protein -1 (HP1) has an essential role
in both the assembly of higher-order chromatin struc-
ture and epigenetic inheritance. Various proteins
important for chromatin structure and gene transcrip-
tion have been found to interact with the HP1 CSD.
They include the large subunit of chromatin assembly
factor-1 (CAF-1) and components of the cellular tran-
scriptional machinery. In addition, the largest subunit
of the origin recognition complex (Orc 1) interacts with
full-length HP1, rather than individual domains. A
recent addition to the list of HP1-interacting proteins
is EMSY, which was identified as a protein that inter-
acts with the exon-3-encoded transcriptional activation
domain of breast cancer susceptibility gene 2
(BRCA2). EMSY has been implicated in BRCA2-asso-
ciated sporadic breast and ovarian cancer.
The EMSY sequence implicated in HP1-binding,
RLVPL, deviates from the consensus HP1 binding
sequence PXVXL (positions -2 to +2) at the -2 posi-
tion. In the structure of the HP1 CSD-CAF-1 peptide
complex, the proline at position -2 occupies a shallow
hydrophobic pocket, which an arginine would not be
able to bind. To determine the exact mode of interac-
tion between the HP1 CSD and EMSY, we have deter-
mined the crystal structure of the HP1I3 CSD in com-
plex with the amino-terminal domain of EMSY at 1.8-
A resolution. Surprisingly, the structure reveals that
EMSY is bound by two HP1 CSD homodimers, and
the binding sequences, LVPLM and FTVTA, differ
from the consensus HP 1-binding motif PXVXL. This
structural information expands our understanding of
HP1-binding specificity and provides insights into
interactions between HP1 homodimers that are likely
to be important for heterochromatin formation.
RECOGNITION OF METHYLATED HISTONE TAILS BY
THE DOUBLE-TUDOR DOMAIN OF JMJD2A
Biological responses to histone methylation critically
depend on the faithful readout and transduction of the
methyl-lysine signal by "effector" proteins, yet our
understanding of methyl-lysine recognition has so far
been limited to the study of histone binding by chro-
modomain and WD40-repeat proteins. The double-
tudor domain of JMJD2A, a Jmjc-domain-containing
histone demethylase, binds methylated histone H3-K4
and H4-K20. We found that the double-tudor domain
has an interdigitated structure, is
required for its ability to bind methylated histone tails.
The cocrystal structure of the JMJD2A double-tudor
domain with a trimethylated H3-K4 peptide reveals
that the trimethyl-K4 is bound in a cage of three aro-
matic residues, two of which are from the tudor-2
motif, whereas the binding specificity is determined
by side-chain interactions involving amino acids from
the tudor-1 motif. Our study provides mechanistic
insights into recognition of methylated histone tails by
tudor domains and reveals the structural intricacy of
methyl-lysine recognition by two closely spaced effec-
tor domains.
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CANCER: GENETICS
In some cases, the fusion of human cells is a normal process that leads, for instance, to the formation of
muscle and bone. Seemingly innocuous infections by common viruses can also cause cells in our bodies
to fuse. Such fused cells are widely considered to be harmless because they are generally believed to die
and be cleared from the body without consequences for our health. This view of cells fused by viruses as
being harmless may need to be revised. A recent study of cultured cells by Yuri Lazebnik and his col-
leagues has revealed that cell fusion triggered by common viral infections may be a significant factor in the
development of human cancer. Lazebnik's group is currently testing this possibility in animal models. Non-
CSHL scientists are developing fusogenic viruses as gene delivery tools for human gene therapy.
Lazebnik's research indicates that because these viruses might cause cancer, their use for therapeutic
purposes should be carefully evaluated.
It is becoming clear that cancer and aging are inextricably intertwined by molecular pathways that link
the two processes. Alea Mills is using a variety of mouse models that enable her to investigate these links.
Specifically, she is interested in p63, a protein similar to the well-known tumor suppressor protein p53.
Mills's recent experiments have demonstrated that loss of the p63 gene accelerates aging in mice. She is
now investigating p63's role in the delicate balance between aging and cancer, work that may lead to anti-
cancer therapies.
A desire to understand why nearly all cancers contain multiple copies of some portions of chromo-
somes drove investigators Michael Wig ler and Rob Lucito to develop a powerful method for measuring
the difference in DNA copy number between normal and cancer cells. Using their method, called repre-
sentational oligonucleotide microarray analysis, or ROMA, they have identified chromosomal regions that
had not previously been known to have a role in cancer. Some of these regions are common to both early
and advanced cancers, and others are seen predominantly in advanced disease. A particular hallmark of
lethal cancers is a type of lesion Wig ler has dubbed "firestorms" to describe highly unstable chromosomal
regions. Through the sort of "DNA biopsy" that the ROMA technology provides, the researchers are aim-
ing to improve the way all major forms of cancer are diagnosed and treated. Lucito is also modifying
ROMA so it can be used to analyze modifications to DNA, so-called epigenetic changes, that often
accompany cancer.
Jonathan Sebat is using ROMA to test the idea that changes in gene-copy number contribute to spo-
radic cases of autism. An initial study of 110 sporadic cases of autism identified six spontaneous muta-
tions, five of which have been previously reported in association with autism. The sixth variant is a dele-
tion on chromosome 20 that contains multiple genes potentially involved in human development, particu-
larly of the central nervous system. Locating this new autism-associated region could help researchers
identify the underlying genetic changes that lead to autism.
Eli Hatchwell is also interested in mutations that arise spontaneously and cause sporadic cases of dis-
ease. Because spontaneous mutations are typically rare and are usually not inherited, traditional methods
of locating such mutations by studying related individuals are of no use. However, spontaneous mutations
can provide invaluable clues to the origin of common disorders. For example, the identification of sponta-
neous deletions in chromosome 22 have been linked to schizophrenia. Hatchwell has developed a method
to evaluate large sections of the genome for microdeletions, a type of genetic instability too small to be
identified by karyotyping and other traditional approaches. By using this method, he has located genes
associated with neurological disorders such as autism and the rare but informative Toriello-Carey syn-
drome.
RNA interference (RNAi) is a fundamental molecular process that controls gene expression in many
organisms. CSHL scientists understood the power of RNAi early on and continue to make many seminal
discoveries about it. Moreover, they are putting RNAi to several uses in both basic and applied research.
One such development-the creation of libraries of short interfering RNAs targeted to each gene in the
human and mouse genome-was completed this year by Greg Hannon's group in collaboration with
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investigators at Harvard, Merck, and OSI Pharmaceuticals. Hannon, one of the first scientists to investi-
gate how RNAi controls gene expression, continues to explore the components, mechanisms, and appli-
cations of this powerful gene regulatory system. In collaboration with Scott Lowe, Scott Powers, and
CSHL alumnus Scott Hammond, Hannon and his colleagues discovered that a particular noncoding
"microRNA" has a role-through RNAi-in human cancer. Another investigation by Hannon's group of the
RNAi components in mice led to the discovery of an entirely new class of small RNAs that, interestingly,
are found only in males.
Vivek Mittal studies the mechanism by which tumors spur their own growth by creating new blood ves-
sels to feed themselves. This year, his group established that blood vessel progenitor cells come from the
bone marrow and travel to the tumor site, where they respond to growth signals and form new blood ves-
sels that nourish the growing tumor. Mittal has shown that signals from the tumor activate particular path-
ways within the blood vessel progenitor cells. Experiments using RNAi to knock down the levels of these
signals markedly delays tumor growth and reveals a potential new target for cancer therapy.
Masaaki Hamaguchi (now at Fordham University) studies a tumor suppressor gene he discovered at
CSHL called DBC2 (deleted in breast cancer 2), which he showed is linked to breast and lung cancer. This
year, by using RNAi, Hamaguchi identified some 680 genes whose activity is altered when the Dbc2 pro-
tein is decreased as it is in tumors. His analysis of the isolated genes led to the discovery of four major
cellular networks in which Dbc2 has a significant impact. Further investigation revealed that Dbc2 is criti-
cal for proper protein processing and transport.
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ANALYSIS OF A TUMOR SUPPRESSOR GENE
M. Hamaguchi F.K. Chang
N. Kobayashi
J.L. Meth
Our lab is interested in the discovery and characteriza-
tion of cancer-related genes, especially tumor suppres-
sor genes that are ablated in cancer cells. The identifi-
cation of these genes and subsequent studies into their
biological functions have provided vast new insights
into the development of cancer. A great deal is now
known about the relationship between cancer develop-
ment and cellular functions. We are characterizing
DBC2 (deleted in breast cancer 2), which is likely to
be a tumor suppressor gene for sporadic breast cancer.
Activation of DBC2 in a breast cancer cell line result-
ed in growth arrest of the cells, whereas naturally
occurring DBC2 mutants do not suppress tumor
growth. We have discovered that DBC2 demonstrates
pleiotropism by expression profiling analysis. We fur-
ther investigated each biological pathway suggested to
involve DBC2. The ultimate goal of our research is the
elucidation of tumor suppression mechanisms of
DBC2 and development of new cancer therapy based
on the findings.
DBC2 and Gene Expression
M. Hamaguchi, N. Kobayashi, J.L. Meth
To clarify DBC2's physiological functions, we used
microarray analysis to isolate approximately 700
genes that were disturbed by altered DBC2 expression.
The gene list was overlaid onto a huge cellular path-
way map in a database so that we could identify bio-
logical pathways influenced by DBC2. We discovered
four cellular pathways that are significantly affected
by manipulation of DBC2 function. They are related to
apoptosis, cell cycle control, membrane trafficking,
and cytoskeleton. This discovery is particularly impor-
tant because a gene family, RHOBTB, where DBC2
belongs, has not been characterized; it would provide
a framework for functional studies of this potentially
important gene family.
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DBC2 and Protein Transport
M. Hamaguchi, F.K. Chang
As part of comprehensive research on DBC2 function,
we studied its role in protein transport, using the
VSVG-ts045-GFP (ts045) protein as a reporter of
membrane trafficking. This visible protein is trans-
ported from the endoplasmic reticulum (ER) to the
cellular membrane via the Golgi apparatus in a micro-
tubule-dependent manner. We discovered that when
DBC2 is knocked down by RNA interference (RNAi),
ts045 transport is hindered in certain cells, including
293 and HeLa cells that express DBC2 under physio-
logical conditions. We further demonstrated that
DBC2 movement also depends on the microtubule net-
work. We are currently testing the hypothesis that
DBC2 has a role in connecting vesicles (vehicles for
protein transport) and the cellular motor system.
DBC2 and Cell Cycle Control
M. Hamaguchi, N. Kobayashi
We discovered that DBC2 negatively regulates the
CCND1 protein essential for cell cycle control at the
G1 /S transition. DBC2 also down-regulates CCNE,
which is downstream from CCND1. Certain onco-
genes involved in breast cancer development such as
ras /c- erb -B2 depend entirely on CCND1 to connect to
the cell cycle machinery and some do not. If DBC2
demonstrates antitumor activity via CCND1, it is con-
ceivable that cancer cells will display different sensi-
tivities against DBC2. In fact, DBC2 expression caus-
es growth arrest of a cancer cell line with CCND1
amplification, although it does not affect the growth of
a cell line driven by an oncogene (c-myc). This finding
warrants further questions: Are tumor cells using
CCND1, such as cancers driven by ras and c-erb-B2
oncogenes, sensitive to DBC2? Can CCND1 or CCNE
reactivation rescue the sensitive phenotype? How does
DBC2 suppress CCND1? We needed to answer these
questions because they are directly related to the con-
trol of tumor growth by DBC2. To answer these ques-
tions, we constructed several mammalian expression
vectors, including CCND1 with the constitutive pro-
moter and CCNE with the CCND I promoter. DBC2 -
sensitive tumor cells are now being examined to deter-
mine whether these constructs will allow growth even
with DBC2 activation.
DBC2-deficient Animal Model
M. Hamaguchi, N. Kobayashi, J.L. Meth
The development of "knockout (KO) mice" has creat-
ed a system in which we can study gene functions at
an organismal level. If inheritance of tumor suscepti-
bility is proven by studying KO mice, it will provide
decisive evidence that the targeted gene is a tumor
suppressor. This has been a critical approach to the
investigation of tumor suppressor candidates for spo-
radic cancers. Furthermore, studies in mouse models
have provided information about the roles of targeted
genes in cell cycle control, tumor suppression, DNA-
damage response, regulation of apoptotic pathways,
and preservation of genomic stability. Our attempts to
produce DBC2-deficient mice have failed, and thus we
are taking a conditional knockout strategy to circum-
vent the problem. We have successfully created mice
carrying a "floxed-DBC2" allele that can produce
functional DBC2 and can be excised whenever we
like. We are currently testing the responsiveness of the
allele.
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RNA INTERFERENCE: MECHANISMS AND APPLICATIONS
G. Hannon A. Aravin
S. Boettcher
J. Brennecke
M. Carmell
K. Chang
S. Cheloufi
M. Dus
A. Girard
L. He
X. He
I. Hotta
J. Hunter
I. Ibarra
F. Karginov
J. Liu
M. Mosquera
Several years ago, work in a free-living nematode,
Caenorhabditis elegans, uncovered a previously
unknown biological response through which an
organism exposed to double-stranded RNA specifi-
cally silenced genes that share homology with that
nucleic acid. This phenomenon, called RNA interfer-
ence (RNAi), has since been shown to be an evolu-
tionarily conserved pathway, present in organisms
ranging from fungi to plants to mammals. We contin-
ue to approach RNAi from three perspectives: work-
ing to decipher its underlying mechanism, seeking to
uncover its biological functions in mammals, and
building upon our knowledge of the pathway, to cre-
ate tools that allow RNAi to be used to probe gene
function in mammals and plants.
This year, our efforts have continued toward under-
standing how the RNAi machinery functions to sup-
press gene expression. In particular, we determined
that miRNAs (miRNAs) may act by moving mRNA
targets from a translating pool on ribosomes into a
translationally inactive compartment known as the pro-
cessing body or P-body. P-bodies are intriguing cyto-
plasmic structures that may act as sites of RNA storage
and degradation, consistent with their role in miRNA-
mediated silencing. However, these bodies may also be
analogs of other RNA storage granules that are impor-
tant for determining cell type and tissue identity, par-
ticularly RNP (ribonucleoprotein) granules such as P-
granules or polar granules that specify the germ line
during early development. Interestingly, miRNAs also
direct degradative enzymes to cellular mRNAs, includ-
ing the decapping complex and the major cellular dead-
enylases. These findings raise the possibility either that
repression could occur through several independent
mechanisms or that all of these factors lie in a coordi-
nated pathway for negating mRNA function. Efforts
not only to understand how miRNAs work, but also to
decipher their biological roles led to the identification
of the first oncogenic miRNA. We are now trying to
understand how this miRNA functions in tumorigene-
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E. Murchison
Y. Qi
F. Rivas
J. Silva
D. Siolas
sis through the development of new biochemical meth-
ods to identify miRNA targets.
In an effort to understand the biological roles of
the RNAi machinery more broadly, we have begun to
characterize its potential targets by large-scale
sequencing of small RNAs. In particular, we have
focused on the RISCs (RNA-induced silencing com-
plexes) of Arabidopsis, both the miRNA RISC and the
RISC involved in chromatin modification. Similar
approaches in mammals have led to the discovery of a
new class of small RNAs that appear exclusively in the
germ line. These associate with a separate subfamily
of Argonaute proteins, the Piwi proteins, and may have
roles in meiosis. Overall, these efforts have continued
to expand the biological range of small RNAs to pre-
viously unsuspected cellular processes.
Building on our increasingly deep understanding
of the mechanistic basis and biological functions of
RNAi, we continue to move toward the creation of
genome-wide libraries of RNAi-inducing constructs to
enable genetic studies in mammalian cells and in ani-
mals. Last year, we reported a nearly complete collec-
tion of human artificial miRNAs, targeting more than
30,000 genes. A similar mouse library has also been
created. In collaboration with Scott Lowe and Steve
Elledge here at CSHL, we showed that these tools can
be used to effectively suppress gene expression in ani-
mals, even when only a single copy of the ectopic
locus is present. We are now using these tools to search
for genes that are essential for the growth and survival
of cancer cells or that modify the sensitivity of cancer
cells to therapeutic compounds.
During the past year, we were joined by three new
graduate students: Angelique Girard from the Watson
School, and Ingrid Ibarra and Xingyue He from the
State University of New York. We were also joined by
three new postdoctoral fellows: Katalin Fejes-Toth,
Julius Brennecke, and Alexei Aravin, all coming from
The Rockefeller University. Michelle Carmell and
Ahmet Denli received their Ph.D. degrees, and Ahmet
left to take a postdoctoral position at the Salk Institute.
We also said farewell to Mike Golding, a postdoctoral
fellow, who left to continue his work at the University of
Western Ontario.
Highlights of the progress in the laboratory during
the past year are described in more detail below.
A New Class of Small
RNAs in the Male Germ Line
A. Aravin, M. Carmell, A. Girard, E. Murchison
Small RNAs associate with Argonaute proteins and
serve as sequence-specific guides to regulate mRNA
stability, protein synthesis, chromatin organization,
and genome structure. In animals, Argonautes segre-
gate into two subfamilies. The Argonaute subfamily
acts in RNAi and in miRNA-mediated gene regulation
using 21-22-nucleotide RNAs as guides. The Piwi
subfamily is involved in germ-line-specific events
such as germ-line stem cell maintenance and meiosis.
We have recently shown that Miwi, a murine PIWI
protein, binds a previously uncharacterized class of
about 29-30-nucleotide RNAs that are highly abun-
dant in testes. We named these piRNAs (PIWI-inter-
acting RNAs). piRNAs show distinctive localization
patterns in the genome, being predominantly grouped
into 20-90-1d3 clusters, wherein long stretches of
small RNAs are derived from only one strand.
We are now working to understand the biogenesis
and function of the piRNAs. Dicer is an RNase III
enzyme required for biogenesis of small RNAs enter-
ing the RNAi pathway. Although many features of
piRNAs are indicative of RNase-III-mediated biogen-
esis, their size, distribution, and strand asymmetry are
unusual for Dicer. The generation of mice with Dicer
specifically ablated in testes will allow us to test the
involvement of this enzyme in piRNA biogenesis. In
addition, the identification and characterization of
piRNA-precursor transcripts will permit us to probe
the requirements for piRNA biogenesis in vitro.
Importantly, the function of this new class of small
RNAs must still be resolved, the abundance of piRNAs
in germ-line cells and the male sterility of Miwi
mutants suggest a role in gametogenesis. For example,
piRNAs could act in the homology search that precedes
homologous chromosome pairing during meiosis. They
could also mark meiotic recombination hot spots.
Alternatively, their function could be more similar to
that of known classes of small RNAs. They could work
in establishing the chromatin structure or in regulating
synthesis of spermatogenesis-associated proteins. We
are planning to use a combination of mouse genetics
and biochemical analyses to answer these questions.
The Role of P-bodies
in miRNA-mediated Silencing
J. Liu
Small RNAs, including small interfering RNAs
(siRNAs) and miRNAs, can silence target genes through
several different effector mechanisms. In animals,
siRNA-directed mRNA cleavage is carried out by the
Argonaute2/slicer effector complex. However, the major-
ity of miRNAs regulate gene expression through an
RNAi machinery without inducing cleavage due to
imperfect complementarity. The mechanisms by which
miRNAs repress protein synthesis remain elusive. Our
recent studies, in collaboration with Roy Parker,
University of Arizona, demonstrate that Argonaute pro-
teins, the signature components of RNAi effector com-
plex, RISC, localize to specific cytoplasmic foci known
as the mammalian P-bodies. The localization requires
small RNA binding. More importantly, we demonstrate
that the target mRNAs of miRNAs localize in P-bodies in
a small-RNA-dependent manner. Disruption of the P-
bodies impairs both siRNA- and miRNA-mediated
silencing. Localization of RISC in P-bodies is crucial for
its function. We propose that P-bodies serve as the cyto-
plasmic compartment for RISC effector complexes to
carry out RNAi posttranscriptional gene silencing
(PTGS). P-bodies contain untranslated mRNAs and
serve as sites of mRNA degradation. The target mRNAs
of miRNAs can therefore either be sequestered away
from the translational machinery for repression or be
degraded through a slicer-independent pathway. Further
studies are required to dissect the details of the repression
mechanisms.
Mechanisms of RNAi-mediated
Silencing in Mammals
F. Rivas
Although cell biological studies have proven to be
very informative, the precise biochemical mechanisms
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by which miRNAs repress their targets remain a fun-
damental mystery. To illuminate this process, we have
undertaken a proteomic approach to RISC in mam-
malian cells. To investigate mechanisms of RISC-
mediated repression, we have searched for Argonaute-
interacting proteins by MudPIT (multidimensional
protein identification technology) analysis of
immunoaffinity-purified Agol and Ago2 complexes.
These analyses have been possible by a collaboration
with Dr. James Wohlschlegel and Dr. John Yates at The
Scripps Research Institute. This approach was validat-
ed by the recovery of previously identified Argonaute-
binding proteins including HSP90, Dicer, TRBP, and
DCP1 in both Agol and Ago2 complexes. We also
repeatedly identified a known component of process-
ing bodies (P-bodies), the protein GW182. These
observations were verified by immunoblotting
GW182 immunoprecipitates for myc-tagged Agol and
Ago2 and were shown to be RNase-A-insensitive. Our
lab has gone on to show that knockdown of GW182
impairs the silencing of a miRNA reporter and that
mutations in Ago which impair its ability to localize to
P-bodies prevent miRNA-mediated repression even
when Ago is tethered to its target in an siRNA-inde-
pendent manner. Interestingly, these mutant Ago pro-
teins were still able to bind GW182, suggesting that
repression correlates with localization to the P-bodies
as opposed to the ability to bind this integral P-body
component. Our analysis of Ago MudPIT candidates
has also repeatedly identified components of the
CCR4-NOT (CNOT) complex. CCR4 is the most
prominent deadenlylase activity in mammalian cells.
Our findings are particularly provocative at this time
since miRNA targets in zebra fish and in mammalian
cells have recently been shown to undergo deadenyla-
tion. I have shown that CCR4 coimmunoprecipitates
with Ago, as well as colocalize to the P-body with
other members of the CNOT complex such as CNOT7
and CNOTIO and that knockdown of these proteins
impacts miRNA-mediated repression. We are now
investigating the biochemical mechanism that con-
nects Ago to mRNA deadenlyation. We have also
extended our MudPIT analyses to both nuclear and
cytoplasmic Ago-interacting proteins, as well as asked
whether these interactions were RNA-mediated or
enhanced upon the triggering of the RNAi pathway by
transfection of an siRNA. Remarkably, many novel
Ago-interacting proteins identified by this approach
are orthologs of proteins that have been previously
ascribed a role in RNAi by genetic screens in C. ele-
gans . In addition, some interactions reveal potentially
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novel roles for Argonaute proteins in the cell and are
areas of current investigation in the lab.
miRNAs as Human Oncogenes
L. He
I am interested in looking at the role of miRNA in
tumorigeneisis. To date, more than 200 miRNAs have
been described in humans. Although there was circum-
stantial evidence suggesting that these regulatory, non-
coding RNAs might have a role in tumor development,
it remained largely obscure whether a miRNA could
actually function as an oncogene. A comparison of B-
cell lymphoma samples and cell lines to normal tissues
reveals that substantially increased levels of the mature
miRNAs from the miR17-92 locus are often found in
these cancers. Notably, the gene encoding this miRNA
polycistron is present in a region of DNA amplification
found in human B-cell lymphomas. Enforced expres-
sion of the miR17-92 cluster cooperates with c-myc,
accelerating tumor development in a mouse B-cell lym-
phoma model. Tumors derived from hematopoietic
stem cells (HSCs) expressing mir 1 7-92 and c-myc are
distinguished by an absence of the apoptosis otherwise
prevalent in c-myc-induced lymphomas. Our studies
indicate that noncoding RNAs, specifically miRNAs,
can modulate tumor formation and implicate the
miR17-92 cluster as a potential human oncogene.
The Non-Agocentric View of RNAi
M. Dus
Much of the research in the field has centered on
unraveling the biochemical details of target mRNA
cleavage; however, very little is known about the in
vivo functions of RNAi. The principal focus of my
research stresses the importance of placing the RNAi
pathway in a cellular contest in order to understand its
physiological functions. Indeed, although RNAi is an
extremely useful and profitable technique, it is first
and foremost a biological process, a biological process
of which we know very little. How do Argonaute pro-
teins find the small RNAs? How does the micro-
processor complex find the primary miRNA tran-
scripts among the myriad of nuclear RNAs? How are
pre-miRNAs transported into the cytoplasm? Do other
mRNA processing complexes interact with the RISC
and, if so, what are the scopes and the defined mecha-
nisms of these interactions? These and others are ques-
tions that I (and others in the lab) am trying to address
with different approaches, from biochemistry, to
genetics, to cell biology.
Biochemical Approaches to
Identifying Small RNA Targets
F. Karginov
My research focuses on the function and mechanism
of RNA silencing from a biochemical perspective. In
one area of interest, I am identifying the function of
bacterial Argonaute proteins. Although bacteria lack
the full set of canonical eukaryotic RNAi compo-
nents, several bacterial species have a homolog of
Argonaute, the principal effector protein in RNA
silencing. Although the Aquatex aeolicus Argonaute
has been shown to be active in slicing, other bacterial
Agos lack the necessary catalytic residues, presum-
ably participating in other functions. I believe that
elucidation of bacterial cellular processes that involve
Argonautes will provide a broader understanding of
their potential functions in eukaryotes and may
explain their ancestral roles and evolution.
I am also interested in experimental identification
of miRNA targets. To date, computational methods
have identified hundreds of putative mRNA targets
for given miRNAs, and microarray hybridization
experiments have yielded information on changes in
mRNA levels upon introduction or depletion of par-
ticular miRNAs. I am working on directly identifying
miRNA targets by immunoprecipitation of RISCs. In
this approach, secondary effects seen in microarray
experiments can be avoided, and we can begin to illu-
minate the extensive networks of gene regulation by
miRNAs with more precision. Additionally, a large set
of experimentally verified mRNA-miRNA pairs will
lead to substantial improvement of computational
algorithms for more target prediction.
Genetic Approaches to New Therapeutic
Targets for Cancer
K. Chang, J. Silva, D. Siolas, S. Boettcher
The application of RNAi has transformed the way
we approach mammalian cell genetics. During the
past year we have made significant progress in sev-
eral areas that have enhanced the use of short hair-
pin RNAs (shRNAs) as a tool for genetic screens.
Our second-generation shRNA retroviral library
now covers 32,202 genes (86,128 clones) for
human, 30,629 genes (76,896 clones) for mouse,
and 15,173 genes (31,130 clones) for rat genomes.
For screening using primary or quiescent cultures,
we have begun to construct a lentiviral human
shRNA library (12,099 genes; 15,471 clones).
These shRNA can be delivered into cells, both in
vitro and in vivo, using our optimized viral expres-
sion vectors. More importantly, with these tools, we
have successfully demonstrated the feasibility of
performing genetic screens in mouse and human
cells through our pilot efforts. A screen to search
for potential tumor suppressors in human breast
cancer cells was undertaken by isolating cells that
could survive detachment-induced apoptosis
("anoikis"). As a validation of our approach, we
were able to identify previously known tumor sup-
pressors (PTEN and Rb). Currently, verification is
under way to confirm some of the novel targets.
Using the "synthetic-lethal" genetic approach, we
can now perform drug-induced synthetic-lethal
screens by using cancer drugs that are currently in
clinical trials. This is important as cancer cells can
often develop growth advantage to overcome the
toxic effects of chemotherapeutics. To this end, we
have carried out a screen to identify regulators of
rapamycin (an inhibitor of mTOR) sensitivity in
prostate cancer cells and have identified genes that
were expected to modulate mTOR activity and other
targets which, upon validation, could become can-
didates for combination therapy against prostate
cancer. Bortezomib (Velcade) is the first targeted
therapeutic to the proteasome approved by the FDA
for treatment against multiple myeloma and is cur-
rently in phase II clinical trials for breast and lung
cancers. Our goal is to identify genes that mediate
resistance against Velcade that could serve as poten-
tial drug targets. Screens to investigate genes that
modify sensitivity to other leading targeted thera-
peutics, such as Tarceva (EGFR inhibitor), are also
being carried out. It will be interesting to compare
results across these studies to identify generic
effects of drug resistance.
RNAi technology is a powerful tool that could
potentially be used to study and treat other human
diseases through its application to mammalian cell
genetics.
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SPORADIC HUMAN GENETIC DISEASE
E. Hatchwell Y. Hanada D. Tegay
J. Roohi Y. Wang
We continue to apply modern/novel methodologies to
the analysis of sporadic human genetic disorders.
Approximately 2-3% of all newborns have a disorder
that is at least partially genetic in origin; of these,
approximately 50% are sporadic and, by definition,
not amenable to standard approaches, including link-
age analysis.
Historically, whole-genome analysis was based on
examination of chromosomes using light microscopy.
Although highly successful, this approach is limited
by a maximum resolution of 10 Mb. It is now known
that many disorders are associated with genomic
copy-number variation of much smaller segments
(e.g., Williams-Beuren Syndrome [WBS], which is
associated with heterozygous deletions of 1.5 Mb at
7q11.23).
Array-based comparative genomic hybridization
(aCGH) for the genome-wide detection of copy-number
fluctuations is now possible using a variety of formats,
including oligo and large-clone (based on bacterial arti-
ficial chromosomes [BACs]) DNA micro-arrays.
We have generated BAC microarrays during the
last four years, at increasing density, and our current
arrays contain a complete tile of the human genome
(19,000 BACs arrayed in duplicate on a single slide),
with an average expected resolution of 100 kb. These
were designed in collaboration with James Gergel and
were generated by collaborators at Roswell Park
Cancer Institute ([RPCI] Dr. Norma Nowak and col-
leagues). We continue to focus on specific areas:
Autistic spectrum disorder (ASD)
Congenital heart disease (CHD)
Complex phenotypes and de novo, apparently, bal-
anced translocations
Development of a normal variation database, for
rational interpretation of copy number changes
detected in symptomatic patients
Development of methods to generate haploidy from
diploidy, in order to more effectively analyze het-
erozygous changes
Genome-wide array-based analysis of DNA methy-
lation for both inter- and intragenomic analysis
Autism Spectrum Disorder: Genetics
J. Roohi
We are collaborating with workers at the Cody Center,
Stony Brook, in a multidisciplinary study of a cohort of
patients diagnosed with ASD. In addition to detailed
diagnostic interviews/questionnaires by experts in
autism, all individuals undergo examination by a med-
ical geneticist (Dr. David Tegay) in order to search for
dysmorphic features. All patients undergo standard
chromosome analysis and testing for FRAXA (Fragile-
X type A). To date, more than 80 patients have been
assessed. Chromosomal analysis was reported to be nor-
mal in all cases, except one patient who has a de novo,
apparently balanced, translocation, which we intend to
study in great detail. What has become very clear is how
clinically heterogeneous this disorder is; fully 50% of
patients are dysmorphic or have physical stigmata remi-
niscent of genetic syndromes. To some extent, this is not
altogether surprising, given the number of distinct syn-
dromes known to result in autistic features (e.g.,
FRAXA, Angelman syndrome, and Rett syndrome). It is
therefore clear that ASD should be viewed as a "catch-
all" diagnosis for a large group of heterogeneous disor-
ders whose common endpoint is the autistic phenotype.
In a sense, the ASD label is likely to disappear in the
future with improved phenotypic dissection, as has
occurred in other complex disorders whose etiologies
are beginning to be understood (e.g., mental retardation,
now considered too general a designation to be useful).
It is also important to realize that the application of any
genomic technology to unravel ASD or any complex
phenotype, in the absence of a parallel clinical/pheno-
typic analysis, is unlikely to be informative.
In addition to our medical genetics examinations,
a selected group of patients undergo detailed imaging
analysis, in collaboration with Dr. Benveniste and col-
leagues at Brookhaven National Laboratory.
We have been applying aCGH using tiling-path
BAC arrays to our cohort of ASD patients and have
detected many genomic copy-number abnormalities.
The challenge has been to (1) validate these changes
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and (2) determine whether any validated changes rep-
resent population variants or are specific to ASD.
Our validation relies mainly on "old-fashioned"
yet robust methods such as fluorescence in situ
hybridization (FISH), although we are also utilizing a
variety of molecular approaches, including quantita-
tive polymerase chain reaction (PCR), multiplex liga-
tion-dependent probe amplification (MLPA), and
short tandem repeat (STR) analyses.
We have generated a database of all our aCGH
results, which has enabled us to determine with high
likelihood which changes are likely to be significant
in any given disorder. Our database currently contains
data on more than 320 individuals; this number is like-
ly to rise to close to 500 by the summer. The data have
been generated in both our group and Dr. Norma
Nowak's group at RPCI.
We are currently interested in a specific region of
the genome that appears to be normal in all non-ASD
individuals we have looked at so far. We are analyzing
candidate genes for a variety of mutational types and
are fully confident that we have found a locus that will
turn out to be highly significant in a subset of ASD
(perhaps 5%).
ASD: Environment
This work was performed in collaboration with M
Herbert, Massachusetts General Hospital, Harvard
Medical School.
We have embarked on a study of the possible role of
environmentally responsive genes in ASD etiology.
Although there is much debate, there does exist some
evidence for a true increase in the rates of ASD during
the last 20 years. If real, these increases, which have
occurred in populations whose demography/ethnicity
has changed little, require explanation in terms of envi-
ronmental changes. We have used bioinformatic
approaches to analyze potential overlaps between genes
known to be implicated in responses to the environment
(http://www.niehs.nih.gov/envgenom/egp6.htm) and
ASD linkage regions and have selected a small subset
for further study.
Congenital Heart Disease
Y. Wang
We have a long-standing interest in the genetics of
CHD; 8/1000 newborns have CHD. Of these, only 3%
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are Mendelian, and the majority of the remaining 97%
are of unknown etiology, with one major exception.
Velocardiofacial syndrome (VCFS) is a significant
cause of CHD, explaining about 20% of all conotrun-
cal defects (and probably 10% of all CHD). VCFS is
known to be caused by submicroscopic deletions at
chromosome 22811 (3 Mb in 90% of patients, 1.5 Mb
in about 10%). It therefore seems reasonable that other
genomic copy-number alterations will be found in
patients with CHD who are chromosomally normal
and negative for 22q11 deletions.
We have funding from two organizations for this
work: (1) Harrison's Heart Foundation, a private local
charity committed exclusively to CHD research, and
(2) the Gerber Foundation, which funds research
more generally in the pediatric arena. We also have
active collaborations with two major centers of excel-
lence, from which we obtain DNA samples on well-
characterized individuals with CHD: (1) Dr. Piers
Daubeney at The Brompton Hospital, London and (2)
Dr. Steve Webber at The Children's Hospital,
Pittsburgh.
To date, we have obtained samples from 150
patients with CHD and have thus far analyzed 50 indi-
viduals. By comparison with non-CHD individuals in
our database, we have identified at least one region
that appears to be of interest.
Complex Phenotypes and
De Novo Translocations
Y. Wang, D. Tegay
The methods we have developed for studying ASD
and CHD are applicable to a wide range of complex
disorders. We collaborate actively with a large number
of clinicians, including Dr. Helga Toriello, a distin-
guished dysmorphologist, and Dr. David Tegay, Head
of Medical Genetics at Stony Brook, currently a visit-
ing scientist in our group.
De novo translocations may provide important
clues to the etiology of certain phenotypes. In one such
example, which we have studied in depth, we have
cloned a novel gene that is interrupted by a de novo t(2;
22) translocation in a patient with Joubert syndrome. In
a second individual, who has Toriello-Carey Syndrome,
we have isolated a candidate gene and have amassed a
large collection of individuals with this very rare syn-
drome, in whom mutation analysis is under way.
In addition to these projects, we have recently
uncovered relevant copy-number changes in:
A patient with atypical Williams Syndrome. This
patient serves to better define genotype/phenotype
correlations with regard to the cognitive features in
this condition.
A patient with Smith Magenis Syndrome (SMS) in
whom mutations of RAI1 have been excluded. We
collaborate with Dr. Sarah Elsea (Virginia
Commonwealth University), who has furnished us
with 24 patients with SMS unrelated to RAI1 muta-
tions.
Development of Methods
to Generate Haploidy
from Diploidy
Y. Hanada
Once copy-number fluctuations are validated, it is
often of interest to study these in greater detail to
determine precise genomic boundaries and to under-
stand possible genomic structural predispositions to
rearrangement. Liquid DNA is diploid (unless isolat-
ed from single sperm), and it is problematic to sepa-
rate the two alleles for further study. A traditional
approach to separating chromosomal homologs is the
generation of somatic cell hybrids. This method,
although robust, is extremely time consuming and
labor intensive.
We are experimenting with the separation of chro-
mosome homologs by universal amplification of dilu-
tions of chromosome suspensions generated from
patients of interest. Chromosomes are diluted to final
concentrations of approximately 23 chromosomes per
well in a 96-well plate, and the material is amplified
using multiple displacement amplification with the
highly processive enzyme phi29. PCR analysis of the
amplified material is then used to determine whether
the two homologs have been separated in different
wells of the same plate. Our results to date are
encouraging, both in terms homolog separation and in
our ability to avoid contamination with exogenous
DNA.
Genome-wide Array-based
Analysis of DNA Methylation
E. Hatchwell
Intergenomic Methylation Comparison: MZ Twins.
The underlying causes of phenotypic variation in
human genetic disorders are still largely not under-
stood. Although "genetic background" is often invoked
to explain variation in nonidentical individuals, this
appears not to be relevant to monozygotic (MZ) twins
(although somatic mutations cannot be excluded). One
possible source of phenotypic variation in MZ twins is
the epigenome-the state of the genome unrelated to
DNA sequence variation. Preliminary evidence sug-
gests that MZ twins may vary greatly in their methyla-
tion. Such studies have, however, been limited to the
examination of specific genes.
We have designed and optimized a genome-wide
array, based on the generation of oligonucleotides, in
collaboration with NimbleGen. Our arrays are based
on the use of small HpaII fragments from the human
genome. HpaII cleaves at CCGG, only when the inter-
nal C is not methylated. By recovering small HpaII
fragments from the genome, it is possible to obtain a
genome-wide picture of DNA methylation. We have
studied five sets of MZ twins, both normal and dis-
cordant for reading ability, a collaboration with
Professor Ian Craig, Institute of Psychiatry, London.
Preliminary analysis reveals dramatic differences at
some loci and general differences genome-wide
between concordant and discordant MZ twins.
This work was performed in collaboration with J
Greally, Albert Einstein College of Medicine.
Intragenomic Methylation Analysis. We have con-
tributed to the development of a novel methodology
known as the HELP assay (HpaII tiny fraction [HTF]
enrichment by ligation-mediated PCR). In this method,
a comparison is carried out between small Mspl and
small HpaII fragments from the same genome. This
allows for an intragenomic methylation profile to be
built up. The data have been extensively validated
using pyrosequencing and has demonstrated dramatic
tissue-specific differences in methylation.
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THE ORIGIN AND VIABILITY OF CANCER CELLS
Y. Lazebnik C. Cormier A. Matapurkar
D. Duelli M. Yuneva
S.-C. Lin
Our research focuses on two questions: How are nor-
mal cells converted into cancer cells? How can cancer
cells be killed by manipulating the mechanisms that
control their viability?
CELL FUSION AS A COFACTOR IN CARCINOGENESIS
AND TUMOR PROGRESSION
Our interest in the first question was triggered by an
accidental observation that cells in tissue culture fuse
with each other. Studies of published reports on cell
fusion revealed that it is a process that induces aneu-
ploidy, a hallmark of cancer cells, and further increas-
es cell diversity by combining, segregating, and rear-
ranging epigenetic and other regulatory networks of the
fusion partners. A century ago, the observation that cell
fusion causes aneuploidy led to a hypothesis, which has
been evolving, that accidental cell fusion can produce
cancerous cells. If cell fusion can indeed lead to cancer,
one question is how this fusion is induced.
In the body, fused cells come from two sources:
physiological and aberrant cell fusion. Physiological cell
fusion is a part of normal development that is required to
produce the zygote and several types of multinuclear
somatic cells. Importantly, with the exception of the
zygote, cells produced by physiological cell fusion are
terminally differentiated and do not proliferate. Aberrant
cell fusion can be caused by a variety of agents, includ-
ing viruses, chemicals, and fibers (e.g., asbestos) or by
abnormal expression of cellular proteins.
Viruses are of particular interest as pathological
fusogens because they are ubiquitous, diverse, amplifi-
able, can persist in cells inconspicuously, and have
been implicated in carcinogenesis. Yet, cells fused by
viruses are considered harmless because they die. We
provided evidence that a primate virus uses both viral
and exosomal proteins involved in cell fusion to pro-
duce transformed proliferating human cells. While nor-
mal cells indeed fail to proliferate after fusion, expres-
sion of an oncogene or a mutated tumor suppressorp53
just in one of the fusion partners is sufficient to pro-
duce heterogeneous progeny. We also demonstrated
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that this virus can produce viable oncogenically trans-
formed cells by fusing cells that are otherwise destined
to die. Therefore, we proposed that viruses can con-
tribute to carcinogenesis by fusing cells (Fig. 1).
In particular, our model proposes how a virus can
contribute to carcinogenesis or tumor progression
without becoming a part of the affected cells. Indeed,
a current view is that viruses transform cells by intro-
duction of oncogenes or by modifying normal gene
expression through integration into the host genome.
This concept implies that if a virus is an etiological
agent of cancer, cancer cells must carry or have carried
the viral genome. Our model implies that a virus may
produce cancer cells without infecting them, a notion
that may help to understand better the numerous cor-
relative links between retroviruses and human cancers.
METABOLIC CHANGES AS A BASIS FOR KILLING
CANCER CELLS SELECTIVELY
The second part of our research is based on the notion
that understanding how cancer cells are generated may
not provide a clue on how to kill them. Therefore, we
are exploring differences between normal and cancer
cells that allow for their selective or preferential
killing of cancer cells. In a search for these differ-
ences, we have been focusing on apoptosis and, in par-
ticular, on its regulation by nutrients.
Apoptosis is a type of cell death that is carried out
by specialized cellular machinery. The current knowl-
edge is sufficient to design and implement tools that
kill cells quickly and efficiently by inducing apoptosis.
However, the major problem is how to induce apopto-
sis in cancer cells selectively. One approach to solving
this problem is to learn how apoptosis is induced by
oncogenic transformation. This approach is based on a
paradoxical observation that some oncogenes, includ-
ing myc and adenovirus El A, either induce apoptosis
or sensitize cells to cytotoxic agents, including those
used for chemotherapy. One implication of this obser-
vation is that some oncoproteins are pro-apoptotic
activities specific for transformed cells. If true, then
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FIGURE 1 Cell fusion as a link between viruses and carcinogenesis. Illicit cell fusion induced by viruses has no consequences for car-
cinogenesis if resulting cells either die or do not proliferate. However, events that deregulate the cell cycle, which includes viral proteins
such as E1 A or E7, enable proliferation of fused cells. The majority of these cells die within a few cell divisions because of chromoso-
mal aberrations associated with abnormal mitoses or other consequences of cell fusion. The few cells that survive have a deregulated
cell cycle, lack normal response to this deregulation, are aneuploid, and have epigenetic regulation that is an unpredictable result of the
merger between fusion partners. A combination of these properties in a minute fraction of the fused cells may be sufficient to make
them cancerous. Considering that a single cell can give rise to a cancer, the frequency with which cell fusion produces such cells does
not need to be high to have pathological consequences. A cancer cell may fuse to another cell, thus increasing diversity of a tumor.
understanding how the apoptotic machinery is regulat-
ed by oncogenes may can-
cer cells selectively.
A prevailing approach for activating caspases in
cancer cells is cell damage that induces activation of
the apoptotic machinery. For largely historical reasons,
this damage usually involves DNA, a molecule that is
identical chemically in normal and transformed cells,
and modifications of which often cause mutations,
some of which can lead to cancer. An evolving alter-
native approach to selective killing of cancer cells is
based on exploiting metabolic differences between
normal and cancerous cells.
Our way of developing this approach was to inves-
tigate how expression of E1A or Myc affects metabo-
lism of human cells and, in particular, how these onco-
genes change dependence of the cells on major nutri-
ents. We found that, in contrast to previous studies,
expression of Myc does not affect sensitivity of the
cells to glucose withdrawal, as both normal cells and
cells that express Myc die without this nutrient, and
cell death has no signs of apoptosis. However, we
found that depletion of glutamine induces apoptosis in
cells that express Myc but does not affect viability of
normal cells. Previously, glutamine depletion and glu-
tamine analogs that interfere with metabolism of this
amino acid were exceptionally efficient in mouse
models of cancer and were used in the clinic, but they
were abandoned because of their toxicity. We thought
that by understanding how glutamine deficiency caus-
es cell death in transformed cells, we would be able to
suggest how to retain the therapeutic benefits of the
previous treatments but avoid their toxicity.
During this year, we tested whether interfering
with multiple pathways of glutamine metabolism
would mimic the effect of glutamine depletion on cell
viability. We found that interfering with none of these
pathways could kill cells as efficiently as did gluta-
mine depletion. In September of this year, Dr. Maria
Yuneva, who was working on this project moved to Dr.
Michael Bishop's lab at University of California at San
Francisco (UCSF) where she continues this line of
investigation in collaboration with us.
Overall, this part of our studies continued to use
simple experimental systems in order to understand
how cancer cells can be killed selectively.
PUBLICATIONS
Duelli D.M., Hearn S., Myers M.P., and Lazebnik Y. 2005. A
primate virus generates transformed human cells by
fusion. J. Cell. Biol. 171: 493-503.
59
REGULATION OF APOPTOSIS AND SENESCENCE
BY CANCER GENES
S. Lowe A. Bric K. Diggins M. Narita W. Xue
D. Burgess M. Hemann S. Nunez M. Yang
E. Cepero Y. Hippo P. Premsrirut L. Zender
C. Chang V. Krizhanovsky C. Rosenthal Z. Zhao
A. Chicas M. McCurrach M. Spector J. Zilfou
R. Dickins M. Narita H. Wendel J. Zuber
Apoptosis is a genetically controlled form of cell death
that is important for normal development and tissue
homeostasis. Senescence produces "genetic death" in
that the senescent cell is incapable of further propaga-
tion. Both processes are frequently disrupted in cancer
cells, implying that each can limit tumor development.
Moreover, radiation and many chemotherapeutic
agents can induce either apoptosis or senescence, rais-
ing the possibility that the integrity of these pro-
grammed responses influences the outcome of cancer
therapy in patients. The goal of our research is to
understand how cancer genes control apoptosis and
senescence in normal cells, and how mutations that dis-
rupt these processes impact tumor development and
therapy. Our approach emphasizes genetics, and we
have increasingly relied on new types of animal mod-
els and gene manipulation technologies to study tumor
development and cancer therapy in vivo.
Control of Apoptosis by Oncogenes
Tumor Suppressor Genes
A. Bric, D. Burgess, E. Cepero, M. Hemann, M. McCurrach,
M. Narita, W. Xue, L. Zender, J. Zilfou [in collaboration with
former laboratory member A. Samuelson]
Normal cells possess intrinsic tumor suppressor mech-
anisms that limit the consequences of aberrant prolif-
eration. For example, deregulated expression of the c-
Myc or disruption of the Rb (retinoblastoma) pathway
in normal cells can force aberrant S-phase entry and
predispose cells to apoptotic cell death. This increased
sensitivity to apoptosis acts through both p53-depen-
dent and independent pathways and potently limits
tumor development. We have previously shown that
oncogenes can engage the ARF-p53 pathway to pro-
mote apoptosis, and that disruption of this pathway
cooperates with oncogenes to transform normal cells
in vitro and promote tumorigenesis in vivo. We are
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currently interested in identifying additional compo-
nents of these programs and understanding how they
function in a "tumor suppressor network."
Historically, we have used the E1A oncoprotein to
study how proliferation is coupled to apoptosis. Using
a structure-function approach, we recently showed that
E1A induces ARF and p53 and promotes apoptosis in
normal fibroblasts by physically associating with Rb
and a p400/TRRAP complex, and that its interaction
with p300 is largely dispensable for these effects
(Samuelson et al. 2005). We further showed that E1A
increases p400 expression and, conversely, that sup-
pression of p400 using stable RNA interference
reduces the levels of ARF, p53, and apoptosis in E1A
expressing cells. Therefore, although E1A inactivates
Rb, it requires p400 to efficiently promote cell death.
More recently, we collaborated with William Tansey
and Gregory Hannon to explore how E1A binding to
p400 contributes to El A's apoptotic potential and
transforming capabilities.
Like E1A, the cellular c-Myc oncoprotein drives
proliferation and cell death. In Burkitt's lymphoma,
this deregulation occurs via reciprocal translocations
that juxtapose c-myc with an immunoglobulin (Ig)
promoter, leading to gross overexpression of c-myc
mRNA in the B-cell lineage. In addition, point muta-
tions are often found in the translocated myc alleles,
clustering in a conserved region known as Myc box I.
Although some mutations can increase Myc stability
and transforming activity in vitro, their impact on the
pathogenesis of Burkitt's lymphoma is unclear. In fact,
translocated c-myc genes are subject to hypermutation
in vivo that can also alter noncoding sequences, rais-
ing the possibility that these mutations are a conse-
quence and not a cause of tumor development.
This year, we showed that two common mutant
myc alleles derived from human Burkitt's lymphomas
uncouple proliferation from apoptosis and, as a result,
are substantially more effective than wild-type myc at
promoting B-cell lymphomagenesis in mice (Fig. 1)
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FIGURE 1 Tumor-derived myc mutants are highly oncogenic in
vivo. Mice were reconstituted with hematopoietic stem cells
expressing wild-type myc or two tumor-derived myc mutants
(P57S and T58A) together with green fluorescent protein. Animals
were monitored for tumorigenesis using lymph node palpation (A)
and whole body fluorescence imaging (8) (Hemann et al. 2005).
(Hemann et al. 2005). Mutant Myc proteins retain
their ability to stimulate proliferation and activate
p53, yet are defective at promoting apoptosis due to a
failure to induce the BH3-only protein Bim and effec-
tively inhibit Bcl -2. Disruption of apoptosis through
enforced expression of Bcl -2, or loss of either Bim or
p.53, enables wild-type myc to produce lymphomas as
efficiently as mutant myc. These data reveal how par-
allel apoptotic pathways act in concert to suppress
Myc-induced transformation and how mutant Myc
proteins, by selectively disabling a p53-independent
pathway, allow tumor cells to evade p53 action during
lymphomagenesis.
Control of Cellular Senescence
D. Burgess, C. Chang, A. Chicas, V. Krizhanovsky,
M. Narita, M. Narita, S. Nunez
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in cul-
tured human fibroblasts and is characterized by a series
of poorly understood markers. Senescent cells remain
metabolically active, but they are unable to proliferate
and display changes in gene expression that could alter
tissue physiology. As such, they are genetically "dead"
and cannot contribute to tumor development. Although
"replicative" senescence is triggered by telomere attri-
tion and can be prevented by telomerase, an identical
endpoint can be produced acutely in response to activat-
ed oncogenes, DNA damage, oxidative stress, and sub-
optimal cell culture conditions. These observations have
led us to propose that senescence acts in parallel to apop-
tosis as a cellular response to stress and acts in a similar
way to suppress tumorigenesis and mediate responses to
chemotherapy (for review, see Narita et al. 2005). Indeed,
on the basis of this analogy, much of our work on senes-
cence is guided by our past experience on apoptosis.
We continue to identify and characterize new fac-
tors that modulate senescence, with a particular empha-
sis on the senescence machinery, i.e., molecules that
contribute to the irreversibility of the arrest. We recent-
ly reported that some senescent human fibroblasts accu-
mulate a novel type of chromatin structure (named
senescence-associated heterochromatic foci or SAHF)
that is dependent on the Rb tumor suppressor and is
associated with the stable silencing of E2F target genes.
To gain insight into the chromatin changes linked with
senescence, we have begun a proteomics analysis to
identify molecules that selectively associate with chro-
matin in senescent cells. These studies have identified
the high-mobility-group A (HMGA) proteins as pro-
teins that accumulate on chromatin in senescent cells,
where they localize with SAHFs. These results are para-
doxical, as HMGA proteins have previously been linked
to oncogenic transformation. Unraveling the role of
HMGA proteins in senescence and their paradoxical
role in cancer is one of our current challenges.
Modulation of Gene Expression In Vivo
Using RNA Interference
R. Dickins, M. Hemann, P. Premsrirut, W. Xue, L. Zender,
J. Zilfou [in collaboration with G. Hannon and L. He,
Cold Spring Harbor Laboratory]
RNA interference (RNAi) is a powerful method for sup-
pressing gene expression in mammalian cells. Stable
knockdown of gene expression can be achieved by con-
tinuous expression of synthetic short hairpin RNAs
(shRNAs), typically from RNA polymerase III promot-
ers. However, primary microRNA transcripts (pri-
miRNAs), which are endogenous triggers of RNAi, are
normally synthesized by RNA polymerase II (pol II). In
collaboration with Gregory Hannon, we showed that
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pol II promoters expressing rationally designed pri-
miRNA-based shRNAs (shRNAm'r) produce potent, sta-
ble, and regulatable gene knockdown in cultured cells
and in animals, even when present at a single copy in
the genome (Dickins et al. 2005). Most notably, by
tightly regulating p53 knockdown using tetracycline-
based systems, we showed that cultured mouse fibrob-
lasts can be switched between proliferative and senes-
cent states and that tumors induced by p53 suppression
and cooperating oncogenes regress upon p53 reexpres-
sion. In practice, this shRNAm'r vector system is remark-
ably similar to cDNA overexpression systems and
should be a powerful tool for studying gene function in
cells and animals. We are taking advantage of these
tools to explore various aspects of tumor suppressor
gene networks in vitro and in vivo (see, e.g., Ramiero et
al., in press; Zender et al., in press].
In parallel to these efforts, we have also collaborat-
ed with Dr. Hannon to study the oncogenic potential of
endogenous microRNAs (miRNAs). To date, more than
200 miRNAs have been described in humans; however,
the precise function of these regulatory, noncoding
RNAs remains largely obscure. A comparison of B-cell
lymphoma samples and cell lines to normal tissues
reveals that substantially increased levels of the mature
miRNAs from the miR17-92 locus are often found in
these cancers. Notably, the gene encoding this miRNA
polycistron is present in a region of DNA amplification
found in human B-cell lymphomas. Enforced expres-
sion of the miR17-92 cluster cooperates with c-myc,
accelerating tumor development in a mouse B-cell lym-
phoma model (He et al. 2005). Tumors derived from
hematopoietic stem cells expressing mir/ 7-92 and c-
myc are distinguished by an absence of the apoptosis
that is otherwise prevalent in c-myc-induced lym-
phomas. These studies indicate that noncoding RNAs,
specifically miRNAs, can modulate tumor formation
and implicate the miR17-92 cluster as a potential human
oncogene. We continue to work with the Hannon group
to characterize the oncogenic properties of mIR17-92.
A New Mouse Model of
Hepatocellular Carcinoma
Y. Hippo, M. Spector, W. Xue, L. Zender [in collaboration
with R. Lucito, D. Mu, S. Powers, and M. Wigler,
Cold Spring Harbor Laboratory; C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center; and
P. Flemming, Hanover Medical School]
Hepatocellular carcinoma (HCC) represents the fifth
most frequent neoplasm worldwide. However, due to a
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lack of treatment options, it constitutes the third lead-
ing cause of cancer death (>500,000 deaths per year).
The only curative treatment options for HCC are sur-
gical resection or liver transplantation. Unfortunately,
at the time of diagnosis, the majority of patients have
an advanced tumor and are not candidates for surgical
therapy. Systemic chemotherapeutic treatment is inef-
fective against HCC, and so there is a great need for
new therapies to treat this disease.
Our understanding of the molecular genetics and
biology of liver cancer lags behind that of other major
cancers, and these deficiencies represent a major
obstacle to the development of new therapies. To better
study this disease, we generated a new mouse model of
hepatocellular carcinoma that is based on the ex vivo
manipulation of liver progenitor cells, followed by the
seeding of these cells into normal recipients. These
methods allowed us to rapidly produce in situ liver can-
cers of defined genetic origin. After retroviral gene
transfer of oncogenes or shRNAs targeting tumor sup-
pressor genes, genetically altered liver progenitor cells
are seeded into the liver of otherwise normal recipient
mice. We show that histopathology of the engineered
liver carcinomas reveals features of the human disease.
Furthermore, representational oligonucleotide micro-
array analysis (ROMA) of murine liver tumors initiat-
ed by two defined genetic hits revealed spontaneously
acquired genetic alterations that are characteristic for
human hepatocellular carcinoma. This model provides
a powerful platform for applications like cancer gene
discovery and high-throughput preclinical drug testing.
Working with collaborators at CSHL, we are using this
to interrogate the genetics and biology of liver cancer,
with the ultimate goal of using this model to validate or
test new therapies.
Molecular Genetics of Drug
Sensitivity and Resistance
D. Burgess, M. Hemann, Y. Hippo, M. McCurrach,
C. Rosenthal, H. Wendel, M. Yang, L. Zender, J. Zilfou,
J. Zuber [in collaboration with C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center; S. Kogan,
University of California, San Francisco]
A major goal of our research is to understand the bio-
logical and molecular basis of drug sensitivity and
resistance in tumors. Conventional approaches to
identify factors that dictate treatment sensitivity often
rely on human tumor cell lines treated in vitro or as
ectopic xenografts. As an alternative approach, we are
using transgenic mouse models to study drug action in
spontaneous tumors. One system exploits the Ei-myc
transgenic mouse, which develops B-cell lymphomas
at short latency with high penetrance. Using this sys-
tem, we have identified a number of biologic and
genetic determinants of treatment sensitivity to con-
ventional chemotherapy in vivo.
More recently, insights into the molecular basis of
cancer have enabled the development of more rational
drugs that attack activities involved in the oncogenic
process. These "targeted" therapeutics are often less
toxic than conventional drugs and have remarkable
activity against some cancers. Nevertheless, de novo
or acquired resistance to these agents remains a clini-
cal problem. In an effort to understand factors that
influence resistance to targeted agents, we are study-
ing that action of the drug Gleevec in a mouse model
of myeloid leukemia. Gleevec is a small-molecule
inhibitor of the Bcr-Abl oncoprotein (the cause of
chronic myelogenous leukemia) and represents the
paradigm of targeted therapy.
Using a mouse model of Bcr-Abl-induced
leukemia, we demonstrated that p53 potentiates the
action of Gleevec in vivo, such that mice harboring
p53-deficient leukemias are more resistant to this
agent. We believe that this reflects a new mode of
resistance to targeted cancer therapy, and we will con-
tinue to explore the basis for this effect. We are also
continuing a multi-institutional effort to use mouse
models of acute myelogenous leukemia to identify
molecular determinants of both conventional and tar-
geted therapies, with the goal of translating this infor-
mation to human patients. We are excited about the
potential of the program, as it provides all of the ele-
ments necessary to validate the use of new mouse
models as preclinical test systems and translate this
information into clinical trials.
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GENOMIC MICROARRAY ANALYSIS OF CANCER
R. Lucito T. Auletta S. EI -ftesi
S. Chen S. Khan
0. Dovirak K. Kuntz
Mutation of the genome is central to the development
and progression of cancer. Mutations occur in the
genome of precancerous cells and accumulate, alter-
ing gene function until the growth of these cells goes
unchecked. The genes responsible for cancer must be
identified if we are to understand the cellular pathways
that become subverted to allow the cell to become can-
cerous. We have developed a genomic microarray
technique, representational oligonucleotide microar-
ray analysis (ROMA), to identify copy-number fluctu-
ations, which borrows the methodology of complexity
reducing representations developed for RDA (repre-
sentational difference analysis) to increase hybridiza-
tion efficiency and increase signal to noise. A repre-
sentation is a reproducible sampling of the genome,
produced by first cleaving the genome with a restric-
tion enzyme such as BglII, ligation of adaptors, and
polymerase chain reaction (PCR) amplification. BglII
representations of tumor and normal that are differen-
tially labeled are compared on such an array to identi-
fy copy-number fluctuations. The array is composed
of oligonucleotides based on the sequence of the
human genome. We are using microarrays photochem-
ically synthesized by Nimblegen Systems, Inc.
Currently, we are using arrays with 85,000 probes dis-
tributed throughout the genome and soon will be mov-
ing to an array of 390,000 probes.
We have continued surveying the genome of sever-
al cancer types to identify regions that have undergone
increased or decreased gene copy number, namely,
amplifications or deletions, since these changes can be
used as markers for the location of oncogenes or tumor
suppressor genes, respectively. Regions are being
informatically searched for gene candidates, and then
functional analysis of these candidates is being carried
out to determine which genes have oncogenic poten-
tial. Once identified, these gene functions can be inves-
tigated to understand their role in the path to tumorige-
nesis. In addition, by analyzing the regions alongside
clinical data, we will determine if there are any regions
or combination of regions that correlate with clinical
outcome. The application of this type of an array spans
many areas of biology, from cancer to genetic diseases.
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We will be using this microarray method to categorize
the mutations that occur in primarily two tumor types
initially, pancreatic and ovarian cancer.
PANCREATIC CANCER
There will be an estimated 30,000 cases of pancreatic
cancer this year. Of those, 29,700 patients will suc-
cumb to the disease. Although the number of cases is
low in comparison to several other cancers such as
colon, lung, or breast, the survival rate for pancreatic
cancer is one of the lowest. Treatments can extend sur-
vival or alleviate pain but seldom cure the patient. In
fact, the mean survival time is approximately 6
months. Because lifespan after diagnosis is very short,
the number of patients who receive tumor resections is
very low. This translates to few samples available for
analysis. Because of this, we are collaborating with
many clinicians to put together a useful tumor bank of
pancreatic tissue for analysis by ROMA. Currently, we
are collaborating with Dr. Ralph Hruban of Johns
Hopkins University, Dr. Daniel Von Hoff of the
Arizona Cancer Center, and Dr. Vijay Yajnic of
Massachusetts General Hospital, who will be provid-
ing pancreatic specimens and invaluable clinical infor-
mation and expertise. To date, we have analyzed 66
samples composed of 33 primary tumors, 15 cell lines,
and 18 xenografts. In addition, we have compiled pub-
lished data for an additional 16 primary tumor samples
into our data set to increase the information content.
We have confirmed that many of the known mutated
regions are altered in this set, including genes such as
the INK4a-ARF locus, SMAD4, p53, and c-myc to
name a few. In addition, there are other less character-
ized regions deleted (2p23, 3p, 4q23, 5p15, 10p15,
and 12p) and amplified (1q42-43, 3q26, 6p21, 7p21,
14q21, 18q11, and 19q12) frequently in this cancer,
and we are continuing to study these regions to identi-
fy possible gene candidate tumor suppressors and
oncogenes.
Although we are working on several regions at this
time, we will summarize one region amplified on
19q12 in specifics. A number of tumors and cell lines
have this region amplified, but with two tumors that
have the most informative amplicons, the epicenter or
common region of mutation was delimited to approx-
imately 2 million bases. This region contains 20 gene
candidates. In the samples that have gene amplifica-
tion, it is highly likely that the target gene is overex-
pressed at the RNA level, and the nontarget genes will
not be overexpressed, although they may be overex-
pressed as a consequence of being gene-amplified. To
decrease the number of viable gene candidates, gene
expression analysis was performed on the cell lines
and one of the primary tumors that have the amplicon.
After this analysis was completed, the number of can-
didates was decreased to only two. Immunohisto-
chemistry on one of the tumors that had gene amplifi-
cation clearly demonstrated that one candidate was
expressed highly in the normal as well as the tumor
sample. The other candidate, a gene called p21-acti-
vated kinase or PAK4, was nearly absent in the normal
but was found at extremely high levels in the tumor
sample tissue. To determine if the encoded protein is
active, we performed an in vitro kinase assay on
extracts from cell lines that have the amplicon. In
comparison to a cell line that did not have amplifica-
tion of this gene, the cell lines had 10-15 more protein
and 8- to 10-fold more kinase activity. Mutated or
activated forms of PAK4 have been shown to increase
tumorigenicity. We are presently sequencing the PAK4
gene in these samples to determine if the gene present
encodes a constitutively active protein. However,
another way of activating PAK4 is to activate RAS, an
extremely common event in pancreatic cancer. Codon
12 (the most commonly mutated codon) of RAS was
sequenced for these samples and four of five have an
oncogenic form of the RAS protein. It is possible that
PAK4 itself is activated in this fifth sample, and we
will dermine this shortly. In the future, we plan to use
short hairpin RNA (shRNA) constructs to knockdown
the level of PAK4 in cells with the amplicon to deter-
mine the effect on tumorigenicity. We will also be
moving this gene into an animal model for pancreatic
cancer.
OVARIAN CANCER
We are also focusing on the analysis of ovarian cancer
using ROMA. Ovarian cancer has a relatively high
incidence and approximately 50% survival rate. In
many patients, the cancer is diagnosed late, often hav-
ing metastasized, the first symptoms being an accu-
mulation of fluid in the abdominal cavity. There have
been few genes discovered that are involved in the pro-
gression of ovarian cancer. We will be collaborating
with Dr. Michael Pearl of SUNY Stony Brook for
access to tissue and clinical information. We will also
be performing ROMA on a tumor set of approximate-
ly 200 ovarian cancer samples to identify gene copy-
number fluctuations to identify candidate tumor sup-
pressor and oncogenes.
At present, we have analyzed 75 tumors and have
compiled the data to identify regions commonly ampli-
fied or deleted. We have identified uncharacterized
regions commonly amplified (1q21, 3q26, 6p, 11q13,
12p, and 20p13) and regions that are deleted frequent-
ly (1p35, 3p26, 4p15, 4q34, 5814, 5q34, 6q22, 9q22,
12q, 13q13, 16q, 19p, and 22q13). We have character-
ized these regions for gene content and have chosen
several to move further for gene characterization.
One such region we are further characterizing is a
deletion on chromosome 5q14. This region is relative-
ly small and contains only seven gene candidates.
Since there were so few candidates in this region, we
performed quantitative PCR (QPCR) on the mRNA of
a large panel of cell lines and primary ovarian tumors.
Presently, we have removed all candidates from analy-
sis based on the expression data (similarly to what we
have done for the pancreatic region discussed above),
and have three candidates to further characterize. One
gene in this region, Centrin 3 (CETN3), is of particular
interest. CETN3 is a component of the centrosome and
takes part in the cellular duplication process. In lower
organisms, there is only one centrin, and experimental
deletion of this gene resulted in centrosome amplifica-
tion and aneuploidy, a common phenotype of cancer
cells. We are presently studying whether the removal of
this gene contributes to aneuploidy in cancer cells.
Methylation-specific Oligonucleotide
Microarray Analysis (MOMA)
0. Dovirak, S. Chen, K. Kuntz, S. Khan
In addition to genetic mutation such as amplification
and deletion, there are epigenetic mechanisms used to
influence the transcriptional activity of a gene. One
such mechanism is methylation of the cytosines pre-
sent in the DNA of the transcriptional control region,
which often suppresses the expression of the gene. It
has been known that methylation of DNA has been
involved in the silencing of gene expression in
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imprinting and in cancer. Recent advances including
technical and also the sequencing of the genome have
made detection of methylation at loci more reliable
and accurate. However, few methods can identify
methylation changes over the entire genome. We have
adapted ROMA to methylation-specific oligonu-
cleotide microarray analysis (MOMA). Currently, we
are utilizing this procedure to survey the changes that
occur in cancer, but in principle, this method would
have applications for identifying methylation differ-
ences involved in imprinting or other syndromes that
do not involve genetic mutation.
We have taken advantage of several enzymes that
discriminate methylated and unmethylated cytosines
(MOMA). For example, a sample can be treated with
two restriction enzymes, McrBC, which cleaves at
(G/A)"'C (N40_3000) (G/A)mC, and MspI, which cleaves at
all sites of CCGG, in effect depleting the representation
of fragments that have methylated CpGs. A second
aliquot of the same sample is mock-digested for McrBC
and digested with HpalI, which is an isoschizomer of
Mspl (recognizes the same sequence) but cleavage is
blocked if the cytosine is methylated. The two different-
ly processed samples are then compared.
We are continuing to develop this method. We
have redesigned the array to represent known CpG
islands of the genome, to make an array that is more
specific for methylation detection and transcription
control. We have tested the array with several samples
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and have demonstrated that it can discriminate when a
CpG island is methylated or not methylated. We can
also see, as others have reported, that when a cell
becomes cancerous, there is a paradoxical decrease in
global methylation and an increase in CpG island
methylation. We have analyzed a cell line that has been
reported to have the p16 CpG island hypermethylated.
After analyzing this sample by MOMA, we can iden-
tify that the p16 promoter is more methylated than in
normal samples. We plan to perfect this method so that
it can be utilized to rapidly analyze the methylation
state of the CpG islands in the genome. It is becoming
clear that methylation silencing has an important role
in cancer, and we intend to marry both techniques-
ROMA and MOMA-as well as expression analysis
to obtain a more complete picture of tumorigenesis.
Both mutation and methylation have an effect on the
level of gene transcription, a good example being the
deletion of one copy of the 1NK/ARF locus and the
hypermethylation of several of the CpG islands within
this locus, specifically that in front of the p16 gene. By
analyzing those regions of the genome that have been
physically mutated whether amplified or deleted and
those regions of the genome that are differentially
methylated, we will get a more complete picture of the
cancer cell. Ultimately, all of these data will be incor-
porated together and analyzed alongside the clinical
information to determine whether any genetic or epi-
genetic factors correlate with clinical outcome.
MAMMALIAN FUNCTIONAL GENOMICS
A. Mills A. Bagchi W. Keyes
E. Garcia C. Papazoglu
X. Guo Y. Wu
The Mills laboratory designs and utilizes novel mod-
els for elucidating the genetic and molecular basis of
human disease. Research areas include (1) the func-
tional identification of novel tumor suppressor genes
mapping to the short aim of human chromosome 1
and (2) investigation of the role of the p53-related pro-
tein p63 in development, cancer, and aging.
MOUSE MODELS OF HUMAN CANCER
A very exciting project in our lab has been the gener-
atation of a series of mouse strains harboring chromo-
some 4 deletions in an attempt to functionally identify
novel tumor suppressor(s) mapping to the correspond-
ing region of the human genome-the short arm of
chromosome 1. Briefly, chromosome engineering
combines the power of gene targeting with Cre /loxp
recombination and allows the generation of mouse
strains that harbor precise deletions, which if they were
to encompass a genomic interval to which a tumor sup-
pressor maps, and a second hit were to inactivate the
remaining functional copy of the suppressor, would
provide a mouse model of hereditary cancer that could
be used to design new anticancer therapies. The ulti-
mate goal would be to identify the tumor suppressor
within that region. A great advantage of chromosome
engineering is that duplications corresponding to the
deletion interval can also be generated, providing pow-
erful genetic tools. By generating mouse models of
hereditary human cancer, we hope to identify novel
tumor suppressor genes.
FUNCTION OF THE p53 HOMOLOG p63
p63 Deficiency Is Tumor Protective. The discovery
that the p53 tumor suppressor is a member of a multi-
gene family that also includes p63 and p73 has
brought the p53 field into a new era. p63 is a tran-
scription factor structurally and functionally similar to
p.53; in contrast to p53, however, p63 is rarely inacti-
vated in human cancers. In fact, the 3q27 region to
which p63 maps is frequently amplified, or p63 is
overexpressed in the majority of epithelial tumors,
suggesting that p63 has oncogenic potential. Several
years ago, we identified p63 and generated several
p63-deficient mouse models. What was clear from the
phenotype was that despite the striking similarities
between p63 and p53, they perform very different
functional roles in vivo: p63 is essential for develop-
ment of stratified epithelia, whereas p53 is dispens-
able during embryogenesis but functions as a potent
tumor suppressor in the adult. But does p63 also func-
tion as a tumor suppressor? We addressed this ques-
tion by determining whether p63+i- mice were cancer-
prone. In contrast to the high incidence of spontaneous
tumors in p53-'/- mice, p63+1- mice were not predis-
posed to cancer. In fact, p63 heterozygosity decreased
the high tumor incidence of p53+'- mice, indicating
that haploid levels of p63 may even be tumor protec-
tive. Loss of the wild-type p63 allele did not occur and
p63 expression was maintained in the rare tumors that
did develop in the p63+1- cohort. Given p63's essential
role and robust expression in stratified epithelia, we
examined whether chemical carcinogens applied
directly to the skin might reveal a tumor predisposition
that was not appreciated by assessing spontaneous
tumorigenesis. However, p63+1- mice were not suscep-
tible to chemically induced tumors. Indeed, p63+'--
mice developed similar numbers of papillomas, the
same percentage of these progressed to squamous cell
carcinomas, and p63 expression was maintained. This
work reveals that p63 does not perform a role equiva-
lent to p53 in tumor suppression and that reduced p63
may provide a novel tumor suppressive mechanism,
suggesting that modulation of p63-mediated pathways
could offer an effective strategy for anticancer therapy.
p63 Links Cellular Senescence and Aging. During
the course of the tumor study outlined above, we dis-
covered that p63+/- mice had a significant reduction in
life span and developed age-related pathology. To
investigate the role of p63 in the adult, we generated a
conditional system in which p63 could be disrupted in
a tissue-specific and -inducible manner. This model
circumvents the neonatal lethality imposed by p63
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FIGURE 1 Induced loss of p63 in adult skin causes cellular
senescence. Eight-month-old mice were treated with inducer to
activate Cre. Cre-mediated recombination disrupts the p63
locus and efficiently ablates p63 protein (upper panels) in
p63flox/flox/KSCrePR1 [ablated; right]), but not in control (left)
skin. p63 ablation induces markers of cellular senescence such
as senescence-associated-0-galactosidase (SA-0-gal; middle
panels) and p16 (lower panels). These results indicate that p63
modulates the senescent process in vivo.
deficiency; phenotypically "normal" mice are gener-
ated, and Cre is activated specifically within stratified
epithelia such as the skin by treatment with inducer at
the desired time point. This system efficiently dis-
rupts p63 and ablates p63 protein in vivo-during
embryogenesis, in the neonate, and in the adult. In
addition, this model provides a relevant cell-based
system to study p63 function: primary keratinocytes.
To date, we have used this system to reveal an unan-
ticipated link among p63, cellular senescence, and
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aging. p63 deficiency activates a program of cellular
senescence and leads to accelerated aging. Both germ-
line-induced and somatically induced p63 deficiency
causes up-regulation of senescence markers SA-13-gal,
promyelocytic leukemia (PML), and p16 in the
embryo. When p63 is ablated in adult mice, the aging
process is dramatically accelerated, and markers of
cellular senescence are up-regulated (Fig. 1).
Although p63 deficiency-induced cellular senescence
in the germ line is p53 independent, senescence is pre-
vented in Cre-infected primary keratinocytes by short-
hairpin RNA interference (shRNAi)-mediated knock-
down of p53 or PML, but not by knockdown of p16.
The finding that p63 deficiency activates cellular
senescence suggests a mechanism for the low tumor
incidence of p63+- mice: cellular senescence effec-
tively removes aberrantly proliferating cells from the
proliferative pool, thus providing a tumor-suppressive
mechanism. A further understanding of how p63-
mediated pathways modulate the senescent process
will impact our ability to design more effective anti-
cancer regimens in the future.
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ANGIOGENESIS-MEDIATED TUMOR GROWTH AND METASTASIS
V. Mittal K. Bambino J. Marku
B. Cong A. Mel lick
D. Gao D. Nolan
A. Jadali R. Stephen
Neovascularization is a distinguishing hallmark of
cancer malignancy. The induction of tumor vascula-
ture, termed the "angiogenic switch," is critical for
tumor progression and metastasis. Proangiogenic
growth factors such as VEGF (vascular endothelial
growth factor), FGF (fibroblast growth factor),
angiopoietins released by tumor cells promote activa-
tion, proliferation, and migration of endothelial cells
(ECs) to tumor tissues, allowing for rapid formation of
functional neovessels. Thus, targeting angiogenesis in
tumors is a promising anticancer therapy. Indeed, the
first antiangiogenic cancer drug-the anti-VEGF anti-
body Avastin-has provided an overall survival bene-
fit in colorectal, breast, and lung cancer patients when
combined with conventional chemotherapy. Despite
promising success, cancer patients receiving a single
class of angiogenesis inhibitors, even in combination
with chemotherapy, eventually succumb to their dis-
ease. Several possible mechanisms exist that may
explain the acquired resistance of antiangiogenic
drugs. For instance, continuous angiogenic block is
often followed by a regrowth phase. These regrowing
tumors display a more invasive and malignant pheno-
type associated with reinduction of angiogenesis and
the reestablishment of tumor vasculature. It has also
been suggested that the recruitment of bone marrow
(BM)-derived proangiogenic cells may also provide a
potential mechanism of escape to some antiangiogenic
strategies. Thus, targeting ECs or the principal angio-
genic factor VEGF alone may not suffice to eradicate
malignant tumors, and other components, including
the endothelial progenitor cells (EPCs), may need to
be targeted as well.
Solid tumors are composed of malignant cells and
many other nonmalignant cell types. This produces a
unique microenvironment that can modify the neo-
plastic properties of the tumor cells. The tumor
microenvironment contains many resident cell types,
such as adipocytes, fibroblasts, and migratory
hematopoietic cells, most notably macrophages, neu-
trophils, and mast cells. Tumor-derived angiogenic
factors also promote recruitment of BM-derived
hematopoietic stem/progenitor cells, endothelial prog-
enitors, and pericyte progenitors. All of these cells
have pivotal roles in the progression of primary
tumors, as well as metastatic dissemination. Although
the perivascular contribution of BM-derived hemato-
poietic cells in neovasculature formation has received
much attention, little is known about the nature and
function of BM-derived EPCs.
The focus of research in our laboratory is to under-
stand how tumors build blood vessels by de novo
recruitment of BM-derived EPCs and how we can
exploit these cells in delivering and evaluating antian-
giogenic therapy. In last year's Annual Report, we
described the establishment of a BM transplantation
(BMT) model to determine how tumors direct the
expansion, mobilization, and incorporation of EPCs
into the functional tumor neovasculature. We showed
that BM-derived ECs had incorporated into functional
neovessels in the tumor. We also determined up-regu-
lation of transcription factors Idl in tumor-challenged
BM precursors. Consequently, short hairpin RNA
(shRNA)-mediated suppression of Id gene expression
resulted in a significant delay in tumor growth as a
consequence of vascular defects. We have now
expanded upon the critical role of EPCs further by (1)
defining their contribution to vessel formation at vari-
ous stages of tumor growth, (2) understanding the
molecular mechanisms that govern EPC mobilization,
and (3) determining their broader role in neovascular-
ization of tumors in the metastatic sites.
To Identify, Characterize, and
Determine the Contribution of
EPCs in Tumor Neoangiogenesis
D. Nolan, K. Bambino, B. Gong, A. Jadali [in collaboration with
D. Scheinberg and R. Benezra, Memorial Sloan-Kettering
Cancer Center, New York]
We have continued to exploit the BMT model further
to determine the contribution of BM-derived EPCs in
neovessel formation at various stages of tumor growth.
Early tumors showed a marked recruitment of BM-
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derived EPCs at the periphery of the advancing tumor
margins. These cells represent EPCs as judged from
their uniform cell surface expression of VE-cadherin,
low CD31 (greater than tenfold), VEGFR2, and stem
cell marker Prominin I. These cells were distinct from
hematopoietic lineages as they did not express mark-
ers such as CD1 lb (monocytes, macrophages, granu-
locytes), CD45RB (monocytes, granulocytes, subsets
of T and B cells), and CD41 (megakaryocytes).
Analysis of later tumors showed a reduction in the
number of EPCs at the tumor periphery and recruit-
ment of CD31+ mature blood vessels. These vessels
had luminally incorporated BM-derived green fluo-
rescent protein (GFP) mature ECs. We quantitated
luminally incorporated BM-derived EC in tumor ves-
sels. Approximately 17% of all vessels had incorpo-
rated BM-derived ECs, and these vessels markedly
decreased with tumor growth. We also performed sys-
temic perfusion with fluorescently labeled isolectin
IB4, which specifically stains distinct oligosaccha-
rides of the ECs in functional blood vessels. Flow
cytometry analysis showed that approximately 8% of
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ECs in orthotopic melanomas and about 18% in LLCs
were BM-derived ECs. Although the recruitment of
BM-derived ECs was observed persistently in the
tumor vasculature, the notion that EPCs are required
for angiogenesis-mediated tumor growth needed for-
mal substantiation. To determine this, we directly
ablated EPCs with the VE-cadherin function-blocking
antibody E4G10. Importantly, E4G10 recognizes the
exposed monomeric epitope of VE-cadherin that has
not yet engaged in trans-adhesion observed in mature
ECs in vessels. Therefore, E4G10 does not target nor-
mal vasculature or tumor vasculature but recognizes
the monomeric VE-cadherin present on EPCs. To
increase the potency of E4G10 at low concentrations,
we conjugated it to radioactive actinium-225 (225Ac).
Administration of 225Ac-labeled E4G10 at days 3, 5, 7,
and 10 significantly reduced the accumulated tumor
burden per animal (by -50%, compared to the admin-
istration of 225Ac-labeled IgG isotype control [Fig.
la]). The impaired tumor growth was associated with
a marked reduction (>45%) in VE-cadherin+ EPCs
(Fig. lb). This effect was specific because no
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FIGURE 1 Ablation of endothelial progenitor cells impacts tumor growth in vivo. Representative sections are
from 3 to 6 mice/group. Error bars represent standard deviations. Asterisks represent significant by t-test. (a)
Lewis lung carcinoma tumor volume at day 6 (white box) and day 14 (black box) in animals administered with
control 225Act-labeled IgG or 225Act-labeled E4G10 antibody (n = 8). (b) BM-derived GFP* VE-cadheririf CD31-
CD11b- cells in early tumors in animals administered with control 225Act-labeled IgG or 225Act-labeled E4G10
antibody (n = 6-9). (c) CD11 b' cells in animals treated as in c (n = 10 mice). (d) Vessel density in tumors in ani-
mals treated with control and test antibody (day 14). (e) CD31 immunostaining of tumor sections (day 14).
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detectable change was observed in the CD11b+
hematopoietic cells among "'Act-labeled E4G10,
225Act-labeled IgG, or untreated animals (Fig. 1c).
Thus, ablation of VE-cadherin+ EPCs resulted in
marked delay in tumor growth as a consequence of
vascular defects (Fig. 1 d,e).
We are currently identifying pure EPC populations
resident in total BM, dissecting the role of the Id path-
way, and exploiting EPCs to serve as cellular vehicles
for delivering effective therapeutics in the form of (1)
DNA-encoded inhibitory shRNAs, targeting proangio-
genic genes (e.g., components of the Id pathway) and
(2) other therapeutic cargos (e.g., suicide genes and
antiangiogenic gene products) directly and specifical-
ly to the sites of the tumor neovasculature to inhibit its
growth and metastasis.
To Determine Transcriptional
and Posttranscriptional Events
Regulating Mobilization of EPCs
A. Mellick [in collaboration with E. Turner, University of
California, San Diego]
The molecular pathways that determine EPC mobi-
lization/differentiation are largely unknown. We have
used DNA microarray technology to identify candi-
date genes and endogenous microRNAs (miRNA) that
mediate mobilization of EPCs in response to tumor
challenge.
Gene expression changes were identified in freshly
isolated Lin- BM progenitors from tumor-challenged
animals at days 0, 4, 6, and 9 using DNA microarrays.
Of the 14,000 genes examined, on average, 150 of the
transcripts were found to be differentially regulated by
at least 1.5-fold. For validation by real-time quantita-
tive polymerase chain reaction (Q-PCR), we selected
candidates whose expression profiles followed the
clearance (days 4-6) profile of VE-cadherin+ cells
from the BM, as these might be particularly indicative
of early EPC-specific changes (occurring in the BM) in
response to tumor challenge. In this way, certain candi-
date genes, such as helix-loop-helix transcription fac-
tor Id], chemokine receptor CXCR4, stroma-derived
factor SDF1, VE-cadherin, flk1NEGFR2, GATA2,
and Brn3a, were identified. The expression of some of
these candidate genes was localized to the Lin VE-
cadherin+ EPCs.
To determine posttranscriptional events that regu-
late EPC mobilization, we have developed a system for
identifying the differential expression of all known
mouse, human, and rat miRNA. To determine miRNA
changes that may regulate EPC mobilization, we isolat-
ed miRNAs from freshly harvested BM Lin progeni-
tors from tumor-challenged animals at days 0, 4, 6, and
9. Each miRNA sample was labeled with Cy5 or Cy3
and hybridized to the array. Quantitative changes in
miRNA expression showed that 53 miRNAs were dif-
ferentially regulated (at least twofold) in at least one
time point in the Lin- BM, following tumor challenge.
All regulated miRNAs with unknown mRNA targets
were analyzed by computer-based target prediction
algorithms. We selected miRNAs whose expression
profiles followed the clearance (day 6) profile of VE-
cadherin+ cells from the BM, as these might be partic-
ularly indicative of early EPC-specific changes in
response to tumor challenge. We are currently investi-
gating the role of these candidates in EPC mobilization.
To Determine the Role of EPCs in the
Progression of Avascular
Micrometastases to Vascularized
Macrometastases
D. Gao
The progression of micrometastases into vascularized
macrometastases is the leading cause of mortality in
cancer patients. However, not much is known about
the regulation of the antigenic switch or the dynamics
of vessel assembly during this progression. To this
aim, we will investigate the role of EPCs in neovascu-
larization of metastatic lesions. It is conceivable that
targeting EPCs may be a more clinically appropriate
therapeutic approach in blocking growth of metastatic
lesions as compared to primary tumors. This is
because in many cases, by the time a primary tumor is
detected, EPC-mediated neovascularization has
already occurred.
We have developed a system for tracking both
BM-derived cells and tumor cells in vivo, so that these
cells can be localized in the metastases in secondary
organs. Tumor cell lines, including LLCs and an iso-
genic pair of metastatic (B16F10) and nonmetastatic
(B16F0) melanomas, stably expressing monomeric
red fluorescent protein (RFP, cherry version), were
generated. Clonal tumor cell lines were derived, prop-
agated, and tested for their ability to form metastases.
Colonies that expressed high levels of RFP and suc-
cessfully formed metastases were used in subsequent
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experiments. To determine the contribution of BM-
derived EPCs to the formation of neovasculature in
the metastatic colonies, we challenged GFP+ BM
reconstituted mice intradermally with either RFP-
expressing LLCs, which metastasize to the lungs and
occasionally the liver, or B16 melanoma cells, which
possess a more widely disseminated metastatic poten-
tial. The primary tumors were allowed to grow for 2
weeks (average size 300 mm3) and were then resected
to control morbidity associated with excess primary
tumor burden, which would otherwise have occurred
at later time points. We observed the appearance of
micrometastases (average 2-5 per animal, -0.5 mm in
diameter) at the time of primary tumor resection (day
14). Macrometastases were visible after 1 week.
Notably, in most metastases, GFP+ BM-derived cells
colocalized with the tumor cells, indicating the impor-
tance of these BM-derived cells in the growth of these
metastatic lesions. Metastasis was also successfully
tracked in melanoma cells implanted orthotopically in
the skin. Histological analysis on these tumors to
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determine the status of their vasculature showed that
the early tumors were avascular as determined by the
absence of CD31+ vessels in the tumor bed. Analysis
of macrometastases (days 21-28) showed the recruit-
ment of CD31+ mature vessels, indicating that these
colonies had undergone an angiogenic switch.
Notably, some of the early-stage micrometastases
showed recruitment of BM-derived EPCs. Analysis of
tumor vasculature showed incorporation of BM-
derived GFP' CD31+ mature ECs in macrometastases.
We are expanding upon these observations further, by
quantifying EPC contribution, and determining their
functional role in angiogenesis-mediated tumor
growth. We will next determine the consequences of
blocking EPC function on the progression of these
metastatic lesions. As a first line approach, we will use
the VE-cadherin-blocking antibody E4G10, which
specifically targets the monomeric VE-cadherin epi-
tope. In parallel, EPC function will be blocked by
shRNAs-mediated conditional suppression of Idl and
VE-cadherin.
Kathryn Bambino
CANCER GENES
S. Powers A. Bakleh D. Mu
R. Kohnz K. Nguyen
C. Kuscu
This year marks the first full year for our laboratory,
which we set up in October of 2004. Our broad interest
is to identify, validate, and acquire new biological or
clinical knowledge about human cancer genes. We are
committed to perform studies that can benefit cancer
treatment in the near-term, either by validating a new
cancer therapeutic target or by developing biomarkers
than can be used to guide treatment. Along these lines,
this year, we engaged in a productive collaboration
with Scott Lowe's lab that led to the development of a
new and powerful integrative approach to cancer gene
discovery and validation. This approach uses compara-
tive genomic analysis of human and mouse model can-
cers. Key to this project was the implementation of the
highly innovative representational oligonucleotide
microarray analysis (ROMA) technology, and its asso-
ciated informatics tools, developed over the past years
at CSHL by Mike Wigler, Rob Lucito, and key people
in Wigler's informatics group. Using this approach, we
discovered and validated this year a new human onco-
gene operative in hepatocellular carcinoma, a highly
lethal cancer that is neglected by the pharmaceutical
industry due to its Third World status. Rebecca Kohnz,
a Stony Brook graduate student, started this year and is
working jointly on this project with Lars Zender, who
developed the hepatocellular carcinoma (HCC) mouse
model in Scott Lowe's lab, along with key collaborators
Mona Spector, Wen Xue, and David Mu. We are excit-
ed about a recently uncovered additional oncogene
amplified in both human and mouse HCC that we hope
will lead directly to the development of a new mono-
clonal antibody treatment.
Another collaborative project, headed by Greg
Hannon's group, led to the definitive functional vali-
dation of a human oncogene encoded by a microRNA,
a new class of genetic regulators. This was the first
strong indication that microRNAs can have a substan-
tial functional role in cancer, and it was published
alongside a surprising report that microRNA expres-
sion profiling is a more powerful discriminator of
tumor types than mRNA profiling.
Following up on last year's ROMA-based discov-
ery that colorectal cancers have frequent focal dele-
tions, this year, we discovered that the most common
deletion in human colon tumors, present in approxi-
mately 20% of tumors, affects a specific splicing fac-
tor gene. Of the remaining 80% of colon tumors, one
half of them have an alternative mechanism for sup-
pressing expression of this gene. Thus, dysregulation
of this gene affects the majority of colorectal cancers.
Cem Kuscu, a graduate student from Stony Brook,
recently obtained preliminary functional data which
indicate that this gene is a bona fide tumor suppressor.
It is possible that alternatively spliced proteins caused
by this deletion will provide selective targets for can-
cer drug development, and we are collaborating with
Adrian Krainer's laboratory to identify these targets.
This work dovetails with the prior collaboration David
Mu had with the Krainer lab concerning the largely
understudied role of dysregulated alternative splicing
factors in cancer progression.
This year, we began a project in colon cancer that
runs parallel to breast cancer efforts in Mike Wigler's
lab to utilize genomic profiles of human tumors to
predict future clinical outcome and response to differ-
ent treatments. Here, we aim to meet the challenge of
developing DNA-based diagnostic tests to guide treat-
ment choices for individual cancer patients. Although
it is clear from our results that recurrent, metastatic
colon cancers on average have more DNA-copy-num-
ber alterations than nonrecurrent curable colon cancer,
we have yet to determine whether or not there are spe-
cific loci associated with metastasis.
Finally, David Mu has completed a ROMA project
where he has analyzed approximately 250 human lung
cancer samples. He found that the number of distinct
focal loci (<5 Mb) affected by either high-level ampli-
fication or deletion is more than 500, well over the
current estimates of 300 human cancer genes.
Remarkably, more than 300 of these loci occur only
once, and only a handful of amplicons and deletions
have frequencies above 5%. Although it is easy to dis-
miss these rare amplicons or deletions as background
noise generated by the genomic instability of tumors,
there are several validated human cancer genes within
this group. David is currently using short hairpin RNA
(shRNA) constructs from the CSHL RNAi Codex
library to address the functional significance of rare
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FIGURE 1 Frequent deletion of the alternative splicing factor gene in colorectal tumors as
detected by ROMA analysis.
amplicons. It could be that a much larger degree of
diversity exists in the genomic alterations that can
contribute to cancer than previously realized.
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GENE COPY-NUMBER VARIATION AND ITS ROLE
IN HUMAN DISEASE
J. Sebat J. Lloyd
D. Malhotra
S. Yoon
Large-scale differences in gene copy number called
copy-number polymorphisms (CNPs) are a significant
source of human genetic variation. In contrast to DNA
sequence variants such as single nucleotide polymor-
phisms (SNPs) and microsatellite repeats, CNPs have
not been well-characterized. We seek to understand
more about the genomic locations, frequency, and sta-
bility of these structural variants and their role in
human disease.
Determining the Genetic
Basis of Autism
J. Sebat, S. Yoon, D. Malhotra [in collaboration with
M. Wigler, K. Ye, B. Lakshmi, A. Krasnitz, and B. Yamrom,
Cold Spring Harbor Laboratory]
Autism is a neuropsychiatric disorder characterized by
deficits in social interaction and communication and
unusual and repetitive behavior. Autism affects an esti-
mated 1 in 250 births, and its prevalence is increasing.
The causes of autism are poorly understood. On the
basis of the results of twin studies, it has been clearly
determined that genes have a major role in the etiolo-
gy of the disease, but genetic studies have succeeded
in identifying very few good gene candidates. To make
further progress in understanding the genetic basis of
autism, it is critical to use novel methods that are com-
plementary to traditional genetic approaches. We have
developed a novel approach for directly identifying the
underlying mutations that cause autism: high-resolu-
tion analysis of gene copy number. Our approach uses
a method developed by Rob Lucito and Mike Wigler
called representational oligonucleotide microarray
analysis (ROMA). We are using ROMA to test the
hypothesis that alterations in gene dosage are a basis
for heritable and sporadic neuropsychiatric disorders.
Our data provided compelling evidence that sub-
microscopic alterations in gene copy number are
important in autism. ROMA analysis of 110 sporadic
cases of autism (and parental DNAs from a subset of
families) has identified six mutations that occurred
spontaneously in the child (see the example in Fig. 1).
Five of these variants have been previously reported in
association with autism. We identified one novel vari-
ant that consists of a deletion of chromosome 20p13.
The deleted region contains multiple genes potentially
involved in development, some of which are predomi-
nantly expressed in the central nervous system. In an
attempt to identify inherited copy-number variants that
cause autism, we screened a second sample of approx-
imately 150 patients from families with multiple
affected siblings. No spontaneous mutations were
identified in these patients, which is consistent with
the notion that the genetic factors here are more likely
to be inherited. Inherited variants were identified that
are more frequent in autism than in controls. We have
typed several of these inherited variants in affected
and unaffected family members and determined a sub-
set that segregate with autism in small families.
We have succeeded in identifying novel candidate
genes by detecting spontaneous mutations in patients
with sporadic autism. Further characterization of these
novel autism candidate genes may yield insight into the
processes of brain development that are impaired in
autism. By expanding our analysis of sporadic autism,
we hope to discover additional causative mutations.
Second, to more thoroughly evaluate the association of
inherited copy-number variants with autism, we will
screen a larger sample of families with multiple affects.
Analysis of Large-scale
Copy-number Variation
in the HapMap
J. Sebat, S. Yoon, J. Lloyd, D. Malhotra [in collaboration with
K. Ye and B. Lakshmi, Cold Spring Harbor Laboratory]
Much remains to be learned about the extent of "nor-
mal" structural variation in the human genome and its
implications for genetic studies of populations. We
have initiated a CNP discovery effort that will focus on
DNA samples from the International HapMap Project.
The key advantage of using the HapMap samples for
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FIGURE 1 A submicroscopic deletion of chromosome 2q37 was detected in a patient with autism.
ROMA analysis of DNA from both parents revealed that this deletion occurred spontaneously in the child.
Data points represent the fluorescence ratio measured by individual ROMA probes. Known genes pre-
sent within the deleted region are shown.
A
D
B GM 10510 C SKN1
Base Pas it i0111 1 2409881 25N3.0g1,..sotteer5el,ts 2:4:1gBgec, tte:041, m::::IgIc1og:T9Bel
6,326.3
es Based on S SS-PROT, TrEMBL ntIndil.RefSeq
FIGURE 2 DUSP22 locus selected for analysis of SNPs in linkage disequilibrium with
CNRs. (4) ROMA data showing a 4:3 difference in copy number between two individu-
als. (B,C) FISH (fluorescence in situ hybridization) results on the same two individuals
confirm the presence of four and three copies, respectively, the polymorphic allele
occuring at 16q11. (D) Display of the amplified genomic region.
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this study is the availability of high-density SNP geno-
types on the same individuals. CNP data can be com-
bined with SNP data to determine, for example,
whether a polymorphic duplication or deletion is asso-
ciated with a unique SNP haplotype (indicating that the
variant results from an ancestral event that was inherit-
ed by descent) or with many different haplotypes (sug-
gesting recurrent structural mutation at that site). In
addition, direct analysis of copy-number variation is
helpful for resolving aberrant patterns in the HapMap
data that result from CNPs, such as apparent non-
Mendelian patterns of inheritance. Here, we analyzed
copy-number variation in 30 CEPH trios using ROMA.
In an initial attempt to integrate a structural variant
into the HapMap, we analyzed linkage disequilibrium
between SNPs and a single CNP identified by ROMA:
duplication of the dual specificity phosphatase 22
gene, DUSP22 (Fig. 2). We genotyped each individual
as having two, three, or four copies of the gene, corre-
sponding to genotypes of -/-, +/-, and +/+ for the
duplicated allele. We then tested association with all
HapMap markers across the genome and identified
four markers showing a very strong association with
this CNP (LOD = 7.4-9.7). These markers were
mapped to within the DUSP22 gene itself, thus validat-
ing our computational approach to defining the SNP
haplotype on which a given CNP resides. In addition,
we used publicly available mRNA expression data to
examine the expression of DUSP22 in 37 HapMap
individuals to determine the effect of copy number on
DUSP22 expression in lymphoblasts. There was a pos-
itive correlation between copy number and expression
that is statistically significant (p = 0.03). These data
illustrate how our results may help create new opportu-
nities for researchers to apply computational approach-
es to existing data to understand biological significance
of this newly discovered type of human variation.
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COPY-NUMBER ANALYSIS AND HUMAN DISEASE
M. Wig ler J. Alexander
M. Andrade
M. Chi
C. Danielski
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V. Grubor
J. Healy
J. Hicks
L. Hufnagel
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A. Krasnitz L. Muthuswamy P. Roccanova H. Wang
Y.-H. Lee N. Navin L. Rodgers B. Yamrom
E. Leibu D. Pai J. Sebat S. Yoon
A. Leotta A. Reiner
Our studies of cancers and leukemia center around a
technology developed in this lab called representation-
al oligonucleotide microarray analysis (ROMA).
ROMA is a high-resolution, high-throughput method
for detecting copy-number changes in the genome,
such as amplifications and deletions characteristic of
the mutations that drive malignancies. These changes
are manifest as alterations in the genome "profile" of
a cancer or leukemic cell.
GENOMIC ANALYSIS OF CANCER AND LEUKEMIA
Breast Cancer. In a long-standing collaboration with
Anders Zetterberg at the Karolinska Institute in
Stockholm, Sweden and Anne-Lise Borresen-Dale at
the Norwegian Radium Hospital, University of Oslo,
Norway, we have profiled more than 250 breast cancer
tumors from separate collections of Norwegian and
Swedish populations. We have reached several impor-
tant conclusions. First, we observed a type of genomic
rearrangement that we call "firestorms"-regions of
chromosomal instability localized within chromosome
arms-and we have determined which chromosomal
regions are prone to this destabilization. Even a single
firestorm is an especially significant prognostic mark-
er of poor outcome. Second, the number and spacing of
genomic lesions correlate very strongly with survival.
We derived a mathematical measure that captures the
essential geometric features of the profiles that corre-
late with survival in the population of pseudodiploid
cancers (p = 10-7). This is a far stronger correlation
than is obtained from knowledge of any particular
locus and may subsume any locus-based predictive
determination. The information in this measure is inde-
pendent of the location of amplifications and deletions,
and of classical clinical parameters such as node status,
stage, and expression of hormone receptors. Our mea-
sure will thus have clinical utility in patient evaluation.
Our data from the above studies also help to delim-
it the location of loci of oncogenes and tumor sup-
pressor genes. We have worked out a variety of proba-
bilistic and heuristic methods that sum over the data
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set that mark what we believe to be the most likely
locations for cancer genes. We observe a similar set of
loci whether examining pseudodiploid or aneuploid
cancer subpopulations, even though the latter have
many more lesions, suggesting that these loci confer
advantage to the tumor, regardless of the degree and
type of genomic instability.
The overall similarity in the location of regions of
genome instability in breast cancers in Swedish and
Norwegian populations is striking. These data provide
a baseline from which we can seek differences in indi-
viduals of other ethnic backgrounds and geographic
locations. Such comparative studies might reveal the
extent of genetic and environmental contributions to
the initiation and development of breast cancer or, for
that matter, any cancer.
Mouse Models of Human Malignancy. In a collabo-
ration with Robert Lucito here at CSHL, we have used
our experience in designing a human ROMA copy-
number array to design and test a mouse ROMA chip.
This array can be used to study the amplifications and
deletions that occur in mouse tumors, and that data can
be compared to profiles of similar tumor types in
humans. In another collaboration with Scott Powers
and Scott Lowe's labs here at CSHL, this approach has
been used successfully to define a common gene
amplified in mouse and human liver cancers, which
encodes an inhibitor of apoptosis. The mouse-human
synteny relationships are used to define the common
genetic elements in amplified or deleted loci. As a
general approach, the profiling of human cancer
genomes and the analysis of mouse models of human
cancer is a powerful combination for defining the
causes of this disease.
In a collaboration with David Botstein and Robert
Pelham of Princeton University, New Jersey, we have
used mouse ROMA to examine the "normal" stroma
that grow in response to implantation of a human can-
cer cell line in mice. We detect clear evidence that
stroma have clonal subpopulations that carry small
deletions and duplications. Although preliminary, the
implications could be profound: If tumors cultivate or
recruit mutant stroma, a vulnerability in the cancer-
host communications could be potentially disrupted,
leading to novel therapeutic approaches.
Leukemia. In a collaboration with Nick Chiorazzi at
North Shore University Hospital in Manhasset, New
York, we have initiated a study of chronic lymphocytic
leukemia (CLL), the major form of lymphoma/
leukemia in adults. We use ROMA to examine copy-
number changes in leukemic cells, using normal blood
neutrophils from the same patient as a control. We have
completed a series of 21 patient samples. In summary,
10/21 samples have a 13q deletion, and five of these
deletions are homozygous. The epicenter spans DLEU7
but not mir-15a or mir-16-1, the micro RNAs
(miRNAs) that others have proposed to be in the epi-
center, throwing into question the validity of the
hypothesis that expression of these miRNAs are impor-
tant in this form of leukemia. In addition, 3/21 samples
show multiple narrow deletion events and define a new
class of chromosomal instability in CLL, which is not,
to our knowledge, previously reported. Two new loci
are the recurrent target of small-sized events, one at a
gene proposed to be involved in membrane trafficking
and one at a locus containing no known genes.
ANALYSIS OF HUMAN GENETIC DISEASE
Our studies of human genetic disease likewise center
around ROMA. In general, with ROMA we can
observe two types of phenomena: (1) spontaneous
mutation that results in a copy-number change in an
afflicted human and (2) an inherited polymorphism of
copy number that affects the likelihood or severity of
a disease. Neither of these genetic events were readily
detectable by prior methodology, so ROMA, or an
equivalent copy-number measurement technique,
opens new possibilities for understanding forms of
human disease with strong genetic components. Our
particular interests lie in autism and other neuropsy-
chiatric disorders of early onset, in a collaboration
with Jonathan Sebat of CSHL; congenital heart dis-
ease with Dorothy Warburton and Wendy Chung of
the Columbia UniversityCollege of Physicians and
Surgeons, New York; and familial prostate cancer, in a
collaboration with Bill Isaacs of Johns Hopkins
University School of Medicine, Baltimore, Maryland.
As a baseline for all of these studies, we must ana-
lyze the "normal" variation of the human genome.
This baseline catalog of copy-number polymorphisms
(CNPs) is necessary to distinguish novel events that
might be associated with disease from preexisting
events that are part of normal human copy-number
variations. Currently, we have identified approximate-
ly 510 unique CNPs from 500 individuals.
Distinction between Sporadic and Inherited Autism.
We have established a distinction between sporadic and
familial autism, in particular, we established the role of
de novo mutation as a cause of autism in the former, as
we originally postulated. In 90 samples from families
with one autistic child but with no other history of the
disease, we have observed six confirmed examples of
spontaneous deletion or duplications. There may be
additional examples of these, much smaller in size, that
await confirmation by higher-resolution ROMA. In
contrast, in the AGRE (Autism Genetic Research
Exchange) set of 170 patients who derive from families
with two or more affected children, we see only one
possible example of a spontaneous mutation. This is on
the X chromosome and is found in both affected chil-
dren, but not in the parents.
We have limited data on the rate of spontaneous
amplifications/deletions in normal family trios, but in
30 family trios we have found no clear examples of
new mutations. We need to solidify these observations
with more rigorous standards and more data, but our
findings point to the conclusion that sporadic autism
can result from spontaneous mutation.
This observation has an important implication for
how the community of genetic researchers proceed in
the discovery of mutations that cause autism. Trios of
mother, father, and child, where there is no other
affected child or history of autism in the family, may
be the preferred population in which to search for
spontaneous mutations. Unfortunately, most of the
community's effort has been directed to the collection
of families with more than one affected child, where
transmission genetics has a greater role.
Protective Variation in Autism. In familial autism, we
have preliminary evidence for the possible involve-
ment of relatively common alleles in the penetrance of
the disorder. In particular, our data suggest the
involvement of the CHRNA7 locus encoding the nico-
tinic acetylcholine receptor oa. This locus is of inter-
est because of its suspected involvement in schizo-
phrenia and attention deficit disorders. Our data indi-
cate that this region is hypervariable in the human
population and may thus be under strong selective
pressure. Duplication at this locus is observed in indi-
viduals from all populations, including sporadic cases
of autism, at rates about 15%, but in the AGRE set, the
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frequency of duplication is much lower, around 5%.
These results suggest that the presence of duplication
at this locus might protect against autism of the inher-
ited variety.
This hypothesis is important in several respects. If
correct, it suggests that in some cases, pharmacologi-
cal approaches might alleviate development of the dis-
order. Second, it may provide mechanistic insight into
the nature of the disease. Third, the hypothesis raises
hope that other genetically linked disorders could
yield to similar approaches. Important hypotheses
require extremely careful analysis, and far more work
than what we have completed thus far is needed to
confirm this observation.
ADVANCES IN ROMA TECHNOLOGY
ROMA offers a fresh perspective on human disease,
but its potential is still largely untapped.
Improvements to the methodology in terms of resolu-
tion, reliability, data access, and cost are a continuing
and challenging activity within our group.
New Designs and Applications. We have successfully
developed and tested a high-resolution 390,000 probe
ROMA chip, with more than four times the probe den-
sity of our previous 85,000 probe chip. With this
microarray, we can see cancer lesions with far greater
clarity than before, which should aid greatly in deter-
mining the location of genes causing cancers and
leukemias. Work remains to modify the processing soft-
ware that we have developed for the 85,000 array,
including normalization and segmentation protocols.
(Normalization is a method for standardizing interpre-
tation of raw hybridization signals, and segmentation is
a method for interpreting the hybridization data as alter-
ations of chromosomal loci.) We have also developed
methods that should enable the calibration of each
probe on the array, which we predict will dramatically
improve our segmentation methods and also help in
selecting probes as we design new arrays in the future.
Additional statistical methods now allow us to per-
form hybridizations in single color, minus a reference
sample. The ability to perform hybridization in one
color, the omission of a reference sample, and the abil-
ity to reuse arrays after high-stringency washing
reduces the consumption of arrays and other reagents
and reduces costs almost twofold. Finally, we have
established that we can obtain reliable data from tissue
freshly fixed in formalin, which is the way in which
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breast and most other cancer biopsies are routinely
prepared for clinical-pathological appraisal. All of
these developments should facilitate the adoption of
our methods in a clinical setting.
Data Access. ROMA generates raw data files on the
order of megabytes per sample, and each sample is
associated with critical biological information. The
"accessibility" of our data has been a nagging problem.
We have assays on over 2000 samples in our collective
group (cancer and genetics), and each sample may
have several dozen important associated clinical facts.
Each assay may yield a table 40 x (85 x 103), and four
times that for the high-resolution arrays. The raw data
undergo a variety of processing steps and are stored in
a variety of workspaces and formats distributed
throughout the dispersed computers in four different
geographic centers and two continents. Accessing all of
this information in a seamless manner has been a try-
ing experience. Our first implementation as a large
centralized relational database of raw data was only a
partial success, because it did not reference properly
either sample information or the processed data files.
We have therefore taken two steps. The first is to
implement an "Ark." The Ark contains all of the
processed data files in a logical folder architecture on a
central server as ASCII text, with specially designed
"headers" in each file that identify and describe the inter-
nal structure of each file. Each folder contains an index
to its contents in a standardized "language." We have
developed tools for the rapid integration of this data back
into the working directories of our numerical processing
environment for comparative analysis, for graphical dis-
play, or as a jumping-off point to the Internet.
The second step has been to develop a customizable
database language. It is a hybrid between object-orient-
ed and relational database languages. Called "Pentuple,"
it uses something akin to natural language-a flexible
linguistic structure with hierarchical permissions to alter
that structure, allowing a user group to enter, organize,
integrate, and search very large amounts of data. We
hope that Pentuple will lead to a general purpose multi-
user archival language system.
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CANCER: CELL BIOLOGY
For a cell to multiply, it must first make an exact copy of its DNA to pass along to the two new cells. Bruce
Stillman studies the molecular machinery inside the cell that coordinates and directs the process of DNA
replication. First, the cell must "know" where to begin copying. DNA contains start sites called origins that
direct the initiation of DNA replication. Binding to these origins are large complexes of proteins that have
a role in the process. Recent work in the Stillman lab has revealed that two such proteins-Orc2 and
Orc3-bind to centromeres or the "handles" on DNA through which chromosomes are pulled to the oppo-
site ends of a cell before the cell divides. Stillman's group discovered that in the absence of Orc2 or Orc3,
chromosomes either cannot duplicate or the duplicated chromosomes are improperly segregated, result-
ing in a loss or a gain of chromosomes as is often seen in cancer cells.
Arne Stenlund is using the papillomavirus replication system to gain a better understanding of the cru-
cial first steps of how DNA is copied in human cells. He has managed to recapitulate the assembly of the
viral "helicase," providing the first description of how such a protein-DNA complex is formed. The helicase
is the enzyme that unwinds DNA in preparation for DNA replication. Until now, little has been known about
precisely how this complex forms in human cells. Stenlund's efforts to dissect the helicase assembly
process provides an opportunity to achieve a detailed understanding of the initiation of DNA replication in
mammalian systems.
The body uses several families of proteins as biological "on/off" switches to control many processes.
One such biological switch is the family of proteins that includes Rac and Rho. These proteins control a
variety of important cellular activities including cell proliferation, cell-cell interactions, and cell signaling. In
part of her work, Linda Van Aelst studies the role of Rac and Rho in the hippocampus, a part of the brain
involved in the formation of new memories and the retrieval of older memories. Recently, she and her col-
leagues have identified a series of proteins that regulate Rac and Rho signaling and have shown that these
proteins are required for proper nerve cell development and function in the hippocampus.
Nicholas Tonks is evaluating the links between a family of proteins called protein tyrosine phosphatases
(PTPs) and human disease. Using information available from the human genome sequence, his group is
studying the PTP "superfamily" of some 108 genes. Tonks and his colleagues are using RNA interference
to uncover the function of each member of the PTP family. Initial studies include a collaboration with
Senthil Muthuswamy to explore the function of the PTP superfamily in development of breast cancer.
Several investigators are beginning to find that cancer may arise in part from disruptions in tissue orga-
nization or the interactions among varying cell types within an organ. Muthuswamy studies the interaction
between cancer cells and the surrounding tissue and structural proteins that organize breast tissue. He
has developed a three-dimensional tissue culture system that mimics the basic glandular structure of the
breast. Using this system, his group has identified a direct relationship between ErbB2, a gene known to
be misregulated in nearly half of all breast cancers, and molecules that regulate cell architecture. ErbB2
appears to inactivate proteins that help establish normal breast tissue structure. This ability of ErbB2 to
disrupt breast tissue organization may contribute to the observed disruption of normal tissue organization
in breast cancer.
Tatsuya Hirano studies how cells organize and manage chromosomes during preparation for cell divi-
sion. His current studies are focused on two protein complexes, called cohesin and condensin, that have
key roles in compacting DNA and ensuring each daughter cell receives only one copy of each chromo-
some. The proteins belong to the SMC (structural maintenance of chromosomes) family, members of
which are found in a wide variety of organisms from bacteria to humans. During the past year, Hirano stud-
ied SMC proteins of the bacterial species Bacillus subtilis as a model for more complex mammalian SMC
proteins. His group showed that when the SMC protein first binds to DNA, the binding triggers a hinged
section of the protein to move two swinging arms into place. These results help explain how SMC pro-
teins control chromosome behavior.
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David Spector and his colleagues have identified a messenger RNA that lingers uncharacteristically in
the cell nucleus but can be rapidly released into the cytoplasm in response to cellular stress (or other sig-
nals) such as viral infection. The "cut-and-run" mechanism revealed by this study is a new paradigm of
gene regulation that is likely to be broadly relevant to biology and biomedical research. It establishes a role
for the cell nucleus in harboring mRNA molecules that are not immediately needed to produce proteins,
but which are ready at a moment's notice to produce protein in response to stress or other cellular sig-
nals.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano N. Aono M. Hirano
R. Gandhi I. Onn
P. Gillespie K. Shintomi
The long-term goal of our research program is to
understand the molecular basis of higher-order chro-
mosome architecture and dynamics. Studies during
the past decade have established that structural main-
tenance of chromosome (SMC) proteins are among
the most fundamental regulators of chromosome
dynamics conserved from bacteria to humans. In
eukaryotic cells, SMC proteins constitute the core of
two multiprotein complexes, condensin and cohesin,
that have central roles in chromosome condensation
and cohesion, respectively. In bacterial cells, SMC
proteins function as part of a complex that also has a
crucial role in chromosome segregation. Mutations in
these SMC protein complexes lead to genome insta-
bility in many organisms. Moreover, emerging studies
provide evidence that misregulation of condensin and
cohesin might be linked to developmental diseases in
humans. In our laboratory, we take multidisciplinary
approaches to understand how condensin, cohesin,
and SMC proteins might work at a mechanistic level
both in vivo and in vitro.
Structural and Functional
Dissection of Condensin I
and Condensin II In Vitro
I. Onn, M. Hirano, T. Hirano
Previous studies from our laboratory have shown that
vertebrate cells have two different condensin com-
plexes, referred to as condensin I and condensin II.
The two complexes share the same pair of SMC
ATPase subunits (SMC2 and SMC4), but they contain
different sets of non-SMC regulatory subunits.
Despite clear demonstration that the two condensin
complexes have critical roles in mitotic chromosome
assembly and segregation in vivo, very little is known
about how they might work at a mechanistic level in
vitro. To address this fundamental question, we have
used the baculovirus system to express recombinant
subunits of condensin I and condensin II. Pairwise
coexpression of individual subunits, followed by
immunoprecipitation, allows us to construct a subunit
interaction map for each complex. To refine specific
interacting domains in each subunit, a panel of trun-
cated proteins is constructed. We also reconstitute
holo- and subcomplexes of condensins and assess the
functional contribution of individual subunits to their
DNA-binding, ATPase, and supercoiling activities.
Furthermore, we prepare a panel of mutant complexes
deficient in different stages of the SMC ATPase cycle
and attempt to gain insights into the mechanochemical
cycle of condensin I and condensin II. These efforts
will undoubtedly enrich our mechanistic understand-
ing of this amazing class of chromosome condensation
machinery.
Dissection of Condensin
Regulation in Xenopus
Egg Extracts
N. Aono, L Onn, T. Hirano
In Xenopus extracts, condensin I is loaded onto chro-
mosomes in a mitosis-specific manner. To understand
how this tight regulation of condensin loading is
achieved, we currently focus on two specific ques-
tions: (1) What is the role of the ATPase cycle of SMC
subunits in condensin loading? and (2) what is the
contribution of individual non-SMC subunits and their
phosphorylation in this process? To address the first
question, we add back recombinant human condensin
complexes containing either wild-type or mutant
forms of SMC subunits into Xenopus egg extracts and
test their ability to associate with chromosomes. We
also test whether the added back fractions may func-
tionally complement extracts depleted of endogenous
Xenopus condensins. To address the second question,
we add back individual recombinant subunits or sub-
complexes and test their association with chromatin.
Once basic information is obtained, the effect of muta-
tions in potential phosphorylation sites will be tested.
A genetic study in fission yeast suggests that con-
densin I (the sole condensin complex in this organism)
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may have a role in DNA repair and checkpoint
responses. In vertebrates, condensin I is sequestered in
the cytoplasm, whereas condensin II is located within
the nucleus during interphase. We therefore hypothe-
size that condensin II, but not condensin I, may have a
specialized role in DNA repair functions. This hypoth-
esis is now being tested by asking how the two com-
plexes may respond to damaged or undamaged chro-
matin templates in Xenopus egg extracts. Information
derived from this line of experiments will also help us
establish a comprehensive molecular picture of the
loading and unloading mechanisms of condensin.
A Potential Link between Condensin
Regulation and Microcephaly
T. Hirano [in collaboration with M. Trimborn, D. Schindler, and
H. Neitzel, Institute for Human Genetics, Berlin]
Primary autosomal recessive microcephaly is a neu-
rodevelopmental disorder characterized by marked
reduction in brain size and mental retardation.
Mutations in the MCPH1 gene, encoding micro-
cephalin, cause a unique cellular phenotype with pre-
mature chromosome condensation in early G2 phase
and delayed decondensation postmitosis. In collabora-
tion with H. Neitzel's group in Berlin, we show that in
MCPH1 patient cells, small interfering RNA
(siRNA)-mediated depletions of condensin II subunits
lead to a pronounced reduction of cells with the con-
densation defects in both G, and G, phases of the cell
cycle. Similar results are obtained when micro-
cephalin and condensin II are simultaneously depleted
in HeLa cells. In contrast, depletions of condensin I
subunits do not reverse the cellular phenotype.
Consistently, condensin I stays in the cytoplasm in the
prophase-like cells of MCPH1 patients. Our results
offer a molecular explanation for the aberrant chro-
mosome condensation in MCPH1 deficiency and pro-
vide additional evidence that condensin I and II are
regulated by distinct pathways.
Molecular Basis of Sister
Chromatid Cohesion
K. Shintomi, P. Gillespie, T. Hirano
Although previous studies in many organisms have
demonstrated that the cohesin complex is the key
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player in sister chromatid cohesion during mitosis and
meiosis, very little is known about how it might work
at a mechanistic level. To fully understand the molec-
ular basis of sister chromatid cohesion, we have recon-
stituted holo- and subcomplexes of cohesin from its
recombinant subunits by using the baculovirus expres-
sion system. We are now testing their behaviors and
functions in Xenopus egg extracts. Mutant forms of
cohesin will be included in this series of experiments
to understand the role of the SMC ATPase cycle in
cohesin functions. Another yet related aim of this pro-
ject is to understand how establishment of cohesion
might be coupled with DNA replication. To this end,
we have devised a protocol for isolating the chro-
matin-bound fraction of cohesin from nuclei assem-
bled in the extracts. By using various biochemical and
immunological techniques, we plan to test whether
cohesin might undergo conformational changes in a
DNA replication-dependent manner or might recruit
additional proteins during such a process.
Interplay of Centromeric
and Arm Cohesion
during Mitosis
R. Gandhi, T. Hirano
In vertebrate cells, cohesin is released from chromo-
somes by a two-step mechanism during mitosis. In
prophase, most of the cohesin is released from chro-
mosome arms, at least in part, by the action of two
mitotic kinases, polo-like kinase (Plk 1) and aurora B.
A residual level of cohesin, primarily enriched at cen-
tromeres, supports cohesion until anaphase when pro-
teolytic cleavage of a cohesin subunit triggers sister
chromatid separation. We are interested in understand-
ing exactly how these unloading processes of cohesin
are regulated and how they are coordinated with other
chromosomal events, such as condensin loading and
maturation of mitotic centromeres. Our current effort
is focused on a newly identified cohesin-interacting
protein that appears to have a crucial role in these
processes. Emerging lines of evidence suggest that the
reorganization of chromosomes that occurs in
prophase may be much more dynamic than anticipat-
ed before and that it may involve an active cross-talk
between the arm and centromeric regions. We are cur-
rently testing this idea by using a combination of cell
biology and RNA interference in human tissue culture
cells. These studies will help us understand the high-
fidelity mechanism of chromosome segregation,
defects of which lead to aneuploidy commonly associ-
ated with cancer and other human genetic disorders.
Dissection of the Mechanochemical
Cycle of SMC Proteins
M. Hirano, T. Hirano
We have been using the Bacillus subtilis SMC protein
(BsSMC) as a model system for studying the basic
mechanism of action of SMC proteins. Like eukaryot-
ic SMC proteins, BsSMC forms a V-shaped dimer in
which a central hinge domain connects two long
coiled-coil arms, each having an ATP-binding head
domain at its distal end. During the past year, we have
performed a comprehensive set of mutational analyses
and have shown that the hinge domain has essential
roles in modulating the mechanochemical cycle of
SMC proteins. An initial interaction of the hinge
domain with DNA leads to opening of the arms by
triggering hydrolysis of ATP bound to the head
domains, which are located approximately 50 nm
away from the hinge. This conformational change
allows the inner surface of the hinge domain to stably
interact with DNA by an ATP-independent mechanism
and primes ATP-driven engagement between the liber-
ated head domains either within a dimer or between
different dimers. Our results suggest that SMC pro-
teins possess an intrinsic property to change their own
conformations upon binding to DNA and initiate its
manipulation in an energy-dependent manner. The
basic principles of SMC action elucidated in this pro-
ject will readily be applicable to our understanding of
the actions of condensin and cohesin.
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EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy V. Aranda M. Nolan
K. Bergami A. Rosenberg
T. Haire B. Xiang
A. Lucs L. Zhan
Precancerous lesions of the breast are characterized by
increased rates of proliferation and abnormal organi-
zation of epithelial cells, both properties routinely
used by pathologists during prognostic evaluations.
Over the years, the cancer research community has
made tremendous strides to understand how oncogenic
signals deregulate proliferation control and this has
led to major discoveries that continue to shape cancer
research. However, we do not know the mechanisms
that regulate abnormal organization of epithelial cells
in cancerous glandular structures. Although cell pro-
liferation is common to both physiological and onco-
genic stimuli, abnormal tissue/cell organization is
restricted to a pathogenic state, suggesting that onco-
genic signaling must possess unique mechanisms, not
shared by physiological stimuli, that promote disrup-
tion of tissue/cell organization in precancerous
lesions. Understanding the molecular mechanisms that
regulate precancerous lesions will allow us to identify
novel targets that will assist in diagnosis and treatment
of early lesions.
Using mammary epithelial cells grown under
three-dimensional culture conditions, we investigate
the mechanisms by which epithelial organization reg-
ulates proliferation control under normal physiologi-
cal conditions and how oncogenic signaling deregu-
lates tissue organization and proliferation control.
MORPHOGENESIS OF EPITHELIA
The human mammary epithelial cell line, MCF-10A,
when plated on the extracellular matrix, undergoes a
program of proliferation and apoptosis to form prolif-
eration-arrested three-dimensional acini-like struc-
tures that share several properties with acini in an
adult breast. To have an unbiased analysis of how
MCF-10A cells undergo proliferation arrest during
morphogenesis, we performed microarray analyses of
proliferating, proliferation-arrested cells grown under
three-dimensional culture conditions. We identified a
group of 119 genes that are up-regulated during pro-
liferation arrest, suggesting that these genes have
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important roles during morphogenesis-regulated pro-
liferation control. These analyses led to the identifica-
tion of a protein tyrosine phosphatase, PTPRO. Down-
regulating expression of PTPRO promotes formation
of acini-like structures that require a significantly
longer time to undergo proliferation arrest, suggesting
that the regulation of tyrosine phosphorylation status
by PTPRO has an important role in regulating prolif-
eration control. We are very excited about this obser-
vation because several studies suggest that PTPRO
functions as a tumor suppressor in lung cancers. In
collaboration with the Tonks lab here at CSHL, we are
investigating whether PTPRO functions as a tumor
suppressor in breast cancers.
ERBB2-INDUCED DISRUPTION OF EPITHELIAL
ORGANIZATION
Our studies-aimed at understanding how activation
of the oncogenic receptor tyrosine kinase, ErbB2, dis-
rupts three-dimensional organization of epithelial
cells-have taken too many twists and turns and have
finally come to a clear and exciting conclusion.
We and other investigators have demonstrated that
oncogenic signaling in polarized epithelial cells pro-
motes disruption of apical-basal polarity and aberrant
organization of cell layers; however, the mechanism by
which this happens is not known. To gain insight into
the mechanisms by which activation of ErbB2 disrupts
organized epithelia, we first determined the temporal
order by which oncogenic signaling by ErbB2 affects
cell polarity. Using proteins that are asymmetrically
localized in polarized epithelia, we determined that
oncogenic signaling induces loss of apical polarity and
that such a loss is initiated at a region defined as the api-
cal-basal border. The apical-basal border is home to
cell-cell junction structures, such as tight junctions that
serve as permeability and membrane diffusion barriers
in glandular structures. Formation and maintenance of
cell-cell junction complexes at the apical-basal border is
driected by the Par polarity complex, a protein complex
composed of Par3, Par6, atypical protein kinase C
(aPKC), and the small GTP-binding proteins,
CDC42/Racl. Because ErbB2 disruption of cell polari-
ty initiates at the apical-basal border, we investigated
whether oncogenic signaling regulates the Par polarity
complex. These analyses revealed a novel link between
oncogenic signaling by ErbB2 and regulation of the Par
polarity complex, where, on the one hand, ErbB2 asso-
ciates with Par6/aPKC and, on the other hand, ErbB2
inactivates the active Par polarity complex. The impor-
tance of this interaction was determined by expressing a
mutant version of Par6 (Par6Kl9), which fails to bind
aPKC and thus prevents ErbB2 from inactivating the
Par complex. Cell expressing the Par6K19 prevented
the ability of ErbB2 to induce large multiacinar struc-
tures but did not have a significant impact on the abili-
ty of ErbB2 to promote proliferation. Thus, we have
identified a novel signaling pathway that uncouples the
ability of an oncogene to disrupt epithelial organization
from its ability to promote proliferation.
Along the course of this investigation, we stum-
bled on to an unexpected observation: overexpression
of Par6 promotes epidermal growth factor (EGF) -
independent proliferation of MCF-10A cells and pro-
motes epithelial morphogenesis under suboptimal
concentration of EGF. This has got our attention
because it is possible that Par6 overexpression may
have a significant impact for sensitizing cells to the
growth factor requirement in vivo. To gain insight, we
have generated a series of par6 mutants and deter-
mined that the ability of Par6 to promote EGF-inde-
pendent proliferation is mediated by the ability of Par6
to activate aPKC. We are pursuing these studies to
investigate the mechanism by which Par6 promotes
EGF-independent proliferation.
ERBB2-INDUCED DISRUPTION OF
THREE-DIMENSIONAL ACINI
Activation of ErbB2 in proliferation-arrested three-
dimensional structures reinitiated proliferation by
increasing cyclin E/Cdk2 activity, but not cyclin
D 1 /Cdk4 activity. The increase in Cdk2 activity was
coordinated by up-regulating cyclin E and down-regu-
lating p27kiP'. These observations are consistent with
several studies that report a strong correlation between
increased Cdk2 activity and ErbB2 overexpression in
breast cancers. More importantly, overexpression of
ErbB2 does not show a significant correlation with
cyclin D1 expression or increased Cdk4 activity. Thus,
we have defined a system that models a condition
observed in ErbB2 overexpressing cancers in vivo. We
are in the process of investigating how ErbB2 directly
regulates the cyclin E/Cdk2 complex; such analyses
will lead to novel insights into the mechanisms by
which ErbB2 promotes deregulated proliferation in
vivo.
Although coexpression of ErbB1 and ErbB2 is
associated with poor patient prognosis, the mecha-
nisms by which receptor heterodimerization regulates
tumor progression are not clear, in part, due to lack of
methods that allow controlled activation of specific
receptor heterodimers in mammary epithelial cells.
We have developed an approach to activate ErbBl-
ErbB2 heterodimers without interference from
endogenous ErbB receptors. Using such a method, we
demonstrated that although both ErbB2 homodimers
and ErbB 1 -ErbB2 heterodimers were equally potent in
activating the Ras/MAPK pathway, the heterodimers
were more potent in activating the PI3 "kinase and
phospholipase Cyl pathways than ErbB2 homod-
imers. We combined the dimerization system with a
three-dimensional cell culture approach to demon-
strate that although both ErbB2 homodimers and
ErbB 1 -ErbB2 heterodimers induced disruption of
three-dimensional acini-like structures, only het-
erodimers promoted invasion of cells through the
extracellular matrix. The ability of heterodimers to
induce invasion required the ErbB1 kinase activity and
required activation of PI3 "kinase, Ras/MAPK, and
phospholipase Cyl signaling pathways. Thus, we have
identified cell invasion as a heterodimer-specific bio-
logical outcome, and we suggest that coexpression of
ErbB1 may critically regulate invasive progression of
ErbB2-positive breast cancers.
In addition to providing insights into mechanisms
by which ErbB receptors regulate transformation of
organized epithelial cells, we have thus uncovered a
novel arm of oncogenic signaling that critically regu-
lates epithelial organization. Since loss of epithelial
organization is observed in various pathological states,
such as chronic inflammation, our findings have broad
significance for diseases associated with glandular
epithelia in vivo.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector P. Bubulya
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S.M. Janicki
I. Kumaran
K.V. Prasanth
H. Sunwoo
Most cellular processes can trace their beginnings to
the nucleus where a gene is activated, resulting in the
production of an RNA molecule that must get
processed and transported to the cytoplasm. Although
much biochemical information is available regarding
many of the factors involved in gene expression, the
spatial and temporal aspects of gene expression and
the dynamics of the nuclear domains that the gene
expression machinery occupies are less well under-
stood. During the past year, we have focused a signif-
icant amount of our efforts on two main areas: (1)
examining the mechanism by which epigenetic marks
are transmitted to daughter cells through the cell cycle
and (2) characterizing centromere positioning and
dynamics in living Arabidopsis plants.
DYNAMICS OF EuHMTAsEl DURING
DNA REPLICATION
Methylation at lysine 9 (K9) of histone H3 is associat-
ed with both constitutive heterochromatin (trimethyl
K9) and facultative heterochromatin (mono- and
dimethyl K9). Among the H3K9-specific methyltrans-
ferases, EuHMTasel and G9a target euchromatin,
whereas SET-DB1, Suv39h1, and Suv39h2 are respon-
sible for tri-methylation of H3K9 in constitutive hete-
rochromatin. To elucidate how the epigenetic state of
gene activity is transmitted to cellular progeny through
the cell cycle, we studied the methylation of histone
H3K9 during DNA replication. We investigated the
localization and dynamics of EuHMTasel and G9a,
which are involved in the regulation of gene activity.
To provide insight into the transmission of the pattern
of dimethyl H3K9 at euchromatin, we first investigat-
ed the subcellular localization of EuHMTasel. On
immunolabeling of HeLa cells with an antibody
against EuHMTasel, we observed a fluorescent
nuclear signal in all cells; however, approximately
20% of the cells in an asynchronous population exhib-
ited different patterns of fluorescent foci. These foci
colocalized with sites of BrdU incorporation (Fig. 1),
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indicating that they represented sites of DNA replica-
tion. We used live-cell microscopy to follow the
dynamics of YFP-EuHMTasel throughout the cell
cycle. Interestingly, the association of EuHMTasel
with DNA replication sites was observed throughout S
phase, from early DNA replication foci (enriched in
active genes) to late replication foci (constitutive het-
erochromatin). Because G9a is generally associated in
a heterodimeric complex with EuHMTasel, we also
examined its localization in HeLa cells by coimmuno-
labeling with sites of BrdU incorporation. Similar to
EuHMTasel, G9a was localized at sites of DNA repli-
cation throughout S phase, suggesting that G9a and
EuHMTasel are both present, most probably as a com-
plex, at sites of DNA replication. After DNA replica-
tion was completed, EuHMTasel showed a diffuse
nuclear localization. To further study the association
Eu-HMTasel BrdU
FIGURE 1 Immunolocalization in MCF-7 cells showing that
EuHMTasel colocalizes with sites of DNA replication through-
out S phase. (Figure provided by Laurence Denis.)
and dynamics of EuHMTasel with DNA replication
foci, we performed a fluorescence recovery after pho-
tobleaching (FRAP) analysis using U2OS cells
expressing YFP-EuHMTasel protein. After bleaching
a spot in the nucleus using a pulse with a 488-nm laser,
we measured the recovery of fluorescence intensity in
the bleached square. First, we analyzed the recovery
after photobleaching YFP-EuHMTasel at replication
foci in early- or late-S phase by fitting exponential
functions to the recovery curves. Single exponential
functions could not be fitted to any of the recovery
curves, indicating the presence of multiple distinct
populations of YFP-EuHMTasel. However, by fitting
bi-exponential functions, we could determine resi-
dence times of a rapidly exchanging fraction of YFP-
EuHMTasel, which increased from 6.2 ± 1.5 s (mean
± sip.) during early-S phase to 10.3 ± 5.8 s during late-
S phase. The residence time of this fraction on non-S-
phase chromatin was significantly shorter (3.1 ± 1.2 s;
p < 0.001 when compared by t-test with early- or late-
S phase). In addition, a fraction of approximately 40%
bound with a longer residence time, increasing from
21.6 ± 8 s in non-S-phase cells to 106.4 ± 109 s in late-
S-phase cells. The increased residence time at replica-
tion foci supports the idea of a functional association
of Eu-HMTasel at DNA replication sites.
Interestingly, the residence time increased from early
to later stages of S phase, which is likely a conse-
quence of structural changes of chromatin at late repli-
cation foci. To determine the function of EuHMTasel
and G9a during DNA replication, we used RNA inter-
ference to deplete these proteins from p53-positive
RKO cells. In cycling mammalian cells, EuHMTasel
depletion leads to a drastic diminution in the methyla-
tion (mono-, di-, and trimethylation) of lysine 9 at his-
tone H3. In addition, we detected a significant
increase of the Go/G, population in EuHMTasel -
depleted cells as compared to control cells, indicative
of a cell cycle arrest in G1. However, knockdown of
G9a did not foster any obvious cell cycle modifica-
tion. Under these conditions, BrdU incorporation was
maintained, suggesting that EuHMTasel is not direct-
ly involved in DNA replication per se.
We have identified a specific and dynamic associ-
ation of the EuHMTasel /G9a histone methyltrans-
ferase complex with DNA replication sites. Because
depletion of EuHMTasel or G9a leads to a significant
decrease of histone H3 methylation, these results
establish the importance of DNA replication for the
establishment and/or maintenance of the dimethyla-
tion pattern of H3K9. Moreover, they suggest that this
complex has a central role in epigenetic maintenance
of chromatin organization and gene expression.
Although chromatin regions with different histone H3
methylation states globally replicate at different times
during S phase, regions of facultative heterochromatin
may be distributed throughout the genome and there-
fore may be replicated throughout S phase. This can
explain the association of EuHMTasel with replica-
tion sites throughout S phase. Furthermore, the
EuHMTasel complex may modify histone H3 with a
dimethyl-K9 so as to mark it for incorporation into
newly synthesized DNA irrespective of the chromatin
state (euchromatin or heterochromatin). It will be of
particular interest to decipher the kinetics of recruit-
ment and activity of the EuHMTasel complex relative
to DNA synthesis and chromatin formation and the
coordination of this event with further modifications
of chromatin (i.e., H3.3 exchange at active sites of
transcription, CENP-A loading at centromeres or
H3K9 trimethylation at constitutive heterochromatin
[catalyzed by SETDB1 or Suv39h1/ Suv39h2]).
CENTROMERE POSITIONING AND DYNAMICS IN
LIVING ARABIDOPSIS PLANTS
The centromere, the primary constriction of the chro-
mosome, is a DNA-protein structure that directs the
movement of chromosomes during mitosis and meiosis.
All centromeric regions contain specialized nucleo-
somes in which histone H3 is replaced by the cen-
tromere-specific histone H3 (CENH3). The organiza-
tion and dynamics of the genome has been shown to
influence gene expression in many organisms. Data
from mammalian tissue culture cells have provided con-
flicting conclusions with regard to the extent to which
chromatin organization is transmitted from mother to
daughter nuclei. Here, we have taken advantage of
Arabidopsis thaliana, with only 10 centromeres in
diploid cells, to study the three-dimensional organiza-
tion and dynamics of centromeres in interphase nuclei
and through mitosis in living Arabidopsis plants. We
developed transgenic Arabidopsis lines in which cen-
tromeres were tagged with a green fluorescent protein
(GFP) fusion of the centromere-specific histone H3
(HTR12). Using four-dimensional live-cell imaging
and quantitative analysis, we revealed that all cen-
tromeres localize predominantly at the nuclear periph-
ery (Fig. 2) in different cell types in living Arabidopsis
plants. In addition, we were able to demonstrate that
Arabidopsis centromeres are constrained at the nuclear
periphery during interphase, and the organization of
endoreduplicated sister centromeres is cell-type depen-
89
A8' / '
D
N., _4,2
/
6 8
c_l_D30°
EL7120°
\3-
F
sue_ n
C
C__;_D180°
7
FIGURE 2 Maximum intensity projections of guard cells from the leaf of a living Arabidopsis
transgenic plant. Projections at different angles showing centromeres labeled by HTR12-
Venus in gray dots and chromatin labeled by histone HTB1-CFP. (A) Projection image of
guard cells from 20 image sections with a z-interval of 0.2 pm. Centromeres in one guard
cell were arbitrarily numbered 1-10. (4C) Diagram of positions of centromeres in A. The X axis
represents the cell wall between two guard cells, the Y axis is vertical to the X axis, and the
Z axis is directed to the bottom of the guard cell nuclei. Centromeres were defined as the
brightest spots in the local fluorescent locus. Centromeres from sections 1-10 are repre-
sented by numbered arrows 1, 2, 4, 5, and 10. Centromeres from sections 11-20 are rep-
resented by numbered arrows 3, 6, 7, 8, and 9. (8) Projection image of guard cells after 30°
counterclockwise rotation along the vertical axis. Centromeres (3, 6, 7, 9) at the bottom side
of the nuclei move left. Centromere 9 can be observed at the periphery of the projected
nuclei. Centromeres (4, 10) at the topside of the nuclei move right. (C) Projection image of
guard cells after 60° counterclockwise rotation along the vertical axis. (D) Projection image
of guard cells after 90° counterclockwise rotation along the vertical axis. Centromeres 4 and
7, which were at the center of the projected image at 0° (A), can be observed at the nuclear
periphery of the projected nucleus. (E) Projection image of guard cells after 120° counter-
clockwise rotation along the vertical axis. (F) Projection image of guard cells after 150° coun-
terclockwise rotation along the vertical axis. (G) Projection image of guard cells after 180°
counterclockwise rotation along the vertical axis. Bar, 5 gm. (From Fang et al. 2005. Mot.
Biol. Cell 16, 5710-5718.)
dent with predominant clustering in leaf epidermal cells
and dispersion in root epidermal cells. The constrained
movement suggests that centromeres anchor the chro-
mosomes within the nucleus. Four-dimensional track-
ing of the entire set of centromeres through mitosis in
growing root meristemic cells demonstrated that global
centromere position is not precisely transmitted from
the mother cell to daughter cells, indicating that precise
positioning of centromeres/chromosomes is not essen-
tial for gene expression. However, positioning of sub-
chromosomal domains and nuclear bodies may exist,
resulting in distinct local environments that may affect
the activities of individual genes or gene clusters. These
results provide important insight into our understanding
of chromatin organization and dynamics among differ-
ent cells of a living organism.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund D. Dolezal
X. Liu
S. Schuck
The papillomaviruses are a group of viruses that infect
and transform the basal epithelium, inducing prolifer-
ation of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents one of the few
firmly established links between viral infections and
the development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These
viruses normally require specialized differentiating
cells that only with difficulty can be generated in cell
culture. However, for a bovine papillomavirus (BPV-
1), a convenient cell culture system exists where viral
gene expression, oncogenic transformation, and viral
DNA replication can be studied. Thus, BPV has
become a useful model for these aspects of the viral
life cycle. The DNA replication properties of the
papillomaviruses show some unique and interesting
characteristics. As part of their normal life cycle, these
viruses can exist in a state of latency, which is charac-
terized by maintenance of the viral DNA as a multi-
copy plasmid in infected cells. The copy number of the
viral DNA is tightly controlled and the viral DNA is
stably inherited under these conditions. Papilloma-
viruses therefore provide a unique opportunity to
study plasmid replication in mammalian cells. In addi-
tion, the viral DNA replication machinery represents
one of the most promising targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. In recent years, we have direct-
ed our attention toward the biochemical events that are
associated with initiation of DNA replication. We are
studying the biochemical properties of the viral E 1
and E2 proteins and how these two proteins interact
with the viral origin of DNA replication and with the
cellular replication machinery to generate initiation
complexes. Our studies demonstrate that the El pro-
tein has all the characteristics of an initiator protein,
including on recognition, DNA-dependent ATPase
activity and DNA helicase activity. The transcription
factor E2, whose precise function has remained more
elusive, appears to serve largely as a loading factor for
El. Through direct physical interactions with both El
and the ori, E2 provides sequence specificity for the
formation of the initiation complex.
We are currently attempting to elucidate how the
El and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication at
the viral ori. These events include binding of the ini-
tiator to the ori, the initial opening of the DNA duplex
(melting), and the assembly and loading of the E1
replicative helicase at the replication fork. Our studies
so far indicate that these activities are generated in an
ordered process that involves the sequential assembly
of El molecules on the ori. This sequential assembly
generates different complexes with different proper-
ties that in turn recognize ori, destabilize the double
helix, and function as the replicative DNA helicase.
ASSEMBLY OF A DOUBLE HEXAMERIC HELICASE
One of the factors that have severely hampered the
study of viral initiator proteins such as E 1 has been the
inability to generate simple and robust assays for
analysis of the complexes that these proteins form
with DNA. This has led to the interesting paradox that
the largest known complex, a double hexamer (dode-
earner), is the best-characterized form of these pro-
teins and virtually nothing is known about the com-
plexes that precede formation of the double hexamer.
We have made the development of an electrophoretic
mobility-shift assay (EMSA) for El a very high prior-
ity. By using carefully controlled conditions and, in
particular, by providing specific probes of precise
length, we have been able to develop a robust EMSA
that we have used to recapitulate the assembly of a
double hexameric helicase on the viral origin of DNA
replication.
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FIGURE 1 Probe dependence for El complex formation. El forms ADP-dependent trimers and ATP-dependent hexamers on probes
without sequence dependence (1). In the presence of paired El BS, and on a longer probe, this translates into the formation of the
functional forms of these complexes: a double trimer in the presence of ADP and a double hexamer in the presence of ATP (2). On a
very short probe, in the presence of paired El BS, a dimer is formed in the presence of ADP and a double hexamer forms in the pres-
ence of ATP (3). If one pair of El BS is mutated (4), complex formation is identical to that observed for the nonspecific probe in1.
By using our newly developed EMSA, we could
demonstrate that El has the intrinsic propensity to
form trimers on DNA in the presence of ADP and
hexamers in the presence of ATP. Formation of the
trimer and the hexamer of El does not depend on the
presence of particular DNA sequences. However, in
the presence of the paired E1 binding site (BS) in the
ori, this translates into formation of a head-to-head
double trimer in the presence of ADP and a double
hexamer in the presence of ATP (Fig. 1). An obvious
possibility was that the ADP-dependent double trimer
represented a precursor for the double hexamer. This
would be consistent with a requirement for nucleotide
binding for formation of the double timer and for
nucleotide hydrolysis for the formation of the double
hexamer. By performing a time-course experiment,
we could demonstrate that the double trimer indeed
serves as a precursor for the double hexamer and that
the double trimer is quantitatively converted into a
double hexamer in the presence of ATP.
Our previous data has demonstrated that a second
DNA-binding activity, in addition to the El DNA-
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binding domain (DBD), is present in the El helicase
domain and that this activity is responsible for binding
to the DNA sequences flanking the El BS. The lack of
a requirement for El BS for trimer and hexamer for-
mation indicated that formation of these complexes
relied on this DNA-binding activity. Candidates for
such an interaction are the residues that are present in
the center of the ring structure, which these initiator
proteins form. The structure of the helicase domains of
initiator proteins from the papovavirus family, includ-
ing SV40 T antigen and El, contain a highly con-
served structural element termed a I3-hairpin which
also has a counterpart in archaeal MCM proteins. This
b-hairpin forms a narrow constriction on the inside of
the ring lining the channel where DNA is predicted to
be present. We generated a point mutation, H507A, in
one of these conserved residues and tested it in a
DNase footprint assay. As expected for a mutation that
affects the DNA-binding activity present in the heli-
case domain, these mutations resulted in a protein that
still bound to the El BS in a normal manner but that
failed to bind to the DNA sequences flanking the El
BS. This mutant also failed to form a trimer, indicat-
ing that the 13-hairpin is directly involved in recogni-
tion of the flanking sequences and that formation of
the trimer relies on the DNA-binding activity present
in the helicase domain. H507A also failed to form a
double trimer, and as expected from the precursor-
product relationship between the double trimer and the
double hexamer, H507A was also defective for double
hexamer formation. Interestingly, we could show that
this defect for double hexamer formation was directly
caused by the failure to form a double trimer, since on
a very short probe, where double trimer formation is
not required, H507A formed a double hexamer.
These results indicated that on the on -sized probe,
the double trimer (DT) precursor in some way modi-
fies the DNA structure to allow for the formation of a
double hexamer. To determine whether this was the
case, we performed permanganate reactivity assays in
the presence of ADP under conditions where the dou-
ble trimer, but not the double hexamer, forms. Under
these conditions, we could detect significant reactivi-
ty, indicating that the double trimer is capable of melt-
ing double-stranded DNA and that likely the require-
ment for the double trimer precursor reflects a require-
ment for melting of the template prior to formation of
the double hexamer. We could also demonstrate direct-
ly that the double trimer serves as a functional precur-
sor for the complex that unwinds the DNA (i.e., the
DNA helicase). Consequently, we can now identify the
pathway by which the DNA template is prepared for
initiation of DNA replication (Fig. 2). A dimer of El
is responsible for initial binding to ori. Upon ATP
binding, the double trimer forms and generates initial
melting of the template. Upon ATP hydrolysis, the
double trimer and the melted template serves as a sub-
strate for formation of the double hexamer, which can
unwind the template and generate single-stranded
DNA. The ability to generate these different complex-
es and analyze them by EMSA now provides the
opportunity to analyze initiation of DNA replication in
unprecedented detail.
MUTATIONAL ANALYSIS OF THE El DBD SURFACE
The DBD of the El protein clearly is responsible for
the site-specific DNA binding of which the El protein
is capable. This site-specific DNA binding in turn is
responsible for recognition of the origin of DNA repli-
cation in the viral genome. Furthermore, on the basis
of both structural and biochemical studies of the El
DBD, the DBD also provides the dimerization surface
Dimer
ATP binding
Double Trimer
ATP hydrolysis Melting
Double hexamer
Unwinding
FIGURE 2 Assembly pathway for a functional El double hexa-
mer. El binds to DNA as a dimer. In the presence of ATP, the
dimer is converted to a double trimer, which melts the on DNA.
As a consequence of ATP hydrolysis, the double trimer is con-
verted to a double hexamer, which unwinds the on DNA gener-
ating free single-stranded DNA.
for the El protein and also contains an interaction sur-
face for the DBD from the E2 protein. In addition, on
the basis of imaging analysis of, for example, SV40 T
antigen, it is likely that the El DBD takes an active
part in formation of large complexes such as the dou-
ble hexamer, which appear to be the entity that
unwinds the origin of DNA replication.
To identify additional functions in the DBD, we
have performed a complete surface mutagenesis of the
El DBD. Based on the high-resolution structure of the
El DBD, we have substituted 63 surface residues for
alanine, avoiding areas known from structural analysis
to be involved in DNA binding and dimerization. After
screening these El mutants for expression and for in
vivo DNA replication activity, we were able to identi-
fy 16 mutants with defects in DNA replication. Four of
these mutants were defective for expression in vivo,
whereas the remaining 12 gave rise to wild-type levels
of full-length protein. To determine which biochemi-
cal functions might be defective in these mutants, we
expressed the 12 mutant El proteins in Escherichia
coli and purified them. We tested these mutants in dif-
ferent in vitro assays related to DNA replication. From
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the behavior of the mutants in these assays, we could
group these mutants into four categories depending on
which aspect of DNA replication was affected by the
mutation. The results from in vitro DNA replication
were particularly informative. Of the 12 mutants, 8
had severe defects for in vitro DNA replication. These
mutants clearly had biochemical defects for replica-
tion-related processes. The remaining four mutants
(Group I) still had activity for replication in vitro.
These mutants are therefore likely to affect processes
that are only required for DNA replication in vivo,
such as regulation of viral DNA replication, for exam-
ple, by cell cycle mechanisms.
Despite our efforts to avoid residues involved in
DNA binding, four substitutions (Group II) had slight
defects for DNA binding, most likely because these
mutants affected the structure of the El DBD.
Although these four mutants may also affect other
activities, such effects would be obscured by the
defect for DNA binding. A third group (III) consists of
two mutants that have wild-type activity for all the
biochemical activities that we can measure, with the
exception of in vitro DNA replication. These two
mutants are likely to affect a function required only
for DNA synthesis, such as the interaction with cellu-
lar DNA replication factors. The final and fourth
group consists of two mutants that have specific
defects in the formation of the double trimer and dou-
ble hexamer. These mutants also show the expected
defects for unwinding activity.
It is apparent that there are many ways to disable
the DNA replication activity of the El protein, which
is a testimony to the multitude of diverse functions
that this class of protein encodes. It is surprising, how-
ever, that so many of these activities appear to depend
to some extent on the El DBD. This provides good
evidence that the El DBD takes part in many bio-
chemical activities that previously have been consid-
ered to reside in other domains.
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Chromosomal DNA replication in eukaryotes is a
highly regulated process that involves the licensing of
chromosomes at origins prior to S phase. The licensing
occurs by the formation of a prereplicative complex
(RC) at origins of DNA replication. The pre-RC con-
sists of the origin recognition complex (ORC) that
recruits Cdc6, Cdtl, and minichromosome mainte-
nance (MCM) proteins to form a stable complex at
each origin. Later, after activation of cyclin-dependent
and Cdc7-Dbf4 protein kinases prior to entry into S
phase, pre-RCs recruit other proteins that eventually
promote the priming of DNA synthesis at each origin.
Previous studies from our laboratory have shown
that ORC interacts with a regulatory protein called
Cdc6 in an ATP-dependent manner and that this inter-
action changes how ORC interacts with the DNA. The
addition of Cdc6 protein to the ORC-DNA complex
causes a dramatic change in the way both ORC and
Cdc6 bind to DNA. ORC normally binds to about 48
base pairs in the origin DNA and protects them from
digestion in vitro by deoxyribonuclease I (DNase I).
On addition of Cdc6, and only in the presence of ATP,
the DNase I footprint is greatly extended to about 85
base pairs, resembling the region of the origin that
binds proteins in vivo during the G, phase of the cell
cycle, prior to the initiation of DNA replication. ATP
hydrolysis by Cdc6 is required for formation of the
extended footprint over the origin DNA since mutant
versions of Cdc6 that lack ATPase activity cannot sup-
port the reaction. Furthermore, nonhydrolyzable
analogs of ATP fail to support formation of the extend-
ed footprint, even though they do support Cdc6 bind-
ing to ORC on origin DNA.
Five of the ORC subunits are members of the
AAA+ family of proteins. In collaboration with Huilin
Li's group at the Brookhaven National Laboratory, we
have begun to investigate the structure of ORC, the
ORC-Cdc6 complex, and the structure of these com-
plexes bound to DNA. Using computer-assisted recon-
struction of single particles of ORC and ORC-Cdc6
complexes viewed by electron microscopy, the struc-
ture of these complexes has been determined. The
technique provides a view of the structure of the pro-
teins with a resolution of about 20 A. ORC in the
absence of any nucleotide forms an extended, three-
domain structure about 18 nM long, sufficient to cover
about 50 base pairs of DNA. In the presence of ATP or
of ATPyS, an analog that is not easily hydrolyzed,
ORC assumes a slightly different shape, but still with
the same extended, three-domain configuration.
Addition of Cdc6 to ORC in the presence ATPyS
formed a ring structure with the same length dimen-
sions as ORC. Thus, the extended footprint on origin
DNA formed by ORC and Cdc6 most likely represents
wrapping of the DNA around the protein complex. In
the presence of ATP and in the absence of origin DNA,
an ORC-Cdc6 complex is unstable.
To carry the structural information further, with
Huilin Li's lab, we have developed a technique to
extend the electron microscopy reconstruction data by
tagging the subunits of ORC with an approximately
42 -kD protein, the Escherichia coli maltose-binding
protein. The amino termini and carboxyl termini of
each of the ORC subunits were tagged, and the indi-
vidual tagged proteins were assembled into the ORC
complex. In this manner, most of the ORC subunits
could be localized to the ORC structure. Electron
microscopy reconstructions of ORC missing the
smallest subunit, Orc6, enabled the location of this
subunit to be determined.
The ATPase activities of the various complexes
have been determined. As shown previously by other
investigators, when ORC binds to the origin DNA, its
intrinsic ATPase activity is reduced by about fivefold
to sevenfold. Addition of Cdc6 greatly stimulates the
ATPase activity of the complex, and the ATPase is
dependent on both Cdc6 and ORC ATPase activities.
In the absence of DNA, the ATPase activity of Cdc6
promotes dissociation of the ORC from the Cdc6. We
have also found that Cdc6 also promotes the dissocia-
tion of ORC from non-origin DNAs, a reaction that
requires the Cdc6 ATPase activity. This suggests that
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ORC-Cdc6 complexes can only stably bind to authen-
tic origin DNA sequences. Thus, Cdc6 contributes to
the selection of origin DNA by ORC. We suggest that
this mechanism exists in all species, particularly in
those species such as Schizosaccharomyces pombe,
Drosophila, and mammals where ORC by itself does
not bind to specific DNA sequences. Cdc6 is struc-
turally very similar to the largest ORC subunit Orel
and it is likely that the ORC-Cdc6 complex, with its
six AAA+ family members, is the real functional com-
plex that determines origin specificity.
In collaboration with Rui-Ming Xu's lab here at
CSHL, X-ray crystallography has been used to study
the structure of subdomains of Orcl. These studies
have identified the structure of a novel bromodomain-
associated homology (BAH) domain in the amino ter-
minus of Orcl that interacts with a protein called Sirl .
Sirl contributes silencing of gene expression at two
mating-type loci in yeast by binding to ORC, which is
in turn bound to cis-acting silencer DNA sequences.
We determined the structure of the Orc 1 BAH domain
bound to the ORC interacting region from Sirl pro-
tein. The structure shows a multidomain interaction
surface between Orcl and Sirl that allows the remain-
der of Sirl to interact with other silencing regulators.
In essence, ORC tethers Sirl to regions of the genome
that are destined to be heterochromatic. In mam-
malian cells, we have shown that ORC interacts with
heterochromatin protein 1 (HP1), and we are in the
process of determining how HP1 interacts with ORC
and the consequences for heterochromatin formation
in mammalian genomes.
We have also investigated the assembly of the
human ORC complex. Unlike the yeast protein,
human ORC does not form a stable complex through-
out the cell cycle. The Orel subunit is degraded at the
Gi- to S-phase transition, and Orc6 is not stably bound
to the other subunits. We have demonstrated that
human ORC is assembled in an ATP-dependent man-
ner that is also dependent on the Orc4 and Orc5 ATP-
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binding motifs. Loading of Orc4 onto the Orc2 and
Orc3 core complex requires prior binding of the Orc5
subunit. Once the Orc2,3,4,5 complex is assembled,
Orcl can bind, and then Orc6 interacts to form the
entire ORC. However, the binding of Orc6 is regulat-
ed. We have previously demonstrated that Orc6 partic-
ipates in other protein complexes in human cells at
kinetochores and at the midbody during cytokinesis.
Current studies are aimed at identifying the func-
tion of the ORC subunits in human cells. In addition
to specifying the starts sites for the initiation of DNA
replication, ORC subunits are localized and have
important roles at centromeres, kinetochores, and cen-
trosomes, as well as heterochromatin.
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The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects the activity of the kinases
that phosphorylate it and the protein phosphatases that
catalyze the dephosphorylation reaction. We study the
family of protein tyrosine phosphatases (PTPs),
which, like the kinases, comprise both transmem-
brane, receptor-linked forms as well as nontransmem-
brane, cytoplasmic species and represent a major fam-
ily of signaling enzymes. We are integrating a variety
of experimental strategies to characterize the physio-
logical function of members of the PTP family.
Disruption of normal patterns of tyrosine phosphory-
lation has been implicated in several human diseases.
Therefore, insights into the mechanisms involved in
modulating PTP function may ultimately yield impor-
tant information to help counter such diseases.
During the last year, there have been several
changes in the lab. Having completed her Ph.D., May
Chen left for postdoctoral studies at Harvard. Bob Del
Vecchio left to take up a position in industry, and
Lifang Zhang is now pursuing a second postdoc. Ben
Boivin joined us as a postdoctoral fellow having com-
pleted his Ph.D. in Bruce Allen's lab in Montreal. This
was a challenging year-flooding in the Demerec
building severely impacted tissue culture facilities,
which slowed research considerably. Nevertheless,
progress has been made in several areas.
FUNCTIONAL ANALYSIS OF THE PTP FAMILY
Unlike the protein kinases, which are derived from a
common ancestor, the protein phosphatases have
evolved in separate families that are structurally and
mechanistically distinct. We have now cataloged the
human PTP genes and more recently have extended
our genomic sequence analysis to other organisms.
The PTPs, which are defined by the active site signa-
ture motif HC(X)5R, are divided into the classical,
pTyr-specific phosphatases and the dual specificity
phosphatases (DSPs). The 38 classical PTP genes
encode receptor-like proteins, which have the potential
to regulate signaling directly through ligand-con-
trolled protein dephosphorylation, as well as nontrans-
membrane, cytoplasmic enzymes. There are about 65
genes encoding a heterogeneous group that are broad-
ly described as DSPs. In general they share the same
catalytic mechanism as the classical PTPs, but the con-
struction of the DSP active site allows them to accom-
modate pSer/pThr residues as well as pTyr residues in
proteins. Nonetheless, in terms of physiological func-
tion, the "DSPs" may actually show preference for
either Tyr or Ser/Thr residues. Some even target non-
protein substrates such as inositol phospholipids and
RNA. The DSPs include the VH1-like enzymes, which
are related to the prototypic DSP VH1, a 20-kD pro-
tein that is a virulence factor of vaccinia virus; and the
cdc25s, which are key regulators of the cell cycle and
various phosphatidyl inositol phosphatases including
the myotubularins. Overall, there are approximately
100 human PTP genes, compared to 90 human PTK
genes, suggesting similar levels of complexity
between the two families. However, the number of
genes only illustrates the minimal level of complexity
in the family, with additional diversity introduced
through use of alternative promoters, alternative
mRNA splicing, and posttranslational modification.
This structural diversity is indicative of the functional
importance of the PTPs in the control of cell signaling.
It is now apparent that the PTPs have the capacity to
function both positively and negatively in the regula-
tion of signal transduction. Furthermore, the PTPs
have the potential to display exquisite substrate, and
functional, specificity in vivo. Therefore, the defini-
tion of the "PTP-ome" provides a foundation for
detailed analyses of the structure, regulation, and
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physiological function of this important family of sig-
nal transducing enzymes.
To facilitate research on the PTPs within the signal
transduction community, we are making our analysis
of the PTP family available as a Web-accessible
resource at two locations: http://ptp.cshl.edu and a
replica site at http://science.novonordisk.com/ptp.
This resource contains our database of PTP accession
numbers, multiple sequence alignments, phylogenetic
trees, structure files, annotated molecular graphics
files, chromosomal mapping data, analysis of exon
structure, pseudogenes, and disease linkages. The PTP
database can be searched by key words or by sequence
similarity using our BLAST server, which also pro-
vides a tool for phylogenetic classification of anony-
mously submitted sequences based on PTP domain
homology and neighboring joining trees. This is prov-
ing to be a popular resource, and we are continuing to
update the site with the goal of maintaining it as the
definitive source of information on the PTP family for
the scientific community.
RNA interference is a powerful approach to con-
duct loss-of-function analyses as a method for exam-
ining the physiological function of particular proteins
in mammalian cells. Having defined the composition
of the PTP superfamily in humans, we have now
designed and constructed a library of short hairpin
RNA constructs that will allow us to examine system-
atically the function of individual PTPs in a variety of
cell systems. We are using the pMLP retroviral expres-
sion vector constructed by Ross Dickins in Scott
Lowe's lab here at CSHL, which includes a green fluo-
rescent protein (GFP) marker and a puromycin selec-
tion cassette for generation of stable lines. Our first
application of this library is currently ongoing as a
collaboration with Senthil Muthuswamy here at
CSHL. We are using his three-dimensional culture
system to explore the effect of attenuating PTP expres-
sion on MCF-10A mammary epithelial cell differenti-
ation, as a first step to defining roles for members of
the PTP superfamily in breast cancer.
THE DUAL SPECIFICITY PHOSPHATASES
Many of the 43 DSPs we defined in our analysis of the
human genome sequence are uncharacterized.
Phylogenetic analyses divided these enzymes into
three classes, revealing characteristics that were used
to prioritize further studies. Currently, we are focusing
on the following:
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JSP-1
Multiple DSPs have been identified that have the abili-
ty to dephosphorylate and inactivate various MAP
kinases, constituting a complex response network for
attenuation of MAPK-dependent signals. We identified
a novel DSP and observed, contrary to expectation, that
it had the capacity to activate Jnk specifically, hence
JSP-1 (Jnk stimulatory phosphatase 1). In addition, we
observed enhanced phosphorylation of MKK-4, which
phosphorylates and activates Jnk. Furthermore, expres-
sion of a dominant-negative mutant form of MKK-4
abolished the activation of Jnk by JSP-1, suggesting a
site of action of the phosphatase upstream of MKK-4 in
the Jnk signaling cascade. This study illustrates a new
potential tier of control of the Jnk signaling pathway
and a novel aspect of the role of protein phosphatases in
the control of MAPK signaling. This raised the possi-
bility that JSP-1 may offer a different perspective to the
study of various inflammatory and proliferative disor-
ders associated with aberrant Jnk signaling.
We have now generated JSP-1 knockout mice,
which contain a targeted deletion at exon 3 resulting in
the production of a truncated, inactive protein of
approximately 20 amino acids. These mice reproduce
at normal Mendelian ratios, display no obvious physi-
cal abnormalities, and have a life expectancy similar
to their wild-type controls. Histopathological evalua-
tion of aged (18-24 months) wild-type, and knockout
mice revealed no gross abnormalities due to JSP-1
ablation in heart, kidney, liver, or brain. However, aged
JSP-1 knockout mice display splenomegaly and
splenic lymphoid hyperplasia; the cause of this is cur-
rently unknown but is under investigation.
We are characterizing two aspects of their pheno-
type-one of which implicates JSP-1 in the regulation
of innate immunity and the other indicates that JSP-1
may have a role in the neurodegenerative processes that
lead to Parkinson's disease. The backcrossing programs
are now nearing completion, which will allow us to
study the phenotypes on a consistent genetic back-
ground. We are currently breeding F10 generation het-
erozygotes in the C57/BL6 background and F8 with
BALB/c. Thus far, we have observed that ablation of
JSP-1 leads to attenuation of the inflammatory response
to gram-negative bacterial endotoxin, and the knockout
mice display defective production of (TNF-a) in
response to lipopolysaccharide (LPS) administration,
suggesting an important role in the innate immune sys-
tem. We have now extended the observation to show
that the heterozygotes display an intermediate response.
The mechanistic basis for this effect is currently under
investigation. We have been trying to identify a suitable
cell type from the mouse in which to investigate the sig-
naling pathways responsible for the defective TNF-a
response. The goal was to find a cell type that, in cul-
ture, would recapitulate the in vivo response (decreased
LPS-induced production of TNF-a) and that could be
cultured in sufficient numbers for biochemical analysis
of signaling downstream from Toll receptors, such as
TLR4, which mediate the effects of LPS. Splenocytes
isolated from JSP-1 knockout mice secrete decreased
TNF-a in response to LPS compared to wild type; how-
ever, the low numbers and short lifespan of these cells
make it difficult to perform biochemical analysis of the
signaling pathways responsible for this difference.
Similar results were also obtained with bone-marrow-
derived dendritic cells, but again this system does not
yield sufficient cells for a comprehensive biochemical
characterization. We did not observe a difference in
LPS-induced TNF-a production between resident
macrophages from the JSP-1 wild-type and knockout
mice; however, in bone-marrow-derived macrophages
from F7 C57/BL6 mice, we observed a reduction of
-50% in TNF-a levels produced from knockout com-
pared to wild-type animals. These cells can be generat-
ed in sufficient numbers to perform signal characteriza-
tion, and preliminary evidence from the use of phos-
phospecific antibodies to TAB1 indicates that JSP-1
may act at the level of the TAK1/TAB complex, down-
stream from TLR4. Experiments are under way to con-
firm this finding and to dissect further the impact on
TAK1 activity, JNK activity, and NF-KB signaling.
In addition, preliminary results indicate that fol-
lowing treatment of JSP-1-/- mice with MPTP (1-
methy1-4-pheny1-1,2,4,6-tetrahydropyridine), the acti-
vation of Jnk is attenuated compared to wild-type con-
trols. MPTP is a neurotoxin that replicates most of the
neuropathological features of Parkinson's disease. We
are currently investigating the mechanism by which
JSP-1 regulates the Jnk pathway in this context and the
extent to which manipulation of JSP-1 may influence
neurodegeneration in Parkinson's disease. These stud-
ies are being performed with Serge Przedborski and
his colleagues at Columbia University.
DUSP23
The gene for this DSP is located at chromosome
1q22.23, a region associated with amplifications,
translocations, and other abnormalities in multiple can-
cers. Our phylogenetic analysis assigned this DSP to a
class of phosphatases that could be considered the most
ancient of the PTPs, due to their relationship to enzymes
found in bacteria and archaea, perhaps indicative of a
role in a fundamental cell function. Preliminary data
suggest that this DSP may be amplified in certain breast
tumors. Using RNA interference, we have shown that
disruption of its expression inhibits proliferation and
transition through the cell cycle. The mechanistic basis
for these effects is under investigation.
MK-STYX
Several members of the PTP superfamily possess con-
served domains with core features of a PTP but which
lack residues that are critical for catalysis. We have been
focusing on one such protein, termed MK-STYX,
which is closely related to the MAP kinase phos-
phatases, for example, MKP-1. Sequence homology is
observed throughout the proteins, including with the
noncatalytic amino-terminal segment of MKP-1, which
is known to serve a regulatory function. MK-STYX is
catalytically inactive due to two substitutions in the sig-
nature motif (IFSTQGISRS, compared to VHCQAG-
ISRS in MKP -1). We observed that mutations in MK-
STYX to "restore" the active-site His and Cys residues
that are known to be critical for activity in MKP-1 cre-
ated a form of MK-STYX that displayed enzymatic
activity. Furthermore, we observed that mutations in the
signature motif that restored activity changed the pat-
tern of associated proteins that were observed to coim-
munoprecipitate with MK-STYX. This suggests that the
proteins whose association with wild-type MK-STYX
is disrupted by mutations in the signature motif may
represent functional MK-STYX "substrates"/binding
partners. Using a mass-spectrometry-based analysis of
MK-STYX-binding proteins, we have identified Ras-
GTPase-activating protein SH3 domain-binding protein
(G3BP) as a candidate "substrate" of MK-STYX.
G3BP interacts with RasGAP and is an endoribonucle-
ase. Moreover, G3BP has been implicated in the regula-
tion of Ras signaling and RNA stability. We are cur-
rently investigating the functional significance of this
association.
PTEN
PTEN is the prototypic tumor suppressor phosphatase;
more than 90% of glioblastomas lose alleles from
chromosome 10q that invariably includes the PTEN
99
locus (10q23-24). In work from our laboratory and
others, PTEN has been shown to dephosphorylate both
proteins and inositol phospholipids; however, only the
lipid phosphatase activity of PTEN has been clearly
demonstrated to have a central role in its ability to
function as a tumor suppressor. The significance of its
protein phosphatase activity and the identity of bona
fide protein substrates are not yet clearly understood.
We have been using two-photon laser scanning
microscopy coupled with biolistic gene delivery into
organotypic slices of the hippocampus as the basis for
an in vivo assay of PTEN function. The organotypic
slice cultures offer a unique physiological system that
provides an easy and quantifiable readout of PTEN
function. To date, we have focused primarily on deter-
mining the effects of expression of PTEN on mor-
phology of rat hippocampus cells (pyramidal neurons).
Although there was no effect on spine density, expres-
sion of PTEN led to a reduction in spine size, which
can be quantified. We have been working with a
tumor-derived mutation in PTEN, the G129E allele,
which we had previously characterized as having
impaired lipid phosphatase activity, but in which pro-
tein phosphatase activity is intact. We have observed
that expression of this mutant produces the same
reduction in spine size as observed with the wild-type
protein. Although other studies have suggested func-
tional significance for the protein phosphatase activity
of PTEN, the organotypic brain slice preparation has
provided us with the first evidence of a function con-
trolled by this protein phosphatase activity in a living
cell within a tissue.
We are currently testing the effects of wild-type
and mutant forms of PTEN on PI3 kinase signaling in
neurons. Furthermore, recent studies from several labs
have focused attention on the potential importance of
sites of phosphorylation at the carboxyl terminus of
PTEN, particularly in the context of control of cell
migration. It has also been proposed that activation of
PI3K may promote phosphorylation and stabilization
of PTEN. We have generated mutant forms of PTEN
in which some of these potential sites of phosphoryla-
tion have been altered, and we are testing the effects of
their expression on neuronal spine size. Overall, we
are testing the potential functional importance of
PTEN autodephosphorylation-its ability to recognize
its own carboxy-terminal phosphorylation sites as sub-
strates. This would reveal an interesting parallel with
the situation for PI3K, which possesses the ability to
both autophosphorylate and phosphorylate exogenous
lipid substrates. Our study, which focuses on the
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capacity of PTEN to function as a protein phosphatase
in vivo, may reveal novel insights into the physiologi-
cal importance of PTEN and improve our understand-
ing of how it functions as a tumor suppressor.
REGULATION OF PTP FUNCTION BY
REVERSIBLE OXIDATION
As might be anticipated for a family of enzymes that
have such critical roles in the regulation of cell signal-
ing, the activity of PTPs is tightly controlled in vivo.
Recently, the production of reactive oxygen species
(ROS), such as hydrogen peroxide, and the resulting
posttranslational modification of proteins by reversible
oxidation has been implicated in the regulation of tyro-
sine-phosphorylation-dependent signaling pathways
initiated by a wide array of stimuli, including growth
factors, hormones, cytokines, and cellular stresses. This
represents a novel tier of control of tyrosine-phospho-
rylation-dependent signaling and is a major emphasis of
the research efforts in the lab. Attention was drawn to
the PTPs as targets of ROS because the signature motif
of this family, [I/V]HCxxGxxR[S/1], contains an
invariant Cys residue, which, due to the unique envi-
ronment of the PTP active site, is characterized by an
extremely low pKa. The low pKa promotes the func-
tion of this Cys residue as a nucleophile in catalysis, but
renders it highly susceptible to oxidation with concomi-
tant abrogation of nucleophilic function and inhibition
of PTP activity. Work from several labs has now estab-
lished that multiple PTPs are transiently oxidized in
response to various cellular stimuli. Oxidation of the
active-site Cys in PTPs can produce either sulfenic (S-
OH), sulfinic (S-0311), or sulfonic (S-03H) acid. For
oxidation to represent a mechanism for reversible regu-
lation of PTP function, it is essential that the active-site
Cys is not oxidized further than sulphenic acid, since
higher oxidation is usually an irreversible modification.
In the classical PTPs, such as PTP1B, we now have a
molecular explanation for how this is achieved. In pre-
vious years in collaboration with David Barford (ICR,
London, United Kingdom), we demonstrated that oxi-
dation of the nucleophilic cysteine to sulphenic acid is
accompanied by conversion to a cyclic sulphenamide
species, which induces profound conformational
changes at the PTP active site that both disrupt the inter-
action with substrate and expose the oxidized cysteine
to the environment of the cell. This serves the dual pur-
pose of preventing irreversible oxidation to higher oxi-
dized forms and facilitating the reduction of the
sulphenamide to restore the active form of the PTP. We
have discovered a mutant form of PTP1B that adopts
this oxidized conformation in a stable manner.
Currently, we are using this mutant as an antigen in a
phage display approach, which will enable us to screen
a large repertoire of antibodies in a single library.
Purified PTP1B mutant protein (PTP1B-OX) was used
as an antigen to generate an immune response in chick-
ens and first-strand cDNA was synthesized using the
isolated mRNA from bone marrow and lymph nodes.
We are now constructing single-chain Fv antibody frag-
ments. Preliminary indications suggest that we have
generated a large library, and screens for antibodies that
recognize the oxidized conformation specifically are
now under way. Such antibodies would have the poten-
tial to trap the oxidized form of PTP1B in a cellular
context and may prove to be powerful tools to charac-
terize further this important regulatory process.
Until now we have been using a modified in-gel
PTP assay to examine reversible PTP oxidation in a
cellular context. In this assay, cells are lysed under
anaerobic conditions in the presence of an alkylating
agent, which irreversibly inactivates any PTPs that are
present in the reduced, active state. Those PTPs that are
in an oxidized state are protected from alkylation. The
lysate is then subjected to SDS-PAGE in a gel that is
cast to contain a radioactively labeled substrate. The
sample is subjected to electrophoresis, and then the
proteins in the gel are taken through a denatura-
tion/renaturation cycle. The renaturation step is con-
ducted in the presence of reducing agent, so that any
PTPs that were oxidized are now restored to the active,
reduced state. They are able to dephosphorylate the
substrate in their vicinity in the gel, and their presence
is visualized by autoradiography as the appearance of a
clear area of dephosphorylated substrate on the black
background of radioactively labeled substrate. This has
proven to be a powerful approach and has allowed us to
characterize the oxidation of several different PTPs in
a variety of signaling contexts, for example, the
reversible oxidation of PTP 1B and TC-PTP in response
to insulin. Nevertheless, the approach is limited by the
ability of the PTP family members to renature in the
gel-not all PTPs are able to do so, in particular, the
receptor PTPs are unable to renature in this way and so
will be missed in this assay format. During the last
year, we have been trying to develop alternative assays.
We have been optimizing a protocol to use a chem-
ical label to tag the oxidized PTPs in a strategy similar
to the modified in-gel phosphatase assay. After block-
ing the cysteine residues of the active PTPs with an
alkylation agent and performing a buffer exchange, we
reduce the PTPs that were oxidized in the original
sample and then label them with an alkylating agent
that is linked to a biotin group. Therefore, the PTPs
that were originally oxidized can now be measured by
an avidin detection system. Using this protocol, we are
already able to detect PTP oxidation upon several
treatments such as hydrogen peroxide and UV irradia-
tion. We also found that this method is highly sensi-
tive. In addition, we are collaborating with Zhong-Yin
Zhang (Department of Biochemistry and Molecular
Biology, Indiana University) to use some of the broad-
specificity small-molecule PTP inhibitors he has
developed in a similar approach. We are still optimiz-
ing this new technique, and this year, we hope to use it
to study the stoichiometry and the specificity of PTP
oxidation in a variety of signaling contexts.
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RAS AND RHO GTPASES AND THE CONTROL OF SIGNAL
TRANSDUCTION
L. Van Aelst B. Boettner R. Packer
J. Janas M. Uchida
K. John Y.-T. Yang
N. Nadif Kasri
Ras and Rho family members have key roles in cellu-
lar activities controlling cell growth control, differen-
tiation, and morphogenesis. Alterations that affect nor-
mal Ras and Rho function have been found to result in
the development of several disease processes includ-
ing cancer, as well as inflammatory and neurological
disorders. Our ultimate goal is to understand how
aberrations in Ras and Rho signaling components con-
tribute to the development of these disease processes.
Toward this end, my lab has continued to define the
functions of selected GTPases, their regulators, and
effectors, in models of cancer and neurological disor-
ders. Below are highlighted the main projects that
have been carried out during the past year.
ROLE OF DOK PROTEINS
IN MITOGENIC AND ONCOGENIC
SIGNALING
Dok-1 (also called p62"k) was initially identified as a
tyrosine-phosporylated 62-1(D protein associated with
Ras-GAP in Ph' chronic myeloid leukemia blasts and
in v-Abl-transformed B cells. This protein was termed
Dok (downstream of kinases), because it was also
found to be a common substrate of many receptor and
cytoplasmic tyrosine kinases. Subsequently, four addi-
tional Dok family members have been identified.
Among them, Dok-1 and Dok-2 share in common the
ability to bind to a negative regulator of Ras, Ras-
GAP, suggesting that they may serve critical, but pos-
sibly redundant, functions. We described previously
that Dok-1 acts as a negative regulator of growth-fac-
tor-induced cell proliferation and that Dok-1 inactiva-
tion in mice causes a significant shortening of the
latency of the fatal myeloproliferative disease induced
by p210b"-abi. Strikingly, in collaboration with Dr.
Pandolfi's group (Memorial Sloan-Kettering Cancer
Center), we also found that mice lacking both Dok-1
and Dok-2 spontaneously develop a chronic myeloge-
nous leukemia (CML)-like myeloproliferative disease,
likely resulting from increased cellular proliferation
and reduced apoptosis.
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Together, our data show that the Dok proteins have
prominent roles as negative regulators of mitogenic
and oncogenic signaling. However, how these proteins
exert their negative effect on mitogenesis and onco-
genic transformation has remained elusive. Using
Dok-1 knockout cells and Dok-1 mutants deficient in
binding to specific Dok- 1-interacting proteins, we
found that Dok-1 interferes with platelet-derived
growth factor (PDGF)-stimulated c-myc induction and
Ras/MAPK activation by tethering different signaling
components to the cell membrane. Specifically, Dok-1
attenuates PDGF-elicited c-myc induction by recruit-
ing Csk to active Src kinases, whereupon their activi-
ties and consequent c-myc induction are diminished.
On the other hand, Dok-1 negatively regulates PDGF-
induced MAPK activation by acting on Ras-GAP and
at least one other Dok- 1 -interacting protein.
importantly, we demonstrated that the actions of Dok-
1 on both of these signaling pathways contribute to its
inhibitory effect on mitogenesis. Our data suggest a
mechanistic basis for the inhibitory effect of Dok-1 on
growth-factor-induced mitogenesis and its role as a
tumor suppressor.
ROLE OF RAP1 SIGNALING IN
EPITHELIAL MIGRATION AND
CELL-CELL ADHESION
The Rapt protein, a member of the Ras family, was
originally identified as an antagonist of oncogenic
Ras, but more recent studies indicate that the function
of Rapl is largely independent of Ras. Rapl is funda-
mental for the maintenance of cell-cell contacts
between nascent epithelial cells and promotes cell
movement. Importantly, a growing body of evidence
suggests a dysregulation of Rap 1 signaling in malig-
nant processes. The signaling pathways mediating
these effects of Rapl remain largely unknown. We pre-
viously described the identification of the mammalian
junctional protein AF-6 as a Rapl-interacting protein.
To demonstrate the physiological relevance of this
interaction, we decided to carry out functional analy-
ses of their orthologs (DRap 1 and Canoe) in the more
genetically tractable Drosophila system. We found
that both DRapl and Canoe are required for epithelial
migration events in the embryo and that Canoe acts as
a downstream effector of DRapl in this process.
Together, these experiments show that Canoe/AF-6 is
a "bona fide" effector of Rap 1 in the process of
epithelial migration.
More recently, we identified a Drosophila Rap 1 -
specific exchange factor, DPDZ-Gef, which is respon-
sible for Rap 1 activation in migrating embryonic
epithelia. Genetic and biochemical experiments
showed that the DPDZ-Gef gene is indispensable for
epithelial migration in the embryo and that it activates
the Rap 1/Canoe pathway. Interestingly, the mam-
malian counterpart of the DPDZ-Gef protein has been
described to interact with the adherens junctional pro-
tein, 13-catenin and, like AF-6/Canoe, localizes to cell-
cell junctions. Our data reveal a novel Rap 1-depen-
dent pathway key in regulating epithelial cell migra-
tion and adhesive processes that likely are conserved
across species.
ROLE OF RAS AND RHO SIGNALING
IN NEURONAL DEVELOPMENT
Accumulating data indicate that several diseases caus-
ing cognitive impairment (including neurofibromato-
sis, autism, and mental retardation) are associated
with mutations in members of the Ras and Rho
GTPases or in the molecules (GEFs and GAPs) that
control their activity. Moreover, aberrant Rho signal-
ing has also been shown to underlie defects in axon
regeneration. A major challenge has been to unravel
how Ras and Rho signaling components affect neu-
ronal development and function. Our studies in col-
laboration with Drs. Zhu, Malinow, and Svoboda here
at CSHL have provided insights into how perturba-
tions in Ras family members can impact neuronal
function. Furthermore, we obtained data demonstrat-
ing a role for two regulators of the Rho GTPases,
oligophrenin-1 and DOCK7, in dendritic spine mor-
phogenesis and axon formation, respectively, of which
a brief summary is given below.
Oligophrenin-1 (OPHN1) encodes a Rho-GTPase-
activating protein (Rho-GAP), whose loss of function
has been associated with nonsyndromic or nonspecif-
ic X-linked mental retardation (MRX). More recent
studies have also reported the presence of OPHN1
mutations in families with mental retardation associ-
ated with epilepsy and/or cerebellar hypoplasia. Until
recently, nothing was known about the function of
OPHN1 in the brain. We obtained evidence for the
requirement of OPHN1 in dendritic spine morphogen-
esis of hippocampal neurons. Using RNA interference
and antisense approaches, we showed that knock down
of OPHN1 levels in CA1 pyramidal neurons in hip-
pocampal slices results in a significant decrease in
dendritic spine length and that this spine length phe-
notype is mediated by the Rho/Rho kinase pathway. In
addition, we recently demonstrated a biochemical
interaction between OPHN1 and Homer, a postsynap-
tic adaptor molecule involved in spine morphogenesis
and synaptic transmission. An interaction between
OPHN1 and Homer raises the intriguing possibility
that OPHN1 acts downstream from glutamatergic
receptors to regulate RhoA activity in spines, and thus
spine morphogenesis. Our future experiments are
geared toward addressing these interactions and their
functional significance in determining dendritic spine
morphology, calcium signaling, and synaptic plastici-
ty. Together, our studies will provide insight as to how
OPHN1 mutations compromise cognitive function.
DOCK7 is a novel Rac-interacting protein we
recently identified in a search for regulators of Rac
GTPase involved in the early steps of neuronal devel-
opment. Blast searches revealed that DOCK7 belongs
to the DOCK180-related superfamily of proteins,
which emerged as novel activators of the Rho
GTPases. We found that DOCK7 is highly expressed
in major regions of the brain during early stages of
development. Importantly, we observed that DOCK7
is asymmetrically distributed in unpolarized hip-
pocampal neurons and becomes selectively localized
to the axon as the neuron polarizes, suggesting a role
for this protein in the early steps of axon formation,
and hence in neuronal polarization. Using a culture of
dissociated primary hippocampal neurons as a model
system, we demonstrated that this is indeed the case.
Knock down of DOCK7 expression prevents axon for-
mation, whereas overexpression induces the formation
of multiple axons. We further demonstrated that
DOCK7 and Rac activation lead to phosphorylation
and inactivation of the microtubule destabilizing pro-
tein stathmin/Op18 in the nascent axon and that this
event is important for axon development. Our findings
unveil a novel pathway linking the Rac activator
DOCK7 to a microtubule regulatory protein and high-
light the contribution of microtubule dynamics to
axon development. Together, our studies contribute to
defining the molecular mechanisms by which neurons
acquire their polarity and may also shed light on axon
regeneration processes.
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NEUROSCIENCE
CSHL neuroscientists are continuing to make extraordinary progress toward understanding many aspects
of normal brain structure and function, as well as what goes wrong in several major diseases including
Alzheimer's and Parkinson's diseases, schizophrenia, and autism.
Writers and poets know that memory is suffused with pain, ecstasy, fear, and desire. Science now sup-
ports the notion that intense emotions drive the changes in our brains that encode learning and memory. As
part of his groundbreaking studies of the molecular basis of learning and memory, Robert Malinow (in col-
laboration with Anthony Zador) recently discovered that fear conditioning-a form of learning and memory-
is encoded by the movement of proteins called AMPA (a-amino-3-hydroxy-5-methyl-3-isoazole) receptors
into synapses in a portion of the brain known to be responsible for basic instinctual learned responses.
Karel Svoboda explores how information gathered from our senses is converted first into electrical
activity and then transferred into memories through changes in synapses, neurons, and neural circuits. He
combines a variety of powerful imaging techniques with rodent models to probe the brain's circuitry and
how it changes over time. Many synaptic connections in the brain persist for months or years, but the pro-
tein components that form such connections between neurons are much shorter-lived. In addition to the
work of Malinow, Svoboda's group recently helped solve this paradox by discovering a mechanism that
controls the comings and goings of proteins at synapses.
When synaptic connections break down, memory is destroyed. Yi Zhong studies this breakdown,
which underlies neurodegenerative disorders such as Alzheimer's disease. In his lab, researchers use the
fruit fly brain as a model system for studying corresponding human genes that affect brain function in
Alzheimer's patients. This analysis is revealing new clues about the disease and is providing insight into
the general molecular mechanisms of learning and memory. Zhong's recent work has focused on neurofi-
bromatosis 1 (NF1) and other genes implicated in Alzheimer's. His group has uncovered the pathways by
which NF1 controls learning and memory and continues to explore the mechanisms that underlie 13-amy-
loid-induced neurodegeneration and memory loss in Alzheimer's disease.
Josh Huang is deciphering how the brain develops neural networks that respond to GABA (y-amino-
n-butyric acid), the primary inhibitory neurotransmitter in the brain. This year, Huang's group discovered
that a cell adhesion protein called CHL1 has a major role in directing how neurons controlled by GABA
connect to other neurons. These findings may have significant implications for understanding schizophre-
nia and other common neurodevelopmental and psychiatric disorders.
Even fruit flies need to learn and remember in order to survive. Moreover, by comparing the mecha-
nisms of learning and memory in flies, humans, and other organisms, Tim Tully has discovered ancient,
fundamental molecular pathways of memory that are shared from flies to man. Tully and his colleagues
have uncovered some 170 candidate memory genes (CMGs) in fruit flies and are in the process of eluci-
dating the roles of these genes in learning and memory.
Josh Dubnau is using several approaches to identify the molecular and anatomical pathways that
underlie learning and memory in flies. His group has identified several genes that the researchers believe
are involved in a mechanism that stores memories in response to external experiences. They are also
using a genetic technique to map the neuroanatomical circuitry involved in memory processing in flies.
Finally, Dubnau is pioneering an "artificial evolution" strategy with the goal of uncovering the network of
gene interactions that govern learning and memory.
Partha Mitra is one of a number of CSHL neuroscientists who combine theoretical, computational, and
experimental approaches to exploring brain function. His group is continuing to develop mathematical
algorithms and powerful software necessary for making sense of large volumes of neurological data. In the
experimental realm, Mitra is collaborating with researchers at City College New York to uncover new infor-
mation about song learning in zebra finches, which is similar to speech acquisition in humans.
Carlos Brody is interested in how neurons interact with one another to form the neural networks that
underlie rapid decision-making and short-term or "working" memory. His group is also exploring how time
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and temporal patterns are sensed and represented in the brain. This year, Brody's group joined those
of Zach Mainen and Anthony Zador to create a Center for the Neural Mechanisms of Cognition
(CNMC). The goal of the Center is to develop rodent models that combine behavioral training with elec-
trophysiological recordings to understand the neurological basis of several complex brain functions
including learning, memory, time perception, motivation, and decision-making.
The ability to direct attention to one sound, for example, a particular person's voice, while ignoring
other concurrent sounds is called "selective auditory attention" (a.k.a. the "Cocktail Party Problem").
Little is known about how the brain prioritizes sounds in this way. By recording the activity of brain neu-
rons as rodents perform learned behaviors that require selective auditory attention, Zador and his col-
leagues have begun to reveal the neurological basis of a fundamental property of the brain.
Mainen studies how odors are detected, represented in the brain, and transformed into decision-
making and other behaviors. A few years ago, his group discovered that rats (and probably somme-
liers and other humans) can respond quickly and accurately to odors in a single sniff. Mainen and his
colleagues continue to study the implications of this finding. From a "neuroeconomic" perspective,
Mainen is studying how the brain deals with the biological "costs" of decision-making (e.g., uncertain-
ty, effort, and delay). His group is also investigating the effects of psychoactive drugs in rodents to
uncover neural circuits that might be targets of improved therapies for schizophrenia, Parkinson's dis-
ease, and other disorders.
Alexei Koulakov uses mathematical methods to explore how real-world neurons form functional net-
works in the brain. Some of his work has generated robust theoretical models of visual and olfactory
neural circuits-models that match experimental observations and, importantly, make testable predic-
tions that are likely to reveal new clues to brain structure and function.
One of the central questions of biology is how changes in gene activity transform one type of cell
into other types. Cold Spring Harbor Fellow Lee Henry studies this process, called cellular differentia-
tion, by using taste bud development as a model system. Taste buds comprise unspecialized "prog-
enitor stem cells" at their periphery. These cells become specialized taste receptor cells within the cen-
ter of the bud. Different taste receptor cells respond to different tastes (sweet, sour, salty, and bitter).
Henry is working to define taste at the level of individual genes. To do this, he and his colleagues have
developed a method that allows the gene products of individual cells to be attached to magnetic
beads, which are then "read" using a series of chemical modifications. By comparing specialized taste
receptors to unspecialized stem cells, the researchers aim to understand how individual taste receptor
cells tell our brains, for example, "this is sweet."
The simple molecule nitric oxide (NO) has emerged as one of the key signals that controls neuro-
genesis, i.e., when and where stem cells in the brain become specialized neurons. Grigori Enikolopov
uses fruit flies, frogs, and mice as models to study how NO controls neurogenesis in the human brain.
His group focuses in part on exploring how new neurons are generated in the developing and adult
brain under conditions of health and disease, and on the role that NO may have in the development of
new nerve cells. These studies have led Enikolopov to groundbreaking discoveries concerning the role
that neurogenesis defects have in depression and other mood disorders.
A complete picture of brain function must include an understanding of how the shape of individual
neurons and their patterns of connections contribute to brain structure. Dmitri Chklovskii pursues this
goal by building theoretical models based on engineering principles that include physical, electro-
chemical, and other "design constraints." In 2005, his group completed and validated reconstructions
of rat brain circuits from the geometry of known neural shapes. In related work, Chklovskii used math-
ematics and other approaches to discover why the brain is segregated into the familiar "gray matter"
and "white matter" and why brain microcircuits are connected the way they are.
Holly Cline studies how specific patterns of connections among brain neurons arise and how these
patterns can change over time. By using time-lapse imaging of developing tadpoles, Cline's group is
revealing the fundamental molecular and cellular mechanisms that are likely to underlie brain plasticity
across species, including in humans.
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COMPUTATIONAL SYSTEMS
C. Brody S. Chakraborty C. Machens
S. Chow M. Nikichenko
E. Glushenkova S. Pai
S. Lima
Our lab is interested in how neurons interact with each
other to form networks that underlie flexible cognitive
acts, such as decision-making and short-term memory.
We are also interested in how time and temporal pat-
terns are sensed and represented in the brain. Our
approach to these questions is both experimental and
computational. During 2005, the lab joined in efforts
by Zachary Mainen and Anthony Zador's labs here at
CSHL to create the "Center for the Neural Mecha-
nisms of Cognition" (CNMC). Our goal is to develop
rodent behavioral training, and electrophysiological
recordings, to the same quantitative control and
finesse as used in highly developed primate models,
but with greatly increased throughput and experimen-
tal manipulability. Within the CNMC framework,
Shraddha Pai has trained rats to discriminate between
sounds of different durations and will be investigating
the neurophysiological underpinnings of time percep-
tion. Susana Lima, a postdoctoral member of Anthony
Zador's lab, has been working with us to train rats in a
two-stimulus-interval discrimination task, previously
used with much success in primates, and which will
allow us to investigate short-term memory and deci-
sion-making in rodents. In computational efforts,
Santanu Chakraborty completed his Ph.D. thesis on
analysis and computational modeling of slow time
covariations in persistent activity networks in gold-
fish. Christian Machens has extended his models of
persistent activity mechanisms for short-term and
working memory. Finally, Maxim Nikitchenko has
continued the project started by previous lab member
Amandine Penel, investigating the psychophysics of
temporal pattern perception in humans.
Determining the Neuroanatomical
Loci and Electrical Correlates
of Temporal Bisection in the Rat
S. Pai
Interval timing (IT) is the ability to estimate time, and
is used in decision-making in tasks where timing is
important. For example, in foraging, the renewability
of food sources must be timed to maximize food
intake. Identifying the sources and electrophysiological
correlates of IT have been challenging due to the lack
of a controlled behavioral paradigm in a model organ-
ism amenable to lesion studies and electrophysiology.
Discrimination of pure-tone durations using the two-
alternative forced-choice (2AFC) paradigm in rats is a
powerful yet simple model to study relative IT. We have
developed a behavioral paradigm in which rats dis-
criminate pure-tone durations that are longer than a
standard interval, from those that are shorter (temporal
bisection). The 2AFC paradigm is extremely well-con-
trolled, allowing us to precisely measure the accuracy
and extent of temporal bisection, using psychophysical
analysis. We plan to lesion different auditory struc-
tures-specifically, the medial geniculate body of the
thalamus, the auditory cortex, and auditory striatum-
using a combination of reversible and permanent
lesioning techniques to determine the brain regions that
infer the ability to time auditory stimuli. These experi-
ments will also be conducted in animals that have
learned to discriminate relative pitches of stimuli, thus
distinguishing structures specific to timing from those
required for more common audition-based decision-
making. We will then conduct multielectrode extracel-
lular recordings in identified regions to determine the
electrophysiological correlates of relative IT. In addi-
tion to localizing structures responsible for timing- and
pitch-specific capabilities, this project will contribute
to our understanding of the different auditory struc-
tures in audition-based decision making.
Two-stimulus-interval Discrimination
Tasks in Rodents
S. Lima
Much work in our lab has been based on data collected
by Ranulfo Romo's group in Mexico, recording from
monkeys trained in a two-stimulus-interval discrimina-
tion task. In such tasks, a first stimulus (f1) is delivered
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and then there is a delay, typically lasting several sec-
onds. A second stimulus (f2) is then delivered, and the
subject must compare the two stimuli and make a two-
alternative, forced choice as to which of the two is the
larger (fl > f2? Yes or No). The task therefore requires
short-term memory to remember fl in the delay between
fl and f2, a comparison computation, and decision mak-
ing. One of the goals of the CNMC is to bring such high-
level tasks, whose neurophysiology is often explored
with monkeys, into the rodent domain. This would pro-
vide a far more tractable model system for data collec-
tion and manipulation of brain activity. We have begun,
and are focusing on, developing protocols to train rats in
two-stimulus-interval discrimination tasks.
Temporal Dynamics of
Short-term Memory
C. Machens
In a continuation of our research on working memory,
we have now focused on the temporal dynamics of neur-
al activities in the prefrontal cortex. Electrophysiologi-
cal data from awake behaving monkeys, recorded by
Ranulfo Romo (Universidad Nacional Aut6noma de
Mexico), show that the activity of individual neurons
correlates with a remembered sensory stimulus. Within
a time scale of a few seconds, many of these neurons
show systematic changes in their firing rates. Even
though these temporal changes differ greatly between
cells, we have managed to reduce the apparent com-
plexity by decomposing the firing rate of each cell into
a few generic components. Standard dimensionality
reduction techniques (such as principal component
analysis) have shown that three generic components suf-
fice. During the presentation of the sensory stimulus,
the stimulus information shifts from the first to the sec-
ond component; after the presentation of the sensory
stimulus, we observe a further shift from the second to
the third component. We are now working on building a
model that explains and replicates the observed tempo-
ral dynamics and integrates it with our previously devel-
oped mutual inhibition network.
An Analytical Framework
for Line Attractors
C. Machens
Line attractors have been proposed as a conceptual
foundation for persistent activity and short-term
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memory in many neural systems. However, the
process of designing neural network models of line
attractors based on realistic, nonlinear neurons has so
far proved extremely complicated. As a spin-off to our
previous work, we have developed a general analytical
framework for the construction of line attractor net-
works. This framework is based on a simple geometri-
cal principle: local translational invariance in the con-
nectivity matrix of a neural network. As special cases,
our framework includes the two types of line attractor
networks that have been developed in the literature so
far: (1) the bump attractor model based on the so-
called "Mexican hat" network connectivity with short-
range excitation and long-range inhibition and (2)
monotonic line attractors based on a network connec-
tivity matrix that can be written as the outer product of
two vectors. This largely mathematical work seeks to
further our understanding of line attractor design.
Human Psychophysics of
Temporal Perception
M. Nikitchenko
Following work begun in our lab by Amandine Penel,
who now holds a faculty position in Marseille, France,
we are investigating the psychophysics of the percep-
tion of temporal patterns. We have developed two new
reporting methods: After subjects hear an auditory tem-
poral pattern, presented as a series of short sound blips
("pulses"), we ask them to reproduce the pattern by (1)
voicing it and (2) tapping it on a touchpad. By examin-
ing systematic deformations and variability between the
presented and the reproduced temporal patterns, we can
determine biases and perceptual properties in how the
sounds are perceived by the subjects. We developed an
algorithm to precisely and automatically determine
onset times of individual pulses in voiced patterns. We
will use our new methods to investigate the perception
of patterns more complex than those investigated previ-
ously, i.e., patterns involving four or more pulses.
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PRINCIPLES OF BRAIN DESIGN
D.B. Chklovskii B.L. Chen
Y. Mishchenko
Q. Wen
Understanding brain function requires unraveling
synaptic connectivity in neuronal circuits. Therefore,
the main goal of our laboratory now is to assemble the
brain wiring diagram. We pursue this ambitious goal
from several directions. First, we assemble a proba-
bilistic description of neuronal circuits based on light
microscopy data. Although light microscopy does not
establish synaptic connectivity unequivocally, it is,
currently, the only feasible approach to complex neu-
ronal networks, such as the cortical column. Second,
we are developing an algorithm for automatic recon-
struction of the brain wiring diagram from serial-sec-
tion electron microscopy. This may be the most
promising approach to describing smaller networks,
such as invertebrate brains or smaller subsets of the
vertebrate nervous system. Third, we are using sam-
pled physiological data to assemble a statistical
description of functional connectivity. In addition, we
are analyzing assembled wiring diagrams to make
connections between anatomy and behavior. This
analysis is difficult because the appropriate level of
abstraction is not known. To make progress in this
direction, we attempt to determine "engineering" prin-
ciples that governed brain evolution. These principles,
like the laws of conservation in physics, can narrow
down the set of possible scenarios and help focus our
efforts in the search for the models of brain function.
In 2005, we made excellent progress on all of these
research directions. Some of the highlights include
understanding segregation of gray and white matter in
mammalian neocortex, assembling the missing parts
of the Caenorhabditis elegans wiring diagram from
existing electron microscopy analysis, explaining the
placement of neurons in C. elegans by using advanced
methods from computer engineering, assembling the
potential wiring diagram of a cortical column, and the
identification of multineuron connectivity motifs in
rat neocortex, proving that neuronal morphology fea-
tures-such as branching axons and dendrites and
spines-are necessary to wire up a cortical column
with small conduction delays.
RECONSTRUCTION OF THE C. ELEGANS WIRING
DIAGRAM FROM ELECTRON MICROSCOPY
Because synapses are submicron objects, they can be
unequivocally detected only with electron microscopy
(EM). However, describing synapses of even a single
neuron requires reconstructing neuropil over several
hundred microns. In principle, this range of scales can
be covered by serial section EM. In practice, however,
neuronal circuit reconstructions are rare because this
technique is laborious and time-consuming. The most
extensive reconstruction, that of the C. elegans ner-
vous system, relied on approximately 104 serial sec-
tions and took about 10 years. Even this reconstruction
was not completed-the exact synaptic connectivity of
the ventral cord has never been published. We are
finalizing the C. elegans reconstruction by using
White's EM photographs and lab notebooks, as well as
newly obtained EM photographs (in collaboration
with D. Hall, AECOM). This reconstruction is all but
complete and provides the first "proof of principle"
connectivity matrix of the full nervous system.
HIGH-THROUGHPUT AUTOMATED EM
Reconstructions on a scale larger than C. elegans can-
not be done manually and require high-throughput
automated EM, which could be based on one of the
following technologies: transmission EM, high-volt-
age EM tomography, and serial block-face scanning
EM. With serious efforts to develop high-throughput
EM currently under way in several laboratories, we
expect that the leading candidate will emerge in the
next couple of years. Meanwhile, we are developing
automated reconstruction algorithms that will be nec-
essary to handle gigantic data sets to be generated by
high-throughput EM (in collaboration with A.
Koulakov). A successful algorithm must produce a
connectivity matrix of neuronal circuits such as the
one for C. elegans. In addition, it must extract the
shapes of neurons and the locations of individual
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synapses. Although this project is extremely challeng-
ing, we believe that this is the right time to do it
because of recent developments in digital image pro-
cessing, continuing improvements in computer perfor-
mance, and the existence of high-level programming
environments such as MATLAB.
AUTOMATED ALIGNMENT OF SERIAL SECTIONS
The crucial first step for reconstructions using trans-
mission EM and, to a lesser extent, for the other two
technologies, is alignment of serial sections. The need
for alignment arises from irregular placement of the
sections on the grid and from their physical distortion,
including stretching and shear. Traditionally, such
alignment is performed manually and is rather time-
consuming, especially if significant distortion is pre-
sent. We developed an automatic algorithm for section
alignment that overcomes distortion (including non-
linear). To assess the quality of alignment, we image
the two consecutive sections in red and green chan-
nels. Currently, we perform alignment of real-life
stacks of hundreds of serial EMs for our collaborators.
If funding becomes available, we will build a Web site
for automated reconstruction open to the neuroscience
community.
SEGMENTATION OF EM IMAGES AND 3D ASSEMBLY
In our approach, we first segment images into cross-
sections of individual neurons in 2D and then string
them together in 3D. Traditionally, 2D segmentation is
done by manually tracing contours of the objects of
interest. Our algorithm performs segmentation auto-
matically and for the whole volume at once. One of
the challenges was to overcome a nonuniform contrast
across the image. The next step of the reconstruction
is to assemble 2D cross sections into 3D shapes of
axons and dendrites. We have developed an automatic
algorithm based on evaluating proximity and similari-
ty of the 2D cross sections. To validate our algorithm,
we compare the results of automatic reconstructions
with those done manually by the experts on the same
data set.
OPTIMAL INFORMATION STORAGE
IN NOISY SYNAPSES
Experimental investigations have revealed that
synapses possess interesting and, in some cases, unex-
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pected properties. We propose a theoretical framework
that accounts for four of these properties: typical cen-
tral synapses are noisy; the distribution of synaptic
weights among central synapses is wide; synaptic con-
nectivity between neurons is sparse; and synaptic
weights may vary in discrete steps. Our approach is
based on maximizing information storage capacity of
neural tissue under resource constraint. On the basis of
previous experimental and theoretical work, we use
volume as a limited resource and utilize the empirical
relationship between volume and synaptic weight.
Solutions of our constrained optimization problems
not only are consistent with existing experimental
measurements, but also make nontrivial predictions.
WHAT DETERMINES THE PLACEMENT
OF NEURONS IN THE BODY?
We pursued the hypothesis that neurons minimize the
cost of wiring between them. By using a method bor-
rowed from computer engineering, we found the opti-
mal layout for the given wiring diagram and compared
it with the actual layout. Although most neurons fol-
low wiring optimization predictions, some are dis-
placed significantly. Interestingly, we find that outlier
neurons have additional developmental functions
(they pioneer axonal growth along the ventral cord),
which may explain their misplacement. This finding
illustrates how comparing theoretical predictions of
the optimization approach with experimental data
leads to the detection of discrepancies, which point to
functional constraints that were not included in the
original formulation.
WHAT IS THE ROLE OF AXONAL
AND DENDRITIC ARBORS IN
INFORMATION PROCESSING?
Since C. elegans neurons do not have elaborate arbors,
we addressed this question in the context of cortical
neurons. We find that wiring up of a highly intercon-
nected network such as the cortical column is a diffi-
cult problem. The solution to such a problem in the
allotted volume requires all of the major features of
neuronal morphology, such as axon and spiny den-
drites. Therefore, one needs not look further to find a
reason for their existence. To understand branching
and specific placement of synapses, we need to invoke
"path-length cost," which increases with the distance
between synapses and cell bodies. This cost arises due
to delay and attenuation in dendrites. Minimization of
the path-length cost predicts the shape of axonal and
dendritic branches consistent with experimental data.
This work provides an explanation for the functional
significance of neuronal shape.
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BRAIN DEVELOPMENT AND PLASTICITY
H. Cline C. Aizenman
C. Akerman
J. Bestman
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S.-L. Chiu
J. Demas
R. Ewald
K. Haas E. Rial Verde
A. Javaherian E. Ruthazer
K. Jensen P. Sharma
J. Lee-Osbourne K.V. Thirumalai
Sensory input into the brain is essential for organizing
brain connectivity and circuit function during devel-
opment and for modifying neuronal circuits as a result
of learning in both the developing and mature nervous
system. The goal of the research in our lab is to deter-
mine the cellular and molecular mechanisms that reg-
ulate the establishment and modification of brain con-
nections. Nervous system dysfunction may arise from
failure of these mechanisms to operate during devel-
opment. We address this issue by examining the struc-
tural and functional development of the brain and
spinal cord in tadpoles and zebra fish. These animals
are transparent, which allows us to observe directly the
development of the brain in living animals using time-
lapse imaging methods. In addition, we assess neu-
ronal function using electrophysiological assays of
synaptic connectivity and synaptic plasticity. We com-
bine these studies with gene-transfer methods that
allow us to test the function of genes of interest in
brain development. Given the high degree of conser-
vation of mechanisms related to brain development
and plasticity, our work will identify key regulatory
mechanisms governing brain plasticity across species.
HOMER EXPRESSION IN THE XENOPUS TADPOLE
NERVOUS SYSTEM
Homer proteins are integral components of the postsyn-
aptic density and are thought to function in synaptogene-
sis and plasticity. In addition, overexpression of Homer in
the developing Xenopus retinotectal system results in
axonal pathfinding errors. This year, we found that
Xenopus contains the Homer] gene, expressed as the iso-
form, xhomerlb, which is highly homologous to the
mammalian homer]b. The mammalian homer] gene is
expressed as three isoforms: the short form homer]a and
the long forms homer]b and homer]c. In Xenopus, we
cloned three very similar variants of homer]b, identified
as Xenopus homerlb.1, xhomerlb.2, and xhomerlb.3.
xhomerlb.2 and xhomerlb.3 display up to 98% homolo-
gy with each other and 90% similarity to mammalian
homer]b. Furthermore, we demonstrate that Xenopus
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also contains a short form of the Homer 1 protein, which
is induced by kainic acid injection and is homologous to
the mammalian Homerla. Xenopus Homerlb expression
was unaffected by neuronal activity levels but was devel-
opmentally regulated. Peak protein expression of both
isoforms correlated with the period of synaptogenesis.
Within the brain, the spatial and temporal distribution of
both Homer isoforms was similar in the neuropil and cell
body regions. Homerl was detected in motor axons.
Differential distribution of the two isoforms was appar-
ent: Homerlb immunoreactivity was prominent at junc-
tions between soma and the ventricular surface; in the
retina, the Mueller radial glia were immunoreactive for
Homerl, but not Homerlb, suggesting that the retinal
glia contain only the Homerla isoform. Homer lb expres-
sion in muscle was prominent throughout development
and was aligned to the actin striations in skeletal muscle.
The high level of conservation of the xhomerl gene and
the protein expression in the developing nervous system
suggest that Homerl expression may be important for
normal neuronal circuit development.
VISUAL EXPERIENCE REGULATES mGLuR-MEDIATED
PLASTICITY OF AMPA-R SYNAPTIC TRANSMISSION BY
HOMER1A INDUCTION
A fundamental adaptive feature of neurons within a
functional network is their ability to respond to afferent
activity by changing the strength of synaptic connec-
tions. At most excitatory synapses, changes in ionotrop-
ic a-amino-3-hydroxy-5-methyl-3-isoazole-receptor
(AMPA-R) transmission underlie changes in synaptic
strength, whereas the ligand and voltage-dependent N-
methyl-o-aspartate receptors (NMDA-Rs) and metabo-
tropic glutamate receptors (mGluRs) are thought to
modulate AMPA-R synaptic plasticity and downstream
signaling events. Activation of mGluRs results in bidi-
rectional plasticity of AMPA-Rs, yet little is known
about how mGluRs mediate such changes in AMPA-R
synaptic transmission. We considered the possibility
that the interaction of mGluRs with cytoplasmic scaf-
folding proteins may affect mGluR-dependent plastici-
ty. We investigated the potential role of the Homer fam-
ily of scaffolding proteins in modulating mGluR-medi-
ated plasticity of AMPA-Rs in the retinotectal system of
Xenopus tadpoles.
Brief mGluR activation leads to plasticity of
AMPA-R synaptic transmission. To test whether
mGluR-mediated plasticity of AMPA-R transmission
is influenced by recent neuronal activity, we manipu-
lated visual activity in Xenopus laevis tadpoles in vivo.
We compared mGluR-mediated plasticity of AMPA-R
transmission in optic tectal cells of tadpoles with low
levels of previous synaptic activity (overnight in the
dark) to transmission in neurons from animals follow-
ing 4 hours of constant visual stimulation. mGluR-
mediated plasticity of AMPA transmission was signif-
icantly decreased in neurons with recent activity. We
tested the role of the activity-regulated mGluR scaf-
folding protein, Homerla, in modulating mGluR-
mediated changes in AMPA-R transmission. We found
that by changing the ratios of Homer 1a to Homer lb
in vivo, either by induction of endogenous Homerla
by visual activity or by ectopic expression of Homerla
or Homerlb, we could change the direction of mGluR-
mediated plasticity. This is the first evidence that
mGluR-mediated changes in AMPA transmission can
be regulated by Homer proteins in response to physio-
logically relevant stimuli.
Previous experiments in the our lab demonstrated
that a 4-hour period of visual stimulation increases the
rate of tectal cell dendritic arbor growth, regulates tec-
tal cell intrinsic excitability, and controls retinal axon
arbor growth. Here, we report that experience-depen-
dent changes in Homerla expression in optic tectal
neurons provide a means to homeostatically regulate
mGluR-mediated plasticity of retinotectal AMPA-R
transmission.
COORDINATED MOTOR NEURON AXON GROWTH
AND NEUROMUSCULAR SYNAPTOGENESIS ARE
PROMOTED BY CPG15 IN VIVO
The development of axon arbors involves a series of
orchestrated events that take place after the axon reach-
es the target. These events include recognition of sites
in the target where branching takes place, formation of
branches and synapses, and refinement of the arbor
structure through retraction and elimination of synaps-
es and branches. We examined the possibility that
motor axon innervation of the periphery could develop
through a dynamic process of branch addition, mainte-
nance, and retraction, concurrent with the formation of
synaptic connections by collecting time-lapse images
of motor neuron axons as they elaborated complex
arbors and formed neuromuscular synapses.
We have used in vivo time-lapse two-photon imag-
ing of single motor neuron axons labeled with green
fluorescent protein (GFP) combined with labeling of
presynaptic vesicle clusters and postsynaptic acetyl-
choline receptors in X laevis tadpoles to determine the
dynamic rearrangement of individual axon branches
and synaptogenesis during motor axon arbor develop-
ment. Control GFP-labeled axons are highly dynamic
during the period when axon arbors are elaborating.
Axon branches emerge from presynaptic sites, sug-
gesting that mechanisms that govern synapse forma-
tion may also affect axon arbor elaboration. These data
indicate that motor neuron axon elaboration and
synaptogenesis are concurrent and iterative.
We tested the role of candidate plasticity gene 15
(CPG15, also known as Neuritin) in motor neuron
axon arbor development and neuromuscular synapto-
genesis. Previous work from our lab has shown that
CPG15 is a highly conserved, extracellular, GPI-
linked protein that promotes axonal and dendritic
arbor growth as well as synapse maturation in the cen-
tral nervous system (CNS). Furthermore, CPG15 pro-
tein is targeted to axons in the developing CNS. One
of the earliest sites of cpg15 expression is in the ven-
tral spinal cord, suggesting that it may also have a role
in the development of motor neuron axons and neuro-
muscular synaptic connections. To test this idea, we
coexpressed CPG15, yellow fluorescent protein
(YFP), and synaptophysin cyan fluorescent protein
(CFP) in single motor neurons. We imaged the devel-
oping axons in vivo and found a startling increase in
the elaboration of the motor neuron axon arbors and a
significant increase in neuromuscular synapses.
Further analysis demonstrated that CPG15 expression
enhances the development of motor neuron axon
arbors by promoting neuromuscular synaptogenesis
and by increasing the addition of new axon branches at
sites of synaptic contacts.
REGULATION OF RETINAL AXON ARBOR
ELABORATION AND BRANCH DYNAMICS
BY SYNAPTIC CONTACTS
Patterned neural activity and synaptic transmission
guide the remodeling of axonal arbors in the develop-
ing CNS by regulating the addition, stabilization, and
elimination of branches as arbors grow. In the retino-
tectal projection of frogs and fish, the dynamic
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rearrangement of axonal branches actively refines and
maintains the retinotopic map. Previous work in the
our lab had demonstrated a critical role for activity-
dependent Hebbian mechanisms in controlling axon
branch retraction. We showed that the cellular mecha-
nisms involved retrograde signaling downstream from
activation of postsynaptic tectal NMDA receptors,
which effectively function as correlation detectors.
These and other studies, including our studies on
motor neuron axon development, suggest a central role
for synaptic connections in axon arbor remodeling and
raise the intriguing possibility that as synapses mature
and strengthen, they may serve double duty as struc-
tural sites for axon branch stabilization.
To examine the role of synaptogenesis and synap-
tic maturation in the structural development of axon-
al projections during the formation of the topograph-
ic retinotectal projection, we coexpressed cytosolic
fluorescent protein (FP) and FP-tagged synapto-
physin (SYP) in small numbers of retinal ganglion
cells in living albino X laevis tadpoles to reveal the
distribution and dynamics of presynaptic sites within
labeled retinotectal axons. Two-photon time-lapse
observations followed by quantitative analysis of
tagged SYP levels at individual synapses demonstrat-
ed the time course of synaptogenesis: Increases in
presynaptic punctum intensity are detectible within
minutes of punctum emergence and continue over
many hours. Puncta lifetimes correlate with their
intensities. Furthermore, we found that axon arbor
dynamics are affected by synaptic contacts. Axon
branches retract past faintly labeled puncta but are
locally stabilized by mature synapses with intensely
labeled SYP puncta. Visual stimulation for 4 hours
enhanced the stability of the arbor at intense presy-
naptic puncta while concurrently inducing the retrac-
tion of exploratory branches with only faintly labeled
sites or no synaptic sites.
DEPOLARIZING GABAERGic CONDUCTANCES
REGULATE THE BALANCE OF EXCITATION TO
INHIBITION IN THE DEVELOPING RETINOTECTAL
CIRCUIT IN VIVO
Neurotransmission during development regulates
synaptic maturation in neural circuits, but the contri-
bution of different neurotransmitter systems is unclear.
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We investigated the role of GABAA-receptor-mediated
Cl- conductances in the development of synaptic
responses in the Xenopus visual system. Intracellular
Cl- concentration ([C111) was found to be high in
immature tectal neurons and then falls during a period
of several weeks. GABAergic synapses are present at
early stages of tectal development, and, when activat-
ed by optic nerve stimulation or visual stimuli, they
induce sustained depolarizing Cl- conductances that
facilitate retinotectal transmission by NMDA-Rs. To
test whether depolarizing GABAergic inputs cooper-
ate with NMDA-Rs during activity-dependent matura-
tion of glutamatergic synapses, we prematurely
reduced [Cl -]. in tectal neurons in vivo by expressing
the Cl- transporter KCC2. This blocked the normal
developmental increase in AMPA-R-mediated retino-
tectal transmission and increased GABAergic synaptic
input to tectal neurons. Therefore, depolarizing
GABAergic transmission has a pivotal role in the mat-
uration of excitatory transmission and controls the bal-
ance of excitation and inhibition in the developing
retinotectal circuit.
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GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Altick S. Dennison
A. Blum E. Kockenmeister
The long-term goal of our research is to understand
memory. Dissection of complex behaviors such as
memory and learning will require a multidisciplinary
approach that will include discovery and manipulation
of the relevant genetic, cellular, and anatomical path-
ways, as well as computational modeling of how infor-
mation is processed in the brain. Work in genetic
model systems such as Drosophila can contribute to
our understanding in two main ways. First, by enabling
discovery of genes and genetic pathways underlying
behavior, genetic model systems provide entry points
for subsequent interventionist experiments. Second,
systematic manipulation of gene function in relevant
anatomical loci of the brain allows a conceptual inte-
gration of findings from cellular and behavioral neu-
roscience.
We use the Drosophila model system, which offers
an economy of scale to discover and develop hypothe-
ses in a relatively cost-effective and rapid manner.
Then, given the remarkable evolutionary conservation
of genetic, cellular, and behavioral functions, these
hypotheses can be pursued in mammalian model sys-
tems.
Gene Discovery with
DNA Microarrays
A. Altick, J.Dubnau [in collaboration with T. Tully
and N. Sinha, Cold Spring Harbor Laboratory]
In collaboration with the Tully lab, we have used a
combination of behaviorally specific training proto-
cols and expression profiling with DNA chips to iden-
tify transcriptional responses during memory consoli-
dation (Dubnau et al., Curr. Biol. 13: 286 [2003]). We
have used this approach to compare gene expression
profiles after spaced training, which induces both
short-term and protein-synthesis-dependent long-term
memory, and massed training, which only induces
short-lived memory. We have identified a large num-
ber of candidate memory genes differentially
expressed at three different retention intervals after
spaced versus massed training. Using real-time poly-
merase chain reaction (PCR) follow-up assays, we
have confirmed differential expression for nearly 60
of these transcripts. This effort has identified candi-
date memory genes (CMGs), which serve as entry
points for molecular genetic investigation of gene
function in memory. These CMGs then become fodder
for in vivo genetic manipulations to forge mechanistic
connections between individual gene pathways and
memory formation. With that aim in mind, we are
focusing on local translational control, one of several
pathways suggested from the array experiments. Our
genetic studies already support a role in memory for
several components of this pathway. These include
staufen and oskar, which are known components of a
cellular mRNA localization machinery in oocytes, and
pumilio, which is a translational repressor protein. A
large number of the known components of the mRNA
localization machinery, as well as of the apparatus for
regulating cytoplasmic polyadenylation-stimulated
translational control, also are differentially expressed.
Genetic reagents to manipulate these pathways are
extant in Drosophila.
Functional Anatomy
A. Blum, S. Dennison, J. Dubnau [in collaboration
with A.S. Chiang, Taiwan]
In both vertebrate and invertebrate animals, anesthetic
agents cause retrograde amnesia for recently experi-
enced events. In contrast, older memories are resistant
to the same treatments. In Drosophila, anesthesia-
resistant memory (ARM) and long-term memory
(LTM) are genetically distinct forms of long-lived
memory that exist in parallel for at least a day after
training. ARM is disrupted in radish mutants but is
normal in transgenic flies overexpressing a CREB
repressor transgene. In contrast, LTM is normal in
radish mutants but is disrupted in CREB repressor
transgenic flies. These and other genetical and phar-
macological experiments indicate the presence of at
least five mechanistically distinct temporal phases of
memory (short-term, middle-term, ARM, and LTM).
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Although a neural structure called the mushroom bod-
ies has a demonstrated role in early memory and in
memory retrieval at several time points, very little else
is known about the anatomical circuitry underlying
each of the above memory phases.
To map the neural circuits required for memory
formation, storage, and retrieval, we are using a tem-
perature-sensitive dynamin transgene, which disrupts
synaptic transmission reversibly and on the timescale
of minutes. With this approach, we are now able to
reversibly silence reproducibly specific groups of neu-
rons in vivo. We already have demonstrated a role for
synaptic transmission in mushroon body (MB) neu-
rons during memory retrieval but, surprisingly, not
during acquisition or storage of early memory
(Dubnau et al., Nature 411: 476 [2001]). These data
suggest that the synaptic plasticity underlying olfacto-
ry associative learning initially reside in MB dendrites
and/or upstream of the MB and that the resulting alter-
ations in synaptic strength modulate MB output dur-
ing memory retrieval. But virtually nothing is known
about the neural circuitry involved in the subsequent
consolidation of short-term, middle-term, anesthesia-
resistant, or CREB-dependent LTM phases. And noth-
ing is known about the downstream circuitry of mem-
ory retrieval. We are using a panel of Gal4 enhancer
drivers to focus expression of this dynamin transgene
within specific subpopulations of neurons. Given the
right Gal4 lines, this approach permits us to function-
ally map the circuit requirements for learning, memo-
ry retrieval, and each of the above temporal phases of
memory.
To select Gal4 lines for Functional Anatomy
investigations, we have used two approaches. First,
Ga14 insertion mutations in genes involved in memo-
ry permit a first-pass evaluation of the green fluores-
cent protein (GFP) reporter expression pattern of bio-
logically relevant genes. These then are used in com-
FIGURE 1 C133 reporter expressions A Ga14 insert in the radish
gene drives GFP reporter expression in a complex pattern
including a number of neurons that innervate the antennal lobes
and MB. Frontal (top) and rear (bottom) views are shown.
bination with the dynamin mutant to reversibly silence
synaptic transmission. This strategy already has given
us an entry to study ARM. An enhancer-trap allele of
radish (C133) (Chiang et al., Cure. Biol. 14: 263
[2004]) does not label mushroom bodies, which are
the primary anatomical focus of olfactory memory
research in Drosophila. Instead, C133-driven expres-
sion reveals a number novel neuronal types, several of
which project into MB (Fig. 1).
Using the dynamin approach, we have shown a
temporally graded requirement for neural activity
within this population of neurons. In addition, we have
a series of Ga14 lines that express in small subsets of
these C133 neurons. One of these, which was initially
identified by a Ga14 insertion mutation with a memo-
ry phenotype (Chiang et al., Cure. Biol. 14: 263
[2004]), drives expression specifically in APSP neu-
rons (Fig. 2, left). This neuron type, which was first
identified by C133 reporter expression, sends den-
FIGURE 2 (Left) APSP neurons; (middle) DAL neurons; (right) DPM2 neurons.
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drites into the antennal lobes. Axonal projections of
these neurons terminate in the posterior superior pro-
tocerebrum (PSP). Using the dynamin approach, we
have shown that activity in these APSP neurons is
required after training for maintenance of an interme-
diate form of memory (not shown). In contrast, the
APSP neurons are not required during learning (not
shown). Our current efforts are focused on using sev-
eral additional Ga14 drivers each of which express in
specific neuron types that were identified in C133
(e.g., Fig. 2) to conduct an anatomical dissection of
the neural circuits in which radish functions. In a sim-
ilar manner, we also are making use of Ga14 insertions
in a large panel of additional memory mutants
(Dubnau et al., Curr. Biol. 13: 286 [2003]).
A second approach that we are using to select rel-
evant Ga14 driver lines is based solely on their expres-
sion pattern, rather than their insertion in a "memory
gene." In collaboration with A.S. Chiang, we have
access to a growing panel of Ga14 enhancer lines that
yield remarkably specific expression in neurons that
send projections into different substructures of the
MB. These identified MB "extrinsic" neurons consti-
tute a significant fraction of the inputs, outputs, and
modulation of MB. With the dynamin method, we can
functionally manipulate these neuronal populations.
The VAM neuron driver, for example, yields expres-
sion in four neurons whose dendrites project to the
axon outputs of the mushroom body alpha lobe (Fig.
3). Axon outputs of the VAM neurons terminate in the
PSP, nearby to the APSP neurons. With the dynamin
approach, we have established a role for these neurons
4
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in an intermediate-term memory (Fig. 3). Like the
APSP neurons, these VAM neurons appear to be dis-
pensable for learning (not shown). Ongoing efforts are
focused on filling in the rest of the circuitry for these
"early" memory phases, as well as for long-term mem-
ory and for memory retrieval.
Selective Breeding of
rutabaga Suppression
A. Altick, E. Kockenmeister, J. Dubnau
Genetic investigation of memory has revealed that
underlying mechanisms are highly conserved across
phyla. The cAMP cascade, for example, has been
implicated in memory in both invertebrate and verte-
brate animals, including humans The informative
power of genetics derives in part from identification of
genes that influence phenotype, but also from analysis
of gene interaction. Saturation mutagenesis for embry-
onic patterning, for instance, identified most of the
relevant genes. Equally important, however, were sec-
ond-site suppressing and enhancing screens. This
approach allowed cell-signaling pathways and mecha-
nistic insights to be distilled from what otherwise
would be unconnected gene lists.
In the case of complex behavioral phenotypes such
as memory, forward mutagenesis has identified a
number of relevant genes (Margulies et al. 2005). Here
too, the most informative instances are where mecha-
nistic interactions among genes are understood. cAMP
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FIGURE 3 VAM neurons send dendrites to the mushroom body alpha lobes. VAM axon terminals terminate in the dorsal protocere-
brum. VM neurons are required for an intermediate-term form of memory. Transient disruption of these neurons in the first 30 min
after training (2, middle panel) or in the second 30-min period (3, middle panel) causes a partial disruption of memory measured 3 hr
after training.
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signaling is the most notable example. Assembly of
genes into functional networks, such as the cAMP
cascade, is the most challenging aspect of genetics.
Although suppressor/enhancer screens have yielded
some success, this approach is often not feasible for
complex quantitative traits such as memory.
Moreover, modifier screens are only designed to
detect interactions between pairs of genes, but gener-
ally do not identify more complex gene networks. We
are using experimental evolution with identified
memory mutants (Dubnau et al., Carr. Biol. 13: 286
[2003]) in Drosophila as a strategy to screen for net-
works of gene interaction capable of suppressing or
enhancing the role of cAMP signaling.
Selective breeding of extremes in behavioral phe-
notypes has a long and fruitful history. In contrast
with screening for induced mutations, this strategy
normally relies on the presence of preexisting (natur-
al) genetic heterogeneity in a starting population. This
method was first used to establish a genetic basis for
several complex behavioral traits in a variety of
species, including learning ability in Drosophila. This
approach provided a means to estimate genetic varia-
tion in natural populations, to examine the process by
which complex traits evolve through selection, and to
investigate pleiotropy. Genetic analyses of the select-
ed strains also demonstrated that phenotypic extremes
typically derived from interactions among a constella-
tion of alleles. Unlike forward mutagenesis, this quan-
titative genetic strategy relies on selection of combi-
nations of alleles, thereby placing individual gene
function within a network of interactions. This strate-
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gy also has potential to reveal mechanisms underlying
evolution of phenotypic variation. In contrast with for-
ward mutagenesis, however, quantitative genetic
strategies on their own have not afforded an efficient
means to identify and manipulate individual genes.
Even with a variety of powerful quantitative-genetic
mapping methods (e.g., QTL mapping), molecular
identification of underlying loci has been challenging.
Each of the above genetic strategies thus offers
complementary strengths for discovery of mecha-
nisms underlying complex behavioral biology. Recent
progress in genome-wide sequencing and expression
profiling raises the possibility of combining the above
methods. There is as yet no case, however, where arti-
ficial selection of molecularly identified alleles has
been used fur memory, no example where the evolu-
tion of a phenotype has been followed over successive
generations at a mechanistic level, and no study where
selection has been used to directly screen for suppres-
sion or enhancement of a known signaling pathway.
We are using this strategy to identify networks of gene
interactions. Our approach relies on artificial selection
over the course of multiple generations to "evolve"
combinations of known and molecularly tagged gene
variants that interact to produce extreme levels of
learning. Current efforts have focused on establishing
the founding population for this selection experiment.
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STEM CELLS, SIGNAL TRANSDUCTION, AND DIFFERENTIATION
G. Enikolopov J. Encinas
J. Hemish
M. Maletic-Savatic
L. Manganas
T. Michurina
B. Mish
J.-H. Park
N. Peunova
K. Ravi
Stem cells have a unique ability to self-renew and to
produce progenitor cells that eventually generate dif-
ferentiated cells. The cascade of transitions from stem
cells to their differentiated progeny is under dynamic
control, ensuring a rapid response to demands for
more cells due to stress, damage, or altered environ-
ment. We study signals that regulate distinct steps in
the differentiation cascade and guide cells to become
integrated into the tissue they belong. We use fruit
flies, frogs, and mice as models to study the regulation
of division of stem and progenitor cells.
Our main focus is on how new neurons are gener-
ated in the developing and adult brain in health and
disease. An important focus of our studies remains
stem and progenitor cells in non-neuronal tissues. We
also continue to generate new animal models to study
neurogenesis. Finally, we started to focus on the role
that neurogenesis may have in depression and other
mood disorders.
NEURAL STEM AND PROGENITOR CELLS
IN THE ADULT BRAIN
New neurons are constantly being generated in the
adult brain (albeit in only a few areas) and can become
fully functional several weeks after they are born. The
functional role of this constant supply of new cells is
still unclear; however, the fact that it takes place in the
hippocampus, the area of the brain that has long been
associated with learning and memory and, increasing-
ly, with mood, has attracted much interest to the possi-
bility that adult neurogenesis may be related to mem-
ory and mood disorders.
Recent findings indicate a close link between the
action of a diverse range of antidepressant therapies
and augmented generation of new neurons in the adult
hippocampus. Moreover, these findings suggest that
adult hippocampal neurogenesis not only accompa-
nies, but is required for the behavioral effects of anti-
depressants of the selective serotonin reuptake
inhibitors (SSRI) class (e.g., fluoxetine). This discov-
ery may clarify several observations regarding the
clinical course of action of antidepressant drugs. For
instance, it may explain why an appreciable clinical
effect of the drugs usually takes at least 3-4 weeks:
This period is comparable with the time required for a
detectable increase in neurogenesis in rodents after
behavioral stimulation and may reflect the time
required for neural stem cells to proceed through the
neuronal differentiated cascade and become fully dif-
ferentiated neurons.
One of the problems in understanding how antide-
pressants (or most of the other neurogenic stimuli)
increase adult neurogenesis is that it is not known
which steps of the neuronal differentiation cascade they
affect. Particular targets (e.g., stem cells vs. early prog-
enitors vs. advanced neuroblasts) may imply different
molecular mechanisms of controlling cell division and
survival, different circuits affected by the drugs, and
different insights on the behavioral action of the drugs.
To address this problem, we generated a novel
reporter mouse line (nestin-CFPnuc mice) that allows
us to quantitatively assess changes in stem/progenitor
cells of the adult brain. In this line, the reporter (cyan
fluorescent protein) is fused to a nuclear localization
signal, and the distribution of stem and progenitor
cells in the neurogenic areas is visualized as a dotted
pattern; this greatly reduces the complexity of the pat-
tern and permits unambiguous enumeration of stem
and progenitor cells.
We used this reporter line to define discrete steps
in the neuronal differentiation cascade (leading from
stem cells to differentiated granule neurons), based on
the morphology of the cells, the marker proteins that
they express, and their mitotic activity, thus generating
the most complete current scheme of the differentia-
tion cascade in the adult hippocampus.
We then used the reporter line and the elucidated
scheme of the differentiation cascade to determine the
target of the action of fluoxetine in the adult hip-
pocampus. We found that fluoxetine does not affect
division of stem-like cells in the dentate gyrus, but
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increases symmetric divisions of an early progenitor
cell class. We further demonstrated that this is the sole
class of neuronal progenitors targeted by fluoxetine in
the adult brain and that the fluoxetine-induced
increase in new neurons arises as a result of the expan-
sion of this cell class.
These results thus identify a specific functional
target of fluoxetine, link early progenitor cell classes
to the action of SSRI antidepressants, and, important-
ly, suggest a general strategy to investigate the changes
induced by other neurogenic stimuli. We are now
applying this approach to identify the targets of anti-
depressant drugs and treatments in the adult and devel-
oping brain.
STEM CELLS IN NON-NEURAL TISSUES
Tissue maintenance in the adult organism requires a
constant supply of new cells to replace differentiated
cells lost to stress and damage or destroyed as part of
the normal cell death program. This replacement is
made possible through the activity of adult tissue-spe-
cific stem cells. These cells are set aside during devel-
opment or soon after birth, persist in the adult tissue,
and produce committed progeny that eventually gives
rise to differentiated cells. Self-renewal of adult stem
cells and their production of lineage-committed prog-
eny are controlled by a host of intrinsic and extrinsic
factors and are primarily governed by the interactions
between the stem cells and their microenvironment,
the stem cell niche.
We found that in our reporter mouse lines (which
were generated primarily to study neural stem cells),
expression of the reporter (nestin-GFP or nestin-
CFPnuc) marks stem and progenitor cells in several
non-neural tissues. We have shown that such reporter-
expressing cells can be found in the bulge region of
the hair follicle where they represent a population of
cells with stem properties and a capacity to generate
neuronal cells in vivo and in vitro, in testis, where they
persist as precursors to the steroidogenic Leydig cells,
in the ciliary margin of the eye, and in the anterior
pituitary. Furthermore, in the liver, reporter expression
marks oval cells, which have long been purported to
serve as stem cells after exposure to carcinogens or in
the settings where the proliferative response of hepa-
tocytes (a usual mode of liver regeneration) is sup-
pressed. We now study the ability of these tissue-spe-
cific stem cells to demonstrate their properties in vivo,
e.g., upon transplantation, or to be recruited to
noncognate tissues for regeneration.
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NO AND EARLY DEVELOPMENT OF THE XENOPUS
NERVOUS SYSTEM
During the early steps of development, two major mor-
phogenetic processes, cell division and cell movement,
are tightly linked. Active cell duplication is required to
generate a sufficient number of cells; however, it must
be coordinated with precise morphogenetic cell move-
ments during gastrulation and organogenesis to build a
correctly structured organ or a tissue. In many cases,
temporary cessation of cell division is an integral part
of the morphogenetic program during early develop-
ment. However, the nature of the signals that coordi-
nate cell division and cell movement during develop-
ment has been elusive. We investigated whether nitric
oxide (NO), a signaling molecule with both antiprolif-
erative and pro-motility potential, can link these two
major morphogenetic processes. We used gain- and
loss-of-function approaches to demonstrate that NO,
affecting both the formation of cGMP and nitrosyla-
tion of key proteins, acts through RhoA to regulate cell
proliferation and morphogenetic cell movements.
Excess NO decreases proliferation but does not inter-
fere with cell movement; in contrast, deficiency of NO
increases proliferation and disturbs cell movements
(manifested as defects in the neural tube closure and
axis extension). We found that NO controls cell prolif-
eration by regulating, in a cGMP-dependent way, the
activity of Rho-dependent kinase (ROCK), a down-
stream target of RhoA, and that this regulation is
essential for the distribution of the cdk inhibitor p21
between the nucleus and the cytoplasm and for its sta-
bility. We also found that NO regulates cell movement
through nitrosylation of RhoA and through direct
interactions with Dsh, a crucial regulator of RhoA in
the planar cell polarity pathway. This affects cell polar-
ity, which is essential for the directional morphogenet-
ic movements of cells of the embryonic nervous sys-
tem and the notochord. This concurrent NO-mediated
control of convergent extension and cell division helps
ensure that the crucial processes of cell proliferation
and morphogenetic movements are coordinated during
early development of the nervous system.
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CONSTRUCTION AND PLASTICITY OF GABAERGic CIRCUITS
Z.J. Huang F. Ango S. Kuhlman
B. Chattopadhyaya C.A. Paul
G. diCristo H. Taniguchi
Y. Fu C. Wu
S. Wu
X. Wu
H. Yang
Brain functions that control behavior emerge from
activities of vast underlying neural networks. In many
areas of the vertebrate brain, neural networks often
consist of repeated functional modules. The neocor-
tex, for example, seems to have arisen from duplica-
tion of stereotyped local circuits with subtle special-
izations in different cortical areas and species.
Unraveling the logic of the basic design and operation
of local neuronal circuits is essential to the theory of
brain function. The major components of neocortical
local circuits are pyramidal neurons, which have rela-
tively stereotyped anatomical, physiological, and mol-
ecular properties; the shear number and intricate
design of these excitatory glutamatergic neurons
endow them with enormous potential for information
coding, storage, and plasticity. On the other hand,
GABAergic interneurons, although a numerical
minority, provide the largest degree of heterogeneity
in the neocortex. Different classes of interneurons dis-
play highly distinct morphologies, physiological prop-
erties, connectivity patterns, and gene expression pro-
files. This rich diversity suggests that these inhibitory
components have evolved not simply to balance exci-
tation, but, through the variety and fine details of inhi-
bition, to control neural communication and circuit
configuration.
Decades of studies begin to reveal a major theme
on the function of GABAergic interneurons: timing in
neurons and networks. GABAergic transmission pow-
erfully controls synaptic integration, probability, and
timing of action potential generation. Interneurons
also generate and maintain network oscillations and
are thought to provide the temporal structures for
coordinating the activity of neuronal populations and
for orchestrating the dynamic formation of functional
ensembles. The biophysical properties of at least cer-
tain classes of interneurons seem to be optimized to
achieve physiological timing, such as fast, precise, and
reliable conversion of excitatory inputs to powerful
inhibitory outputs. Different classes of interneurons
further display highly distinct axon arbors and inner-
vation patterns, which distribute their outputs within
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and between cortical columns, among local neuronal
populations, and among subcellular compartments of
target neurons. These connectivity patterns therefore
translate temporal regulation to discrete spatial
domains and help group or segregate cell assemblies
during all aspects of circuit operation. Unraveling the
design, construction, and modes of operation of
GABAergic circuits is therefore a key to understand-
ing the architecture and computation of local neural
circuits. My laboratory is studying the construction,
plasticity, and function of GABAergic circuits in mice,
using the neocortex and cerebellum as complementary
experimental systems. We have focused on three areas
in the past year.
SUBCELLULAR ORGANIZATION OF GABAERGic
SYNAPSES: Li CAMS AND ANKYRIN
MEMBRANE SKELETONS
A striking feature of GABAergic innervation is the
targeting of different classes of synapses to subcellu-
lar compartments of principal neurons (spines, den-
drites, soma, and axon initial segment [AIS]).
Subcellular spatial segregation of inhibitory synapses
is essential for the precise regulation of input integra-
tion, spike probability, timing, and back propagation,
but the underlying mechanism is unknown.
Combining cell-type-specific transcriptional promot-
ers, bacterial artificial chromosome (BAC) transgenic
reporter mice, and high-resolution imaging, we have
established powerful in vivo and in vitro systems to
visualize and manipulate defined classes of
GABAergic interneurons. Our study is beginning to
outline the mechanisms underlying subcellular organi-
zation of GABAergic synapses in mammalian brain.
First, we discovered that subcellular targeting of
GABAergic synapses in the sensory cortex does not
require instructions from sensory input and thus is
largely guided by genetically encoded mechanisms
and experience-independent forms of neuronal activi-
ty. Second, we began to define the molecular signals
directing synapse targeting in cerebellum. We discov-
ered that the ankyrinG-based membrane cytoskeleton
is the key molecular machinery which, through sub-
cellular recruitment of neurofascin, a member of the
L1 family immunoglobulin cell adhesion molecules
(L1CAMs), directs GABAergic innervation to the
AIS. Third, we recently discovered that another mem-
ber of L1CAM, CHL1 (close homolog of L1), is
involved in targeting a different class of GABAergic
synapses to Purkinje dendrites (E Ango et al., in
prep.). Both the ankyrin and L1CAM families contain
multiple members localized to distinct subcellular
compartments. Our general hypothesis is that mem-
bers of L1CAMs recruited to subcellular domains by
different ankyrins may constitute a set of "compart-
mental codes" in principal neurons for subcellular
organization of GABAergic synapses. A major revela-
tion is that subcellular organization of GABAergic
synapses in superimposed upon an elaborate subcellu-
lar organization of ion channels. Such spatial align-
ment of biophysical properties and synaptic inputs
upon the same macromolecular complex may confer
the ultimate temporal precision for regulating electri-
cal signaling within and among neurons. These stud-
ies suggest an unexpected link from subcellular mole-
cular organization to synaptic connectivity and net-
work properties. Our studies raise many more ques-
tions: What are the mechanisms of GABAergic
synapse targeting in a more complex circuit such as
the neocortex? What are the receptors in different
classes of GABAergic neurons for L1CAMs?
ACTIVITY-DEPENDENT DEVELOPMENT
AND PLASTICITY OF GABAERGic SYNAPSES
AND INNERVATION PATTERN: A NOVEL
FUNCTION OF GABA
Another highly characteristic feature of the
GABAergic innervation pattern is its local exuber-
ance: A single basket interneuron axon in the rodent
neocortex innervates hundreds of neurons in its vicin-
ity and forms multiple, clustered synapses onto the
soma and proximal dendrites of each target. Such exu-
berant innervation is likely crucial for effective con-
trol of spike timing and synchrony among target neu-
rons, but the underlying mechanisms are unknown.
We found that the maturation of perisomatic innerva-
tion is a protracted process influenced by sensory
experience during adolescence. In addition, the basic
features of perisomatic innervation can develop to a
substantial extent in organotypic culture and are regu-
lated by neuronal activity.
As direct mediators of neural activity, neurotrans-
mitters are particularly well suited to sculpt synaptic
growth and refinement in response to functional trans-
mission. Indeed, signaling through glutamate regulates
nearly all aspects of excitatory synapse development
and lies at the heart of the emerging rules underlying
activity-dependent plasticity. The role of GABA in the
development of inhibitory synapses has not been
explored due to technical and conceptual roadblocks.
Using conditional knockout of GABA synthetic
enzymes (GAD67) restricted to basket interneurons
(Fig. 1), we recently discovered that the level of
GABA synthesis and signaling are crucial in regulat-
ing interneuron axon growth and synapse formation in
adolescent cortex, when GABA transmission has
become largely hyperpolarizing. These results reveal a
novel function of GABA in regulating inhibitory
synapse and circuit development, which is distinct
from its early trophic role largely due to depolarizing
action, as well as from its classic role as an inhibitory
transmitter. Because GAD67 level is strongly coupled
to neuronal input, activity-dependent GABA synthesis
and signaling may provide a cell-wide and synaptic
mechanism to sculpt the innervation pattern of
GABAergic interneurons. These findings beg a major
revision in the current concept of GABA function in
the vertebrate brain and raise a whole series of ques-
tions regarding the underlying mechanisms: What are
the cellular and signaling mechanisms mediating
GABA-regulated synapse and axon growth? What are
the physiological mechanisms and function of activi-
ty-dependent regulation of GAD67 expression and
GABA synthesis? Our findings suggest an unexpected
parallel between the role of glutamate in regulating the
morphogenesis of excitatory synapses and that of
GABA for inhibitory synapses. On the other hand, our
findings also imply fundamental differences between
these two systems. For example, activity-dependent
cell-wide regulation of "GABA resource" implies a
novel logic for the plasticity of GABAergic synapses
and innervation patterns.
MATURATION OF GABAERGic TRANSMISSION AND
CRITICAL PERIOD PLASTICITY IN VISUAL CORTEX
Maturation of GABAergic inhibition has been impli-
cated in the onset of the critical period for ocular dom-
inance (OD) plasticity, but the underlying cellular
mechanism remains elusive. In particular, it is unclear
whether GABAergic transmission regulates synaptic
competition among converging inputs, a defining fea-
123
A.
deprivation activity
GAD67 knockdown maturation
B.
GAD67 mRNA
GAD67
Act.- dep.
signaling
FIGURE 1 (A) Perisomatic synapses and innervation field of the basket interneuron influenced by
GAD67. (Top) A basket interneuron (large circle) innervates many pyramidal neurons (triangles) with
charateristic perisomatic synapses (black dots). (Bottom) A reduction of GAD67-mediated GABA
synthesis by genetic knockdown or activity deprivation leads to decreased axon arbor branching
and reduced perisomatic synapse density. (8) Activity-dependent GABA synthesis and signaling
regulate GABAergic synapse development. At GABAergic synapses, GABABR and GABABR local-
ize to pre- and postsynaptic and glia components. GABA release regulates synaptic morphogen-
esis in addition to mediating synaptic transmission (black arrow). At basket cell soma, GAD67 pro-
duction is regulated by input activity, which results in cell-wide adjustment of GABA synthesis and
level.
ture of OD plasticity. Using visual cortical slice prepa-
rations in which inhibition was left intact, we found
that converging layer-4 inputs cooperated to drive spik-
ing in layer-2/3 pyramidal neurons in the third postna-
tal week, but were antagonistic in the fourth week.
Antagonism was mediated via enhanced GABAA
receptor signaling which correlated with the increase
(peak) of OD plasticity. In contrast, this age-dependent,
spike-timing-dependent plasticity (STDP) mechanism
was equally potent before and after the onset of OD
plasticity. By simulating the antagonistic effect of
synaptic inhibition to a model integrate-and-fire neu-
ron, we demonstrated that enhanced synaptic inhibition
increases the effectiveness of STDP-driven competi-
tion to promote selective weakening of asynchronous
inputs. Therefore, maturation of GABAergic inhibition
124
appears to regulate the integration window and coinci-
dence detection of layer-2/3 pyramids in a manner that
promotes competition among eye-specific inputs and
thus may underlie heightened OD plasticity at the peak
of the critical periods (S. Kuhlman, in prep.).
We recently discovered a novel function of PSA-
NCAM (polysialic-acid-linked neural cell adhesion
molecule) in the maturation of GABAergic innerva-
tion and critical period plasticity in the visual cortex.
We found that PSA-NCAM expression is regulated
developmentally and by visual experience in the post-
natal visual cortex, but is inversely correlated to the
maturation of GABAergic innervation. Earlier
removal of PSA accelerated the maturation of
GABAergic inhibition and onset of the critical period.
Our results suggest that PSA-NCAM normally "holds
off" the maturation of GABAergic inhibition in the
early postnatal visual cortex. Activity-dependent
removal of PSA after eye opening enables maturation
and promotes plasticity (G. diCristo, in prep.).
GENE EXPRESSION PROFILE AND PROGRAMS IN
DIFFERENT CLASSES OF GABAERGic INTERNEURONS
Decades of physiological and anatomical studies have
revealed stunning heterogeneity and complexity of
GABAergic interneurons in their intrinsic and synaptic
physiology, morphology, and connectivity. Such com-
plexity is likely conferred by differential gene expres-
sion among different cell types, at different develop-
mental stages, and in response to stimulus. A thorough
characterization of gene expression profiles among
GABAergic interneurons may provide the most com-
prehensive and quantitative description of their molec-
ular makeup and yield fundamental insight into their
classification, biophysical repertoire, and the genetic
program directing their development. A bottleneck for
such an effort is the ability to purify defined classes of
interneurons in sufficient quantity for microarray stud-
ies. In collaboration with us, Sacha Nelson and col-
leagues at Brandeis University have succeeded in
a method to manually purify GABA neu-
rons for microarray analysis. This method is reliable
and sensitive and demonstrated a profound molecular
heterogeneity among 12 classes of neurons in the
mouse forebrain. We are applying this method to dif-
ferent developmental times in the neocortex and cere-
bellum. The cerebellum is appealing since various
transgenic mice label every major class of GABAergic
neuron as well as Bergmann glia cells from early devel-
opmental stages. Combined with bioinformatics analy-
sis, these studies will reveal novel biophysical proper-
ties, signaling pathways, and transcription programs
among interneurons. They should also yield better
tools (such as genes that define novel cell types) for
more refined genetic manipulations. Such a nonhy-
pothesis-driven approach is essential to elucidate the
genetic design of the GABAergic system, its function,
and its capacity for plasticity.
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BIOPHYSICAL BASIS FOR NEURAL COMPUTATION
A. Koulakov D. Tsigankov
This year, we continued focusing on the theoretical
model for development of connectivity in the visual
system. Our model combines the effects of binding
and activation of chemical labels, such as Eph recep-
tors and their ligands, ephrins, and Hebbian plasticity.
We also included this year the effects of growth fac-
tors, such as BDNF, in our model. We studied both the
final connectivity configurations and the dynamics of
axons and dendrites when this connectivity is formed.
Our model allows us to study the role of various fac-
tors on neural development and make experimentally
testable predictions. We thus showed that in some
cases, Hebbian mechanisms can contribute to the for-
mation of neural connectivity with single-neuron pre-
cision. General methods advanced by us this year
allow us to represent formation of a more abstract
neural network as a result of interplay between genet-
ic factors represented by molecular labels and envi-
ronmental information given by neuronal electric
activity. Our theoretical methods will allow us to
address a broad range of questions pertaining to the
dynamics and configurations of biologically realistic
neural networks in the future.
A Unifying Model For Activity-
dependent and Activity-independent
Mechanisms of Topographic Map
Development
D. Tsigankov, A. Koulakov
In developing brains, axons are able to find and rec-
ognize their targets based on specific chemical cues
that are emitted into intercellular space or localized on
the cellular membranes. Further refinement of neural
connectivity is dependent on correlated neural activi-
ty. To understand the relationship between the effects
of chemical labels and activity-dependent refinement,
we investigated a quantitative model that is capable of
including both of these factors. Our model generalizes
Sperry's chemoaffinity principle. We postulate that the
system of axons follows a gradient and optimizes the
binding affinity of axons to their targets. The affinity
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includes contributions from binding and activation of
chemical labels as well as activity-dependent contri-
butions. Inputs in our model include the distribution
of chemical cues expressed by axons and dendrites,
the affinity matrix between these cues, and the corre-
lation function of electric activity between connecting
cells. This model allows us to obtain the complete
connectivity matrix between cells. To test our model,
we investigated the formation of topographic connec-
tivity between retina and superior colliculus or optic
tectum that depends on binding and activation of the
Eph family of receptor tyrosine kinases by their lig-
ands, ephrins. We obtained the following results: (1)
Combined effects of chemoaffinity and correlated
activity can help to organize connectivity with single-
neuron precision. (2) In Is12/EphA3 knockin mice
described recently, the requirements imposed by mol-
ecular cues may contradict the activity-dependent
Hebbian factors. In these animals, the winning factor
depends on the relative strength of these contribu-
tions. (3) The axonal branch dynamics observed in the
optic tectum of Xenopus tadpoles is reproduced in
detail by our model. (4) Finally, geometric connectiv-
ity inferred from the overlap of dendritic and axonal
arbors does not necessarily reflect functional connec-
tivity. Our model therefore suggests a general method
to combine disparate contributions affecting neural
circuitry (Fig. 1).
Speed Accuracy Trade-off in Olfaction
A. Koulakov [in collaboration with D. Rinberg and A. Gelperin,
Monell Chemical Senses Center, Philadelphia]
We report the first direct observation of speed accura-
cy tradeoff (SAT) in olfaction. We developed a behav-
ioral paradigm in which both the time of odor expo-
sure and the difficulty of the odor discrimination task
were controlled by the experimenter. The accuracy of
odor discrimination performance increases with the
duration of odor exposure, and the rate of this increase
is slower for harder tasks. We also present a unifying
picture of two previous, seemingly disparate, experi-
14
FIGURE 1 Coordinated dynamics of axon, dendrite, and
synapses of this axon (black circles) in our model. The arbors
are shown for four numbered time points. This dendrite and
axon end up having 80% of their synaptic connections with
each other, which implies a single-neuron innervation. The sin-
gle-neuron innervation is possible because the arbors of axon
and dendrite are highly correlated in geometric space. The
soma location determines the level of ephrin expression. This
simulation included 900 axons and 900 dendrites (only one
pair is shown).
ments studying the timing of rodent odor discrimina-
tion. The presence of SAT in olfaction provides evi-
dence for temporal integration in olfaction and con-
strains the applicability of different models of olfacto-
ry information processing.
Combinatorial On/Off Model for
Olfactory Coding
A. Koulakov [in collaboration with D. Rinberg and A. Gelperin,
Monell Chemical Senses Center, Philadelphia]
The glomerular response specificities are understood
statistically, based on experimentally measured distri-
butions of detection thresholds. A simple version of
the model, in which glomerular responses are binary
(the on/off model), allows us to quantitatively account
for the following results of human/rodent psy-
chophysics: (1) just-noticeable differences in the per-
ceived concentration of a single odor (Weber ratios)
are dC/C-0.1, (2) the number of simultaneously per-
ceived odors can be as high as 12, and (3) extensive
lesions of the olfactory bulb do not lead to significant
changes in detection/discrimination thresholds. We
conclude that a combinatorial code based on a binary
glomerular response is sufficient to account for the
discrimination capacity of the mammalian olfactory
system.
We study a model for olfactory coding based on spa-
tial representation of glomerular responses. In this
model, distinct odorants activate specific subsets of
glomeruli, dependent on the odorant's concentration.
Saha Formula in Olfaction
A. Koulakov [in collaboration with D. Rinberg and A. Gelperin,
Monell Chemical Senses Center, Philadelphia]
Olfactory perception is based on interactions between
odor molecules and olfactory receptor proteins. The
molecular specificity of binding and activation of the
receptors by odorants forms the basis for discrimina-
tion of smells of different quality and quantity. In this
study, we considered the reaction of binding between
odor molecules and receptor protein and derived the
general relationship for the degree of receptor binding.
We show that this relationship has a form of the Saha
equation. We argue that the olfactory Weber law may
be a consequence of the Saha equation for general
assumptions about specificities of odorant-olfactory
receptor-binding affinities.
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THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen C.E. Feierstein
G. Felpen
A. Kepecs
M.C. Quirk
S. Ranade
D.L. Sosulski
N. Uchida
H.A. Zariwala
Our laboratory is studying the neural mechanisms of
goal-directed behavior. We work with a simple but
flexible psychophysical paradigm in which rats use
odors to guide spatial choices to obtain reward. We are
particularly interested in how olfactory information is
encoded and transformed into adaptive decisions. We
discovered several years ago that rats can respond
accurately to sensory information extremely quick-
ly-in a single sniff-and we are continuing to study
the temporal limits and mechanisms of rapid olfactory
discrimination, as well as more complex computation-
al problems such as concentration- and background-
invariant odor recognition and odor-guided navigation.
To get at the underlying neural mechanisms, we are
using chronic multielectrode recording to monitor sin-
gle-neuron activity and neural circuit interactions. We
recently found that the orbitofrontal cortex (OFC)
integrates spatial and reward information to construct
maps of behavioral goals. Ongoing recordings focus
on temporal coding in the olfactory cortex and the
dynamics of representations during learning. From a
broader neuroeconomic perspective, we are also
studying how the brain deals with the costs of deci-
sions (effort, delay, uncertainty). Finally, we are inves-
tigating how psychoactive drugs alter behavior, begin-
ning with ketamine, a drug thought to mimic aspects
of psychosis. We hypothesize that drug states can be
understood as specific perturbations of neural circuit
dynamics. An understanding of neuropharmacology at
the circuit level may lead to more effective treatments
for disorders such as Parkinson's disease and schizo-
phrenia.
Temporal Integration in
Odor Discrimination
H.A. Zariwala, N. Uchida, A. Kepecs
Time can have an important role in the process of
deciding between competing options. It is observed
that human subjects can sacrifice speed for accuracy
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in many types of decisions, and a large class of formal
decision models is based on the integration of infor-
mation over time. However, the time scale of integra-
tion may vary depending on the nature of the task and
the neural systems underlying it.
In a reaction time two-alternative forced choice
odor mixture discrimination task (Uchida and Mainen,
Nat. Neurosci. 6: 1224 [2003]), we found that rats per-
formed the most difficult discriminations with a very
small increase in reaction time (-10%) compared to the
easiest discriminations. As a follow-up to those obser-
vations, our goal has been to motivate rats to use longer
odor-sampling times to increase accuracy.
In a first set of experiments, we manipulated task
parameters to discourage speed and/or encourage
accuracy. We introduced (1) a random delay before
odor delivery to prevent motor stereotypy from con-
straining timing, (2) a long time out or air puff for
incorrect choices to increase the cost of errors, (3) a
fixed delay (2 sec) from odor onset to reward to deem-
phasize speed, and (4) a stimulus schedule in which
difficult problems were presented in blocks, rather
than interleaved with easy problems. We saw no
change in either speed or accuracy for the first two
manipulations. For the second two, accuracy improved
significantly on the hardest problem, but reaction time
was not slowed.
In a second set of experiments, we designed a
delayed response task by training rats to withhold
responding until an auditory "go" signal. This allowed
us to enforce a minimum odor-sampling duration
more strictly. Using this paradigm, odor-sampling
durations increased from approximately 250 msec in
the reaction time task to 1000 msec. However, surpris-
ingly, the accuracy on the delay task was not greater
than in the reaction time version of the task across all
difficulties.
These results show that rapid olfactory reaction
times are not simply a question of motivation, but
rather, they reveal fundamental underlying neural con-
straints. Important factors that may favor rapid pro-
cessing of olfactory information is decreasing infor-
mation rates due to sensory adaptation and chunking
by the sniff cycle. Coding of elementary olfactory
information in discrete snapshots may facilitate high-
er-order olfactory computations such as associating
olfactory cues with spatial landmarks or navigating
toward odor sources.
Control of Sniffing:
Active Sensation and
Olfactory Behavior
A. Kepecs, N. Uchida
Sensory organs are not passive receivers but active
instruments controlled by the brain. A familiar exam-
ple of active sensation is saccadic eye movement-
control known to be critical to vision. Olfaction also
depends on an active motor process, sniffing, but rel-
atively little is known about how it is regulated during
behavior or what role this regulation has in olfactory
processing.
A nasal thermocouple (small temperature-sensing
probe) allows us to monitor respiration in freely
behaving animals. Using this method, we are examin-
ing the regulation of respiration in rats performing a
two-alternative olfactory discrimination task.
Respiration frequency varied over a wide range (<2 to
>12 Hz) during the course of a behavioral session,
systematically changing in relation to significant
behavioral events such as entry into the odor sampling
or reward ports. However, when examined in relation
to the precise timings of behavioral events, rather than
a continuous distribution, discrete frequency modes
were observed. In particular, rats switched to a 0 fre-
quency (7-10 Hz) mode shortly before odor port
entry, remained locked to this mode throughout odor
presentation, and then switched to a higher mode
(9-12 Hz) before entry into the goal port. Switches
between modes occurred very rapidly, almost always
within a single respiration cycle. Interestingly, the
timing of respiration was related not only to the sen-
sory demands of odor sampling, but also to other
motor processes. In particular, the timing of head
retractions from the odor and choice ports was pre-
cisely coordinated with the respiratory cycle. These
observations reveal a powerful and rapid top-down
control of respiratory central pattern generators
(CPGs), allowing both expectations to direct sensory
acquisition as well as the coordination of respiratory
and motor processes.
Odor Coding in the
Olfactory Cortex
N. Uchida
Our psychophysical studies showed that a single sniff
of 150 msec can provide precise information about an
odor for a rat (Uchida and Mainen, Nat. Neurosci. 6:
1224 [2003]). These findings suggested that the sniff
cycle may be a fundamental unit of odor information
coding and processing (Kepecs et al. 2005) and raised
the question of how olfactory information is encoded
on such a time scale. Two candidate mechanisms that
might allow especially rapid odor coding are precise
timing of spikes in reference to spikes of other neu-
rons (synchrony coding) or timing of spikes relative to
the sniffing cycle (latency or phase coding).
To test these ideas directly, we are performing
chronic multielectrode recordings of multiple neurons
in the olfactory cortex in behaving rats (Fig. 1). Rats
are trained to perform a two-alternative olfactory dis-
crimination task using two to three odor pairs. Sniffing
is simultaneously recorded using a thermocouple (tem-
perature sensor) implanted in the nasal cavity. Rats are
trained to perform at high levels of accuracy, but the
stimuli include interleaved binary odor mixtures that
A
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FIGURE 1 Single-unit data from one recording session. These
data demonstrate that spikes are indeed precisely locked the
sniffing cycle, achieving an instantaneous rate of almost 150 Hz
less than 50 msec after sniff onset. (4) Response of an olfacto-
ry cortical neuron recorded in a behaving rat during sampling of
presentation of an odor (ethyl 3-hexenoate). (Top) Spike rasters
from 20 representative trials. (Bottom) Poststimulus time his-
togram. (8) Same data aligned to the first sniff cycle after odor
onset (represented by the dotted line). Note tight locking of
response to the respiratory cycle.
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test the psychophysical limits of performance.
Critically, with this paradigm, the efficiency of candi-
date codes can be assessed by optimal observer decod-
ing in comparison to behavioral performance. Are
spike count codes sufficient to explain the psy-
chophysical performance or are spike timing codes
necessary?
Single-unit Encoding of
Goal-directed Behavior in
the Orbitofrontal Cortex
C.E. Feierstein
Every day we face the need to make decisions: We
choose between different alternatives to achieve a par-
ticular goal. This is the essence of "goal-directed"
behavior. Making a decision is a complex process that
depends on integrating information about the environ-
ment, the alternative actions and their consequences,
and choosing what is more likely to result in the
accomplishment of our goal.
We are interested in understanding the neural basis
of decision making and goal-directed behavior. In par-
ticular, we study olfactory-guided decisions. Our stud-
ies have focused on the OFC, an area of the prefrontal
cortex that forms part of a network of brain regions
important in decision making. The most prominent
representation described in this area is that of the
reward value associated with stimuli.
We are using chronic multielectrode recording
techniques to monitor the activity of ensembles of neu-
rons in rats performing a two-alternative odor discrim-
ination task; rats must learn to associate each stimulus
with a movement to one of two spatial goals to obtain
reward. In this paradigm, we found that a large fraction
(56%) of OFC neurons was selective for choice (move-
ment) direction or goal location (left/right). Neurons
responded also during and in anticipation of reward
delivery or omission. Interestingly, a large subset of the
direction selective neurons was jointly selective for the
trial outcome (e.g., a cell would fire differently in left
choice trials that resulted in an error versus left trials
that resulted in a correct response).
These findings demonstrate that circuits in the
rodent OFC integrate value information with an objec-
tive representation of the spatial environment, thus
forming a map of behavioral goals. How do these rep-
resentations arise in the OFC? We are now recording
the activity of neurons in the OFC during learning of
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new associations, trying to understand the role of this
area in olfactory-guided behavior.
Behavioral Impact and Neural
Representation of Uncertainty
in Perceptual Decision Making
A. Kepecs, N. Uchida
Making good decisions requires the anticipation of the
consequences associated with each alternative.
Because outcomes are rarely certain, a core compo-
nent of decision making involves the prediction and
evaluation of uncertainty about different options. To
study uncertainty in decision making, we are using the
standard odor mixture discrimination paradigm devel-
oped in our lab.
Rats are trained on binary mixtues of two odors,
"A" or "B," in different ratios (100/0, 80/20, 68/32,
56/44, etc.). Rats are rewarded at the left port for mix-
tures A/B < 1 and at the right port for A/B > 1. For
stimuli near the boundary, A/B = 1, there is ambiguity
in the relationship of a given odor mixture to the prop-
er choice. Much like asking whether a particular blend
of blue and green colors is more blue than green
depends on an arbitrary convention of color categories,
this training protocol enforces an arbitrary boundary
between two odor mixtures. Therefore, there are at
least two major sources of decision uncertainty for the
rat: variability associated with the encoding of odors
(sensory uncertainty) and variability in the memory of
the true decision boundary (memory uncertainty).
To explore the neural representation of decision
uncertainty, we have recorded from the OFC. Because
rewards are fixed in our task (for correct choices), the
current value associated with each choice depends
directly on the uncertainty of decisions. An accurate
estimate of uncertainty should vary with mixture ratio
(because rats make more mistakes and hence are more
uncertain of odors near the boundary) as well as with
accuracy (because, on average, their performance will
reflect their uncertainty). Our preliminary findings
show that a large fraction of OFC neurons systemati-
cally encode mixture ratios, as well as predict choice
accuracy during the period of reward anticipation.
These observations suggest that orbitofrontal activity
provides an estimate of uncertainty.
We therefore wondered if uncertainty actually con-
tributes to decisions made by the rats on a trial-to-trial
basis. Because learning that the decision boundary
may require continual updating, we tested whether
previous trials affected performances. According to
statistical learning theory, the rate of learning should
be proportional to uncertainty: For difficult problems
(e.g., 56/44 mixture), the outcome is very informative
about location of the decision boundary, whereas the
outcome of pure-odor trials reveals little about the
boundary. Consistent with this, we found that rats
biased their decisions to the more recently rewarded
direction as if their decision boundary was shifted and
the shift was proportional to the uncertainty of the
problem. These results suggest that rats possess a rep-
resentation of uncertainty associated with their deci-
sions and ongoing adjustments in behavior depend on
the magnitude of this variable.
How a Delay Affects the Perceived
Value of a Reward, Behaviorally
and Neuronally
G. Felsen, H.A. Zariwala
Animals make choices based on the perceived values
of their associated outcomes. Understanding how
value is computed and assigned is thus critical for
explaining behavior. One factor that strongly influ-
ences value is the duration of the delay that precedes
the outcome: The subjective value of a reward decreas-
es as the delay preceding its presentation increases. In
other words, given a choice between two rewards of
equal magnitude, animals (including humans) will typ-
ically prefer the reward associated with the shorter
delay and often even select a reward with a smaller
magnitude if the alternative is sufficiently delayed. For
example, a human subject may opt to receive $10 after
2 minutes rather than $20 after 2 days.
To study this process, known as delay discounting,
we are developing a paradigm in which rats freely
choose between rewards of differing delays and mag-
nitudes. In our first set of experiments, we obtained a
result that would not have been predicted by existing
theories: When the delay period is spent where the
reward is to be delivered, rats choose to endure longer
delays over shorter ones. We speculate that such
behavior could result from the formation of a positive
association with the location itself (since that is where
the reward is ultimately delivered), which overrides
any decrease in the reward value due to the longer
delay. Although this unexpected finding is interesting
in itself, in order to observe behavior influenced by
delay discounting, we will modify the task such that
the location of reward delivery will be dissociated
from where the delay itself is spent.
Ultimately, we would like to use this behavioral par-
adigm to study how delay is represented in the pre-
frontal cortex. We plan to record from populations of
neurons in the OFC, an area implicated in the subjective
assignment of value to rewards, of rats as they perform
the behavioral task. Our results will allow us to quanti-
fy neuronal selectivity for reward delay and to study
how that selectivity evolves and develops during the
processes of decision making and attainment of reward.
Recordings from Serotonergic
Raphe Nuclei in Awake
Behaving Rats
S. Ranade
Serotonin is an important neuromodulator implicated
in a range of behavioral, cognitive, and psychiatric dis-
orders. Serotonin is secreted by neurons located in a
set of nuclei in the midbrain called the raphe nuclei
that send diffuse projections through the entire neu-
raxis. Although much knowledge of serotonergic func-
tion has been gained through pharmacology there are
only a few recordings studies from raphe nuclei in
awake animals and none in an animal engaged in a
task. Therefore, to gain insight into serotonin function,
we would like to record from raphe neurons in rats
performing a behavioral task. On the basis of rein-
forcement learning models and a variety of anatomical
and pharmacological data, we hypothesize that raphe
neuronal firing will encode negative outcomes (e.g.,
reward omission).
During the past year, we solved most of the techni-
cal hurdles involved in recording from raphe nuclei. We
have developed a procedure for tetrode drive implanta-
tion to reliably target these nuclei. This involves placing
a guide cannula through the midline sagittal sinus up to
a depth of 3 mm from the skull surface and lowering the
drive through the cannula into the brain. This technique
allows us to accurately localize fine-wire tetrodes to the
dorsal and median raphe nuclei.
We first recorded neurons from these nuclei in
awake, freely behaving rats and determined their firing
properties. Neurons were classified on the basis of fir-
ing rate, spike width, and rhythmic modulation. A sub-
set of high-firing-rate neurons showed rhythmic modu-
lation at 0, 0, and/or y frequencies. A very small pro-
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portion of low-firing-rate neurons (<10% of total pop-
ulation) had wide spikes (>400-msec peak to valley),
similar to serotonergic neurons reported in literature.
To study responses of raphe neurons during goal-
directed behavior, we trained rats on a two-alternative
choice odor discrimination task. To test responses of
raphe neurons to negative outcomes, we introduced
probabilistic reinforcement. In this modified task, we
omitted reward on a small proportion (10-20%) of
randomly interleaved trials. Omission of expected
reward is a negative outcome, and we hypothesize that
raphe neurons will show firing-rate modulation in
response. Our future goals involve testing our
hypotheses of serotonin neuron firing in reinforce-
ment and sniffing.
Inter-areal Coordination
among Brain Regions
during Olfactory Decisions
A. Kepecs
Much is understood about how individual brain
regions represent specialized properties of the envi-
ronment and perform dedicated processing, but it
remains unclear how the brain coordinates its many
regions to arrive at coherent decisions. The dynamic
coordination of activity is essential for any complex
network like the brain, where multiple nodes or
regions are needed to accomplish a particular func-
tion. For instance, if you were asked to switch from
writing down what you are hearing to what you are
smelling, your brain would have to dynamically mod-
ulate the flow of information between its auditory,
olfactory, and motor areas, turning off an auditory-
motor pathway and turning on an olfactory-motor
pathway. Yet the long-range wiring of the brain is
essentially fixed. How then do neural networks in the
brain accomplish dynamic and flexible routing of
information? Or to put it another way, How does the
massively parallel and asynchronously operating brain
coordinate its operation?
We are exploring the idea that transient and dynam-
ic oscillatory synchronization between brain regions is
used to differentially route and thus coordinate infor-
mation flow. In particular, we recorded local field
potentials (representing the summed coherent activity
in local neuronal populations) simultaneously from the
several areas relevant to the olfactory task: olfactory
bulb, olfactory cortex, and the dorsal and ventral hip-
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pocampus while rats performed olfactory discrimina-
tions. Strong 0 (6-10 Hz, similar to sniffing frequency)
oscillations occurred at all recording sites during the
task, but only the hippocampal areas were coherent. In
contrast, transient 13 (20-30 Hz) oscillations appeared
and became phase-locked between the olfactory bulb
and ventral CAI areas. Around the time of response
initiation, the ventral CA1 region showed strong 13
coherence with the olfactory bulb and, at the same
time, 0 coherence with the dorsal CAl region. Thus
inter-areal coherence across different brain regions can
be frequency specific, and the same brain region can be
coherent at different frequency bands with different
regions. Currently, we are examining how coherent
inter-areal activity is modulated by behavioral contin-
gencies during the task.
Network Dynamics of
Cortical Interneuron Subtypes
M.C. Quirk
A distinguishing feature of the neocortex is its cellular
diversity. Consequently, a prerequisite for understand-
ing the computations performed by cortical circuits is
the ability to identify and study distinct cell classes.
This issue is particularly acute in studies of cognitive
function in behaving animals where access is generally
limited to extracellular recordings. To address this prob-
lem, we have developed methods for distinguishing
physiologically distinct neurons in chronic multielec-
trode recordings from the neocortex of behaving rats.
Using unsupervised clustering algorithms applied
to a set of extracellular waveform and spike interval
metrics, we have been able to identify both excitatory
pyramidal cells and two classes of inhibitory interneu-
rons, termed NS I and NS2. By comparing our data
with previous in vitro studies, NS 1 neurons appear to
correspond to a relatively homogeneous class of somat-
ically targeting interneurons called basket cells, where-
as NS2 cells correspond to a more diverse set of
intemeurons that generally provide dendritic inhibition.
Although inhibitory interneurons have been exten-
sively studied in vitro, little is known of their properties
in vivo. We find that NS1 and NS2 neurons display dis-
tinct network dynamics. NS I neurons are well situated
to provide both feedback and lateral inhibition to
neighboring pyramidal cells. The firing activity of spa-
tially separated NS1 neurons is also highly synchro-
nized, suggesting that the NS I neurons have an impor-
tant role in coordinating the output of spatially distrib-
uted but functionally related cell populations. In con-
trast, the network properties of NS2 neurons are more
varied, suggesting that these neurons participate in a
diverse host of yet unknown processes. Preliminary
behavioral analysis further suggests distinct computa-
tional functions of NS1 and NS2 neurons.
Given that somatic and dendritically targeting
interneurons exhibit differential and selective vulner-
ability across a variety of neurological and psychiatric
states, the ability to identify distinct classes of
interneurons in vivo will provide an important avenue
for defining neural circuit endophenotypes of psychi-
atric diseases.
Neural Circuit Mechanisms
Underlying the Ketamine-Induced
Dissociative State
D.L. Sosulski, M.G. Quirk
Dissociatives are a class of drugs that includes ketamine,
phencyclidine (PCP), and dizocilpine (MK-801). At
high doses, these drugs produce anesthesia and amnesia.
At lower doses, they can produce a form of altered con-
sciousness in which cognitive activity is disconnected
from sensory information processing. At these subanes-
thetic doses, dissociatives have been proposed to model
acute psychosis. From a clinical perspective, ketamine
can mimic not only the "positive" clinical symptoms of
schizophrenia (e.g., delusions), but also the "negative"
symptoms (e.g., social withdrawal) and impairment of
cognitive functions (e.g., working memory).
The dissociative state can be understood as the
mental and behavioral correlate of a specific form of
altered neuronal dynamics produced by the action of
this class of drugs. A characterization at the neuronal
level of the phenomenology of this state and a better
understanding the mechanisms that produce it should
provide new insight into the mechanism of action of
psychoactive drugs and could help to define neural
endophenotypes of schizophrenia.
To address these issues, we are examining the
effect of ketamine on neural activity in the prefrontal
cortex of behaving rats. Chronic multielectrode
recording techniques are used to isolate ensembles of
single neurons in the behaving animal. Using the tech-
niques described above ("Network dynamics..."), we
identified putative fast-spiking interneurons and pyra-
midal neurons. Rats are given daily injections alter-
nating between ketamine (30 or 7 mg/kg) and control
solution (1% saline).
We find that ketamine, at both 7 and 30 mg/kg
doses, produces a robust suppression of interneuron
firing. Pyramidal neuron firing rates are also altered
but show mixed effects, with approximately half
increasing and half decreasing. We are currently using
measures of oscillatory synchrony as a means to fur-
ther characterize the circuit dynamics produced by
dissociatives.
Our findings begin to define the nature of a psy-
chosis-like state at the level of single neuron activity.
We suggest that ketamine, an NMDA (N-methyl-n-
aspartate) receptor antagonist, acts either directly or
indirectly by disrupting the activity of one or more
classes of interneurons, probably localized to the pre-
frontal cortex. This in turn appears to cause a broader
disorganization of neuronal activity in the pyramidal
cell population, the characteristics of which remain to
be defined. These observations lend support to the the-
ory that the symptoms of schizophrenia may reflect
alterations in brain function resulting from dysregula-
tion of interneuron activity.
PUBLICATIONS
Egger V., Svoboda K., and Mainen Z.F. 2005. Dendrodendritic
synaptic signals in olfactory bulb granule cells: Local spine
boost and global low-threshold spike. J. Neurosci. 25:
3521-3530.
Feierstein C.E., Quirk MC., and Mainen Z.F. 2005. Orbitofrontal
cortex responses during acquisition of novel stimulus-
response associations. Soc. Neurosci. Abstr. 278.11.
Gurden H., Pain F., Desbree A., Mastrippolito R., Bonventom
G., Hantraye P., Uchida N., Mainen Z.F., and Laniece P.
2005. Odor-evoked activation of olfactory glomeruli: An
attractive model to probe neurometabolic and neurovascu-
lar coupling mechanisms by optical and radioisotopic tech-
niques. Soc. Neurosci. Abstr. 189.6.
Kepecs A., Uchida N., and Mainen Z.F. 2005. Sniffing patterns
in rats performing an olfactory discrimination task. Soc.
Neurosci. Abstr 278.6.
Kepecs A., Uchida N., and Mainen Z.F. 2006. The sniff as a unit of
olfactory processing. Chem. Senses 31: 167-179. Advanced
online publication, Dec. 2005.
Sosulski D., Quirk M.C., and Mainen Z.F. 2005. Ketamine
inhibits interneuron firing in prefrontal cortex of behaving
rats. Soc. Neurosci. Abstr. 444.12.
Sato T., Yasuda R., Mainen Z.F., and Svoboda K. 2005. Using
[Ca21 imaging to detect single action potentials in multiple
neurons in the mouse somatosensory cortex in vivo. Soc.
Neurosci. Abstr. 625.14.
Zariwala H.A., Uchida N., and Mainen Z.F. 2005. A study of
speed and performance accuracy in an olfactory discrimi-
nation task. Soc. Neurosci. Abstr 278.9.
133
TRANSMISSION AND PLASTICITY IN MAMMALIAN CENTRAL
SYNAPSES
R. Malinow W. Benjamin H. Hsieh B. Li
J. Boehm H. Hu T. Takahashi
N. Dawkins-Pisani H. Kessels W. Wei
I. Ehrlich C. Kopec
My laboratory is directed toward understanding synap-
tic function, synaptic plasticity, and synaptic dysfunc-
tion. Through such an understanding we hope to eluci-
date how learning and memory are achieved and how
diseases corrupt them. This year, we continued to exam-
ine the regulation of a-amino-3-hydroxy-5-methylisox-
azole-4-propionic acid (AMPA) and N-methyl-D-
asparate (NMDA) receptors at synapses that may under-
lie plasticity and the malfunction that could lead to dis-
eases. Some of our studies are summarized below.
AMPA-R Removal Underlies
AO-induced Synaptic Depression
and Dendritic Spine Loss
H. Hsieh, R. Malinow [in collaboration with S. Sisodia,
University of Chicago]
Beta amyloid (A13), a peptide generated by neurons, is
widely believed to underlie the pathophysiology of
Alzheimer's disease when overproduced. Recent stud-
ies indicate that this peptide can drive endocytosis of
AMPA- and NMDA-type glutamate receptors. We now
show that AP uses signaling pathways of long-term
depression (LTD) to drive endocytosis of synaptic
AMPA receptors. Synaptic removal of AMPA recep-
tors is key, because it is necessary and sufficient to
drive loss of dendritic spines and synaptic NMDA
responses. Our results indicate that increased levels of
AP tap into endogenous physiological processes to
depress synaptic structure and function.
PSD-95 Is Required for Activity-driven
Synaptic Development
t Ehrlich, R. Malinow
The activity-dependent regulation of AMPA-type glu-
tamate receptors and the stabilization of synapses are
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critical to synaptic development and plasticity. One
candidate molecule implicated in maturation, synaptic
strengthening, and plasticity is PSD-95. Here, we find
that acute knockdown of PSD-95 in brain slice cul-
tures by RNA interference arrested activity-driven
development of synaptic structure and function, mani-
fested by reduced synaptic strength and altered spine
morphology. Surprisingly, PSD-95 was not necessary
for the induction and early phase of long-term potenti-
ation (LTP) expression. However, following PSD-95
knockdown, chemically induced LTP produced small-
er changes in the size of stable spines, and we
observed a larger fraction of transient spines that
turned over more readily. Taken together, our data sup-
port a model in which PSD-95 is required for activity-
dependent synapse stabilization following initial phas-
es of synaptic potentiation.
Signaling by Neuregulin/ErbB4,
Genes Implicated in Schizophrenia,
Is Critical to Proper Maturation of
Excitatory Synapses
B. Li, R. Malinow [in collaboration with L. Mei, College of
Georgia]
Neuregulin 1 (NRG1) and its receptor ErbB4 activate
signaling cascades that are essential for the develop-
ment and function of many organ systems including
the neural system. However, the function and mecha-
nism of NRG1 and its receptors in the central gluta-
matergic synapse are poorly understood. Here, we
show that NRG1 signals via erbB4 to control spine
growth, synaptic maturation, and synaptic plasticity
at the Schaffer collateral-CAI synapse. Our data sug-
gest that the defect in glutamatergic synapse devel-
opment caused by a perturbation in the NRG1/erbB4
signaling pathway may contribute to the etiology of
schizophrenia.
Postsynaptic Receptor Trafficking
Underlying a Form of Associative
Learning
S. Rumpel, A. Zador, R. Malinow [in collaboration
with J. LeDoux, New York University]
To elucidate molecular, cellular, and circuit changes
that occur in the brain during learning, we investigat-
ed the role of a glutamate receptor subtype in fear
conditioning. In this form of learning, rodents associ-
ate two stimuli, such as a tone and a shock. In this
study, we found that fear conditioning drives AMPA-
type glutamate receptors into the postsynapse of a
large fraction of neurons in the lateral amygdala, a
brain structure essential to this learning process.
Furthermore, memory was reduced if AMPA-receptor
synaptic incorporation was blocked in as few as 10-
20% of lateral amygdala neurons. Thus, the encoding
of memories in the lateral amygdala is mediated by
AMPA-receptor trafficking, is widely distributed, and
displays little redundancy. We have continued these
studies by examining dendritic spines in vivo before
and after fear conditioning.
Spine Enlargement Precedes
AMPA-receptor Exocytosis
during LTP
C. Kopec, B. Li, W. Wei, J. Boehm, R. Malinow
The changes in synaptic morphology and receptor
content that underlie neural plasticity are poorly
understood. In this study, we used a pH-sensitive
green fluorescent protein (GFP) to tag recombinant
glutamate receptors and showed that chemically
induced LTP drives robust exocytosis of AMPA recep-
tors onto dendritic spines. In contrast, the same stim-
ulus produced a small reduction of NMDA receptors
from spines. LTP produced similar modification of
small and large spines. Interestingly, during LTP
induction, spines increased in volume before surface
incorporation of AMPA receptors, indicating that dis-
tinct mechanisms underlie changes in morphology
and receptor content. We are continuing these studies
by establishing optical methods to detect synapses that
have undergone plasticity.
Differential Subcellular Overexpression
of AMPA-receptor Subunits in CA1
Neurons
H. Kessels, M. Klein, R. Malinow
The role of AMPA-type glutamate receptors in synap-
tic plasticity can be studied by the introduction of
recombinant AMPA subunits in glutamatergic neurons.
Here we show that, whereas transient expression of
AMPA subunits leads to considerable overproduction
in neuronal somata of organotypic hippocampal slices,
at dendrites they remain close to endogenous levels.
These results provide evidence for a tightly controlled
transport mechanism of AMPA-R complexes traveling
from soma to dendritic compartments. We have now
evidence that the AMPA-R associated protein,
stargazin, is a rate-limiting protein in the transport of
AMPA-Rs from cell bodies to dendrites. This transport
system is selective for certain AMPA-R subunits.
Direct Phosphorylation by PKC
at a Novel Site on AMPA-R
Subunit Glurl Controls Synaptic
Incorporation during LTP
J. Boehm, R. Malinow in collaboration with R. Huganir,
Johns Hopkins University]
Incorporation of GluR 1 -containing AMPA-Rs into
synapses has an important role in several forms of
neural plasticity. A number of signaling pathways have
been identified, but the direct modifications of GIuR1
that control its synaptic incorporation have not yet
been found. Previous studies indicate that activation of
protein kinase C (PKC) is required to generate LTP, a
leading model of synaptic plasticity. However, the tar-
gets of PKC responsible for LTP have not been deter-
mined. We find that G1uR1 Ser-818, which is highly
conserved evolutionarily, is phosphorylated by PKC in
vitro and by LTP in hippocampal slices. Acute phos-
phorylation by PKC at GIuR1 Ser-818 as well as mol-
ecular mimicking phosphorylation at this site drives
GIuR1 into synapses. Preventing GIuR1 Ser-818 phos-
phorylation blocks LTP and PKC-driven synaptic
incorporation of GluR 1 . Thus, GluRl Ser-818 is
rapidly phosphorylated by PKC during LTP induction
and is required for its incorporation into synapses.
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INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra P. Andrews H. Maniar
H. Bokil A. Puniyani
Our basic research philosophy is to bring theoretical,
computational, and experimental tools to bear on bio-
logical questions, in general, and neurobiological
questions, in particular, to make sense of biological
complexity and provide understanding and potential
therapies for disease. There are three basic branches to
the research: Neuroinformatics, Theoretical Engineer-
ing, and Quantitative Behavior and Electrophysiology.
The first involves the application of statistical and sig-
nal processing tools to large volumes of neurobiologi-
cal data. This continuing research effort, reflecting
several years of work, has given rise to the Chronux
analysis platform and is associated with the Neuro-
informatics summer course at the Marine Biological
Laboratories in Massachusetts. The second branch of
research deals with the question of theoretical princi-
ples underlying the design of biological systems.
Since biological organisms are evolved to perform
their tasks robustly under uncertain circumstances,
both in terms of the environment and the parametric
uncertainty in components making up the system, it is
expected that the mathematical theories developed by
engineers to help design man-made systems that per-
form under similarly challenging circumstances may
also apply to these systems. The goal of this research
is to identify the engineering principles most germane
to biology and to study selected examples drawn from
different levels of the organizational hierarchy. The
third component of the research is experimental and
includes behavioral and electrophysiological studies in
multiple species including the zebra finch, the
macaque, and more recently, Drosophila.
Our laboratory personnel includes Hiren Maniar,
scientific informatics analyst working as part of a con-
sortium funded by the Human Frontiers Science
Foundation on the role of neural synchrony in cross-
modal integration; Hemant Bokil, a postdoctoral fellow
continuing his work on signal processing applications
to neurobiological time series with special emphasis on
neural prostheses; and Peter Andrews, a scientific
informatics manager responsible for the hardware and
software infrastructure for the group; he is also in
charge of the development and maintenance of the
Chronux software platform for neural signal process-
ing. Hemant and Hiren are working with Peter on the
development of Chronux. Amit Puniyani is one of two
newly hired postdocs working on the DART project.
Apart from this group of core personnel, our
research effort includes close collaborative ties with
multiple research groups. A collaborative effort with
Niko Schiff and Keith Purpura at the Weill Medical
School of Cornell University, where I am an adjunct
associate professor, involves electrophysiology in the
awake behaving macaque. A second research effort on
how zebra finches learn their song vocalizations is
being carried out in collaboration with a consortium of
zebra finch researchers based in four different universi-
ties, including a long-standing collaboration with Ofer
Tchernichovski at City College of New York. This col-
laboration has been fruitful, with a publication earlier
in 2005 on the effects of sleep on song development in
the zebra finch. A third collaboration is with Rodolfo
Llinas's group at New York University Medical
College. A fourth consortium-based research effort to
study cross-modal integration between the senses is
funded by the Human Frontiers Science Program,
including the laboratories of Shinsuke Shimojo
(Caltech) and Pascal Fries (EC. Donders Research
Center at Nijemegen). A fifth project started in 2005 is
the integrative analysis of memory formation in the
fruit fly, as part of the Dart Neurogenomic Alliance at
CSHL led by Tim Tully.
Chronux: Open Source Software
for Neural Signal Processing
P. Andrews, H. Bokil
The nervous system stores and executes behaviors and
adapts these behaviors to the environment through
sensory monitoring. Studies of the activity of the ner-
vous system consist primarily of monitoring the
dynamics of units at different levels of hierarchy of the
system, ranging from single neurons measured electri-
cally to large groups of neurons monitored indirectly
through a variety of imaging methodologies. The rele-
vant measurements consist of single or multichannel
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time series data, in the form of continuous or point
processes. Therefore, the statistical analysis of time
series data is central to studying the nervous system.
During the past several years, our research has
involved the development of algorithmic and compu-
tational tools for the analysis of multichannel time
series data from the neurosciences. We are now encod-
ing these tools into an open-source software package
entitled Chronux. This project will proceed in stages
and involve the development of a high-quality numer-
ical analysis library, data I0 and management utilities,
and a user interface that gives experimental neurosci-
entists access to advanced analysis tools. We expect
that tools such as these will be critical to advancing
our understanding of systems neuroscience.
Substantial improvements have been made to
Chronux. The Chronux Mat lab toolbox has now been
released under the open-source software license GPL
V2, which we hope will promote more external contri-
butions to the project. Of significant interest is the
recent incorporation of the entire C Locfit library by
Catherine Loader, a statistics expert at Case Western
Reserve University, as a set of Matlab mex functions.
Locfit adds to Chronux the ability to fit curves and
surfaces to data using local regression and likelihood
methods. Additional algorithms added to Chronux
include nonstationary spectral analysis techniques, and
an algorithm for comparing spectra or coherences from
two groups of trials with unequal sizes that we have
recently developed. These additions are aimed at prob-
lems that arise frequently in neural signal processing.
LBEX: A Toolbox for Source
Localization in MEG
H. Maniar
Magnetoencephalography (MEG) is the noninvasive
imaging of brain activity through measurements of the
weak magnetic fields generated by this activity.
Utility of this imaging modality is contingent on solv-
ing an inverse problem to perform source localization.
Localization aims to spatially pinpoint the neural
activity within the head using externally measured
recordings. During the past decade, localization has
been used not only to understand the temporal aspects
of brain dynamics, but also to chart out various human
cognitive abilities. In recent years, localization is also
increasingly being used in clinical settings for presur-
gical planning of epileptic cases.
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Various localization techniques are currently
employed by researchers, but not all perform satisfac-
torily. A significant degree of interdisciplinary knowl-
edge is required in conceiving new algorithms. We
have developed a new source localization methodolo-
gy called local basis expansions (LBEX). The tech-
nique can be viewed as a spatial analog of multitaper
spectral estimation in time-domain, which is the prin-
cipal methodology we employ to perform neural sig-
nal processing. Our goal is to provide neuroscientists
with a sophisticated open-source toolbox for reliable
source localization of neural activity.
Researchers increasingly believe that gamma-band
synchronization in the human brain fundamentally
involves several functions including visual feature
binding, perceptual and attention stimuli selection,
visuomotor control, working memory, and associative
learning. Figure 1 shows the results of applying the
LBEX technique to MEG data from the laboratory of
Pascal Fries (Radboud University, Nijmegen). The
data are taken from an experiment in which the subject
performs a visual attention task. The figure shown
superimposes the power change in a subject's gamma-
band activity with visual attention, as evaluated by
LBEX, with the subject's structural MRI.
Integrative Analysis of Memory
Formation
P. Mitra, A. Punyani
This is the first project year of the Mitra component of
the Dart Alliance at CSHL. The broad goal of the
Mitra component is integrative data analysis and mod-
eling of memory formation in the fruit fly, spanning
scales including genetic, cellular, and neural systems
as well as behavioral levels. This represents the princi-
pal theoretical modeling component of the alliance.
The work so far has been in two areas. The first of
these involves microarray data analysis, and the sec-
ond involves theoretical studies relating to experimen-
tal design for a project being carried out by another
member of the Dart Alliance (Josh Dubnau). The goal
of the selection study (Dubnau and Altick) is to breed
flies with better performance on an odor memory task
while allowing combinatorial changes to take place in
multiple loci simultaneously. This will help elucidate
the network of genes that underlie the function being
studied. The study poses numerous theoretical ques-
tions, including those of efficient experimental design,
which we are pursuing actively.
FIGURE 1 Localization of gamma-band activity in a visual attention task using the LBEX technique.
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EXPERIENCE-DEPENDENT PLASTICITY OF SYNAPSES AND
SYNAPTIC CIRCUITS
K. Svoboda B. Burbach A. Holtmaat
I. Bureau A. Karpova
V. De Paola T. O'Connor
N. Gray L. Petreanu
C. Harvey T. Sato
V. Scheuss L. Wilbrecht
G. Shepherd R. Yasuda
A. Sobczyk C. Zhang
G. Tervo H. Zhong
R. Weimer K. Zito
The functional properties of the brain change in
response to salient sensory experiences. The nature of
these changes at the level of synapses, neurons, and
their networks, also known as the engram, is unknown.
We are dissecting the mechanisms of experience-depen-
dent plasticity in the developing and adult neocortex.
Neocortical tissue is dauntingly complex: 1 mm3
contains nearly a million neurons, each of which con-
nects to thousands of other neurons. To probe neurons
and synapses within the intact network, we build and
use sensitive tools. Two-photon laser scanning
microscopy (2PLSM) allows us to image single
synapses in intact tissues and to track changes in intra-
cellular calcium and signal transduction events.
Excitation of neuronal elements by focal uncaging of
neurotransmitters allows us to probe the connectivity
of neural networks with high efficiency. We combine
these optical methods with electrophysiological mea-
surements of synaptic currents and potentials and mol-
ecular manipulations of neurons.
We use both in vivo measurements to address sys-
tem level questions and in vitro methods to get at
detailed mechanisms. As a model system, we use the
rodent barrel cortex, where whiskers are represented
in a topographic manner, with information from each
whisker represented by a small cortical region (barrel).
Whisker maps are shaped by experience during devel-
opment and reshaped in the adult. The cellular mech-
anisms underlying sensory map plasticity are likely to
share mechanisms with those underlying learning and
memory in other brain regions and other species.
Function and Plasticity
of Single Synapses
V. Scheuss, A. Sobczyk, K. Zito
Long-term changes in synaptic efficacy are triggered
by NMDA (N-methyl-o-aspartate) receptor-mediated
increases in [Ca"] in the postsynaptic neuron. On the
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basis of 2-photon imaging and 2-photon glutamate
uncaging, we have developed quantitative assays to
measure NMDA-R (receptor) function at single
synapses. Using these techniques, we have found that
NMDA-Rs undergo a novel form of activity-dependent
plasticity involved with changes in ion selectivity. We
are also measuring the time course with which new
synapses acquire different types of glutamate receptors.
[Ca2+] Dependent Signaling in Single
Dendritic Spines
C. Harvey, R. Yasuda, H. Zhong
Postsynaptic Ca" activates diverse Ca"-dependent
signal transduction mechanisms. We have designed
high-sensitivity fluorescence resonance energy trans-
fer (FRET) sensors for Ras and MAPK activation and
cAMP levels. Fluorescence lifetime imaging
microscopy (FLIM) allows us to image the Ca"-
dependent signal transduction cascades activated by
synaptic transmission in dendrites and spines. We can
for the first time study the biochemical dynamics of
Ca"-dependent Ras signaling in neuronal microcom-
partments. For example, we find that Ras acts as a
Ca2tdependent switch and that activation of single
synapses can lead to local activation of Ras. Ras acti-
vation is required for spine growth.
Experience-dependent Plasticity
in the Adult Cortex In Vivo
V. DePaola, A. Holtmaat, L. Wilbrecht [in collaboration
with G. Knott, Lausanne]
Sensory representations in the adult brain are stable,
yet we are able to learn. To understand the underpin-
nings of stability and plasticity, we image structural
dynamics in vivo. We find that the large-scale arboriza-
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FIGURE 1 Stability of PSD-95 clusters in the intact mouse neo-
cortex. A sparse subpopulation of layer 2/3 neurons expressed
a red cytoplasmic protein (mCherryl) and PSD-95 fused to a
green fluorescent protein (GFP). (Left) Overview of a dendritic
branch; (right) time-lapse imaging of a region of interest (white
box in the left image; ages are indicated in the panels). Note the
stable relative sizes of the bright spots indicating stable relative
synapse sizes (N. Gray, R. Weimer, K. Svoboda).
tion of axons and dendrites is stable, but that neurons
display a rich repertoire of micrometer-level structural
plasticity of dendritic spines, axonal terminals, and
axonal branch tips. Experience-dependent changes in
spines and boutons are cell-type specific. By combin-
ing in vivo imaging with retrospective serial section
electron microscopy, we have found that new spines
grow to make synapses and that they preferentially
grow toward existing boutons in the neuropil.
Mechanisms of Synapse
Stability In Vivo
N. Gray, R. Weimer
We have recently turned our attention to synapse sta-
bility. Many synapses persist for months, perhaps the
entire life of the animal, and also maintain their size.
This is remarkable because synapses are tiny struc-
tures composed of just a handful of proteins of a given
type. Protein lifetimes are on the order of days. To
study the underpinnings of synapse stability, we have
developed methods to measure the trafficking of
synaptic proteins at the level of individual synapses in
vivo. We find that the major scaffolding protein PSD-
95 unbinds from synapses over tens of minutes and
exchanges with proteins in neighboring synapses (Fig.
1). Larger synapses scavenge diffusing PSD-95 more
efficiently and also hold on to PSD-95 longer. The
interactions between synapses and their proteins are
thus tuned to maintain the synaptic status quo against
dissipation by diffusion.
Circuit Mechanisms of
Cortical Plasticity and
Dysfunction
G. Shepherd, I. Bureau, A. Karpova, L. Petreanu [in collabora-
tion with M. Chklovskii, Cold Spring Harbor Laboratory]
The wiring diagram is fundamental to understanding
cortical function and plasticity. However, little quanti-
tative information about functional circuits is avail-
able. What are the sources of input to a neuronal sub-
type in a particular layer and column and what are
their relative strengths? Which connections change
with novel sensory experience?
We have developed laser-scanning photostimula-
tion (LSPS) into a quantitative and rapid tool for cir-
cuit analysis. In brain slices, we mapped the excitato-
ry circuits impinging onto L2/3 and L5B neurons. To
determine if morphology can predict functional cir-
cuits between excitatory neurons, we directly com-
pared functional LSPS maps with "geometric circuits"
computed from quantitative reconstructions of axons
and dendrites. Functional connections were accurately
predicted by geometry within a particular projection
(with interesting exceptions), but the ratio of function-
al to geometric connectivity differed greatly ( >20-
fold) between projections. This finding implies new
forms of specificities in cortical circuits.
We performed an unbiased search for experience-
dependent synaptic pathways impinging onto two
types of L5B pyramidal cells: regular spiking and
intrinsically bursting. Experience-dependent changes
in excitatory L2/3->L5B synapses were cell-type spe-
cific. Whereas regular-spiking neurons lost input from
their home column in an experience-dependent man-
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ner, intrinsically bursting cells gained input from sur-
round columns.
We have used LSPS to explore the circuit and
defects in animal models of fragile-X mental retarda-
tion. We found specific defects in the function and
plasticity of excitatory L4-->L2/3 synapses.
Microorganization of the
Sensory Cortex
T Sato
We are using 2-photon microscopy combined with
Ca' imaging to measure the activity in neuronal pop-
ulations in the intact neocortex. Neurons are labeled
with a membrane-permeable synthetic Ca' indicator.
Ca' transients evoked by action potentials can be
detected as sawtooth-shaped fluorescence changes.
We have developed algorithms to detect and count
individual spikes based on Ca" imaging. Our tech-
niques allow us to study the firing of populations of
neurons with well-defined spatial relationships. We
are using these tools to learn about the microorganiza-
tion of cortical maps in the somatosensory cortex and
how this organization is shaped by changes in sensory
experience.
Molecular Methods to Reversibly
Inactivate Synapses In Vivo
G. Tervo, A. Karpova, N. Gray, B. Burbach
Inducible and reversible silencing of selected neurons
in vivo is critical to understanding the structure and
dynamics of brain circuits. We have developed mole-
cules for inactivation of synaptic transmission
(MISTs) that can be genetically targeted to allow the
reversible inactivation of neurotransmitter release.
MISTs consist of modified presynaptic proteins that
interfere with the synaptic vesicle cycle when cross-
linked by small-molecule "dimerizers." MISTs based
on the vesicle proteins VAMP2/synaptobrevin and
synaptophysin induced rapid (-10 min) and reversible
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block of synaptic transmission in cultured neurons and
brain slices. In transgenic mice expressing MISTs in
Purkinje neurons, administration of dimerizer reduced
learning and performance of the rotarod behavior.
MISTs allow for specific, inducible, and reversible
lesions in neuronal circuits and may provide treatment
of disorders associated with neuronal hyperactivity.
We are now constructing knock-in mice expressing
MISTs in specific neuronal populations.
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NEUROGENETICS OF MEMORY IN DROSOPHILA
T. Tully J. Barditch J. Luo
F. Bolduc M. Regulski
L. Grady N. Sinha
J. Kui S. Xia
D. Leong
Studies on Pavlovian learning in many animals have
revealed remarkably similar behavioral properties of
associative learning. Surprisingly, Pavlovian learning in
fruit flies also displays these behavioral properties, sug-
gesting a common underlying mechanism. Neural
architecture of the Drosophila brain bears no resem-
blance to mammalian brains, of course, which suggests
that the behavioral "homology of function" must result
from conserved cellular/molecular mechanisms.
Consistent with this view, several genes and genetic
pathways have been identified to function in both ver-
tebrate and invertebrate-associative learning, including
NMDA (N-methyl-p-aspartate) receptors, cAMP sig-
naling, CREB-dependent gene transcription, and
staufen-mediated local regulation of protein translation.
We have recently investigated the relationship of
associative learning (plasticity) to olfactory discrimi-
nation. We have designed three novels assays, which
nevertheless are based on the original choice behavior
of our standard T maze. These assays are designed to
distinguish behavioral responses to odor identity from
behavioral responses to odor intensity. In addition,
these responses can be assessed in naïve or trained
(Pavlovian olfactory conditioning) flies. Our results
reveal a genetic dissection of G-protein-mediated sig-
naling pathways between odor identity and odor inten-
sity in mushroom bodies. More interestingly, our data
suggest that associative mechanisms induced by con-
ditioned discrimination between two odors, in fact,
occur via changes in the perception of odor intensity,
rather than odor identity, as has been widely assumed
by learning theorists. Consistent with this view, condi-
tioned discrimination between two different odors dis-
appears as odor concentrations are increased to satu-
rating levels (Fig. 1).
MUTANTS AND MICROARRAYS
We continue work derived from earlier experiments on
regulated gene expression induced during memory
formation. To date, we have confirmed 59 of 170 can-
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FIGURE 1 Odor discrimination learning fails as odor concen-
trations increase. (a) Conditioned discrimination between two
odors (methycyclohexanol [MCH] and benzaldehyde [BA])
declines to zero as odor concentrations increase to saturating
levels. (b) When given a choice between each of these odors
and air, in contrast, odor avoidance responses increase as odor
concentrations increase, demonstrating the flies' ability smell
each odor.
didate memory genes (CMGs). Our goal is to confirm
in vivo that these CMGs are involved in adult memo-
ry formation. Using RNA interference or other domi-
nant-negative transgenic constructs, we have obtained
in vivo validation for three genes, including dNR1.
CIRCUITS AND PHASES
We continue spatiotemporal experiments, which
reveal where in the adult brain CREB-dependent
memory formation occurs. To date, we have deter-
mined that the upstream activation sequence (UAS)-
driven expression of a CREB-repressor transgene,
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using several different mushroom body GAL4 drivers
does NOT block long-term memory (LTM) formation.
Conversely, we have identified several enhancer-
GAL4 drivers expressing UAS-CREB-r in other brain
regions that do block spaced training-specific 1-day
memory (LTM). We currently are attempting to under-
stand the circuitry in common among these various
GAL4 drivers.
We have established a reliable new method to cell-
sort green fluorescent protein (GFP)-expressing neu-
rons from dissociated adult brains. To maximize the
protocol, we expressed GFP in mushroom bodies and
sorted dissociated cells into GFP' versus GFP- subsets.
With these conditions, QPCR (quantitative polymerase
chain reaction) reveals (1) preferential expression in
mushroom bodies of fasll and rutabaga and (2) no
preferental expression in mushroom bodies of
dCREB2 and Adfl. These observations are consistent
with published immunohistochemical observations.
GENETIC MODELS OF DISEASE
In vertebrate systems, STAUFEN is known to associ-
ate with Fragile-X protein (FMRP) in neural granules.
On the basis of this observation, we have begun to
study the fly homolog of FMRP. To date, we have
shown that FMR1 mutants are defective in olfactory
learning and that this learning deficit can be rescued
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by transgenic expression of a genomic construct. We
continue to evaluate an acute role for FMR1 in mem-
ory formation.
We are overexpressing human a-synuclein in
dopaminergic cells as a fly model of Parkinson's dis-
ease. Interestingly, we have shown that tyrosine hydrox-
ylase (TH) immunostaining disappears in an age-related
manner, before dopaminergic neurons die. This observa-
tion supports our ongoing microarray experiments to
identify cc-synuclein-induced changes in genome regu-
lation that may underlie neurodegeneration.
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NEURAL SUBSTRATE OF SELECTIVE AUDITORY ATTENTION IN
THE CORTEX
A. Zador H. Asari S. Lima L.-H. Tai
M. DeWeese G. Otazu M. Wehr
T. Hromadka H. Oviedo Y. Yang
E. Kramer S. Rumpel
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our
goal is to understand this computation at the synaptic,
cellular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one
voice at a cocktail party, and tune out the others-a
task that remains beyond the capacity of modern
computers-we are engaging in a form of selective
auditory attention. Our ability to attend selectively is
not limited to the auditory domain: Analogous tasks
demand selective attention in the visual and even
somatosensory domains. In monkeys, visual atten-
tion selectively enhances neural activity even in the
earliest stages of visual cortical processing. This
enhancement is surprising because the areas associ-
ated with these first stages of visual processing have
traditionally been thought of as representing the sen-
sory world faithfully, in a way that depends only on
the properties of the sensory input itself. The discov-
ery of attentional modulation overturns the notion
that the peripheral sensory cortex is a passive "TV
screen" available for viewing by a "homunculus"
buried deep within the cortex.
The specific projects in our laboratory fall into two
main categories. First, we are interested in how neu-
rons represent auditory stimuli, and how these repre-
sentations are computed from the cochlear inputs half
a dozen synapses away. To address these questions, we
are using electrophysiological and imaging approach-
es in anesthetized rats, as well as also computational
approaches to characterize the properties of natural
sounds. Second, we are interested in how these repre-
sentations are modified dynamically-within seconds
to hours or longer-in awake behaving rats by atten-
tion and other forms of learning.
Variability of Coding in the
Auditory Cortex
M. DeWeese
Computers rely on extremely precise, low-noise com-
ponents to compute, whereas the components that
make up neural circuits appear to be very noisy.
Nevertheless, brains outperform computers on the
kinds of hard computational problems required for sur-
vival in the real world. To understand how brains com-
pute in the presence of such high levels of apparent
noise, we are characterizing the sources of variability
(i.e., noise) in single neurons. Using in vivo whole-cell
patch-clamp recording techniques, we are examining
the trial-to-trial variability of the postsynaptic potential
(PSP) elicited by brief tone pips. In some neurons, trial-
to-trial variability in the PSP is small, consistent with
"private" sources limited to only the neuron under
study; however, for other neurons, "shared" sources of
variability produce circuit-wide fluctuations in the
synaptic drive to the neuron and its neighbors, greatly
increasing the apparent noise in the PSP. These stimu-
lus-independent correlations could provide a substrate
for feedback underlying cognitive processes, such as
attention and motivation. (DeWeese et al. 2005).
Sparse Synchronous Inputs
Drive Neurons in the
Auditory Cortex In Vivo
M. DeWeese, T. Hromadka
Cortical neurons receive most of their synaptic drive
from other cortical neurons. This fact imposes a strong
constraint on models of cortical activity: The dynam-
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ics of one neuron's spiking output must be consistent
with the ensemble activity of the population of neu-
rons that synapse onto it. The usual solution to this
self-consistency constraint posits that both excitatory
and inhibitory neurons fire asynchronously, varying
their rates only slowly. According to this model, sub-
threshold fluctuations in membrane potential should
be well described by a random walk. However, on the
basis of our experiments using the in vivo whole-cell
patch-clamp technique, we have developed an alter-
nate model in which inputs are organized into syn-
chronous volleys. According to this model, subthresh-
old fluctuations should be small most of the time,
punctuated by large excursions corresponding to the
arrival of volleys. Our results show that activity is
organized into synchronous volleys superimposed on
a relatively quiet background. This observation has
implications for coding and computation. In particu-
lar, the correlations we have found among the synap-
tic population are precisely what is required for
sparsely encoded signals to successfully propagate
from one stage of cortical processing to the next.
Separation of Sound Sources
by Awake Behaving Animals
G. Otazu, L.-H. Tai
Sounds in the natural world rarely occur in isolation,
but rather as part of a mixture. To survive, the auditory
system must be able to attend selectively to one sound
source and ignore others, and it does so more effective-
ly than any artificial system yet devised. To understand
how this is performed, we are using multielectrode
recording (tetrode) technology to monitor the activity
of many neurons simultaneously in awake, behaving
rodents performing an auditory discrimination task.
Synaptic Mechanism Underlying
Tone-Shock Learning
S. Rumpel [in collaboration with R. Malinow, Cold Spring
Harbor Laboratory]
Does learning change the strength of neuronal connec-
tions in the brain? Insertion of new postsynaptic
amino-3-hydroxy-5-methy1-3-isoazole (AMPA) recep-
tors (AMPA-Rs) has been identified as a major process
leading to increased synaptic strength. However, these
results have been obtained primarily in cultured neu-
rons, and the relationship of these processes to learning
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in the intact animal has remained unclear. To elucidate
molecular, cellular, and circuit changes that occur in the
brain during learning, we investigated the role of a glu-
tamate receptor subtype in fear conditioning. In this
form of learning, animals associate two stimuli, such as
a tone and a shock. We have found that fear condition-
ing drives AMPA-type glutamate receptors into the
postsynapse of a large fraction of neurons in the lateral
amygdala, a brain structure essential for this learning
process. Furthermore, memory was reduced if AMPA-
R synaptic incorporation was blocked in as few as
10-20% of lateral amygdala neurons. Thus, the encod-
ing of memories in the lateral amygdala is mediated by
AMPA-R trafficking, is widely distributed, and displays
little redundancy. We are currently extending these
results to the auditory cortex (Rumpel et al. 2005).
Synaptic Mechanisms of Forward
Masking in Rat Auditory Cortex
M. Weir
In the auditory cortex, brief sounds elicit a powerful
suppression of responsiveness known as forward
masking. Forward masking has usually been attributed
to inhibition. We are using
whole-cell recordings in vivo to assess the role of
synaptic inhibition to forward masking in the auditory
cortex. We are measuring the excitatory and inhibito-
ry synaptic conductances elicited by brief sounds pre-
sented at intervals from tens to hundreds of millisec-
onds. We find that inhibitory conductances rarely last
longer than 50-100 msec, whereas spike responses
and synaptic inputs remain suppressed for hundreds of
milliseconds, indicating that at these longer intervals,
mechanisms other than inhibition dominate. We con-
clude that postsynaptic inhibition contributes to for-
ward masking for only the first 50-100 msec after a
stimulus and that long-lasting suppression in cortical
cells is instead due to other mechanisms such as
synaptic depression (Wehr and Zador 2005).
Sparse Representations for
the Cocktail Party Problem
H. Asari [in collaboration with B. Pearlmutter, Cold Spring
Harbor Laboratory]
To extract the behaviorally relevant information imbed-
ded in natural acoustic environments, animals must be
able to separate the auditory streams that originate
from distinct acoustic sources (the "cocktail party
problem"). The auditory cortex has several orders of
magnitude more neurons than does the cochlea, so that
many different patterns of cortical activities may faith-
fully represent any given pattern of cochlear activity.
We have been exploring the hypothesis that the cortex
exploits this excess "representational bandwidth" by
selecting the sparsest representation within an over-
complete set of features. We have constructed a model
showing how sparseness can be used to separate
sources perceived monaurally. The model makes
testable predictions about the dynamic nature of repre-
sentations in the auditory cortex. Our results support
the idea that sparse representations may underlie effi-
cient computations in the auditory cortex.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong H.-C. Chiang K. lijima
I. Hakker A. Mamiya
F. Hannan M. Pagani
I. Ho Y. Wang
We are interested in the neural basis of learning and
memory and are taking an approach of combining
functional analyses with genetic manipulation in the
study of Drosophila. Currently, we are pursuing two
major projects. First, we are establishing Drosophila
models for studying genes involved in human neu-
rodisorders that impair learning and memory. In par-
ticular, we are interested in genes known to contribute
to neurofibromatosis 1 (Nfl) and Alzheimer's disease.
Nfl patients are identified by neurofibromas and other
symptoms including learning defects. We have shown
that different fragments of NF1 are involved in regula-
tion of different signal transduction pathways and have
distinct roles in mediating formation of short-term
memory versus long-term memory (LTM). For
Alzheimer's disease, we have shown that overexpres-
sion of AP peptides in Drosophila is able to recapitu-
late many aspects of clinical manifestations, including
age-dependent learning defects, late onset of neurode-
generation, and cumulation of AP deposits. We are
now attempting to understand the molecular basis for
AP toxicity. Second, we are making efforts in an
attempt to visualize memory traces in the mushroom
body, a brain structure critical for insect learning and
memory through calcium imaging in the living fly
brain. The specific projects are described below.
NF1 Is Involved in Learning
and Memory Processes
I.S. Ho, F. Hannan, I. Hakkar, M. Pagani
NF1 is a dominant genetic disorder that affects 1 in
3500 individuals. Besides the predisposition to malig-
nant and benign tumors of the nervous system, 40% of
the afflicted children have learning defects. Studies
with Nfl `/- mice have shown that they exhibit deficit in
the Morris water maze paradigm that can be rescued by
lowering Ras dosage either genetically or pharmacolog-
ically. On the other hand, our lab reported that in the
Drosophila system, NF1 null mutants showed olfactory
learning defects, which can be remedied by overex-
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pressing a constitutively active form of protein kinase A
(PKA). An in-depth study of the Morris water maze
paradigm indicated that the training protocol employed
induced a form of memory that is protein-synthesis
dependent (LTM). We hypothesized that the NF1 pro-
tein may be involved in different phases of learning and
memory. By expressing fragments of the NF1 human
transgene, as well as point mutations found in patients,
to rescue learning and memory defects in NF1 null
mutant flies, we found that NF1-GRD is necessary and
sufficient to confer its functionality in protein-synthe-
sis-dependent memory. In addition, our data from olfac-
tory learning suggest that sequences in the carboxy-ter-
minal region are able to rescue NF 1 's learning defects.
In conclusion, we dissected the NF1 protein into
regions of distinct functionality in the processes of the
Pavlovian olfactory conditioning paradigm: The
GTPase-activating protein (GAP)-related domain
(GRD) is required for LTM, whereas the sequences in
the carboxy-terminal region are essential for learning.
These results suggest that NF1-dependent learning and
memory processes are dependent on separate pathways.
A Drosophila Model of Alzheimer's
Disease
K. lijima, I. Hakker, H.-C. Chiang
Alzheimer's disease (AD) is a progressive neurode-
generative disorder characterized clinically by memo-
ry impairments followed by global cognitive deficits.
AD is defined by pathological changes in the brain,
including neuronal loss, the formation of neurofibril-
lary tangles (NFTs), and senile plaques (SPs). AD is
the most common senile dementia, and the number of
AD patients is increasing as the world population
ages. To date, there is no effective therapy for AD.
AP42 is a major component of SPs and is derived
from P-amyloid precursor protein (APP) by sequential
cleavage of P-site APP-cleaving enzyme (BACE) and y-
secretase complex including presenilin 1 or 2. More
than 95% of AD cases are late-onset AD (LOAD) with-
out obvious familial segregation; however, there is a
rare early-onset familial AD (EOFAD) with onset
before age 65. To date, more than 160 mutations are
found in three genes: APP, presenilinl (PSEN1), and
presenilin2 (PSEN2). All of these mutations enhance
either production or aggregarion of A1342 and accelerate
its accumulation in the brain. Since there is no apparent
difference in clinical and pathological phenotypes
between LOAD and EOFAD, the accumulation ofA1342
in the brain during aging has been widely accepted as
the causative event in AD pathogenesis. Extensive
research efforts have been targeted on A1342 to develop
mechanism-based AD therapy. However, little is known
about the molecular mechanisms underling memory
defects and neurodegeneration caused by A1342.
We use the fruit fly, Drosophila, as a model organ-
ism to study Af342 toxicity in vivo. In addition to the
state-of-the-art genetic tools, a number of behavioral
tasks such as learning and memory enable us to mon-
itor disease progression during aging. We have
demonstrated for the first time that the transgenic
Drosophila-expressing human AP42 can faithfully
reproduce AD-like phenotypes, including adult onset,
progressive Af342 amyloidosis, olfactory memory
defects, and severe neuronal loss. This fly model is
especially unique in terms of its extensive cell death,
which is observed in AD patients but rarely seen in
existing mouse AD models. Our results strongly sup-
port the idea that excessive accumulation of A1342 is
sufficient to cause memory defects and neuronal cell
death and suggests that the molecular basis underlying
the A, toxicity can be conserved in a fruit fly.
To study the structure-toxicity relationship of A1342
in vivo, we have established several new transgenic
flies expressing mutated A1342 with different aggrega-
tion/accumulation properties in the brain. Our fly
model of AD will help us to understand the molecular
and cellular mechanisms underlying memory defects
and neurodegeneration induced by A1542.
Imaging of Learning and Memory-
associated Changes in the Mushroom
Body in Adult Drosophila Brain
Y. Wang, A. Mamiya
The Drosophila mushroom body is a higher-order brain
center that is crucial for olfactory learning and memo-
ry. It is a symmetrical structure, consisting of about
2500 intrinsic neurons in each brain hemisphere. There
are three types of morphologically distinct mushroom
body intrinsic neurons, also called Kenyon cells (KCs),
in which axons are bundled separately into respective
ot/13, a'/I3', and y lobes. The development of the KCs
follows a sequential order. Neurons that give rise to the
y lobe are born first, before the mid-third-instar larval
stage, followed by those giving rise to cc711' lobes,
which are born between the mid-third-instar larval stage
and puparium formation. Neurons that give rise to the
a/13 lobes are born last, after the puparium formation.
Studies have shown that the y lobe is required for
short-term memory. The c/a" lobes are suggested to be
involved in long-term memory. However, how their
involvement in learning and memory is manifested at the
neuronal activity level is unclear. To address this ques-
tion, we imaged neuronal activities in the mushroom
body lobes with a genetically engineered calcium sensor
after the flies were trained in a T maze where they learned
to avoid an odor that is paired with electric shock to the
feet. The rise in intracellular calcium is an indication of
the activation of neurons. We found that activities in the
cC/13' lobes in response to the shocked odor were much
enhanced compared to an odor that was not paired with
electric shock. However, little activities were observed in
the y lobe. One possibility for the lack of response in the
y lobe is that the calcium change in activated neurons is
below the detection threshold of the calcium sensor.
Nevertheless, this finding is further confirmed
with an isolated brain prep in which the olfactory T-
maze training was mimicked by paired electrical stim-
ulation of the antennal nerve (AN) and ventral nerve
cord (VNC). Stimulation of the AN or VNC alone
evoked activities in mushroom body lobes. A single
pairing session of stimulation of the AN and VNC that
mimicked a single olfactory training in behavioral
studies resulted in enhanced activities in the a'/13'
lobes in response to subsequent AN stimulation. The
enhancement lasted up to 90 minutes in the 13' lobe
while much longer in the a" lobe. Unpaired stimula-
tion of the AN and VNC did not induce any activity
changes in the lobes in response to AN stimulation.
We are currently assessing whether the enhancement
of ot713' activities can be correlated with memory
phases revealed in behavioral studies.
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PLANT GENETICS
To casual observers, the astounding variety of the shapes, colors, and forms of plants lend great aesthetic
beauty. But all of these traits-including those of tremendous agricultural significance-have been shaped
by evolution or by human selection. Uncovering the molecular processes that govern how plants grow and
develop is thus of fundamental biological interest and importance.
For example, the specialized shapes of leaves have a vital role throughout plant biology. Moreover, with-
in each leaf, the functions of the upper and lower surfaces are very different. Marja Timmermans's work is
focused in part on understanding how unspecialized stem cells create this dorsoventral (upper/lower) axis
of leaves. Her group has identified two genes, Leafbladeless1 (LbI1) and Rolled leaf1 (R1d1), that are
essential for controlling this process. This year Timmermans discovered that these genes are in turn con-
trolled by the opposing action of two particular microRNAs. One significant aspect of these findings is
that-like classical protein "morphogen gradients"-microRNAs can act as diffusible developmental sig-
nals that move through tissues and thereby control stem cell specialization.
Part of Rob Martienssen's recent work has also explored the role of microRNAs in plant development.
In addition, this year, his group solved a century-old genetic puzzle concerning how the RAMOSA1 gene
controls the architecture of corn and other major cereal crops. The study also revealed telling information
about the domestication of corn from its primitive ancestor.
Unlike developing animal embryos, plant embryos begin to differentiate dramatically from the very first
cell division. This initial unequal cell division seals the fate of all subsequent tissue specializations in the
developing embryo. Wolfgang Lukowitz studies the molecular steps that regulate this unequal cell division
and its impact on later developmental events. His group has identified three proteins that are likely to form
a signaling pathway that controls the earliest steps in plant embryonic development.
David Jackson and his colleagues have isolated a new gene involved in regulating branching in corn
called RAMOSA3. They found that the gene encodes an enzyme that modifies the simple sugar trehalose.
The discovery reveals a previously unknown role in plant development for this ubiquitous sugar. In other
work, Jackson's group made significant progress in characterizing the structure and function of the tiny
channels that link plant cells (called plasmodesmata) and which permit the long-range movement of pro-
teins, RNAs, and plant viruses from cell to cell. By using a novel genetic screen to dissect the function of
these channels, the researchers discovered the first known protein segment that is necessary and suffi-
cient for cell-to-cell transport of molecular cargo through plasmodesmata. Finally, Jackson and his col-
leagues identified new clues about stem cell proliferation in plants (through their characterization of the
thick tassel dwarf mutant) and "phyllotaxy" or the geometric arrangement of leaves (through their studies
of the ABPHYL1 gene).
150
CELL-FATE DECISIONS IN THE EARLY PLANT EMBRYO
W. Lukowitz M. Bayer J. Nemiroff
E. Glushenkova S. Peters
S. Kotkin K. Wetmore
T Nawy J. Williams
In most plants, the early stages of embryogenesis fol-
low a predictable sequence of cell divisions and cell-
shape changes reflecting the coordinated fate deci-
sions that lay down the reference points of the body
plan. Our goal is to identify and understand the genet-
ic network regulating this process. We are working
with the small weed Arabidopsis, an inexpensive
experimental model with very good comparability to
economically important species.
A MAP Kinase Pathway Promoting
Extraembryonic Fate
W. Lukowitz, M. Bayer, J. Williams
Plant development begins with an asymmetric division
of the zygote. This division results in a fundamental
fate decision that sets the stage for all subsequent pat-
terning events: The small apical daughter cell will pro-
duce the embryo, whereas the large basal daughter cell
will mainly form the extraembryonic suspensor. We
are working to elucidate a signaling pathway that pro-
motes suspensor fate in the basal cells.
The first component of this pathway to be identi-
fied was the MAPKK kinase gene YDA. Loss of YDA
activity essentially eliminates formation of the
extraembryonic suspensor, whereas hyperactive vari-
ants of YDA suppress formation of the embryo often to
the extent that all daughters of the zygote appear sus-
pensor-like. On the basis of these findings, we have
proposed that the YDA MAP kinase cascade acts as a
molecular switch that promotes extraembryonic or
suspensor fate.
Recent unpublished results from the labs of J.
Walker and S. Zhang (University of Columbia,
Missouri) have identified a pair of MAP kinase genes:
MPK3 and MPK6, that act downstream from YDA in
postembryonic development. In collaboration, we
have confirmed that the same two MAP kinases also
function in the embryo. The MAPK kinase genes of
the YDA cascade have not yet been found. We are tak-
ing a systematic approach and are expressing hyperac-
tive versions of all ten Arabidopsis MAPK kinase
genes in the yda-deficient background to determine
which ones can suppress the phenotype of mutant
embryos.
Last year, we initiated the analysis of two other
genes that encode key components of the YDA path-
way, SSP and GRD. Both genes were originally identi-
fied in mutant screens: Mutations in SSP and GRD
affect suspensor development in a similar way as loss
of YDA. Double mutants of yda with ssp or grd do not
have a more severe phenotype than yda single
mutants. Furthermore, hyperactive versions of YDA
can suppress the phenotype associated with ssp muta-
tions, but have little effect on the phenotype associat-
ed with grd mutations. The simplest explanation for
these observations is that SSP acts upstream of YDA,
whereas GRD acts downstream from YDA.
The GRD gene encodes a RWP-RK protein. RWP-
RK proteins constitute a small family of putative tran-
scription factors that have only been found in green
algae and higher plants. The first RWP-RK gene
described in the literature was minus dominance (mid)
from the unicellular alga Chlamydomonas. The mid
gene dominantly determines the mating type of
gametes. It is present in mating -type cells, but absent in
mating-type cells. Introduction of mid into mating-
type cells is sufficient to make them differentiate as
minus gametes. The second RWP-RK gene reported
was nodule inception (nin) from the legume Lotus
japonicus. The nin gene regulates a developmental fate
decision triggered by the environment, namely, the
symbiotic interaction between Lotus roots and Meso-
rhizobium bacteria that results in the formation of nitro-
gen-fixing nodules. One of the first steps in nodule
formation involves signaling from the bacteria to the
roots via a secreted lipochitosaccharide, termed Nod
factor. The nin gene is thought to act downstream from
the cell surface receptors for Nod factor to promote for-
mation of infection threads and inception of nodules.
Interestingly, the GRD gene product contains two
predicted MAP kinase phosphorylation sites, one of
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which has a high score with different prediction algo-
rithms and is conserved in the rice homolog of GRD.
We have constructed variants of GRD in which one or
both of these sites have been mutated such that they
cannot be phosphorylated any more or such that they
are mimicking the effects of constitutive phosphoryla-
tion. These variants will be functionally tested in
mutant plants. If the predicted phosphorylation sites
are required for normal GRD function in plants, we
will investigate in vitro whether they are indeed mod-
ified by the YDA MAP kinase cascade.
SSP encodes a member of the receptor-like protein
kinase family. In animals, these proteins operate in
association with cell surface receptors, such as the
Interferon-1 receptor complex. We have found that
SSP protein is myristoylated at its amino terminus and
that this modification effectively anchors the protein
in the plasma membrane (Fig. 1). Myristoylation of
SSP is essential for normal function: Mutation of the
modified glycine residue causes mislocalization of the
SSP protein to the cytoplasm where it remains inac-
tive. Although SSP has been classified as a protein
kinase, a key residue of the catalytic domain is miss-
ing and variants of SSP that harbor transition-state
mutations in the ATP-binding pocket fully comple-
A
FIGURE 1 Localization of the Arabidopsis SSP protein. (A) SSP
protein is anchored in the plasma membrane by the posttrans-
lational addition of a myristoyl residue to its amino terminus. (8)
Variants of SSP that cannot be modified are mislocalized to the
cytoplasm and the nucleus (star) where they cannot function.
The images show SSP protein that has been tagged with yel-
low fluorescent protein inserted between the myristoylation
motif and the kinase domain. This fusion protein complements
the phenotype of mutant embryos when expressed in plants.
For the localization study, the fusion protein was transiently
overexpressed in onion epidermal cells.
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ment the phenotype of mutant embryos. This would
suggest that SSP is a dead kinase. On the other hand,
a small carboxy-terminal TRP domain of SSP that
likely mediates protein-protein interactions is
absolutely essential for normal function. Even dele-
tions of a few amino acids create completely inactive
variants. Taken together, our findings suggest that SSP
functions as an adapter protein at the plasma mem-
brane, perhaps as part of a receptor complex or as a
link between a receptor complex and the YDA MAP
kinase cascade.
Our work so far can be summarized in a tentative
outline of the signaling pathway regulating extraem-
bryonic cell fate in Arabidopsis. At the center of the
proposed pathway is the YDA MAP kinase cascade.
This cascade appears to operate downstream from an
as yet unknown cell surface receptor that is most like-
ly triggered by an extracellular stimulus. The receptor-
like cytoplasmic kinase SSP may form part of the
receptor complex or act downstream from the receptor
complex to activate YDA. Targets of the YDA MAP
kinase cascade would include the transcription factors
that execute suspensor-specific developmental pro-
grams, such as GRD.
We hope that a more complete analysis of the mol-
ecules involved in the YDA signal transduction path-
way will eventually allow us to understand important
aspects about the logic behind early plant develop-
ment. For example, what is the nature of the signal that
triggers the pathway, and where does it originate (per-
haps in the endosperm surrounding the zygote or the
maternal tissue of the seed coat)? How is down-regu-
lation of the pathway in the apical cell and its daugh-
ters tied into the asymmetric division of the zygote?
Role of the YDA MAPKK Kinase
Gene in Maintaining the Stem
Cell Population of the Shoot
Apical Meristem
W. Lukowitz, E. Glushenkova, S. Kotkin fin collaboration
with G.V. Reddy and E.M. Meyerowitz, California
Institute of Technology)
Plant growth is dependent on the continuous produc-
tion of new organs, such as leaves, flowers, or lateral
shoots. All of these organs are initiated by the apical
meristems, a group of cells at the tip of the shoots. The
apical meristems contain a small population of stem
cells that are the ultimate progenitors of all organs.
The size of this stem cell population is regulated by a
feedback loop between the stem cells themselves and
the cells directly below them, called the organizing
center. Stem cells secrete the small protein CLV3 that
is perceived by a cell surface receptor complex includ-
ing CLV1 and CLV2 and represses transcription of the
homeodomain gene WUS. As a consequence, WUS
mRNA is absent in the stem cells and only found in
the cells of the organizing center (negative branch of
the loop). The organizing center, in turn, provides an
inductive signal required to maintain the stem cells in
an undifferentiated state (positive branch of the loop).
It has been proposed that a MAP kinase cascade medi-
ates transduction of the CLV signal from the cell sur-
face to the nucleus. However, experimental evidence
for this claim is lacking, and no candidate genes have
been reported that might function in such a cascade.
We have observed that seedlings harboring a
hyperactive version of YDA often fail to form true
leaves or do so with a substantial delay compared to
wild type. This finding has prompted us to examine
whether the MAPKK kinase YDA operates in the CLA
signal transduction pathway. The shoot meristem of
seedlings is located between the petioles of the two
embryonic leaves or cotyledons. An analysis with the
scanning electron microscope revealed that hyperac-
tive variants of YDA frequently cause fusion of the
cotyledons and eliminate the shoot meristem.
Consistent with this result, CLV3 expression, which
marks the stem cell population of the meristem, is
undetectable in a large portion of embryos harboring
hyperactive YDA variants (Fig. 2).
In collaboration with Venu Reddy in Elliot
Meyerowitz's lab at Caltech, we are developing the
tools to forcibly induce YDA activity in subsets of cells
within the shoot apical meristem. The effect of these
FIGURE 2 Hyperactive variants of the MAPKK kinase YDA elim-
inate the stem cell population of the shoot meristem. (A) In a
mature wild-type embryo, the stem cells of the shoot meristem
can be visualized with a reporter for CLV3 expression (white dot).
(8) No CLV3 expression is detected in a seedling harboring a
hyperactive variant of YDA, indicating that no stem cells are pre-
sent. In addition, the cotyledons of this seedling appear to be
fused. Images were taken with UV illumination, residual chloro-
phyll fluorescence outlining the embryos shown in gray and
expression of the CLV3::green fluorescent protein reporter in
white. Bar, 100 rim.
manipulations will be followed in live plants by imag-
ing cell divisions and marker gene expression in the
growing meristems. These experiments will enable us
to test specific predictions derived from the premise
that YDA operates in the CLV signaling pathway.
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PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
R. Martienssen R. Carrasquillo D. Irvine
P. Ferreira K. Izzo
D. Garcia A. Kloc
D. Goto Z.B. Lippman
J. Horn B. May
U. Ramu
G. Roche
D. Roh
M. Ronemus
R. Shen
Research in our laboratory concerns transposon silenc-
ing, gene control, and stem cell function in plants, as
well as heterochromatic silencing in yeast, which pro-
vide useful models for higher organisms. In maize, stem
cell function is restricted by the branching genes
ramosal and ramosa2, which have undergone differen-
tial selection during maize evolution and domestication.
Stem cell function and axis formation in Arabidopsis
depends on asymmetric leaves], and on RNA interfer-
ence (RNAi) via spatially restricted microRNA
(miRNA) and trans-acting small interfering RNA (ta-
siRNA). In fission yeast, RNAi of centromeric tran-
scripts regulates histone modification, and we have
found similar transcripts in Arabidopsis, where small
RNA, DNA methylation, and chromatin remodeling reg-
ulate heterochromatin through transposons and repeats.
During the last year, Derek Goto left for a faculty
position in Japan, Bruce May traveled to Vietnam to work
in biotechnology, and Zach Lippman started a postdoc-
toral position in Israel, after graduating from the Watson
School last year. We were joined by postdocs Danielle
Irvine and Keith Slotkin, graduate student Anna Kloc,
and URP Rob Carrasquillo. Paulo Ferreira joined the lab
on sabbatical from the University of Rio de Janeiro.
Architecture of Floral Branch
Systems in Maize and
Related Grasses
E. Vollbrecht, R. Martienssen [in collaboration with
E. Buckler, Cornell University]
The external appearance of flowering plants is deter-
mined by flower-bearing branch systems known as
inflorescences. Inflorescence architecture reflects
meristem number, arrangement, and activity, and the
duration of meristem activity correlates with branch
length. Unlike those of rice and sorghum, the inflores-
cences of maize mostly lack long branches, giving rise
to the tassel and familiar corncob. The maize ramosal
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gene controls inflorescence architecture via expres-
sion in a boundary domain near the nascent meristem
base where it imposes short-branch identity. A second
gene, ramosa2, acts through ramosal by regulating
gene expression levels. We have isolated ramosal and
ramosa2 by transposon tagging, which has enabled
identification of the respective genes. ramosal
encodes a zinc finger transcription factor that is absent
in rice, heterochronically expressed in sorghum, and
strongly selected during maize domestication and evo-
lution. ramosa2 is the maize ortholog of LOB], an
Arabidopsis gene detected by enhancer-trap expres-
sion at lateral organ boundaries. LOB1 expression
depends on ASYMMETRIC LEAVES] (ASI). ramosa2
is also likely to encode a transcription factor, and is
expressed in some of the same cells as ramosal.
Specification of Leaf
Polarity in Arabidopsis
via trans-acting siRNA
D. Garcia, R. Martienssen [in collaboration with M. Byrne,
John Innes Center]
In plants, leaves initiate on the flanks of the shoot api-
cal meristem and subsequently develop distinct proxi-
modistal, dorsoventral (adaxial-abaxial), and mediolat-
eral patterns. The SANT (myb) domain gene PHAN-
TASTICA (PHAN) is required for adaxial fate in the
snapdragon Antirrhinum and in other plants, but the
Arabidopsis ortholog AS1 has milder effects on leaf
shape, suggesting the existence of alternate or redun-
dant regulatory functions. We performed a screen for
enhancers of as] with more elongate and dissected
leaves. These enhancers disrupt an RNA-dependent
RNA polymerase (RDR6), ARGONAUTE7 (AGO7)/
ZIPPY, SUPPRESSOR OF GENE SILENCING3
(SGS3), and DICER-LIKE4 (DCL4), which all regulate
ta-siRNA. Microarray analysis revealed that the AUXIN
RESPONSE FACTOR genes ETTIN (ETT) /ARF3 and
AFIGURE 1 The trans-acting siRNA TAS3 is a polarity gene.
The gene-trap insertion GT19682 is located 37 by upstream
of the transcription start of the TAS3 gene AT3g17185 (A) and
results in GUS reporter gene expression (dark) in the upper, or
adaxial, domain of emerging leaves (B,C). Strong staining is
also observed in the stipules.
ARF4 were up-regulated in ago7, whereas FILAMEN-
TOUS FLOWER (FIL) was up-regulated only in as 1
ago7 double mutants. RDR6 and SGS3 likewise repress
ARF3 and ARF4, which specify abaxial fate. We found
that the trans-acting siRNA gene TAS3, which targets
ARF3 and ARF4, is expressed in the adaxial domain
(Fig. 1) and that ett as 1 ago7 triple mutants resemble
asl. Thus, FIL is down-regulated redundantly by AS1
and by TAS3, acting through ETT, revealing a role for
ta-siRNA in leaf polarity. RDR6 and DCL4 are also
required for systemic silencing, implicating ta-siRNA
as a potentially mobile signal. Interestingly, TAS3 also
matches one of six precursor genes for miR165/166,
which we previously showed was abaxially expressed.
Misexpression of miR166 in TAS3 mutants could con-
tribute to the phenotype in some cells, although
miR166 target genes were still expressed in as 1 ago7
double mutants.
miRNA-targeted and siRNA-mediated
mRNA Degradation Regulated by
Argonaute, Dicer, and RdRP
M. Ronemus, M.W. Vaughn, R.A. Martienssen
ARGONAUTE] of Arabidopsis mediates the cleavage
of miRNA-targeted mRNAs, and it has also been impli-
cated in the posttranscriptional silencing of transgenes
and maintenance of chromatin structure. Mutations in
AGO] severely disrupt plant development, indicating
that miRNA function and possibly other aspects of
RNAi are essential for maintaining normal patterns of
gene expression. Using microarrays, we have found that
1-6% of genes display significant expression changes
in several alleles of agol at multiple time points, with
the majority showing higher levels. Several classes of
known miRNA targets increased markedly in agol,
whereas others showed little or no change. Cleavage of
mRNAs within miRNA homologous sites was reduced
but not abolished in an ago] null background, indicat-
ing that redundant slicer activity exists in Arabidopsis.
siRNA (21-22 nucleotides), as well as larger (30-65
nucleotides) RNA fragments, corresponding to highly
up-regulated miRNA target genes accumulated in wild-
type plants, but not in agol, nor in the RNA-dependent
RNA polymerase mutants rdr2 and rdr6, nor in the
Dicer-like mutants dell and dcl3. Both sense and anti-
sense RNAs corresponding to these miRNA targets
accumulated in the agol and dell backgrounds. These
results indicate that a subset of endogenous mRNA tar-
gets of RNAi may be regulated through a mechanism of
second-strand RNA synthesis and degradation initiated
by or in addition to miRNA-mediated cleavage. siRNAs
(21 nucleotides) corresponding to some targets (TIR1-
like genes) were cleaved in register with the miRNA tar-
get site, resembling trans-acting siRNA.
RNA Polymerase II and the Slicer
Function of Argonaute are
Required for Heterochromatic
Silencing and Spreading
D. Irvine, D. Goto, M. Zaratiegui-Biurrun, D. Roh,
M. Vaughn, R. Martienssen [in collaboration with
L. Joshua-Tor, Cold Spring Harbor Laboratory,
and Y. Murakami, Kyoto, Japan]
In the fission yeast Schizosaccharomyces pombe, the
RNAi machinery converts transcripts from pericen-
tromeric repeats into siRNAs, which are required for
the assembly of pericentromeric heterochromatin. A
mutation in the second largest subunit of RNA poly-
merase II (Rpb2) converts an asparagine residue (con-
served in Arabidopsis) into a tyrosine (conserved in
budding yeast). Both wild-type and mutant Rpb2
localized to the pericentromere, and both were func-
tional, but the mutation resulted in specific distur-
bance of pericentromeric heterochromatin caused by
loss of histone modifications and accumulation of
pericentromeric transcripts, accompanied by the loss
of siRNAs. Thus, Rpb2 couples pericentromeric tran-
scription with siRNA production. siRNA guides chro-
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matin silencing via the Argonaute and RNA-depen-
dent RNA polymerase complexes, and this silencing
presumably depends on base pairing with either RNA
or DNA. We have shown that Argonaute requires the
conserved DDH amino acid motif for heterochromatic
silencing and histone H3 lysine-9 dimethylation
(H3K9me2). Argonaute proteins require this motif for
RNase H activity, which cleaves (or slices) target mes-
sages complementary to siRNA. H3K9me2 spreads
into silent reporter genes when they are embedded
within heterochromatic transcripts. Silencing of these
reporter genes requires readthrough transcription by
polymerase II and processing of these transcripts via
Argonaute. Thus, siRNA appears to impact histone
modification by cleaving heterochromatic RNA.
Two Novel Proteins, Dosi and Dos2,
Interact with Rikl to Regulate
Heterochromatic RNAi and
Histone Modification
D.B. Goto, M. Zaratiegui-Biurrun, R. Martienssen
[in collaboration with W. Zacheus Cande, University
of California, Berkeley]
In fission yeast, the heterochromatin protein 1 homolog
Swi6 recognizes H3K9me2, silences transcription, and
retains cohesin at pericentromeric repeats. The DNA-
damage-binding protein (DDB1) homolog, Rikl, and
histone methyltransferase, Clr4, act in a complex to pro-
mote H3K9me2. We have shown that two novel genes,
dos1+ (clr8') and dos2' (c1r7+), are required for local-
ization of Swi6. Deletion of either of these genes results
in chromosome missegregation, defects in mitotic cen-
tromeric cohesion, meiotic telomere clustering, and loss
of heterochromatic silencing. Dos 1 is predominantly
located in the nucleus in a Dos2-dependent manner and
directly interacts with Rikl. Each of these genes is
required for the association of H3K9me2 with cen-
tromeric repeats, as well as for the production of
siRNA. Rikl has a WD-repeat CPSF domain found in
RNA as well as DNA-binding proteins.
Differential Regulation of Strand-specific
Transcripts from Arabidopsis
Centromeric Satellite Repeats
B. May, Z.B. Lippman, R. Martienssen [in collaboration
with D. Spector, Cold Spring Harbor Laboratory]
Centromeres interact with the spindle apparatus to enable
chromosome disjunction, and typically contain thou-
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sands of tandemly arranged satellite repeats interspersed
with retrotransposons. Although their role has been
obscure, centromeric repeats are epigenetically modified,
and centromere specification has a strong epigenetic
component. In S. pombe, long heterochromatic repeats
are transcribed and contribute to centromere function via
RNAi. In Arabidopsis, as in mammalian cells, cen-
tromeric satellite repeats are short (180 bp), found in
thousands of tandem copies, and they are methylated. We
have found transcripts from both strands of canonical,
bulk Arabidopsis repeats. At least one subfamily of 180 -
bp repeats is transcribed from only one strand and regu-
lated by RNAi and histone modification. A second sub-
family of repeats is also silenced, but silencing is lost on
both strands in mutants in the CpG DNA methyltrans-
ferase MET1, the histone deacetylase HDA6 /SILL, or in
the chromatin remodeling ATPase DDM1. This regula-
tion is due to transcription from Athila2 retrotransposons,
which integrate in both orientations relative to the
repeats, and differs between strains of Arabidopsis.
Silencing lost in met] or hda6 mutants is reestablished in
backcrosses to wild type, but silencing lost in RNAi
mutants and in ddml is not. siRNA (24 nucleotides) from
centromeric repeats are retained in met] and hda6, but
not in ddml, and may have a role in this epigenetic inher-
itance. Histone H3 lysine-9 dimethylation (H3K9me2) is
associated with both classes of repeats.
Polyploidy, Transposable Elements,
and Epigenetic Control
M. Tanurdzic, Z.B. Lippman, R. Carrasquillo, K. Slotkin,
M. Vaughn, R. Martienssen [in collaboration with
P. Rabinowicz, TIGR; L. Comai, University of Washington;
W. Thompson, N. Carolina State University; and R.W. Doerge,
Purdue University]
Heterochromatin is composed of transposable elements
(TE) and related repeats. Like TEs, heterochromatin
silences genes located nearby and has a major role in
epigenetic regulation of the genome. siRNA corre-
sponding to heterochromatic sequences can be detected
in plants, animals, and fission yeast, indicating that
these sequences are transcribed. We have used tiling
microarrays to examine these transcripts and their regu-
lation. In plants, siRNA corresponding to different
classes of TE depends on the DNA methyltransferase
MET1, the SWI/SNF ATPase DDM I , or both, but not
on the histone deacetylase SIL I. All three genes are
required for silencing transposons in the absence of
RNAi, but they depend on siRNA for resilencing in
backcrosses. DNA methylation is concentrated in TEs
and heterochromatin, but many genes have low levels of
methylation in their coding region. Genic methylation is
not associated with H3K9me2, is highly polymorphic,
does require DDM1, and is inherited in recombinant
inbred lines, but it has little effect on gene expression.
Polyploidy in plants results in a variety of genetic
and epigenetic changes in gene expression from gener-
ation to generation following the establishment of
allopolyploids. The mechanisms that underlie these
changes are important in the short term (hybrid vigor)
as well as in the long term, as polyploids are stabilized
during evolution. We are profiling chromatin modifi-
cations that may underlie novel gene expression in syn-
thetic allopolyploids derived from crosses between
tetraploidA. thaliana and tetraploid A. arenosa, as well
as those derived from crosses between doubled hap-
loids of Brassica oleracea and B. rapa. Although
changes in heterochromatin are relatively modest,
some transposons are activated in the allotetraploids.
We are also comparing diploid chromatin modification
profiles with the pattern of replication of chromosomal
DNA using BrdU incorporation in synchronized cells.
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PLANT SIGNALING AND DEVELOPMENT
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Plants display incredible morphological diversity,
making them a rich system for studies in developmen-
tal biology. Our lab is working to identify the molecu-
lar signals that regulate pattern formation and mor-
phogenesis during plant growth. These signals regulate
stem-cell activity, cell division, and expansion and
have shaped plant evolution and crop development. In
the past year, we have made significant progress in our
studies of intercellular transport of regulatory proteins
through tiny channels called plasmodesmata. We have
used a novel genetic screen to dissect the function of
these channels and have reported the first known
domain in any protein that is both necessary and suffi-
cient for cell-to-cell transport. We also reported a new
player in the classical CLAVATA signaling pathway in
maize. The thick tassel dwarf mutant encodes a recep-
tor kinase whose expression regulates stem-cell prolif-
eration, and genetic evidence suggests that it may act
independently of FASCIATED EAR2, a receptor-like
protein that we previously characterized. Biochemical
experiments to investigate possible interactions
between these signaling proteins are under way. We
also continue our studies of the ABPHYLI gene.
Mutations in this gene are unique in that they alter the
geometric arrangement of leaves made by the shoot,
and this gene encodes a protein that regulates signal-
ing by the hormone cytokinin. Our recent results sug-
gest an intriguing and possibly direct interaction of
this gene with auxin signaling and transport.
We have also isolated the RAMOSA3 gene, which
is involved in regulating inflorescence branching in
maize. RA3 encodes a phosphatase, and we found that
the substrate of this enzyme is a simple disaccharide,
trehalose. Our results point to a novel developmental
role for this ubiquitous sugar. Our ultimate goal is to
link the different signaling pathways into networks of
regulatory activities, giving rise to a "virtual" plant. To
this end, we have embarked on genomics-enabled pro-
jects to characterize the localization and interaction
partners of developmental proteins in maize and rice.
These plants are model systems as well as important
crops, and our findings point to important differences
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in regulatory networks between these "monocot"
plants and the more common model, Arabidopsis.
Studies of Maize Phyllotaxy
B.-h. Lee, Y. Yang, A. Mohanty
We are interested in how leaves are geometrically
arranged in plants-a fascinating phenomenon called
phyllotaxy. We have previously reported a characteri-
zation of the maize abphyll (abphl) mutants and
cloning of the ABPH1 gene. abphl mutants have
opposite pairing of leaves, instead of the normal alter-
nating pattern, and the ABPHI gene encodes a
cytokinin-inducible type A response regulator. In the
past year, we continued to investigate the function of
ABPH1 in phyllotaxy regulation.
As many genes involved in cytokinin signaling
have been identified in Arabidopsis, a dicot model
plant, the developmental phenotypes of Arabidopsis
mutants defective in several cytokinin signaling genes
were examined; however, no distinct phyllotactic
defects were observed, suggesting that the maize
abphl mutants provide a unique genetic system to
study phyllotaxy.
Another plant hormone, auxin, has been implicat-
ed in phyllotaxy regulation, and thus we studied
whether ABPHI may interact with auxin signal trans-
duction. First, we localized ABPHI expression in
shoot apices cultured with an auxin polar transport
inhibitor (N-1-naphthylphthalamic acid [NPA]) and
found that this treatment represses ABPHI expression
in the shoot apical meristem. This result suggests that
polar auxin transport is required for ABPHI expres-
sion. A second approach was immunolocalization of
PINFORMED1 (PIN1) in the maize shoot apex using
an Arabidopsis anti-PIN1 antibody. PIN1 protein is a
polar auxin efflux facilitator and is involved in phyl-
lotaxy regulation. We found that the Arabidopsis anti-
PIN1 antibody can detect the maize PIN1 protein
(ZmPIN1) in the same pattern found in Arabidopsis, in
a polar localization on one side of the cell. In addition,
we found that ZmPIN1 localization marks maize leaf
initiation in a manner similar to that in Arabidopsis.
ZmPIN1 expression appeared to be lower in abphl
than in normal maize meristems. Quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR)
assays also suggest a reduced expression of ZmPINI in
abphl mutants. These results indicate that ZmPIN1
expression is dependent on ABPH1 and a mutual inter-
action exists between auxin and cytokinin-regulated
phyllotaxy control.
Type-A response regulators in Arabidopsis can
function as either activators or repressors in cytokinin
signaling. Our genetic data suggest that ABPH1 acts
as a repressor. To investigate this, we overexpressed
the rice ABPH1 homolog in rice callus tissue that was
induced to regenerate. We observed a failure of shoot
regeneration in the ABPHI-overexpressing calli, con-
firming that ABPHI acts as a repressor of shoot
development. We also produced transgenic maize
lines harboring the ABPHI gene internally fused with
yellow fluorescent protein under the control of the
ABPHI endogenous promoter. This transgene was
made using the "fluorescent tagging of full-length
proteins" method developed in our lab. Transient
expression of the fusion in onion epidermal cells
revealed nuclear localization of the ABPH1 fusion
protein. In maize plants, ABPH1-YFP was specifical-
ly expressed in shoot apical meristems, in a pattern
similar to that previously observed by in situ
hybridization. These ABPHI -YFP-expressing plants
will facilitate ABPH1 expression studies to under-
stand its role in phyllotaxy regulation.
We have also carried out microarray analysis of
normal versus abphl embryos collected 10 days after
pollination, when the shoot apical meristem is just ini-
tiated. For robust statistical analysis, we included five
biological replicates. The expression of 377 genes is
affected in abphl mutants, with 314 genes expressed
lower and 63 genes higher in abphl. Some of these
genes include auxin response factors, a putative auxin
transporter-associated protein, and a protein involved
in auxin conjugation, supporting the interaction
between ABPHI and auxin signaling pathways. These
results will be validated and candidate target genes
studied using a reverse genetics strategy.
To identify additional factors involved in the con-
trol of phyllotaxy, we identified a second maize phyl-
lotaxy mutant, abph2. Like abphl, the abph2 mutant
has a bigger shoot meristem than normal and shows
abnormal phyllotaxy. We mapped ABPH2 to the short
arm of chromosome 7 using molecular markers. To
facilitate positional cloning of ABPH2, transposon
tagging and ethylmethane sulfonate (EMS)-mutage-
nized mutant populations are being generated and will
be screened for additional alleles.
Characterization of the RAMOSA3
Gene of Maize
N. Satoh-Nagasawa, J. Linder [in collaboration with
N. Nagasawa, H. Sakai, DuPont; S. Malcomber, California
State University, Long Beach; D. Johnson, University of
Illinois; W. Huang and V. Brendel, Iowa State University]
Inflorescence branching is one of the major yield traits
in crop plants, and it is controlled by the developmental
fate of axillary shoot meristems. To obtain insight into
the genetic and molecular mechanism of inflorescence
branching, we characterized the ramosa3 (ra3) mutant,
which has enhanced inflorescence branching. Scanning
electron microscopy showed that RA3 functions to
establish the correct identity and determinacy of axil-
lary meristems in the maize inflorescences. We cloned
RA3 by positional cloning, and it encodes a predicted
protein with significant similarity to trehalose-6-phos-
phate phosphatases (TPPs) and is expressed predomi-
nantly in young inflorescences in a localized pattern at
the base of the axillary meristems (Fig. 1).
FIGURE 1 In situ hybridization in developing maize ear primor-
dia, showing expression of RAMOSA3, at the base of the axil-
lary meristems.
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For further characterization of RA3, we took sever-
al approaches. To investigate whether RA3 has TPP
activity, we performed phosphatase assays and yeast
complementation tests. Both experiments suggested
that RA3 acts specifically as a TPP in vitro as well as
in vivo. To investigate whether RA3-like genes might
also have a developmental function in other plants, we
isolated homologs from several grasses. Phylogenetic
and expression analyses indicate that RA3 function is
probably conserved at least throughout the grasses. To
elucidate the genetic pathway in which RA3 acts, we
also compared global gene expression in wild-type
and ra3 mutant developing ears by microarray analy-
sis. We identified some candidate developmental
genes with statistically significantly different expres-
sion levels, and these are being verified by quantitative
RT-PCR. In a candidate gene approach to find other
players in the RA3 pathway, we analyzed double
mutants and examined the expression of RA3 and
other genes in single and double mutants. Surprisingly,
we found that RA3 functions upstream of the predict-
ed transcriptional regulator RAMOSA1, suggesting
that RA3 may have a transcriptional role in addition to
its enzymatic function.
Our studies provide the first indication that tre-
halose metabolism can regulate specific developmen-
tal pathways, and the nature of RA3 is novel among
genes that regulate maize inflorescence branching.
Thus, we expect to obtain unique insight into the con-
nection between sugar metabolism and maize inflores-
cence development by further investigation of RA3.
Molecular and Genetic Characterization
of Plant Intercellular Channels
Y. Benitez, J. Wang, P. Yin, S.J. Locke
Communication between cells regulates development
in both animals and plants. In plants, this function
involves plasmodesmata (PD) channels that traverse
the cell walls of neighboring plant cells. PD not only
provide cell-cell connectivity but, more importantly,
function to exchange metabolites and nucleic acids
and protein signals. Despite their importance, PD
structure and function are far from resolved. Our
group invests great effort toward this goal through the
characterization of Arabidopsis mutants that show a
defect in PD trafficking.
We have isolated a number of mutants that exhibit a
restriction in the unloading of green fluorescent protein
(GFP) from the phloem vascular cells of the root to the
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surrounding meristematic cells. These mutants were
named gat (pronounced "gate") for GFP altered traf-
ficking. We are currently focused on the characteriza-
tion of two of these mutants, gall and gat2. We have
determined that both are recessive and show a seedling-
lethal phenotype. Our immediate aims are to determine
which genes are mutated and to identify the specific
trafficking pathways disrupted in these mutants.
Both gatl and gat2 mutants appear to be morpho-
logically normal during the globular and heart stages
but are delayed in their development. The major dif-
ference is seen when embryos reach the cotyledon
stage. For example, gat2 mutants have a large embryo
structure that seems unable to bend within the seed
coat. Symplasmic trafficking is being analyzed in
mutant embryos using dye-loading experiments. As
expected, wild-type embryos traffic HPTS (8-hydrox-
ypyrene-1,3,6-trisulfonic acid), a 0.5-kD dye, in all
embryonic stages (Fig. 2). We are studying the trans-
port of this and larger dyes such as a 10-1(D F-dextran-
fluorescein isothiocyanate conjugate to compare their
movements in wild-type and gat embryos.
gall plants were also crossed with cell-specific
GFP lines, obtained from the Benfey lab of Duke
University, and used to confirm that mutant embryos
and seedlings form normal phloem and root meristem
structure. By quantification of GFP restriction in gall
seedlings expressing cytoplasmic GFP and in gall
seedlings expressing GFP-ER, we believe that gall is
affected in the GFP unloading out of the companion
cells (CC) of the phloem. We are also interested in
testing the systemic propagation of posttranscriptional
FIGURE 2 gat2 mutant embryos loaded with HPTS show
symplasmic connectivity (fluorescence) throughout embryonic
tissues.
gene silencing/RNA interference (RNAi), using lines
provided by the Voinnet lab of CNRS (Strasbourg,
France). Our preliminary results suggest that gat I is
not affected in spreading of the RNAi signal from the
phloem to surrounding tissues, and we are currently
testing other gat mutants. To analyze the targeted traf-
ficking of developmental proteins, such as SHR and
STM, in gat mutant meristems, we are crossing them
to GFP reporter lines for these proteins. Finally, we are
starting to study morphological differences in PD
assembly and structure using transmission electron
microscopy (TEM) with the help of Stephen Hearn
here at CSHL.
The region containing the gatl mutation has been
narrowed down to a 22-kb region of chromosome 2
using fine mapping. We are currently conducting com-
plementation analyses with candidate genes to deter-
mine which one is responsible for the observed pheno-
type. T-DNA insertion lines of the putative mutated
genes have also been obtained, and we are performing
allelism tests. Similarly, we have made progress in the
mapping of gat2. We have fine-mapped the mutation to
an approximately 35-kb region of chromosome 1 that
contains nine genes. Candidate genes are being
sequenced from the mutant, and allelism tests with
other embryonic-lethal mutants located in this genom-
ic region are being conducted to identify new alleles.
Toward an Understanding of the Role
of mRNA Trafficking by Transcription
Factors in Plants
A. Maizel [in collaboration with ISV, CNRS Gif-sur-Yvette,
France]
The intercellular transfer of regulatory transcription
factors and mRNAs has become a new paradigm in
plant biology in recent years. The transcription factor
KNOTTED1 (KN1) was the first such example of a
developmental signal that traffics from cell to cell. Its
conserved DNA-binding domain, the homeodomain,
is sufficient to mediate its own transfer from cell to
cell in vivo, as well as promoting transfer of the KN1
mRNA (Kim et al. 2005).
RNA-binding activity of transcription factors has
already been reported. The best-studied example is the
homeodomain protein BICOID, which binds caudal
mRNA and represses its translation in the Drosophila
embryo. The homeodomain is sufficient to bind direct-
ly to both RNA and DNA molecules, and a specific
position of the homeodomain DNA recognition helix
discriminates RNA versus DNA binding. However,
noncell autonomous activity of bicoid has never been
reported, which makes the observation that KN1 can
escort its own messenger more intriguing and raises
questions about the molecular mechanism and the sig-
nificance of this transfer. A recent project developed in
the lab aims at understanding the molecular mecha-
nisms as well as, in the long term, the physiological
significance of an interaction between a trafficking
transcription factor and its mRNA.
As the homeodomain of KN1 is necessary and suf-
ficient to traffic from cell to cell and mediate transfer
of the KN1 mRNA, we postulated that a direct interac-
tion between the homeodomain and the RNA is likely.
To gain further insights in the molecular mechanisms
of this interaction, we tested in yeast the interactions
between KN1 and its mRNA. We used the yeast 3-
hybrid system, which allows for detection of RNA/pro-
tein interaction in a cellular context. Not knowing
which part of the messenger is required for the interac-
tion, we used a systematic approach by testing overlap-
ping fragments covering the whole KN1 mRNA.
Preliminary results indicate weak interactions between
KN1 and two fragments of its mRNA that have stem-
loop conformations. Further in vitro experiments are
currently under way to confirm this interaction.
To address the question of where in the cell this
interaction takes place, we adapted to plants an innova-
tive system to detect protein/RNA interaction in vivo. A
portion of the Venus fluorescent protein (Venus FP) will
be tethered to the KN1 mRNA by the well-characterized
bacteriophage MS2 coat protein-RNA operator interac-
tion. The complementary portion of Venus FP will be
fused to the KN1 -HD. If the KN I-HD is able to associ-
ate with KN1 mRNA, it will bring the two portions of
Venus FP in close proximity to form a fluorescent com-
plex, while simultaneously identifying their site of inter-
action within the cell. Recombinant clones have been
obtained and the first assays are currently under way.
Regulation of Meristem
Size in Maize
P. Bommert, K. Lau, N. Seidl, A. Leibfried, J. Wang
in collaboration with W. Bruce, Pioneer]
Shoot meristems have the remarkable ability to regulate
their size during development. They do this by balanc-
ing stem-cell division with the incorporation of cells
into new primordia. In Arabidopsis, this balance is con-
trolled by the CLAVATA signaling pathway. The current
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model proposes that a heterodimeric receptor complex
composed of the receptor kinase CLAVATA] and the
receptor-like protein CLAVATA2 limits the expression of
the stem-cell-promoting factor WUSCHEL. Analysis of
the fasciated earl (fea2) and thick tassel dwarf] (tdl)
genes in maize suggests that this pathway is conserved
among angiosperms, as feat encodes an a leucine-rich
repeat (LRR) receptor protein orthologous to CLV2 and
tdl encodes an LRR receptor-like kinase orthologous to
CLV1. We are presently using biochemical approaches
to characterize the FEA2 receptor complex. The size of
the FEA2 complex has been determined to be 450 la
using gel-filtration chromatography and glycerol gradi-
ent centrifugation. We hope to identify other compo-
nents of this complex by analyzing its size in extracts
from other fasciated mutants.
We have also constructed a genomic FEA2 fusion to
the tandem affinity purification (TAP) tag, using the
endogenous fea2 promoter. Initial immunoblot analysis
indicates that the FEA2-TAP fusion protein is expressed
at levels equal to, or higher than, the endogenous FEA2
protein. Currently, we are in the process of purifying the
FEA2 complex using the TAP epitopes and will perform
mass spectrometric analysis of the complex to identify
novel components. Any interactors that are identified
will be analyzed by expression profiles, mutant pheno-
types, and generic interactions with feat and tdl.
We have also started to isolate the compact plant2
(ct2) gene via mapped based cloning. ct2 mutants
develop strongly fasciated ears, indicating that this
mutation affects meristem size regulation similar to
fea2 and tdl. The ct2 gene was previously mapped to
the short arm of chromosome 1. By using a combina-
tion of SSR and CAPS markers and 150 mutant indi-
viduals, we were able to locate the chromosomal posi-
tion of ct2 to a 3-cM interval. Fine mapping of the ct2
locus using approximately 1000 mutants is in
progress, and we have isolated several new alleles of
ct2 that will enable identification of the gene once we
have mapped it to a small interval.
Developing Tools for a
Protein-Protein Interaction
Map of Rice
A. Mohanty [in collaboration with M. Myers and
W.R. McCombie, Cold Spring Harbor Laboratory]
We have developed a high-throughput methodology to
tag plant genes in their native genomic context for func-
tional analysis, including their subcellular localization
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and identification of interacting proteins. Recently, we
have extended this approach, originally developed for
Arabidopsis, to the economically important crops rice
and maize. Although the rice genome has been fully
sequenced, the function of only a handful of genes is
known. To fill this gap, we are using a plant-optimized
TAP tag with the aim of studying protein-protein inter-
actions. We have already generated several transgenic
rice lines harboring TAP-tagged rice proteins expressed
under their native promoters, and protein complexes
isolated from these lines are being analyzed by mass
spectroscopy to identify the interacting proteins. We
would like to extend this work to generate a compre-
hensive map of interacting proteins in rice.
Hormonal Signaling in Maize
A. Mohanty, Y. Yang [in collaboration with A. Chan, The
Institute of Genomic Research; X. Ling and A. Sylvester,
University of Wyoming]
Plant hormones have critical roles in growth and
development. Although they have been studied for
decades, their molecular mechanism of action is poor-
ly understood. Recently, there has been significant
progress, as receptors for ethylene, auxin, and
cytokinins have been identified. Among these,
cytokinins are especially interesting as they regulate a
variety of processes including crop yield. Cytokinins
are perceived by histidine kinase receptors (HKs),
which upon binding of cytokinins initiate a phospho-
relay transfer to response regulators (RRs) via histi-
dine phosphotransfer (HP) proteins. The B-type
response regulators act as transcription factors to acti-
vate the A-type response regulators and regulate a
variety of downstream cellular processes. We recently
uncovered a specific developmental role for the maize
A-class RR gene ABPHYL], in the regulation of
meristem size and phyllotaxy.
We have taken a localization-based approach to
decipher the developmental roles of the auxin and
cytokinin signaling pathways in maize. We are gener-
ating genomic fusions with fluorescent proteins to the
HPs, HKs, and RRs, as well as cytokinin oxidase and
auxin transporter genes, and are generating maize
plants expressing these fusions. We are interested in
addressing whether the subcellular localization of
these proteins is regulated in a tissue-specific manner
and whether the nucleocytoplasmic shuttling observed
in transient assays holds true for these genes expressed
in their native developmental context. We are also
interested in evaluating expression patterns in multiple
organs and cell types to develop an atlas of expression
patterns in maize. These lines will greatly aid our
understanding of plant hormone signaling. Since the
subcellular and tissue-specific localization signals
have hardly been characterized in maize, we are also
generating a series of marker lines for compartments
such as the nucleus, cytoskeleton, tonoplast, and per-
oxisome to aid data interpretation. We have already
obtained maize lines harboring some of these markers,
and they are being analyzed by confocal microscopy.
In the coming year, we will continue our expansion
into using proteomics, microarrays and genome-scale
localization approaches to piece together developmen-
tal signaling pathways into integrated networks.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans M. Guo F. Nogueira
S. Madi T. Phelps-Durr
K. Marren
Development in higher plants is a continuous process
as organs emerge throughout the entire plant life
cycle, which for some plants extends over hundreds of
years. The growing tip of a plant, referred to as shoot
apical meristem (SAM), contains a population of stem
cells that divide to maintain the SAM and to generate
daughter cells from which lateral organs, such as
leaves and flowers, arise. The research in our lab aims
to understand the molecular mechanisms that distin-
guish indeterminate stem cells from their differentiat-
ing derivatives. In addition, we are studying the role of
stem-cell-derived signals in the patterning of lateral
organs. Observations from our lab indicate that
microRNAs (miRNAs) are among these meristem-
derived signals. Moreover, stem cells produce signals
required for the establishment of determinacy. This
process involves an epigenetic silencing mechanism,
indicating that the switch from stem cell to differenti-
ated cell is not simply encoded in DNA but also by
proteins associated with DNA.
Adaxial/Abaxial Patterning of
Lateral Organs in Maize
E Nogueira, S. Madi
Outgrowth and patterning of the leaf requires the
establishment of adaxial/abaxial (dorsoventral) polari-
ty. Last year, we reported that this asymmetry is spec-
ified in part through the polarized expression of class
III homeodomain leucine zipper (HD-ZIPIII) tran-
scription factors that specify adaxial/upper fate.
Through in situ hybridization analyses we were able to
show that the adaxial specific expression of the hd-
zipIII gene rolled leaf] (rld1) is set up by the expres-
sion pattern of a 21-nucleotide miRNA, miR166.
miRNAs are endogenous, small (-22 mer), noncoding
RNAs that mediate the cleavage or translational
repression of target transcripts containing a comple-
mentary sequence, and thus control gene expression
posttranscriptionally. Interestingly, we showed that the
peak of miR166 expression occurs immediately below
the incipient leaf and below the domain in which
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miR166 acts on the hd- zipllI genes, but that an expres-
sion gradient of miR166 is established that spreads
from the abaxial/lower site throughout the developing
leaf and sets up leaf polarity.
Specification of adaxial fate also requires the activ-
ity of leafbladelessi (1b11). Recessive mutations in lbll
lead to formation of abaxialized leaves. Double mutant
and expression analyses indicate that lbll acts
upstream of rldl and is required for the accumulation
of rldl transcripts in the developing leaf. The effect of
lbll on polarity is mediated via miR166. Reverse trans-
criptase-polymerase chain reaction (RT-PCR) analysis
showed that transcript levels for mir166c,mir166h, and
mir166i are increased in lbll apices compared to wild
type. Moreover, using in situ hybridization we have
shown that loss of lbll function affects the pattern of
miR166 accumulation and leads to misexpression of
miR166 throughout the initiating leaf. These results
indicate a key role for lbll in the spatiotemporal regu-
lation of miR166.
We have cloned lbll and found that this gene
encodes SUPPRESSOR-OF-GENE SILENCING3,
which is required for the biogenesis pathway of a sec-
ond family of small regulatory RNA, the trans-acting
short interfering (ta-siRNAs). We have identified four
loci in maize that generate ta-siRNAs. These tas loci
produce typical RNA-Poll' transcripts that are capped
and polyadenylated. Importantly, the tas transcripts are
targets for miR390-directed cleavage. However, in con-
trast to most miRNA-directed cleavage products, the
resulting tas cleavage fragments are converted to dou-
ble-stranded RNAs (dsRNAs) and are subsequently
processed by Dicer into 21-bp ta-siRNAs. Because
Dicer cleavage initiates at the processed end of the tas
precursor, ta-siRNAs are generated in a 21-nucleotide
phase starting at the miR390 cleavage site. The ta-
siRNAs generated from each tas locus can therefore be
predicted, and this enables the identification of poten-
tial target genes using computational approaches.
Interestingly, we have found that the primary mir166i
transcript has complementarity to one of the ta-
siRNAs: ta-siR2142. This suggests that this mir166
precursor could be a direct ta-siRNA target, and we are
currently using 5' RACE analysis to test if the effect of
lbll on mir166i expression is mediated directly by ta-
siR2142. In addition, ta-siR2142 regulates expression
of auxin response factor3 (arf3) genes. However, the
mir 166c and mir 1 66h precursors have no complemen-
tarity to the known ta-siRNAs, indicating that the
effect of lbll on their expression is indirect. The possi-
bility that expression of these mir166 precursors is
under control of the arf3 genes is being investigated.
Our observations indicate that SGS3 is essential
for adaxial/abaxial patterning in maize, and we pre-
sent the intriguing possibility that adaxial/abaxial
polarity is specified through the opposing action of
two small regulatory RNAs: ta-siR2142 and miR166.
Our results further illustrate the complexity that can
be found in small RNA-controlled networks, because
we have shown that the expression pattern of miR166
is under control of ta-siR2142, which in turn is regu-
lated by miR390. By studying the genetic pathway
involving lbll and rldl, we hope to improve our
understanding of the role of small regulatory RNAs as
developmental signals.
The Spatiotemporal Regulation of
miR166 Expression in
Developing Leaves
F. Nogueira
This work was performed with contributions from
D. Chitwood, WSBS rotation student.
The dynamic expression pattern and the gradient of
miR166 expression are reminiscent of a movable sig-
nal and suggest that expression of the mir166 precur-
sors is under such control or, alternatively, that miR166
can move between cells. Obviously, resolving these
possibilities is of key importance because the knowl-
edge that miRNAs can act as mobile signals will have
major implications regarding the role of small RNAs in
developmental biology. The maize genome contains at
least nine mir166 genes, suggesting that the dynamic
miR166 expression pattern may result in part from the
differential regulation of individual mir166 family
members. Expression analyses of individual mir genes
by in situ hybridization have been unsuccessful. We
therefore used laser capture microdissection (LCM) in
combination with RT-PCR to analyze the expression
profiles of mir 1 66 genes in specific domains of the
SAM and young leaves (Fig. 1). Of the mir166 genes
we have tested thus far, each display unique tissue and
cell-type-specific expression patterns. Our results indi-
A 166a 166b 166c 166d 166e rldl kanl tub
RT + - + - + - + - + - + - + - + -
1 CMIMMIHIMINIMINI IMIIIM111:1111
2 11M1=1:21111:1101M11 1:3111C3111M11
3 111111 OEM =1=1=
4 111.1101111111111 Cal Cal ®M®
5 MEINI1111111111111111:111
FIGURE 1 mir166 genes are expressed in distinct but overlap-
ping domains within the vegetative apex. (A) Cells were captured
from five regions within the vegetative apex: 1, tip of the SAM; 2,
base of the SAM; 3, young leaf primordia (P2, P3); 4, older leaf
primordia (P4, P5); 5, stem tissue. mRNA was linearly amplified
and used in one-step RT-PCR to monitor expression of selected
mir166 genes as indicated. Loading and RT controls are shown.
(8) Longitudinal section of a maize apex with a diagram of the
regions captured by LCM. (C) Longitudinal section of an apex
after capturing cells from the young leaf primordia (P2, P3). Note
the precision with which cells can be captured.
cate that the pattern of miR166 accumulation likely
results in part from the intricate transcriptional regula-
tion of its precursors. One of the tissue samples tested
included cells from immediately below the incipient
leaf that accumulates relatively high levels of miR166.
Three mir 1 66 family members are expressed in that
domain and are thus important for setting up
adaxial/abaxial leaf polarity. Interestingly, the mir 1 66a
precursor was found to be expressed at the tip of the
SAM. This result was surprising, because these cells
do not accumulate miR166 and express the target rldl.
This suggests that miR166 accumulation may be regu-
lated in part at the posttranscriptional level. At this
time, LCM RT-PCR analysis on more precisely defined
developmental domains in the SAM and leaf primordia
is being used to establish whether miR166 is mobile.
We have shown that in Arabidopsis miR166
exhibits a similar highly dynamic expression pattern.
Four MIR166 family members are expressed in vege-
tative tissues, including MIR166a. The 5' end and
polyadenylation sites of the MIR166a primary tran-
script were identified, and we found that MIR166a
uses two distinct transcription start sites. Using pro-
moter::GUS transcriptional fusions, we established
the expression pattern of MIR166a in developing
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seedlings. MIR166a is expressed in the apical region,
but not in young leaves. In older leaves, expression
initiates at the tip and extends basipetally in both vas-
cular and ground tissues. Promoter deletions showed
that a 200-bp promoter fragment is sufficient for vas-
cular expression. Interestingly, this small fragment is
part of the larger MIR166a primary transcript, provid-
ing another example of the complex regulation of
miR166 expression. Several observations suggest that
expression of MIR166a may be regulated by the plant
hormone auxin. Its promoter includes binding sites for
auxin response transcription factors, and transcript
levels are increased in the pinl mutant (PINT is a
transmembrane protein involved in polar auxin trans-
port). We are currently analyzing the role of auxin in
adaxial/abaxial patterning and, specifically, its contri-
bution to the dynamic miR166 expression pattern.
Establishment of Determinacy
during Organ Development
M. Guo
This work was performed with contributions from
Vanessa Ringgold of the Undergraduate Research
Program at CSHL.
Indeterminacy within the SAM is specified in part by
the KNOX homeobox genes. Down-regulation of
KNOX expression is a key factor that distinguishes
stem cells and their immediate derivatives in the SAM
from lateral organ founder cells. Moreover, establish-
ment of determinacy in developing organs requires the
continued silencing of the KNOX genes. This process
involves the highly conserved MYB domain proteins
ROUGH SHEATH2 (RS2) and ASYMMETRIC
LEAVES1 (AS1) from maize and Arabidopsis, respec-
tively. On the basis of expression and genetic analyses,
we proposed that these proteins function as epigenetic
regulators that, in response to a stem cell signal, keep
KNOX genes in an "off" state during organogenesis,
thus preventing differentiating cells from reverting
into indeterminate stem cells. In the past few years, we
have gained important new insights into the mecha-
nism of KNOX gene silencing by RS2 /AS1 that con-
firm this hypothesis. We have shown that RS2 and
AS I form highly conserved repressor complexes that
include the Zn-finger transcription factor ASYM-
METRIC LEAVES2 (AS2), an RNA-binding protein
named RIK, and the histone chaperone HIRA.
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Last year, we reported genetic data that suggested
that AS1 acts as a transcriptional corepressor that may
bind directly to the KNOX genes. We therefore used
chromatin immunoprecipitation (ChIP) to determine
which regions of BP, one of the KNOX genes, mediate
AS 1 complex binding. As a first step, we generated
transgenic Arabidopsis lines that express an epitope-
tagged version of AS1. These were used in ChIP analy-
sis, which identified three regions within the BP gene
that interact with the AS1 complex: two sites in the
promoter and one in the coding region of BP. To con-
firm the significance of the AS1 complex-binding sites
for BP silencing in vivo, we expressed different BP
promoter: GUS reporter constructs in transgenic plants
and analyzed expression in wild-type as well as as1
and as2 mutants. In our analysis, BP promoter frag-
ments that included both AS1 complex-binding sites
were found to contain all sequence information
required for normal BP expression in the meristem and
for AS I/AS2-mediated repression in leaves. Deletion
of either AS1 complex-binding site resulted in misex-
pression of BP in wild-type leaves, verifying the
importance of these sites for stable KNOX repression.
Currently, we are using gel shift assays to analyze
which proteins in the AS 1 complex mediate these inter-
actions and to more precisely define cis sequences
required for protein binding. These data will eventual-
ly clarify the assembly of the AS 1 complex in the
process of stable KNOX gene silencing and the estab-
lishment of determinacy in developing lateral organs.
The interaction of the RNA-binding protein RIK
with AS1 and RS2 complexes suggests that silencing at
the KNOX loci may involve an RNA component.
Noncoding RNAs are known to have a role in a wide
range of silencing phenomena and can guide chro-
matin-modifying complexes to specific target loci.
Using strand-specific RT-PCR, we found that an anti-
sense transcript derived from the BP locus is expressed
in seedlings. This antisense RNA overlaps the AS1
complex-binding site within the coding region of BP.
Further analysis revealed that this antisense RNA is
polyadenylated, and preliminary data suggest that its
expression level is increased in mutants affecting the
AS1 complex, including asl, as2, and rik. We are cur-
rently using artificial miRNA technologies to reduce
antisense expression. These studies can identify the
biological function of the KNOX antisense transcripts
in recruitment of the AS 1 repressor complex and the
silencing of BP. Depending on the time and site of
action of these RNAs, a first clue into the mechanism
by which KNOX genes become down-regulated during
founder cell recruitment may also be obtained.
The Role of HIRA in
Plant Development
T. Phelps-Durr
This work was carried out with contributions from
S. Meyerholz, Locust Valley High School.
HIRA was identified as a protein that interacts with
RS2 and AS1. HIRA is a chromatin remodeling pro-
tein and was first identified in yeast as a regulator of
histone gene expression.
Subsequently, it was shown that HIRA proteins
modulate chromatin structure during both heterochro-
matic gene silencing and to control the spatial and tem-
poral expression of specific euchromatic genes in both
yeast and mammals In Drosophila, HIRA is required
for the decondensation of the sperm nucleus and the
establishment of an epigenetic distinction between the
maternal and paternal genomes. The mechanism by
which HIRA establishes gene silencing is unknown.
HIRA is a histone chaperone that assembles the his-
tone variant H3.3 independently of DNA replication.
In addition, HIRA can interact with histone deacety-
lases. Both of these activities could lead to changes in
local chromatin state. We are currently testing whether
KNOX gene silencing is associated with changes in
chromatin organization or histone modifications.
In mammals, loss of HIRA results in gastrulation
and patterning defects that lead to early embryo
lethality. In addition, improper regulation of HIRA
may contribute to DiGeorge syndrome, a cranio-facial
disorder arising from improper regulation of neural
crest cell derivatives during development. We are per-
forming detailed expression analyses and are using
the reverse genetic resources available in Arabidopsis
to dissect the role of HIRA in plant development. In
situ hybridization of HIRA transcripts in Arabidopsis
vegetative meristems show that HIRA is expressed in
all tissues, but that expression corresponds predomi-
nantly to actively dividing cells. To characterize HIRA
expression in whole plants and throughout develop-
ment, the HIRA promoter was fused to the GUS
reporter gene and transformed into Arabidopsis.
Characterization of several independent transgenic
lines revealed that HIRA has a very dynamic expres-
sion pattern throughout development. Consistent with
the results obtained by in situ hybridizations, HIRA is
ubiquitously expressed in the early leaves. However,
as leaves expand, HIRA expression becomes restricted
to the indeterminate cells at the leaf margins.
Expression of HIRA in the flowers also changes as flo-
ral development progresses. Early in floral develop-
ment, expression is found at the base of flowers, in the
carpels, sepals, and at the base of the anthers, whereas
in older flowers, expression is limited to the develop-
ing pollen within the anthers.
Last year we reported that loss-of-function muta-
tions in HIRA are embryo-lethal, but that reduced
expression of HIRA causes formation of leaf and floral
defects that resemble the defects observed in as1 and
as2 mutants. Such hira mutant leaves misexpress sev-
eral KNOX genes. Because these defects in hira do not
result from loss of AS1 or AS2 expression, we proposed
that AS1 and AS2 assemble into a protein complex that
targets HIRA to the KNOX loci in organ founder cells
and perhaps establishes a stable silenced chromatin
state at these loci. As a result, stem cell fate remains
repressed in determinate, differentiating cells of devel-
oping lateral organs. To further dissect the role of HIRA
in development, we utilized the Arabidopsis TiLLing
service to screen for EMS-induced mutations in the
amino-terminal WD40-repeat protein interaction
domain and the carboxy-terminal region of HIRA that
interacts with RS2/AS1. Perhaps the most interesting
allele is hira-serpent, a point mutation changing gluta-
mate 240 to lysine in the WD40-repeat domain.
Phenotypic analysis of hira-serpent shows that it leads
to defects in pollen development and embryonic lethal-
ity. Mutant embryos abort at diverse stages during
embryogenesis. The most intriguing aspect of this allele
is the fact that at a low frequency, it can be recovered as
a homozygous plant; surprisingly, these plants have no
leaf phenotype. Detailed characterization of this allele
is ongoing. It has been crossed to marker lines to deter-
mine if meristem formation, auxin localization, and
root formation are perturbed. Genetic interactions
between hira-serpent and asl are also under way.
Global Expression Analysis of Meristem
Function and Leaf Initiation
S. Madi [in collaboration with M. Scanlon, Cornell University;
P. Schnable, Iowa State University; and B. Buckner and
D. Janick-Buckner, Truman State University]
Plant meristems comprise distinct histological and
functional domains. For instance, the stem cells are
located at the most apical tip in the so-called central
zone, whereas lateral organ founder cells are located on
the flanks of the SAM. Traditional genetic analyses
have demonstrated the importance of this meristematic
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organization for normal plant development and have
led to the identification of some genes required for
meristem function and lateral organ development. To
identify novel and potentially redundant or essential
genes that function in discrete domains of the SAM or
developing leaf primordia, we are using LCM, which
allows the isolation of transcripts from specific cell
types within a tissue or organ. For use in LCM, target
tissues are fixed, sectioned, and immobilized onto
microscope slides. Cells of interest are dissected and
separated from the rest of the tissue using a laser beam.
RNA is then extracted from the captured cells and used
in microarray analyses to compare global gene expres-
sion patterns between different cell populations. We
previously optimized the LCM technique, which was
originally designed for the dissection of animal cells,
for use on the small cell-wall-encapsulated cells with-
in the plant SAM. This past year, we further optimized
the RNA extraction and amplification protocols and
found that RNA collected from just a few hundred cells
is sufficient for the preparation of cDNA for use in
microarray analyses of gene expression.
We are using maize as our experimental system
because of the relatively large size of its vegetative
meristem when compared to, for instance, Arabidopsis.
We intend to compare global expression patterns
between approximately 20 different functional meris-
tematic and leaf primordia domains, or experimental
conditions. The following are examples of the type of
comparisons we are making: (1) among the expression
profiles of the stem cells, their immediate derivatives
in the SAM, and the initials of lateral organs; (2)
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among the different tissue layers of the SAM; (3)
among different stages of leaf development; (4) among
the upper and lower surfaces of developing leaves; and
(5) between SAMs and/or leaf primordia from devel-
opmental mutants and wild-type plants. Our initial
results indicate that nearly 1300 genes are differential-
ly expressed among the SAM, young leaf primordia,
and older leaf tissues. Potential differentially expressed
genes are being verified by more traditional expression
analyses such as real-time RT-PCR and in situ hybrid-
ization. The function of genes of particular interest will
be determined using functional genomics resources
available in maize and Arabidopsis. Even though this
project is still in its infancy, it will soon provide novel
insight into meristem function and organogenesis.
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BIOINFORMATICS AND GENOMICS
Now that the full genome sequences of many organisms have been completed, scientists are increasing-
ly turning their attention to the important task of putting this gene sequence information to work to explore
biology, improve agriculture, and advance biomedical research.
This year, W. Richard McCombie and his colleagues were part of an international team that published
the complete genome sequence of humanity's most important food source: rice. McCombie has also
been testing the first of a new generation of DNA sequencing machines using the rice genome as a model.
The goal of this project is to develop new, more rapid, and cost-effective methods for comparing DNA
sequences and identifying differences between varieties of rice that might be of agricultural value. The
same method would facilitate several other large-scale comparative genomic studies, including those of
human genomes for the investigation of many diseases.
For plant breeders and others interested in the major crop plants-rice, corn, wheat, oats, and bar-
ley-the availability of a publicly accessible comparative genome database has the potential to speed the
development of improved varieties to meet the world's increasing food demands. Lincoln Stein and his
colleagues have created just such a database, dubbed Gramene. These efforts were rewarded in 2005
with a large grant to sequence and annotate the maize (corn) genome. Stein's group is also part of a pub-
lic-private effort-the International HapMap Consortium-whose aim is to chart the patterns of genetic
variation that are common in the world's human population. As a cover story in the journal Nature, this
year, the researchers published the first comprehensive collection of their results called a "haplotype map"
or HapMap of the human genome. The HapMap is already accelerating the search for genes involved in
common diseases including cancer, heart disease, diabetes, asthma, and macular degeneration.
We tend to think of DNA as a long thread or the familiar twisted ladder, but inside cells, DNA is coat-
ed with accessories: proteins and chemical modifications that change how and when the DNA code is
read. To make sense of one such modification, DNA methylation, Michael Zhang and his colleagues have
identified large-scale DNA methylation patterns in the human genome and developed a new computer
algorithm (Human DNA Methylation Finder) that predicts DNA methylation profiles in the human genome.
This work has implications for many diseases including cancer.
The study of related protein families frequently offers clues to the function of newly discovered proteins
or proteins of unknown function. Andy Neuwald uses comparative methods to study protein mechanisms
through statistical analysis of the constraints imposed on protein sequences during evolution. With these
methods, Neuwald and his colleagues compared a family of key enzymes called eukaryotic protein kinas-
es (EPKs) to a set of protein kinases called "atypical protein kinases," proteins that do not appear to fit into
any known protein kinase family. The result of this analysis indicates that EPK regulatory mechanisms
evolved through modification of an ancestral structure. The finding provides clues to the functions of EPKs
and EPK-like kinases, many of which are implicated in cancer, diabetes, and other diseases.
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Sequencing the Rice Genome
V. Balija, F. Katzenberger, M. Kramer, B. Miller, S. Muller,
L. Nascimento, L Spiegel in collaboration with R. Wing,
University of Arizona]
Rice is the most important crop in the world. It is the
major food crop for a large part of the world's popula-
tion. It is also an important model organism for the
cereals, which include corn, wheat, barley, oats, and
other important crops. In 2004, we finished the bulk
sequencing of major segments of the rice genome as
described in last year's Annual Report.
This year, we focused on two areas of the rice
genome-sequencing project. We participated in the
analysis and annotation of the genome. This was done
as part of the Rice Annotation Project (RAP) and as
part of the analysis for publication of the sequences of
chromosomes 11 and 12 (Rice Chromosomes 11 and
12 Sequencing Consortia 2005) as well as the whole-
genome sequencing and analysis (IRGSP 2005).
We also have been working with our collaborators
at the University of Arizona to fill as many of the
remaining gaps in the genome as possible. One way
this is being done is by selecting clones from a close-
ly related rice strain (Oryza nivara) that fill gaps in the
Nipponbare target genome. These bacterial artificial
chromosomes (BACs) are in turn partially sequenced,
and the sequence information used to attempt to iso-
late the relevant Nipponbare BACs that are then
sequenced. We have generated sequences from 13
Nivara BAC clones, and the Arizona group has used
this sequence to probe Nipponbare fosmid and BAC
libraries. Probes from 8 of the 13 Nivara clones were
successful in identifying potential Nipponbare fos-
mid/BAC clones to help fill gaps on five different
chromosomes. The Indica rice draft sequence is also
currently being utilized to design probes to screen for
potential BAC/fosmid clones to fill gaps in the
Nipponbare sequence. In addition, we have finished
567,298 by (CSHL + Arizona = 696,941 bp) from a set
of previously unanchored Nipponbare clones, several
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of which either closed or extended into gaps in the
genome sequence.
Also as part of the "end game" with the rice
genome, we are attempting to finish clones that some
of our collaborators in the International Rice Project
were unable to finish. This is typically due to a high
repeat content in the clones in question. We have fin-
ished 726,935 bases of such sequence and currently
have seven BAC clones in progress. These final stages
of the project are for the most part slow and tedious
work. However, they are necessary to provide the best
rice genome reference sequence possible.
Rice Transcript Analysis
V. Balija, F. Katzenberger, M. Kramer, L. Nascimento,
L. Palmer, T. Zutavern
As the rice genome was nearing completion, we initi-
ated a project to define the transcriptome of rice. As a
first step in this process, we wanted to test to see if the
gene structures currently annotated based on a large-
scale cDNA study done by the RIKEN cDNA group
(Kikuchi et al. Science 301: 376 [20031), accurately
and completely represented the transcripts of the genes
in question.
We selected a number of genes represented in the
RIKEN set and carried out RACE-PCR (rapid ampli-
fication of cDNA ends-polymerase chain reaction) on
those genes using 5'-Cap-selected mRNA from rice
leaves. The results are shown in Figure 1. The figure
shows the somewhat surprising result that the RIKEN
data set is rather incomplete in capturing the transcript
initiation sites of rice genes. This is not to say that the
RIKEN set is inaccurate, but rather that there seems to
be a substantial number of genes having alternate ini-
tiation sites that are not represented in the database.
Looking in more detail at the results, we also discov-
ered that the genes we examined contain a substantial
percentage of genes that are alternately spliced (see
Different from RIKEN 112 -Similar to RIKEN
FIGURE 1 Comparison of transcriptional start site in 5 -RACE
products to RIKEN rice cDNAs. 5'-RACE sequences as well as
RIKEN cDNAs were mapped to the rice genome. The first base
of the RACE product after the RACE adapter sequence was
compared to the first base of the RIKEN cDNA. A 5"-RACE
product was considered similar if the first base at the 5' end
mapped to within 10 bases of the 5' end of the RIKEN cDNA.
The RACE product was considered different if it mapped further
than 10 bases from the RIKEN cDNA. The overlap between
these sets consists of cases where there were multiple tran-
scripts present, some of which were similar and some of which
were different from the RIKEN cDNA.
Fig. 2). These results were quite surprising given pre-
vious estimates of alternate splicing in plants of about
7% (Brett et al. Nat. Genet. 30: 29 [2002]; Haas et al.
Genome Biol. 3: RESEARCH29 [2002]; Yuan et al.
2005). We are currently examining these genes in
other tissues to discover the full scope of the alternate
splicing, as well as analyzing other facets of our cur-
rent data.
2
Examination of Current Gene
Annotation in Human
ENCODE Regions
V. Baia, M. Kramer, L. Nascimento [in collaboration
with M. Zhang, Cold Spring Harbor Laboratory]
The ENCODE consortium has established 44 regions
encompassing 30 Mb of the human genome
(ENCODE Project Consortium Science 306: 636
[2004]) in which identification of all functional ele-
ments is the focus. A major facet of this project is the
identification of all the genes (coding and noncoding)
and promoters associated with them. Direct examina-
tion of the 5' end of genes is valuable in verifying
known exons, identifying novel exons, and recovering
the full 5' UTR (untranslated region). Additionally,
experimental assessment of the 5'-end annotation will
allow the transcriptional start site(s) to be accurately
established, which will aid in promoter identification.
With this in mind, a study was initiated with the fol-
lowing goals: (1) Validiate the current gene annotation
in the ENCODE regions, (2) identify alternate and
novel first exons, (3) identify novel splice isoforms,
(4) recover the total 5' UTR, and (5) identify alternate
transcriptional start sites. All nonredundant RefSeq
a or spixisdomis
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FIGURE 2 Splice variation in rice genes. The RACE products and the RIKEN cDNAs
were analyzed for splice variation in terms of how many splice isoforms could be
identified between the RACE and the RIKEN cDNA sequences. Alternate splice
forms within the RIKEN cDNA were also included in this analysis. A total of 198
genes were identified that were represented by more than one splice isoform.
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FIGURE 3 5"-end annotation of ENCODE region genes and gene predictions is incomplete.
The RACE-PCR fragments from each category were aligned to the May 2004 build of the
human genome using BLAT (Kent et al. Genome Res. 12: 996 [2002]). The percentage of
genes in each category where exons observed in the RACE-PCR fragment that were not anno-
tated in the respective gene model is shown. The number of genes where alternate first exons
were observed in the RACE-PCR fragment is also depicted.
gene models (342 genes), unique knownGenes not
associated with RefSeq gene models, a random sam-
pling of mRNA sequences (37 mRNAs), and more
than 200 gene predictions were chosen for amplifica-
tion by 5' RACE from 20 pooled human tissues/
stages.
Analysis of the RACE products reveals that a large
number unannotated and novel exons were present that
were represented in the associated gene model or gene
prediction model (Fig. 3). Further analysis revealed
that novel alternatively spliced isoforms were also pre-
sent in the RACE products (Fig. 4). These data indi-
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cate that the current state of annotations in the
ENCODE regions is incomplete.
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Category
# ofgenes
,
"
# of genes with
multiple splice
isoforms
# of total
isoforms
identifed
% of isoforms
that are novel
Refscq 251 84 318 22%
knownGene 20 5 22 14%
mRNA 19 7 14 43%
Ens embl 4 4 9 33%
Genscan 8 8 11 55%
FIGURE 4 Multiple splice isoforms observed in all categories. Genes in each category were
analyzed to determine the level of splice variation that was observed in the RACE-PCR frag-
ment.
PREDICTING PROTEIN MECHANISMS THROUGH BAYESIAN
INFERENCE OF EVOLUTIONARY CONSTRAINTS
A.F. Neuwald N. Kannan
A major goal of structural biology is to understand
protein mechanisms in atomic detail within the con-
text of the living cell. Such an understanding is impor-
tant for drug design, for protein engineering, and for
generally advancing technologies relevant to agricul-
ture, the environment, and human disease. It is also
extremely valuable in advancing the emerging field of
nanotechnology by revealing basic principles underly-
ing nature's designs through reverse engineering.
Despite remarkable progress in determining pro-
tein structures, many aspects of protein mechanisms
remain unclear. Although these mechanisms can only
be determined experimentally, the design of such
experiments is itself nontrivial and requires that one
first formulate the right hypotheses. Such hypotheses
are not formulated in a conceptual vacuum, however,
but rather, they are based on clues obtained from pre-
liminary observations. The evolutionary constraints
imposed on protein sequences are a potential source of
information in this regard inasmuch as they are due to
and thus reflect these mechanisms. Moreover, because
natural selection imposes these constraints on the
genomic sequences of living organisms within their
native environments, such information lacks the arti-
factual biases sometimes associated with in vitro
experimental systems or with in vivo cell cultures and
may reveal functionally critical features that have been
overlooked due to the inherent limitations of current
experimental methods. Thus, the examination of evo-
lutionary constraints, in light of structural and other
biological data, can suggest feasible hypothetical
mechanisms and thereby aid experimental design.
Science works by obtaining information about
what we cannot see, the hidden mechanisms underly-
ing natural phenomena, through an analysis of what
we can see, experimental "observables." We seek to
obtain such information about underlying protein
mechanisms through computational analysis of empir-
ical sequence and structural and taxonomic data. To do
this, we use a Bayesian approach, where ideally we
would determine the probabilities associated with var-
ious hypothetical protein mechanisms given these
data. Currently, this is impossible to do, however,
because too little is known about the correspondence
between protein mechanisms and the observables. On
the other hand, evolutionary constraints, which reflect
underlying mechanisms, are straightforward to model
based on conserved sequence patterns. Thus, we sta-
tistically infer evolutionary constraints based strictly
on empirical observations, but interpret these con-
straints in light of structural and biochemical data.
Although methods for analysis of sequence con-
straints have been around for a long time, Bayesian
approaches can characterize sequence constraints in
statistically rigorous and previously unexplored ways,
leading to new insights. Bayesian approaches to scien-
tific inference have three advantages: (1) Given the
number of empirical observations made, they provide
an explicit measure of how certain we may be about
specific hypotheses, (2) they allow computers to make
(statistical) discoveries by directly applying the scien-
tific method to nonhypothesis-driven data, and (3)
when provided with sufficient data, they can infer cor-
related properties of complex biological systems,
which is very difficult to do through single-hypothesis
experimentation. This year, we have continued to
develop Bayesian approaches while applying them to
two major classes of proteins: AAA+ ATPases and
protein kinases. AAA stands for ATPases associated
with a variety of activities.
Analysis of Eukaryotic DNA
Clamp Loader AAA+ ATPases
A. Neuwald
In higher organisms (the eukaryotes), five distinct
replication factor C (RFC) AAA+ ATPases associate
with each other to form an RFC complex involved in
the loading of a circular clamp onto DNA. This clamp
has an important role in keeping polymerase from
falling off during DNA replication. In archaebacteria
(primitive organisms from which the eukaryotes are
believed to have evolved), typically, only two types of
RFC ATPases, however, make up the clamp loader
complex: one copy of one subunit and four copies of
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the other subunit. This implies that during evolution,
one of these archaeal clamp loader subunits has
diverged into four distinct eukaryotic subunits. Each
of the eukaryotic subunits thus has been subject to
slightly different selective constraints due to their
functional specialization. My analysis, which was
published this year, characterized the constraints
imposed on these distinct categories of clamp loader
ATPases in order to predict critical aspects of the
clamp loader machinery.
This analysis suggests that one of these RFC
ATPases possesses a triggering component for initiat-
ing DNA-dependent ATP hydrolysis and, as a result,
loading of the clamp onto DNA. It also suggests that
starting with this ATPase subunit, three other RFC
ATPases are sequentially activated through propaga-
tion of a series of conformational switches in which a
conserved (positively charged) arginine moves into
contact with (negatively charged) DNA thread
through the center of the RFC/clamp complex and
thereby swings away from a position in which it dis-
ruptively interacts with key catalytic residues.
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Notably, these conserved structural features explain
the dependence of ATP hydrolysis by the clamp loader
on association with DNA. Finally, this analysis
revealed that by far the one feature that most distin-
guishes clamp loader ATPases from other AAA+
ATPases is a conserved lysine (Fig. 1, top) that elec-
trostatically interacts with the center of the clamp-
binding region of RFC subunits (Fig. 1, bottom).
Moreover, this lysine is highly buried in those ATPases
that are bound to the clamp in the RFC complex crys-
tal structure, which is very unusual for a lysine that
does not have a critical functional role. Thus, this
lysine appears to mediate association of the clamp
loader with the clamp.
AAA+ ATPases are a vast class of functionally
diverse proteins involved in the assembly, operation,
and disassembly of a wide variety of cellular com-
plexes. A number of these proteins are associated with
human diseases such as rhizomelic chondrodysplasia
punctata, a rare autosomal recessive disorder with
many associated medical complications; hereditary
spastic paraplegia; the human neurologic disease
All clamploaders vs unrelated AAA+ ATPases
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FIGURE 1 A lysine residue that most distin-
guishes clamp loader subunits from other AAA-,
ATPases. (Top) Alignment quantifying (via the
histogram) the constraint imposed on this lysine
(K109 in the RFC B subunit). The consensus
residues and integers below the alignment sum-
marize the conserved features of 581 clamp
loader subunits (a 9 below position 109, for
example, indicates that lysine PI is 90-100%
conserved at this position). (Bottom) Structural
features associated with the conserved lysine.
The side chain of this lysine electrostatically
interacts with the center of the region of contact
between RFC and the DNA clamp.
early-onset torsin dystonia; and the neurologic disor-
ders Zellweger syndrome, neonatal adrenoleukodys-
trophy, and infantile Refsum disease. Hence, this
analysis is of biomedical importance inasmuch as it
sheds light on the general principles involved in the
coupling of ATP hydrolysis by AAA+ ATPases to
coordinated conformational changes linked to corre-
sponding cellular functions.
Analysis of Eukaryotic
Protein Kinases
N. Kannan, A. Neuwald
This year, we also published a comparative analysis of
eukaryotic protein kinases (EPKs), distantly related
EPK-like kinases, and very distantly related atypical
protein kinases. EPKs have important roles in cellular
signaling pathways and have been implicated in various
diseases, including cancer and diabetes. A main interest
in studying these proteins is to glean insights into their
underlying mechanisms with a view to drug design.
Indeed, this work is being conducted in close collabora-
tion with the laboratory of Dr. Susan Taylor (Department
of Chemistry, Biochemistry, and Pharmacology at the
University of California at San Diego), who is now fol-
lowing up experimentally on our predictions.
A comparison of the evolutionary constraints
imposed on these three types of kinases suggests that
EPK regulatory mechanisms evolved through elabora-
tion of an ancient structural component and provides
clues regarding common regulatory themes. The most
distinctive features of this component include three
ancient features: a characteristic (HxD) motif adjoined
to the protein kinase catalytic loop, another (DFG) motif
adjoined to the activation loop, and a helix (the F-helix)
located below the catalytic loop (to which it is linked via
a conserved aspartate). Detailed evolutionary and struc-
tural analyses suggest that these features are associated
with conformational changes and with coordinated
movements associated with phosphate transfer and ADP
release (the two products of ATP hydrolysis). The histi-
dine of the HxD motif may be a focal point for signal
integration inasmuch as it both associates with key cat-
alytic elements and influences the DFG region, which
can undergo dramatic conformational changes. More-
over, the EPKs (as opposed to these two other classes of
kinases) have acquired additional structural features
linking this ancient component both to likely substrate-
interacting regions at either end of the F-helix and to
three regions undergoing conformational changes upon
kinase activation: the activation segment, the nucleotide-
binding pocket, and another helix (the C-helix) impli-
cated in kinase regulation. Hypothetical mechanisms
suggested by this analysis have provided direction for
ongoing studies on these modes of regulation.
Extensions of Our Bayesian Methods
A. Neuwald
This year, I have also initiated further extensions of
our Bayesian approaches in several ways. In collabo-
ration with statisticians Jun Liu at Harvard, Wally
Gilks at Cambridge, and Kanti Mardia at Leeds, I
have initiated the development of statistical models
for structural analysis of evolutionary constraints.
(Previously, statistical analyses were limited to
sequence constraints.) I aim to infer those hypotheti-
cal structural conformations that can best explain the
evolutionary constraints imposed on the correspond-
ing protein sequences. This project requires concur-
rent generation of protein structural models and the
use of molecular dynamics procedures to explore the
"space" of hypothetical models. We are also develop-
ing statistical procedures involving multiple cate-
gories of sequence constraints (right now, analyses
are limited to two categories). Although this work is
still in a very early stage, very promising preliminary
results have been obtained for bacterial y clamp
loader subunits.
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The International Hap Map Project (www.hapmap.org)
is an international project to map out regions of com-
mon genetic variability in the human genome by geno-
typing three major world populations at a resolution of
one marker every 2000 bases of sequence. The result-
ing "haplotype map" will greatly reduce the cost of
genetic association studies to find cancer susceptibili-
ty genes and other disorders with genetic components.
Our lab is a central participant in this project in our
role as the Data Coordinating Center (DCC). We man-
age the central database for the project; allocate single-
nucleotide polymorphisms (SNPs) to the 11 genotyp-
ing centers; coordinate data submission, quality
checks, and quality control; and manage the public
release of project data. The Hap Map Web site, which
was developed in our lab, describes the project in the
five languages of the project participants (English,
French, Chinese, Japanese, Yoruba) and provides
access to the data both for bulk download and for inter-
active querying and browsing.
During 2005, we completed the Hap Map and pub-
lished the complete data set of 1 billion genotypes and
their inheritance patterns on the CSHL Web site (Fig.
1). A paper describing the map and its analysis was
featured on the cover of Nature, and our findings
became the basis for roughly a dozen satellite articles
describing the implications of the map. In addition to
its medical research uses, the Hap Map provides an
insight into the evolutionary history of the human pop-
ulation. It confirms the "out of Africa" hypothesis and
identifies multiple locations in the human genome that
have been sites of adaptation by migrant populations
as they adapted to different environmental conditions.
GRAMENE: A COMPARATIVE MAPPING
RESOURCE FOR GRAINS
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
Gramene allows researchers to compare the genetic
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and physical maps of the major monocot crops, name-
ly, maize, barley, oats, sorghum, and wheat, to the
emerging rice genomic sequence. This allows
researchers to identify candidate genes in the rice
genome that correspond to genetically mapped
mutants and quantitative traits in the nonrice crop they
are studying. Hence, the resource allows researchers
studying traits in maize, barley, and so forth the bene-
fit of genomic sequencing without waiting for the
sequencing of these much larger genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
mapped more than 1 million monocot expressed
sequence tags (ESTs) to the rice genome, allowing
gene predictions to be further refined based on cross-
species comparisons. In previous years, we created an
integrated map of the rice and maize genomes. This
year, we extended that work by adding integrated maps
of Arabidopsis and sorghum. These integrated maps
allow researchers to move back and forth between var-
ious genetic and physical maps of these species in order
to apply the knowledge developed in one organism to
finding functionally significant genes in the other.
A major achievement was the release of a "diver-
sity module" for Gramene. This module holds infor-
mation about the evolution of rice and maize by track-
ing patterns of genetic changes in domestic and wild
populations. By characterizing these patterns, one can
learn which regions of the rice and maize genomes
were selected for during domestication and improve-
ment. This information, in turn, can be used to breed
new robust varieties.
We also used the information in the Gramene data-
base to identify previously unknown microRNAs
(miRNAs) in the rice and maize genomes. miRNAs
are thought to be responsible for regulating key events
during development and maturation. In addition to
providing important information about the evolution-
ary history of miRNA families, this information will
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increased the number of BBS candidate genes. In fact,
soon after we developed our list of candidate human
genes, one of them was clinically confirmed to be
responsible for BBS in a group of human patients.
Thus, comparative genomics in the nematode can lead
to findings directly relevant to human disease.
REACTOME
Reactome (www.reactome.org) is a collaboration with the
European Bioinformatics Institute (EBI) and the Gene
Ontology Consortium to develop a Web-accessible resource
for curated information about biological processes.
Reactome is organized like a review journal.
Bench biologists are invited to create modules that
summarize a particular aspect of their field. Currently
summations include DNA replication, transcription,
translation, intermediary metabolism, the cell cycle,
RNA splicing, and hemostasis, together covering
about 10% of the human division of SwissProt. Many
more modules are under way. Modules are similar to
minireviews, except that each paragraph of text is
reduced to a series of logical assertions that are
entered into a database of processes and macromole-
cules. The database is then used to drive a Web site
that can be browsed like a textbook or searched with
queries to discover pathways and connections.
During 2005, we brought the number of genes
curated in Reactome to just under 1200, covering
about 11% of the annotated portion of the human
genome. We also added a new interface that allows
users to interpret microarray data sets based on where
affected genes are placed in the reaction map.
GENERIC MODEL ORGANISM DATABASE PROJECT
In collaboration with the model organism system data-
bases FlyBase, SGD, and MGD, the Generic Model
Organism Database (GMOD) project is developing a
set of database schemas, applications, and interfaces
suitable for creating a model organism system data-
base. The hope is to significantly reduce the time and
expense required to create new databases to curate
genomic information coming out of various model
organism system sequencing projects (e.g., rat,
Dictyostelium, and Plasmodium).
By an informal count, several hundred laboratories
are now using one or more of the GMOD tools, and
increasing numbers of new databases are proposing to
adopt GMOD for their infrastructure.
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FIGURE 2 Visualizing genome-scale patterns with GMOD. Above is a diagram generated by the
GMOD Karyotype tool. This tool allows large amounts of quantitative data to be projected onto a rep-
resentation of the whole genome. In this case, the diagram is displaying patterns of gene density. It
demonstrates that there are regions of the genome that are relatively gene rich, and others that are rel-
atively gene poor. The causes of this unequal distribution of genes remains a topic of investigation.
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During 2005, we added new genome-wide visual-
ization tools to GMOD, including one that allows the
user to view very large quantitative data sets onto a
depiction of the human chromosome set (Fig. 2).
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In the last year or so, several members have left the lab
and moved on to their new careers: Nila Banerjee
graduated and became a postdoctoral fellow at
Columbia University near the end of 2004; Jinhua
Wang became a bioinformatics research scientist in
Memphis, Tennessee in the beginning of the year;
Fang Zhao left in March and is now a consultant for
Merck; Raj Das left in May to work for Eli Lilly;
Cizhong Jiang left in June and is a research associate
at the University of North Carolina; and in July, Debo
Das became a research associate at the Lawrence
Berkeley Laboratory and Pavel Sumazin moved on to
become an assistant professor at Portland State
University in Oregon.
Our main achievements last year were the (1) con-
struction of a human, rat, and mouse promoter database
that not only contains well-annotated promoters, but
also predicts potentially novel promoters based on both
cDNA and comparative genomic analysis; (2) further
integration of motif analysis tools for finding tissue-
specific transcription-factor-binding sites when com-
bining genomic sequences with microarray data; (3)
study of large-scale structure of human brain DNA
methylation patterns and development of a support vec-
tor machine prediction algorithm (in collaboration with
Columbia groups); (4) investigation of exonic splicing
enhanced distribution (in collaboration with the
Krainer lab here at CSHL) and splicing array classifi-
cation of tumors (in collaboration with the University
of California, San Diego and Illumina); and finally, (5)
discovery of a new class of noncoding RNAs (in col-
laboration with the Spector lab here at CSHL).
CSHLmpd: Cold Spring Harbor
Laboratory Mammalian
Promoter Database
Z.Y. Xuan, F. Zhao, J.H. Wang, G.X. Chen, M.Q. Zhang
Large-scale and high-throughput genomics research
needs reliable and comprehensive genome-wide pro-
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moter annotation resources. We have conducted a sys-
tematic investigation on how to improve mammalian
promoter prediction by incorporating both transcript
and conservation information. Using a well-character-
ized set of 8949 human genes with known promoters
and with orthologous genes in rodents, we found that
for the 5 "- truncated cDNAs (1) the incorporation of
transcript information can enhance specificity (Sp) and
sensitivity (Sn) of de novo promoter prediction by 11%
and 3%, respectively and (2) homologous genomic
sequence comparison can further increase Sp and Sn by
27% and 2%, respectively. For non-CpG-related pro-
moters in particular, the Sp can be improved from 5%
to 55% with Sn only dropped 4%. This enabled us to
build a better multispecies promoter annotation
pipeline and hence to create CSHLmpd (Cold Spring
Harbor Laboratory Mammalian Promoter Database)
for the biomedical research community, which can act
as a starting reference system for more refined func-
tional annotations. (http://rulai.cshl.edu/CSHLmpd2/).
Mining ChIP-Chip Data for
Transcription Factor and
Cofactor-binding Sites
A.D. Smith, P. Sumazin, D. Das, M.Q. Zhang
Single motifs and motif pairs were identified that can
be used to predict transcription factor localization in
ChIP-chip data and gene expression in tissue-specific
microarray data. We developed methodology to identi-
fy de novo individual and interacting pairs of binding-
site motifs from ChIP-chip data, using an algorithm
that integrates localization data directly into the motif
discovery process. We combine matrix-enumeration-
based motif discovery with multivariate regression to
evaluate candidate motifs and identify motif interac-
tions. When applied to hepatocyte nuclear factor
(HNF) localization data in liver and pancreatic islets,
our methods produce novel motifs or improved known
motifs. All motif pairs identified to predict localiza-
tion are further evaluated according to how well they
predict expression in liver and islets and according to
how conserved the relative positions of their occur-
rences are. We find that interaction models of HNF1
and CDP/Cux (CCAAT-displacement protein/cut
homeobox) motifs provide excellent prediction of
both HNF1 localization and gene expression in liver.
Our results demonstrate that ChIP-chip data can be
used to identify interacting binding-site motifs.
Distribution of SR Protein Exonic
Splicing Enhancer Motifs
in Human Protein-coding Genes
J.H. Wang, M.Q. Zhang [in collaboration with the Krainer lab,
Cold Spring Harbor Laboratory]
Exonic splicing enhancers (ESEs) are pre-mRNA cis-
acting elements required for splice site recognition.
We previously developed a Web-based program called
ESEfinder that scores any sequence for the presence
of ESE motifs recognized by the human SR proteins
SF2/ASF, SRp40, SRp55, and SC35 (http://rulai.cshl.
edu/tools/ESE/). Using ESEfinder, we have undertak-
en a large-scale analysis of ESE motif distribution in
human protein-coding genes. Significantly higher fre-
quencies of ESE motifs were observed in constitutive
internal protein-coding exons, compared with both
their flanking intronic regions and with pseudo exons.
Statistical analysis of ESE motif frequency distribu-
tions revealed a complex relationship between splice
site strength and increased or decreased frequencies of
particular SR protein motifs. Comparison of constitu-
tively and alternatively spliced exons demonstrated
slightly weaker splice site scores, as well as signifi-
cantly fewer ESE motifs, in the alternatively spliced
group. Our results underline the importance of ESE-
mediated SR protein function in the process of exon
definition, in the context of both constitutive splicing
and regulated alternative splicing.
Profiling Alternative Spliced
mRNA lsoforms for Prostate
Cancer Classification
C.L. Zhang, M.Q. Zhang [in collaboration with
the Fu lab at the University of California, San Diego
and the Fan lab at Illumina]
Prostate cancer is one of the leading causes of cancer
illness and death among men in the United States and
worldwide. There is an urgent need to discover good
biomarkers for early clinical diagnosis and treatment.
Previously, we developed an exon-junction microar-
ray-based assay and profiled 1532 mRNA splice iso-
forms from 364 potential prostate-cancer-related
genes in 38 prostate tissues. Here, we investigate the
advantage of using splice isoforms, which couple tran-
scriptional and splicing regulation, for cancer classifi-
cation. As many as 464 splice isoforms from more
than 200 genes are differentially regulated in tumors at
a false discovery rate (FDR) of 0.05. Remarkably,
about 30% of genes have isoforms that are called sig-
nificant but do not exhibit differential expression at
the overall mRNA level. A support vector machine
(SVM) classifier trained on 128 signature isoforms
can correctly predict 92% of the cases, which outper-
forms the classifier using overall mRNA abundance
by about 5%. It is also observed that classification per-
formance can be improved using multivariate variable
selection methods, which take correlation among vari-
ables into account. These results demonstrate that pro-
filing of splice isoforms is able to provide unique and
important information that cannot be detected by con-
ventional microarrays.
Large-scale Structure of Genomic
Methylation Patterns and a
Human Brain DNA
Methylation Prediction Algorithm
R. Das, N. Dimitrova, M.O. Zhang in collaboration with the
Bestor and Ju labs at Columbia University]
The mammalian genome depends on patterns of
methylated cytosines for normal function, but the rela-
tionship between genomic methylation patterns and
the underlying sequence is unclear. We have charac-
terized the methylation landscape of the human
genome by global analysis of patterns of CpG deple-
tion and by direct sequencing of 3073 unmethylated
domains and 2565 methylated domains from human
brain DNA. The genome was found to consist of short
(<4 kb) unmethylated domains embedded in a matrix
of long methylated domains. Unmethylated domains
were enriched in promoters, CpG islands, and first
exons, whereas methylated domains comprised inter-
spersed and tandem-repeated sequences, exons other
than first exons, and nonannotated single-copy
sequences that are depleted in the CpG dinucleotide.
The enrichment of regulatory sequences in the rela-
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tively small unmethylated compartment suggests that
cytosine methylation constrains the effective size of
the genome through the selective exposure of regula-
tory sequences. This buffers regulatory networks
against changes in total genome size and provides an
explanation for the C value paradox, which concerns
the wide variations in genome size that scale indepen-
dently of gene number. This suggestion is compatible
with the finding that cytosine methylation is universal
among large-genome eukaryotes; many eukaryotes
with genome sizes <5 x 10(8) by do not methylate
their DNA. We have also developed a computational
pattern recognition method that is used, for the first
time, to produce a human brain methylation map. This
method can be applied both to CpG islands and to
non-CpG island regions. It computes the methylation
propensity for an 800-bp region centered around a
CpG dinucleotide based on specific sequence features
within the region. We tested several classifiers for
classification performance, including K-means clus-
tering, linear discriminant analysis, logistic regression,
and support vector machine (SVM). The best per-
forming classifier uses the SVM approach. Our pro-
gram (called HDMFinder) presently has a prediction
accuracy of 86%, as validated with CpG regions for
which methylation status has been experimentally
determined. Using HDMFinder, we have depicted the
entire genomic methylation patterns for all 22 human
autosomes.
Regulating Gene Expression
through RNA Nuclear
Retention
Z.Y. Xuan, M.Q. Zhang [in collaboration with the Spector lab,
Cold Spring Harbor Laboratory)
In collaboration with the Spector lab, we have discov-
ered a new class of noncoding RNAs (see description
in the Spector lab report).
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research by out-
standing young scientists who, during their graduate studies, displayed exceptional promise of becoming
leading scientists of the future. The purpose of this program is to provide an opportunity for these young sci-
entists to work independently at the Laboratory for a period of up to 4 years on projects of their own choos-
ing. Fellows are provided with a salary, research support, and technical assistance so that they can accom-
plish their goals free of distraction. The interaction among research groups at the Laboratory and the program
of courses and meetings on diverse topics in biology contribute to a research environment that is ideal for
innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1987), Scott Lowe (1995), and Maria
Timmermans (1998) are currently members of the faculty at the Laboratory. After 9 years at the Laboratory,
Carol Greider (1988) left to join the Department of Molecular Biology and Genetics at Johns Hopkins University
School of Medicine. Eric Richards (1989) is currently in the Department of Biology at Washington University.
After finishing his fellowship, David Barford (1991) returned to the Laboratory of Molecular Biophysics at Oxford
University. Ueli Grossiklaus (1994) was a member of our faculty before leaving to join the Friedrich Miescher
Institut in Basel, Switzerland in 1998. Terence Strick joined the Laboratory in 2000 after earning his Ph.D. in
molecular and cellular biology at Eco le Norma le Superieure in Paris with David Benisimon and Vincent
Croquette. Terrence left to join the l'Institut Jacques Monod at the Centre National de la Recherche Scientifque.
The Laboratory currently has three CSHL Fellows, Gilbert (Lee) Henry, who joined the Laboratory in 2000,
and Patrick Paddison and Ira Hall, both of whom joined the Laboratory in 2004. Their reports are listed below.
Lee joined us from Doug Melton's laboratory at Harvard University, where he earned his Ph.D. for studies on
Xenopus development. Lee is studying the molecular biology of taste receptor cell differentiation. Patrick
Paddison was a graduate student at the Watson School of Biological Sciences here at CSHL, where he worked
in Greg Hannon's lab generating an RNA interference (RNAi) library. Patrick's research goal is to functionally
map the genetic requirements for embryonic stem (ES) cell specification. Ira Hall was also a graduate student
at the Watson School of Biological Sciences, where he worked in Shiv Grewel's lab on the biology of small
RNAs and RNAi. He is currently interested in forming a descriptive analysis of mammalian genomic instability
and plasticity, and in characterizing the contribution of DNA copy-number polymorphisms to genetic variation.
P.J. Paddison
I. Hall
L. Henry
Genes Required for Stem
Cell Specification
P.J. Paddison
Mouse embryonic stem (ES) cells are cell lines derived
from preimplantation embryos that can be expanded in
culture while retaining the functional attributes of
pluripotent early embryo cells. Mouse ES cells can be
induced to differentiate in vitro within complex cellular
aggregates called embryoid bodies. Previous studies
have demonstrated that embryoid bodies undergo a
developmental program which recapitulates many of
the early events of mammalian embryogenesis with
respect to the kinetics of development and differential
gene expression. Fully differentiated somatic cell types,
which in the developing mouse embryo are derived
from precursor cells in each of the three primary germ
layers (i.e., ectoderm, endoderm, and mesoderm) can
now be specified in vitro from embryoid bodies.
At my bench, the initial goal of the research is to
functionally map the genetic requirements for ES cell
specification. To this end, I will introduce genetic lesions
into ES cells that serve to block individual gene function
and ask whether cell specification is also blocked at a
particular stage: pregerm, germ, or postgerm layer.
Presumably, blocks occurring early on during lineage
commitment will affect most lineages, whereas those
occurring later will only affect cells derived from partic-
ular lineages (e.g., neural-ectodermal).
To block individual gene functions in ES cells and
also "stage" particular developmental lesions, I will
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employ the CSHL genome-wide RNA interference
(RNAi) libraries (Paddison et al. 2004) in combination
with lineage-specific mouse ES cell reporter lines.
Hopefully, these studies will not only offer new insight
into stem cell biology and mammalian development,
but also provide a toe-hold for preclinical applications
of stem cells in cell replacement therapies.
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Investigation of DNA
Copy-number Fluctuation
Using Genomic Microarrays
I. Hall, C. Egan
We are interested in pursuing a genome-wide exami-
nation of genetic instability and plasticity and in char-
acterizing the contribution of DNA copy-number poly-
morphisms (CNPs) to genetic variation. The arrange-
ment and copy number of chromosomal segments may
vary between species, strains, and individuals, and
spontaneous DNA rearrangements are recognized to
be causal in the clonal evolution of cancers and in the
etiology of certain human diseases. Ancestral sequence
relationships within and between mammalian genomes
indicate a major architectural role for duplication and
deletion in shaping genomes over evolutionary time,
but little is known about how these processes con-
tribute to genetic variation across more rapid time
scales within normal populations and organisms. We
aim to use the laboratory mouse as a model system to
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investigate the fundamental properties of DNA copy-
number fluctuation in mammals utilizing a form of
comparative genome hybridization termed representa-
tional oligonucleotide microarray analysis (ROMA)
(Lucito et al., Genome Res. 13: 2291 [2000]).
Internal relationships within sequenced genomes
show that a significant portion (2-5%) of chromoso-
mal DNA in mammals is contained within segmental
duplications (defined as stretches of DNA within a
single genome >1 kb in length and >90% identical to
one another), and duplicative events underlie the his-
torical amplification and diversification of many
important gene families. Sequence comparisons are
essential to identify ancient copy-number changes, but
they are not well suited to detect recent and ongoing
genetic events because a complete genome sequence
(1) is usually derived from a single individual, (2)
relies upon assembly methods that are confounded by
large identical repeats, and (3) is still impractical to
attain for large genomes. Traditional molecular tech-
niques are inevitably limited (and directed) to a small
number of loci, and cytogenetic methods lack suffi-
cient resolution to detect most changes. ROMA allows
for the simultaneous detection of CNP and restriction-
fragment-length polymorphisms (RFLPs) between
any two related DNA samples through comparative
hybridization of simplified genomic representations to
high-density oligonucleotide microarrays. This tech-
nique assays a large portion of the genome in a rela-
tively unbiased manner, and it requires only that a
complete genome sequence exists for the organism in
question. A number of recent studies have cataloged
extensive copy-number differences between humans,
indicating that CNPs may account for a substantial
portion of existing genetic variation.
The apparent evolutionary importance and con-
temporary prevalence of segmental copy-number vari-
ation raises fundamental questions. How often do new
CNPs arise? Do CNPs arise through a random
process? Does copy number generally reflect the
ancestry of a locus? What are the prevalent mecha-
nisms of duplication and deletion? Are different chro-
mosomal regions or classes of DNA sequences more
variable than others? Do distinct cells or cell types of
an organism contain the same genetic material?
The laboratory mouse is an ideal model system for
such investigations in that the human and mouse
genomes appear to have been shaped by similar muta-
tional forces, and the mouse offers the significant
technical advantages of controlled crosses, experimen-
tal manipulation, and a known breeding history.
GENETIC DIVERSITY IN INBRED MICE
During the past century, a large number of phenotypi-
cally diverse inbred strains have been derived from a
small number of founder mice through brother-sister
mating. Because these founders were mixed descen-
dants of Asian and European subspecies, each modern
inbred line contains a unique, recombinant mixture of
chromosomal segments of distinct genetic origin.
These genetic differences are thought to underlie the
many interesting physical and behavioral traits for
which modern strains vary.
To gain an understanding of the current genetic
composition of the laboratory mouse and to evaluate the
utility of ROMA as a tool for mouse genetics, we have
profiled the genomes of a number of commonly used
inbred strains. Using a microarray containing approxi-
mately 83,000 probes, we have identified about 15,000
ROMA polymorphisms from 12 strains. More than one
third of these markers can be observed in a single strain
comparison, and further investigation with independent
methods indicates that about one fifth of them are CNPs
(the remainder are RFLPs). These markers are distrib-
uted throughout the genome in a punctate, highly non-
random fashion, and in collaboration with S. Sridhar
(Carnegie Mellon), we have developed a segmentation
algorithm to identify ancestrally divergent haplotypes
and CNPs within our data (this model is based on pre-
vious work by L. Muthuswamy and M. Wigler here at
CSHL). We have compared ROMA polymorphisms to
a curated set of 3.8 million single-nucleotide polymor-
phisms (SNPs) and found that while the majority of
ROMA differences are ancient in origin and mirror the
distribution of SNPs, significant genomic changes have
occurred since the establishment of inbred lines in the
early part of the 20th century.
GENOME STABILITY AND PLASTICITY
To assess the importance of segmental duplication and
deletion in generating de novo generic variation, we are
examining genome stability through normal cycles of
somatic development and germ-line transmission by
measuring the frequency and pattern of DNA copy-num-
ber alterations in diverse cellular lineages of the mouse.
Mutation in the germ line is the basis for the intro-
duction of new alleles to a species and is relevant to
our understanding of evolution, population structure,
and sporadic human disease. Previous estimates of the
germ-line mutation rate have relied on the observation
of spontaneous loss of function at a small number of
genes and do not adequately distinguish between
classes of mutations. The rates of de novo segmental
duplication and deletion are not known. Our analysis
of genetic diversity described above utilized multiple
individuals from each strain and thus represents a test
of the purportedly homozygous and uniform nature of
the inbred mouse genome. We found that inbred mice
are extremely inbred, but rarely identical. We did not
observe residual heterozygosity, but in the majority of
cases, we encountered one or more spontaneous CNPs
between different individuals of the same strain. A fur-
ther sampling of eight C57BL/6 individuals revealed
five CNPs, and a comparison of two substrains
demonstrated that even very closely related lineages
may differ by a large number of CNPs.
On the basis of these results, we have initiated a
study to measure the rate of spontaneous copy-number
change. We have collected pedigreed mice from many
different substrains that have been separated from
each other for 10-100 generations of inbreeding. Our
preliminary results from this study indicate that genet-
ic drift is rapid and prevalent and that CNPs arise at a
surprisingly high rate compared to a single nucleotide
mutation. The spontaneous genomic changes identi-
fied thus far vary dramatically in size (-1 kb to 15
mb), can encompass well-known genes and highly
conserved elements, and have in notable cases inde-
pendently arisen within distinct inbreeding lineages
and/or recurred within a single lineage.
A description of the genetic variation normally
present in somatic cells is important for a few major
reasons. Each cancer is thought to begin with a single
cell that has genetically diverged from its relatives,
and various theories contend that the accumulation of
mutations is a primary cause of aging. DNA
rearrangement is also an established regulatory mech-
anism; our own bodies generate a staggering diversity
of immunological molecules precisely through such
"mutagenic" processes, and more simple genetic sys-
tems (such as various yeasts and bacteria) utilize
reversible DNA rearrangements to make heritable
transcriptional decisions. It is not known how common
such mechanisms are in mammals. In collaboration
with J. Hicks here at CSHL, we are pursuing a survey
of somatic cell diversity. As a first pass, we are simply
analyzing different tissues from the same individual,
but we plan to obtain more pure cell populations via
flow cytometry and microdissection. We are also col-
laborating with K. Eggan (Harvard University) to test
the genetic equivalence of different cells and cell types
using somatic cell nuclear transfer. We hope that these
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studies result in an estimate of clonal variegation in
mammals and help to identify unstable or potentially
hypervariable regions of the genome.
Structural and Functional
Studies of the Vertebrate
Taste Bud
L. Henry, M. Siddiqui
We are interested in the molecular biology of taste
receptor cell differentiation. The mammalian taste bud
is a dynamic structure consisting of mitotically active
progenitor cells at its periphery and differentiated
taste receptor cells within its core. The basic goal of
our research is to understand how the daughters of the
progenitors select a particular fate. As different recep-
tor cells are known to respond to different classes of
tastants, we hope that understanding this differentia-
tion process will help to illuminate both details of
taste bud structure and function. Toward this end, we
have undertaken an exhaustive effort to define the cel-
lular diversity of the murine taste bud at the level of
transcription. To do this, single-cell profiling is being
used to analyze the transcriptomes of taste receptor
and progenitor cells. We are currently developing a
novel procedure to produce single-cell profiles that
rely on the attachment of single-cell levels (picogram)
of mRNA to magnetic beads. The immobilization of
picogram amounts of nucleic acid allows manipula-
tions, free from complicating purification procedures,
to be performed that would usually require microgram
amounts of material. Various aspects of this procedure
have been optimized during the past year, including
the identification of a novel first-strand cDNA-prim-
ing scheme that solves a key background problem
associated with the procedure. The design and synthe-
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sis of a novel cleavable linker both provide flexibility
for the priming oligonucleotide and a means to detach
eDNA from the magnetic bead after a series of modi-
fication steps.
SOLID-PHASE mRNA AMPLIFICATION
In the past year, we have completed all of the synthetic
chemistry steps required to assemble the solid-phase
system used in our amplification procedure. A highly
efficient five-step synthesis was developed for the pro-
duction of polyethylene-glycol-based linkers of vary-
ing lengths (4-37 atoms). The linker is an ortho-nitro
benzene sulfenyl (oNBS) monoprotected diamine that
contains a periodate cleavable cis-diol proximal to the
oNBS end of the molecule. We have tested a series of
linkers and determined that 25 atoms is the minimal
length of the molecule needed for our assay.
Thiol-modified oligomers were attached to 3-lim
magnetic beads via the aforementioned linker in a
four-step procedure. The protected linker was attached
to the bead via a carbodiimide-based acylation. After
oNBS deprotection, the distal end of the linker was
adapted with a commercially available heterobifunc-
tional linker that places a maleimide on the bead that
then accepts the thiol-modified oligomer. Using this
procedure, we can produce beads that bind at a mini-
mum 10 pmoles of poly(dA).
We are currently using this bead system to ampli-
fy picogram amounts of starting material. We will test
the fidelity of the system by assessing the ability of
our procedure to maintain relative transcript levels in
amplified versus nonamplified tester pools of mRNA.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
It was once more an eventful year for the Watson School of Biological Sciences! A Watson School stu-
dent, Zachary Lippman, was the recipient of the Harold Weintraub Award, the Arnold and Mabel
Beckman Foundation renewed-and increased-its support of our graduate program, the National
Science Foundation renewed its support of our summer undergraduate program, and six more stu-
dents were awarded their doctoral degrees!
The Second Watson School Graduation
April 17th saw the Watson School's second graduation ceremony. Michelle Cilia, Ahmet Den li, Elena
Ezhkova, Zachary Lippman, Masafumi Muratani, and Ji-Joon Song made up the graduating class of
2005. The graduation itself was a wonderful occasion at which honorary degrees were bestowed on
Drs. Daniel Koshland and Bruce Alberts, with Dr. Alberts giving the keynote address. We were further
honored that the parents of Elena Ezhkova and Masafumi Muratani traveled from Russia and Japan,
respectively, to attend the graduation ceremony.
The graduating class is a truly impressive group. All six have taken up postdoctoral research posi-
tions, and we wish them every success on the next leg of their scientific journey. We are also delight-
ed to report that Zachary Lippman has been awarded a Human Frontiers Long Term Fellowship for his
(Left to right) Elena Ezhkova, Zachary Lippman, Michelle Cilia, Ji-Joon Song, Masafumi Muratani, Ahmet Den li
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postdoctoral studies, and Ji-Joon Song was awarded a Helen Hay Whitney Fellowship for his post-
doctoral studies.
Student Thesis advisor
Michelle Cilia David Jackson
Ahmet Den li Gregory Hannon
Elena Ezhkova William Tansey
Zachary Lippman Robert Martienssen
Masafumi Muratani William Tansey
Ji-Joon Song Leemor Joshua-Tor
Current Postdoctoral Position
With Dr. Sondra Lazarowitz, Cornell University
With Dr. Fred Gage, The Salk Institute
With Dr. Elaine Fuchs, The Rockefeller University
With Dr. Dani Zamir, Hebrew University of Jerusalem
With Dr. Richard Treisman, Cancer Research, United Kingdom
With Dr. Robert Kingston, Massachusetts General Hospital
In addition to the six students who graduated this year, we saw another two students move on.
Izabela Sujka of the entering class of 2003 decided to leave the program, after completing the require-
ments for a Master's degree, to move to a job in industry. Before joining our graduate program, Izabela
had worked as a research technician for 2 years. She is now working as a research assistant at OSI
Pharmaceuticals, in the area of cancer biology. Molly Perkins of the entering class of 2004, and her hus-
band, relocated to Oxford, England. We are happy to report that Molly was able to transfer to a Ph.D.
program at Oxford University where she will continue with her Ph.D. research under the mentorship of
Dr. Andrew McMichael, working in the field of immunology.
THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 1999
Ahmet E. Den li, March 29, 2005
Processing of pri-microRNAs by the Microprocessor com-
plex.
Thesis Examining Committee
Chair: Nouria Hernandez
Research Mentor: Gregory Hannon
Academic Mentor: Adrian R. Krainer
Committee Member: Scott Lowe
Committee Member: Robert Martienssen
External Examiner: Gail Mandel, Stony Brook
University
ENTERING CLASS OF 2000
Santanu Chakraborty, December 9, 2005
Analysis and modeling of neural connectivity in a short-term
memory system.
Thesis Examining Committee
Chair: Zachary Mainen
Research Mentor: Carlos D. Brody
Academic Mentor: Michael Wigler
Committee Member: Karel Svoboda
Committee Member: Bhubaneswar Mishra
External Examiner David W. Tank, Princeton University
Elena Ezhkova, March 25, 2005
Role of the proteasome in gene control.
Thesis Examining Committee
Chair: Nouria Hernandez
Research Mentor: William Tansey
Academic Mentor: Jan A. Witkowski
Committee Member: Bruce Stillman
Committee Member: Rui-Ming Xu
External Examiner: Jerry Workman, Stowers Institute
Masafumi Muratani, March 31, 2005
Regulation of gene expression by the ubiguitin-proteasome
system.
Thesis Examining Committee
Chair: David L. Spector
Research Mentor: William Tansey
Academic Mentor: Nouria Hernandez
Committee Member: Tatsuya Hirano
Committee Member: Mark Ptashne
External Examiner: Michael Tyers, University of Toronto
ENTERING CLASS OF 2001
Ji -Joon Song, April 1, 2004
Structural and biochemical studies of argonaute reveal the
slicing mechanism of RISC-RNAi effector complex.
Thesis Examining Committee
Chair: Gregory Hannon
Research Mentor: Leemor Joshua-Tor
Academic Mentor: Scott Lowe
Committee Member: Robert Martienssen
Committee Member: Christopher D. Lima
External Examiner: Craig Mello, U. Mass Medical
School
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Zachary Lippman Becomes the Second Weintraub Awardee for the Watson School
I am delighted to report that a second Watson School student, Zachary Lippman of the enter-
ing class of 2000, was a 2005 recipient of the prestigious Weintraub Award. The Harold M.
Weintraub Award for excellence in graduate studies is given annually to 15 students by the Fred
Hutchinson Cancer Research Center. This is the second time a Watson School student has
received this international award-Amy Caudy of the first entering class was a recipient in 2003.
Alumni Spotlight
Amy A. Gaudy, Ph.D., received a B.A. from Washington University in St. Louis and was a
member of the first entering class of the Watson School of Biological Sciences as well as the
School's first graduate. Dr. Caudy was awarded the prestigious Fred Hutchinson Cancer
Research Center's Harold M. Weintraub Award and was also the recipient of a Howard
Hughes Medical Predoctoral Institute Fellowship during her time at the Watson School. She
completed her postdoctoral research with Dr. John Atkinson at Washington University in St.
Louis and is currently a Lewis-Sigler Fellow at the Lewis-Sigler Institute for Genomics at
Princeton University. Says Amy of her time at Cold Spring Harbor Laboratory:
CSHL is one of the most perfect places to do science that I could imagine. First, there are
terrific interactions between people in diverse disciplines. The institution is just the right
size to make it possible fora person working on RNAi in Drosophila and mammals to con-
tinually rub shoulders with neurobiologists, plant biologists, and cancer biologists.
Second, CSHL makes it easy to do ambitious experiments by providing many excellent
shared resource facilities. The Watson School fosters an environment of high expecta-
tions. The intellectual rigor of the Scientific Reasoning and Logic core course sets the
stage for a research environment where graduate students can eagerly debate the latest
results and plot the course for exciting new experiments with research advisors, post-
docs, and other graduate students.
The Fall Term Curriculum
Zachary Lippman
Our faculty members continue to do an outstanding job developing and delivering the curriculum. As
ever, the Curriculum Development and Integration Committee (CDIC), headed by William Tansey, con-
tinues to carefully monitor and develop the curriculum. This year, Josh Huang joined the CDIC, which
now comprises William Tansey (Chair), Lilian Gann, Z. Josh Huang, David L. Spector, and Nicholas
Tonks. For Fall 2005, the Scientific Reasoning and Logic core course has undergone some instructor
turnover, although the content of many of the modules remains the same. Carlos D. Brody, Hollis Cline,
and Arne Stenlund stepped down as full instructors. Z. Josh Huang, W. Richard McCombie, and Scott
Powers were recruited to fill these spots. In addition, Gregory Hannon stepped down as lead instruc-
tor, but remains a course instructor, and Senthil K. Muthuswamy is now lead instructor.
For 2005, the Scientific Exposition and Ethics (SEE) core course has essentially remained the same,
following on from its highly successful revamp in 2004. This course continues to attract outstanding
guest instructors who this year included:
Robert Charrow Greenberg Traurig, LLP, Washington, D.C.
Colin Goddard OSI Pharmaceuticals, Melville, New York
Peter Petre Fortune, New York
Philip Reilly Interleukin Genetics, Inc., Waltham, Massachusetts
Bodo Stern Cell Press, Cambridge, Massachusetts
David Vaux Walter and Eliza Hall Institute, Victoria, Australia
The CDIC continues to interact closely with potential Specialized Disciplines course instructors not only
to identify new topics, but to help them develop courses and their methods of assessment and to mon-
itor workloads. For Fall 2005, the Molecules to Networks course was replaced by a neuroscience course
Neuroscience: Systems and Behavior, taught by Carlos D. Brody (lead instructor) and Zachary Mainen.
Amy Gaudy
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Patrick M. Finigan, University of California, Davis
George A. and Marjorie H. Anderson Fellow
Amy Y. Leung, Cornell University
Beckman Graduate Student
Sarahjane Locke, Wells College
George A. and Marjorie H. Anderson Fellow
Hiroshi Makino, University of St. Andrews
Elizabeth Sloan Livingston Fellow
ENTERING CLASS OF 2005
Katherine McJunkin, Princeton University
Robert and Theresa Lindsay Fellow, Leeds Family Scholar
Nicholas E. Navin, Skidmore College
Goldberg-Lindsay Fellow
Frederick D. Rollins, Cornell University
Cashin Fellow
Oliver Tam, University of Sydney, Australia
Bristol-Myers Squibb Fellow
Jeremy E. Wilusz, Johns Hopkins University
Beckman Graduate Student
Entering class of 2005. (Left to right) Nicholas Navin, Katherine McJunkin, Amy Leung, Frederick Rollins,
Hiroshi Makino, Oliver Tam, Jeremy Wilusz, Sarahjane Locke, Patrick Finigan
Entering Class of 2005
On August 29, 2005, the Watson School opened its doors for the seventh time to welcome yet anoth-
er new class. Nine students-Patrick Finigan, Amy Leung, Sarahjane Locke, Hiroshi Makino, Katherine
McJunkin, Nicholas Navin, Frederick Rollins, Oliver Tam, and Jeremy Wilusz-make up the Entering
Class of 2005. Amy Leung was a participant in our summer undergraduate research program in 2004,
and Nicholas Navin came to us having spent 2 years as a scientific programmer with Michael Wig ler.
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Recruiting Efforts
Recruitment of the graduate program's entering class of 2006 and of par-
ticipants for our summer 2006 undergraduate research program (URP) was
once more managed by Ms. Dawn Meehan, the School's admissions,
recruitment, and student affairs manager. Throughout 2005, Dawn, traveled
the length and breadth of the country to recruit students to our graduate
and undergraduate programs. She has done an outstanding job represent-
ing Cold Spring Harbor Laboratory and the Watson School, and I am deeply
indebted to her for her efforts. The table below details the different recruit-
ment fairs and conferences the School has participated in, together with the
names of faculty, students, and administrators who represented the School
on these occasions.
The School is also deeply indebted to its graduate program's
Admissions Committee, who review, interview, and select candidates for our doctoral program. The
Admissions Committee for the 2005 entering class comprised Gregory Hannon (Chair), Carlos D.
Brody, Josh Dubnau, Adrian R. Krainer, Robert Lucito, Alea A. Mills, Michael P. Myers, Karel Svoboda,
Linda Van Aelst, and William Tansey (ex officio). They are a truly remarkable team!
William Tansey and Watson School student Shraddha Pai
Event
2005 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Location
Ronald E. McNair Scholars Conference
Wellesley College Summer
Undergraduate Research Program
Stony Brook University Summer
Undergraduate Research Program
University of Maryland, Baltimore
County Biology Department Seminar and
Meyerhoff Scholarship Program Visit
XVI Undergraduate Research
Symposium NSF/UMET Model
Institutions for Excellence
Washington, D.C. Area Universities
Graduate and Professional School Fair
Cornell University Graduate and
Professional School Day
New York University Graduate School Fair
Society for Advancement of Chicanos and
Native Americans in Science (SACNAS)
Howard University Graduate School Fair
California Institute of Technology Career Fair
University of California, Berkeley Graduate
School Fair
Brandeis University Graduate School Fair
University of California, Davis Graduate
School Information Day
California Forum for Diversity in Graduate
Education
Hunter College Graduate School Fair
Annual Biomedical Research Conference
for Minority Students (ABRCMS)
University of Maryland, College Park
Wellesley College
Cold Spring Harbor Laboratory
University of Maryland, Baltimore
County
Universidad Metropolitana, San
Juan, Puerto Rico
George Washington University
Cornell University
New York University
Denver, Colorado
Howard University
California Institute of Technology
University of California, Berkeley
Brandeis University
University of California, Davis
California State University,
Sacramento
Hunter College
Atlanta, Georgia
Date
March 17-20
WSBS Attendees/Titles
Dawn Meehan (Admissions, Recruitment,
and Student Affairs Manager)
July 20 Dawn Meehan, Dr. William Tansey
(Director of Graduate Studies)
July 22 Dawn Meehan, Dr. Lilian Clark Gann
(Dean), Dr. William Tansey
Sept. 14-15 Dawn Meehan, Dr. William Tansey
Sept. 16-17 Dawn Meehan, Dr. William Tansey
Sept. 26
Sept. 27-28
Sept. 28
Sept. 29-Oct. 1
Oct. 4
Oct. 12
Oct. 13
Oct. 19
Oct. 28
Oct. 29
Nov. 1
Nov. 2-5
Dawn Meehan
Dawn Meehan, Dr. William Tansey
Dr. Alyson Kass-Eisler (Curriculum Admini-
strator and Postdoc Program Officer),
Dr. Robert Lucito (Assistant Professor)
Dawn Meehan, Dr. William Tansey, Oliver
Fregoso (Graduate Student)
Dawn Meehan
Dawn Meehan, David Simpson (Graduate
Student)
Dawn Meehan, David Simpson
Dr. Alyson Kass-Eisler, Dr. Tim Tully
(Professor)
Dawn Meehan, Dr. William Tansey
Dawn Meehan, Dr. William Tansey
Dr. Josh Dubnau (Assistant Professor),
Shraddha Pai (Graduate Student)
Dawn Meehan, Dr. Lilian Clark Gann,
Keisha John (Graduate Student),
Eva Radeck (Administrative Assistant)
195
Academic Mentoring
The Watson School takes great pride in the level of mentoring it offers its students. One of the very spe-
cial aspects in this regard is its academic mentoring program, led by William Tansey. In this program,
entering students select by mutual agreement a member of the research or nonresearch faculty to
serve as an academic mentor-a watchful guardian to look over and encourage students through the
sometimes-trying process of a doctoral education. This program continues to receive much support
Student
DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
ENTERING CLASS OF 1999
Ahmet Den li Adrian Krainer Gregory Hannon
David Koch Fellow
Thesis Defense: March 2005
ENTERING CLASS OF 2000
Santanu Chakraborty
George A. and Marjorie H. Anderson Fellow
Thesis Defense: December 2005
Elena S. Ezhkova
Engelhorn Scholar
Thesis Defense: March 2005
Rebecca C. Ewald
Engelhorn Scholar
Marco Mangone
Charles A. Dana Foundation Fellow
Masafumi Muratani
George A. and Marjorie H. Anderson Fellow
Thesis Defense: March 2004
ENTERING CLASS OF 2001
Catherine Y. Cormier
Beckman Graduate Student
NSF Graduate Research Fellow
Claudia E. Feierstein
George A. and Marjorie H. Anderson Fellow
Tomas Hromadka
Engelhorn Scholar
Charles D. Kopec
Goldberg-Lindsay Fellow
NRSA Graduate Research Fellow
Ji-Joon Song
Bristol-Myers Squibb Fellow
Thesis Defense: March 2005
Dougal G.R. (Gowan) Tervo
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
ENTERING CLASS OF 2002
Allison L. Blum
Barbara McClintock Fellow
Darren Burgess
Engelhorn Scholar
Michael Wigler
Jan A. Witkowski
Bruce Stillman
Linda Van Aelst
Nouria Hernandez
David J. Stewart
Linda Van Aelst
William Tansey
Anthony Zador
Scott Lowe
Carlos D. Brody
Leemor Joshua-Tor,
Hollis Cline
Nicholas Tonks
Processing of pri-microRNAs by the micro
processor complex.
Carlos D. Brody Analysis and modeling of neural connectivity in
a short-term memory system.
William Tansey Role of the proteasome in gene control.
Hollis Cline NMDA receptor subtypes and dendritic arbor
morphology.
Analysis of the HCF-1 basic region and its role
in sustaining cell proliferation.
Regulation of gene expression by the ubiquitin-
proteosome system.
Winship Herr
William Tansey
Yuri Lazebnik Caspase activation in unidentified apoptotic
pathways.
Zachary Mainen Odor coding and neural correlates of behavioral
choice in the olfactory cortex.
Anthony Zador Stimulus optimization in the auditory cortex.
Roberto Malinow AMPA receptor trafficking and their effect on
spine enlargement during long-term potentiation.
Leemor Joshua-Tor Structural and biochemical studies of Argonaute
reveal the slicing mechanism of RISC-RNAi
effector complex.
Karel Svoboda An inducible and reversible lesion of the corti-
cothalmic projection.
Josh Dubnau
Scott Lowe
Genetic, behavioral, and anatomical characteri-
zation of Radish-dependent memory.
Mammalian RNAi genetic screens: Discovery
and characterization of genes mediating the
response to cancer therapy.
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from the faculty who volunteer to be academic mentors, and it has rightfully become a vital ingredient
in the Watson School's success. The following are this year's new academic mentors for the entering
class of 2005: Senthil K. Muthuswamy (Patrick M. Finigan); Robert Lucito (Nicholas E. Navin); William
Tansey (Amy Y. Leung); Jan A. Witkowski (Frederick D. Rollins); Josh Dubnau (Sarahjane Locke); David
Jackson (Oliver Tam); Hollis Cline (Hiroshi Makino); John R. Inglis (Jeremy E. Wilusz); and Terri
Grodzicker (Katherine McJunkin)
Student
DOCTORAL THESIS RESEARCH (continued)
Mentor
Academic Research
Mentor Thesis Research
Beth L Chen
Beckman Graduate Student
Shu-Ling Chiu
Elisabeth Sloan Livingston Fellow
Jonathan Kui
Alfred Hershey Fellow
Senthil K. Muthuswamy Dmitri Chklovskii
Alea A. Mills
David Jackson
Elizabeth Murchison John Inglis
Engelhom Scholar
ENTERING CLASS OF 2003
Hiroki Asari
Farish-Gerry Fellow
Rebecca Bish
David H. Koch Fellow
Francois Bolduc
William R. Miller Fellow
Monica Dus
Engelhom Scholar
Angeligue Girard
Florence Gould Fellow
Christopher Harvey
David and Fanny Luke Fellow
Izabela Sujka
Beckman Graduate Student
Wei Wei
George A. and Marjorie H. Anderson Fellow
Z. Josh Huang
Linda Van Aelst
Hollis Cline
John Inglis
Jan Witkowski
Adrian Krainer
Marja Timmermans
Jan Witkowski
ENTERING CLASS OF 2004
Daniel Chitwood Alea A. Mills
George A. and Marjorie H. Anderson Fellow
Galen Collins
Beckman Graduate Student
Oliver Fregoso
Seraph Foundation Fellow
William Randolph Hearst Scholar
Keisha John
Ford Foundation Fellow
William Randolph Hearst Scholar
Shraddha Pai
Charles A. Dana Fellow
David Simpson
Beckman Graduate Student
Marja Timmermans
Adrian R. Krainer
Josh Dubnau
Anthony Zador
Scott Lowe
Neuronal network of C. elegans: From anatomy
to behavior.
Hollis Cline Role of insulin receptor in the development of
neuronal structure and function.
Tim Tully Identification and characterization of candidate
memory genes in Arleekin, a Drosophila
memory mutant.
Gregory Hannon Role of Dicer in mammalian development.
Anthony Zador Sparse overcomplete representation as a pried-
ple for computation in the brain.
Michael Myers A proteomics approach to the study of
ubiquitylation.
Tim Tully Role of dFMR1 and the RNAi pathway in
Drosophila learning and memory.
Gregory Hannon Characterization of the biological roles of the
PIWI subfamily.
Gregory Hannon Role of the PIWI family and PIWI-associated
small RNAs in mammalian spermatogenesis.
Karel Svoboda Visualization of MAPK activity in neurons.
Senthil K. Muthuswamy Involvement of polarity genes in ErbB1- and
ErbB2-induced tumorigenesis in vivo.
Roberto Malinow Activity-dependent modulation of APP process-
ing and cri3 production in rat hippocampal
neurons.
Leemor Joshua-Tor Structural and biochemical characterization of
the Schizosaccharomyces pombe RITS
complex.
William Tansey Role of ubiquitin ligases and activator
destruction in transcription.
Michael P. Myers Identifying the mechanism of adeno-associated
virus (AAV) integration and gene targeting and
development of a novel molecular biology tool.
Linda Van Aelst Identification of the molecular determinants
contributing to DOCK7's role in neuronal
polarity.
Carlos D. Brody Determining the neuroanatomical loci and
electrical correlates of duration discrimination
in the rat.
Willliam Tansey Revealing insights into cancer biology with
tumor-derived mutations in c-Myc.
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Student
NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
CSHL Research Mentor Program
Abishek Chakraborty
Cindy Chang
Hsueh-Cheng Chiang
Xingyue He
Ingrid lbarra
Danny Khalil
Anna Kloc
Cam Kuscu
Jane Lee -Osbourn
Xiaofei Liu
Prem Premsrirut
Smita Srivastava
Shuying Sun
Hongjae Sunwoo
Xiaoyun Wu
Wen Xue
Yu-Ting Yang
William Tansey
Scott Lowe
Yi Zhong
Gregory Hannon
Gregory Hannon
William Tansey
Robert Martienssen
Scott Powers
Hollis Cline
Arne Stenlund
Scott Lowe
Jacek Skowronski
Adrian R. Krainer
David L Spector
Z. Josh Huang
Scott Lowe
Linda Van Aelst
Stony Brook, Molecular and Cellular Biology
Stony Brook, Genetics
Stony Brook, Neuroscience
Stony Brook, Genetics
Stony Brook, Genetics
Stony Brook, Genetics
Stony Brook, Genetics
Stony Brook, Molecular and Cellular Biology
Stony Brook, Neuroscience
Stony Brook, Molecular and Cellular Biology
Stony Brook, Genetics
National Institute of Immunology (New Delhi)
Stony Brook, Molecular and Cellular Biology
Stony Brook, Molecular and Cellular Biology
Stony Brook, Genetics
Stony Brook, Molecular and Cellular Biology
Stony Brook, Molecular and Cellular Biology
Interinstitutional Academic Interactions
It is important to remember that many of the graduate students studying at Cold Spring Harbor
Laboratory are not Watson School students. Indeed, the largest percentage of students are from Stony
Brook University, via the programs we have shared with them for some 30 years. The Watson School
provides an on-site "home" for all of these students to help them feel that they are part of the
Laboratory community and to help them as much as possible with the complexities of performing doc-
toral research away from the parent institution. This year, the students listed above joined us.
Graduate Student Seminar Series
One of the most important but often overlooked elements of the graduate student experience at Cold
Spring Harbor Laboratory is the weekly Graduate Student Seminar Series. The Laboratory is special in
that it has a diverse multi-institutional graduate student community, especially the mixing of Stony
Brook University and Watson School students. The graduate student seminars, which are held each
September to May, enable all graduate students studying at the Laboratory to hear seminars from their
colleagues.
Students present their research once a year, with two students presenting each week moderated
by a graduate student chair. In attendance are the graduate students and two members of a core set
of six faculty mentors whose attendance rotates each week. The seminar series, which is open to the
entire Laboratory community, serves three important roles. First, it gives students an opportunity to
hone their oral presentation skills. Second, it provides students with an opportunity to defend their
research without the assistance of their research mentors, such that they experience standing on their
own two feet as they will have to throughout their careers. Third, the students in the audience have an
opportunity to ask questions within their own peer group, thus (earning the important roles of audience
participation for the advancement of research. At the end of the evening, the two faculty mentors pro-
vide each presenting student a critique of the seminar. In addition, members of the audience complete
(anonymously) seminar evaluation forms that are given to the presenting students. Josh Dubnau, Terri
Grodzicker, Alea A. Mills, Andrew Neuwald, Arne Stenlund, and Yi Zhong served as faculty mentors
and brought a breadth of knowledge and experience to the seminar series.
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Faculty Changes
One new research faculty member joined the Watson School this year. Jonathan Sebat joined us as an
assistant professor. Jonathan came to the Watson School after completing his postdoctoral studies in
Michael Wigler's laboratory here at Cold Spring Harbor Laboratory. Jonathan's research will focus on
the role of gene copy-number variation in neurological disease. We are excited to have him here and
look forward to his participation in Watson School activities.
This year we also saw the departure of three faculty members. Winship Herr, the founding dean of
the Watson School, moved his laboratory to Switzerland. Winship joined the Universite de Lausanne
as a Professor in the Center for Integrative Genomics. His current interests focus on understanding how
HCF-1 regulates cell proliferation, especially as it pertains to cancer and cell differentiation.
Nouria Hernandez, who had been an integral part of the Watson School since its inception, also
moved to the Universite de Lausanne this year. Nouria served on the School's Admissions Committee
for 5 years and as its chair for 3 years. She was a guest lecturer in the Scientific Reasoning and Logic
core course, the Mechanisms of Transcriptional Regulation: From E. coif to Elephants specialized dis-
ciplines course, and the Scientific Exposition and Ethics core course. Nouria served as a laboratory
rotation advisor, an academic mentor, and a thesis committee chair. Nouria has joined the Universite
de Lausanne as a Professor and as the Director of the Center for Integrative Genomics. Her research
focuses on understanding fundamental mechanisms of transcription and transcriptional regulation.
Masaaki Hamaguchi, who served as a laboratory rotation advisor, is now an Associate Professor in
the Department of Biological Sciences at Fordham University. His research focuses on studying the
genes responsible for cancer development.
We are deeply indebted to all three for their efforts and wish them well in their new "homes."
Graduate Students and Postdoctoral Fellow Departures
With each year comes not only new arrivals, but also departures. The following graduate students and
postdoctoral fellows departed from the Laboratory during 2005:
Graduate Students
Bidisha Chattopadhyaya
Stephen D. Clow
Elena Ezhkova
Agnes Fischer
Hilde Grassmo-Wendler
Kendall Jensen
Lukasz C. Kozaczkiewicz
Andrea Leibfried
Postdoctoral Fellows
Jean-Raymond Ango
Andres Barria-Roman
Carine Becamel
Paula A. Bubulya
Hsu Hsin Chen
Debopriya Das
Rajdeep Das
Elisa De Stanchina
Robert Del Vecchio
Hiyuan Ding
Farida Emran
Zachary B. Lippman
Masafumi Muratani
Togay Oztaskin
Molly R. Perkins
Thomas A. Pologruto
Evan E. Santo
Ashish Saxena
Peter J. Gillespie
Derek Goto
Eve Govek
Hui-Fu Guo
Susan M. Janicki
Cizhong Jiang
Natarajan Kannan
Carla E. Margulies
Jinrong Min
Pol O'Fearghail
Lance E. Palmer
Noriko Simorowski
Srinath Sridhar
Ji-Joon Song
Izabela Sujka
Zankhana Thakkar
Francisca von Saint Paul
Chia-Lin Wu
Vijay Patankar
Amandine Penel
Emiliano Rial Verde
Jose L. Roig
Kalpana Samudre
Clare L. Scott
Gordon Shepherd
Pavel Sumazin
Shweta Tyagi
Vanisree Velamoor
The Postdoctoral Program at Cold Spring Harbor Laboratory
The Postdoctoral Program Office at Cold Spring Harbor Laboratory is continuing its efforts to meet the
needs of the Laboratory's postdoctoral fellows (postdocs) and faculty, under the day-to-day manage-
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ment of Alyson Kass-Eisler and the scientific leadership of Nicholas Tonks. This year, the Laboratory
welcomed 31 new postdocs and saw 32 depart. The departing postdocs went on to positions at the
Blanchette Rockefeller Neuroscience Institute, Duke University, Eli Lily and Company, GlaxoSmithKline,
Hokkaido University, Lawrence Livermore National Laboratory, Northwestern University, The University
of Oregon, Portland State University, Stony Brook University, Walter and Eliza Hall Institute of Medical
Research, Washington University, The Wistar Institute, and Wright State University, to name but a few.
We wish them every success for the future.
Postdocs at the Laboratory are encouraged to apply for individual fellowships to enhance their
careers, as well as provide support for the Laboratory. The Postdoctoral Program Office provides our
postdocs with an individualized list of eligible fellowships to which they can apply. These fellowships are
highly competitive and require a great deal of work on the part of the applicant. We are very proud of
our postdocs who have received these prestigious fellowships. In 2005, postdocs received awards
from the following foundations: Alzheimer's Foundation, Army, Burroughs Wellcome Foundation,
Canadian Institute of Health Research, Damon Runyon Cancer Research Foundation, FRAXA
Foundation, Helen Hay Whitney Foundation, Hereditary Disease Foundation, Human Frontier of
Science Program, Jane Coffin Childs Memorial Fund for Medical Research, Leukemia and Lymphoma
Foundation, National Alliance for Research on Schizophrenia and Depression, National Institutes of
Health, National Science Foundation, and Wellcome Trust.
Assisting postdocs with career development continues to be an important goal of the School. We
were pleased to have been chosen in 2005 to participate in the Merck Research Laboratories
Ambassador Recruiting Program. The goal of the program is to establish a long-standing relationship
between the Merck Ambassador and the Laboratory's graduate students and postdoctoral trainees so
that they can learn about potential career opportunities in industry directly from a Merck scientist. The
"Ambassador" is Dr. Jing Li, a Research Fellow at MRL. In addition, MRL has provided a monetary gift
to the graduate and postdoctoral programs to provide support for activities that promote scientific
exchanges and career opportunity discussions among the trainees at the Laboratory. In one such lec-
ture, David Vaux, Senior Principal Research Fellow in the Walter and Eliza Hall Institute's Molecular
Genetics of Cancer Division, presented a lively lecture entitled "Ten rules of thumb for the presentation
and interpretation of data in publications." In addition to the programs that we conduct here, the
Laboratory's continuing partnership with the New York Academy of Science, Science Alliance has given
our postdocs additional opportunities for networking and obtaining career development advice. This
year, the Science Alliance seminar titles included:
Faculty Search Committees: What Are They Looking For?
Job Search Fundamentals
Bioscience Research: Where Do You Fit In?: Naturejobs/NYAS Career Fair and Symposium
Postdoctoral trainees have had the opportunity to participate in teaching undergraduate and graduate
students at the School. This year, participation has included course lectures, moderating discussion ses-
sions in core courses, and student tutoring. Additionally, postdocs at the Laboratory gave lectures in the
Undergraduate Research Program's Bioinformatics Workshops. We are extremely grateful for the exper-
tise our postdocs have been able to share with the School's other educational programs.
To complement our local efforts, we have been involved on a national level in workshops aimed at
shaping the postdoctoral experience. In 2004, we became founding members of the National Postdoc
Association (NPA). In March 2005, Alyson Kass-Eisler attended the third annual meeting in San Diego,
California. Topics of interest to the Laboratory's postdocs included:
The NPA's Agenda for Change
The Sigma Xi Postdoc Survey
An overview of the NIH K Awards Program
Career and Job Search Strategies for Postdocs
Trends in Postdoctoral Training, Evaluating Best Practices
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Effective Strategies for Enhancing the Postdoctoral Experience
Postdoc Policy 101
A Comprehensive Pilot Mentoring Program
Policy Roundtable: Fostering Collaboration
Postdoc Work Visa Options
Academic-Industry Relations
Keynote Address by Steven Sample (President, University of Southern California)
Executive Committee
A large measure of the Watson School's success can be traced to the sage advice, guidance, and gov-
ernance of the School's Executive Committee. January 2005 saw the induction of a new faculty mem-
ber Terri Grodzicker, replacing Jan A. Witkowski who had faithfully served for 6 years. As happens each
year, there was also turnover among the student representatives. The Watson School representative
Darren Burgess was replaced by Hiroki Asari, and the Stony Brook University representative Mar lies
Rossmann was replaced by Despina Siolas. The School is indeed thankful for their frank, honest, and
thoughtful advice.
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher of
Molecular Biology of the Ce//, who died of cancer in 1991) brings to the Laboratory an eminent
researcher and educator to give the Gavin Borden Lecture, dedicated to the graduate students at the
Laboratory. Dr. Huda Zoghbi from the Baylor College of Medicine and an Investigator with the Howard
Hughes Medical Institute, as well as a practicing clinician, was this year's Fellow. Her lecture "Cross-
species Studies to Unfold the Pathogenesis of a Neurodegenerative Disease" was thoroughly enjoyed
as evidenced by the standing-room-only audience. In addition, Huda shared her experiences as a sci-
entist and clinician at a roundtable discussion with the students the following day.
The Watson School Continues to Benefit from Generous Benefactors
For the last 5 years, the School has been the recipient of a grant from the Arnold and Mabel Beckman
Foundation. Ms. Jacqueline Dorrance, Executive Director of the Beckman Foundation, made a site visit
to the School in November 2004. Following on from her very successful visit and meetings with the stu-
dents and faculty, in April 2005, we were invited to submit an application for renewed funding. I am
extremely pleased to report that we have been awarded a second grant of $1.75 million from the
Beckman Foundation! This 5-year grant will fund five students per year and contribute $100,000 annu-
ally toward the core courses. I would like to take this opportunity to thank Kiryn Haslinger
from the Laboratory's Development Office for her superb assistance in preparing the
funding application. In addition, we were notified in April that the School's National
Institutes of Health training grant has been renewed for another year; we have again
been awarded five slots. This spring, the School will submit a competitive renewal for this
grant.
The Watson School Administration
The Watson School administration (a.k.a. Team Watson!) continues to grow from
strength to strength. I am pleased to announce that Eva Radeck joined us as the
School's administrative assistant in April. Eva took over from Mark Beavers who moved
to Meetings and Courses earlier this year. Eva is a native of Germany, who studied
Eva Radeck
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administration and foreign languages (English, French, and Spanish).
Before joining the Laboratory, she worked for 7 years at the European
Molecular Biology Laboratory in Heidelberg.
The WSBS Family Continues to Grow
On July 15, 2005, Beth Chen, of the entering class of 2002, and her
husband, Pavel, welcomed a beautiful baby daughter, Madeleine
Ekaterina, who weighed in at 7 pounds, 7 ounces. All are thriving!
This year has also seen several engagements. Shraddha Pai (from
the entering class of 2004) announced her engagement to Lincoln
Stein, and David Simpson (also from the entering class of 2004)
announced his engagement to Erin Dann. And our very own "Team
Watson" member, Dawn Meehan, became engaged to former gradu-
ate student Thomas Pologruto in February. Our congratulations and
best wishes go to all of them!
Lilian Clark Gann
Dean
SPRING CURRICULUM
TOPICS IN BIOLOGY
ARRANGED BY Dawn Meehan
Alyson Kass-Eisler
Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting Lectureship; The
Fairchild Martindale Visiting Lectureship; The Lucy and Mark Ptashne Visiting Lectureship;
The Michel David-Weill Visiting Lectureship
Each year, one instructor or a team of invited instructors offer 7-day courses at the Banbury Conference
Center to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory facul-
ty. These courses include morning or evening lectures as well as afternoon sessions during which stu-
dents read assigned papers. These intensive courses are modeled on the Cold Spring Harbor
Laboratory Lecture Courses held each summer at the Banbury Conference Center. In Spring 2005,
there were two such courses: Human Behavior and Evolution.
Human Behavior
Attended by the entering classes of 2001 and 2002
INSTRUCTOR Jill M. Mateo, University of Chicago
GUEST LECTURER Michael J. Owren, Cornell University
TEACHING FELLOW Kara Nuss, University of Chicago
(Left to right, kneeling) Jonathan Kui, Shu-Ling Chiu, Allison Blum. (Left to right, standing) Beth Chen,
Claudia Feierstein, Tomas Hromadka, Gowan Tervo, Charles Kopec, Elizabeth Murchison, Catherine
Cormier, Kara Nuss, Darren Burgess, Jill Mateo
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The essence of this course was a radically different way of thinking about why animals, including
humans, behave as they do. In contrast to physiological, developmental, cognitive, or other "proxi-
mate" approaches to behavior, in this course, evolutionary or functional approaches were primarily
used. The question repeatedly asked was "How does a particular behavior contribute ultimately to the
survival and reproductive success of an individual exhibiting the behavior?" A shorthand of this is "What
is the adaptive significance of the behavior?" Topics in the course included an overview of Darwin's the-
ory of evolution by natural selection, inclusive fitness, kin selection, and the evolution of altruism, genet-
ic-developmental influences on behavior, the evolution of sexual reproduction and of the sex ratio, the
evolution of mating systems and sexual selection, and the evolution of male and female reproductive
strategies, among others. Note that most of these behaviors are social behaviors. The greatest pro-
portion of attention was given to animals other than humans, but with the intention of understanding
the behavior of all animal species, including humans, in an evolutionary framework. The course
revolved around Darwin's theory of organic evolution by the process of natural selection. This theory
and some of its recent extensions were used to examine animal behavior in an evolutionary context.
The emphasis of course content was on concepts, ideas, and theories, which were described and clar-
ified with specific examples from many animal species.
The course ran from Sunday to Saturday (March 28-April 3) and was organized and largely taught
by Jill Mateo. It integrated lectures by the instructors, daily quizzes, directed readings of research
papers, seminars by the instructors, and a field trip to the Bronx Zoo. The students, many of whom
had little prior awareness of the subject, rated the course very highly.
Evolution
Attended by the entering classes of 2003 and 2004
INSTRUCTOR Nipam H. Patel, University of California, Berkeley
GUEST LECTURERS Casey Bergman, Cambridge University, United Kingdom
Rob De Salle, American Museum of Natural History
Neil Shubin, University of Chicago
TEACHING FELLOWS Brian Kraatz, University of California, Berkeley
Danielle Liubicich, University of California, Berkeley
John Novembre, University of California, Berkeley
The field of evolutionary biology touches upon all other areas of the biological sciences, since every
form of life and every biological process represent an ongoing evolutionary "experiment." The aim of
this course was both to discuss the understanding of the mechanisms of evolution and to explore how
evolutionary data can be used to further the understanding of various biological problems.
The course began with a discussion of the diversity of organisms that currently exist and our meth-
ods for understanding the evolutionary relationships among these organisms. It went on to study how
paleontological data are collected and used to understand the history of life on earth and then exam-
ined how DNA sequence data can be used to understand the evolutionary history of organisms, genes,
and genomes. Within this molecular and genetic framework, the focus shifted to the mechanisms of
evolutionary change and how variation within populations leads to the evolution of new species. Finally,
there were discussions about how morphological changes are brought about through evolutionary
changes in development and gene regulation. The hope was that this course would provide the stu-
dent with a general overview of evolutionary biology and how to use evolutionary data to gain further
insight into all manner of biological problems.
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(Left to right) John Novembre, Brian Kraatz, Shraddha Pai, Keisha John, Oliver Fregoso, Daniel Chitwood, Izabela Sujka, Molly Perkins, Casey
Bergman, David Simpson, Galen Collins, Nipam H. Patel, Monica Dus, Hiroki Asari, Francois Bolduc, Wei Wei, Christopher Harvey, Evan Santo,
Danielle Liubicich
The course ran from Sunday to Saturday (April 17-April 23) and was organized and largely taught by
Nipam H. Patel. It integrated lectures by the instructors, directed readings of research papers, seminars
by the instructors and guest lecturers, and a creation of a "tree of life" based on their hands-on study of
living biological samples. As in previous years, the course was highly rated by all of the students.
Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Mick los
INSTRUCTORS Craig Hinkley (Lead Instructor, High School)
Erin Maroney (Lead Instructor, Middle School)
Athanasios (Tom) Bubulya
Elna Carasco
Jeanette Collette
Uwe Hilgert
Amanda Mc Brien
ADMINISTRATOR Carolyn Reid
As science has an increasing role in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory's Dolan DNA Learning Center,
205
where students teach laboratory courses to high school and middle school students. From these
teaching experiences, they learn how to communicate with nonbiologists and to inspire and educate
creative young minds. The teaching module entailed pairs of students teaching one morning or after-
noon a week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the
Watson School students the didactic process-it was not until the fifth week that the graduate stu-
dents taught on their own. At the end of the 12 weeks, the students were very excited about their
teaching experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in
laboratory rotations. These rotations provide students and faculty the opportunity to get to know each
other and to explore possibilities for doctoral thesis research. At the end of each rotation, students
make short presentations of their studies to the other students and their rotation advisors. These talks
give students an opportunity to share their laboratory experiences and to learn how to give a scientif-
ic presentation. With this latter goal in mind, in addition to the research mentors, the instructors of the
Scientific Exposition and Ethics core course and members of the School's Executive Committee attend
the talks and give individual feedback to students on their presentations. This year, 17 faculty mem-
bers served as rotation mentors, some mentoring more than one student.
ROTATION MENTORS Carlos D. Brody
Josh Dubnau
Leemor Joshua-Tor
Eli Hatchwell
Scott Lowe
Zachary Mainen
Alea A. Mills
Senthil K. Muthuswamy
Michael P. Myers
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Scott Powers
David L. Spector
Lincoln Stein
William Tansey
Marja Timmermans
Nicholas Tonks
Linda Van Aelst
Michael Q. Zhang
FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation; The William Stamps Farish Lectureship
INSTRUCTORS Senthil K. Muthuswamy (Lead)
Gregory Hannon
Z. Josh Huang
W. Richard McCombie
Scott Powers
Marja Timmermans
GUEST LECTURERS Grigori Enikolopov Patrick J. Paddison
Leemor Joshua-Tor Cordula Schulz
Adrian R. Krainer William Tansey
Scott Lowe Nicholas Tonks
Wolfgang Lukowitz Bruce Stillman
Michael P. Myers
VISITING LECTURER William C. Merrick, Case Western Reserve University
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the Fall Course a broad base of knowledge
in the biological sciences, (2) learned the scientific method, and (3) learned how to think critically about
biological concepts. This course consisted of six 2-week modules, each of which had a different
theme. For each module, students read an assigned set of research articles (generally four articles) and
provided written answers to a problem set that guided them through two (or, occasionally, one) of the
articles. Twice weekly, students attended lectures related to the week's topic, which included concepts
and experimental methods. During the week, the students met among themselves to discuss assigned
papers not covered by the problem set. At the end of each week, the students spent the evening dis-
cussing these papers with faculty. In the final module, Study Section, the students participated in a
mock review of real, funded Federal RO1 grants including oral presentations and written critiques.
Module 1 Gene Expression Module 4 Development
Module 2 Cell Division Cycle Module 5 Genomics and Proteomics
Module 3 Signal Transduction Module 6 Study Section
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The Darrell Core Course on Scientific
Exposition and Ethics
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation; The John P. and Rita M. Cleary
Visiting Lectureship; The Seraph Foundation Visiting Lectureship; The Susan
T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS William Tansey (Lead)
Yuri Lazebnik
Jan A. Witkowski
VISITING LECTURERS Robert P. Charrow, Greenberg Traurig LLP
Colin Goddard, OSI Pharmaceuticals
Peter Petre, Fortune Magazine
Philip Reilly, Interleukin Genetics
Bodo Stern, Cell Press
David Vaux, Walter and Eliza Hall Institute
This core course offered instruction in the fundamental elements of scientific exposition-writing skills
and public speaking-and ethics. The ability to communicate effectively and to appreciate the intrica-
cies of ethical issues are essential skills for biologists; both subjects were taught in a series of exam-
ple-based lectures and discussion groups. Writing skills included the fundamentals of modern scientif-
ic English and the organization and preparation of papers, research abstracts, and grant applications.
Oral presentation skills were taught by scientists with excellent, albeit different, modes of presentation.
Together with instructors, students critiqued formal seminar presentations at the Laboratory. Instruction
and discussions about ethics included the ethical implications of biological discovery on society (e.g.,
the implications of the cloned sheep Dolly for human cloning) as well as the nature and boundaries of
ethical behavior of scientists and their rights and responsibilities. A primary objective of the course was
that students consider exposition and ethics an integral part of scientific research.
Research Topics
ARRANGED BY Lilian Clark Gann
Eva Radeck
This core course provided students with an in-depth introduction to the fields of research that Laboratory
scientists investigate. Students and faculty attended a weekly Research Topics seminar, at which faculty
members presented their current research topics and methods of investigation each Wednesday evening
over dinner. The students learned how to approach important problems in biology. These seminars,
together with the annual fall Laboratory In-House symposium, provided students with a basis for select-
ing laboratories in which to do rotations. The weekly speakers were:
Week 1 Carlos D. Brody, Hollis Cline, Grigori Enikolopov
Week 2 Gregory Hannon, Z. Josh Huang, David Jackson
Week 3 Leemor Joshua-Tor, Alexei Koulakov, Adrian R. Krainer
Week 4 Scott Lowe, Yuri Lazebnik, Robert Lucito
Week 5 Wolfgang Lukowitz, Zachary Mainen, Robert Martienssen
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Week 6 W. Richard McCombie, Alea A. Mills, Vivek Mittal
Week 7 Senthil K. Muthuswamy, Michael P. Myers, Jonathan Sebat
Week 8 David L. Spector, Lincoln Stein, Arne Stenlund
Week 9 Bruce Stillman, William Tansey, Maria Timmermans
Week 10 Linda Van Aelst, Michael Wig ler, Anthony Zador
Week 11 Michael Q. Zhang, Yi Zhong
SPECIALIZED DISCIPLINES COURSES
Genetics
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship; The Pfizer Lectureship; The
George B. Rathmann Lectureship; The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Tim Tully (Lead)
Josh Dubnau
Lincoln Stein
GUEST LECTURER Wolfgang Lukowitz
VISITING LECTURER Bambos Kyriacou, University of Leicester, United Kingdom
The human genome sequence and continued advances in molecular biological techniques have initi-
ated a paradigm shift in the biological sciences, from phenomenological description to genetic per-
spective. Genes now can be manipulated in experiments, permitting interventionist studies of their
roles in various aspects of biological function. These experimental data can be integrated (1) "verti-
cally" to understand how molecular mechanisms influence functional output from various levels of bio-
logical organization and (2) "horizontally" to understand how genetic pathways have been conserved
evolutionarily.
This course placed classical organismal genetics into the context of modern molecular biology and
genomics. History, perspective, and technique were described around four levels of analysis: pheno-
type, genotype, variation, and genome. How do gene mutations help to define biological processes?
How are more complex traits genetically dissected into simpler (underlying) components? What con-
cepts and techniques are used to organize genes into pathways and networks? How are genes
mapped, cloned, and engineered to identify functional domains of proteins? What gene variation
exists in natural populations? What are the functional consequences of gene variation? How is it
detected? How are genomes organized and coordinately regulated? How can genomic information
be cataloged, organized, and mined? These questions and concepts were fleshed out using exam-
ples from the literature.
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Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship; The Sigi Ziering Lectureship; The Martha
F. Gerry Visiting Lectureship
INSTRUCTORS David L. Spector (Lead)
Linda Van Aelst
VISITING LECTURERS Michael Caplan, Yale University
Gregg Gundersen, Columbia University
Con ly Rieder, Wadsworth Center, New York State Department of Health
Marc Symons, North Shore-LIJ Research Institute
Graham Warren, Yale University
With the complete genome sequence available for many organisms, there is now an increasing empha-
sis on understanding the function of the gene products. This understanding requires an increasing appre-
ciation of the structure and function of the cell as well as dynamic associations within the cell. This course
provided a basic overview of the structural and functional organization of cells with particular emphasis
on cellular compartmentalization and communication. Topics of focus included the cytoskeleton, cell
adhesion and signaling, membrane transport, gene expression, and nuclear organization. In addition, the
course provided insight into the basic toolbox of the cell biologist of the 21st century.
Neuroscience: Systems and Behavior
FUNDED IN PART BY The George W. Cutting Lectureship; The Klingenstein Lectureship
INSTRUCTORS Carlos D. Brody (Lead)
Zachary Mainen
GUEST INSTRUCTORS Dmitri Chklovskii
Roberto Malinow
This course introduced students to neuroscience, with a focus on systems and behavior. No prior
knowledge of neuroscience was assumed. The course began by describing the basics of electrical sig-
naling in neurons: membrane potentials, ion channels, action potentials, and synaptic transmission.
How do such building blocks translate into whole-organism behavior? The instructors first discussed
classical conditioning and asked how changes insynaptic transmission could underlie such behavior.
They then discussed associative learning, Hebb's postulates, LTP (long-term synaptic potentiation),
and some computational models of associative learning. From behaviors that focus on simple memo-
ries, they turned to behaviors that require making perceptual decisions. Some basic concepts of per-
ceptual neuroscience, such as neuronal "receptive fields," were covered and then used to discuss cur-
rent results and models of perceptual decision making. Finally, they turned to the learning of temporal
sequences and discussed the temporal credit assignment problem, dopamine and VTA neuron
responses, temporal difference models of learning, and addictive behavior.
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UNDERGRADUATE RESEARCH PROGRAM
Program Directors: David Jackson
Lincoln Stein
Program Administrator: Dawn Meehan
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time faculty members. The
program was initiated in 1959. Since that year, 676 students have participated in the course and many
have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, molecular cellular, and structural
biology, neuroscience, and genomics; and (4) a personal acquaintance with research, research work-
ers, and centers for study.
During the program, the students are housed together on the Laboratory grounds. Nearly all of the
students arrive at the same time and share the entire experience. For programmatic reasons, we limit
the number of students to 25. In this manner, we ensure a cohesive program with substantial scientif-
ic and social interactions among the students. The students are required, at the beginning of the pro-
gram, to present to their peers a concise oral description of the background and the design of the
experiments they will be performing. At the end of the 10-week program, the undergraduates present
a 15-minute seminar describing the background, design, and results of the experiments during the
course of a 2-day undergraduate symposium. During their stay, the participants attend a series of fac-
ulty talks given by both young and established scientists at the Laboratory. These seminars are attend-
ed by only the students to assure that the seminars remain at a level appropriate for the undergradu-
ates. It also encourages questions in an informal and comfortable setting. In addition to scientific dis-
cussion, these presentations cover important issues such as personal experiences and choices that
led the scientists to their current area of research and position. The following students, selected from
597 applicants, took part in the 2005 program:
(Top row, left to right) Alexei Finski, Wei Gan, Alexandra Nica, Victoria Svinti, Tasleem Samji, Christian Sanchez-Jordan,
Albert Almada, Dailia Francis, Jonathan Chen, Margot Rommens, Laura Wherity, Kelly Wetmore. (Bottom row, left to right)
David Wurtz, Robert Carrasquillo, Krishnan Palaniappan, Marek Kudla, Vanessa Ringgold, Scott Millman, Nora Seidl, Yaniv
Erlich, Ye Wang, Christopher Javadi, Vineeta Argawala, Thomas Takara, Betty Kong
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Vineeta Agarwala, Stanford University
Advisor: Dr. Michael Q. Zhang
Sponsor: National Science Foundation
CTCF binding-site specificity and distribution.
Albert Almada, University of California, Irvine
Advisor: Dr. Andrew Neuwald
Sponsor: National Science Foundation
Exploring the relationship between sequence, structure, and
function in the ap hydrolase fold family.
Robert Carrasquillo, Washington University, Saint Louis
Advisor: Dr. Robert Martienssen
Sponsor: National Science Foundation
Effects of differential methylation on transposon activation and
gene expression in A. thaliana.
Jonathan Chen, Oberlin College
Advisor: Dr. Gregory Hannon
Sponsor: Burroughs-Wellcome Fund
Utilizing RNAi to identify metastasis-associated genes.
Yaniv Erlich, Tel-Aviv University
Advisor: Dr. Partha P. Mitra
Sponsor: Emanuel Ax Fund
Novel wireless sensor network for electrophysiology and
behavioral research.
Alexie Finski, International University, Bremen
Advisor: Dr. Zachary Mainen
Sponsor: H. Bentley Glass
Two-photon imaging of spines and cell populations in head-
fixed awake behaving animals.
Dailia Francis, Hunter College
Advisor: Dr. Alea A. Mills
Sponsors: William Townsend Porter Foundation and Hunter College
Novel tumor suppressor gene(s) at human 1 p36.
Wei Kevin Gan, Harvard College
Advisor: Dr. William Tansey
Sponsor: Olney Foundation
Exploring the role of the 20S proteasome subunit in transcrip-
tion regulation.
Christopher Javadi, University of Texas, Austin
Advisor: Dr. Josh Dubnau
Sponsor: National Science Foundation
Drosophila deficiency mapping using whole-genome tiling arrays.
Betty Kong, Rutgers University
Advisor: Dr. Vivek Mittal
Sponsor: Joan Redmond Read Fund
Developing an in vitro assay for studying the function of bone-
marrow-derived lineage-depleted cells in vasculature for-
mation.
Marek Kudla, Warsaw University
Advisor: Dr. Rui-Ming Xu
Sponsor: Former URP Fund
Prp8: The elusive structure of a crucial spliceosomal component.
Scott Millman, Cornell University
Advisor: Dr. Adrian R. Krainer
Sponsor: Joe Lewis Jefferson Foundation
Mutational analysis of the oncogenic activity of SF2/ASF.
Alexandra Nica, International University, Bremen
Advisor: Dr. W. Richard McCombie
Sponsor: Former URP Fund
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Genome-wide SNP detection in Otyza sativa strains using a
massively parallel sequencing strategy.
Krishnan Palaniappan, Carnegie Mellon University
Advisor: Dr. Bruce Stillman
Sponsor: National Science Foundation
Binding of mitotic cyclins to Cdc6 and ORC as regulators of
prereplication complex formation.
Vanessa Ringgold, University of California, Davis
Advisor: Dr. Marja Timmermans
Sponsor: National Science Foundation
Investigations into the affects of ASYMMETRIC LEAVES 1 in
Arabidopsis.
Margot Rommens, University of Leuven
Advisor: Dr. Linda Van Aelst
Sponsor: Jephson Educational Trust
Oligophrenin: Where art thou? Detecting OPHN-specific phage
clones for subsequent germ-line manipulation in mice.
Tasleem Samji, Cambridge University
Advisor: Dr. Senthil K. Muthuswamy
Sponsor: C. Bliss Memorial Fund
Silencing Par 6a in breast epithelial cell lines.
Christian Sanchez-Jordan, Johns Hopkins University
Advisor: Dr. Robert Lucito
Sponsor: Garfield Fellowship
High-throughput RT-qPCR: Narrowing the list of candidate
tumor suppressor genes in ovarian and other cancers.
Nora Seidl, Cambridge University
Advisor: Dr. David Jackson
Sponsor: Von Stade Fellowship
Isolation of FEA2 and associated proteins.
Victoria Svinti, Nui Maynooth, Ireland
Advisor: Dr. Lincoln Stein
Sponsor: Libby Fellowship
Programmed frameshifts in Paramecium.
Thomas Takara, Grine II University
Advisor: Dr. Leemor Joshua-Tor
Sponsor: National Science Foundation
A structural investigation of papillomavirus replication initiation
protein El.
Ye Wang, University of Rochester
Advisor: Dr. Cordula Shultz
Sponsor: National Science Foundation
ppd-To be stem cells, or not to be.
Kelly Wetmore, University of California, Los Angeles
Advisor: Dr. Wolfgang Lukowitz
Sponsors: Steamboat Foundation and the National Science
Foundation
Mapping quantitative trait loci that modify mutations in SHORT
SUSPENSOR, a predicted kinase regulating plant embryo-
genesis.
Laura Wherity, Oxford University
Advisor: Dr. Alexei Koulakov
Sponsor: William Shakespeare Fellowship
Obtaining graded values of synaptic strength in the CaMKII
and PP1 feedback loop in neurons.
David Wurtz, Olin College of Engineering
Advisor: Dr. Yuri Lazebnik
Sponsor: Jephson Educational Trust
The cause and effect of multinucleation.
PARTNERS FOR THE FUTURE
Program Director: Yuri Lazebnik
Program Administrator: Lynn Hardin
The Partners for the Future Program, established in 1990, brings Long Island high school students into
Cold Spring Harbor laboratories and gives them a taste of the real world of biomedical research. The
program is open to all Long Island high school students entering their senior year; each high school
science chairperson may nominate three students from his or her school during their junior year. The
six students selected spend a minimum of 10 hours per week, September through March of their
senior year, doing original research under the watchful eye of a scientist mentor. At the conclusion, the
students give oral presentations of their research projects to an enthusiastic audience of the students'
scientific mentors, Lab administrators, parents, and teachers. Although the students learn a great deal
about modern biology and state-of-the-art research techniques, the main advantage of the program is
in exposing the students to day-to-day life in a working lab. Debunking the mythical scientist in a lab
coat image, the students are introduced to a world of relatively young scientists and their interactive
support staff in a relaxed, problem-solving atmosphere. The 2005-2006 Partners for the Future are:
Partner High School CSHL Mentor Laboratory
Daniel Capurso Sayville High School Anindya Bagchi Alea A. Mills
Faith Chang Syosset High School Vivek Mittal Robert Martienssen
Yuting Chiang The Wheatley School Cordula Schulz
James Gurtowski Cold Spring Harbor High School Ravi Sachidanandam
Yuri Hanada Farmingdale High School Eli Hatchwell
George Roche Cold Spring Harbor High School Matthew Vaughn Robert Martienssen
(Left to right) Daniel Capurso, Faith Chang, Yuting Chiang, Yuri Hanada, James Gurtowski, George Roche
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to
acquire greater knowledge and understanding of their environment. Through a series of specialized
field courses, younger students can engage in introductory programs such as Nature Bugs, Nature
Detectives, and Nature Discovery and older students can enroll in more advanced programs such as
Marine Biology.
During the summer of 2005, 321 students participated in 31 courses within the program. The
classes were held outdoors, weather permitting, at the Southdown School where the Laboratory has
equipped and maintains classroom and laboratory facilities. This facility is used as a base for the stu-
dent's exploration of the local environment. Field classes are held on Laboratory grounds, St. John's
Preserve, Fire Island National Seashore, the Nature Conservancy, the Cold Spring Harbor Fish
Hatchery and Aquarium, as well as other local preserves and sanctuaries.
In addition to the three 2-week sessions, the Adventure Education course met again on July 15,
2005 when we chartered the Schooner Phoenix for an exciting environmental education program.
Living samples of the fauna of Long Island Sound were collected by using the Otter Trawl. The chil-
dren were encouraged to hold and touch the sea life as part of their experience. Sea Stars and horse-
shoe crabs were of particular interest. We did experiments measuring the depth of the waters we
were in, the salinity, and temperature. Pollution and the cause and effects on the animals and the
water were discussed. We also used a microscope to examine plankton and other microorganisms.
After we motored out to the sound, the children were shown how to raise and lower the sails.
On July 22, 2005, Adventure Education went on a 6-mile canoe trip on the Nissequogue River in
Smithtown to navigate and explore the waters of Long Island. The course emphasized the plant and
animal life indigenous to the area as well as historic points of interest.
This year, we had Nature Photography I and //. The courses focused on taking pictures out in the
field as well as studio shots. A darkroom was set up so that the students could develop and print
their own black and white film, as well as experiment with different photographic techniques.
Students in Photography II were introduced to digital photography. One of their projects was to make
a photo collage of the pictures they took. We set
up a computer and a color printer as well as the
'
dark room so that the children could always be
developing their skills.
PROGRAM DIRECTOR: William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR: Sharon Bense, Cold Spring Harbor Laboratory
INSTRUCTORS: Amy Friedank, B.S. in Marine Science, Long Island University, Southampton College
Jimmie Hamilton, Pratt Institute, Graphic Design/Photography
Ann Marie LaRuffa, B.A in Natural Science, Adelphi University
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COURSES
Nature Bugs (Kindergarten): Exploration, games, stories, and dramatics are used to introduce the
young child to a variety of natural habitats.
Nature Detectives (Grades 1-2): An introductory course in nature study, stressing interrelationships
between plants and animals. A variety of habitats are explored.
Nature Discovery (Grades 1-2): Students continue their discovery of nature through activities and
concepts.
Ecology Explorers (Grades 3-4): Natural communities, food webs, and a succession of communi-
ties are studied. Students study the diversity of plant and animal forms native to the Cold Spring
Harbor Laboratory area.
Pebble Pups (Grades 3-4): Elementary geology for students interested in making a basic study of
rocks and minerals available on Long Island. Each student completes a rock and mineral collection.
Dinosaurs and fossils are featured themes. Some of the highlights of this course include field trips to
local museums.
Frogs, Flippers, and Fins (Grades 3-4): Designed for younger students as an introduction to aquat-
ic ecosystems, fresh water and marine habitats are explored.
Seashore Life (Grades 5-7): Children examine plant and animal life found below the tidemark. Fish,
marine worms, algae, shellfish, beach plants, and shore birds are studied.
Freshwater Life (Grades 5-7): Students study the vertebrate, invertebrate, and plant life found in area
bogs, ponds, lakes, and streams.
Nature Photography (Grades 5-7): Students take pictures and use the darkroom to learn techniques
of printing and developing. Photographic techniques relating to nature photography are emphasized.
Adventure Education (A) Schooner Phoenix (Grades 5-7): Students join the Nature Study staff for
a 4-hour sail on board the Phoenix (a 71-foot schooner), where they identify some of the animals
brought up in the ship's trawl, learn how to navigate, and see how this tall ship operates from stem to
stern (the Phoenix is a USCG-certified vessel)
.
Adventure Education (B) Canoe Trip (Grade 6-10): This course is a 6-mile canoe trip up and down
the Nissequouge River exploring the flora and fauna of the waterway.
Marine Biology (Grades 8-10): This course offers a more sophisticated study of plants and animals
native to the inner and outer harbors. It provides field trips, dissection, use of the microscope, and
laboratory experiments.
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ACADEMIC AFFAIRS
The academic program of meetings and courses represents a diversified year-round effort. It includes
advanced laboratory courses; summer lecture and workshop courses held at the Laboratory's Banbury
Center; large meetings and winter biotechnology conferences held in Grace Auditorium; and short
bioinformatics courses that take place at the Woodbury campus. Scientists attending these events
range from graduate students and postdoctoral fellows to senior faculty.
In 2005, 27 laboratory and lecture courses were held. These covered a diverse array of topics in
molecular biology, neurobiology, structural studies, and bioinformatics. The primary aim of the courses
remains to teach students the latest advances in technologies and concepts that can be immediately
applied to their own research. Courses are always being evaluated and updated to include the latest
concepts and approaches. For example, the course on DNA Microarray Applications was twinned with
a new course on Statistics of Microarray and Related Biological Data because the majority of investi-
gators are increasingly interested in the experimental design and analysis of the large data sets gener-
ated by these kinds of experiments.
Instructors, course assistants, and course lecturers come from universities, medical schools,
research institutes, and companies around the world to teach at Cold Spring Harbor. Their excellence
and dedication make the course program work so well. The full program of 2005 courses and instruc-
tors is listed on the following pages.
Grants from a variety of sources support the courses. These include multiple awards from the
National Institutes of Health (NIH) and the National Science Foundation (NSF). We also have a valuable
large education grant from the Howard Hughes Medical Institute for the support of neurobiology cours-
es and new courses. The courses also depend on equipment and reagents that are loaned or donat-
ed by a large number of companies, which are invaluable for making it possible to keep up with the lat-
est technologies.
The Laboratory held 22 meetings this year, which brought together more than 6000 scientists from
around the world to discuss their latest research. A prime feature of the meetings is that there are very
few invited speakers. Meetings organizers select talks from abstracts that are submitted. This format
ensures that the latest findings will be presented and that young scientists will have the chance to
describe their work.
As often happens, many of this year's meetings were oversubscribed, including The Biology of
Genomes, Retroviruses, Mechanisms of Eukaryotic Transcription, and Neurobiology of Drosophila, as
well as the annual Symposium. Many of the meetings have become essential for those in the field and
are held on a biannual basis. Partial support for individual meetings is provided by grants from NIH,
NSF, Department of Energy, foundations, and companies. Core
support for the meetings program is provided by the Laboratory's
Corporate Benefactors, Sponsors, Affiliates, and Contributors.
The Symposium-now in its 70th year-continues to be the
flagship conference of the meetings program. This year's meeting
on "Molecular Approaches to Controlling Cancer" addressed many
aspects of cancer research and featured 72 talks and 240 poster
presentations. Opening night speakers included Dennis Slamon,
Harold Varmus, Mina Bissell, and James Allison, and Tyler Jacks
gave a very eloquent summary. Titia de Lange presented the
Reginald Harris lecture on "Protection of Human Telomeres."
Charles Sawyers gave the Dorcas Cummings lecture on "Making
Progress through Molecular Attacks on Cancer" to a mixed audi-
ence of scientists and lay friends and neighbors of the laboratory.
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J. Watson and S. Gottesman at Advanced Bacterial
Genetics 60th Anniversary Symposium
The joint Cold Spring Harbor/Wellcome Trust conference series held at the genome campus south
of Cambridge, England, was expanded to include meetings on lnteractome Networks, Prion Biology,
and Functional Genomics of Mammalian Nervous Systems. These conferences follow the Cold Spring
Harbor model in that the majority of talks are selected from the abstracts.
The success of the very large number of meetings and courses is also due to the skilled work of
many Cold Spring Harbor Laboratory staff and faculty who contribute their expertise, efforts, and good
humor to the program.
Advanced Bacterial Genetics 60th Anniversary
Symposium pool party at Banbury Center
Terri Grodzicker
Assistant Director
for Academic Affairs
David Stewart
Executive Director,
Meetings and Course
Searching for clues in the
Courses scavenger hunt
The Courses
Scavenger Hunt
winning team
members of the
Proteomics
course
The plate race
Attendees at the Symposium to Celebrate the Scientific Explorations of Walter Gilbert
Walter (Wally) Gilbert
at Tasting The Art of
Science Symposium to
Celebrate the Scientific
Explorations of
Walter Gilbert
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70TH COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Molecular Approaches to Controlling Cancer
June 1-6 515 participants
ARRANGED BY Bruce Stillman and David Stewart, Cold Spring Harbor Laboratory
During the past quarter century or so, much effort has been devoted to understanding the molecular
basis of cancer. We now know that cancer is primarily a genetic disease of mutations in the tumor
genome that is acquired over a lifetime. The products of oncogenes and tumor suppressor genes have
been placed into pathways of gene networks that are altered in tumor cells, compared to normal cells
in tissue. Furthermore, we also understand that tumors function as abnormal organs, forming an archi-
tecture of a number of different cell types and recruiting a blood supply, albeit an irregular one. Many
Symposia in this series have dealt with cancer directly and even more have focused on basic biology.
These have contributed greatly to understanding cancer.
As a result of some interesting developments in cancer diagnosis and therapy during the past 5
years, it was appropriate that a Symposium be devoted for the first time to molecular approaches to
cancer therapy. Several examples now exist of targeted therapy that works in patients who have been
profiled on the basis of the genetic diagnosis of the patient's tumor. Additionally, therapies targeting the
tumor as an organ, such as anti-angiogenic therapy, are now in the clinic with modest success. The
hope is that this type of molecular approach to cancer therapy will accelerate and become more effec-
tive in the future.
In organizing this Symposium with help from Tern Grodzicker, we relied on the assistance of a num-
ber of colleagues including David Livingston, Craig Thompson, and Scott Lowe for suggestions on the
choice of speakers. We thank them for their valuable advice. We also wish to thank the first evening
speakers, Dennis Slamon, Harold Varmus, Mina Bissell, and Jim Allison, for providing an overview of
the areas to be covered. This year's Reginald Harris Lecture was delivered by Titia de Lange on telom-
ere biology and genomic stability. We particularly wish to thank Tyler
Jacks for delivering a thoughtful and realistic summary of the progress
we have made toward reaching our goal. Charles Sawyers, who con-
veyed the excitement that many of us feel that some inroads into
treating cancer will be made by targeted therapies, presented the
Dorcas Cummings Lecture to the local community and attending sci-
entists. The effort put into the Dorcas Cummings Lecture by Charles
and the summary by Tyler were highlights of the meeting.
This Symposium was attended by 515 scientists and clinicians,
and the program included 71 oral presentations and 239 poster pre-
sentations. A discussion, chaired by Bruce Alberts, discussed the
proposal to analyze the genomes of all major human cancers to
advance cancer diagnosis and therapy approaches.
Essential funds to run this meeting were obtained from the
National Cancer Institute, a branch of the National Institutes of Health.
In addition, financial help from the corporate benefactors, sponsors,
affiliates, and contributors of our meetings program is essential for
these Symposia to remain a success, and we are most grateful for
their continued support. Corporate Benefactors include Amgen Inc.;
Bristol-Myers Squibb Company; GlaxoSmithKline; Novartis Institutes for
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B. Clarkson, B. Stillman
Bio Medical Research. Corporate Sponsors include Applied Biosystems; AstraZeneca; BioVentures,
Inc.; Diagnostic Products Corporation; Forest Laboratories, Inc.; Genentech, Inc.; Hoffmann-La Roche
Inc.; Johnson & Johnson Pharmaceutical Research & Development, LLC; Kyowa Hakko Kogyo Co.,
Ltd.; Lexicon Genetics, Inc.; Merck Research Laboratories; New England BioLabs, Inc., OSI
Pharmaceuticals, Inc.; Pall Corporation; Schering-Plough Research Institute; Wyeth Genetics Institute.
Plant Corporate Associates include Arbor Gen; Monsanto Company. Corporate Affiliates include
Affymetrix, Inc.; Agencourt Biosciences Corporation. Corporate Contributors include Aviva Systems
Biology; Biogen, Inc.; EMD Bioscience; II lumina; IRx Therapeutics; Qiagen. Foundations include Albert
B. Sabin Vaccine Institute, Inc.; Hudson Alpha Institute for Biotechnology.
R. Bernards, T. Grodzicker, E. Harlow
Cancer Genome Project Discussion Panel: Eric Lander, Sydney Brenner, Harold Varmus,
Bruce Alberts, Joan Brugge, June Peterson, Anne Barker R. Kalluri, J. Watson, D. Hanahan
Corporate sponsor wine and cheese party by the gazebo
D. Livingston, B. Ponder, M.-C. King
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PROGRAM
Introduction
B. Stillman, Cold Spring Harbor Laboratory
DNA Damage Response and Cancer Genetics
Chairperson: D. Lane, University of Dundee, United Kingdom
Cancer Genetics and Genomes
Chairperson: J. Brugge, Harvard Medical School, Boston,
Massachusetts
Tumor Responses to Microenvironment
Chairperson: C. Greider, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Cancer Genome Project Discussion
Chairperson: Bruce Alberts, National Academy of Sciences,
Washington, D.C.
Reginald G. Harris Lecture: Protection of Human
Telomeres
Chairperson: T. de Lange, The Rockefeller University New
York
Telomeres, Senescence, and Aging
Chairperson: S. Lowe, Cold Spring Harbor Laboratory
Animal Models for Cancer
Chairperson: M. Tessier-Lavigne, Genentech Inc., South San
Francisco, California
Gene Expression and Cancer
Chairperson: J.M. Bishop, University of California, San
Francisco
Dorcas Cummings Lecture: Making Progress through
Molecular Attacks on Cancer
Speaker: Charles Sawyer, University of California, Los Angeles
Discovering Cancer Targets
Chairperson: M. Barbacid, Centro Nacional de Investigaciones
Ontologica, Madrid, Spain
Biology of Cancer Cells and Tissues
Chairperson: C. Sherr, Howard Hughes Medical Institute, St.
Jude Children's Research Hospital, Memphis, Tennessee
Stem Cells, Cancer Genes, and Therapeutic Approaches
Chairperson: J. Lees, Massachusetts Institute of Technology
Cambridge
More Therapeutic Approaches
Chairperson: B. Ponder, University of Cambridge, United
Kingdom
Summary
Tyler Jacks, Howard Hughes Medical Institute, Massachusetts
Institute of Technology
Grace lobby after the Dorcas Cummings lecture
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MEETINGS
Imaging Neurons and Neural Activity: New Methods, New Results
March 10-13 236 participants
ARRANGED BY Atsushi Miyawaki, RIKEN Brain Science Institute
Joshua Sanes, Harvard University
Karel Svoboda, Cold Spring Harbor Laboratory
This new Cold Spring Harbor winter conference focused on imaging neuronal structure and function
using a variety of advanced techniques, including a wide range of light microscopy techniques, elec-
tron microscopy approaches, and magnetic resonance imaging. It also explored emerging methodolo-
gies for manipulating neuronal function with a particular emphasis on genetics and chemistry. This
unique forum was designed to stimulate future research studies in this important area and to promote
interactions among researchers in diverse basic scientific areas relevant to this field. Roger Tsien deliv-
ered a fascinating keynote address on "Imaging Neuronal Protein Synthesis and Signaling." The major-
ity of the talks were chosen from openly submitted abstracts. In all, this new conference attracted 127
abstracts, and progress in the field was summarized in thoughtful concluding remarks by Atsushi
Miyawaki. The general consensus of participants was that the meeting should be held again at Cold
Spring Harbor in 2007.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, cor-
porate affiliates, corporate contributors, and foundations provided core support for this meeting.
G. Rubin, D. Stewart, J. Huang
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PROGRAM
Introductory Remarks and Keynote Address: Imaging Imaging Cellular Structure and Function
Neuronal Protein Synthesis and Signaling Chairpersons: R. Wong, Washington University, St. Louis,
K. Svoboda, Cold Spring Harbor Laboratory; R. Tsien, Howard Missouri; S. Fraser, California Institute of Technology,
Hughes Medical Institute, University of California, San Diego Pasadena
Probing Connectivity
Chairpersons: L. Luo, Stanford University California; C. Du lac,
Howard Hughes Medical Institute, Harvard University
Cambridge, Massachusetts
New Imaging Modalities I
Chairpersons: W. Denk, Max-Planck Institute for Medical
Research, Heidelberg, Germany; S. Dymecki, Harvard
Medical School, Boston, Massachusetts
New Imaging Modalities II
Chairpersons: A. Konnerth, Ludwig-Maximilians-University,
Munich, Germany; H. Monyer, University of Heidelberg,
Germany
Assaying and Manipulating Neuronal Activity
Chairpersons: E. Callaway, Salk Institute for Biological Studies,
La Jolla, California; G. Miesenboeck, Yale University New
Haven, Connecticut
Fluorescent Reporters and Other Labeling Strategies
Chairpersons: E. lsacoff, University of California, Berkeley;
0. Griesbeck, Max-Planck Institute of Neurobiology
Martinsried, Germany
Concluding Remarks
Atsushi Miyawaki, RIKEN Brain Science Institute
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K. Svoboda, E. Nedivi B. Salzberg, W. Webb
K. Ibaraki, M. Nishi, M. Zlatic
Systems Biology: Global Regulation of Gene Expression
March 17-20 207 participants
ARRANGED BY Jack Keene, Duke University Medical Center
Peggy Farnham, University of California, Davis
Saeed Tavazoie, Princeton University
Gene expression is one of the most important processes determining the functional characteristics of
organisms. Investigating the mechanisms that regulate gene expression is essential to understanding
all biological processes and diseases. Most knowledge of the regulation of gene expression in the past
has been derived from investigations of single interactions and outcomes. However, the onset of the
genomic revolution has allowed for the first time the ability to investigate many events in gene expres-
sion simultaneously and in parallel. Much progress has been made in the study of transcriptional reg-
ulation, but the global regulation of gene expression involving posttranscriptional mechanisms as well
is especially challenging. Therefore, the global analysis of gene expression involving both transcription
and posttranscription was the subject of this third meeting on Systems Biology. It was thus unique in
that it brought together researchers using three major approaches to global gene expression and sys-
tems biology, including transcription, posttranscription (RNA splicing, localization, stability, and transla-
tion), and computational analysis. The sessions were structured with an opening keynote speaker
whose research overlaps all of these three areas and was followed in the first session by representa-
tive presentations from each of the three areas. The subsequent sessions considered first computa-
tional, then transcriptional, then posttranscriptional, and then comparative genomics, followed on the
last day with a session on emerging technologies. A diverse poster session represented these three
approaches to understanding global gene expression and provided direct interactions among investi-
gators with these common interests. Many participants commented on the quality of the meeting and
in a planning session, enthusiasm was expressed to continue this meeting series in its current format.
J. Keene, J. Witkowski, A. Krainer
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A decision was made to include a tutorial prior to the formal meeting that would familiarize participants
with computational methods relevant to transcriptional and posttranscriptional regulation of global
gene expression.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, cor-
porate affiliates, corporate contributors, and foundations provided core support for this meeting.
PROGRAM
Keynote Address: Overture
R. Young, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts
Computational Approaches to Identifying Cis-regulatory
Elements
Chairperson: S. Tavazoie, Princeton University, New Jersey
Advances in Detection of Transcription Factor/DNA
Interactions
Chairperson: P. Farnham, University of California, Davis
Transcriptional and Posttranscriptional Network
Modeling
Chairperson: J. Keene, Duke University Medical Center,
Durham, North Carolina
Comparative Genomics of Global Gene Regulation
Chairperson: A. Gasch, University of Wisconsin, Madison
Emerging Technologies and Concepts in Systems
Biology
Chairperson: M. Bulyk, Harvard Medical School, Boston,
Massachusetts
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R. Young, D. Gifford, Y. Ruan S. Sperling, J. Lohmann, W. Busch, D. Arnosti
S. West, T. Silkov, N. Nogoy
Learning and Memory
April 20-24 175 participants
ARRANGED BY John Byrne, University of Texas, Houston Medical School
Joseph LeDoux, New York University
Erin Schuman, HHMI, California Institute of Technology
This year's meeting tackled the issue of plasticity on many levels, ranging from neurogenesis to behav-
ioral memory mechanisms. Presenters in the neurogenesis session discussed the effects of the environ-
ment and NMDA receptor activity on new neuron survival, as well as the contribution of neurogenesis to
some forms of learning. Two talks in a plasticity session reemphasized the importance of intrinsic excitabil-
ity changes, rather than synaptic changes, in bringing about plasticity at the level
of neural circuits and behavior. Switch-like mnemonic firing patterns of entorhinal
cortical neurons were also described. Other talks emphasized neurotransmitters
and signaling pathways that contribute to long-term potentiation. In a session
emphasizing structural plasticity, alterations in spines induced by the molecules
I3-catenin and Shank were discussed. In addition, the trafficking of polyribo-
somes into spines following LTP was also shown; spines with polyribosomes are
enlarged. Imaging experiments demonstrated a relationship between the initial
spine size and the facility with which plasticity can be induced: Small spines con-
taining functional NMDA receptors and small numbers of functional AMPA recep-
tors are more likely to show plasticity. One session highlighted local control of
plasticity at the synapse. Topics such as regulation of local protein translation by
miniature synaptic events and mGluRs were discussed. In addition, the impor-
tance of the specific pattern of synaptic input activation, and its location on the
dendritic tree, was discussed. In the session dedicated to memory encoding in cortical circuits, the impor-
tance of 0 rhythms for both semantic and episodic memory was discussed. The firing properties of a sub-
set of medial entorhinal cortical cells were also described; these "grid cells" fire at specific intersection
points in the animal's environment. In a session addressing the role of transcription factors in learning and
memory, several presentations discussed the role of CaMKII as a molecular memory molecule. In addi-
tion, the role of CREB and IEG activation in memory formation was addressed. An epigenetic model for
E. Schuman, J
T. Houpt, D. Lockwood, G. Golden
Byrne
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cellular memory was also presented. A session on the complexities of simple systems included several
presentations addressing various molecular mechanisms underlying long-term memory, intermediate-
term memory, and the differences between classical and operant conditioning in Aplysia. Other talks cov-
ered the role of Synaptotagmin 4 in retrograde signaling underlying synapse-specific potentiation and
growth in the Drosophila neuromuscular junction, as well as the role of the dorsal paired medial neurons
in the Drosophila mushroom body in olfactory memory. Finally, there were systems-level sessions on con-
solidation/reconsolidation and on extinction. Presentations in the consolidation/reconsolidation focused
in particular on the roles of the prefrontal cortex and amygdala. One talk presented evidence that inhibi-
tion of protein synthesis in the mPFC following reactivation of a fear memory had no effect on memory,
suggesting that reconsolidation does not occur in this structure. Another presentation examined the mol-
ecular cascades activated in the mPFC in extinction of conditioned fear and found evidence that similar
molecular cascades are activated in both the amygdala and mPFC. A talk investigating the interaction
between extinction and reconsolidation of fear memory in the amygdala indicated no competition
between these two processes in the basal lateral amygdala. Finally, data were presented indicating that
extinction acquisition depends on activation of the L-type voltage-gated calcium channel in the BLA and
that extinction expression is mediated by increases of GABA(A) transmission in the BLA.
Major sponsorship for this meeting was provided by the National Institute of Neurological Disorders
and Stroke, a branch of the National Institutes of Health, and the National Science Foundation.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, corpo-
rate affiliates, corporate contributors, and foundations also provided core support for this meeting.
PROGRAM
Neurogenesis
Chairperson: F. Gage, Salk Institute for Biological Studies,
La Jolla, California
Plasticity within and between Cells
Chairperson: D. Johnston, University of Texas, Austin
Structural Plasticity and Memory
Chairperson: Y. Goda, University College London, United
Kingdom
Local and Distributed Synaptic Processing
Chairperson: M. Ehlers, Duke University Medical Center,
Durham, North Carolina
Encoding of Memory in Cortical Networks
Chairperson: E. Moser, Norwegian University of Science and
Technology Trondheim, Norway
Learning, Memory, and Transcription Factors
Chairperson: C. Alberini, Mount Sinai School of Medicine,
New York
Complexities of Simple Systems
Chairperson: D. Baxter, University of Texas-Houston Medical
School
Reconsolidation and Extinction
Chairperson: Y. Dudai, Weizmann Institute of Science,
Rehovot, Israel
M. Collado, J. Pita-Almenar
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S. Rose, K. Lukowiak
The Ubiquitin Family
April 27-May 1 270 participants
ARRANGED BY Joan Conaway, Stowers Institute for Medical Research
Ray DeShaies, California Institute of Technology
Peter Howley, Harvard Medical School
This was the second Ubiquitin Family meeting following its successful inauguration in 2003. The meet-
ing focused on ubiquitin and the structurally related "ubiquitin-like" proteins, and their regulation in cel-
lular processes. The meeting focused on the central role of ubiquitin and ubiquitin-like protein modifi-
cations in protein regulation and turnover. Critical questions in the field relate to molecular basis of
specificity with regards to the recognition of the various ubiquitin family members and to the molecu-
lar mechanisms that underlie substrate specificity for the ubiquitin and ubiquitin-like protein enzymatic
pathways. Research in the area of ubiquitin and related molecules has con-
tinued to grow remarkably in the past few years, with an appreciation of how
these molecules affect normal and abnormal physiologic processes.
The meeting this year attracted more than 270 scientists who discussed
the role of ubiquitin and ubiquitin-like molecules in a variety of key cellular
processes, including chromatin structure and transcription, cell cycle, signal-
ing, apoptosis, endocytosis, membrane trafficking, and pathology. The
reported experimental systems ranged from yeast to humans, whereas the
interests of speakers varied from analysis of protein structure and enzymatic
pathways to human cancer and neurodegenerative diseases. Despite such
diversity, the participants commented that the meeting was focused, informa-
tive, and exciting. In summary, the Ubiquitin Family meeting has become a
unifying forum that is helping us understand the key roles that ubiquitin and
the related ubiquitin-like molecules have in cellular physiology and disease.
Major sponsorship for this meeting was provided by the National Institutes of Health. Contributions
from our corporate benefactors, corporate sponsors, plant corporate associates, corporate affiliates, cor-
porate contributors, and foundations also provided core support for this meeting.
P. Howley
J. Burton, M. Solomon
229
PROGRAM
Cell Signaling Pathways
Chairpersons: S.Reed, Scripps Research Institute, La Jolla,
California; J.-M. Peters, Research Institute of Molecular
Pathology, Vienna, Austria
Enzymes of Ubiquitin Family Protein Systems
Chairpersons:B. Schulman, St. Jude Children's Research
Hospital, Memphis, Tennessee; C. Pickart, Johns Hopkins
University Baltimore, Maryland
Endocytosis and Membrane Trafficking; Proteasome
Chairpersons: L. Hicke, Northwestern University Evanston,
Illinois; P. DiFiore, FIRC Institute of Molecular Oncology
Milan, Italy
Protein Quality Control
Chairpersons:M. Hochstrasser, Yale University, New Haven,
Connecticut; T. Sommer, Max-Delbrack Center for Molecular
Medicine, Berlin, Germany
Regulation and Dysregulation in the Brain
Chairpersons: J. Kaplan, Harvard Medical School, Boston,
Massachusetts; T. Dawson, Johns Hopkins University
School of Medicine, Baltimore, Maryland
Chromatin Structure, Gene Regulation, and DNA Repair
Chairpersons:S. Berger, Wistar Institute, Philadelphia,
Pennsylvania; W. Tansey, Cold Spring Harbor Laboratory
Cell Cycle Regulation and Cancer
Chairpersons: J.W. Harper, Harvard Medical School, Boston,
Massachusetts; W. Kaelin, Dana-Farber Cancer Institute,
Boston, Massachusetts
New Technologies and Therapeutic Strategies
Chairpersons:M. Tyers, Samuel Lunenfeld Research Institute,
Toronto, Canada; H. Ploegh, Harvard Medical School,
Boston, Massachusetts
K. Ross, S. Plafker
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Telomeres and Telomerase
May 4-8 286 participants
ARRANGED BY Titia de Lange, The Rockefeller University
Joachim Linger, Swiss Institute for Experimental Cancer Research
Vicki Lundblad, Salk Institute for Biological Studies
The conference consisted of eight sessions of talks and three poster sessions. As in 1999, 2001, and
2003, the format was to invite two chairs per session, who were a mix of established scientists in the
field and younger scientists who had already made their mark by publishing
as independent investigators. Many session chairs gave a scientific (12 min)
presentation. The rest of the presentations (also 12 min) were chosen from
submitted abstracts, allowing as many presentations as possible. These pre-
sentations were primarily by graduate students and postdoctoral fellows.
Attendance totalled 286, a high fraction of whom presented the 118 posters
and 73 talks.
The talks and posters covered all aspects of telomere and telomerase
biology, including telomerase structure, enzymology, and regulation; telom-
ere length regulation, protection, and processing of chromosome ends; the
consequences of telomere dysfunction; telomere dynamics in cancer; and
telomerase-independent telomere maintenance.
The scientific content was very high throughout in both the talks and the
posters. A large body of unpublished data was presented and extensively dis-
cussed in an open fashion. Formal and informal discussions were lively and
informative. The conference was judged to be highly successful based on verbal and e-mail communi-
cations to the organizers. There is strong enthusiasm for another meeting on the same topic in 2007.
Major sponsorship for this meeting was provided by the National Institute on Aging, a branch of the
National Institutes of Health; and the National Science Foundation. Contributions from our corporate
benefactors, corporate sponsors, plant corporate associates, corporate affiliates, corporate contribu-
tors, and foundations also provided core support for this meeting.
V. Lundblad, T. de Lange
S. Ahmed, E. Blackburn
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PROGRAM
Telomerase Structure and Biochemistry
Chairpersons: K. Collins, University of California, Berkeley; N.
Lue, Weill Medical College of Cornell University New York
Telomere Length Regulation I
Chairpersons: E. Blackburn, University of California, San
Francisco; V. Geli, CNRS, Marseille, France
Telomere Length Regulation II
Chairpersons: J. Lingner, Swiss Institute for Experimental
Cancer Research, Epalinges; D. Shippen, Texas A&M
University College Station
End Protection and Resection
Chairpersons: V Lundblad, Salk Institute for Biological
Studies, LaJolla, California; R. Wellinger, University of
Sherbrooke, Canada
Consequences of Telomere Dysfunction
Chairpersons: T. de Lange, The Rockefeller University; M.
Longhese, University di Milano-Bicocca, Italy
Telomeres and Recombination
Chairpersons: R. Reddel, Children's Medical Research
Institute, Westmead, Australia; E. Louis, University of
Leicester, United Kingdom
Structural Studies of Telomeres and Telomere Proteins
Chairpersons: V Zakian, Princeton University New Jersey; P.
Lansdorp, British Columbia Cancer Research Center,
Vancouver, Canada
Senescence, Apoptosis, and Cancer
Chairpersons: C. Greider, Johns Hopkins University School of
Medicine, Baltimore, Maryland; W. Wright, University of
Texas Southwestern Medical Center, Dallas
L. Rudolph, S. Artandi
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Workshop on Chicken Genomics and Development
May 8-11 121 participants
ARRANGED BY Dave Burt, Roslin Institute
Olivier Pourquie, Stowers Institute for Medical Research
This meeting marked the third annual gathering of some of the premier researchers in the field from
around the world. The chicken is now clearly recognized as a model genome and is of tremendous
value in evolutionary comparisons.
The meeting was attended by 121 researchers with 76 abstracts
presented, representing submissions from scientists in 16 countries.
The workshop began with a keynote presentation by Lincoln Stein,
who described the most recent venture into the use of computation-
al tools such as the "Genetic Model Organism Database" (GMOD).
Scientific presentations covered genetic resources (such as SNPs,
haplotype analysis, and QTL identification), expression profiling, and
sequence to function. Additional discussions centered on gynandro-
morphs, endogenous viral elements, and transgenesis, serving to
emphasize some of the novel approaches now in progress.
Presentations during the final developmental biology session high-
lighted efforts on developmental mutants and signaling pathways. A
wrap-up of the session included an exploration of "What Now" and
"What Next," with plans to continue these meetings at Cold Spring
Harbor. The results of this meeting resulted in a clear map as to what
precisely should happen next, beginning with a plan to hold another
Cold Spring Harbor meeting in 2006.
0. Pourquie, D. Burt
K. Beemon, P. Neiman
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Major sponsorship for this meeting was provided by ARK-Genomics, Applied Biosystems,
Affymetrix, Cobb Vantress Inc., Aviagen, Genesis Faraday, and Developmental Dynamics.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, corpo-
rate affiliates, corporate contributors, and foundations also provided core support for this meeting.
PROGRAM
Opening Remarks
D. Burt, Roslin Institute, United Kingdom
Plenary Session: Model Organism Databases
L. Stein, Cold Spring Harbor Laboratory
Analysis of the Chicken Genome and the Chicken Gene
Set I
Chairperson: J. Dodgson, Michigan State University East
Lansing
Analysis of the Chicken Genome and the Chicken Gene
Set II
Chairperson: J. Dodgson, Michigan State University East
Lansing
SNPs and QTL Mapping
Chairperson: L. Andersson, University of Uppsala, Sweden
Genome Browser Tutorials
Chairperson: J. Burnside, Delaware Biotechnology Institute,
Newark
Evolutionary Biology
Chairperson: D. Burt, Roslin Institute, Edinburgh, United
Kingdom
Gene Regulation and Expression
Chairperson: P. Antin, University of Arizona, Tucson
The Chick: A Leading Model in Developmental Biology I
Chairperson: 0. Pourquie, Stowers Institute for Medical
Research, Kansas City Missouri
M. Miller, R. Taylor
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The Biology of Genomes
May 11-15 512 participants
ARRANGED BY Kelly Frazer, Perlegen
Thomas Hudson, McGill University
Svante Paabo, Max-Planck Institute
Richard Wilson, Washington University
This meeting marked the 16th annual gathering of genome scientists in this setting. The past decade or
more has seen remarkable progress in the mapping, sequencing, and annotation of the genomes of many
"model organisms" and publication of finished and draft sequences of the human, mouse, rat, and dog
genomes, in addition to several model organisms and hundreds of bacteria. Just over 500 people from
around the world attended the meeting, with more than 300 abstracts presented describing a broad array
of topics relating to the analysis of genomes from a number of different organisms.
The session topics included areas such as biological insights from comparative genomics, function-
al genomics, organismal biology, computational genomics, and the use of sequence variations to study
populations and mechanisms of disease. There was considerable enthusiasm and discussion regard-
ing current international projects such as the Hap Map and Encode. Once again, projection-style, inter-
active computer demonstrations in Grace Auditorium effectively highlighted the critical new bioinfor-
matics tools being developed for storing, organizing, and analyzing various genomic data sets, includ-
ing expression, mapping, and sequence data. There was also an ELSI (Ethical, Legal, and Social
Implications) panel discussion that focused on issues surrounding (large-scale) medical resequencing.
The major themes of the meeting included the analysis of large-scale variation in genetic variation
across the human genome (with considerable interest with regard to new insight in structural variation),
annotation of the human genome using multispecies sequence comparisons, and a myriad of large-
scale approaches to understand complex biological processes. The Saturday afternoon keynote talks
were delivered by Aravinda Chakravarti, and Tom Gingeras (a former research scientist at CSHL.
Major sponsorship for the meeting was provided by the National Human Genome Research
Institute, a branch of the National Institutes of Health. Contributions from our corporate benefactors,
corporate sponsors, plant corporate associates, corporate affiliates, corporate contributors, and foun-
dations also provided core support for this meeting.
A. Gaudy, J. Hudson
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PROGRAM
High-throughput Biology
Chairpersons: E. Green, NHGRI, National Institutes of Health,
Bethesda, Maryland; B. Andrews, University of Toronto,
Canada
Computational Genomics
Chairpersons: D. Haussler, University of California, Santa Cruz;
E. Eichler, University of Washington, Seattle
Perturbations of Genome Systems
Chairpersons: C. Austin, NHGRI, National Institutes of Health,
Bethesda, Maryland; A. Fraser, Wellcome Trust Sanger
Institute, Hinxton, United Kingdom
Haplotype Variation and Intraspecies Resequencing
Chairpersons: T. Hudson, McGill University and Genome
Quebec Innovation Centre, Montreal, Canada; E. Mardis,
Washington University St. Louis, Missouri
Keynote Speakers
T.R. Gingeras, Affymetrix; A. Chakravarti, Johns Hopkins
University School of Medicine
Evolutionary Biology Including Comparative Genomics
of Closely Related Species
Chairpersons: C. Langley, University of California, Davis; T
Mikkelsen, Broad Institute of MIT and Harvard, Cambridge,
Massachusetts
M. Kellis, F Collins, R. Waterston
ELSI Panel Discussion: Medical Sequencing:
Human Genome Sequencing of Phenotyped
Individuals for Large Population Studies
Moderator: V Ota Wang, National Human Genome
Research Institute
Panelists: M.A. Spence, University of California, Irvine;
J.R. Botkin, University of Utah; M.W. Foster,
University of Oklahoma
SNPs and Their Relationship to Biology
Chairpersons: V Cheung, Children's Hospital,
Philadelphia, Pennsylvania; R. Gibbs, Baylor College
of Medicine, Houston, Texas
Non-Human Species Including Comparative
Genomics of Distantly Related Species
Chairpersons: R. Hardison, Pennsylvania State
University University Park; K. Lindblad-Toh, Broad
Institute of MIT and Harvard, Cambridge,
Massachusetts
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Protein Phosphorylation and Cell Signaling
May 18-22 215 participants
ARRANGED BY Nicholas Tonks, Cold Spring Harbor Laboratory
Sara Courtneidge, Van Andel Research Institute
Ben Neel, Beth Israel Deaconess Medical Center
This sixth meeting brought together 215 scientists from the United States, Europe, the Far East, and
South Pacific. Specifically focused on tyrosine phosphorylation in prior years, we expanded this meet-
ing to include the most current work on the structure, regulation, and function of all protein kinases and
protein phosphatases in biology. The meeting began with two opening keynote addresses by Martine
Roussel and Craig Thompson.
The format of the meeting was designed around areas of biological interest, rather than according
to particular enzymes or enzyme families. A major thrust within the pharmaceutical industry is to exploit
signal transduction pathways as sources of targets for novel therapeutic strategies. Therefore, the pro-
gram for this meeting addressed the role of protein phosphorylation in the regulation of signal trans-
duction under normal and pathophysiological conditions.
A variety of systems were described with great progress reported in genetic and biochemical
approaches to the characterization of physiological functions for protein phosphorylation. In particular,
exciting insights were provided into how signaling pathways may be abrogated in a variety of human
disease states and to the identity of novel targets for therapeutic intervention.
Major sponsorship for this meeting was provided by the National Cancer Institute, a branch of the
National Institutes of Health. Contributions from our corporate benefactors, corporate sponsors, plant
corporate associates, corporate affiliates, corporate contributors, and foundations also provided core
support for this meeting.
N. Tonks, S. Courtneidge, B. Neel
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PROGRAM
Keynote Speakers
M. Roussel, St. Jude Children's Research Hospital, Memphis,
Tennessee
C. Thompson, University of Pennsylvania
Receptor-proximal Signaling
Chairperson: D. Cantrell, University of Dundee, United Kingdom
Physiology and Disease
Chairperson: J. Dixon, University of California, San Diego
Downstream Signaling
Chairperson: J. den Hertog, Hubrecht Laboratory Utrecht,
The Netherlands
Cancer
Chairperson: K. Gould, Vanderbilt University Nashville,
Tennessee
Metabolic and Stress Signaling
Chairperson: R. Abraham, The Burnham Institute, La Jolla,
California
Model Systems
Chairperson: W. Muller, McGill University Montreal, Canada
Trafficking and the Cytoskeleton
Chairperson: D. BanSagi, Stony Brook University New York
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S. Yang, G. van Nieuw Amerongen
Retroviruses
May 24-29 430 participants
ARRANGED BY Paul Bieniasz, Aaron Diamond AIDS Research Center
James Cunningham, Harvard Medical School
The 30th annual Retrovirus meeting was organized into three keynote addresses, ten sessions of short
talks on specific topics, and three poster sessions.
Three distinguished scientists delivered keynote addresses on consecutive evenings. On
Wednesday, Dr. Wesley Sundquist gave a scholarly summary of recent advances in understanding
retrovial capsid structure and function. In particular, he outlined rules for capsid oligomerization during
virion assembly and maturation. On Thursday, Dr. Robert Craigie gave a historical perspective on stud-
ies of integrase structure and function, including the role of host factors. On Friday, Dr Beatrice Hahn
discussed her new and exciting field studies on the origin and evolution of HIV from primate lentivirus-
es in Africa.
Ten sessions were devoted to short talks on specific topics including virus entry, assembly, restric-
tion factors, postentry, integration, APOBEC, accessory genes, pathogenesis, reverse transcription,
and RNA synthesis and export. The keynote addresses served, in part, as an introduction to the ensu-
ing oral sessions. Poster sessions were organized by topic such that posters dealing with closely relat-
ed themes were placed together, the goal being to bring scientists with common interests into prox-
imity. Many presenters liked this organization, but there are also some who still prefer the posters to
be arranged alphabetically.
Although the most striking developments this year involved postentry events, significant progress
was made toward elucidating a number of aspects of the retroviral replication cycle. Highlights includ-
ed recent progress in understanding the mechanism by which TRIM5e inhibits retroviral infection, how
the lentiviral Vif protein counteracts the antiviral effects of the cellular enzyme APOBEC3G, and the
smissinuusip ,moommuuncii...
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identification of host factors that can inhibit postentry events. Provocative findings related to function
of retroviral accessory proteins Nef, Vpr, and Bet were also reported. Two new retrovirus receptors
were identified and several new experimental approaches to analyze virus entry were presented. In
addition, new measurements of the efficacy of antiviral therapy were reported. A major theme was the
development of screening protocols to identify host factors that inhibit retroviral infection. It is antici-
pated that further identification and analysis of host factors that act in both a positive and negative
manner to influence retrovirus replication will be a major topic at future meetings.
In other matters, the meeting is increasingly more user-friendly. Strengths are the improved food,
banquet, and A-V/computer support. Weaknesses are off-sight housing, proximity to holiday, length of
evening sessions, and the small size of the bar. This year, poor weather disrupted many of the outdoor
activities. Finally, we very much appreciate the help and guidance of David Stewart, Mark Beavers, and
the CSHL staff, who made the meeting easy and enjoyable to organize.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates,
corporate affiliates, corporate contributors, and foundations provided core support for this meeting.
A. Rein. L. Parent G. Towers, M. Yap, K. Bishop
J. Blomberg, S. Hughes
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PROGRAM
Entry
Chairpersons: J. Silver, National Institutes of Health, Bethesda,
Maryland; D. Sanders, Purdue University West Lafayette,
Indiana
Restriction Factors
Chairpersons: V KewalRamani, National Cancer Institute,
Frederick, Maryland; J. Stoye, National Institute for Medical
Research, London, United Kingdom
Keynote Speaker: Structure and Functions of the
Retroviral Capsid
Wes Sundquist, University of Utah School of Medicine
Assembly I
Chairpersons: H. Gottlinger, Dana-Farber Cancer Institute,
Boston, Massachusetts; J. Lingappa, University of
Washington, Seattle
Assembly II
Chairpersons: C. Carter, Stony Brook University New York;
W. Mothes, Yale University New Haven, Connecticut
Keynote Speaker: Retroviral Integration: An Odyssey
from Genetics to Chemistry and Beyond
Robert Craigie, NIDDK, National Institutes of Health
Postentry
Chairpersons: A. Fassati, University College London Medical
School, United Kingdom; G. Kalpana, Albert Einstein College
of Medicine, Bronx, New York
Integration / Bioinformatics
Chairpersons: A. Engelman, Dana-Farber Cancer Institute,
Boston, Massachusetts; E. Poeschla, Mayo Clinic College of
Medicine, Rochester Minnesota
Keynote Speaker: Natural Reservoirs of HIV-1
Beatrice Hahn, University of Alabama, Birmingham
Accessory Genes
Chairpersons: T. Hope, University of Illinois, Chicago Medical
School; P. Jolicoeur, Institut de Recherches des Cliniques de
Montreal, Canada
APOBEC
Chairpersons: R. Harris, University of Minnesota, Minneapolis;
K. Strebel, NIAID, National Institutes of Health, Bethesda,
Maryland
Reverse Transcription / Pathogenesis
Chairpersons: M. Gotte, McGill University Montreal, Canada;
M. Roth, UMDNJ-Robert Wood Johnson Medical School,
Piscataway New Jersey
RNA Synthesis, Export and Packaging
Chairpersons: B. Felber, National Cancer Institute, Frederick,
Maryland; A. Rice, Baylor College of Medicine, Houston,
Texas
J. Levin, A. Telesnitsky
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New York Structural Biology Group
August 10 226 participants
ARRANGED BY Leemor Joshua-Tor, Cold Spring Harbor Laboratory
Larry Shapiro, Columbia University College of Physicians & Surgeons
David Stokes, Skirball Institute, New York University
The summer meeting of the New York Structural Biology Discussion Group was the
seventh in day-long meetings allowing structural biologists from all over the region
to meet and discuss their latest results. The meeting was open to structural biolo-
gists from different disciplines, including crystallographers, spectroscopists, com-
putational biologists, and biochemists with more than 250 participants from acad-
emia and industry from the tristate area. The program featured 12 talks, a poster
session and concluded with a beach barbecue, allowing a wonderful opportunity
for informal interactions. This meeting complements the bimonthly evening meet-
ings of the group held at The Rockefeller University. No registration was required
and participants were encouraged to set up posters.
Major sponsorship for this meeting was provided by Fluidigm, GE Healthcare, Hampton Research, and
Merck. Contributions from our corporate benefactors, corporate sponsors, plant corporate associates,
corporate affiliates, corporate contributors, and foundations also provided core support for this meeting.
D. Stokes, L. Joshua-Tor, L. Shapiro
H. Robinson, L. Berman
L. Joshua-Tor, W. Hendrickson, R. Spencer
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PROGRAM
Session I
Chairpersons: L. Shapiro, Columbia University College of
Physicians & Surgeons; H. Wu, Weil Medical College of
Cornet University; C. Wang, Columbia University College of
Physicians & Surgeons (Palmer lab); J. Truglio, Stony Brook
University (Kisker lab); J. Ferrara, Rigaku/MSC
Session II
Chairpersons: D. Stokes, Skirball Institute, New York University
Medical School; D. Patel, Memorial Sloan-Kettering Cancer
Center; Y. Song, City College of New York (Gunner lab);
D. Jain, The Rockefeller University (Darst lab); D. Raleigh,
Stony Brook University
Poster Session
Session III
Chairpersons: L. Joshua-Tor, Cold Spring Harbor Laboratory;
Barry Honig, Columbia University College of Physicians &
Surgeons; J. Williams, Columbia University College of
Physicians & Surgeons (Hendrickson lab); C. Lima, Memorial
Sloan-Kettering Cancer Center; E. Crocker, Stony Brook
University (Smith lab); T. Walz, Harvard Medical School
Yeast Cell Biology
August 16-21 245 participants
ARRANGED BY Kerry Bloom, University of North Carolina, Chapel Hill
Chris Kaiser, Massachusetts Institute of Technology
Peter Pryciak, University of Massachusetts Medical School
This tenth biannual international meeting was devoted to major aspects of cell biology in yeast. It is
unusual in that many important areas of cell biology are represented at a single meeting organized
around a simple eukaryotic organism, the budding yeast Saccharomyces cerevisiae, with additional
insights arising from studies using other fungi such as Ashbya gossypii, Candida albicans, Pichia pas-
tons, and Schizosaccharomyces pombe. At this year's conference, the latest research advances were
presented in sessions organized around primary cell biological systems. For example, new develop-
ments were discussed in the areas of the actin and microtubule cytoskeletons, membrane trafficking,
cell cycle and cell division, and signal transduction mechanisms. In addition, functional genomics, pro-
teomics, and bioinformatics were featured prominently, with remarkable examples of using yeast to
study genome-wide changes that accompany evolution. Furthermore, it has become increasingly clear
during the last several years that traditional cell biological systems do not operate in isolation. Instead,
they are highly coordinated, and the mechanisms of this coordination represent some of the most
exciting research areas covered at the meeting, including the organization of membranous organelles
by the cytoskeleton, subcellular compartmentalization of cell cycle control proteins, and regulation of
cytoskeletal organization by signal transduction pathways. Complementing these integrative topics
were new computational models for complex molecular behavior and new microscopic techniques for
probing cell ultrastructure. The result is that the yeast system is approaching an unprecedented degree
of sophistication in the comprehensive, system-wide understanding of cellular function.
By virtue of this common interest in one organism, instead of one topic in cell biology, this meeting
continues to encourage extensive cross-fertilization of ideas, insights and methodologies, ultimately
R. Rothstein, C. Kaiser
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leading to an integrated view of eukaryotic cell structure and function. Yeast remains an important test
bed for new technological developments and conceptual advances in biomedical sciences.
Presentations at the 2005 meeting made clear that yeast will remain at the forefront of model systems
and will advance our understanding of eukaryotic cell biology for many years. In summary, this was an
exciting and memorable meeting with more than 240 scientists in attendance, presenting some 185
scientific reports in 101 talks and 84 posters.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, cor-
porate affiliates, corporate contributors, and foundations provided core support for this meeting.
PROGRAM
Microtubules and SPBs
Chairperson: M. Rose, Princeton University New Jersey
Signaling and Networks
Chairperson: D. Lew, Duke University Durham, North Carolina
Trafficking
Chairperson: T. Graham, Vanderbilt University Nashville,
Tennessee
Kinetochores and Chromosomes
Chairperson: R. Rothstein, Columbia University College of
Physicians & Surgeons, New York
Genomes and Genomics
Chairperson: V. Guacci, Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Actin and Polarity
Chairperson: L. Pon, Columbia University New York
Organelle Biogenesis
Chairperson: T. Fox, Cornell University Ithaca, New York
Physiology
Chairperson: J. Thorner, University of California, Berkeley
Membranes and Morphogenesis
Chairperson: J. Berman, University of Minnesota, Minneapolis
Cell Cycle and Checkpoints
Chairperson: 0. Cohen-Fix, NIDDK, National Institutes of
Health, Bethesda, Maryland
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C. Potenski, M. Kadner
Eukaroytic mRNA Processing
August 24-28 405 participants
ARRANGED BY Elisa Izaurralde, EMBL Heidelberg
Timothy Nilsen, Case Western Reserve University, Cleveland
Donald Rio, University of California, Berkeley
This fifth meeting focused on recent developments in mRNA metabolism. As in the past, there was a
heavy emphasis on regulated and alternative pre-mRNA splicing as well as splicing mechanisms.
Additional areas included mRNA quality control and decay, mRNA trafficking, and 3'-end formation.
Because of increasing interest and progress, sessions on systems approaches and coupling with other
processes (e.g., transcription) were added. Although RNA interference has been covered at this meet-
ing in the past, it was dropped as a session this year because of the new Cold Spring Harbor meet-
ing on RNAi and microRNA function.
In terms of splicing regulation, many specific examples were discussed. Although there has been
significant progress in deciphering detailed regulatory mechanisms, there were few unifying themes.
Each case appears to be unique, and multiple nonoverlapping factors, both positive and negative, have
been identified. In addition, array technology has revealed remarkably complex patterns of tissue-spe-
cific and developmental regulation of alternative splicing.
With regard to splicing mechanism, several talks illuminated new proofreading mechanisms that
function at both the 5' and 3' splice sites. Additionally, surprising results indicate that different introns
show differential dependence on constitutive splicing factors. The majority of presentations on 3'-end
formation focused on new links between polyadenylation and both transcription and splicing. In addi-
tion, identification of the nuclease responsible for 3'-end cleavage was reported.
The RNA trafficking session served to emphasize the complexity of nucleus-cytoplasmic communi-
cation. Particularly exciting were presentations describing the interrelationship between processing
bodies and stress bodies. Furthermore, the role of helicases in transport is finally being illuminated.
In terms of surveillance and decay, significant progress has been made in the biochemical analysis
of the exon junction complex. Nevertheless, it remains unclear how this complex triggers nonsense-
mediated decay in higher eukaryotes. Further complications were introduced when NMD was analyzed
T. Nilsen, E. Izaurralde, D. Rio
A. Stevenson, J.-A. Wise
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in lower eukaryotes. Even though these organisms have the components of the exon junction com-
plex, these components are not required for surveillance. The nuclease(s) responsible for initiating this
type of decay is still unknown.
Finally, the interplay of the cell's environment with the mRNA processing machinery was extensive-
ly discussed. It now seems quite clear that signal transduction pathways have dramatic effects on
alternative splicing, 3"-end formation, and decay. The mechanisms by which these pathways intersect
and effect mRNA maturation remain largely obscure.
Major sponsorship for this meeting was provided by the National Cancer Institute and the National
Institute of Child Health and Human Development, branches of the National Institutes of Health; and
the National Science Foundation. In addition, the Laboratory would like to thank the RNA Society for
its support of this meeting. Contributions from our corporate benefactors, corporate sponsors, plant
corporate associates, corporate affiliates, corporate contributors, and foundations also provided core
support for this meeting.
PROGRAM
Systems-Level Approaches to Regulation of mRNA
Processing
Chairperson: M. Ares, University of California, Santa Cruz
Alternative and Regulated Splicing I
Chairperson: D. Black, Howard Hughes Medical Institute,
University of California, Los Angeles
RNA Trafficking and Localization
Chairperson: U. Kutay, Swiss Federal Institute of Technology
Zurich
Mechanism and Regulation of 3"-end Formation
Chairperson: J. Manley, Columbia University New York
Spliceosome: Mechanism Assembly and Factors
Chairperson: C. Guthrie, University of California, San
Francisco
Mechanisms of mRNA Decay and Surveillance
Chairperson: A.-B. Shyu, University of Texas-Houston Medical
School
Alternative and Regulated Splicing II
Chairperson: A. Krainer, Cold Spring Harbor Laboratory
Coupling and Networks in Pre-mRNA Processing
Chairperson: M. Rosbash, Howard Hughes Medical Institute,
Brandeis University Waltham, Massachusetts
K K K X1,,
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Mechanisms of Eukaryotic Transcription
August 31-September 4 453 participants
ARRANGED BY Joan Conaway, Stowers Institute for Medical Research
Barbara Graves, University of Utah
Jerry Workman, Stowers Institute for Medical Research
Regulation of gene transcription has a central role in the growth and development of eukaryotic organ-
isms. Transcriptional responses occur as a consequence of cell signaling, environmental stresses, and
developmental cues. Thus, the field of transcription encompasses a broad range of study from struc-
tural biology to developmental biology. This meeting appropriately covered all aspects of transcription
and brought together a diverse group of scientists. The meeting consisted of eight plenary sessions
and three poster sessions. One session focused on the most recent structures of RNA polymerases
and their associated transcription factors and on how our understanding of transcription mechanisms
is being illuminated by these structures. Two sessions, entitled Histone Modification and Chromatin
Remodeling, covered the role of chromatin in transcription control. Additional sessions covered func-
tions of DNA-binding transcriptional regulatory proteins and coregulatory complexes, control of elon-
gation and termination, and signaling pathways that regulate transcription. A final session discussed
regulatory networks and mechanisms and included genomic and proteomic approaches.
Major sponsorship for this meeting was provided by the National Cancer Institute and the National
Institute of Child Health and Human Development, branches of the National Institutes of Health; and
the National Science Foundation. Contributions from our corporate benefactors, corporate sponsors,
plant corporate associates, corporate affiliates, corporate contributors, and foundations also provided
core support for this meeting.
B. Graves, M. Balamotis
247
PROGRAM
Transcription Complexes
Chairperson: J. Conaway, Stowers Institute for Medical
Research, Kansas City, Missouri
Signaling
Chairperson: A. Berk, University of California, Los
Angeles
Structure and Mechanism
Chairperson: R. Tjian, University of California, Berkeley
Elongation and Termination
Chairperson: P. Farnham, University of California, Davis
Regulatory Networks
Chairperson: R. Treisman, Cancer Research UK-London
Research Institute
Chromatin Remodeling
Chairperson: S. Mango, University of Utah, Salt Lake City
Activators
Chairperson: T. Archer, NIEHS, National Institutes of Health,
Research Triangle Park, North Carolina
Histone Modifications
Chairperson: G. Almouzni, Institut Curie, Paris, France
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Eukaryotic DNA Replication
September 7-11 331 participants
ARRANGED BY Stephen Bell, HHMI/Massachusetts Institute of Technology
Joachim Li, University of California, San Francisco
Terry Orr-Weaver, Whitehead Institute/Massachusetts Institute of Technology
This was the ninth biannual meeting on eukaryotic DNA replication held at Cold Spring Harbor.
Important progress has been made in our understanding of eukaryotic DNA replication, and this meet-
ing is crucial in bringing together an international array of researchers investigating all aspects of
eukaryotic DNA replication. The most recent advances in the field were presented together with new
approaches for analyzing DNA replication, making this meeting the most important in the field. A large
number of investigators participated in the ten scientific sessions, with nearly 250 platform and poster
presentations. The platform and poster sessions were marked by spirited and enthusiastic exchanges
of new results. In the scientific sessions many audience members participated in the question and
answer sessions, and the poster sessions were well-attended.
The meeting illustrated the rapid advances in our understanding of the function of replication pro-
teins in initiation and elongation of DNA replication, the surveillance mechanisms monitoring the accu-
racy of replication, a global genomic view of replication, and the coordination between DNA replication
and development.
Major sponsorship for this meeting was provided by the National Cancer Institute, a branch of the
National Institutes of Health, and the National Science Foundation. Contributions from our corporate
benefactors, corporate sponsors, plant corporate associates, corporate affiliates, corporate contribu-
tors, and foundations also provided core support for this meeting.
B. Calvi, T. Orr-Weaver
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PROGRAM
Assembly of Replication Initiation Machines
Chairperson: A-K. Bielinsky, University of Minnesota,
Minneapolis
Replication Timing and Origin Activation
Chairperson: B. Brewer, University of Washington, Seattle
Genomic Analysis of DNA Replication and Checkpoint
Control
Chairperson: K. Shirahige, Tokyo Institute of Technology
Japan
Damage Responses and Checkpoint Control
Chairperson: J. Diffley, Cancer Research UK, South Mimms
Replication and the Cell Cycle
Chairperson: J. Walter, Harvard Medical School, Boston,
Massachusetts
Replication Fork Proteins
Chairperson: M. O'Donnell, Howard Hughes Medical Institute,
The Rockefeller University New York
Control of Replication during Development
Chairperson: M. Botchan, University of California, Berkeley
Origin Selection
Chairperson: D. Gilbert, SUNY Upstate Medical University
Syracuse
S. Ayes, Y. Kawasaki, K. Moore
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Microbial Pathogenesis and Host Response
September 14-18 265 participants
ARRANGED BY Paula Sundstrom, Dartmouth Medical School
James Slauch, University of Illinois, Urbana/Champaign
Theresa Koehler, University of Texas, Houston Medical School
Microbial pathogens have coevolved with humans and developed sophisticated mechanisms and to
interact with and manipulate their hosts. Thus, despite advances in modern health care, microbial
pathogens continue to be major causes of human disease and
mortality. The isolation of organisms resistant to all known antimi-
crobials, as well as the emergence of apparently new pathogens
and an increased awareness of the potential use of microbial
pathogens as agents of bioterrorism, emphasizes the need for
increased understanding of pathogenic mechanisms with the
goal of developing new therapies and other preventive strategies.
Elucidating aspects of microbial pathogenesis requires an inter-
disciplinary approach, integrating the fields of microbiology,
eukaryotic cell biology, and immunology. The meeting attracted a
diverse group of international scientists who approach the study of
bacterial and fungal pathogens from a broad range of perspec-
tives. The continued participation of a large number of young sci-
entists is particularly noteworthy. The program included a keynote
address by Aaron P. Mitchell, Professor of Microbiology at
Columbia University. Trained in classical yeast genetics, he is now
a leader in the field of fungal pathogenesis and genomics.
The oral sessions included mixtures of established investigators presenting their recent results as well
as graduate students and postdoctoral fellows presenting their new findings. Sessions focused on how
T. Koehler, P. Sundstrom
K. McIver, T. Kinkel, A. Almengor
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certain pathogens establish a niche and grow inside eukaryotic cells, how pathogens alter their surface
properties to interact with the host, how the host immune response deals with certain pathogens, and
how bacterial toxins are secreted and carry out their biological function. The session on novel vaccines
and therapeutic strategies also included a general discussion of the challenges of developing antimicro-
bials in the modern pharmaceutical industry. The remaining sessions focused on virulence gene regula-
tion in response to the host environment and novel animal models to study host-pathogen interactions.
The talks and poster sessions generated lively, interactive discussions. Many presentations describing
the use of a new method to solve a complex problem led to animated discourses about how the
approach could be applied to answer recalcitrant questions about other host-pathogen interactions.
Some of these interactions have already produced fruitful scientific collaborations.
Despite the active scientific research on microbial pathogenesis and the impressive progress in this
field, it is clear that as one problem is solved, another microbial pathogen rapidly takes its place. Hence,
there will be a continual need for the free, interactive exchange of ideas like that stimulated by this
meeting.
Major sponsorship for this meeting was provided by the National Institute of Allergy and Infectious
Diseases and the National Institute of Dental and Craniofacial Research, branches of the National
Institutes of Health; and the Burroughs Wellcome Fund. Contributions from our corporate benefactors,
corporate sponsors, plant corporate associates, corporate affiliates, corporate contributors, and foun-
dations provided core support for this meeting.
PROGRAM
Intracellular Biology
Chairperson: D. Holden, Imperial College, London, United
Kingdom
Microbial Surfaces
Chairperson: W. Goldman, Washington University School of
Medicine, St. Louis, Missouri
Host Responses
Chairperson: S. Levitz, Boston University, Massachusetts
Toxin/Effector Delivery and Function
Chairperson: P. Schlievert, University of Minnesota Medical
School, Minneapolis
Vaccines
Chairperson: D. Higgins, Harvard Medical School, Boston,
Massachusetts
Therapeutics
Chairperson: S. Projan, Wyeth-Ayerst Research, Pearl River,
New Jersey
Gene Regulation
Chairperson: A. Camilli, Tufts University, Boston,
Massachusetts
Keynote Speaker: The Landscape of Gene Function in
C. albicans
Chairperson: A. Mitchell, Institute for Cancer Research,
Columbia University New York
Host/Microbe Interactions
Chairperson: V. Miller, Washington University School of
Medicine, St. Louis, Missouri
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Programmed Cell Death
September 21-25 329 participants
ARRANGED BY Hermann Steller, HHMI/Massachusetts Institute of Technology
Jurg Tschopp, University of Lausanne, Switzerland
Jungying Yuan, Harvard Medical School
The opening keynote address formed part of the opening session on Mechanisms and Functions of
the Bcl -2 Family and was delivered by Craig Thompson on Programmed Cell Death: The New
Frontiers. Thompson's laboratory has pioneered the study of the Bcl -2 family of oncogenes, or cancer-
causing genes, and their role in regulating cell survival. On the basis of this research, future treatments
could be designed to block the ability of cancer cells to survive and thus limit tumor size and prevent
the cancer from spreading. The opening session was followed by seven oral sessions and two poster
sessions. In all, the meeting featured 234 presentations and was attended by participants from more
than 20 countries.
Major sponsorship for this meeting was provided by the National
Institute on Aging, the National Cancer Institute, and the National
Institute of Child health and Human Development, branches of the
National Institutes of Health; and the National Science Foundation.
Contributions from our corporate benefactors, corporate sponsors,
plant corporate associates, corporate affiliates, corporate contributors,
and foundations also provided core support for this meeting.
H. Stellar, M. Jaatella
J. Yuan, J. Tschopp
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PROGRAM
Keynote Address: Programmed Cell Death: The New
Frontiers
C. Thompson, Abramson Family Cancer Research Institute,
University of Pennsylvania
Mechanisms and Functions of BCL-2 Family
Chairpersons: A. Strasser, Walter & Eliza Hall Institute of
Medical Research, Parkville, Australia; Y. Tsujimoto, Osaka
University Medical Center, Japan
Regulation of Apoptosis in Invertebrates
Chairpersons: K. White, Massachusetts General Hospital,
Harvard Medical School, Charlestown; D. Xue, University of
Colorado, Boulder
Apoptotic Signaling
Chairpersons: J.M. Hardwick, Johns Hopkins University
Baltimore, Maryland; S. Nagata, Osaka University Medical
School, Japan
Apoptosis in Cancers
Chairpersons: S. Lowe, Cold Spring Harbor Laboratory;
E. White, Rutgers University Piscataway New Jersey
Neuronal Cell Death
Chairpersons: V. Dawson, Johns Hopkins University of School
of Medicine, Baltimore, Maryland; P. Nicotera, University of
Leicester, United Kingdom
Regulation of Autophagy and Alternative Cell Death
Pathway
Chairpersons: M. Jaatela, Danish Cancer Society
Copenhagen; B. Levine, University of Texas Southwestern
Medical Center, Dallas
Mechanism and Functions of Caspases
Chairpersons: T. Mak, University Health Network, Toronto,
Canada; Y. Shi, Princeton University New Jersey
Ubiquitination in Apoptosis
Chairpersons: Y. Lazebnik, Cold Spring Harbor Laboratory;
X. Wang, University of Texas Southwestern Medical Center,
Dallas
Summary
Hermann Steller, The Rockefeller University New York
P SkouPos. N. Mulherkar
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RNAi
September 28-October 2 257 participants
ARRANGED BY Greg Hannon, Cold Spring Harbor Laboratory/HHMI
Phillip Zamore, University of Massachusetts Medical School
This was the first meeting on RNA interference (RNAi) held at Cold Spring Harbor. Although the field is
young, studies of RNAi and the related microRNA pathway are advancing rapidly. There were 9 scien-
tific sessions and 53 platform and 71 poster presentations. Richard Jorgensen, the pioneering plant
biologist who in 1990 first reported the RNA silencing phenomenon, "cosuppression," delivered the
keynote address. Interest in the mechanisms and regulation of RNAi in eukaryotic cells continues to
increase, and we hope that this meeting will grow to be the key meeting for the field, fostering the
exchange of new ideas and experimental approaches.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, cor-
porate affiliates, corporate contributors, and foundations provided core support for this meeting.
C. Rosenau, S. Engle
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PROGRAM
Keynote Speaker
R. Jorgensen. University of Arizona
Small RNA Biogenesis and Function
Chairperson: T. Nilsen, Case VVestern Reserve University
Cleveland, Ohio
Nuclear Roles for Small RNAs
Chairperson: E. Sontheimer, Northwestern University
Evanston, Illinois
Biological Functions of miRNAs
Chairperson: R Zamore, University of Massachusetts
Medical School, Worcester
Experimental Uses of RNA Silencing I
Chairperson: S. Hammond, University of North Carolina,
Chapel Hill
miRNA Expression and Targets
Chairperson: R. Plasterk, Hubrecht Laboratory Utrecht,
The Netherlands
Experimental Uses of RNA Silencing II
Chairperson: G. Hannon, Cold Spring Harbor Laboratory
Small RNAs, Small Details
Chairperson: L. Joshua-Tor, Cold Spring Harbor
Laboratory
C. Dean, D. Chalker
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M. Ghildiyal, J. Broderick
Neurobiology of Drosophila
October 5-9 429 participants
ARRANGED BY Leslie Griffith, Brandeis University
Davie Van Vactor, Harvard Medical School
The goal of this meeting, as it has been since its inception, was to foster communication of ideas, tech-
niques, and new discoveries within the field of Drosophila neurobiology. The meeting was structured
with platform and poster presentations by a variety of researchers, including graduate students, post-
doctoral fellows, and junior and senior faculty; all platform presentations were selected by session
chairs from the abstracts submitted. The topics for the platform sessions were chosen from the areas
where exciting advances are being made in understanding molecular and cellular mechanisms: neuro-
physiology, behavior, sensory systems, axon guidance, synapse formation and function, neuronal and
glial determination, and neuronal cell biology and pathology. The research reported relied on a wide
range of techniques, including genetic, molecular, cellular, neurophysiological, behavioral, and genom-
ic approaches to basic questions of nervous system development and function. Among the highlights
of the meeting were presentations of new and exciting developments including visualization of synap-
tic transmission at the level of individual boutons, identification of new molecules contributing to axon
guidance, and genomic analysis of glial cell functions. The Elkins plenary lecture, which was present-
ed by recent Ph.D. graduate Greg Jefferis, described exciting work on the establishment of an olfac-
tory map in the brain before the arrival of olfactory neuron axons. The environment of the meeting
allowed many opportunities for informal discussions among all participants. The high quality of the pre-
sentations, novel findings, and new techniques discussed at the meeting demonstrated the vitality of
Drosophila research. The character of the discussions led to cross-fostering of ideas that was valuable
to everyone in the field.
Major sponsorship for this meeting was provided by the National Institute of Neurological Disorders
and Stroke, a branch of the National Institutes of Health; and the National Science Foundation.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, corpo-
rate affiliates, corporate contributors, and foundations also provided core support for this meeting.
L. Griffith, S. Crews, C. Klarnbt, D. Van Vector
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PROGRAM
Behavior
Chairperson: R. Davis, Baylor College of Medicine, Houston,
Texas
Sensory Systems
Chairperson: L. Vosshall, The Rockefeller University New York
Peter Kolodziej Memorial Lecture: Neuronal Function
Chairperson: B. Stewart, University of Toronto, Canada
Cell Biology and Pathology
Chairperson: N. donini, University of Pennsylvania,
Philadelphia
Synapse Formation
Chairperson: V Budnik, University of Massachusetts, Amherst
Glial Biology
Chairperson: V Auld, University of British Columbia,
Vancouver, Canada
Elkins Memorial Lecture
Chairperson: Mathias Wernet, Stanford University
Process Formation
Chairperson: A. Kolodkin, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Cell Fate Specification
Chairperson: S. Thor, Linkoping University Sweden
Visual System Development
Chairperson: T. Wolff, Washington University School of
Medicine, St. Louis, Missouri
Emerging Technologies
Chairpersons: L. Griffith, Brandeis University, Waltham,
Massachusetts; D. Van Vector, Harvard Medical School,
Boston, Massachusetts
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Genome Informatics
October 28-November 1 228 participants
ARRANGED BY Tim Hubbard, Wellcome Trust Sanger Institute
Suzanna Lewis, University of California, Berkeley
Lincoln Stein, Cold Spring Harbor Laboratory
The fifth Cold Spring Harbor Laboratory-Wellcome Trust conference gave participants the opportunity
to enjoy Halloween festivities at Cold Spring Harbor. This conference series alternates between Cold
Spring Harbor and the Wellcome Trust Genome Campus south of Cambridge, United Kingdom and
follows a format similar to that of traditional Cold Spring Harbor meetings, in that the majority of oral
presentations are drawn from openly submitted abstracts. The explosion of biological data requires a
concomitant increase in the scale and sophistication of information technology. This ranges from the
storage of data and their associated data models, to the design of effective algorithms to uncover
nonobvious aspects of these data sets, to ontologies to concisely describe biological information, and
finally to software systems to support curation, visualization, and exploration. The conference brought
together some of the leading scientists in this growing field, and researchers from other large-scale
information-handling disciplines were also invited to attend. In addition to the organizers, discussion
leaders included Zhirong Bao, Christopher Burge, Thomas Down, Anne Ferguson-Smith, Jennifer
Harrow, Robert Martienssen, Webb Miller, Francis Ouellette, Roded Sharan, Lisa Stubbs, Jason
Swedlow, and Paul Thomas. The keynote talk was given by David Haussler. In all, 228 participants
attended, with more than 25% of delegates coming from outside North America, and the meeting host-
ed 169 scientific presentations in talks and posters.
Major sponsorship for this meeting was provided by the National Human Genome Research
Institute, a branch of the National Institutes of Health. Contributions from our corporate benefactors,
corporate sponsors, plant corporate associates, corporate affiliates, corporate contributors, and foun-
dations also provided core support for this meeting.
C. Lawrence, R. Voelker
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PROGRAM
High-throughput Genomics
Chairpersons: J. Harrow, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; B.F.F. Ouellette, University of
British Columbia, Vancouver, Canada
Pathways and Proteomics I
Chairpersons: P. Thomas, Applied Biosystems, Foster City
California; R. Sharan, Tel Aviv University Israel
Pathways and Proteomics II
Chairpersons: P. Thomas, Applied Biosystems, Foster City
California; R. Sharan, Tel Aviv University Israel
Keynote Address
D. Haussler, Howard Hughes Medical Institute, University of
California, Santa Cruz
Epigenomics
Chairpersons: A. Ferguson-Smith, University of Cambridge,
United Kingdom; R. Martienssen, Cold Spring Harbor
Laboratory
Birds of a Feather
Images, Atlases, and Phenotypes
Chairpersons: J. Swedlow, University of Dundee, United
Kingdom; Z. Bao, University of Washington, Seattle
Genetic Regulation
Chairpersons: T Down, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; C. Burge, Massachusetts Institute
of Technology Cambridge
Comparative and Evolutionary Genomics I
Chairpersons: W. Miller, Pennsylvania State University
University Park; L. Stubbs, Lawrence Livermore National
Laboratory California
Comparative and Evolutionary Genomics II
Chairpersons: W. Miller, Pennsylvania State University
University Park; L. Stubbs, Lawrence Livermore National
Laboratory California
Expect the Unexpected
Chairpersons: T Hubbard, Wellcome Trust Sanger Institute;
S. Lewis, University of California, Berkeley; L. Stein, Cold
Spring Harbor Laboratory
M. Ashburner, T Fiedler
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Vector Targeting Strategies for Gene Therapy
November 11-13 94 participants
ARRANGED BY David T. Curie!, University of Alabama, Birmingham
Michael Barry, Baylor College
Stephen Russell, Mayo Foundation
Jan Schnitzer, Sidney Kimmel Cancer Center
The paramount requirement for advancement of gene therapy is the development of vector systems
possessing the capacities for efficient and cell-specific gene delivery. The achievement of these goals
requires that the vector system recognizes specific cell signatures. In the first regard, both nonviral and
viral vectors have been engineered to address this goal. Furthermore, a variety of high-throughput
methods have been advanced for identification of cell-specific markers. Investigators at this meeting
provided an update of key technologies relevant to these goals. Since the last conference in 2003,
progress has been noted in this field. Especially noteworthy was the progress achieved in the content
of viral vector tropism modifications and targeted gene knockout and imaging technologies. This
progress includes the proposed translation of novel, advanced generation vectors into the human clin-
ical context. Additionally, the means to make targeted vectors available for clinical investigators remains
a challenge. Future work will be required to define the range of cell-specific signatures of relevance in
the clinical context. Nonetheless, the linkage of these relevant technologies-target definition, vector
targeting, and imaging-is already yielding important advances in outcomes achievable via gene ther-
apy methods and providing targeted vector agents for human clinical translation.
Major sponsorship for this meeting was proviced by Biogen Idec, C.G.T. Corporation, Cell Genesys,
Inc.; GenVec, Inc.; Louisiana Gene Therapy Research Consortium, Inc; Vector Logics, Inc.; and Wyeth
Vaccines Research. Contributions from our corporate benefactors, corporate sponsors, plant corpo-
rate associates, corporate affiliates, corporate contributors, and foundations also provided core sup-
port for this meeting.
D. Cudel, S. Hedley
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PROGRAM
Opening Day
D. Curiel, University of Alabama, Birmingham
Keynote Speaker
Chairperson: T. Waldmann, National Cancer Institute,
Bethesda, Maryland
Adenovirus
Chairperson: M. Barry, Baylor College of Medicine, Houston, Texas
AAV
Chairperson: K. Warrington, University of Florida College of
Medicine
Invited Speaker and Breakout Session
Chairperson: D. Curiel, University of Alabama, Birmingham
RNA/Retrovirus
Chairperson: S. Russell, Mayo Clinic College of Medicine,
Rochester, Minnesota
Cell Vehicle and Nonviral Vector
Chairperson: M. Everts, University of Alabama, Birmingham
Imaging and Miscellaneous
Chairperson: M. Yamamoto, University of Alabama,
Birmingham
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D. Brough, M. Trepel N. Wolfrum, S. Schule
J. Weinstein, M. Nakayama, H. Ugai
Molecular Approaches to Vaccine Design
December 1-4 85 participants
ARRANGED BY Peter Beverley, Edward Jenner Institute for Vaccine Research
Emilio Emini, Wyeth Pharmaceuticals
Susan Swain, Trudeau Institute
This fourth winter conference set out to examine whether the revolution in the understanding of mole-
cular and cell biology and in new technologies that has taken place in recent years had begun to have
a real impact on how new vaccines are designed. There were sessions on the immunological basis of
vaccine immunity; HIV immunity and vaccines; advances in research into malaria, tuberculosis, and
respiratory infections; and a final session on new vaccines and underlying immune concepts. It is clear
that at the level of the whole immunized animal, there remain many gaps in understanding of factors
that determine how different types of protective immunities are generated and maintained in response
to different organisms and in different tissue sites. However, several presentations stressed that too vig-
orous a primary response can lead to terminal differentiation of T cells, resulting in less generation of
memory. Improved methods for detection and quantitation of antigen-specific cells are beginning to
shed light on how different immunization protocols result in
distinct types of immune responses. Genetic analysis of
hosts and pathogens suggests that the diversity of
response seen in outbred humans may eventually become
predictable.
More encouragingly at the level of defined cell types and
signaling pathways, particularly in antigen-presenting cells,
progress is being made in the definition of ligands and
downstream pathways that lead to clearly distinct func-
tions. Toll-like receptor ligands, siRNA, and pharmaceutical
agents were all shown to be capable of modulating
immune responses in predictable and useful ways and
should eventually supplant or at least explain the mode of
action of empirically defined adjuvants, which currently per-
form this function.
The meeting also heard of the strikingly successful trials
of new rotavirus and papillomavirus vaccines. The rotavirus
vaccine, composed of recombinantly engineered human-
bovine reassorted rotaviruses, is effective in preventing and
mitigating rotaviral disease in infants, yet the mechanism of
protection and the immunological correlates of the protec-
tion remain unclear. Although this is a striking example of a successful empirical approach to vaccine
development, there remain many diseases for which empirical vaccine development has failed.
Hopefully, vaccines for these diseases will eventually be successfully developed as fundamental knowl-
edge of the cellular and molecular basis of immune response increases, and as this knowledge is sys-
tematically integrated into vaccine design research. Appreciation of the need for such integration was
one of the conference's goals, and the goal was, by all accounts of the participants, successfully
achieved.
Contributions from our corporate benefactors, corporate sponsors, plant corporate associates, cor-
porate affiliates, corporate contributors, and foundations provided core support for this meeting.
P. Beverley, D. Doolan
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PROGRAM
Immunological Basis of Vaccine Immunity I
Chairperson: E. Emini, Wyeth Pharmaceuticals, Collegeville,
Pennsylvania
Immunological Basis of Vaccine Immunity II
Chairperson: S. Swain, Trudeau Institute, Saranac Lake,
New York
HIV-1 Immunity and Vaccines
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
Advances in Malaria and TB Vaccine Research
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
Respiratory Infections
Chairperson: S. Swain, Trudeau Institute, Saranac Lake,
New York
CSHL Public Lecture: Bird Flu and the Global Threat of
Emerging Respiratory Diseases
Kanta Subbarao, NIAID, National Institutes of Health,
Bethesda, Maryland
New Vaccines and Underlying Immune Concepts
Chairperson: E. Emini, Wyeth Pharmaceuticals, Collegeville,
Pennsylvania
J. ter Meulen, A. Hill
M. Page, A. Ojugo
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D. Galbi, J. Kowalski
Winter Biotechnology Conference: Rat Genomics and Models
December 8-11 123 participants
ARRANGED BY Timothy Aitman, Imperial College, London
Howard Jacob, Medical College of Wisconsin
James Shull, University of Nebraska Medical Center
This fourth winter biotechnology conference followed three successful previous meetings held at the
Cold Spring Harbor Laboratory in 1999, 2001, and 2003. Drs. Shull and Altman joined Dr. Jacob in
organizing the conference this year. This series of conferences is the first in the United States to focus
exclusively on the rat as a model organism for biological research and directly complements meetings
focused on rat genetics/genomics held outside of the United States in the intervening years (i.e., Kyoto
Japan in 2002 and Copenhagen Denmark in 2004). The primary goals of this meeting are (1) to pro-
mote interactions between biomedical researchers who utilize rat models in the study of physiology,
pathophysiology, toxicology, neuroscience, and oncology and (2) to provide an interface between the
research community and the various public and commercial resources that exist to support biomed-
ical research in which rat models are utilized.
The meeting was organized into oral presentations by invited speakers as well as speakers select-
ed following evaluation of submitted abstracts, poster sessions, and workshops. Invited speakers
included Tim Altman, Imperial College, London, UK; Artur Rangel-Filho, Medical College of Wisconsin,
Milwaukee, WI; Bina Joe, Medical University of Ohio, Toledo, OH; Jonathan Flint, Oxford University,
Wellcome Trust Centre, Oxford, UK; Percio Gulko, North Shore Long Island Jewish Research Institute,
New York, NY; Colin Bishop, Baylor College of Medicine, Houston, TX; John Critser, University of
Missouri, Columbia, MO; Janan Eppig, Jackson Laboratory, Bar Harbor, ME; Howard Jacob, Medical
College of Wisconsin, Milwaukee, WI; Norbert Hubner, Max Delbruck Center, Berlin Germany; Janet
Young, Fred Hutchinson Cancer Center, Seattle, WA; Linda Moran, Imperial College, London, UK;
Nelson, Ruiz-Opazo, Boston University, Boston, MA; Pernilla Stridh -Igo, Karolinska Institute,
MEETINGS
COURSES
BOOKSTORE
H. Jacob, S. Old
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Stockholm, Sweden; Eva Redei, Northwestern University, Chicago, IL; Robin Wait, Imperial College,
London, UK; Andrea Gore, University Texas, Austin, TX; Michael Waters, NIEHS, Research Triangle
Park, NC; Michael Atkinson, GSF-National Research Center for Environment and Health, Neuherberg,
Germany. Representatives from the Rat Genome Database presented workshops on the use of this
database for accessing data on the rat genome, OIL, and rat strains. This meeting featured 95 pre-
sentations and attracted 123 participants from around the world.
Major sponsorship for this meeting was provided by the National Heart, Lung, and Blood Institute,
a branch of the National Institutes of Health. Contributions from our corporate benefactors, corporate
sponsors, plant corporate associates, corporate affiliates, corporate contributors, and foundations also
provided core support for this meeting.
PROGRAM
Positional Cloning
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; T Serikawa, Kyoto University Japan
Resources I
Chairpersons: T Altman, Imperial College, London, United
Kingdom; J. Ye, NHLBI, National Institutes of Health,
Bethesda, Maryland
Rat Genome Database Demo and Discussion
Neuroscience
Chairpersons: J. Young, Fred Hutchinson Cancer Research
Center, Seattle, Washington; E. Cuppen, Hubrecht
Laboratory Utrecht, The Netherlands
Proteomics, Expression
Chairpersons: R. Wait, Imperial College, London, United
Kingdom; N. Hubner, Max-Delbruck Center for Molecular
Medicine, Berlin, Germany
Resources II
Chairpersons: S. Old, NHLBI, National Institutes
of Health, Bethesda, Maryland; A. Kwitek,
Medical College of Wisconsin, Milwaukee
Cancer and Induced Neoplasia
Chairpersons: C. Walker, University of Texas
MD Anderson Cancer Center, Smithville; J.
Shull, University of Nebraska Medical
Center, Omaha
Diabetes
Chairperson: M. Pravenec, Czech Academy
of Sciences, Prague
Models
Chairpersons: Y. Yagil, Ben Gurion University
Ashkelon, Israel; L. Carr, Indiana University
School of Medicine, Indianapolis
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T. Laragione, M. Brenner, T. Aitman
T. Saunders, E. Bryda
CSHL/WELLCOME TRUST CONFERENCES
These conferences were held at the Hinxton Hall Conference Centre, located several miles south of
Cambridge in the United Kingdom, which forms part of the Wellcome Trust Genome Campus togeth-
er with the Sanger Institute and the European Bioinformatics Institute. The conferences are managed
jointly by Cold Spring Harbor Laboratory and the Wellcome Trust and follow the Cold Spring Harbor
style in that the majority of talks are chosen from openly submitted abstracts. The topics of the joint
conference series emphasize genomics and bioinformatics, or topics of particular interest in the United
Kingdom and Europe.
Interactome Networks
August 31-September 4 77 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Anne-Claude Gavin, Cellzome Inc.
Marc Vidal, Dana-Farber Cancer Institute/Harvard Medical School
The first meeting on Interactome Networks brought together senior and junior investigators and post-
doctoral and (post)graduate researchers in a range of disciplines to share existing research and expe-
rience. The conference addressed topics including ORFeome and other clone resources and Y2H and
other binary assay maps; pull-down mass spectrometry approaches; finishing orthogonal binary
assays; assembly/annotation: integration with phenotypic, transcriptome, and localization clustering
data; domain-domain networks; and interaction-defective genetics.
PROGRAM
ORFeome
Transcriptional Networks
Binary Maps
Cocomplex Membership Maps
Workshop 1
Interactome Modeling: Functional Integration
Domain Mapping
Disease-related Networks
Workshop 2
Interactome Modeling: Informatics I
Interactome Modeling: Informatics II
Networks and Evolution
Francis Crick Auditorium
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Prion Biology
September 7-11 113 participants
ARRANGED BY Adriano Aguzzi, University Hospital of Zurich
Bruce Chesebro, Rocky Mountain Laboratories
Mick Tuite, University of Kent
Reed Wickner, National Institutes of Health
This first Prion Biology conference on focused on important advances in prion research in both animals
and fungi. Human prions are unique types of infectious agents, whereas fungi prions act as protein-
based epigenetic determinants of phenotype. The conference provided a forum to report and discuss
the latest discoveries on prions and brought together scientists from a wide range of disciplines in the
biological and clinical sciences.
PROGRAM
SESSION 1
M. Tuite, University of Kent, United Kingdom
SESSION 2
S. Liebman, University of Illinois, Chicago
SESSION 3
A. Aguzzi, University Hospital Zurich, Switzerland
SESSION 4
S. Saupe, University of Bordeaux, France
SESSION 5
C. Soto, University of Texas Medical Branch, Galveston
SESSION 6
B. Caughey, Rocky Mountain Laboratories, NIAID, Hamilton,
Montana
SESSION 7
R. Wickner, NIDDK, National Institutes of Health, Bethesda,
Maryland
SESSION 8
B. Chesebro, Rocky Mountain Laboratories, NIAID, Hamilton,
Montana
Welcome Trust Conference Center and Hinxton Hall
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Pharmacogenomics
September 14-18 120 participants
ARRANGED BY Steve Leeder, Children's Mercy Hospital
Debbie Nickerson, University of Washington
Munir Pirmohamed, University of Liverpool
Dick Weinshilboum, Mayo Medical School
C. Roland Wolf, University of Dundee
This third annual conference built on successful conferences held in Hinxton in 2003 and Cold Spring
Harbor in the fall of 2004. The meeting again focused on opportunities presented by the growing con-
tribution of emerging genomic information and technologies to interdisciplinary approaches in the study
of variable responses of humans to drugs and toxic agents, and how research may benefit the individ-
ual. Topics provided an in-depth focus on diverse areas including the biochemistry and physiology of
drug action, uptake and metabolism, and how this is affected by genetics; the opportunities for dis-
covery and design of new therapeutic agents; personalizing medicine; understanding and managing
adverse drug reactions; the impact of academic and commercial initiatives; and ethical, legal, regula-
tory, and social consequences of genetics applied to medicine.
PROGRAM
Genome Structure and Variation
Chairpersons: D. Bentley, (Former) Wellcome Trust Sanger
Institute, Hinxton, United Kingdom; B. Weir, North Carolina
State University Raleigh
Molecular Approaches to Phenotype
Chairpersons.' J. Nicholson, Imperial College London, United
Kingdom; T Nikolskaya, Gene Go Inc., St. Joseph, Michigan
Disease Genetics
Chairpersons: C.R. Wolf, University of Dundee, United
Kingdom; M. Bamshad, University of Utah, Salt Lake City
Translation into Clinical Practice
Chairpersons: D. Weatherall, University of Oxford, United
Kingdom; M. Pirmohamed, University of Liverpool, United
Kingdom
Societal/Economic Impact and ELSI Issues
Chairpersons: R.M. Weinshilboum, Mayo Medical School,
Rochester, Minnesota; N.K. Spurr, GlaxoSmithKline,
Stevenage, United Kingdom
Preclinical Aspects
Chairpersons: S. Leeder, Children's Mercy Hospital, Kansas
City Missouri; M. Ingelman-Sundberg, Karolinska Institutet,
Stockholm, Sweden
Basic Approaches
Chairpersons: D. Balding, Imperial College London, United
Kingdom; J.P. loannidis, University of Ioannina, Greece
Grounds of the Wellcome Trust Genome Campus
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Functional Genomics of Mammalian Nervous Systems
September 28-October 2 65 participants
ARRANGED BY Jacqueline Crawley, National Institute of Mental Health
Seth Grant, Welcome Trust Sanger Institute
Nathaniel Heintz, HHMI/The Rockefeller University
The theme of this first CSHLNVellcome Trust conference on Functional Genomics of Mammalian
Nervous Systems was to understand the structural and functional complexity of the vertebrate nervous
system. The meeting brought together scientists with interests in approaches ranging from molecular
biology to behaving animal studies, from single gene to complex sets of genes, and from synapses to
networked brain functions. Advances in genomics and proteomics are defining the molecular building
blocks that underpin the structural complexity of the brain and its behavioral output. Combining genet-
ic discoveries with anatomical, electrophysiological, and behavioral findings is now making it feasible
to integrate this knowledge.
PROGRAM
Behavior
Chairperson: J. Crawley, NIMH, National Institutes of Health,
Bethesda, Maryland
Welcome and Introduction
Chairperson: Seth Grant, Wellcome Trust Sanger Institute
Workshop 1: Databases and Bioinformatics
Chairperson: J.D. Armstrong, University of Edinburgh
Brain Gene Expression Mapping and Transcriptome
Chairperson: N. Heintz, Howard Hughes Medical Institute, The
Rockefeller University New York
Sanger Institute
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Residential Court
Proteomics of the Nervous System
Chairperson: S. Grant, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Workshop 2: Scalable Neuroscience Technology
Chairperson: S.G.N. Grant, Wellcome Trust Sanger Institute
Vertebrate Genetic Systems
Chairperson: W. Skarnes, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Human and Primate Studies
Chairperson: J. Noebels, Baylor College of Medicine,
Houston, Texas
POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities
do not adequately treat them. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into research in a particular
area. To ensure up-to-date coverage of current research work, we bring together course faculty from
many laboratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 6-19
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
K. Severinov, Waksman Institute, Rutgers University, Piscataway, New Jersey
ASSISTANTS
K. Adelman, Cornell University, Ithaca, New York V.-C. Lee, M.D. Anderson Cancer Center/University of Texas,
V. Bergendahi, University of Wisconsin, Madison Houston
H. Duong, University of California, Los Angeles M. Nie, University of California, Los Angeles
K. Gibson, Massachusetts Institute of Technology, Cambridge N. Thompson, University of Wisconsin, Madison
B. Glaser, University of Wisconsin, Madison C. Winkler, University of California, Los Angeles
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This course was for scientists who were not familiar with techniques of protein isolation and character-
ization. It is a rigorous program that included laboratory work all day and a lecture with a discussion
session every evening. Each student became familiar with each of the major techniques in protein
purification by actually performing four separate isolations including (1) a regulatory protein from mus-
cle tissue; (2) a sequence-specific, DNA-binding protein; (3) a recombinant protein overexpressed in E
coil, and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and chro-
matographic techniques included precipitation by salts, pH, and ionic polymers; ion-exchange, gel-fil-
tration, hydrophobic interaction, and reverse-phase chromatography; lectin affinity, ligand affinity,
oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel electrophoresis and
electroblotting; and high-performance liquid chromatography. Procedures were presented for solubiliz-
ing proteins from inclusion bodies and refolding them into active monomeric forms. Methods of pro-
tein characterization were utilized to include immunological and biochemical assays, peptide mapping,
amino acid analysis, protein sequencing, and mass spectrometry. Emphasis was placed on strategies
of protein purification and characterization. Guest lecturers discussed protein structure, modification of
proteins, methodologies for protein purification and characterization, and applications of protein bio-
chemistry to cell and molecular biology. Speakers in the 2005 course included Yuri Lazebnik (Cold
Spring Harbor Laboratory), Leemor Joshua-Tor (Cold Spring Harbor Laboratory), Bruce Stillman (Cold
Spring Harbor Laboratory), Bill Studier (Brookhaven National Laboratory), and Nick Tonks (Cold Spring
Harbor Laboratory).
This course is supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Allen, N., Ph.D., Stanford University School of Medicine,
California
Blazek, D., Ph.D., University of California, San Francisco
Brito Lira, C., B.A., Universidade Estadual de Campinas,
Brazil
Hess, H., B.S., Massachusetts Institute of Technology,
Cambridge
Hoang, T., M.S., University of Bergen, Norway
Hundahl, C., Ph.D., Aarhus University, Denmark
Infante, R., RS., University of Texas Southwestern Medical
Center, Dallas
SEMINARS
Burgess, R., University of Wisconsin, Madison: Introduction to
protein purification, immunoaffinity chromatography; RNA
polymerase -o factor interactions and use of LRET-based
assays for drug discovery and biochemistry.
Courey, A., University of California, Los Angeles: Groucho and
Yan mediate the spreading of chromosomal silencing.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Protein crys-
tallography introduction and demonstration; The crystal
structure of Argonauts: The secret of life slicer.
Lazebnik, Y., Cold Spring Harbor Laboratory: Oncogenic
transformation as a cause of apoptosis.
Lin, S.-H., M.D. Anderson Cancer Center/University of Texas,
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Kristensen, C., M.S., Poalis AS, Denmark
Kustka, A., Ph.D., Princeton University, New Jersey
Leibman, M., BA., Harvard Medical School, Boston,
Massachusetts
Luo, Y., B.S., State University of New York at Stony Brook
Martin, ,J., B.S., University of California, Irvine
Patil, R., Ph.D., Abbott Laboratory, Abbott Park, Illinois
Pearson, C., Ph.D., University of Colorado, Boulder
Pesters, T, M.S., Katholieke Universiteit Leuven, Belgium
Tian, L., Ph.D., The Samuel Roberts Noble Foundation,
Ardmore, Oklahoma
Houston: The bone marrow proteome as a discovery plat-
form to understand prostate cancer progression.
Severinov, K., Waksman Institute, Rutgers University,
Piscataway, New Jersey: Analyzing inhibitors of bacterial
RNA polymerase.
Stillman, B., Cold Spring Harbor Laboratory: The role of ATP
in replication origin recognition.
Studier, B., Brookhaven National Laboratory, Upton, New
York: Protein production in the inducible T7/E. coli expres-
sion system.
Tonks, N., Cold Spring Harbor Laboratory: Signal transduction
from the protein tyrosine phosphatase perspective.
Cell and Developmental Biology of Xenopus
April 9-19
INSTRUCTORS J. Heasman, Children's Hospital Research Foundation, Cincinnati, Ohio
C. Wylie, Children's Hospital Research Foundation, Cincinnati, Ohio
ASSISTANTS B. Birsoy, Children's Hospital Research Foundation, Cincinnati, Ohio
M. Kofron, Children's Hospital Research Foundation, Cincinnati, Ohio
T. Nakayama, University of Virginia, Charlottesville
J. Taylor, Washington University, St. Louis, Missouri
Xenopus is the leading vertebrate model for the study of gene function in development. The combina-
tion of lineage analysis, gene knockout strategies, experimental manipulation of the embryo, and
genomic /bioinformatic techniques makes it ideal for studies on the molecular control of embryo pat-
terning, morphogenesis, and organogenesis. The course combined intensive laboratory training with
daily lectures from recognized experts in the field. Students learned both emerging technologies and
classical techniques to study gene function in Xenopus development. An important element was the
informal interaction between students and course faculty. Technologies covered included oocyte and
embryo culture, lineage analysis and experimental manipulation of embryos, gain- and loss-of-function
analyses using mRNAs and antisense oligos, whole-mount in situ hybridization, immunocytochemistry,
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RT-PCR, and genomic/bioinformatic techniques, preparation of transgenic embryos, use of egg
extracts to study the cell cycle and use of Xenopus tropicalis for genetic analyses. This course was
designed for those new to the Xenopus field, as well as for those wanting a refresher course in the
emerging technologies. The course was open to investigators from all countries. Additional lecturers in
the 2005 course included Stefano Piccolo, Ray Keller, Aaron Zorn, Kristen Kroll, Betsy Pownall, Matt
Kofron, Paul Krieg, and Hironon Funabiki.
This course is supported with funds provided by the National Institute of Child Health and Human
Development, the National Science Foundation, and the Howard Hughes Medical Institute.
PARTICIPANTS
Babu, P., Ph.D., University of California, Livermore
Daniel, J., Ph.D., McMaster University, Hamilton, Canada
Darden, A., Ph.D., The Citadel, Charleston, South Carolina
Jean, S., B.S., Laval University, Quebec, Canada
Jelaso, A., Ph.D., Western Michigan University, Kalamazoo
Jorgensen, P., Ph.D., Harvard Medical School, Boston,
Massachusetts
Kefalov, V, Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Lee, W.M.K., Ph.D., Centre de Biologie du Development,
Toulouse, France
SEMINARS
Funabiki, H., The Rockefeller University, New York: Cell cycle
control and spindle formation in Xenopus egg extracts.
Heasman, J., Cincinnati Children's Hospital Research
Foundation, Ohio: Maternal control of development.
Keller, R., University of Virginia, Charlottesville: Tissue move-
ments in the early embryo.
Kofron, M./Zorn, A., Cincinnati Children's Hospital Research
Foundation, Ohio: Bioinformatics and Xenopus.
Krieg, P., University of Arizona College of Medicine:
Development of the cardiovascular.
Kroll, K., Washington University School of Medicine, St. Louis,
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Malone, J., M.S., The University of Texas, Arlington
Millaras, N., Ph.D., University of Virginia School of Medicine,
Charlottesville
Nishanian, T., Ph.D., National Cancer Institute, Frederick,
Maryland
Roose, M., M.S., Universitatsklinikum Essen, Germany
Susanto, J., B.S., University of Bath, United Kingdom
Tomlinson, M., B.S., The University of East Anglia, Norwich,
United Kingdom
Watanabe, K., Ph.D., The University of Texas, Austin
Missouri: Making neurons in the early embryo.
Piccolo, S., University of Padua, Italy: Establishment of the pri-
mary germ layers.
Pownall, B., University of York, United Kingdom: Learning
about cell signaling from Xenopus tropicalis.
Schriml, L., National Center for Biotechnology Information,
Bethesda, Maryland: Bioinformatics and Xenopus.
Wylie, C., Cincinnati Children's Hospital Research Foundation,
Ohio: Classical experiments in Xenopus.
Zorn, A., Cincinnati Children's Hospital Research Foundation,
Ohio: Endoderm development.
Molecular Neurology and Neuropathology
June 8-14
INSTRUCTORS S. Gandy, Thomas Jefferson University, Philadelphia, Pennsylvania
J. Hardy, National Institutes of Health/NIA, Bethesda, Maryland
H. Orr, University of Minnesota, Minneapolis
This intensive 1-week discussion course offered successful applicants a unique opportunity to learn
the latest concepts and methodologies associated with the study of human neurological disorders
such as Alzheimer's disease, Parkinson's disease, and epilepsy. Participants discussed in detail the
strengths and weaknesses of the accumulated experimental evidence underlying our current under-
standing of these diseases. Fundamental questions-such as how and why particular neurons die in
certain disorders-were discussed in the context of identifying the best experimental approaches to
finding answers, whether through the use of transgenic and/or lesion-induced mouse models, func-
tional brain and/or cellular imaging, gain-/loss-of-function molecular and viral approaches, cellular
transplantation, or a combination of these approaches. The course examined why many of these dis-
orders share apparently common features-protein aggregation, specific vulnerability of certain class-
es of neurons, long incubation period-and discussed to what extent these features reflect common
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pathological mechanisms. The course further explored how the underlying mechanisms in these dis-
parate disorders were targeted for potential diagnostic and therapeutic gain. Extended seminars and
discussion by a wide range of leading investigators further illuminated developments in this rapidly
moving field. Participation in the course provided an essential conceptual and methodological frame-
work for anyone intending to pursue rigorous research. Speakers this year included John Collinge
(University College London), Mark Cookson (National Institute on Aging), Monica Driscoll (Rutgers, The
State University of New Jersey), Katrina Gwinn-Hardy (NINDS), Michael Hutton (Mayo Clinic,
Jacksonville), Mathias Jucker (Gerontology Research Center), Ron Kopito (Stanford University), Marcy
MacDonald (Massachusetts General Hospital), James McNamara (Duke University Medical Center),
Diane Murphy (NINDS), Henry Paulson (University of Iowa Hospital and Clinics), Peter Schofield (The
Garvan Institute of Medical Research), Jerome Siegel (Veterans Affairs Greater L.A. Health Care
System), and Maurice Swanson (University of Florida).
PARTICIPANTS
Adighibe, O., M.S., National Institutes on Aging, Bethesda,
Maryland
Chang, T.Y., Ph.D., Dartmouth Medical School, Hanover, New
Hampshire
Davis, R., Ph.D., State University of New York Upstate
Medical University, Syracuse
Fung, H.-C., M.D., National Institutes of Health, Bethesda,
Maryland
Gollamudi, S., Ph.D., Albert Einstein College of Medicine,
Bronx, New York
Horsford, D.J., Ph.D., National Institutes of Health, Bethesda,
Maryland
Jain, S., B.S., National Institutes on Aging, Bethesda, Maryland
Kim, J., B.S., Mayo Clinic College of Medicine, Jacksonville,
Florida
SEMINARS
Collinge, J., University College London, United Kingdom:
Molecular biology of prior propagation.
Cookson, M., NIA/NIH, Bethesda, Maryland: Parkinson's
disease,
Driscoll, M., Rutgers, The State University of New Jersey,
Piscataway: Genetic dissection of molecular mechanisms of
necrosis in C. elegans.
Gandy, S., Thomas Jefferson University, Philadelphia,
Pennsylvania: Amyloid and Alzheimer's disease.
Gwinn-Hardy, K., NINDS/NSC, Bethesda, Maryland: Clinical
features of neurodegenerative disorders.
Hardy, J., NIA/NIH/Laboratory of Neurogenetics, Bethesda,
Maryland: Genetic analysis in neurological diseases.
Hutton, M., Mayo Clinic Jacksonville, Florida: The
Tauopathies: Genetics and pathobiology.
Jucker, M., Gerontology Research Center, Baltimore,
Maryland: Cerebral amyloidoses.
Kopito, R., Stanford University, California: The cell biology pro-
tein aggregation diseases.
276
Klupsch, K., M.S., London Research Institute, United
Kingdom
Lindemann, L., Ph.D., F Hoffmann-La Roche Ltd., Basel,
Switzerland
Marlowe, L., B.A., National Institutes of Health, Bethesda,
Maryland
McFarlane, D., D.V.M., Atlantic Veterinary College,
Charlottetown, Canada
Oyenuga, K.O., Ph.D., Philadelphia College of Pharmacy,
Pennsylvania
Rasse, T., Ph.D., Max-Planck Society, Goettingen, Germany
Stewart, H., B.S., Umea University, Sweden
van de Leemput, J., M.S., National Institutes of Health,
Bethesda, Maryland
Macdonald, M., Massachusetts General Hospital,
Charlestown: Huntington's disease.
McNamara, J., Duke University Medical Center, Durham,
North Carolina: Epilepsy overview; Neurotrophines and
epileltogenesis.
Murphy, D., NINDS/NIH, Rockville, Maryland: NIH grant
process.
Orr, H., University of Minnesota, Minneapolis: SCA1, a neu-
rodegenerative disease from gene to cellular pathway.
Paulson, H., University of Iowa: RNA interference and its appli-
cation to neurobiological diseases.
Schofield, R, The Garvan Institute of Medical Research,
Sydney, Australia: The inhibitory glycine receptor: Molecular
studies of structure, function, and disease.
Siegel, J., Veterans Affairs Greater L.A. Health Care System,
North Hills, California: Narcolepsy and the role of
hypothalmic peptide hypocretin (orexin).
Swanson, M., University of Florida, Gainesville: The myotonic
dystrophies; RNA-mediated disease.
Advanced Bacterial Genetics
June 8-28
INSTRUCTORS K. Hughes, University of Washington, Seattle
U. Jenal, University of Basel, Switzerland
K. Pogliano, University of California, San Diego
ASSISTANTS S. Aung, University of California, San Diego
B. Christen, University of Basel, Switzerland
S. Weissman, Children's Hospital and Regional Medical Center, Seattle, Washington
The course presented logic and methods used in the genetic dissection of complex biological process-
es in eubacteria. Laboratory methods used included classical mutagenesis using transposons, muta-
tor strains, and chemical and physical mutagens; the mapping of mutations using genetic and physi-
cal techniques; modern approaches to the generation and analysis of targeted gene disruptions and
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fusions using PCR and cloning methods; epitope insertion mutagenesis; and site-directed mutagene-
sis. Key components of the course were the use of sophisticated genetic methods in the analysis of
model eubacteria and the use of the wealth of new genomic sequence information to motivate these
methods. Invited lecturers presented various genetic approaches to study eubacterial mechanisms of
metabolism, development, and pathogenesis. Speakers in the 2005 course included Dan Andersson
(Uppsala University), Steve Busby (University of Birmingham), Victor Di Rita (University of Michigan
Medical School), John Kirby (Georgia Institute of Technology), Susan Lovett (Dana-Farber Cancer
Institute), Anca Segall (San Diego State University), Gisela Storz (National Institute of Child Health and
Human Development), Michael Surrette (University of Calgary), and Barry Wanner (Purdue University).
This course is supported with funds provided by the National Science Foundation.
PARTICIPANTS
Aertsen, A., Ph.D., Katholieke Universiteit Leuven, Belgium
Andrews, S., Ph.D., Lawrence Berkeley National Laboratory,
California
Fernandes, A., Ph.D., Lisbon and University of Zurich, Oeiras,
Portugal
Fineran, P., B.S., University of Cambridge, United Kingdom
Guberman, J., A.B., Princeton University, New Jersey
Gummesson, B., B.S., Goteborg University, Sweden
Haenni, M., M.C., University of Lausanne, Switzerland
Higashi, J., Ph.D., University of California, San Francisco
Jaeger, T, B.S., University of Konstanz, Germany
SEMINARS
Andersson, D., Uppsala University, Sweden: Where do new
genes come from? Clues from studies of antibiotic resis-
tance.
Busby, S., University of Birmingham, United Kingdom:
Transcriptional regulation at complex bacterial promoters.
Di Rita, V, University of Michigan Medical School, Ann Arbor:
Genetic approaches to the study of bacterial pathogenesis.
Kirby, J., Georgia Institute of Technology, Atlanta:
Chemosensory regulation of bacterial gene expression.
Lovett, S., Dana-Farber Cancer Institute, Boston,
Massachusetts: E. coil's response to replication fork arrest.
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Jones, S., BA., Baylor College of Medicine, Houston, Texas
Larsson, D., M.S., Uppsala University, Sweden
Laubacher, M., B.S., Pennsylvania State University, University
Park
Rowland, S., B.S., University of Connecticut Health Center,
Farmington
Shimizu, T, Ph.D., Harvard University, Cambridge,
Massachusetts
Shinar, G., M.S., Weizmann Institute of Science, Rehovot,
Israel
Zheng, J., M.S., University of Maryland, College Park
Segall, A., San Diego State University, California: DNA repair, a
new target for antibiotics: A journey from the esoteric to the
practical.
Storz, G., National Institute of Child Health and Human
Development, Bethesda, Maryland: The genes that were
missed: An expanding universe of small RNAs and small
CRFs.
Surrette, M., University of Calgary, Canada: Adaptations to
polymicrobial life: Pathogen-normal flora interaction.
Wanner, B., Purdue University, W. Lafayette, Indiana: Red, GRIM,
CAS, and FICkle (changeable) bacterial designer systems.
Ion Channel Physiology
June 8-28
INSTRUCTORS M. Farrant, University College London, United Kingdom
M. Hausser, University College London, United Kingdom
N. Spruston, Northwestern University, Evanston, Illinois
COINSTRUCTORS B. Clark, University College London, United Kingdom
J. Diamond, National Institutes of Health, Bethesda, Maryland
Z. Nusser, Institute of Experimental Medicine, Budapest, Hungary
I. Soltesz, University of California, Irvine
ASSISTANTS T. Aman, Northwestern University, Chicago, Illinois
C. Foldy, University of California, Irvine
T. Jarsky, Northwestern University, Chicago, Illinois
The primary goal of this course was to investigate, through lectures and laboratory work, the proper-
ties of ion channels that allow neurons to carry out their unique physiological functions in a variety of
neural systems. Areas of particular interest included channels that (1) are activated by the neurotrans-
mitter at central and peripheral synapses, (2) are activated by voltage changes in axons and dendrites,
and (3) responded to neuromodulators with changes in functional properties. The research interests of
guest lecturers reflected these areas of emphasis.
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The laboratory component of the course introduced students to electrophysiological approaches for
the study of ion channels in their native environments. Hands-on exercises centered on patch-clamp
recording of ion channel activity in neurons in brain slice preparations. Different recording methods
were used to examine in isolation the activity of specific voltage and ligund-gated ion channels and to
investigate the contribution of specific ionic currents to the generation of neuronal activity. The advan-
tages and disadvantages of each method, preparation, and recording technique were considered in
relation to the specific scientific questions being asked. Admissions priority was given to students and
postdocs with a demonstrated interest, specific plans, and a supportive environment to apply these
techniques to a defined problem. Guest speakers in 2005 included Angel Alonso (McGill University),
Bruce Bean (Harvard Medical School), Benoit Roux (Cornell University), Richard Horn (Jefferson
Medical College), Jeffry Isaacson (University of California, San Diego), Dan Johnston (University of
Texas), Rodo Ito Llinas (New York University School of Medicine), Jeffrey Magee (LSUHSC), Sacha
Nelson (Brandeis University), Karel Svoboda (HHMI/Cold Spring Harbor Laboratory), Tomoyuki
Takahashi (University of Tokyo Graduate School of Medicine), and Rachel Wilson (Harvard Medical
School).
This course is supported by the Howard Hughes Medical Institute.
PARTICIPANTS
Blankenship, A., B.A., University of California, San Diego
Branco, T.A., M.D., University College London, United
Kingdom
Carrasquillo, Y., B.S., Baylor College of Medicine, Houston,
Texas
Christian, C., BA., University of Virginia, Charlottesville
Genoux, D., Ph.D., College de France, Paris, France
Jefferis, G., Ph.D., University of Cambridge, United Kingdom
Luikart, B., Ph.D., University of Texas Southwestern Medical
School, Dallas
SEMINARS
Alonso, A., McGill University, Montreal, Canada: Diversity of
intrinsic excitability in the central nervous system.
Bean, B., Harvard Medical School, Boston, Massachusetts:
Voltage-gated Na' channels; Na' channels and spontaneous
firing.
Diamond, J., National Institutes of Health, Bethesda,
Maryland: Glutamate receptors and synaptic excitation.
Horn, R., Jefferson Medical College, Philadelphia,
Pennsylvania: Voltage-gated K+ channels.
Isaacson, J., University of California, San Diego:
Microcircuits.
Johnston, D., University of Texas, Houston: Ion channels and
integration.
Llinas, R., New York University School of Medicine: Integration
in neurons with intrinsic electrical attitude.
Magee, J., Louisiana State University Health Sciences Center,
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Macpherson, L., B.S., Scripps Research Institute, La Jolla,
California
Matthews, E., B.S., Northwestern University, Chicago,
Illinois
Ozkan, E., B.S., University of Texas Southwestern Medical
School, Dallas
Pratt, K., Ph.D., Brown University, Providence, Rhode
Island
Szabadics, J., Ph.D., University of Szeged, Hungary
New Orleans: Hyperpolarization-activated cation channels.
Nelson, S., Brandeis University, Waltham, Massachusetts:
Long-term synaptic plasticity.
Nusser, Z., Hungarian Academy of Sciences, Budapest,
Hungary: Synaptic inhibition and interneuron diversity.
Roux, B., Cornell University, Ithaca, New York: The structure of
K+ channels.
Soltesz, I., University of California, Irvine: Endocannabincoid-
mediated short -term plasticity.
Svoboda, K., Cold Spring Harbor Laboratory: Imaging meth-
ods for studying ion channels.
Takahashi, T, University of Tokyo Graduate School of
Medicine, Japan: Voltage-gated Ca' channels.
Wilson, R., Harvard Medical School, Boston, Massachusetts:
Intrinsic conductances and synaptic properties of Drosophila
neurons.
Molecular Embryology of the Mouse
June 8-25
INSTRUCTORS B. Cape!, Duke University Medical Center, Durham, North Carolina
M. Shen, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
COINSTRUCTORS D. Threadgill, University of North Carolina, Chapel Hill
P. Trainor, Stowers Institute for Medical Research, Kansas City, Missouri
ASSISTANTS D. Coveney, University of North Carolina, Chapel Hill
D. Escalante-Alcalde, Institute of Cellular Physiology-UNAM, Mexico
A. Lulianella, Stowers Institute for Medical Research, Kansas City, Missouri
J. Rivera, University of North Carolina, Chapel Hill
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse development. Lectures provided the conceptual basis for contempo-
rary research in mouse embryogenesis and organogenesis, and laboratory practicals provided exten-
sive hands-on introduction to mouse embryo analysis. Experimental techniques covered included in
vitro culture and manipulation of pre- and postimplantation embryos, embryo transfer, culture and
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genetic manipulation of embryonic stem cells, production of chimeras by embryo aggregation and by
ES cell injection, and transgenesis by pronuclear microinjection. In addition, this year's practicals fea-
tured increased emphasis on phenotypic analysis of mutants, including techniques of histology, in situ
hybridization, immunohistochemistry, skeletal preparation, organ culture, and tissue recombination.
Confirmed speakers for this year included Kathryn Anderson, Greg Barsh, Richard Behringer, Jeff
Christiansen, Frank Constantini, Gordon Fishell, Kat Hadjantonakis, Tyler Jacks, Rudolf Jaenisch,
Robin Lovell-Badge, Terry Magnuson, Anne McLaren, Andras Nagy, Tony Perry, Nadia Rosenthal,
Janet Rossant, James Sharpe, Austin Smith, Davor Solter, Phillippe Soriano, Colin Stewart, Joseph
Takahashi, Patrick Tam, Daniel Turnbull, and Rolf Zeller.
PARTICIPANTS
Brachner, A., M.S., Medical University of Vienna, Austria
Colon, M., Ph.D., University of Puerto Rico, San Juan
Cox, M., Ph.D., Mayo Clinic Arizona, Scottsdale, Arizona
Duncan, K., B.S., Harvard University, Cambridge,
Massachusetts
Elso, C., Ph.D., Lawrence Livermore National Laboratory,
California
Enciso, J., M.D., Baylor College of Medicine, Houston,
Texas
Hamalainen, R., M.S., University of Helsinki, Finland
SEMINARS
Anderson, K., Memorial Sloan-Kettering Cancer Center, New
York: Forward genetic screens.
Barsh, G., HHMI/Stanford University, California: Biology of pig-
mentation and its applications.
Behringer, R., The University of Texas/M.D. Anderson Cancer
Center, Houston: Transgenics and insertional mutants.
Capel, B., Duke University, Durham, North Carolina:
Intermediate mesoderm.
Capel, B., Duke University, Durham, North Carolina/Shen, M.,
UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Arrival, introductions, overview.
Costantini, F, Columbia University, New York: Kidney develop-
ment and branching morphogenesis.
Fishell, G., The Skirball Institute, New York University Medical
Center: Cellular and developmental genetic mechanisms
underlying the establishment of cell fate in the brain.
Hadjantonakis, K., Columbia University, New York: Optical
imaging.
Jacks, T., HHMI/Massachusetts Institute of Technology,
Cambridge: Cancer models.
Jaenisch, R., Whitehead Institute/Massachusetts Institute of
Technology, Cambridge: Epigenetics and stem cells.
Lovell-Badge, R., MRC National Institute for Medical
Research: Sex determination.
Magnuson, T., University of North Carolina, Chapel Hill: Mouse
genetics.
McLaren, A., University of Cambridge, United Kingdom: Germ
cells.
Nagy, A., Samuel Lunenfeld Research Institute, Toronto,
Canada: Gene targeting strategies.
Perry, T., RIKEN Center for Developmental Biology, Kobe,
Japan: Nuclear reprogramming and oocyte activation.
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Hopyan, S., Ph.D., The Hospital for Sick Children, Toronto,
Canada
Kanning, K., B.A., University of Washington, Seattle
Lecoin, L., Ph.D., Institut Curie, Orsay, France
Regard, J., Ph.D., University of California, San Francisco
Rodriquez, A., Ph.D., Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Sears, K., Ph.D., University of Colorado Health Sciences
Center, Aurora
Winter, J., Max-Planck Institute, Berlin, Germany
Rosenthal, N., EMBL, Monterotondo-Scala, Italy: Cardiac
organogenesis.
Rossant, J., Samuel Lunenfeld Research Institute, Toronto,
Canada: Studying gene function without germ line transmis-
sion: Chimeras and siRNA.
Sharpe, J., MRC Human Genetics Unit, Edinburgh, United
Kingdom: OPT microscopy and the Edinburgh mouse
atlas.
Shen, M., UMNDJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Nodal signaling and embryo pat-
terning.
Smith, A., University of Edinburgh, United Kingdom: Stem
cells: Pluripotency and lineage restriction.
Solter, D., Max-Planck Institut fur Immunobiologie, Freiburg,
Germany: Fertilization and preimplantation development.
Soriano, P., Fred Hutchinson Cancer Research Center, Seattle,
Washington: Functional analysis of signaling pathways/gene
traps.
Stewart, C., National Cancer Institute, Frederick, Maryland: ES
cells.
Takahashi, J., Northwestern University, Evanston, Illinois:
Behavioral genetics.
Tam, P., Children's Medical Research Institute, Sydney,
Australia: Introduction to mouse development; Gastrulation
and formation of the body plan.
Threadgill, D., University of North Carolina, Chapel Hill:
Quantitative traits.
Trainor, P., Stowers Institute for Medical Research, Kansas
City, Missouri: Hox genes and the body axis.
Turnbull, D., New York University Medical Center:
Ultrasound/MRI imaging.
Zeller, R., EMBL, Heidelberg, Germany: Limb development.
DNA Microarray Applications
June 14-21
INSTRUCTORS A. Khodursky, University of Minnesota, St. Paul
J. Lieb, University of North Carolina, Chapel Hill
C. Murphy, University of California, San Francisco
ASSISTANTS S. Hanlon, University of North Carolina, Chapel Hill
A. Hastings, Molecular Devices Corporation, Union City, California
P. Killion, University of Texas, Austin
M. Llinas, Princeton University, New Jersey
P. Mieczkowski, Duke University, Chapel Hill, North Carolina
D. Sangurdekar, University of Minnesota, Minneapolis
DNA microarrays are simple, inexpensive, and versatile tools for experimental exploration of genome
structure, gene expression programs, gene function, and cell and organismal biology. In this hands-on
8-day course, students were introduced to various applications of DNA microarray technology. Using
whole-genome spotted DNA microarrays as a platform, students learned to design and carry out the
procedures required for DNA microarray hybridization experiments, including fluorescent probe prepa-
ration, nucleic acid amplification, microarray manipulation, image acquisition and processing, visualiza-
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tion and interpretation of high-dimensional transcriptional data, and data storage and retrieval. In addi-
tion to learning the techniques involved in microarray experiments, they also discussed the basics of
multivariate data analysis, the basics of statistical inference and classification, and, most importantly,
biological interpretation of microarray experiments.
Experimental applications covered in the course included systematic studies of global gene expres-
sion programs, inferring gene function using microarrays, genome-wide DNA-protein interactions, and
measuring changes in gene-copy number. Guest lecturers presented the state of the art in new tech-
nology, experimental applications, and interpretation of genome-wide data sets from a systems biolo-
gy perspective. Students who complete this course should be equipped with the practical and theo-
retical skills to introduce or apply DNA microarray technology at their own laboratories or institutions.
Speakers this year included Patrick Brown (Stanford University Medical Center), Elva Diaz (University
of California, Davis), Gavin Sherlock (Stanford University), Damian Verdnik (Axon Instruments), and
David Wang (Washington University School of Medicine).
PARTICIPANTS
Ahlgren, S., Ph.D., Children's Memorial Research Center,
Chicago, Illinois
Braby, C., Ph.D., Monterey Bay Aquarium Research Institute,
Moss Landing, California
Bryant, P., B.M., B.C., Murdoch Children's Research Institute,
Parkville, Australia
Connelly, J., Ph.D., Duke University, Durham, North Carolina
Hamilton, A., Ph.D., Lawrence Livermore National Laboratory,
California
Huang, Z.J., Ph.D., Cold Spring Harbor Laboratory
Jung, W.H., Ph.D., University of British Columbia, Vancouver,
Canada
Kanae, I.-A., Ph.D., Cold Spring Harbor Laboratory
Kinney, J., BA., Princeton University, New Jersey
Kundzewicz, A., M.S., University of Lausanne, Switzerland
SEMINARS
Brown, P., Stanford University Medical School, California:
Regulation of Alzheimer amyloid precursor trafficking and
processing.
Diaz, E., University of California, Davis: R and bioconductor
for microarray data analysis.
Hanlon, S., University of North Carolina, Chapel Hill: ChIP-chip
experimental setup; Analysis of ChIP-chip data.
Hastings, A., Axon Instruments, Union City, California: Data
analysis with acuity; Microarray scanning and first-pass
analysis with Genepix Pro.
Khodursky, A., University of Minnesota, St. Paul: Statistical
primer for microarray data analysis; Statistical design and
analysis of microarray data #2.
Killion, P., University of Texas, Austin: The why and how of
experiment submission using the longhorn array database;
Data analysis of gene experiments using LAD.
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Nikic, S., M.S., Imperial College, London, United Kingdom
Rehfuss, M., Ph.D., University of California, Davis
Segal, E., Ph.D., The Rockefeller University, New York
Swigonova, Z., Ph.D., University of Pittsburgh, Pennsylvania
Tilley, P., M.D., Provincial Laboratory for Public Health,
Calgary, Canada
Vaidyanathan, R., Ph.D., Epicentre Technologies, Madison,
Wisconsin
Waisberg, M., M.S., Universidade Federal de Minas Gera lis,
Belo Horizonte, Brazil
Wang, Q., Ph.D., Dana-Farber Cancer Institute/Harvard
Medical School, Boston, Massachusetts
Wyatt, S., Ph.D., Ohio University, Athena
Zhu, Y., Ph.D., East Carolina University, Greenville, North
Carolina
Llinas, M., Princeton University, New Jersey: Dissecting the
developmental transcriptome of Plasmodium.
Mieczkowski, P. University of North Carolina, Chapel Hill: Data
analysis for aCGH experiments.
Murphy, C., Princeton University, New Jersey: Experimental
design from a biologist's point of view.
Segal, E., The Rockefeller University, New York: Probabilistic:
Models for inferring gene regulatory networks.
Sherlock, G., Stanford University Medical School, California:
Introduction to DNA microarray technology; Principles of
microarray data analysis.
Wang, D., Washington University, St. Louis, Missouri: Viral
detection and discovery using DNA microarrays.
Wolfinger, R., SAS Institute, Inc., Cary, North Carolina: A work-
flow for array data analysis.
Structure, Function, and Development of the Visual System
June 16-29
INSTRUCTORS B. Chapman, University of California, Davis
W.M. Usrey, University of California, Davis
ASSISTANT H. Allito, University of California, Davis
This lecture/discussion course explored the functional organization and development of the visual sys-
tem as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It was
designed for graduate students and more advanced researchers who wish to gain a basic understand-
ing of the biological basis for vision and to share in the excitement of the latest developments in this field.
Topics included phototransduction and neural processing in the retina; functional architecture of striate
cortex; cellular basis of cortical receptive field properties; the anatomy, physiology, and perceptual sig-
nificance of parallel pathways; functional parcellation of extrastriate cortex; role of patterned neuronal
activity in the development of central visual pathways; and molecular mechanisms of development and
plasticity in the visual system. Speakers in the 2005 course included Dora Angelaki (Washington
University School of Medicine), Mark Bear (Massachusetts Institute of Technology/HHMI), Tobias
Bonhoeffer (Max-Planck Institute of Neurobiology), Ken Britten (University of California, Davis), Matteo
Carandini (The Smith-Kettlewell Eye Research Institute), E.J. Chichilnisky (The Salk Institute), Dennis
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Dacey (University of Washington, Seattle), Marla Feller (University of California, San Diego), David
Fitzpatrick (Duke University), Karl Geggenfunter (GieBen University), William Guido (Louisiana State
University Medical Center), Takao Hensch (RIKEN Brain Science Institute), Judith Hirsch (Universityof
Southern California, Los Angeles), Richard Krauzlis (Salk Institute for Biological Studies), John Maunsell
(Baylor College of Medicine), J. Anthony Movshon (New York University), Jay Neitz (Medical College of
Wisconsin), John Reynolds (The Salk Institute), Michael Shad len (University of Washington), S. Murray
Sherman (University of Chicago), Lawrence Snyder (Washington University School of Medicine),Peter
Sterling (University of Pennsylvania), and Leland Stone (NASA Ames Research Center).
This course is supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Calamusa, M., B.S., Institute of Neuroscience, CNR, Pisa,
Italy
de Labra, C., Ph.D., University of La Goruna, Spain
EI-Shamayleh, Y., B.A., New York University
Graf, A., Ph.D., New York University
Hall, A., B.S., University of Texas, Dallas, Richardson
Kuchenbecker, J., B.S., Medical College of Wisconsin,
Milwaukee
Lovejoy, L., B.S., The Salk Institute for Biological Studies, La
Jolla, California
Lui, L., B.S., Monash University, Victoria, Australia
SEMINARS
Angelaki, D., Washington University School of Medicine, St.
Louis, Missouri: Visual and vestibular interactions in a com-
plex environment.
Bear, M., HHMI/Massachusetts Institute of Technology,
Cambridge: How monocular deprivation shifts ocular domi-
nance in visual cortex.
Bonhoeffer, T., Max-Planck Institut fur Neurobiologie,
Muenchen-Martinsried, Germany: Functional architecture of
the primary visual cortex.
Britten, K., University of California, Davis: Neural correlates of
heading and self-locomotion.
Carandini, M., Smith-Kettlewell Eye Research Institute, San
Francisco, California: Receptive fields and suppressive fields
in the early visual system.
Chapman, B., University of California, Davis: How the visual
system got its stripes.
Chichilnisky, E.J., The Salk Institute, La Jolla, California:
Ensemble coding of visual information in primate retina.
Dacey, D., University of Washington, Seattle: Ganglion cell
diversity and function.
Feller, M., University of California, San Diego: The how and
why of retinal waves.
Fitzpatrick, D., Duke University, Durham, North Carolina:
Columns, connections, and representations: Probing the
functional architecture of the primary visual cortex.
Gegenfurtner, K., GieBen University, Germany: Signals for
speed perception and smooth pursuit eye movements.
Guido, B., Louisiana State University Medical Center: Cellular
mechanisms underlying the remodeling of developing retino-
geniculate connections.
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Mancuso, K., B.S, Medical College of Wisconsin, Milwaukee
Nauhaus, I., B.S, University of California, Los Angeles
Puri, M., B.S., University of California, Davis
Restani, L., Ph.D., Scuola Norma le Superiore, Pisa, Italy
Sher, S., Ph.D., University of California, Santa Cruz
Speer, C., B.S., University of California, Davis
Thaler, L., B.A., The Ohio State University, Columbus
Troncoso, X., B.S., Barrow Neurological Institute, Phoenix,
Arizona
Varela-Castro, C., Ph.D., University of Chicago, Illinois
Watson, T., B.R, University of Sydney, Australia
Hensch, T., Brain Science Institute, Wako-shi, Japan:
Molecular mechanisms of ocular domainance plasticity.
Hirsch, J., University of Southern California, Los Angeles:
Cellular mechanisms for visual responses in the LGN and
primary visual cortex.
Krauzlis, R., The Salk Institute, San Diego, California:
Coordination of voluntary eye movements.
Maunsell, J., HHMI/Baylor College Medicine, Houston, Texas:
The effects of attention in extrastriate visual cortex.
Movshon, T., New York University: Motion processing in
extrastriate cortex.
Neitz, J., Medical College of Wisconsin, Milwaukee: Evolution
of color vision.
Reynolds, J., The Salk Institute, La Jolla, California: Attentional
control of visual processing in the macaque.
Shad len, M., University of Washington, Seattle: Decision mak-
ing in extrastriate cortex.
Sherman, M., University of Chicago, Illinois: Cell and circuit
properties of the thalamus.
Snyder, L., Washington University School of Medicine, St.
Louis: Motor-specific regulation of visual signals in the
extrastriate visual cortex?
Sterling, P, University of Pennsylvania, Philadelphia: Efficient
circuits from stochastic synapses; Why the retina uses paral-
lel pathways.
Stone, L., NASA Ames Research Center, Moffiett Field,
California: Visual signals linking eye movements and
perception.
Usrey, M., University of California, Davis: Dynamic properties
of neural circuits for vision.
Statistics of Microarrays and Related Biological Data
June 21-26
INSTRUCTORS J. Cabrera, Rutgers University, Piscataway, New Jersey
V. Carey, Harvard University, Boston, Massachusetts
M. Reimers, National Institutes of Health, Bethesda, Maryland
ASSISTANT J. Gentry, Massachusetts General Hospital, Charlestown, Maryland
High-throughput biology, epitomized by the rapid growth of DNA microarray-based experiments, is
rapidly generating enormous observation sets. Biologists seeking to make sense of this growing body
of data need to have a firm grasp of statistical methodology. This short residential course was designed
to build competence in statistical and related quantitative methods for the analysis of high-throughput
biological and biochemical data, from which meaningful inferences about biological processes can be
drawn.Topics included R minitutorial; bioconductor; review of multivariate statistics; discrimination and
classification; expression arrays including experimental design, array design, quality control, normaliza-
tion, and probe-level analysis for spotted arrays and for Affymetrix(TM) chips; exploratory analysis and
tests of significance; and leveraging annotations (e.g., gene ontology).
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The course was offered as a supplement to the 2005 course on DNA microarray applications.
Preference was given to students accepted into that course, but the supplemental course also attract-
ed biologists with a strong interest or background in quantitative thinking, as well as students with a
background in mathematics, physics, and related disciplines who already demonstrated a firm grasp
of major biological concepts and were interested in focusing their efforts on large biological data sets
such as whole-genome or expression microarray data.
PARTICIPANTS
Connelly, J., Ph.D., Duke University, Durham, North Carolina
Contreras-Morei, B., Ph.D., Universidad Autonoma Nacional
de Mexico (UNAM), Cuernavaca
Cortes, D., B.S., Virginia Tech University, Blacksburg
Einecke, G., M.D., University of Alberta, Edmonton, Canada
Gao, H., Ph.D., Karolinska Institutet, Huddinge, Sweden
Hamilton, A., B.A., Lawrence Livermore National Laboratory,
California
Konieczka, J., B.S., University of Arizona, Tucson
Kundzewicz, A., M.S., University of Lausanne, Switzerland
Krasnitz, A., Ph.D., Cold Spring Harbor Laboratory
Pai, D., M.S., Cold Spring Harbor Laboratory
Raby, B., M.D., Harvard Medical School, Boston,
SEMINARS
Cabrera, J., Rutgers University, Piscataway, New Jersey:
Exploratory methods.
Cabrera, ,J., Rutgers University, Piscataway, New
Jersey/Carey, V., Harvard University, Boston, Massachusetts:
cDNA workflow.
Carey, V., Harvard University, Boston, Massachusetts:
Bioconductor introduction; Machine learning.
Reimers, M., National Institutes of Health, Bethesda,
Maryland: Affy workflow.
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Massachusetts
Swigonova, Z., Ph.D., University of Pittsburgh, Pennsylvania
Tan, R., M.S., University of Alabama, Birmingham
Torres, K., B.S., IIT Research Institute, Chicago, Illinois
Vaidyanathan, R., Ph.D., Epicentre Technologies, Madison,
Wisconsin
Waisberg, M., M.D., Universidade Federal de Minas Gerais,
Belo Horizonte, Brazil
Wang, L., Ph.D., Vanderbilt University, Nashville, Tennessee
Wyatt, S., Ph.D., Ohio University, Athens
Zhu, Y., Ph.D., East Carolina University, Greenville, North
Carolina
Reimers, M., National Institutes of Health, Bethesda,
Maryland/Cabrera, J., Rutgers University, Piscataway, New
Jersey: Low-level analysis and QC; Formal
inference/siggenes; GO and functional inference.
Reimers, M., National Institutes of Health, Bethesda,
Maryland/Cabrera, J., Rutgers University, Piscataway, New
Jersey/Carey, V., Harvard University, Boston,
Massachusetts: Introduction to the course.
Molecular Approaches in Plant Science
July 1-21
INSTRUCTORS J. Bender, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
L. Hobbie, Ade 1phi University, Garden City, New York
H. Ma, Pennsylvania State University, University Park
S. McCormick, Plant Gene Expression Center, Albany, California
ASSISTANTS B. Feng, Pennsylvania State University, University Park
S. Johnson-Brousseau, University of California, Berkeley
A. Wijeratne, Pennsylvania State University, University Park
This course provided an intensive overview of topics in plant physiology and development, focusing on
molecular genetic approaches to understanding plant biology. It emphasized recent results from
Arabidopsis thaliana and other plants and provided an introduction to current methods used in plant
molecular biology. It was designed for scientists with some experience in molecular techniques or in
plant biology who wish to work with Arabidopsis and other plants using the latest technologies in
genetics and molecular biology. The course consisted of a vigorous lecture series, a hands-on labora-
tory, and informal discussions. Discussions of important topics in plant research were presented by the
instructors and by invited speakers. These seminars included plant morphology and anatomy, plant
development (such as development of flowers, leaves, roots, male and female gametophytes, meris-
terns, the vascular tissue, and embryos), perception of light and photomorphogenesis, and synthesis,
function, and perception of hormones. Lectures describing bioinformatics tools available to the plant
community and the resources provided by plant genome projects were also included. Speakers pro-
vided overviews of their fields, followed by in-depth discussions of their own work. The laboratory ses-
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sions provided an introduction to important techniques currently used in plant research. The laborato-
ry sessions included studies of plant development, microsopic techniques including Normarski/DIC,
fluorescence, and SEM, enhancer traps, analysis of pollen development and meiosis, analysis of quan-
titative traits using natural variation, mutant analysis, histochemical staining, transient gene expression,
applications of green fluorescent protein fusions, protein interaction and detection, proteomics
approaches, transcription profiling, and techniques commonly used in genetic and physical mapping.
The course also included several short workshops on important themes in genetics. Invited speakers
for the 2005 course included Jody Banks (Purdue University), Gloria Coruzzi (New York University),
Savithramma Dinesh-Kumar (Yale University), Jennifer Fletcher (USDA-ARS/University of California,
Berkeley), Ueli Grossniklaus (University of Zurich Switzerland), Roger Hangarter (Indiana University),
John Harada (University of California, Davis), Paul Herzmark (University of California, San Francisco),
Thomas Jack (Dartmouth College), David Jackson (Cold Spring Harbor Laboratory), Teh-Hui Kao
(Pennsylvania State University), Jiangming Li (University of Michigan), Wolfgang Lukowitz (Cold Spring
Harbor Laboratory), Jocelyn Malamy (University of Chicago), Timothy Nelson (Yale University), Thomas
Nuhse (The Sainsbury Laboratory, UK), Neil Olszewski (University of Minnesota), Robert Pruitt (Purdue
University), Eric Richards (Washington University), G. Eric Schaller (Dartmouth College), and Marja
Timmermans (Cold Spring Harbor Laboratory).
PARTICIPANTS
Baker, R., B.A., University of Colorado, Boulder
Brudenell, L., B.S., University of Bath, United Kingdom
Chen, Y., Ph.D., Agricore United, Manitoba, Canada
Chow, K.-S., Ph.D., Rubber Research Institute of Malaysia,
Selangor
Conrad, P., Ph.D., State University of New York, Plattsburgh
Fick, J., B.S., University of Virginia, Charlottesville
Fuell, C., Ph.D., Institute of Food Research, Norwich, United
Kingdom
Greenberg, N., B.A., University of Colorado, Boulder
SEMINARS
Banks, J., Purdue University, W. Lafayette, Indiana: Gameto-
phytes and evolution.
Bender, J., Johns Hopkins University Bloomberg School of
Public Health, Baltimore, Maryland: Epigenetics II.
Coruzzi, G., New York University: Systems biology.
Dinesh-Kumar, S., Yale University, New Haven, Connecticut:
Plant-pathogen interactions.
Fletcher, J., USDA-ARS/University of California, Berkeley:
Inflorescence.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophytes.
Hangarter, R., Indiana University, Bloomington: Light responses.
Harada, J., University of California, Davis: Seed development.
Herzmark, P., University of California, San Francisco:
Microscopy lecture and lab.
Hobbie, L., Ade 1phi University, Garden City, New York: Auxin
signaling.
Jack, T, Dartmouth College, Hanover, New Hampshire:
Flower development.
Jackson, D., Cold Spring Harbor Laboratory: Meristems.
Kao, T.-H., Pennsylvania State University, University Park:
Self-incompatibility.
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Gutzat, R., M.S., Swiss Federal Institute of Technology, Zurich,
Switzerland
Hou, Y., M.S., Iowa State University, Ames
Jensen, J., M.S., The Royal Veterinary and Agricultural
University, Frederiksberg, Denmark
Jugulam, M., Ph.D., University of Western Ontario, Guelph,
Canada
Kondo, M., B.S., The University of Tokyo, Japan
White, M., M.S., University of Wisconsin, Madison
Li, J., University of Michigan, Ann Arbor: Brassinosteroids.
Lukowitz, W., Cold Spring Harbor Laboratory: Embryo devel-
opment.
Ma, H., Pennsylvania State University, University Park: Plant
anatomy; Genetics I: Mutagenesis; Microsporogenesis;
Evolution of flower development.
Malamy, J., University of Chicago, Illinois: Roots.
McCormick, S., Plant Gene Expression Center, Albany,
California: Pollen development.
Nelson, T., Yale University, New Haven, Connecticut. Vascular
development.
Nuhse, T., John Innes Centre, Norwick, United Kingdom:
Proteomics.
Olszewski, N., University of Minnesota, St. Paul: GA signaling.
Pruitt, R., Purdue University, W. Lafayette, Indiana: Non-
Mendelian Inheritance.
Richards, E., Washington University, St. Louis, Missouri:
Epigenetics I.
Schaller, E., Dartmouth College, Hanover, New Hampshire:
Ethylene.
Timmermans, M., Cold Spring Harbor Laboratory: Maize
shoot patterning.
Neurobiology of Drosophila
July 1-21
INSTRUCTORS R. Baines, University of Warwick, Coventry, United Kingdom
G. Bashaw, University of Pennsylvania, Philadelphia
S. Waddell, University of Massachusetts Medical School, Worcester
ASSISTANTS D. Garbe, University of Pennsylvania, Philadelphia
A. Keene, University of Massachusetts Medical School, Worcester
B. Leung, University of Massachusetts Medical School, Worcester
D. Wright, University of Warwick, Coventry, United Kingdom
This laboratory/lecture course was intended for researchers at all levels-from beginning graduate stu-
dents through established primary investigators-who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The 3-week course was divided into the study of development,
physiology/function, and behavior. Daily seminars introduced students to a variety of research topics
and developed those topics by including recent experimental contributions and outstanding questions
in the field. Guest lecturers brought original preparations for viewing and discussion and direct labora-
tory exercises and experiments in their area of interest. The course provided students with hands-on
291
experience using a variety of experimental preparations that are used in the investigation of current
neurobiological questions. The lectures and laboratories focused on both the development of the ner-
vous system and its role in controlling larval and adult behaviors. In addition to an exposure to the mol-
ecular genetic approaches available in Drosophila, students learned a variety of techniques including
embryo in situ hybridization, labeling of identified neurons, electrophysiological recording from nerves
and muscles and whole grain, and the analysis of larval and adult behavior. Collectively, the course pro-
vided a comprehensive and practical introduction to modern experimental methods for studying the
Drosophila nervous system. This year's lecturers included Marcus Allen (University of Kent), Vanessa
Auld (University of British Columbia), Justin Blau (New York University), Akira Chiba (University of
Illinois), Josh Dubnau (Cold Spring Harbor Laboratory), Daniel Eberl (University of Iowa), Donald Gailey
(California State University, Hayward), Tanja Godenschwege (University of Massachusetts), Stephen
Goodwin (University of Glasgow), Gregory Jefferis (University of Cambridge), Edward Kravitz (Harvard
Medical School), Susana Lima (Cold Spring Harbor Laboratory), Greg Macleod (University of Arizona),
Paul Shaw (Washington University School of Medicine), James Skeath (Washington University School
of Medicine), Bryan Stewart (University of Toronto), Bruno van Swinderen (Neurosciences Institute),
Tanya Wolff (Washington University School of Medicine), Bing Zhang (University of Texas, Austin), and
Karen Zito (Cold Spring Harbor Laboratory).
PARTICIPANTS
Adolph, S., M.S., University of Copenhagen, Denmark
Bustamante, E., B.S., Stanford University, California
Dason, J., M.S., University of Toronto, Canada
Dixit, R., M.S., National Centre for Biological Sciences,
Bangalore, India
Douglas, S., Ph.D., University of Toronto at Mississauga,
Canada
Edwards, A., B.S., North Carolina State University, Raleigh
Fernandez, M.d.I.P., Licentiate, Biotechnology, Leloir Institute
Foundation, Buenos Aires, Argentina
SEMINARS
Allen, M., University of Kent, United Kingdom: Physiology of
the giant fiber system.
Auld, V., University of British Columbia, Vancouver, Canada:
Bioinformatics 101; Gilal development.
Baines, R., University of Warwick, United Kingdom: Synaptic
plasticity; CNS electrophysiology.
Bashaw, G., University of Pennsylvania, Philadelphia: Axon
guidance; Fly genetics 101.
Blau, J., New York University: Circadian rhythm.
Chiba, A., University of Illinois, Urbana: Dendritic develop-
ment.
Dubnau, J., Cold Spring Harbor Laboratory: Long-term
memory.
Eberl, D., University of Iowa, Iowa City: Hearing and smell.
Gailey, D., California State, Hayward: Drosophila courtship.
Godenschwege, T., University of Massachusetts, Amherst:
Giant fiber system.
Goodwin, S., University of Glasgow, United Kingdom: Fruitless
and control of sexual behavior.
Jefferis, G., Cambridge University, United Kingdom: Olfactory
system development; Fly genetics 102.
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Haines, N., Ph.D., University of Toronto at Scarborough,
Toronto, Canada
Kaiser, M., B.S., The University of Manchester, United
Kingdom
Leiss, F., M.S, Max-Planck Institute of Neurobiology,
Martinsried, Germany
Logan, M., Ph.D., University of Utah, Salt Lake City
Neely, G., Ph.D., Institute of Molecular Biotechnology of the
Austrian Academy of Sciences, Vienna, Austria
Kravitz, E., Harvard Medical School, Boston, Massachusetts:
Aggression.
Lima, S., Cold Spring Harbor Laboratory: Remote control of fly
behavior.
Macleod, G., University of Arizona, Tucson: Imaging neural
activity.
Shaw, P., Washington Medical School, St. Louis, Missouri:
Sleep.
Skeath, J., Washington University, St. Louis, Missouri:
Neuronal identity.
Stewart, B., University of Toronto, Canada: Electrophysiology
101; Synaptic release.
Van Swinderen, B., Neuroscience Institute, San Diego,
California: Visual learning.
Waddell, S., University of Massachusetts Medical School,
Worcester: Introduction; Olfactory learning and memory.
Wolff, T., Washington University, St. Louis, Missouri:
Visual system.
Zhang, B., University of Texas, Austin: The Fly NMJ.
Zito, K., Cold Spring Harbor Laboratory: Light and confocal
microscopy.
Workshop on Schizophrenia and Related Disorders
July 6-19
INSTRUCTORS P. Harrison, University of Oxford, United Kingdom
Z.J. Huang, Cold Spring Harbor Laboratory
J. Lieberman, Columbia University, New York
J. Lisman, Brandeis University, Waltham, Massachusetts
D. Stewart, Cold Spring Harbor Laboratory
D. Weinberger, NIMH/Neuroscience Center, Bethesda, Maryland
Recent progress in genetics, developmental neurobiology, and systems neuroscience presents an
unprecedented opportunity to study the biological basis of this class of elusive diseases. This 2-week
workshop addressed four main broad themes: clinical descriptions of schizophrenia and related disor-
ders and current treatments; emerging clues from genetics and genomics of psychiatric disorders; cur-
rent perspectives in brain development; and neuroanatomy and (mal)function of circuits and networks.
Discussion of the four themes was led by moderators, who had individual responsibility for the individ-
ual workshop sections. The workshop included two seminars per day (morning and late afternoon/
evening), although some days featured one or three talks depending on topic. Modules, moderators,
and speakers included Clinical Background: History, Symptoms/Phenotypes, Treatments (Lieberman);
Genetics, Genomics, and Epigenetics (Harrison/Weinberger); Development and Function of Neural
Circuits (Huang); and Neural Systems, Cognition, and Psychosis (Lisman).
293
This workshop was supported with funds provided by the Oliver Grace Fund, and additional sup-
port for a limited number of U.K. student scholarships (including travel) was provided by the Medical
Research Council.
PARTICIPANTS
Arana, F., M.S., University of Cambridge, United
Kingdom
Baker, J., M.S., Washington University School of
Medicine, St. Louis, Missouri
Barkus, E., Ph.D., University of Manchester, United
Kingdom
Basu, A., Ph.D., Harvard Medical School, Belmont,
Massachusetts
Buonanno, A., Ph.D., National Institutes of Health,
Bethesda, Maryland
Chen, Y.-J., M.S., Columbia University, New York
Chubb, J., M.S., University of Edinburgh, United
Kingdom
Corlett, P., M.S., Cambridge University, United
Kingdom
Cressman, V., Ph.D., New York State Psychiatric Institute
Fejgin, K., M.S., Goteborg University, Sweden
Flinn, L., M.S., University of Washington, Seattle
Gil leen, J., M.S., Institute of Psychiatry, London,
United Kingdom
Haggarty, S., Ph.D., Broad Institute of Harvard/
SEMINARS
Behrendt, R.-P., The Retreat Hospital, York, United
Kingdom: Thalamus and hallucinations in
schizophrenia.
Bell, C., Oregon Health Science University, Beaverton:
Review of cortical circuits underlying corollary discharge:
Role of the thalamus; Possible connection to the Llinas
hypothesis; Mechanisms by which expected sensory
signals are cancelled: Known mechanisms in the electric
fish.
Cox, D., Perlegen Science, Mountain View, California:
Human genetic variation and common human disease.
Coyle, J., Harvard University/McLean Hospital, Belmont,
Massachusetts: Glutamate hypothesis.
Davis, K., Mount Sinai School of Medicine, New York:
Oligodendroglia and myelination in schizophrenia.
Falls, D., Emory University, Atlanta, Georgia: Neuregulin.
Ford, J., Yale University, New Haven, Connecticut: Study of
dysfunctional corollary discharge in schizophrenia as
studied by fMRI and EEG coherence.
Frank, M., University of Colorado, Boulder: Normal
function of the basal ganglia and reward systems;
Model of set-shifting deficits in schizophrenia.
Goldberg, T, National Institutes of Mental Health,
Bethesda, Maryland: Cognitive deficits.
Greenspan, R., The Neuroscience Institute, San Diego,
California/A. Klar, National Institutes of Health, Frederick,
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Massachusetts Institute of Technology, Cambridge,
Massachusetts
Hall, J., Ph.D., University of Edinburgh, United Kingdom
Kumra, S., Ph.D., Albert Einstein College of Medicine, Bronx,
New York
Menzies, L., M.S., University of Cambridge, United Kingdom
Morris, J., Ph.D., Northwestern University, Chicago, Illinois
Ozaki, M., Ph.D., Waseda University, Tokyo, Japan
Petryshen, T, Ph.D., Broad Institute of
Harvard/Massachusetts Institute of Technology, Cambridge,
Massachusetts
Raghavachari, S., M.S., Duke University Medical Center,
Durham, North Carolina
Sahay, A., M.S., Columbia University, New York
Schobel, S., Ph.D., New York State Psychiatric Institute, New
York
Shriki, O., Ph.D., Weizmann Institute of Science, Rehovot,
Israel
Tinsley, M., Ph.D., University of California, Los Angeles
Maryland: Handedness, laterality, and schizophrenia
discussion.
Heckers, S., Harvard Medical School, McLean Hospital,
Belmont, Massachusetts: Hippocampus in s
chizophrenia.
Huang, Z.J., Cold Spring Harbor Laboratory:
Construction of GABAergic circuits and synapses.
Javitt, D., Nathan Kline Institute, Orangeburg, New York:
The biophysical basis of evoked potentials abnormal in
schizophrenia: The involvement of the NMDA channel.
Jones, P., University of Cambridge, United Kingdom:
Development-epidemiology.
Kapur, S., University of Toronto, Canada: Pathophysiology.
Karayiorgou, M., The Rockefeller University, New York:
Genetic animal models of schizophrenia.
Kinsbourne, M., The New School, New York: Origins of
voices: Exploring our conscious and unconscious selves.
Laruelle, M., Columbia University, New York: Dopamine.
Law, A., The University of Oxford, United Kingdom:
Neuregulin transcription and posttranscriptional
regulation.
Levitt, P., Vanderbilt University, Nashville, Tennessee:
Development of cortical circuitry and disorders of
information processing: Autism and schizophrenia.
Lewis, D., University of Pittsburgh, Pennsylvania: GABA.
Lisman, J., Brandies University, Waltham, Massachusetts:
The hippocampus, prefrontal cortex, basal ganglia,
and VTA: An integrated system that underlies some
of the cognitive deficits of schizophrenia; The loop
between the hippocampus and the dopaminergic
neurons of the VTA: Hippocampal hyperactivity in
schizophrenia.
Llinas, R., New York University: Thalamocortical
dysrhythmia.
Mathalon, D., Yale University, New Haven, Conneticut:
Corollary discharge mechanism: How it works and
why its dysfunction may explain auditory hallucinations;
Abnormalities in corollary discharge as measured by
auditory sensory event-related brain potentials; Role
of the N1 component.
McGuire, R, Institute of Psychiatry, London, United
Kingdom: Understanding the mechanisms of
hallucinations.
McKay, R., National Institutes of Health, Bethesda,
Maryland: Constructing the dopaminergic brain.
McKnight, S., University of Texas Southwestern Medical
Center, Dallas: Transcription factors, mouse models.
Miller, E., Massachusetts Institute of Technology,
Cambridge: Normal function of the PFC: Goal-directed
behavior.
Mimics, K., University of Pittsburgh, Pennsylvania:
Genomic studies of schizophrenia: The good, the
bad and the ugly.
O'Donnell, P., Albany Medical College, New York:
Hypofrontality: Abnormalities in the accumbens/PFC/
hippocampal/VTA system in schizophrenia; Normal
function of accumbens.
O'Donovan, M., University of Wales, Cardiff, United Kingdom:
Overview of schizophrenia genetics: Concepts, methods,
current status.
Petronis, A., Center for Addiction and Mental Health,
Toronto, Canada: Epigenetics and psychiatric diseases.
Porteous, D., University of Edinburgh, United Kingdom:
DISC-1.
Rakic, P. Yale University, New Haven, Connecticut:
Neurogenesis, lineage, migration, evolution?
Rapoport, J., National Institutes of Mental Health, Bethesda,
Maryland: Watch normal and abnormal brains grow:
Childhood onset schizophrenia.
Role, L., Columbia University, New York: Neuregulin:
Synpatic physiology; Nicotinic acetycholin receptor
signaling in schizophrenia.
Sebat, J., Cold Spring Harbor Laboratory: Gene copy-
number variation in human disease.
Shergill, S., Institute of Psychiatry, London, United
Kingdom: Review of psychological evidence for
abnormalities in sense of self; Theory of mind.
Skuse, D., University College London, United Kingdom:
Neurodevelopmental perspectives on genetics and
cognition.
Straub, R., National Institutes of Mental Health, Bethesda,
Maryland: Dysbindin and muted-susceptibility genes in
the BLOC-1 complex.
Walsh, C., Harvard University, Cambridge, Massachusetts:
Development and evolution of neocortex discussion.
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Advanced Techniques in Molecular Neuroscience
July 6-21
INSTRUCTORS J. Eberwine, University of Pennsylvania Medical School, Philadelphia
T. Hughes, Montana State University, Bozeman
C. Lai, Scripps Research Institute, La Jolla, California
D. Lavery, Purdue Pharma LP, Cranbury, New Jersey
ASSISTANTS L. Barrett, University of Pennsylvania Medical Center, Philadelphia
H. Butler, Montana State University, Bozeman
A. Dowell, The Scripps Research Institute, La Jolla, California
K. Haas, University of British Columbia, Vancouver, Canada
R. Lansford, California Institute of Technology, Pasadena
J. Tan, The Scripps Research Institute, La Jolla, California
This newly revised laboratory and lecture course was designed to provide neuroscientists at all levels
with a conceptual and practical understanding of several of the most advanced techniques in molec-
ular neuroscience. The course curriculum was divided into three sections: an extensive and up-to-date
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set of laboratory exercises, daily lectures covering the theoretical and practical aspects of the various
methods used in the laboratory, and a series of evening research seminars. The informal and interac-
tive evening lectures were given by leading molecular neuroscientists and served to illustrate the ways
in which the various experimental approaches have been used to advance specific areas of neurobiol-
ogy. In this year's course, the laboratory portion included topics such as an introduction to the design
and use of animal virus vectors in neurobiology; the use of small interfering RNAs for regulating the
expression of specific genes in neurons; practical exercises in gene delivery systems including mam-
malian cell transfection protocols and single-cell electroporation techniques for targeted gene transfer
in vivo; an introduction to overall strategies, use and design of BAC transgenic vectors; multiplex and
whole-genome expression analyses using the most recent DNA microarray technologies (including
labeled probe preparation, data analyses, mining, and interpretation); quantitative real-time RT-PCR
analyses from small numbers of cells (RNA purification, PCR optimization, interpretation of results); sin-
gle-cell PCR and cDNA library construction; methods and application of RNA amplification (aRNA).
Each laboratory module was followed by comprehensive data analyses and interpretation, protocol
troubleshooting, and suggestions for ways to improve or modify the existing technique. Finally, course
participants were introduced to bioinformatics and a wide range of Internet resources that are available
to molecular neuroscientists. This year's invited speakers included Don Baldwin (University of
Pennsylvania), Catherine Berlot (Geisinger Clinic), Robert Darnell (HHMI/The Rockefeller University),
Ardem Patapoutian (The Scripps Research Institute), Anne Marie Quinn (Montana Molecular, LLC),
Heidi Scrable (University of Virginia), Lino Tessarollo (National Cancer Institute), and Frederick X. William
Yang (David Geffen School of Medicine, UCLA).
PARTICIPANTS
Agathocleous, M., BA., Cambridge University, United
Kingdom
Brown, A., B.S., Stanford University, California
Chevere, I., B.S., University of Puerto Rico, San Juan
Drapeau, E., Ph.D., Columbia University, New York
Ems ley, J., Ph.D., Harvard Medical School/Massachusetts
General Hospital, Boston
Haag, N., Dipl., University Hospital Jena, Germany
Hammond, R., B.S./B.A., Oregon Health and Science
University, Portland
Huberman, A., Ph.D., Stanford University, California
SEMINARS
Berlot, C., Weis Center for Research, Danville, Pennsylvania:
Splitting GFP to look at G-protein signaling.
Darnell, R., HHMI/The Rockefeller University, New York:
Applying molecular biology to study the role of RNA-binding
proteins in neurologic disease.
Eberwine, J., University of Pennsylvania Medical Center,
Philadelphia: Molecular analysis of the neuronal dendite:
More and more surprises... .
Patapoutian, A., The Scripps Research Institute, La Jolla,
MacLeod, K., Ph.D., University of Maryland, College Park
Makino, Y., M.A., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Pellissier, F., M.S., University of Geneva, Switzerland
Perez, J., B.A., University of Michigan, Ann Arbor
Ryabinin, A., Ph.D., Oregon Health & Science University,
Portland
Sands, T., B.A./B.S., Columbia University, New York
Veals, S., Ph.D., Fred Hutchinson Cancer Research Center,
Seattle, Washington
Wilbrecht, L., Ph.D., Cold Spring Harbor Laboratory
California: How do you feel? Molecular basis of temperature
sensation.
Scrable, H., University of Virginia, Charlottesville: Inducible expres-
sion in the mouse with the lac operator/repressor system.
Tessarollo, L., National Cancer Institute, Frederick, Maryland:
Dissecting neurotrophin functions in vivo: Lessons from engi-
neered mouse models.
Yang, X.W., University of California, Los Angeles: Mouse molec-
ular genetic study of basal ganglia function and dysfunction.
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Proteomics
July 8-21
INSTRUCTORS P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Institute of Proteomics, Cambridge, Massachusetts
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
ASSISTANTS E. Hainsworth, Harvard Medical School, Boston, Massachusetts
J. Jennings, Vanderbilt University School of Medicine, Nashville, Tennessee
W. Montor, University of Sao Paulo, Brazil
N. Ramachandran, Harvard Institute of Proteomics, Cambridge, Massachusetts
E. Simon, University of Michigan, Ann Arbor
S. Volk, University of Michigan, Ann Arbor
This intensive laboratory and lecture course focused on two major themes in proteomics: protein pro-
filing and functional proteomics. In the profiling section of the course, students learned about cutting-
edge protein separation methods, including hand-on experience with two-dimensional gel elec-
trophoresis, multidimensional liquid chromatography, and affinity purification of protein complexes. The
course covered both MALDI and ESI high-sensitivity mass spectrometry including peptide mass map-
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ping and tandem mass spectrometry, quantification using isobaric tags, and phosphoproteomics.
Students learned to use several informatics tools available for analyzing the data. In the functional pro-
teomics section of the course, students learned about recombinational cloning, high-throughput pro-
tein isolation, and protein microarrays. Students used robots to execute high-throughput methods
including expression, purification, and characterization of proteins. They also printed and analyzed their
own self-assembling protein microarrays, which were used for protein-protein interaction studies. The
overall aim of the course was to provide each student with the fundamental knowledge and hands-on
experience necessary to be able to perform and analyze proteomics experiments, and to learn to iden-
tify new opportunities in applying proteomics approaches to his/her own research. This year's speak-
ers included Steven Carr (Broad Institute of Harvard and MIT), Brian Chait (The Rockefeller University),
Pierre Chaurand (Vanderbilt University School of Medicine), Kevin Coombes (M.D. Anderson Cancer
Center), Wade Hines (Beyond Genomics), Peter Juhasz (BG Medicine, Inc.), Akhilesh Pandey (Johns
Hopkins University), Darryl Pappin (Applied Biosystems), Michael Snyder (Yale University), and Forest
White (MIT).
PARTICIPANTS
Auger -Messier, M., Ph.D., Cincinnati Children's Hospital
Medical Center, Cincinnati
Borhan, M., Ph.D., Saskatoon Research Centre, Canada
Callegari, E., Ph.D., University of South Dakota School of
Medicine,Vermillion
Chung, J., Ph.D., McGill University, Montreal, Canada
Cora, E., Ph.D., University of Puerto Rico-Medical Sciences,
San Juan
Esashi, F., Ph.D., Cancer Research, United Kingdom, Potters
Bar, Herts
Gould, M., Ph.D., Universidad Autonoma de Baja California,
Ensenada, B.C., Mexico
SEMINARS
Carr, S., Broad Institute, Cambridge, Massachusetts:
Biological mass spectrometry applications.
Chait, B., The Rockefeller University, New York: Hypothesis-
driven mass spectrometry.
Chaurand, R, Vanderbilt University, Nashville, Tennessee:
Imaging tissue by mass spectrometry.
Hines, W., Beyond Genomics, Cambridge, Massachusetts:
Interpretating the tandem mass spectrum.
Juhasz, P., Beyond Genomics, Cambridge, Massachusetts:
Huang, S., Ph.D., Baylor College of Medicine, Houston, Texas
Keech, 0., M.S., Umea University, Sweden
Navarrete, M., B.S., Universidad Andres Bello, Santiago, Chile
Rossetti, S., Ph.D., Roswell Park Cancer Institute, Buffalo,
New York
Scott, A., B.A., University of California, Berkeley
Soh, H., Ph.D., University of California, Santa Barbara
Valliyodan, B., Ph.D., University of Missouri, Columbia
Wood, N., Ph.D., GE Global Research, Niskayuna, New York
Ye, Y., Ph.D., Centers for Disease Control and Prevention,
Atlanta, Georgia
Biomaker discovery.
Pandey, A., Johns Hopkins University, Baltimore, Maryland:
Protemics databases and signaling pathways.
Pappin, D., Applied Biosystems, Foster City, California:
Quantitative mass spectrometry using isobaric tags.
Snyder, M., Yale University, New Haven, Connecticut: Protein
arrays.
White, F., Massachusetts Institute of Technology, Cambridge:
Phosphoproteomics.
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Biology of Memory
July 22-August 4
INSTRUCTORS K. Martin, University of California, Los Angeles
J. Raymond, Stanford University, California
This lecture course provided an introduction to cellular, molecular, and systems approaches to learn-
ing and memory. It was suited for graduate students and postdoctoral fellows in molecular biology,
neurobiology, and psychology, as well as research workers who are interested in an introduction to this
field. The course covered topics ranging from behavioral considerations of learning and memory to
gene regulation in the nervous system. The lectures provided an intensive coverage of modern behav-
ioral studies of learning and memory, the cell and molecular biology of neuronal plasticity, cellular and
molecular mechanisms of simple forms of learning and memory, and systems approaches to learning
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in vertebrates and humans. Lectures were complemented by exercises in which students worked in
small groups with lecturers to discuss topical issues in learning and memory, to evaluate recent stud-
ies, and to identify and formulate new research questions and approaches. The course is thus
designed not only to introduce students to the field of learning and memory, but also to provide an intel-
lectual framework upon which future studies can be built. Lecturers for this year's course include Jack
Byrne, Yang Dan, Ron Davis, Howard Eichenbaum, Peter Holland, Mary Kennedy, Dan Madison, Earl
Miller, Karim Nader, Larry Squire, Mriganka Sur, and Karel Svoboda.
The course was held at the Laboratory's Banbury Conference Center and was supported with funds
provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Banerjee, S., Ph.D., Yale University, New Haven,
Connecticut
Brasier, D., BA., University of California, San Diego
Christensson, M., M.S., Lund University, Sweden
Einarsson, E., BA., McGill University, Montreal, Canada
Jirenhed, D.-A., M.S., Lund University, Sweden
Kan, K.-H.C., M.S., Chinese University of Hong Kong
Ledderose, J., M.D., Universitat Freiburg, Germany
Lin, S.-C., M.D., Duke University Medical Center, Durham,
North Carolina
Maczko, K., B.A., Stanford University, Menlo Park, California
SEMINARS
Byrne, J., University of Texas/Houston Medical School:
Learning mechanisms in aplysia.
Dan, Y., University of California, Berkeley: Spike-timing-depen-
dent plasticity.
Davis, R., Baylor College of Medicine, Houston: Genetic
approaches to learning and memory.
Eichenbaum, H., Boston University, Massachusetts: Role of
the hippocampus.
Holland, R, Johns Hopkins University, Baltimore, Maryland:
Psychology and ethology of learning; Learning theory.
Kennedy, M., California Institute of Technology, Pasadena,
California: Biochemistry of synaptic plasticity.
Madison, D., Stanford University, California: Synaptic plastici-
ty: LTP and LTD.
Markram, K., M.A., Brain and Mind Intsitute, Lausanne,
Switzerland
McKay, B., M.S., University of Calgary, Canada
Neunuebel, J., M.S., University of Texas Graduate School of
Biomedical, Houston
Sakamoto, T, Ph.D., Okinawa Institute of Science and
Technology, Uruma, Japan
Valente, A., MA., Harvard University, Cambridge,
Massachusetts
Wang, D., Ph.D., University of California, Los Angeles
Zhao, G., Ph.D., Stanford University, California
Martin, K., University of California, Los Angeles: Cell biology of
synaptic plasticity.
Miller, E., Massachusetts Institute Technology, Cambridge: The
prefrontal cortex.
Nader, K., McGill University, Montreal, Canada: Consolidation
and reconsolidation.
Raymond, J., Stanford University, California: Cerebellum-
dependent learning.
Squire, L., University of California, San Diego: Memory sys-
tems in the brain; Medial temporal lobe.
Sur, M., Massachusetts Institute of Technology, Cambridge:
Cortical plasticity: Networks.
Svoboda, K., Cold Spring Harbor Laboratory: In vivo imaging
of cortical plasticity.
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Eukaryotic Gene Expression
July 25-August 1
INSTRUCTORS L. Attardi, Stanford University, California
M. Bulger, University of Rochester School of Medicine, New York
A. Shilatifard, St. Louis University, Missouri
L. Tora, IGBMC, Illkirch, France
ASSISTANTS T. Hilton, IGBMC, Illkirch, France
G. Isaacs, Cornell University, Ithaca, New York
T. Johnson, Stanford University, California
A. Wood, St. Louis University Health Sciences Center, Missouri
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the exciting area of gene regulation. The course focused on state-of-the-art strategies and
techniques employed in the field. Emphasis was placed both on in vitro and in vivo protein-DNA inter-
actions and on novel methodologies to study gene regulation. Students made nuclear extracts, per-
formed in vitro transcription reactions and measured RNA levels using primer extension.
Characterizations of the DNA-binding properties of site-specific transcription factors were carried out
using electrophoretic mobility-shift and DNase I footprinting assays. In addition, students learned tech-
niques for the assembly and analysis of chromatin in vitro, including transcription assays, chromatin
footprinting, and chromatin remodeling assays.
During the past few years, the gene regulation field has developed in vivo approaches to study gene
regulation. Students were exposed to the chromatin immunoprecipitation technique. They also used
RNAi for specific knockdown experiments in mammalian cells. In addition, determining cellular gene
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expression profiles has been accelerated tremendously by DNA microarray technology. Students
received hands-on training in performing and interpreting results from DNA microarrays.
Experience with basic recombinant DNA techniques was a prerequisite for admission to this course.
Lectures by the instructors covered the current status of the gene expression field, theoretical aspects
of the methodology, and broader issues regarding strategies for investigating the regulation of gene
expression in eukaryotes. Guest lecturers discussed contemporary problems in eukaryotic gene regu-
lation and technical approaches to their solution. Speakers for 2005 were David Allis (The Rockefeller
University), Genevieve Almouzni (Institut Curie), Shelley Berger (Wistar Institute), Keith Blackwell (Jos lin
Diabetes Center, Harvard Medical School), Stephen Buratowski (Harvard Medical School), David
Bushnell (Stanford University), Joan Conaway (Stowers Institute for Medical Research), Sharon Dent
(University of Texas, Anderson Cancer Center), Barbara Graves (University of Utah), Gordon Hager
(National Cancer Institute), James Kadonaga (University of California, San Diego), Ramin Shiekhattar
(The Wistar Institute), Jerry Workman (The Stowers Institute for Medical Research), and Carl Wu
(National Cancer Institute, NIH).
PARTICIPANTS
Barrera, L., B.S., University of California, San Diego
Bolouri, H., Ph.D., Institute for Systems Biology, Seattle,
Washington
Chandran, N., M.S., Wayne State University, Detroit, Michigan
Fager, V, B.S., Stockholm University, Sweden
Ferguson, P., Ph.D., University of South Carolina, Columbia
Fischer, J., M.S., Max-Planck Institute of Molecular Genetics,
Berlin, Germany
Freitas, F., B.A., Institute de Quimica, Sao Paulo State, Brazil
Gardini, A., M.S., The FIRC Institute of Molecular Oncology
Foundation, Milan, Italy
Gordon, F., B.S., The Ohio State University Medical Center,
SEMINARS
Allis, D., The Rockefeller University, New York: Beyond the
double helix: Writing and reading the histone code.
Almouzni, G., Institute Curie, Paris, France: Chromatin assem-
bly from nucleosome to heterochromatin.
Attardi, L., Stanford University, California: Using mouse mod-
els to dissect the function of the p53 trans-activator in
tumor suppression.
Berger, S., Wistar Institute, Philadelphia, Pennsylvania:
Histone covalent modifications in gonomic regulation.
Blackwell, T.K., Harvard Medical School, Cambridge,
Massachusetts: Transcription regulation in C. elegans
oocytes and early embryos.
Bulger, M., University of Rochester, New York:
Hyperacetylated domains and tissue-specific gene expres-
sion in erythroid cells.
Buratowski, S., Harvard Medical School, Cambridge,
Massachusetts: Coupling transcription with chromatin and
mRNA processing.
Bushnell, D., Stanford University, California: Structural insights
into RNA polymerase II initiation and elongation.
Conaway, J., Stowers Institute for Medical Research, Kansas
City, Missouri: Fundamental transcription mechanisms.
Columbus
Maruggi, G., Ph.D., University of Modena, Italy
Mojzita, D., M.S., Gothenburg University, Sweden
Palsgaard, J., M.S., Hagedorn Research Institute &
Copenhagen University, Gentofte, Denmark
Peiro, S., Ph.D., Institut d'Investigacio Medica, Bacelona,
Spain
Segal, E., Ph.D., The Rockefeller University, New York
Sichero, L., Ph.D., Ludwig Institute for Cancer Research, Sao
Paulo, Brazil
Walker, R., B.S., Meharry Medical College, Nashville,
Tennessee
Dent, S., University of Texas, Houston: In vivo functions for
histone-modifying enzymes.
Graves, B., University of Utah, Salt Lake City: ETS domain
proteins: Signaling into the nucleus.
Hager, G., NCl/NIH, Bethesda, Maryland: The dynamics of
transcription factor recruitment and promoter progression.
Kadonaga, J, University of California, San Diego: Studies of
the RNA polymerase II core promoter.
Shiekhattar, R., The Wistar Institute, Philadelphia,
Pennsylvania: Brave new world of small RNA.
Shilatifard, A., St. Louis University School of Medicine,
Missouri: Yeast COMPASS points the way to human MLL
and its role in pathogenesis of leukemia.
Tora, L., Institut de Genetique et be Biologie Moleculaire at
Cellulaire, France: Different sets of promoter recognition fac-
tors regulate the transcription initiation of RNA polymerase II.
Workman, J., Stowers Institute for Medical Research, Kansas,
Missouri: Protein complexes that activate or silence genes in
chromatin.
Wu, C., NCl/NIH, Bethesda, Maryland: ATP-dependent chro-
matin remodeling complexes for transcription.
303
Imaging Structure and Function in the Nervous System
July 26-August 15
INSTRUCTORS F. Engert, Harvard University, Cambridge, Massachusetts
M. Hubener, Max-Planck Institute of Neurobiology, Martinsried, Germany
D. Kleinfeld, University of California, San Diego
ASSISTANTS A. Kampff, Harvard University, Cambridge, Massachusetts
V. Nagerl, Max-Planck Institute of Neurobiology, Martinsried, Germany
Q.T. Nguyen, University of California, San Diego
V. Staiger, Max-Planck Institute of Neurobiology, Martinsried, Germany
P. Tsai, University of California, San Diego
R. Vislay, Harvard University, Cambridge, Massachusetts
J. Waters, Northwestern University, Chicago, Illinois
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies. The primary
emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as use of different types of electronic cameras, laser-scanning systems, function-
al fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell
function, including calcium-sensitive dyes, voltage-sensitive dyes, photoactivated ("caged") com-
pounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological
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methods were covered. Particular weight was given to multiphoton laser-scanning microscopy and to
newly available biological fluorophores, especially green fluorescent protein and its variants. We used
a spectrum of neural and cell biological systems, including living animals, brain slices, and cultured
cells. Applicants had a strong background in the neurosciences or in cell biology. Lecturers in 2005
included William Betz (University of Colorado Medical School), Winfried Denk (Max-Planck Institute for
Medical Research), Jahn Douglas (Coherent), Jason Eichenholz (Newport-Spectra Physics), Steven
Fadul (University of Colorado Medical School), Oliver Griesbeck (Max-Planck Institute of Neurobiology),
Stefan Hell (Max-Planck Institut fur Biophysikalische Chemie), Mark Hobson (Hamamsutu), Fred Lanni
(Carnegie-Mellon University), Jeff Lichtman (Harvard University), Jerome Mertz (Boston University),
Valentin Nagerl (Max-Planck Institute of Neurobiology), James Remington (University of Oregon),
Gordon Shepherd (Cold Spring Harbor Laboratory/HHMI), Karel Svoboda (HHMI, Cold Spring Harbor
Laboratory), Sebastian Tille (Zeiss), Jack Waters (Northwestern University), Eiji Yokoi (Olympus
American Inc.), and David Zenisek (Yale University).
This course was supported with funds provided by the National Institute of Mental Health, National
Institute on Drug Abuse, and the Howard Hughes Medical Institute.
PARTICIPANTS
Aguirre, A., Ph.D., CNMC, Center for Neurosciences,
Washington, D.C.
Cheng, L., B.S., The Johns Hopkins University School of
Medicine, Baltimore, Maryland
Christie, J., Ph.D., Oregon Health & Sciences University,
Portland
Gallio, M., Ph.D., University of California, San Diego
Hajj, G., Ph.D., Ludwig Intitute for Cancer Research, Sao
Paulo, Brazil
Hsu, Y., Ph.D., University of Massachusetts, Amherst
SEMINARS
Betz, W., University of Colorado Medical School, Denver:
Imaging secretion using FM 1-43.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Frontiers in optics; Frontiers in EM.
Eichenholz, J., Newport-Spectra Physics: Theory of lasers.
Engert, F., Harvard University, Cambridge, Massachusetts:
Introduction to tadpole preparation; Applications of tadpole
preparations.
Griesbeck, 0., Max-Planck Institute of Neurobiology,
Martinsried, Germany: XFP-based Ca probes.
Hell, S., Max-Planck Institut fOr Biophysikalische Chemie, Got-
tingen, Germany: Nonlinear absorption and diffraction limits.
Hobson, M., Hamamastu: Principles and technology of CCD
imaging.
Hubener, M., Max-Planck Institute of Neurobiology,
Martinsried, Germany: Primer on intrinsic optical signals;
Frequent domain methods for intrinsic signals.
Jahn, D., Coherent: Ultrafast lasers; OPAs, regenerative amps.
Kilborn, K., Intelligent Imaging Innovations, Inc., Santa
Monica, California: Software for microscopy.
Kleinfeld, D., University of California, San Diego: Basic optical
design; Basics of organic Ca indicators; Data analysis:
Primer on the frequency domain; Data analysis: Noise
sources and optimal S/N; Data analysis: Applications to
imaging.
Lampff, A., Harvard University, Cambridge, Massachusetts:
Introduction to image J.
Lang, S., M.A., Max-Planck Institute of Neurobiology,
Martinsried, Germany
Pouille, F, Ph.D., University of California, San Diego
Rozsa, B., M.D., Institute of Experimental Medicine,
Pharmacology, Budapest, Hungary
Sumbre, G., Ph.D., University of California, Berkeley
Uzzell, V., B.A., University of California, San Diego
van We lie, I., Ph.D., The Salk Institute for Biological Studies,
La Jolla, California
Lanni, F, Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Point spread functions; Diffraction theory; Confocal
microscopy and grating imager.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Applications of confocal microscopy; Brainbow multilabels:
Data analysis.
Mertz, J., Boston University, Massachusetts: Nonlinear techniques.
Nagerl, V, Max-Planck Institute of Neurobiology, Munich,
Germany: Applications of 2p imaging.
Nguyen, Q.T., University of California, San Diego: Brain, brain-
stem, and semi-intact preparations.
Remington, J., University of Oregon, Eugene: The world of
XFPs.
Shepherd, G., Cold Spring Harbor Laboratory: Caged com-
pounds and circuit analysis.
Svoboda, K., HHMI, Cold Spring Harbor Laboratory: Basics of
2p imaging; Advanced applications of 2p microscopy; FRET
and fluorescence lifetime imaging.
Tille, S., Zeiss: Overview of the Zeiss Meta and Pascal.
Tsai, P., University of California, San Diego: Fluorescence.
Waters, J., Northwestern University, Chicago, Illinois:
Advanced aspects (loading, quantitative modeling) of
organic Ca indicators.
Yokoi, E., Olympus American Inc., Melville, New York:
Overview of Olympus FluoView.
Zenisek, D., State University of New York, Stony Brook: Total
internal reflectance fluorescence (TIRF).
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Yeast Genetics and Genomics
July 26-August 15
INSTRUCTORS D. Amberg, State University of New York, Syracuse
D. Burke, University of Virginia, Charlottesville
J. Strathern, National Cancer Institute, Frederick, Maryland
M. Whiteway, NRC Biotechnology Research Institute, Montreal, Canada
ASSISTANTS S. Li, SUNY Upstate Medical Center, Syracuse, New York
M. Sambade, University of Texas Southwestern Medical Center, Dallas
D. Waller, NRC Biotechnology Research Institute, Montreal, Canada
This course is a modern, state-of-the-art laboratory course designed to teach the students the full
repertoire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces
cerevisiae. Combinations of classical genetic approaches were emphasized, including the isolation and
characterization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular
genetic techniques, including various types of yeast transformation, gene replacement with plasmids
and PCR, construction and analysis of gene fusions, and generation of mutations in cloned genes,
were also emphasized. Students used classical and molecular approaches to gain experience in iden-
tifying and interpreting various kinds of genetic interactions, including suppression and synthetic lethal-
ity. Students were immersed in yeast genomics and performed and interpreted experiments with DNA
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arrays. Students gained first-hand experience in modern cytological approaches such as epitope tag-
ging and imaging yeast cells using indirect immunofluorescence, GFP-protein fusions, and a variety of
fluorescent indicators for various subcellular organelles. Lectures on fundamental aspects of yeast
genetics were presented along with seminars given by outside speakers on topics of current interest.
This year's speakers included Brenda Andrews (Uhiversity of Toronto), Kerry Bloom (University of North
Carolina, Chapel Hill), Jeff Boeke (Johns Hopkins University), Marian Carlson (Columbia University),
Kara Dolinski (Princeton University), Beverly Errede (University of North Carolina, Chapel Hill), David
Garfinkel (NCI-FCRDC ABL-Basic Research Program), Frank Luca (University of Pennsylvania), Aaron
Mitchell (Columbia University), Jasper Rine (University of California, Berkeley), George Sprague
(University of Oregon), Kevin Struhl (Harvard Medical School), and Reed Wickner (National Institutes of
Health).
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Cole, S., B.S., Brandeis University, Waltham, Massachusetts
Fadri, M.T., B.S., Baylor College of Medicine, Houston, Texas
Hessa, T, B.S., Stockholm University, Sweden
Hutchins, G., Ph.D., Fort Lewis College, Durango, Colorado
Li, H., Ph.D., University of California, San Francisco
Lindroos, H., M.S., Karolinska Institute, Stockholm, Sweden
Locke, J., M.S., University of Warwick, Coventry, United
Kingdom
Morris, G., B.S., University of Chicago, Illinois
Narayan, S., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
SEMINARS
Andrews, B., University of Toronto, Canada: An embarrass-
ment of riches: Yeast genetics, functional genomics, and the
cell cycle.
Bloom, K., University of North Carolina, Chapel Hill:
Quantitative microscopy and molecular modeling to dissect
mechanisms of chromosome segregation.
Boeke, J., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Functional genomics of the yeast
genome integrity network.
Burke, D., University of Virginia Medical Center, Charlottesville:
The spindle checkpoint: Orchestrating the mitotic minuet.
Carlson, M., Columbia University, New York: Snfl/AMPK path-
way and nutrient signals in yeast.
Dolinski, K., Princeton University, New Jersey: Introduction to
the Saccharomyces genome database.
Errede, B., University of North Carolina, Chapel Hill: MAPK
Ocampo, M.T., B.S., New York University
Perocchi, F., Laurea., EMBL, Heidelberg, Germany
Ramachandran, G., B.S., Massachusetts Institute of
Technology, Cambridge
Segal, E., Ph.D., The Rockefeller University, New York
Smith, A., B.A., Northwestern University, Evanston, Illinois
Smith, V., Ph.D., Duke University Medical Center, Durham,
North Carolina
Upadhyaya, A., Ph.D. , Massachusetts Institute of Technology,
Cambridge
pathways controlling mating differentiation and pseudohy-
phal development in S. cerevisae.
Garfinkel, D., National Cancer Institute, Bethesda, Maryland:
How budding yeast and Ty retrotransposons coexist.
Luca, F., University of Pennsylvania, Philadelphia: Yeast MEN
and RAM: Two signaling networks that control mitotic exit,
morphogenesis, and daughter-specific transcription.
Mitchell, A., Columbia University, New York: Extending APOYG
into the pathogen Candida albicans.
Sprague, G., University of Oregon, Eugene: Control of cell
type and signal transduction specificity.
Struhl, K., Harvard Medical School, Cambridge,
Massachusetts: Transcriptional regulatory mechanisms.
Wickner, R., National Institutes of Health, Bethesda, Maryland:
Yeast prions: Proteins can be genes.
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C. elegans
July 28-August 15
INSTRUCTORS S. Clark, New York University School of Medicine
M. de Bono, MRC/Cambridge, United Kingdom
M. Labouesse, CNRS/INSERM/UL, France
ASSISTANTS L. Moffat, New York University School of Medicine
A.-S. Nicot, IGBMC/CNRS/INSERM, France
B. Olofsson, MRC/Cambridge, United Kingdom
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome pro-
ject. The course was suited both for those who have a current training in molecular biology and some
knowledge of genetics, but have no experience with C. elegans, and for students with some prior
worm experience who wished to expand their repertoire of expertise. The following topics were cov-
ered both in the laboratory and by lectures from experts in the field: worm picking, C. elegans data-
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bases and worm bioinformatics, anatomy and development, forward genetics, chemical and transpo-
son mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics, con-
struction and screening of deletion libraries, and RNA inactivation. The course was designed to impart
sufficient training to students in the most important attributes of the C. elegans system to enable them
to embark on their own research projects after returning to their home institutions. Speakers in the
2005 course included Jean-Louis Bessereau (Ecole Norma le Superieure-INSERM), Mark Blaxter
(University of Edinburgh), Craig Hunter (Harvard University), Chris Li (City College of New York),
Rueyling Lin (UTSW Medical Center), Kiyoji Nishiwaki (RIKEN Center for Developmental Biology), Amy
Pasquinelli (University of California, San Diego), Fabio Piano (New York University), Joel Rothman
(University of California, Santa Barbara), Jonathan Scholey (University of California, Davis), Lincoln Stein
(Cold Spring Harbor Laboratory), and Kevin Strange (Vanderbilt University Medical Center).
This course was supported with funds provided by the National Institute of Child Health and Human
Development.
PARTICIPANTS:
Choe, K., Ph.D., Vanderbilt University, Nashville, Tennessee
Cole, S., Ph.D., University of Virginia, Charlottesville
Dolgin, E., B.S., University of Edinburgh, United Kingdom
Fleming, A., Ph.D., Syngenta, Bracknell, Berkshire, United
Kingdom
Hayward, S., Ph.D., University of Liverpool, United Kingdom
Hicks, E., B.S., ViaLactia Biosciences, Auckland, New
Zealand
SEMINARS
Bessereau, J.-L., Inserm, Eco le Norma le Superieure, Paris,
France: Building synapses in C. elegans: From ultrastructure
to gene function.
Blaxter, M., University of Edinburgh, United Kingdom:
Comparing nematode genomes across billions of years of
evolution.
Clark, S., New York University School of Medicine:
Establishment of neuronal polarity.
de Bono, M., MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom: Oxygen sensing and the evo-
lution of foraging behavior in C. elegans.
Hunter, C., Harvard University, Cambridge, Massachusetts:
Molecular genetics of systemic RNAi.
Labouesse, M., CNRS/IGBMC, Strasbourg, Germany:
Squeezing a ball into a tube: From genes to possible forces.
Li, C., City College of New York: Using C. elegans as a model
for Alzheimer's disease.
Hobson, R., B.S., University of Toledo, Ohio
Horn, V, Ph.D., Lausanne University, Switzerland
Jaedicke, A., Ph.D., EMBL, Heidelberg, Germany
Kato, M., Ph.D., National Institute of Genetics, Mishima, Japan
Reid, S., Ph.D., University of Auckland, New Zealand
Saha, S., Ph.D., Boston University, Massachusetts
Sauvage, P., B.S., Universito Paris, France
Lin, R., University of Texas Southwestern Medical Center,
Dallas: Cell fate specification in early embryos.
Nishiwaki, K., RIKEN Center for Developmental Biology, Kobe,
Japan: Genetic analysis of gonad morphogenesis.
Pasquinelli, A., University of California, San Diego: MicroRNAs:
A small contribution from worms.
Piano, F, New York University: From genotype to phenotype:
Molecular models of early embryogenesis in C. elegans.
Rothman, J., University of California, Santa Barbara: Biological
switches: Life, growth, and death in C. elegans.
Scholey, J., University of California, Davis: Intraflagellar trans-
port C. elegans neurons: From molecular motors to ciliary
disease.
Stein, L., Cold Spring Harbor Laboratory: Wormbase.
Strange, K., Vanderbilt University Medical Center, Nashville,
Tennessee: Integrative physiology of salt and water home-
ostatsis: New insights from an old worm.
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Cellular Biology of Addiction
August 9-15
INSTRUCTORS B. Madras, Harvard Medical School, Southborough, Massachusetts
M. von Zastrow, University of California, San Francisco
ASSISTANT A. Jassen, Harvard Medical School, Southborough, Massachusetts
Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated
exposure to drugs produces neuroadaption and long-term memory of the experience, but the cellular
and molecular processes involved are only partially understood. The primary objective of the workshop
was to provide an intense dialog of the fundamentals, state-of-the-art advances and major gaps in the
cellular and molecular biology of drug addiction. Targeted to new or experienced investigators, the work-
shop combined formal presentations and informal discussions to convey the merits and excitement of
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cellular and molecular approaches to drug addiction research. With the advent of genomics and pro-
teomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative
processes fundamental to addiction, withdrawal, craving, and relapse to drug use and to brain function,
in general.
A range of disciplines and topics were represented, including noninvasive brain imaging to identify
drug targets and adaptive processes; neuroadaptative processes at the molecular and cellular level,
neural networks and their modulation; the relevance of genotype to susceptibility and drug response;
tolerance and adaptation at the cellular level, and approaches to exploiting the daunting volume gener-
ated by neuroinformatics. This workshop provided an integrated view of current and novel research on
neuroadaptive responses to addiction, fostered discussion on collaboration and integration, and provid-
ed critical information needed to construct a model of addiction as a disease and novel molecular tar-
gets for biological treatments. Beyond the plane of scientific endeavor, the information is vital for formu-
lating public policy and for enlightening the public on the neurobiological consequences of drug use and
addiction. The workshop was designed to generate interest in this level of analysis, open conduits for
collaborations, and present novel routes to investigating the neurobiology of addictive drugs.
Speakers in the 2005 course included George Augustine (Duke University Medical Center), Randy
Blakely (Vanderbilt University School of Medicine), Teresa Branchek (Lundbeck Research America),
Emery Brown (Massachusetts General Hospital), Marc Caron (Duke University Medical Center), Robert
Edwards (University of California, San Francisco), Chris Evans (University of California, Los Angeles),
Gordon Fishell (The Skirball Institute, NYU Medical Center), Joel Gelernter (Yale University School of
Medicine), David Goldman (NIAAA/LNG), Peter Kalivas (Medical University of South Carolina), Mary Jean
Kreek (The Rockefeller University), Angus Nairn (Yale University School of Medicine), Eric Nest ler
(University of Texas Southwestern Medical Center), Daniele Piomelli (University of California, Irvine),
Michael Rosenfeld (University of California, San Diego), George Uhl (NIDA), and Renping Zhou (Rutgers
University College of Pharmacy).
The course was held at the Laboratory's Banbury Conference Center and was supported with funds
provided by the National Institute of Drug Abuse.
PARTICIPANTS
Borg land, S., Ph.D., University of California, San
Francisco
Bowers, M.S., Ph.D., University of California, San
Francisco
Corbit, L., Ph.D., Ernest Gallo Clinic and Research Center,
Emeryville, California
Graber, S., Ph.D., The Burnham Institute, La Jolla,
California
Heifets, B., B.S., Albert Einstein College of Medicine,
Bronx, New York
Hubert, G., Ph.D., Emory University, Atlanta, Georgia
Jacobs, M., B.A., Vanderbilt University Medical Center,
Nashville, Tennessee
Jung, H.Y., Ph.D., HHMI/Massachusetts Institute of
Technology, Cambridge
Kash, T, B.S., Vanderbilt University Medical Center,
Nashville, Tennessee
Lawrence, D., Ph.D., National Institute on Drug Abuse,
Bethesda, Maryland
Lin, Z., Ph.D., Harvard Medical School, Southborough,
Massachusetts
Mangieri, R., B.A., University of California, Irvine
Melendez, R., Ph.D., Medical University of South Carolina,
Charleston
Perrine, S., Ph.D., Temple University School of Medicine,
Philadelphia, Pennsylvania
Simmons, D., B.S., University of Texas Southwestern
Medical Center, Dallas
Sipe, J., M.D., The Scripps Research Institute, La Jolla,
California
Stowers, S., Ph.D., University of California, Berkeley
Tietz, E., Ph.D., Medical College of Ohio, Toledo
Valdez, G., Ph.D., Harvard Medical School, Southborough,
Massachusetts
Wang, H., Ph.D., University of Toronto, Canada
Wang, J.C., Ph.D., Washington University, St. Louis,
Missouri
Wolfe, J., Ph.D., University of Pennsylvania, Philadelphia
Zamanian, J., Ph.D., Stanford University, California
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SEMINARS
Augustine, G., Duke University Medical Center, Durham,
North Carolina: Synapsins: Roles in synaptic vesicle
trafficking and behavioral responses to psychotropic
drugs.
Biederer, T., Yale University, New Haven, Connecticut:
Mechanisms of synaptic differentiation.
Branchek, T., Lundbeck Research, Paramus, New Jersey:
Trace amines and their receptors.
Breiter, H., Massachusetts General Hospital, Boston:
Brain mapping and the circuitry of reward/aversion.
Brown, E., Massachusetts General Hospital, Boston:
Dynamic analyses of neural representations using
the state-space modeling paradigm.
Caron, M., Duke University Medical Center, Durham,
North Carolina: Using animal models to probe the
neuronal plasticity and signaling associated with
drugs of abuse.
Evans, C., University of California, Los Angeles:
Endogenous and exogenous opioids in pain and
leasure.
Fishell, G., New York University Medical Center: Develop-
mental origins of cortical interneurons and the
basal ganglia.
Galli, A., Vanderbilt University, Nashville, Tennessee:
Molecular biophysics of amphetamine action.
Gasic, G., Massachusetts General Hospital, Boston:
Neural system bases of addictive behaviors.
Gelernter, J., Yale University School of Medicine,
New Haven, Connecticut: Genetic linkage studies
of drug dependence and related phenotypes: Brief outline.
312
Goldman, D., NIAAA, Rockville, Maryland
Kalivas, P., Medical University of South Carolina,
Charleston: Neuroplasticity as a pharmacothera-
peutic target in addiction. Can we forget to be
addicted?
Kreek, M.J., The Rockefeller University, New York:
Endorphins, gene polymorphisms, stress responsivity,
and specific addictions: Selected topics.
Nest ler, E., University of Texas Southwestern Medical
Center, Dallas: Transcriptional mechanisms underlying
drug addiction.
Piomelli, D., University of California, Irvine: The endogenous
cannabinoid system and the treatment of drug abuse.
Pollack, J., NIDA/National Institutes of Health, Bethesda,
Maryland: The funding process at NIH.
Rosenfeld, M., University of California, San Diego:
Sensors and signals: Integration of transcriptional
response in development and disease.
Tonegawa, S., RIKEN-MIT Neuroscience Research
Center, Cambridge, Massachusetts: Complex genetics of
alcoholism and other addictions.
Uhl, G., NIDA-IRP, National Institutes of Health,
Baltimore, Maryland: Molecular genetics of addiction.
von Zastrow, M., University of California, San Francisco:
Using receptor cell biology as a window into opiate
drug action and addiction.
Zhou, R., Rutgers University, Piscataway, New Jersey:
Specification of the midbrain dopaminergic pathways.
Workshop on Cereal Genomics
September 13-19
INSTRUCTORS S. Hake, USDA/University of California, Berkeley Plant Gene Expression Center
D. Jackson, Cold Spring Harbor Laboratory
L. Stein, Cold Spring Harbor Laboratory
D. Ware, Cold Spring Harbor Laboratory
ASSISTANTS P. Bommert, Cold Spring Harbor Laboratory
W. Zhao, Cold Spring Harbor Laboratory
This 1-week workshop enabled participants to take advantage of emerging genetic tools and genomics
data in the cereals, including the complete genome sequence of rice and extensive EST and genome
survey sequence from maize, wheat, and other grasses. The workshop featured morning and evening
lectures with afternoon computer lab exercises. The workshop also provided hands-on lab work in the
comparative anatomy, phenotype, and QTL sections in which participants examined samples and made
measurements for statistical analysis to illustrate the power of maize genetics and its relation to
genomics. The faculty (instructors and lecturers) were active researchers in cereal genetics and
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genomics who have made significant contributions to the field, ensuring that the latest techniques and
ideas were presented. The course was structured to provide time for informal discussions and
exchanges with leaders in the field. Topics included the rice genome and its annotation; genetic map-
ping; linking physical and genetic maps; classical maize genetics and tools; comparative anatomy of the
cereals; comparative genomics; the maize genome organization and "partial" sequence; cereals data-
bases; quantitative trait locus mapping, association analysis and evolution; and genome-wide expres-
sion analysis: ESTs, microarrays, and MPSS. Speakers in the workshop included Jeff Bennetzen
(University of Georgia, Athens), Ed Buckler (USDS-ARS Cornell University), Robin Buell (TIGR, The
Institute for Genomic Research), Katrien Devos (University of Georgia, Athens), Elizabeth Kellogg
(University of Missouri, St. Louis), Lisa Harper (University of California, Berkeley), Claire Hebbard
(Gramene), Carolyn Lawrence (USDA-ARS, Iowa State University), Robert Martienssen (Cold Spring
Harbor Laboratory), Blake Meyers (Delaware Biotechnology Institute), Torbert Rocheford (University of
Illinois, Urbana), Carl Schmidt (University of Delaware), Robert Schmidt (University of San Diego), Scott
Tingey (Dupont Company), Virginia Walbot (Stanford University), and Cliff Weil (Purdue University).
This workshop was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Barbosa Neto, J., Ph.D., Universidade Federal do Rio Grande
do Sul, Porto Alegre, Brazil
Campell, M., Ph.D., The Institute for Genomic Research,
Rockville, Maryland
Chan, A., Ph.D., The Institute for Genomic Research,
Rockville, Maryland
Engle, J., Ph.D., USDA-ARS, Raleigh, North Carolina
Goicoechea, J.L., B.S., Arizona Genomics Institute, Tuscon,
Held, M., Ph.D., Purdue University, West Lafayette, Indiana
Hunter, C., B.S., University of Florida, Gainesville
McGill, M.A., B.S., University of Wisconsin, Madison
SEMINARS
Bennetzen, J., Ph.D., University of Georgia, Athens: Maize
genome organization and sequencing strategies.
Buell, C.R., The Institute for Genomic Research, Rockville,
Maryland: Strategies to sequence and annotate the "com-
plete" rice genome.
Devos, K., Ph.D., University of Georgia, Athens: Comparative
cereal genomics.
Harper, L., University of California, Berkeley: Meiosis, recombi-
nation, and mapping.
Kellogg, E., University of Missouri, St. Louis/Schmidt, R.,
University of San Diego, California/Hake, S., Plant Gene
Expression Center, USDA, Albany, California: Introduction to
the cereals: Comparative anatomy and mutants.
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Okori, P., Ph.D., Makerere University Uganda, Uppsala,
Sweden
Paszkowski, U., Ph.D., University of Geneva, Switzerland
Persson, M., B.S., Swedish University of Agricultural Sciences,
Uppsala, Sweden
Preston, J., Ph.D., University of Missouri, St. Louis
Reddy, L., B.S., Washington State University, Pullman
Sakai, H., B.S., National Institute of Agrobiological Sciences,
Tsukuba, Ibaraki, Japan
Stonaker, J., B.S., University of California, Berkeley
Zhang, X., Ph.D., University of Georgia, Athens
Martienssen, R., Cold Spring Harbor Laboratory: Maize trans-
posons, genomics, and epigenomics.
Rocheford, T., Ph.D., University of Illinois, Urbana/Buckler, E.,
North Carolina State University, Raleigh: Quantitative trait
locus mapping, Association analysis and diversity.
Tingey, S., Dupont Company, Newark, Delaware: Future direc-
tions in cereal genomics.
Walbot, V., Stanford University, California/Meyers, B., Delaware
Biotechnology Institute, Newark, Delaware: ESTs, gene
models, and microarrays: MPSS and SAGE.
Weil, C., Purdue University, West Lafayette, Indiana: Reverse
genetics.
X-ray Methods in Structural Biology
October 10-25
INSTRUCTORS W. Furey, V.A. Medical Center, Pittsburgh, Pennsylvania
G. Gilliland, Centorcor, Inc., Radnor, Pennsylvania
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku/MSC, Inc., The Woodlands, Texas
ASSISTANT N. Tolia, Cold Spring Harbor Laboratory
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensified laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who are new to macromolecular crystallogra-
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phy. Topics covered included basic diffraction theory, crystallization (proteins, nucleic acids, and com-
plexes), crystal characterization, X-ray sources and optics, synchrotrons, crystal freezing, data collec-
tion, data reduction, multiple isomorphous replacement, multiwavelength anomalous diffraction, molec-
ular replacement, solvent flattening, noncrystallographic symmetry averaging, electron density interpre-
tation, molecular graphics, structure refinement, structure validation, coordinate deposition, and struc-
ture presentation. Participants learned through extensive hands-on experiments. One or more proteins
were crystallized, and the structure(s) was determined by several methods, in parallel with lectures on
the theory and informal discussions behind the techniques. Applicants were familiar with the creation
and editing of simple text files on Linux workstations using a screen-based editor (either vi or emacs).
PARTICIPANTS
Calabrease, M., B.S., Yale University, New Haven,
Connecticut
Chen, L., Ph.D., Henry M. Jackson Foundation, Bethesda,
Maryland
Chitnumsub, P., Ph.D., National Center for Genetic
Engineering and Biotechnology, Pathumthani, Thailand
De Mattheis, C., Ph.D., The University of Notthingham, United
Kingdom
Gordon, W., Ph.D., Harvard Medical School/Brigham &
Women's Hospital, Boston, Massachusetts
Grundner, C., B.S., University of California, Berkeley
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, Berkeley,
California: Introduction to CNS and PHENIX; Structure
refinement.
Dauter, Z., Brookhaven National Laboratory, Upton, New York:
Anomalous data collection.
Furey, W., V.A. Medical Center, Pittsburgh, Pennsylvania:
Patterson group therapy; Isomorphous replacement and
anomalous scattering; Scaling and merging synchrotron
data; MAD phasing: A classical approach; Solvent flatten-
ing/phase combination; Solving structures with BnP;
Noncrystallographic symmetry averaging.
Gilliland, G., Centorcor Inc., Radnor, Pennsylvania:
Crystallization databases and strategies.
Hendrickson, W., Columbia University, New York: MAD phas-
ing: Theory and practice.
Hung, Li-Wei, Los Alamos National Laboratory, Berkeley,
California: SOLVE and RESOLVE; Just because it's in
Nature, doesn't mean it's true...(macromolecular structure
validation).
Joshua-Tor, L., Cold Spring Harbor Laboratory: Structure pre-
sentation; Argonaute: The secret of Slicer.
Kjeldgaard, M., Aarhus University, Denmark: Electron density
fitting from A to 0.
McPherson, A., University of California, Irvine: Crystallization
of macromolecules I; Crystallization of macromolecules II;
Symmetry, periodicity, unit cells, space groups, miller planes,
and lattices; Waves, vectors, and complex numbers;
Fundamental diffraction relationships and Braggs law;
Diffraction patterns, reciprocal space, and Ewald's sphere;
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Henriksson, L., M.S., Uppsala University, Sweden
Hierro, A., Ph.D., NIH/NIDDK, Bethesda, Maryland
Kuhn, C., M.S., University of Munich, Germany
Matei, E., Ph.D., NIH/NIDDK, Bethesda, Maryland
Park, S., Ph.D., Inha University, Incheon, Massachusetts
Sayre, R., Ph.D., Ohio State University, Columbus, Ohio
Slotboom, D., Ph.D., University of Groningen, Netherlands
Sobolevsky, A., Ph.D., Columbia University, New York
Ulens, C., Ph.D., Netherlands Cancer Institute, Amsterdam,
Netherlands
Xu, M., M.S., Novartis, Cambridge, Massachusetts
Heavy atoms and anomalous scatterers; Fourier transforms
and the electron density equation; Pattern techniques;
Mechanisms of crystal growth.
Perrakis, A., Netherlands Cancer Institute, Amsterdam:
Automated model building and refinement with ARP/WARP;
Shaping the human genome: Structural insights on the
action of retrotransposons.
Pflugrath, J., Rigaku/MSC, Inc., The Woodlands, Texas: Data
collection: Design and setup I; Data collection: Design and
setup II; Cryocrystallography; Away from the Edge: Sulfur
SAD with chromium radiation.
Read, R., University of Cambridge, United Kingdom: Molecular
replacement: From Pattersons to likelihood; Likelihood: Ideas
and applications.
Richardson, D., Duke University Medical Center, Durham,
North Carolina: Detection and repair of model errors using all
atom contacts.
Sweet, R., Brookhaven National Laboratory, Upton, New York:
Fundamentals of crystallography; X-ray sources and optics.
Tronrud, D., University of Oregon, Eugene: Macromolecular
refinement I; Macromolecular refinement II; Difference elec-
tron density maps.
Waugh, David, National Cancer Institute, Frederick, Maryland:
Maximum likelihood strategies for protein expression and
purification.
Westbrook, J., Rutgers University, Piscataway, New Jersey:
The protein data bank.
Xu, R.-M., Cold Spring Harbor Laboratory: Structural mecha-
nisms of epigenetic inheritance.
Advanced Bioinformatics
October 12-25
INSTRUCTORS S. Lewis, University of California, Berkeley
S. Prochnik, Berkeley Drosophila Genome Project, California
L. Stein, Cold Spring Harbor Laboratory
J. Tisdall, DuPont Corporation, Wilmington, Delaware
ASSISTANTS J. Babayev, Pioneer Hi-Bred, Johnston, Iowa
S.J. Cain, Cold Spring Harbor Laboratory
D. Curie!, Pioneer Hi-Bred, Johnston, Iowa
J. Karalius, Seminis Vegetable Seeds, Inc., Woodland, California
T. Marques, Universitat Pompeu Fabra, Barcelona, Catalunya, Spain
S. Robb, University of Utah, Salt Lake City
L. Teytelman, Cold Spring Harbor Laboratory
C. Yamada, University of Cambridge, United Kingdom
Today, the computer is an indispensable part of a research biologist's toolkit. The success of the
human and other organisms genome projects has created terabytes of data on everything from genet-
ic linkage mapping, to nucleotide sequences, to protein structures, stashed away in databases around
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the globe. Large-scale technologies such as DNA microarrays and high-throughput genotyping have
transformed the nature of laboratory experimentation. Furthermore, even when biologists are not gen-
erating large data sets of their own, they will want to collect and analyze data from myriad sources in
the pursuit of novel candidates or even entire research avenues. A few years ago, it might have been
sufficient to use Excel spreadsheets for managing laboratory data and canned Web interfaces for
searching, but as the volume of data grows and the subtlety of analysis increases, these techniques,
even supplemented by some simple programming skills, have become inadequate. Modern biologists
must be adept at juggling disparate data sets in order to pursue their research. Designed for students
and researchers with some prior programming experience, the 2-week Advanced Bioinformatics pro-
gram gave biologists the expanded bioinformatics skills necessary to construct computational systems
that can exploit this increasingly complex information landscape, with an emphasis on fitting the wide
range of existing analysis tools into extensible bioinformatics systems. The course combined formal
lectures with hands-on sessions in which students worked to solve a series of problem sets covering
common scenarios in the acquisition, validation, integration, analysis, and visualization of biological
data.
For their final projects, students posed problems using their own data and worked with one anoth-
er and the faculty to solve them. The prerequisites for the course was basic knowledge of UNIX, pro-
cedural Perl programming, HTML document creation, and the database query language, SQL.
Lectures and problem sets covering this background material were available online and students could
study this material before starting the course.
The primary focus of this course was to provide students with the practical aspects of software
development, rather than to present a detailed description of the algorithms used in computational
biology.
Speakers in the 2005 course included Emina Begovic (University of California, Berkeley), Peter
Brokstein (DOE Joint Genome Institute), Roderic Guigo (Institut Municipal d'Investigacio Medica),
Winston Hide (University Western Cape, South Africa), Garbor Marth (Boston College), Sheldon McKay
(Cold Spring Harbor Laboratory), Chris Mungall (Berkeley Drosophila Genome Project), Lior Pachter
(University of California, Berkeley), William Pearson (University of Virginia), Jason Stajich (Duke
University), Paul Thomas (Applied Biosystems), and Olga Troyanskay (Princeton University).
PARTICIPANTS
Arziman, B.Z., M.S., German Cancer Research Center,
Heidelberg
Aziz, R., B.S., University of Tennessee, Memphis
Berglund, L., M.S., Royal Institute of Technology,
Stockholm, Sweden
Ding, Y., Ph.D., The Jackson Laboratory, Bar Harbor,
Maine
Dirk, W., M.S., University of California, Berkeley
Dixon, J., Ph.D., Johnson and Johnson, Spring House,
Pennsylvania
El Karoui, M., Ph.D., Institut National de la Recherche
Agronomique Jouy en Josas, France
Gopinathrao, G., Ph.D., Cold Spring Harbor Laboratory
Heiser, L., Ph.D., Lawrence Berkeley National Laboratory,
Berkeley, California
Hoffman, M., B.A., Boston College, Chestnut Hill,
Massachusetts
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Kao, C.-F., Ph.D., University of Mexico, Albuquerque, New
Mexico
Kavanaugh, L., M.S., Duke University, Hillsborough, North
Carolina
Manabe, Y., Ph.D., Agriculture and Agri-Food Canada,
Ottawa
Messina, D., M.A., Washington University School of Medicine,
St. Louis, Missouri
Mottagui, S., Ph.D., Karolinska Institutet, Stockholm,
Sweden
Nayak, V., M.S., University of Pennsylvania, Philadelphia
Papadopoulos, C., B.S., University of Georgia, Athens
Rodriguez-Zapata, F, B.S., International Center for Tropical
Agiculture, Cali, Valle, Colombia
Salih, H., B.S., Texas A&M University, College Station
Stillwell, R., B.S., University of Hawaii, Manoa, Honolulu
SEMINARS
Begovic, E., University of California, Berkeley: Molecular
evolution: Molecular clocks, ka/ks, 4DTV; Gene
prediction: Training and running programs.
Guigo, R., Institut Municipal d'Investigacio Medica,
Barcelona, Spain: Gene prediction in ENCODE.
Lewis, S., University of California, Berkeley: Biological
ontologies: Organizing information in machine-readable
form; Graphical visualization systems: Gbrowse, UCSC
browser, Apollo, IGB.
Marth, G., Boston College, Chestnut Hill, Massachusetts:
Sequence variation analysis: SNPs, haplotyes.
McKay, S., Cold Spring Harbor Laboratory: Querying SQL
databases with DBI.pm.
Mungall, C., Berkeley Drosophila Genome Project, Berkeley,
California: Biological database design; Designing and run-
ning bioinformatics pipelines with Perl.
Pachter, L., University of California, Berkeley: Aligning
genomes: Global and local (*multiple) whole-genome
alignment tools and considerations.
Pearson, W., University of Virginia, Charlottesville:
Aligning proteins: Local/global alignment algorithms
(Smith-Waterman and blastp, etc.) + substitution
matrices, part 1; Aligning proteins: Local/global
alignment algorithms (Smith-Waterman and blastp,
etc.) + substitution matrices part 2; Problem set:
Protein alignments.
Prochnik, S., Princeton University, New Jersey: Designing
and writing object-oriented Perl: Writing your own Perl
classes.
Stajich, J., Duke University, Durham, North Carolina:
Introduction to Bioperl: Organization and the basic
classes; Bioperl II: Using Bioperl: More classes and
using them.
Stein, L., Cold Spring Harbor Laboratory: Perl review I:
Files, system calls, basic 10, subroutines; Perl review II:
Data structures, regular expressions; Using object-
oriented programming in Pert: Examples of using off-
the-shelf Perl modules; Creating web graphics in Pert:
GD.pm.
Thomas, P., Applied Biosystems, Foster City, California:
Functional assignment, protein domain assignment,
COGs, panther, pfam.
Tisdall, J., DuPont Experimental Station, Wilmington,
Delaware: Speeding it up: Using multiple processors
and clusters to run complex jobs faster.
Troyanskaya, 0., Princeton University, New Jersey:
Introduction to large-scale expression studies:
Microarrays.
Winning the plate race
319
Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 21-November 3
INSTRUCTORS A. Dernburg, Lawrence Berkeley National Laboratory, Berkeley, California
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
J. Swedlow, University of Dundee, United Kingdom
ASSISTANTS K. Hu, Scripps Research Institute, La Jolla, California
W. Moore, University of Dundee, United Kingdom
J. Peng, University of California, Berkeley
This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochem-
istry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well as protein
and RNA dynamics in living cells. The course emphasized the use of the latest equipment and tech-
320
niques in fluorescence microscopy, including confocal laser-scanning microscopy, deconvolution
methods, digital image processing, and time-lapse imaging of living specimens. The course was
designed to present students with state-of-the-art technology and scientific expertise in the use of light
microscopy to address basic questions in cellular and molecular biology. The course was designed for
the molecular biologist who is in need of microscopic approaches and for the cell biologist who is not
familiar with the practical application of the advanced techniques presented in the course. Among the
methods presented were the preparation of tagged nucleic acid probes, fixation methods, detection of
multiple DNA sequences in single nuclei or chromosome spreads, comparative genomic hybridization,
cellular localization of RNA, localization of nucleic acids and proteins in the same cells, use of a variety
of reporter molecules and nonantibody fluorescent tags, indirect antibody labeling, detection of multi-
ple proteins in a single cell, and the use of GFP variants to study protein expression, localization, and
dynamics. In each method, several experimental protocols were presented, allowing the students to
assess the relative merits of each and to relate them to their own research. Students were encouraged
to bring their own nucleic acid, protein, or antibody probes to the course, which were used in addition
to those provided by the instructors. The laboratory exercises were supplemented with lectures given
by invited distinguished scientists, who present up-to-the-minute reports on current methods and
research using the techniques being presented.
Speakers in this year's course included Richard Day (University of Virginia), Mats Gustafsson
(University of California, San Francisco), Alexey Khodjakov, Thomas Ried (NCl/NIH), David Spector
(Cold Spring Harbor Laboratory), Phong Tran (University of Pennsylvania), and Lani Wu (UTSVV).
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Beebe, D., Ph.D., University of Wisconsin, Madison
Beser, A., M.D., Istanbul University Oncology Institute, Turkey
Campbell, J., B.S., Washington University, St. Louis, Missouri
Carvalho, F., M.S., Cold Spring Harbor Laboratory
Colgan, L., B.S., Center for Neuroscience, University of
Pittsburgh, Pennsylvania
Hinas, A., M.S., Swedish University of Agricultural Sciences,
Uppsala, Sweden
lvakhno, S., M.S., Institute of Molecular Biology and Genetics,
Kyiv, Ukraine
Lampe, T, Dipl., University of Goettingen, Germany
SEMINARS
Day, R., University of Virginia, Charlottesville: Seeing colors:
Applications and limitations of the fluorescent proteins.
Dernburg, A., Lawrence Berkeley National Laboratory,
Berkeley, California: Basic of DNA FISH.
Gustafsson, M., University of California, San Francisco:
Increased resolution fluorescence imaging by linear and
nonlinear structured illumination microscopy.
Hu, K., Scripps Research Institute, La Jolla, California/Murray,
J., University of Pennsylvania School of Medicine,
Philadelphia: Basic introduction to light and fluorescence
microscopy.
Khodjakov, A., Wadsworth Center, Albany, New York: Studies
on mitosis.
Murray, J., University of Pennsylvania School of Medicine,
Leung, A., Ph.D., Massachusetts Institute of Technology,
Cambridge
Manwell, L., B.S., University of Waterloo, Canada
Martin, J., B.S., University of Florida, Gainesville
Orlando, E., Ph.D., Florida Atlantic University at Harbor
Branch Oceanographic Institution, Ft. Pierce
Schmid, D., M.S., The Rockefeller University, New York
Viklund, I.-M., Ph.D., Karolinska Institutet, Stockholm,
Sweden
Weber, L., Ph.D., University of Colorado, Boulder
Zeiss, C., Ph.D., Yale University, New Haven, Connecticut
Philadelphia: lmmunocytochemistry.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia/Swedlow, J., University of Dundee, United
Kingdom: Principles of confocal microscopy and deconvolu-
tion techniques.
Ried, T, NCl/NIH, Bethesda, Maryland: Mechanisms and con-
sequences of chromosomal aberrations in cancer cells.
Spector, D., Cold Spring Harbor Laboratory: Localization of
gene expression by FISH and in living cells.
Tran, P., University of Pennsylvania, Philadelphia: Cameras and
digital imaging fundamentals.
Wu, L., University of Texas Southwestern Medical Center,
Dallas: Cytological profiling.
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Computational Genomics
November 2-8
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT B. Cantarel, University of Virginia, Charlottesville
Beyond BLAST and PASTA-This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics included gene recognition (exon/intron prediction), identifying
signals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises and made extensive use of local WWW
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pages to present problem sets and the computing tools to solve them. Students used Windows and
Mac workstations attached to a UNIX server.
The course was designed for biologists seeking advanced training in biological sequence analysis,
for computational biology core resource directors and staff, and for scientists in other disciplines, such
as computer science, who wish to survey current research problems in biological sequence analysis.
The primary focus was the theory and practice of algorithms used in computational biology, with the
goal of using current methods more effectively and developing new algorithms.
Speakers in the 2005 course included Stephen Altschul (National Library of Medicine), Peter Cooper
(NCBI/NLM), Peter D'Eustachio (New York University Medical Center), Ross Hardison (Penn State
University), and Mark Yandell (HHMI/University of Utah).
PARTICIPANTS
Apostolou, S., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Brodie, S., B.S., State University of New York, Buffalo
Carvalho, F., M.S., Cold Spring Harbor Laboratory
Colombo, T, M.S, New York University
Crow-Sanchez, K., Ph.D., Yale University, New Haven,
Connecticut
Kingan, S., B.S., Harvard University, Cambridge,
Massachusetts
Krasnitz, A., Ph.D., Cold Spring Harbor Laboratory
MacConaill, L., Ph.D., Dana-Farber Cancer Institute, Boston,
Massachusetts
SEMINARS
Altschul, S., National Library of Medicine, Bethesda,
Maryland: Statistics of sequence similiarity scores; Iterated
protein database searches with PSI -BLAST.
Cooper, P., NCBI/NLM, Bethesda, Maryland: NCBI resources
for bioinformatics and computational biology; NCBI genome
resources.
D'Eustachio, P. New York University Medical Center: The
Reactome pathway database.
Hardison, R., Pennsylvania State University, University Park:
Comparative genomics I: Tools for comparative genomics;
Genome computation and gene regulation.
Pishotta, F., M.A., Mayo Clinic, Jacksonville, Florida
Rosengarten, R., B.A., Yale University, New Haven,
Connecticut
Segal, C., M.S., University of Mexico, Mexico City
Sugino, K., Ph.D., Brandeis University, Waltham,
Massachusetts
Venkatraman, A., Ph.D., Texas A&M University, College Station
Wongratanacheewin, S., Ph.D., Khon Kaen University,
Thailand
Zerlotini N.A., B.S., Rene Rachou Research Center-Oswaldo
Cruz Foundation, MG, Brazil
Pearson, W., University of Virginia, Charlottesville: Introduction
and overview; Protein evolution and sequence similarity
searching; Algorithms for biological sequence comparison;
Hidden Markov models and protein profiles; Identifying con-
sensus sites; Alignment algorithms: Large-scale alignment;
Comparative genomics databases: Ensmart.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Approaches to multiple sequence alignment.
Yandell, M., HHMI/University of California, Berkeley: Genome
annotation/sequence ontologies/gene ontologies; Large-
scale computation on genomes.
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Phage Display of Proteins and Peptides
November 9-22
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, La Jolla
ASSISTANTS K. Masek, Neurome Inc., La Jolla, California
K. Noren, New England Biolabs, Beverly, Massachusetts
C. Tuckey, New England Biolabs, Beverly, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and prac-
tical aspects of constructing combinatorial libraries from immune and nonimmune sources, as well as
the construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification and characterization of Fab fragments expressed in E coil were also covered.
Epitopes was selected from peptide libraries and characterized.
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The lecture series, presented by a number of invited speakers, emphasized PCR of immunoglobu-
lin genes, the biology of filamentous phage, and the utility of surface expression libraries, expression of
antibodies in E coli and mammalian cells, antibody structure and function, catalytic antibodies, direct-
ed protein evolution, retroviral and cell display libraries, the immunobiology of the antibody response,
and recent results on the use of antibodies in therapy. The theory and practical implications for selec-
tion from phage-displayed libraries of random peptides, cDNA products, and semisynthetic proteins
were also explored. Seminar speakers in the 2005 course included Carl Goodyear (University of
California, San Diego), Henry Lowman (Genentech, Inc.), Christopher Noren (New England Biolabs),
Eric Ostertag (University of Pennsylvania School of Medicine), Sachdev Sidhu (Genentech, Inc.),
George Smith (University of Missouri), Robyn Stanfield (The Scripps Research Institute), and K. Dane
Wittrup (Massachussetts Institute of Technology).
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Aguilar, R., B.S., M.D. Anderson Cancer Center, Houston,
Texas
Bar, M., B.S., Weizmann Institute of Science, Rehovot, Israel
Chao, D.-Y., Ph.D., Centers for Disease Control, Fort Collins,
Colorado
Fiuza, U.-M., University of Cambridge, United Kingdom
Hong, Y., Ph.D., Tulane University Health Sciences Center,
New Orleans, Louisiana
Huang, Y., Ph.D., Lawrence Livermore National Laboratory,
California
Jayakumar, J., M.S., University of Capetown, South Africa
Lamkin, T., Ph.D., Air Force Research Laboratory, Brooks City-
SEMINARS
Barbas, C., The Scripps Research Institute, La Jolla,
California: Software and hardware for genomes: Polydactyl
zinc finger proteins and the control of endogenous genes.
Goodyear, C., University of California, San Diego:
Blymphocyte development and immunobiology.
Lowman, H., Genetech, Inc., San Francisco, California: SAR
of peptides using phage.
Noren, C., New England Biolabs, Beverly, Massachusetts:
Phage peptide libraries: The PhD for peptides.
Ostertag, E., University of Pennsylvania Medical School,
Philadelphia: Use of phage display to clone human
ADAMTS13 inhibitory antibodies from patients with throm-
botic thrombocytopenic purpura.
Base, Texas
Matoba, N., Ph.D., Arizona State University, Tempe, Arizona
Modin, C., Ph.D., University of Aarhus, Denamark
Muschler, J., Ph.D., California Pacific Medical Center, San
Francisco
Norville, J., B.S., Massachusetts Institute of Technology,
Cambridge
Razumenko, M., M.S., University of Trieste, Italy
Shallice, M., B.S., Invitrogen, Eugene, Oregon
Stolf, B., Ph.D., University of Sao Paulo, Brazil
Yeh, T. -M., Ph.D., National Cheng Kung University, Tainan,
Taiwan
Sidhu, S., Genetech, Inc., San Francisco, California: Antibody
phage display and chemical diversity in antigen recognition.
Siegel, D., University of Pennsylvania Medical Center,
Philadelphia: Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego: Repertoire
cloning of SLE autoantibodies.
Smith, G., University of Missouri, Columbia: Phage display of
peptides.
Stanfield, R., The Scripps Research Institute, La Jolla,
California: Structural biology of the immune system.
Wittrup, K.D., Massachusetts Institute of Technology,
Cambridge: Yeast display libraries.
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The Genome Access Course
April 26-27, August 30-31, November 30-December 1
TRAINERS J. Gergel, Cold Spring Harbor Laboratory
B. King, The Jackson Laboratory
P. Rabinowicz, The Institute for Genomic Research
D. Rasko, University of Texas Southwestern Medical Center
D. Schones, Cold Spring Harbor Laboratory
Initiated in 2002, this course is an intensive 2-day introduction to bioinformatics that was held three
times in 2005 and trained 86 participants in total. The core of the course was designed to cover the
manipulation and analysis of sequence information. The course was broken into modules designed to
give a broad overview of a given topic, with ample time for examples chosen by the instructors. Each
module included three parts, consisting of a discussion of theory and methods, coverage of software
and Web resources, and use of selected tools with examples (including those supplied by the stu-
dents). The modular design allowed the instructors to tailor the presentation to the interests of the stu-
dents. Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple
Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis. Applications to the course were open
to all on a first-come-first-served basis, subject to basic eligibility requirements. The course was held
at the Laboratory's Cancer Genome Research Center.
April 26-27
Barria, A., Ph.D., Cold Spring Harbor Laboratory
Bogusz, A. Ph.D., University of Chicago, Illinois
Bohling, K., B.S., Iowa State University
Bouck, A., Ph.D., Duke University, Durham, North Carolina
Catron, S., Ph.D., Pioneer Hi-Bred International, Johnston,
Iowa
Chen, H., Ph.D., University of Maryland School of Medicine,
Baltimore
Cuenco, K.T., Ph.D., University of Maryland School of
326
Medicine, Baltimore
Deigendesch, N., B.S., Massachusetts Institute of Technology,
Cambridge
Friedlaender, F., Ph.D., Temple University, Philadelphia,
Pennsylvania
Friedlaender, J., Ph.D., Temple University, Philadelphia,
Pennsylvania
Fuller, B., Ph.D., University of Virginia, Charlottesville
Gao, S., Ph.D., State University of New York, Stony Brook
Gould, H., Ph.D., King's College, London, United Kingdom
Kramnik, I. Ph.D., Harvard School of Public Health, Boston,
Massachusetts
Lee, T., Ph.D., University of Toronto, Canada
Li, R., Ph.D., Sam Houston State University, Huntsville, Texas
Muratani, M., B.S., Cold Spring Harbor Laboratory
Pe led, J., B.S., Albert Einstein College of Medicine, Bronx,
New York
Plourde, M., B.S., Universite Laval, Quebec, Canada
Rao, C.P., Ph.D., St. Luke's Memorial Hospital, Utica, New
York
Ronai, D., Ph.D., Albert Einstein College of Medicine, Bronx,
New York
Sprague, G., Ph.D., University of Oregon, Eugene
Su, X., Ph.D., Cedars-Sinai Medical Center, Los Angeles,
California
Tange, T., Ph.D., Howard Hughes Medical Institute, Waltham,
Massachusetts
Teplin, S., Ph.D., Cold Spring Harbor Laboratory
Teshima, K., Ph.D., Brown University, Providence, Rhode
Island
Tewari, D., Ph.D., Pennsylvania Department Agriculture,
Harrisburg, Pennsylvania
Wang, L., Ph.D., Vanderbilt University, Nashville, Tennessee
Yasenchak, J., Regeneron Pharmaceuticals, Tarrytown,
New York
Zhai, B., Ph.D., CBRC, Massachusetts General Hospital,
Charlestown
August 30-31
Barretina Ginesta, J., Ph.D., Dana-Farber Cancer Institute,
Boston Massachusetts
Bartfai, R., Ph.D., Temasek Life Sciences Laboratory,
Singapore
Burns, F, Ph.D., Dupont/Qualicon, Wilmington, Delaware
Caufield, P., Ph.D., New York University
Cohen, E., Ph.D., The Salk Institute for Biological Studies, La
Jolla, California
Costa-Guda, J., B.S., University of Connecticut Health Center,
Farmington
Cui, H., Ph.D., Johns Hopkins University School of Medicine,
Baltimore, Maryland
Das, B., Ph.D., Carnegie Institution of Washington, Baltimore,
Maryland
Davis, R., Ph.D., SUNY Upstate Medical University, Syracuse,
New York
De Mayo, F, Ph.D., Baylor College of Medicine, Houston,
Texas
Doucet, J., Ph.D., Nicholls State University, Thibodaux,
Louisiana
Echlin, T., B.S., National Institutes of Health, Bethesda,
Maryland
Guan, X., Ph.D., Syngenta Biotechnology Inc., Durham, North
Carolina
Horton, M., B.S., University of Chicago, Illinois
Isaac, D., Ph.D., Princeton University, New Jersey
Keller, A., B.S., The Rockefeller University, New York
King, M., Ph.D., University of Rochester, New York
Laster, K., B.S., University of Connecticut, Farmington
Lim, K.-C., Ph.D., University of Michigan Medical School,
Ann Arbor
Moran, U., Ph.D., Icon Laboratories, Farmingdale, New York
Morrow, E., Ph.D., Harvard Medical School, Boston,
Massachusetts
Nasipak, B., B.S., Columbia University, New York
Newman, R., Ph.D., Harvard Medical School, Southborough,
Massachusetts
Ouyang, X., Ph.D., University of Medicine and Dentistry of
New Jersey, Piscataway
Perlman, D., Ph.D., University of Minnesota, Minneapolis
Vega, F., Ph.D., USDA/ARS, Beltsville, Maryland
Vermeirssen, V., Ph.D., University of Massachusetts Medical
School, Worcester
Yoon, C., B.S., Cold Spring Harbor Laboratory
Zhu, R., B.S., University of Texas M.D. Anderson Cancer
Center, Houston
Zieve, G., Ph.D., Stony Brook University, New York
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November 30-December 1
Bain, P. Ph.D., Harvard Medical School, Boston,
Massachusetts
Bellomo, D., Ph.D., Delft Center for Systems & Control
Leiden, The Netherlands
Berry, D., Ph.D., Stony Brook University, Southampton, New
York
Crow, J., Ph.D., Mississippi State University, Mississippi
Cunningham, J., M.D., Columbia Presbyterian Medical Center,
New York
Doucet, J., Ph.D., Nicholls State University, Thibodaux,
Louisiana
Houser, E., B.S., Summit Systems, Brooklyn, New York
Huang, Y.-Y., Ph.D., Columbia University, New York
Jayakumar, J., University of Capetown, South Africa
Li, L., B.S., McGill University, Montreal, Canada
Lin, C.-C., Ph.D., Winona State University, Rochester,
Minnesota
Martinelli, D., B.S., Carnegie Institution of Washington,
Baltimore, Maryland
Martins, S., B.S., Institute of Molecular Pathology and
Immunology, University of Porto, Portugal
Miller, D., B.S., Cornell University, Ithaca, New York
Molinaro, A., Ph.D., Yale University, New Haven, Connecticut
Monroe, J., Ph.D., James Madison University, Harrisonburg,
Virginia
Nishimura, W., Ph.D., Jos lin Diabetes Center, Boston,
Massachusetts
O'Donnell, J., B.S., Pathfinder Regional Vocational Technical
School, Palmer, Massachusetts
O'Sullivan, C., Ph.D., Tufts-New England Medical Center,
Boston, Massachusetts
Ronan, M., B.S., Life Sciences, Branford, Connecticut
Skoneczka, J., B.S., Virginia Tech, Blacksburg, Virginia
Smit, M., Ph.D., Cancer Genome Research Center, Cold
Spring Harbor
Temple, L., Ph.D., James Madison University, Harrisonburg,
Virginia
Vadakkan, K., Ph.D., University of Toronto, Canada
Vyshkina, T., Ph.D., St. Luke's Roosevelt Hospital, New York
Wilt, S., Ph.D., Bellarmine University, Louisville, Kentucky
The Laboratory acknowledges the generosity of the following companies who loaned equipment and reagents to the various courses:
Affymetrix Inc.
Ambion Inc.
A.M.P.I.
Agilent Technologies
Ammo Biosystems
Applied Biosystems
Applied Precision Inc.
Applied Scientific Instrumentation,
Inc.
Astro-Med Inc.
Axon Instruments
Becton Dickinson Labware
Berthold Technologies USA, LLC
Bio-Rad Laboratories
Bioptechs Inc.
BioVision Technologies
Brinkmann Instruments
Burleigh Instruments, Inc.
Cambrex Bo Science Rockland
Inc.
Carl Zeiss, Inc.
Charles River Laboratories Inc.
Chroma Technology Corporation
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Corning Inc.
Dagan Corporation
David Kopf Instruments
Delaware Diamond Knives
Drummond Scientific Company
Epicentre Technologies
Eppendorf Scientific
Fotodyne Inc.
GE Healthcare
Galil Motion Control
Gemway Biotech Inc.
Genetix USA Inc.
Hamamatsu Photonic Systems
Hampton Research
Harvard Apparatus, Inc.
Improvision Inc.
Instrutech Corp.
Intelligent Imaging Innovations Inc.
Invitrogen Corporation
Jackson lmmunoresearch
Laboratories
James A. Hill
Kinetic Systems
Leica Microsystems Inc.
Luigs & Neumann
Modulation Optics, Inc.
Molecular Devices Corporation
Molecular Probes Inc.
Nalge Nunc International
Narishige International USA, Inc.
Nasco
New England BioLabs, Inc.
Nikon Inc.
Olympus America Inc.
Pel Freez Biologicals
Perkin Elmer Life and Analytical
Sciences
Photometrics
Photonic Instruments
Pierce Chemical Co.
Promega Corp.
Q-Imaging Inc.
QIAGEN Inc.
Rigaku/MSC
Roche Applied Science
Instruments Inc.
Santa Cruz Biotechnology Inc.
Scigene
Sigma-Aldrich
Singer Instrument Company
Spectra-Physics Lasers Inc.
Stratagene
Sutter Instruments
Tecan
The Jackson Laboratory
The Vibratome Company
Thermo Finnigan
Thermo Labsystems
T.I.L.L. Photonics Gmbh
Torrey Pines Scientific
Universal Imaging Corporation
Upstate Biotechnology
Warner Instruments
VVVR Scientific Products
Vector Laboratories
Waters Corp.
Zeitz-lnstrumente Vertriebs GmbH
Zymo Research
SEMINARS
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings on a weekly basis. These seminars keep the CSHL staff current on the latest developments
and broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar
speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in
an informal setting.
January
Dr. Michael Grunstein, University of
California, Los Angeles
Dr. David Livingston, Dana Farber
Cancer Institute, Harvard University
Dr. Marc Tessier-Lavigne, HHMI,
Stanford University
February
Dr. Joel Richter, University of
Massachusetts Medical School
Dr. Josh Sanes, Harvard University
Dr. David Sinclair, Harvard Medical
School
Dr. Yuh-Nung Jan, HHMI, University
of California, San Francisco
March
Dr. Walter Mangel, Brookhaven
National Laboratory
Dr. Steve McKnight, Southwestern
Medical Center, The University of Texas
Dr. Ruth Lehmann, Skirball Institute,
New York University
Dr. Jeffrey Pessin, Stony Brook
University
September
Dr. Charalambos Kyriacou, University
of Leicester, U.K.
October
Dr. Louis F. Reichardt, University of
California, San Francisco
November
Dr. Stephen L. Mayo, HHMI, California
Institute of Technology
Dr. Lily Y. Jan, HHMI, University of
California, San Francisco
Dr. George Yancopoulos, Executive Vice
President and Chief Scientific Officer,
Regeneron Pharmaceuticals, Inc.
Title
Functions of histone acetylation sites in yeast.
Functional analysis of the BRCA1 gene and its role in tumor
suppression.
Wiring the brain: The logic and molecular biology of axon
guidance.
Host
Terri Grodzicker
Terri Grodzicker
Grisha Enikolopov
Translational control of developmental and neuronal plasticity. Holly Cline
Analyzing synapse formation with mutant and fluorescent mice. Alla Karpova
(Svoboda Lab)
William TanseyUnraveling the regulators of aging: From plants to yeast to
mammals.
Control of dendrite morphology and remodeling during
development.
Activation of the adenovirus proteinase by a long, branched
signal transduction pathway within the protein: Targets for
antiviral drugs.
Schizophrenia, stem cells, and sprouty signaling.
Germ cells are forever: Germ-line stem cell migration and
development.
Intracellular trafficking of the insulin responsive glucose Holly Cline
transporter.
Molecular biology of the circadian clock. Tim Tully
Linda Van Aelst
Rui-Ming Xu
Bruce Stillman
Cordula Schulz
Roles of cadherins and catenins and their signaling pathways Josh Huang
in synapse development.
Modulation and de novo design of protein-protein interactions. Leemor Joshua-Tor
Potassium channels. David Mu
VEGF trap in cancer trials today, and VelociGene coupled with Terri Grodzicker
Veloclmmune for drug targets of tomorrow.
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IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in organizing, pre-
senting, and defending their research.
January
Jonathan Sebat (Wig ler Lab)
Bruce May (Martienssen Lab)
Jack Chen (Stein Lab)
Cordula Schulz
February
Senthil Muthuswamy
Alea Mills
March
Sandra Kuhlman (Huang Lab)
Guido Wendel (Lowe Lab)
Christian Speck (Stillman Lab)
April
Andrew Smith (Zhang Lab)
October
Rob Martienssen
Jim Hicks (Wig ler Lab)
Kathy Tworkowski (Tansey Lab)
November
Anthony Holtmaat (Svoboda Lab)
Namiko Satoh-Nagasawa (Jackson Lab)
Laurence Denis (Spector Lab)
December
Graziella di Cristo (Huang Lab)
Vivek Mittal
Lars Zender (Lowe Lab)
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Title
Large-scale copy-number variation: A ubiquitous characteristic of the human genome
and a cause of common genetic diseases.
Polar express: Centromeres and heterochromatin in Arabidopsis.
Analysis of chemosensory genes in Caenorhabditis elegans.
Cell intrinsic and extrinsic pathways regulate stem cell function in the Drosophila male
gonad.
Genesis of carcinoma: Does shape matter?
A new look at the role of the p53 homolog p63 in development, cancer, and aging.
GABAergic circuits and the regulation of critical period plasticity.
Tumor suppressors and chemotherapy response.
License to replicate DNA-00(7) proteins in action.
Computational pattern discovery in regulatory sequences.
Making sense of junk RNA.
Breast cancer genomics: Studies of 250 clinical cases using ROMA microarray analysis.
A novel oncogenic mechanism to control Myc proteolysis.
Imaging experience-dependent structural plasticity in the mouse neocortex.
Regulation of maize architecture: A sweet solution.
Establishing the histone H3 K9 methylation pattern during S phase.
Construction of GABAergic circuits in visual cortex: Role of genes and experience.
Vascular progenitors control angiogenesis-mediated tumor growth.
An integrative approach to cancer genetics and cancer biology: Cross-species
comparison of liver cancer in mice and men.
--

BANBURY CENTER
EXECUTIVE DIRECTOR'S REPORT
The year 2005 was remarkable for the Banbury Center, with record numbers of events and participants.
The number of scientific meetings rose 33% from 2004, from 18 to 24, and the Center was used for
11 other events, for a total of 35. The increase in participants paralleled the increase in meetings, with
806 participants compared to 568 in 2004. The proportion of participants from the United States
remained the same at 80%, drawn from 35 states, with New York, California, Massachusetts, and
Maryland leading the way. Foreign participants came from 30 countries, and we were particularly
pleased to welcome participants from eight African countries who came for the Albert B. Sabin vac-
cine meeting.
There were three very significant staffing changes in 2005. Katya Davey retired after 26 years as
hostess at Robertson House. Katya was one of the first staff members at Banbury and is known to
tens of thousands of scientists throughout the world for her kindness and helpful-
ness. She has been an icon of the Banbury Center and her character and per-
sonality will be greatly missed. We were fortunate in finding Barbara Polakowski
who now has the formidable task of looking after the scientists staying on the
Banbury estate. The third of the changes was the appointment of Sydney Gary as
Assistant Director. She is a neuroscientist who worked with Susan Hockfield at
Yale. Sydney has come to develop the neuroscience and mental health meetings
and courses programs at Banbury and on the main campus.
One meeting at Banbury in 2005 broke new ground for Banbury Center meet-
ings, and for Cold Spring Harbor Laboratory in general. Mila Pollack, Director of
Libraries and Archives here at the Laboratory, and Darwin H. Stapleton, Director
of the Rockefeller Archives, organized a meeting on History
and Oral History. This was the first occasion on which a history of science meet-
ing has been held here and it was a great success. Participants reviewed con-
tentious issues such as the preservation of letters and communications in the age
of e-mail, and whether archives should be digitized and made available via the Internet. They also
described how they deal with these issues at their own institutions. The discussion meeting was par-
ticularly useful in helping to promote the Laboratory's initiative in developing a history of molecular biol-
ogy and molecular genetics program, building on the collection donated by Jim Watson.
Five meetings were held relating to cancer, four dealing with specific types of cancer and the fifth
covering a new and potentially very important topic: cancer stem cells. Despite the fact that B-cell
chronic lymphocytic leukemia (B-CLL) is the most common leukemia in the western hemisphere, the
cause of the disease remains enigmatic and the treatments inadequate. However, recent advances
using a variety of techniques and approaches led to a meeting, Chronic Lymphocytic Leukemia, orga-
nized by Nicholas Chiorazzi and Kanti R. Rai (Institute for Medical
Research, North Shore-LIJ Health System) and Michael Wig ler
(Cold Spring Harbor Laboratory). Participants included investiga-
tors using immunological, molecular biological, and genetic
approaches, as well as physicians with expertise in the study and
treatments of B-CLL patients. The meeting structure was ambi-
tious, with multiple short presentations providing an opportunity for
participants to contribute to more than one session.
The Biology of Neuroendocrine Tumors, organized by Arnold J.
Levine (Institute for Advanced Studies) and Evan Vosburgh (Verto
Institute), focused on several topics: Genetic studies using whole-
genome allelotyping, SNPS in the p53 pathway, and LINE1 retro-
transposon studies of human cell lines and tumor samples. These
Katya Davey
Banbury Center conference room, summer
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are beginning to identify specific genetic regions of interest and to characterize the genomic instability of
this class of tumors. The roles of the tumor suppressors, menin and parafibromin, were discussed. Menin
is involved in signaling pathways, proliferation, and cell death, whereas parafibromin is associated with
RNA polymerase and plays a part in histone modifications. Translational research on EGFR and
VEGFNEGFr was complimented by presentations of early clinical studies of anti-EGFR and anti-VEGF
therapies.
Kevin M. Shannon (University of California, San Francisco) and Kim Hunter-Schaedle (Children's
Tumor Foundation) were the organizers of Barriers and Solutions in the Use of Mouse Models to
Develop Therapeutic Strategies for NF1- and NF2-associated Tumors. Mice are used extensively for
the development and assessment of cancer therapies, but there are questions about how best to
model human tumors in mice. Participants examined the advantages, limitations, and potential new
directions of using mouse models of neurofibromatosis 1 and neurofibromatosis 2 in developing ther-
apeutics for neurofibromatosis.
Dorothea Becker (University of Pittsburgh) and Martin McMahon (University of California, San
Francisco) organized A Critical Review of Melanoma: Genomic Approaches with Therapeutic Promise.
The meeting brought together investigators who are using array profiling, SAGE technology, pro-
teomics, and optical imaging, as well as basic scientists and physicians who focus on the identification
and characterization of genes that govern important functions in early and advanced-stage melanoma
and precursor lesions. The goal of the meeting was to outline new strategies for gaining further insights
into the molecular pathways of melanoma in light of a critical review of current research and targeted
therapies for melanoma.
An important new area of cancer research concerns whether stem cells present in adult tissues
might be the sources of cancers. This is not a new idea and was a popular theory of cancer at the end
of the 19th century when it was proposed that embryonic cells, "rests," persisted into the adult and
that these cells could be reactivated and grow in the adult. Now, we have the molecular tools and the
intellectual background to reinvestigate this idea, as was evident in the Cancer Stem Cells meeting,
organized by Max Wicha (University of Michigan) and Jeffrey M. Rosen (Baylor College of Medicine).
Discussions ranged from signaling pathways investigated in embryos, through what is known of stem
cells in leukemias and other cancers, to how this knowledge could change current approaches to can-
cer treatments. Current cancer therapies, which have been developed on the basis of their ability to
cause tumor regression, might selectively target these differentiated cells and spare the cancer stem
cell component. The latter may contribute to a tumor recurrence.
Banbury Center held a meeting on scientific fraud in 1989 and a meeting on nuclear transfer
(cloning) in 2000. I had not thought that the two topics would come together, but circumstances fol-
lowing the 2005 meeting, The Biology and Practice of Mammalian Cloning: A Reassessment, dictated
otherwise. Organized by Peter Mombaerts (The Rockefeller University) and Ian Wilmut (University of
Edinburgh), it was a follow-up to the meeting on cloning of mammals held in 2000, just 4 years after
the cloning of Dolly. Topics covered included nuclear transfer experiments in mice, rats, rabbits, and
cattle, as well as human beings. We were very pleased that the leading exponent of nuclear transfer in
human beings, Woo-Suk Hwang from South Korea, was participating. Now it appears that all of the
work done by Hwang's laboratory on human embryonic stem cells was fabricated. There is no doubt
that the basic premise and promise of human stem cell therapy were not diminished by this scandal
but it is a setback to the field.
Banbury continues to hold meetings on human genetic disorders because much needs to be done
to capitalize on the disease gene discoveries that were so successful in the 1990s. Therapies are still
elusive for so many of these disorders. Translational Approaches to Fragile-X Syndrome: Turning Basic
Research Findings into Therapeutic Targets (organized by Elizabeth Berry-Kravis, Rush Children's
Hospital; William T. Greenough, University of Illinois; and Katie Clapp, FRAXA Research Foundation)
tackled this issue head-on. The participants focused on strategies for translation of basic science
knowledge about phenotypes and therapeutic targets in Fragile-X syndrome and its animal models to
clinical treatment trials in patients. They discussed how to determine treatment targets and methods of
assessing the efficacy of treatments in animal models.
334
The meeting, Spinal Muscular Atrophy: Neuronal Rescue and Repair from Laboratory to Clinic,
examined the potential of therapies and how they might be made available. Held at Banbury, March
13-16, the organizers were Loren Eng (Spinal Muscular Atrophy Foundation, New York), Thomas M.
Jessell (Columbia University), Alex E. MacKenzie (Children's Hospital of Eastern Ontario), Kay E. Davies
(University of Oxford), and Cynthia Joyce (SMA Foundation). The discussions ranged widely from the
biochemistry and cell biology of SMA and what these can tell us of potential drug targets, to SMA
genetics and how this knowledge can be used in the development of animal models, and, finally, to a
discussion of strategies.
Researchers and clinicians working on amyotrophic lateral sclerosis (ALS) are investigating the ther-
apeutic potential of stem cells. Lucie Bruijn (The ALS Association), Stephen M. Strittmatter (Yale
University), and Clive N. Svendsen (University of Wisconsin) organized the meeting Stem Cells and
Axonal Regeneration: Strategies for the Treatment of ALS. In vitro studies have been carried out exam-
ining stem cells that may differentiate and replace dying neurons and/or sick astrocytes in SMA.
Another approach might be to stimulate the proliferation of endogenous stem cells to replace dying
cells. Participants also discussed how any new cells would establish appropriate connections and
reviewed current knowledge of axonal guidance cues.
The genetics of epilepsy are not as advanced as those for Fragile-X or SMA, but the mechanisms
of drugs that have empirically been shown to be effective in epilepsy may provide leads. Norman
Delanty (Royal College of Surgeons in Ireland), David B. Goldstein (Duke Institute for Genome Sciences
and Policy), Ley Sander (University College, London), and Sanjay M. Sisodiya (University College
London) organized Epilepsy Genetics and Pharmacogenetics. Some new developments, including the
availability of HapMap data and a growing understanding of the action of many anti-epileptic drugs,
made this the right moment to bring together those involved in different aspects of epilepsy genetics
to identify research priorities and strategies, and to foster collaborations among groups with different
clinical resources.
Parkinson's disease (PD) is one of the most common movement disorders, afflicting individuals from
all walks of life. It is becoming the subject of increasing research because of the severity of the disor-
der and increasing public awareness. Parkinson's Disease: Basic Mechanisms and Therapies (orga-
nized by Rodolfo Llinas, New York University Medical Center, and Ali Rezai, The Cleveland Clinic
Foundation) critically reviewed the latest findings on the pathophysiology of PD, therapies based on
drug treatment and, most especially, the degree to which surgical interventions ameliorate the move-
ment disturbances.
Mitochondria are the powerhouses of cells, and, not surprising-
ly, illness results when they fail or work inefficiently. It is becoming
clear that mitochondria may be involved in a much broader range
of disorders than had been suspected, and Mitochondria in
Neurological Disease and Aging critically reviewed the evidence for
mitochondrial involvement in these processes. Organized by M.
Flint Beal (Cornell University) and Douglas C. Wallace (University of
California, Irvine), the topics ranged from research on the bio-
chemistry and physiology of mitochondria, through animal models
of mitochondrial disease, to specific diseases, including Friedreich
ataxia, ALS, Huntington's disease, Parkinson's disease, and
Alzheimer's disease.
One of the most fascinating stories in modern biology concerns prions, abnormal proteins with no
associated DNA or RNA that can be transmitted among animals. The diseases they cause were known
as scrapie in sheep and wasting disease in elk, but they came to public attention when, in the early
1980s, cases of a formerly very rare human disorder-Creutzfeld-Jakob disease (CJD)-appeared in
the United Kingdom. Investigation showed that these were a variant form of CJD (vCJD) and were
caused by prions that had been transmitted to human beings who ate contaminated beef. Much still
remains mysterious about prions, and we held a meeting Prion Biology: Puzzles and Paradoxes orga-
nized by John Collinge (University College, London) and Charles Weissmann (The Scripps Institute).
Banbury Center conference room, winter
335
There was extended discussion about whether synthetic prions, which are devoid of nucleic acid, have
been made, and needless to say, much still remains to be resolved. The meeting did set a new record
for a Banbury Center meeting-three of the participants, 12%, were Nobel laureates!
The Banbury conference on The GABAergic System was organized by Josh J. Huang (Cold Spring
Harbor Laboratory) and GyOrgy Buzsaki (Rutgers University) and took place October 30November 2.
GABA is one of the major neurotransmitters and the only mediator of inhibition in the brain. GABA dys-
function has been implicated in a range of neurological, neurodevelopmental, and psychiatric disorders.
Progress in understanding the genetic design, construction, and mode of operation of the GABAergic
system will significantly advance our knowledge of brain development and function. The Banbury meet-
ing brought together scientists using molecular and genomic approaches, and developmental neuro-
biologists, physiologists, system neuroscientists, and clinicians to foster future work in this critical
domain of research.
The most fascinating area of neuroscience research concerns the interface between biology and
higher-level processes. Neurobiology of Decision-making, organized by Carlos Brody (Cold Spring
Harbor Laboratory), Michael N. Shad len (University of Washington), and Xiao-Jing Wang (Brandeis
University), considered such questions as: What are the key computations involved in making a deci-
sion? How are they implemented by neurons? Can we quantitatively formulate the probabilistic nature
of decision-making? What is the predominant source of randomness intrinsic to the brain? Can the
importance of noise in decision-making behavior be tested experimentally? The meeting included
investigators who employ high-level abstract mathematical psychology descriptions, neural network
modeling, and experimental approaches.
The theme of The Intracellular Molecular Environment (David Spector, Cold Spring Harbor
Laboratory, and Jason Swedlow, University of Dundee) can be summarized in the rather naive ques-
tion: What would it be like to be a molecule inside the cell? And from this question, others arise: How
crowded would it be? How would I get to where I needed to be? If I am part of a complex, how do I
find the members of the complex? How do data from in vitro experiments relate to similar processes
in the cell? The meeting brought together scientists who use theoretical and experimental analyses
employing a variety of techniques, including biophysical, biochemical, mathematical, imaging, and cell
biological experimentation.
Plants are remarkable in that they are frequently polyploid, i.e., they have two or more copies of their
genome. Such polyploidy is important for plant functions and evolution. Polyploidy, Heterosis, and
Genomic Balance was organized by Jim A. Birch ler (University of Missouri, Columbia) and Luca Comai
(University of Washington). The participants discussed gene expression in aneuploidy, polyploidy, or
hybrid states (heterosis and species hybrids); the molecular basis of quantitative traits; gene regulato-
ry circuits; the relationship of epigenetic phenomena to gene regulatory mechanisms; and the evolution
of gene regulation.
There were four meetings related to infectious diseases. A rather unusual topic of a Banbury Center
meeting was Computational Approaches for Biomarker Discovery (Suzanne Vernon and William
Reeves, Centers for Disease Control and Prevention). Hiding behind this rather unremarkable title was
a fascinating meeting on a Centers for Disease Control project examining chronic fatigue syndrome
(CFS). This is not an easy subject to study-diagnosis is difficult, laboratory diagnostic tests are not
available, and multiple factors likely contribute to its pathogenesis. CDC has examined a large cohort
of individuals from Wichita Falls, subjecting them to a battery of physical, psychiatric, and laboratory
tests, including gene expression analysis using microarrays. The expectation is that analysis of this
mass of data will reveal patterns common to individuals with CFS. However, this is not a simple task-
it requires the integration of many different kinds of data. Participants included mathematicians, engi-
neers, computer scientists, as well as biologists, trying to develop the most informative ways of han-
dling the data.
Bioterrorism continues to be an important topic, and Banbury had two meetings on viral and micro-
bial forensics. The title of the first meeting, Pathogenesis and Early Events in Viral Infection (organized
by Roger Breeze and Floyd Horn, Institute for Comparative Genomics; William Laegreid, USDA; and
Daniel L. Rock, University of Illinois), would not have been out of place for the Laboratory in the 1970s,
336
when tumor viruses such as SV40 and adenovirus were the subjects of intense research here.
However, the viruses that were the focus of attention for this meeting would not have been studied at
Cold Spring Harbor. They included West Nile virus, rinderpest, and dengue, ebola, and Marburg hem-
orrhagic fever viruses. The second meeting dealt with an ostensibly much more prosaic topic: Microbial
Forensics 2005: Sample Management (organized by Steven Schutzer, UMDNJ; Bruce Budowle,
Federal Bureau of Investigation; and James P. Burans, U.S. Department of Homeland Security).
However, procedures that are commonplace in ordinary investigations (e.g., maintaining chain of cus-
tody) may be unfamiliar or difficult to achieve with biological samples. Or suppose that a test or extrac-
tion procedure for one chemical precludes other tests. How should priorities be determined?
The Albert B. Sabin Foundation Colloquium on Introduction and Sustainable Use of Vaccines in
Developing Countries was organized by Kevin Reilly (Sabin Vaccine Institute) and Francisco F. Songane
(Ministerio da Saude, Mozambique). Participants reviewed the most critical issues facing financiers,
government, industry, and the developing countries that are in need of funds for vaccine purchase and
delivery; defined the performance criteria that will help benefactors and beneficiaries measure the
progress of the developing countries; and made realistic recommendations that best enhance the
prospects for sustained use of needed vaccines in developing countries. A highlight of the meeting was
a talk by Sir George Alleyne of the Pan American Health Organization, Washington, D.C.
Two groups took the opportunity of Banbury meetings to hold associated policy meetings. The
National Cancer Institute-International Workshop on CLL Group and the NSF Polyploidy Group held
premeetings.
In addition to the meetings, Banbury hosted several courses. There were the regular summer cours-
es and a 2-week workshop on schizophrenia. The Watson School of Biological Sciences held two
Topics in Biology courses for its students. Banbury also hosted two courses for outside groups. The
Boehringer Ingelheim Foundation held a course on the conduct of science for its North American fel-
lows, and David Mick los and I, together with Ken Culver, provided a genetics course for part of the
oncology group of Novartis.
Sydney Gary and Barbara Polakowski
The Banbury Center continues to make a unique contribu-
tion to the world of biology, fulfilling the goals and aspirations
set by Charles Robertson and Jim Watson almost 30 years
ago. It does so through the efforts of many people at Cold
Spring Harbor: Bea To liver, Ellie Sidorenko, Sydney Gary,
Barbara Polakowski, Chris McEvoy, and Joe Ellis at Banbury,
and the staff of audiovisual, the meetings office, and the
housekeeping department, and Blackford.
Jan Witkowski
Executive Director
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Parkinson's Disease: Basic Mechanisms and Therapies
January 16-18
FUNDED BY The Thomas Hartman Foundation For Parkinson's Research
ARRANGED BY R. Llinas, New York University Medical Center
A. Rezai, The Cleveland Clinic Foundation
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R. Llinas, New York University Medical Center
A. Rezai, The Cleveland Clinic Foundation
SESSION 1: Morphology and Anatomical Basis of Parkinson's Disease
Chairperson: A. Beric, Hospital for Joint Diseases, New York
E.G. Jones, University of California, Davis: Cortical-thalamic A. Graybiel, Massachusetts Institute of Technology,
pathways. Cambridge: Cortical-basal ganglia-thalamic pathways.
SESSION 2: Physiology and Pathophysiology: Thalamus, Basal Ganglia, and Cortex
Chairperson: A.-L. Benabid, I'Universite Joseph Fourier, Grenoble, France
R. Llinas, New York University Medical Center: Thalamo-corti-
cal rhythm: Function and pathology.
A.M. Lozano, Toronto Western Hospital Research Institute,
Canada: Neurophysiological attributes of Parkinson's dis-
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ease: Insights from intraoperative single neuronal recordings.
F. Lenz, The Johns Hopkins Hospital, Baltimore, Maryland: Feed-
back control in Parkinsonian symptoms of tremor and dysto-
nia: Abnormal gain and phase of thalamic transfer functions.
R. Llinas, A. Grabil, B. Kopell
SESSION 3: Diagnostics and Imaging of Parkinson's Disease
Chairperson: R. Llinas, New York University Medical Center
J. Volkmann, Christian-Albrechts-University, Kiel, Germany: A.Y. Mogilner, North Shore University Hospital, Manhasset,
Clinical neurophysiology of the interaction between basal New York: Anatomic imaging and surgical targeting.
ganglia, brain stem, and spinal pathways in Parkinson's B. Kopell, Medical College of Wisconsin, Milwaukee: The
disease. postoperative role in imaging in DBS and neurostimulation
D. Eidelberg, North Shore University Hospital, Manhasset, surgery.
New York: Imaging and pathophysiology.
SESSION 4: Surgery for Parkinson's Disease
Chairperson: A. Rezai, The Cleveland Clinic Foundation, Ohio
D. Jeanmonod, University Hospital Zurich, Switzerland:
Targets and role of lesioning.
A.-L. Benabid, l'Universite Joseph Fourier, Grenoble, France:
Targets and electrical stimulation.
A.M. Lozano, Toronto Western Hospital Research Institute,
Canada: Intraparenchymal brain delivery of therapeutic
compounds for Parkinson's disease.
M.G. Kaplitt, Weill Medical College of Cornell University, New
York/N. Boulis, The Cleveland Clinic Foundation, Ohio:
Targets and gene therapy/neurotransplantation.
SESSION 5: Emerging Surgical Approaches for Neurological and Psychiatric Disorders and Next Steps
Chairpersons: R. Llinas, New York University Medical Center; A. Rezai, The Cleveland Clinic Foundation, Ohio
B.D. Greenberg, Butler Hospital, Providence, Rhode Island:
Surgery for psychiatric disorders.
A. Rezai, The Cleveland Clinic Foundation, Ohio: Surgical
intervention: Emerging technology and applications-
Chronic pain, cluster headaches, epilepsy, stroke,
Tourette's aggression, obesity.
Summary/Future Steps
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Chronic Lymphocytic Leukemia
February 6-9
FUNDED BY The Karches Foundation
ARRANGED BY N. Chiorazzi, The Institute for Medical Research, North Shore-LIJ Health System
K.R. Rai, The Institute for Medical Research, North Shore-LIJ Health System
M. Wig ler, Cold Spring Harbor Laboratory
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
B. Stillman, Cold Spring Harbor Laboratory
N. Chiorazzi, The Institute for Medical Research, North Shore-LIJ Health System,
Manhasset, New York
SESSION 1
Chairperson: N. Chiorazzi, The Institute for Medical Research, North Shore-LIJ Health System,
Manhasset, New York
K.R. Rai, The Institute for Medical Research, North Shore-LIJ
Health System, New Hyde Park, New York: B-CLL and the
major unanswered questions.
P. Hillmen, Pinderfields Hospital, Wakefield, United Kingdom:
"Pre leukemic" cells that circulate in normal individuals.
F. Caligaris-Cappio, Universita Vita-Salute San Raffaele,
Milano, Italy: Monoclonal CD5* and CD5- B-cell expansions
in the peripheral blood of the elderly.
M.D. Cooper, HHMI, University of Alabama, Birmingham: B-
lymphocyte development and subsets in man.
J. Monroe, University of Pennsylvania School of Medicine,
Philadelphia: B-cell development.
SESSION 2
Chairperson: E. Montserrat, University of Barcelona, Spain
J. Monroe, University of Pennsylvania School of Medicine, Phila-
delphia: Positive and negative selection of the B-cell repertoire.
N. Chiorazzi, The Institute for Medical Research, North
Shore-LIJ Health System, Manhasset, New York: Structure
R. Davis, University of Alabama, Birmingham: Biological
potential of Fc receptor homologs on B lineage cells.
F Caligaris-Cappio, Universita Vita-Salute San Raffaele,
Milano, Italy: CLL cells think B and speak T.
M. Ferrarini, Institute Nazionale per la Ricerca sul Cancro,
Genova, Italy: The B-CLL cell: Identification and
characteristics.
U. Klein, Columbia University, New York: Is the normal cell
equivalent of CLL a memory cell?
F Caligaris-Cappio, Universita Vita-Salute San Raffaele,
Milano, Italy: Expression of ZAP-70 in normal human
mature B cells.
of the BCR in B-CLL cells.
F. Caligaris-Cappio, Universita Vita-Salute San Raffaele,
Milano, Italy: Geographical patterns and pathogenetic
implications of IGHV3-21 gene usage.
J. Monroe, M. Keating, T. Kipps
T.J. Kipps, University of California, San Diego: Function of the
BCR in B-CLL cells.
E. Montserrat, University of Barcelona, Spain: ZAP-70
expression and prognosis in B-CLL.
SESSION 3
Chairperson: T.J. Kipps, University of California, San Diego
S. Lowe, Cold Spring Harbor Laboratory: Apoptosis.
T.J. Kipps, University of California, San Diego: Apoptosis in
B-CLL.
F. Caligaris-Cappio, Universita Vita-Salute San Raffaele,
Milano, Italy: Role of T cell and cytokines in apoptosis
SESSION 4
Chairperson: N. Kay, Mayo Clinic, Rochester, Minnesota
N. Kay, Mayo Clinic, Rochester, Minnesota:
Microenviromental considerations in B-CLL.
H. Schreiber, University of Chicago, Illinois: Role of the micro-
environment in supporting lymphoid cell development and
growth.
M. Lipp, Max DelbrOck Center for Molecular Medicine, Berlin,
Germany: Role of chemokines and cytokines in supporting
lymphoid cell development and growth.
SESSION 5
Chairperson: M. Wig ler, Cold Spring Harbor Laboratory
U. Klein, Columbia University, New York: Gene expression pro-
filing in B-CLL and other B-cell lymphoproliferative disorders.
J.G. Gribben, Barts and Royal London School of Medicine,
United Kingdom: Gene expression profiling of T cells in
B-CLL.
M. Keating, M.D. Anderson Cancer Center, Houston, Texas:
M. Ferrarini, Instituto Nazionale per la Ricerca sul Cancro,
Genova, Italy: Differential triggering through the BCR in B-CLL.
T. Honjo, Kyoto University, Japan: BCR signaling and AID
function.
regulation in B-CLL.
M. Ferrarini, Istituto Nazionale per la Ricerca sul Cancro,
Genova, Italy: Apoptosis in B-CLL.
N. Kay, Mayo Clinic, Rochester, Minnesota: Apoptosis and
green tea extract in B-CLL.
E Caligaris-Cappio, Universita Vita-Salute San Raffaele,
Milano, Italy: Role of the microenvironment in supporting
B-CLL cell development and growth.
T.J. Kipps, University of California, San Diego: Role of nurse
cells in nurturing B-CLL cells.
M. Lipp, Max DelbrOck Center for Molecular Medicine, Berlin,
Germany: Ectopic lymphoid follicle formation.
Difference in gene expression between B-CLL and normal
B cells.
C.M. Croce, Ohio State University Medical Center,
Columbus: Role of micro-inhibitory RNAs in B-CLL.
L. Pasqualucci, Columbia University, New York: Role of Bel-6
in non-Hodgkin's lymphoma.
SESSION 6
Chairperson: P. Hillmen, Pinderfields Hospital, Wakefield, United Kingdom
M. Wig ler, Cold Spring Harbor Laboratory: Genome-wide
genomic screening using ROMA.
P. Lichter, German Cancer Research Center, Heidelberg,
Germany: Genome-wide screening in B-CLL.
C.M. Croce, Ohio State University Medical Center, Columbus:
Tel-1 in B-CLL.
M. Wabl, University of California, San Francisco: Murine
leukemia virus system to generate genomic deletions.
H. Schreiber, University of Chicago, Illinois: Inflammation as a
tumor promoter in cancer induction.
SESSION 7
Chairperson: C.M. Croce, Ohio State University Medical Center, Columbus
T. Honjo, Kyoto University, Japan: Activitation-induced
cytidine deaminease: Structure and function.
M. Nussenzweig, The Rockefeller University, New York:
Activation-induced cytidine deaminase: Structure and func-
tion.
M.D. Cooper, HHMI, University of Alabama, Birmingham:
Somatic diversification of variable lymphocyte receptors in
lower species.
N. Chiorazzi, Institute for Medical Research North Shore-LIJ
Heath System, Manhasset, New York: AID expression in
B-CLL.
M. Keating, M.D. Anderson Cancer Center, Houston, Texas:
Expression of AID and its splice variants in B-CLL.
M. Wabl, University of California, San Francisco: Genome-
wide somatic hypermutation.
L. Pasqualucci, Columbia University, New York: Role of
somatic hypermutation in the pathogenesis of B-cell neo-
plasms.
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SESSION 8
Chairperson: S.L. Allen, The Institute for Medical Research, North Shore-LIJ Health System, Manhasset, New York
M. Hallek, Universitaet zu Koeln, Germany: History and state
of the art of pharmacologic therapy.
M. Keating, M.D. Anderson Cancer Center, Houston, Texas:
Monoclonal antibody therapy in B-CLL.
P Hillmen, Pinderfields Hospital, Wakefield, United Kingdom:
Monoclonal antibody therapy in B-CLL.
R. Berenson, Xcyte Therapies, Inc., Seattle, Washington:
Adoptive T-cell immunotherapy.
R. Dam le, Institute for Medical Research North Shore-LIJ
Health System, Manhasset, New York: Telomere length
and telomerase expression in B-CLL cells.
C.B. Harley, Geron Corporation, Menlo Park, California:
Telomerase inhibition, cancer, and GRN163L.
M. Lipp, Max DelbrUck Center for Molecular Medicine, Berlin,
Germany: Chemokine receptors as potential therapeutic
targets.
SESSION 9
Chairperson: K.R. Rai, The Institute for Medical Research, North Shore-LIJ Health System, New Hyde Park, New York
D. Valmori, Columbia University, New York: Vaccination in B-
CLL.
T.J. Kipps, University of California, San Diego: Gene therapy
in B-CLL.
M. Hallek, Universitaet zu Koln, Germany: Use of adeno-
associated viral vectors for gene therapy.
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J.G. Gribben, Barts and Royal London School of Medical,
United Kingdom: Stem cell transplantation in B-CLL.
E. Montserrat, University of Barcelona, Spain: Al lo- and auto-
transplantation in B-CLL.
T Honjo, Kyoto University, Japan: Role of PD-1 in tumor
immunity.
Translational Approaches to Fragile-X Syndrome: Turning Basic
Research Findings into Therapeutic Targets
February 27-March 2
FUNDED BY NIH-National Institute of Mental Health (through a grant to the University of Illinois)
ARRANGED BY E. Berry-Kravis, Rush Children's Hospital
W.I. Greenough, University of Illinois
K. Clapp, FRAXA Research Foundation
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Phenotype of Fragile X
Chairperson: R.J. Hagerman, University of California, Davis Health System, Sacramento
K. Clapp, FRAXA Research Foundation, Newburyport,
Massachusetts: A parent's perspective on Fragile X.
M.R. Tranfaglia, FRAXA Research Foundation, Newburyport,
Massachusetts: Psychiatric symptoms of Fragile X.
W.I. Greenough, University of Illinois, Urbana:
Neuroanatomical phenotype of FXS and role of the absence
of FMRP.
R.E. Paylor, Baylor College of Medicine, Houston, Texas:
Behavioral phenotypes in mouse model of Fragile X.
B.A. Oostra, Erasmus Universiteit Rotterdam, The
Netherlands: Eye-blinking experiments in mice and
humans.
K. Broadie, Vanderbilt University and Medical School,
Nashville, Tennessee: A Drosophila model of Fragile-X
syndrome.
SESSION 2: Drug Trials: Outcome Measures for Trials in Man
Chairperson: F. Gasparini, Novartis Pharma AG, Basel, Switzerland
S.W. Porges, University of Illinois, Chicago: The Polyvagal
Theory: Insights into the selection of outcome measures.
J.T. McCracken, University of California, Los Angeles
Neuropsychiatric Institute: Lessons from drug therapy of
autism for Fragile X: Measurement challenges.
I. Boutet, University of Toronto, Scarborough, Canada: Novel
behavioral tests to evaluate treatment outcome in Fragile-X
syndrome.
J. Weiler, J. Lauterborn
E. Berry-Kravis, Rush Children's Hospital, Chicago, Illinois:
Safety and efficacy of ampakine CX516 in Fragile-X
syndrome.
R.J. Hagerman, University of California, Davis Health System,
Sacramento: A multicenter trail of lithium for treatment of
Fragile-X syndrome.
SESSION 3: Biology and Regulation of FMRP/FMR1: Phenotype Emanating from Molecular Studies
Chairperson: S.T. Warren, Emory University School of Medicine, Atlanta, Georgia
J. Darnell, The Rockefeller University, New York: RNA targets
of the KH2 domain of FMRP and their role in translation.
J.R. Fallon, Brown University, Providence, Rhode Island:
Regulation of Fmrl gene expression.
E. Klann, Baylor College of Medicine, Houston, Texas:
Alteration in protein expression in Fmr1 knockout mice.
I.J. Weiler, University of Illinois, Urbana-Champaign:
Translational pathways: A diagnostic tool?
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SESSION 4: mGluR Regulation at the Synapse in FXS
Chairperson: W.T. Greenough, University of Illinois, Urbana
M. Hayashi, Massachusetts Institute of Technology,
Cambridge: An interaction between FMRP and p21-activat-
ed kinase (PAK).
M.F. Bear, HHMI/Massachusetts Institute of Technology,
Cambridge: The mGluR theory of Fragile X.
R.P. Bauchwitz, Columbia University, New York: Further evi-
dence for involvement of mGluR signaling in Fragile-X syn-
drome.
R. Denman, New York State Institute for Basic Research,
Staten island: FMRP: A regulator of mGIuR5 mRNA?
K. Huber, University of Texas Southwestern Medical Center,
Dallas: Role of FMRP in synaptic transmission and
plasticity.
G.J. Bassell, Albert Einstein College, Bronx, New York:
Metabotropic glutamate receptor regulation of FMRP traf-
ficking and morphological plasticity.
P.W. Vanderklish, Scripps Research Institute, La Jolla,
California: Regulatory interactions between synaptic struc-
ture and local translation.
R.K.S. Wong, State University of New York-Health Science
Center, Brooklyn: Signaling pathway for neuronal plasticity
in mGluR-induced epileptogenesis.
SESSION 5: Potential Drug Targets and Treatment Strategies
Chairperson: E. Berry-Kravis, Rush Children's Hospital, Chicago, Illinois
T.A. Jongens, University of Pennsylvania School of Medicine,
Philadelphia: Pharmacological rescue of the Drosophila
Fragile-X model.
W. Spooren, F. Hoffmann-La Roche, Basel, Switzerland: A
comparison of the effects of MPEP and diazepam in rodent
models of anxiety and cognition.
M. Toth, Cornell University Medical College, New York:
GABA(B) receptor hypersensitivity and reversal of the
Fragile-X phenotype by baclofen in mice.
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J. Lauterborn, University of California, Irvine: AMPA receptor
up-modulators and mental retardation in Fragile X.
F. Gasparini, Novartis Pharma AG, Basel, Switzerland:
Identification and profiling of PET imaging agents for the
mGlu5 receptor.
K. Shiosaki, Sention, Inc., Providence, Rhode Island:
Development of mGluR receptor antagonist for Fragile X.
General Discussion/Wrap Up and Strategy
Spinal Muscular Atrophy: Neuronal Rescue and Repair From
Laboratory to Clinic
March 13-16
FUNDED BY Spinal Muscular Atrophy Foundation
ARRANGED BY K.E. Davies, University of Oxford
L. Eng, Spinal Muscular Atrophy Foundation
T.M. Jessell, Columbia University
C. Joyce, Spinal Muscular Atrophy Foundation
A.E. MacKenzie, Children's Hospital of Eastern Ontario
Welcome and Introduction of Speaker: T.M. Jessell, Columbia University, New York
D.C. De Vivo, The Neurological Institute, Columbia University Medical
Center, New York: Discussion of clinical manifestations of SMA and
implications for therapeutic development.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Singh, Spinal Muscular Atrophy Foundation, New York
SESSION 1: Biochemistry of SMN
Chairperson: A.E. MacKenzie, Children's Hospital of Eastern Ontario, Canada: Introduction of
session topic.
G. Dreyfuss, HHMI/Universlty of Pennsylvania School of
Medicine, Philadelphia: The SMN complex.
J.L. Manley, Columbia University, New York: Mechanism of
SMN2 exon 7 splicing inhibition.
A. Krainer, Cold Spring Harbor Laboratory: SMN2 splicing as
a target.
General Discussion: B. Wirth, University of Cologne,
Germany
G.J. Bassell, Albert Einstein College, Bronx, New York
D.W. Cleveland, University of California, San Diego, La
Jolla
Key Points
Summary: A.E. MacKenzie, Children's Hospital of Eastern
Ontario, Canada
SESSION 2: Druggable Targets Evolving from SMA Biology
Chairperson: S.C. Landis, NINDS/National Institutes of
Health, Bethesda, Maryland: Introduction of session topic.
L.L. Rubin, Curis, Inc., Cambridge, Massachusetts: Motor-
neuron-based screening for small molecules that increase
SMN levels.
B.R. Stockwell, Columbia University, New York: Diagramming
disease networks with chemical and biological tools.
A. Sands, Lexicon Genetics, The Woodlands, Texas: Mining
the druggable genome for SMA targets.
General Discussion: G. O'Neill, Biogen IDEC, Cambridge,
Massachusetts
C. Keith, CombinatoRx Inc., Boston, Massachusetts
K.W. Klinger, Genzyme Genetics Inc., Framingham,
Massachusetts
D.W. Cleveland, University of California, San Diego
Key Points
Summary: D.W. Cleveland, University of California, San
Diego, La Jolla
A. Krainer, D. De Vivo
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SESSION 3: Cell Biology and Motor Neuron Function
Chairperson: K.H. Fischbeck, NINDS/National Institutes of Health, Bethesda, Maryland: Introduction
of session topic.
G.J. Bassell, Albert Einstein College, Bronx, New York:
Transport of an SMN-Gemin complex in neurons.
M. Sendtner, Universitat Wuerzburg, Germany: Functional
and morphological alterations in isolated motor neurons
from SMN-deficient mice.
E.M.C. Fisher, National Hospital for Neurology and
Neurosurgery, London, United Kingdom: Crossing the Loa
Dynein mutant mouse to a sod transgenic that models
motor neuron diseases/ALS.
General Discussion: Z. He, Children's Hospital, Boston,
Massachusetts
A.J. Tobin, MRSSI/High Q Foundation, New York
G. Davis, University of California, San Francisco
Key Points
Summary: C. Henderson, Institute of Marseille, Universite
de la Mediterranee, France
SESSION 4: Eopic A: Model Organisms and SMA Genetics
Chairperson: K.E. Davies University of Oxford, United Kingdom: Introduction of session topic.
W. Thompson, University of Texas, Austin: Why Schwann
cells are of interest in the pathology of SMA.
G. Davis, University of California, San Francisco: Identification
of new mutations that cause synapse retraction and new
mutations that prevent synapse retraction.
M. van den Heuvel, University of Oxford, United Kingdom: Use
of Drosophila melanogaster as a model for SMA function.
General Discussion: B. McCabe, Columbia University,
New York
A.H. Burghes, Ohio State University, Columbus
U.R. Monani, Columbia University, New York
J. Melki, INSERM, Evry, France
SESSION 5: Topic B: Therapeutic Implications Evolving from Genetics and Cell Biology
Chairperson: K.E. Davies, University of Oxford, United Kingdom: Introduction of session topic.
A.H.M. Burghes, Ohio State University, Columbus: Is SMN2 a
good target for therapy in spinal muscular atrophy?
D.W. Cleveland, University of California, San Diego, La Jolla:
A molecular therapy for familial ALS.
Z. He, Children's Hospital, Boston, Massachusetts: Axon
regeneration and SMA.
SESSION 6: Summary
Chairperson: T.M. Jessell, Columbia University, New York
Discussants: A.E. MacKenzie, Children's Hospital of
Eastern Ontario, Ottawa, Canada
C. Henderson, Universite de la Mediterranee, Marseille,
France
General Discussion: R. Pacifici, MRSSI Inc., New York
J. Jareck, Families of SMA, Libertyville, Illinois
J. Melki, INSERM, Evry, France
Key Points
Summary: K.E. Davies, University of Oxford, United
Kingdom
K.E. Davies, University of Oxford, United Kingdom
D.W. Cleveland, University of California, San Diego, La
Jolla.
Discussion/Next Steps
A Critical Review of Melanoma: Genomic Approaches with
Therapeutic Promise
March 20-23
FUNDED BY Ann L. and Herbert J. Siegel Fund of the Jewish Communal Fund; Melanoma Research
Foundation; Chiron Corporation; Agencourt Bioscience Corporation; PICO Atlantic
ARRANGED BY D. Becker, University of Pittsburgh
M. McMahon, University of California
Introduction and Overview of Meeting: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Becker, University of Pittsburgh, Pennsylvania
M. McMahon, University of California, San Francisco
SESSION 1: Genomic Strategies to Identify Novel Genes in Melanoma and Nevi I
Chairperson: D. Pinkel, University of California, San Francisco
R. Lucito, Cold Spring Harbor Laboratory: ROMA, CNPs, and R. Halaban, Yale University School of Medicine, New Haven,
cancer. Connecticut: Differential gene expression analysis revealing
P. Lichter, DKFZ, Heidelberg, Germany: Matrix-based CGH new pathways, associations, and directions for melanoma.
for tumor progression and diagnostics.
B. Bastian, University of California, San Francisco: Genetic General Discussion and Key Points of Session
classification of melanoma.
SESSION 2: Genomic Strategies to Identify Novel Genes in Melanomas and Nevi
Chairperson: D. Becker, University of Pittsburgh, Pennsylvania
D. Becker, University of Pittsburgh, Pennsylvania: Analysis of S. Hewitt, National Cancer Institute, Bethesda, Maryland:
genes identified in melanoma and nevus SAGE libraries and Tissue microarrays in translational research.
by microarrays. T Kapoor, The Rockefeller University, New York: Chemical
D.E. Elder, Hospital of University of Pennsylvania, genetic analysis of chromosome segregation.
Philadelphia: Gene expression profiling in melanocytic M. McManus, University of California, San Francisco:
lesions. Mammalian RNA interference pathways from the perspec-
F. Marincola, National Institutes of Health, Bethesda, tive of a mouse.
Maryland: cDNA arrays and melanoma immune
responsiveness. General Discussion and Key Points of Session
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SESSION 3: Melanoma Markers, Protein Targets, and Optical Imaging
Chairperson: D.E. Elder, Hospital of University of Pennsylvania, Philadelphia
N. Gruis, Leiden University Medical Centre, The Netherlands:
Tumor markers in uveal melanoma identified by gene
expression profiling.
G.P. Nolan, Stanford University School of Medicine,
California: Potentiated single-cell cancer proteomics define
patient network response to therapy.
A. Gudkov, Lerner Research Institute, Cleveland, Ohio: Why
melanomas frequently maintain wild-type p53.
SESSION 4: Gene Targeting and Analysis of Melanoma
Chairperson: M. McMahon, University of California, San Francisco
E. Dupin, CNRS, Nogent-sur-Marne, France: Neural crest
stem cells in the development and maintenance of
pigment cells.
S. Johnson, University of Washington School of Medicine, St.
Louis, Missouri: Melanocyte stem cells in the zebra fish.
D.E. Fisher, Dana-Farber Cancer Institute, Boston,
Massachusetts: Regulation of the melanoma prognostic
marker, melastatin, in melanocytes and melanoma.
S. Simon, The Rockefeller University, New York: Tracking
metastatic tumor cell extravasation by opitcal imaging and
application of quantum dots.
I.J. Bigio, Boston University, Massachusetts: Optical scatter-
ing spectroscopy to noninvasively distinguish nevi.
General Discussion and Key Points of Session
M. McMahon, University of California, San Francisco:
Oncogenic transformation of mammalian cells by BRAF.
C.R. Goding, Marie Curie Research Institute, Surrey, United
Kingdom: The Brn2-BRAF connection in melanoma.
L Schuchter, University of Pennsylvania, Philadelphia: Mela-
noma therapy: High-dose, low-dose, no dose, which dose?
General Discussion and Key Points of Session
SESSION 5: Insights into Melanoma Gene Regulation
Chairperson: G. Merlino, National Cancer Institute, Bethesda, Maryland
G. Merlino, National Cancer Institute, Bethesda, Maryland:
UV induction of melanoma: What the mouse can tell us.
Z.A. Ronai, The Burnham Institute, La Jolla, California:
Transcription factors as targets for melanoma therapy.
B. Felding-Habermann, The Scripps Research Institute, La
Jolla, California: Targeting adhesive mechanisms in
melanoma metastasis.
M. Bar-Eli, M.D. Anderson Cancer Center, Houston, Texas:
AP-2 expression in melanoma TMAs: Inverse correlation
with progression.
J. Dong, Mount Sinai Medical Center, New York: Effects on
proliferation and melanogenesis by inhibition of mutant
BRAF and expression of wild-type INK4A in melanoma
cells.
Future Avenues and Goals of Melanoma Research
R. Halaban, M. Bar-Eli
History of Science: Archives and Oral History
April 3-5
FUNDED BY The Rockefeller Archive Center and Cold Spring Harbor Laboratory
ARRANGED BY M. Pollock, Cold Spring Harbor Laboratory
D.H. Stapleton, The Rockefeller Archive Center
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M. Pollock, Cold Spring Harbor Laboratory
D.H. Stapleton, The Rockefeller Archive Center, Sleepy Hollow, New York
SESSION 1: Owning the Past, Sewing the Future
Chairperson: L.R. Hiltzik, The Rockefeller Archive Center, Sleepy Hollow, New York
J. Sheppard, Wellcome Library for the History and
Understanding of Medicine, London, United Kingdom: The
transition of ownership: Players and stakes.
P.B. Hite, Cornell University, Ithaca, New York: Copyright
ownership in scientific archives.
S.S. Hodson, The Huntington Library, San Marino, California:
Secrets revealed or sealed: Privacy in collections of person-
al papers.
T.J. Connors, University of Maryland, College Park: Scientific
information in the federal government-The emerging parti-
san divide: A citizen-archivist's impressions.
SESSION 2: Coping with the Digital Era in Scientific
Research
Chairperson: R. Burian, Virginia Polytechnic Institute and
State University, Blacksburg
J. Sheppard, R. Olby
T. Rosko, Massachusetts Institute of Technology, Cambridge: Archives-Rockefeller Archive Center Collaborative Electronic
Challenges of collecting and preserving scientific records in Records Project.
the digital age. R. Moore, University of California, San Diego, La Jolla:
D.H. Stapleton, The Rockefeller Archive Center, Sleepy Preservation of scientific collections using data grid
Hollow, New York: Just doing it: The Smithsonian Institution technology.
SESSION 3: Different Perspectives: Historians, Scientists, and Institutions Views of Archives
Chairperson: M. Sniffin-Marinoff, Harvard University, Cambridge, Massachusetts
M.L. Levitt, American Philosophical Society Library, P.J. Wosh, New York University, New York: Institutional per-
Philadelphia, Pennsylvania: Primary sources: Expectations spectives.
of historians vs. operational realities in archives. C.S. Mead, Oregon State University, Corvallis: Digital collec-
S. de Chadarevian, Max-Planck Institute for the History of tions with narrative: Expanding our constituencies.
Science, Berlin, Germany: A historian's experience working M. Pollock, Cold Spring Harbor Laboratory/D.H. Stapleton,
on current science. The Rockefeller Archive Center, Sleepy Hollow, New York:
R.C. Olby, University of Pittsburgh, Pennsylvania: A biograph- General discussion.
er's hopes and the subject's expectations.
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SESSION 4: Oral History and Science
Chairperson: N.C. Comfort, Johns Hopkins Medical Institutions,
V Dawson, History Enterprises, Inc., Cleveland, Ohio: Oral
history as investigative tool.
R.E. Doel, Oregon State University, Corvallis: Voices in a dis-
cordant chorus: Oral history and the recent history of scien-
tific institutions.
M. Pollock, Cold Spring Harbor Laboratory: Recording sci-
SESSION 5: Discussion on Major Issues of the Meeting
Baltimore, Maryland
ence and life through (oral) autobiography.
E.M. Tansey, Wellcome Trust Centre for the History of
Medicine, London, United Kingdom: Who is oral history
for? Reflections on witness seminars in modern biomedi-
cine.
D.H. Stapleton, The Rockefeller Archive Center, Sleepy Hollow, New York
P.B. Hirt le, Cornell University, Ithaca, New York
Key Points
R. Burian, W. Summers, B. Stillman
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Polyploidy, Heterosis, and Genomic Balance
April 10-13
FUNDED BY
ARRANGED BY J.A. Birch ler, University of Missouri
L. Comai, University of Washington
Cold Spring Harbor Laboratory Corporate Sponsor Program
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J.A. Birch ler, University of Missouri, Columbia
L. Comai, University of Washington, Seattle
SESSION 1
Chairperson: J.A. Birch ler, University of Missouri, Columbia
J. Silverthorne, The National Science Foundation, Arlington,
Virginia: Polyploidy, heterosis, and genomic balance: The
NSF perspective.
G.C. Gibson, North Carolina State University, Raleigh:
Estimating heritability and nonadditivity in fly and human
expression profiles.
C. Disteche, University of Washington, Seattle: The complex
regulation of the mammalian X chromosome: Up-regulation
and inactivation.
B. Oliver, NIDDK/National Institutes of Health, Bethesda,
Maryland: X-chromosome dosage compensation in the
Drosophila germ line.
R.H. Reeves, The Johns Hopkins University, Baltimore,
Maryland: The DSCR is not critical for Down's syndrome.
B. Dilkes, D. Soltis, J. Wendel, K. Adams
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SESSION 2
Chairperson: R.W. Doerge. Purdue University, West Lafayette,
D.N. Duvick, Iowa State University, Ames: Contributions of
heterosis to maize yield, plant height, and maturity, during
six decades of breeding.
D. Zamir, Hebrew University of Jerusalem, Rehovot, Israel:
Heterotic QTLs in tomato are limited to traits associated
with reproductive success.
D. Jackson, Cold Spring Harbor Laboratory: Candidate
SESSION 3
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
T.C. Osborn, University of Wisconsin, Madison: Phenotypic
effects of polyploidy-induced variation in homologous allele
dosage.
L. Comai, University of Washington, Seattle: Polyploidy and
dosage in plants: A matter of chromatin regulation?
R. Scott, University of Bath, United Kingdom: Genomic bal-
ance in Arabidopsis thaliana and its relatives.
B. Dilkes, University of Washington, Seattle: Dosage effects
SESSION 4
Chairperson: T. C. Osborn, University of Wisconsin, Madison
J.C. Pires, University of Wisconsin, Madison: Novel genotypic
and phenotypic changes among resynthesized Brassica
allopolyploids.
B. Chalhoub, INRA/CNRS-URGV, France: Molecular basis of
polyploidy-related gene loss in wheat species (Triticum and
Aegilops).
A.A. Levy, Weizmann Institute of Science, Rehovot, Israel:
SESSION 5
Chairperson: L. Comai, University of Washington, Seattle
R.W. Doerge, Purdue University, West Lafayette, Indiana:
Locating QTL in polyploids: The things to think about... .
Z.J. Chen, Texas A&M University, College Station: Transcrip-
tome divergence and mechanisms of nonadditive gene
regulation in Arabidopsis.
R. Martienssen, Cold Spring Harbor Laboratory: Epigenomic
variation.
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Indiana
genes for quantitative traits underlying inflorescence archi-
tecture in maize.
J.F. Wendel, Iowa State University, Ames: Genome evolution
in polyploid cotton.
K. Adams, University of British Columbia, Vancouver,
Canada: Organ-specific gene silencing in polyploids and
hybrids.
in interploidy crosses of Arabidopsis thaliana.
0. Mittelsten Scheid, Gregor Mendel Institute of Molecular
Plant Biology, Vienna, Austria: Formation of epialleles: Their
maintenance and interaction in polyploid Arabidopsis.
C.S. Pikaard, Washington University, St. Louis, Missouri:
Chromosomal rearrangements and gene-silencing events
affecting NORs and rRNA genes in suecica.
Bread as a model system to study polyploidy and interspe-
cific hybrids.
A. Paterson, University of Georgia, Athens: Polyploidy and
angiosperm comparative genomics.
D.E. Soltis, University of Florida, Gainesville: Genetic and
genomic consequences of recent and recurring allopoly-
ploidy in Tragopogon (Asteracease).
J.A. Birch ler, University of Missouri, Columbia: Biological
implications of regulatory gene balance with special refer-
ence to studies in maize and Drosophila.
General Discussion/Key Points of Meeting
Neurobiology of Decision-making
May 22-25
FUNDED BY The Swartz Foundation
ARRANGED BY C. Brody, Cold Spring Harbor Laboratory
M.N. Shad len, HHMI/University of Washington
X.-J. Wang, Brandeis University
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: M.N. Shad len, HHMI/University of Washington, Seattle
R. Gallistel, Rutgers University, New Brunswick, Piscataway,
New Jersey: The irrelevance of the law of effect in uncon-
strained free choice with random rewards.
D. Lee, University of Rochester, New York: Computation of
values in the primate frontal cortex.
P.W. Glimcher, New York University, New York: Physiological
and economic models of decision-making.
SESSION 2
Chairperson: C. Brody, Cold Spring Harbor Laboratory
H.R. Heekeren, Humboldt University, Berlin, Germany: A gen-
eral mechanism for perceptual decision-making in the
human brain.
M.N. Shadlen, HHMI/University of Washington, Seattle: How
does the brain combine evidence with prior probability?
X.-J. Wang, Brandies University, Waltham, Massachusetts: A
neuronal microcircuit model for reaction time behavior.
SESSION 3
Chairperson: G.D. Logan, Vanderbilt University, Nashville,
Tennessee
J. Gold, University of Pennsylvania, Philadelphia: Multiple
roles of experience in neural circuits that form perceptual
decisions.
P Holmes, Princeton University, New Jersey: What's optimal
about decision-making for two and more choices?
K. Krug, University Laboratory of Physiology, Oxford, United
Kingdom: Controlled intervention in perceptual decision-
making.
P.L. Smith, The University of Melbourne, Victoria, Australia:
An integrated model of decision-making and visual
attention.
S. Deneve, Institut des Sciences Cognitives, Bron, France:
Explicit neural space and implicit probability space.
W. Schultz, University of Cambridge, United Kingdom:
Reward responses as potential input signals for decision-
making.
P.R. Montague, Baylor College of Medicine, Houston, Texas:
Neural correlates of policy adjustment in a dynamic eco-
nomic game.
R. Ratcliff, Ohio State University, Columbus: An analysis of the
effects of aging in two choice tasks using sequential sam-
pling models.
J.D. Schall, Vanderbilt University, Nashville, Tennessee:
Choice, decision, and action investigated with visually guided
saccades.
P. Glimcher, D. Lee
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SESSION 4
Chairperson: X.-J. Wang, Brandeis University, Waltham, Massachusetts
Z.F. Mainen, Cold Spring Harbor Laboratory: Neural circuits
underlying olfactory decisions in the rat.
0. Hikosaka, National Eye Institute, Bethesda, Maryland: Basal
ganglia mechanisms of reward-oriented eye movement.
M. Basso, University of Wisconsin, Madison: Basal ganglia
microstimulation affects memory and movement.
A. Koulakov, Cold Spring Harbor Laboratory: How to define
command neurons?
W.B. Kristan, University of California, San Diego: The dynam-
ics of decision-making by leech neurons.
SESSION 5
Chairperson: J.D. Schall, Vanderbilt University, Nashville, Tennessee
J.D. Cohen, Princeton University, New Jersey: Role of locus
coeruleus in adaptive adjustments of gain and optimal per-
formance in simple decision-making tasks.
C. Brody, Cold Spring Harbor Laboratory: Combining work-
ing memory and decision-making in a simple neural model
of prefrontal cortex.
M. Platt, Duke University Medical Center, Durham, North
Carolina: Neural mechanisms of social decision-making.
A. Kacelnik, Oxford University, United Kingdom: Decision-
making under risk: Biological perspectives.
S. Makeig, Swartz Center for Computational Neuroscience,
University of California, San Diego, La Jolla: Decisions have
consequences.
General Discussion/Key Points of Meeting
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Stem Cells and Axonal Regeneration: Strategies for the Treatment
of ALS
September 11-14
FUNDED BY The ALS Association
ARRANGED BY L. Bruijn, The ALS Association
S.M. Strittmatter, Yale University
C.N. Svendsen, University of Wisconsin
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
L. Bruijn, The ALS Association, Palm Harbor, Florida
SESSION 1: Introductory Session
Chairperson: L. Bruijn, The ALS Association, Palm Harbor, Florida
S.L. Pfaff, Salk Institute, La Jolla, California: Overview of
motor neuron development and cell specification and
cell fate.
S.A. Goldman, University of Rochester Medical Center, New
SESSION 2: Neural Stem Cells
Chairperson: C.N. Svendsen, University of Wisconsin, Madison
P. Homer, University of Washington, Seattle: Endogenous
stem cells in spinal cord and repair.
H. Wichterle, Columbia University, New York: Control of
embryonic stem-cell-derived motor neuron subtype identity.
J.D. Macklis, Harvard Medical School, Massachusetts
General Hospital, Boston: Molecular cues for upper motor
neuron development.
York: Overview of stem cell biology.
S.M. Strittmatter, Yale University School of Medicine, New
Haven, Connecticut: Overview of regeneration, axonal
guidance cues, and inhibitory molecules.
A.R. Kriegstein, University of California, San Francisco:
Neural stem and progenitor cells in the embryonic brain.
M.V. Sofroniew, University of California, Los Angeles: Are
astrocytes stem cells?
N. Gaiano, Johns Hopkins University Medical School,
Baltimore, Maryland: Embryonic neural stem cell hetero-
geneity.
K. Eggan, S. Goldman
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SESSION 3: Axonal Regeneration
Chairperson: S.M. Strittmatter, Yale University School of Medicine, New Haven, Connecticut
M. Filbin, Hunter College of CUNY, New York: Myelin
inhibitors of regeneration: How they work and how to over-
come them.
SESSION 4: Stem Cells and Neurodegenerative Diseases
Chairperson: M. Swash, Royal London Hospital, United Kingdom
J. Lichtman, Harvard University, Cambridge, Massachusetts:
Monitoring growth and retraction of axons in situ.
C.N. Svendsen, University of Wisconsin, Madison: Overview R Aebischer, Integrative Bioscience Institute, Swiss Federal
of stem cells and neurodegenerative diseases: Lessons for Institute of Technology, Lausanne, Switzerland: Lentivirus-
ALS from PD. mediated gene silencing of SOD-1 for the treatment of
S.-C. Zhang, University of Wisconsin, Madison: Generation of ALS.
human motor neurons: Applications for ALS studies.
SESSION 5: Axonal Regeneration
Chairperson: M. Filbin, Hunter College of CUNY, New York
B.A. Barres, Stanford Medical School, California: Why is J.D. Milbrandt, Washington University, St. Louis, Missouri:
Wallerian degeneration so slow in the CNS? Wallerian degeneration, neurotrophins, and axonal growth.
SESSION 6: Application of Stem Cell Technologies in Understanding Disease
Chairperson: S.A. Goldman, University of Rochester Medical Center, New York
I. Wilmut, Roslin BioCentre, Midlothian, United Kingdom:
Cells from cloned human embryos in studies of ALS.
K. Eggan, Harvard University, Cambridge, Massachusetts:
Cloning and stem cells: Building cell-based models of ALS.
L. Goldstein, HHMI/University of California, San Diego
SESSION 7: Stem Cells and Neurodegenerative Diseases
Chairperson: T. Miller, University of California, San Diego
M. Swash, Royal London Hospital, United Kingdom:
Overview of clinical challenges in ALS.
L.J. Martin, The Johns Hopkins University, Baltimore,
Maryland: Adult stem cells and ALS models.
D. Kerr, The Johns Hopkins University, Baltimore, Maryland:
Overview of current efforts in model systems for ALS.
N. Boulis, The Cleveland Clinic Foundation, Ohio:
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School of Medicine, La Jolla: Identifying cells to be
replaced in ALS.
Y. Zou, University of Chicago, Illinois: Guidance of axons
along the rostral-caudal axis of the spinal cord.
Neurosurgical challenges for invasive therapies for ALS.
0. Isacson, Harvard Medical School, Belmont,
Massachusetts: Neuronal replacement therapy for neu-
rodegeneration using stem cells.
General Discussion/Future Directions
Closing Remarks: R.V. Abendroth, Milwaukee, Wisconsin
From Markers to Models: Integrating Data to Make Sense of
Biologic Systems
September 18-21
FUNDED BY Centers for Disease Control & Prevention; CFIDS Association of America
ARRANGED BY S.D. Vernon, Centers for Disease Control and Prevention
W.C. Reeves, Centers for Disease Control and Prevention
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: W.C. Reeves, Centers for Disease Control and Prevention, Atlanta, Georgia
S.D. Vernon, Centers for Disease Control and Prevention,
Atlanta, Georgia: C3: Progress toward the CFS
interaction map.
S.M. Lin, Northwestern University, Chicago, Illinois: Lessons
learned from 5 years of CAMDA.
Team 1: Toward the Nosology of Chronic Unexplained
Fatigue
1. Initial data perusal to direct hypothesis-driven analysis
2. Analytical approach(es)
3. Results and biological interpretation
B. Mishra, New York University: Computational and experi-
mental framework to understand disease pathogenesis.
Team 2: CFS: From Constructs to Mechanisms
1. Initial data perusal to direct hypothesis-driven analysis
2. Analytical approach(es)
3. Results and biological interpretation
J. Shoemaker, Duke University Medical Center, Durham,
North Carolina: Mathematical and statistical challenges for
high-throughput data.
Team 3: Challenges of Elucidating Pathophysiology in
Complex Disorders
1. Initial data perusal to direct hypothesis-driven analysis
2. Analytical approach(es)
3. Results and biological interpretation
P. White, K. McCleary
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SESSION 2
Chairperson: A.H. Miller, Emory University School of Medicine, Atlanta, Georgia
M. Demitrack, Neuronetics, Inc., Malvern, Pennsylvania:
Clinical perspectives on therapeutic interventions for CFS.
J. Di Stefano, University of California, Los Angeles: Dynamic
systems modeling and thyroid hormone regulation and
metabolism in mammals.
Team 4: Bridging the Gap between the Neuroendocrine and
Immune Systems
1. Initial data perusal to direct hypothesis-driven analysis
2. Analytical approach(es)
3. Results and biological interpretation
SESSION 3: Breakout Session for Non-C3 Participants to Evaluate and Summarize Team Approach
B. Mishra, New York University/M. Demitrack, Neuronetics,
Inc., Malvern, Pennsylvania: Report on Team 1.
J. Shoemaker, Duke University Medical Center, Durham,
North Carolina: Report on Team 2.
S.M. Lin, Northwestern University, Chicago, Illinois/W.C.
SESSION 4: Team Breakout Session: Next Steps for Each Team
Regroup?
Complete Analysis?
Delegate?
Publication(s) Plan?
Reeves, Centers for Disease Control and Prevention,
Atlanta, Georgia: Report on Team 3.
J. Di Stefano, University of California, Los Angeles/A.H. Miller,
Emory University School of Medicine, Atlanta, Georgia:
Report on Team 4.
Next Steps
Computational and Biologic Validation
Publications
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Pathogenesis and Early Events in Viral Infection
September 25-28
FUNDED BY U.S. Defense Department (through a grant to the Institute for Comparative Genomics)
ARRANGED BY R. Breeze, Institute for Comparative Genomics
F. Horn, Institute for Comparative Genomics
W. Laegreid, USDA Agricultural Research Service
D.L. Rock, University of Illinois
Introduction and Charge for Meeting: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R. Breeze, Institute for Comparative Genomics, Washington, D.C.
SESSION 1: Early Events in Virus Infection
J.A. Hiscox, University of Leeds, United Kingdom: The nucle-
olus as a gateway to virus infection.
G. Sutter, Paul-Ehrlich-Institut, Langen, Germany: Control of
apoptosis and translation mark essential early checkpoints
SESSION 2: Host Resistance
A.A. Ashkar, McMaster University Health Science Center,
Hamilton, Canada: Induction of innate antiviral immunity by
TLR agonists/ligands.
A. Garcia-Sastre, Mount Sinai School of Medicine, New York:
Reverse-genetics-derived influenza viruses.
H.W. Virgin, Washington University School of Medicine, St.
in the vaccinia virus MVA.
E. Tulman, University of Connecticut, Storrs: Comparative
viral genomics for identification of host-range determinants
and virulence factors.
Louis, Missouri: New approaches to defining mechanisms
of virus resistance and pathogen discovery.
M. Brinton, Georgia State University, Atlanta: Comparison of
the responses of MEFs from congenic flavivirus-resistant
and -susceptible mice to West Nile virus.
A. Perelson, T. Endy, A. Garcia-Sastre
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SESSION 3: Pathogenesis
T. Barrett, Institute for Animal Health, Surrey, United
Kingdom: Molecular determinants of pathogenesis by
rinderpest virus.
T.P. Endy, Walter Reed Army Institute of Research, Silver
Spring, Maryland: Pathogenesis and early events in acute
dengue virus infection.
J.N. Mac Lachlan, University of California, Davis: Role of
vascular epithelium in selected animal virus infections:
SESSION 4: Pathogenesis
E.S. Mocarski, Stanford University School of Medicine,
California: Virus-mediated recruitment of host cells for sys-
temic dissemination within the host.
C. Jones, University of Nebraska, Lincoln: Analysis of a-her-
pesvirus genes expressed in latently infected neurons.
E. lvanovna Ryabchikova, State Research Center of Virology
SESSION V: Pathogenesis
A.S. Perelson, Los Alamos National Laboratory, New Mexico:
Modeling the kinetics of acute virus infection.
J. Paragas, U.S. Army Medical Research Institute of
Infectious Disease, Fort Detrick, Maryland: A bright light in
Villain or victim?
A. Alcami, Centro Nacional de Biotecnologia, Madrid, Spain:
Immune modulation by cytokine receptors from variola and
ectromelia viruses.
L. Hensley, U.S. Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Maryland: Temporal
analysis of ebola and Marburg hemorrhagic fever in
cynomologus macaques.
and Biotechnology, Koltsovo, Russia: Laboratory accident
of ebola hemorrhagic fever: Diagnostics, clinical course,
and treatment.
G. Keil, Friedrich-Loeffler Institut, Greitswald-lnsel Riems,
Germany: Engineering glycoprotein B of bovine herpesvirus
1 as transporter for biologically active secreted proteins.
biodefense for orthopox viruses.
R. Breeze, Institute for Comparative Genomics, Washington,
D.C.: Summary and discussion.
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Mitochondria in Neurological Disease and Aging
October 2-5
FUNDED BY
ARRANGED BY
Introduction:
Cold Spring Harbor Laboratory Corporate Sponsor Program
M.F. Beal, Weill Medical College of Cornell University
D.C. Wallace, University of California
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M.F. Beal, Weill Medical College of Cornell University, New York
D.C. Wallace, University of California, Irvine
SESSION 1: Genetics and Pathophysiology
Chairperson: M.F. Beal, Weill Medical College of Cornell University, New York
G. Attardi, California Institute of Technology, Pasadena:
Termination-factor-mediated DNA looping controls human
mitochondria! rRNA synethesis.
J.A.M. Smeitink, Radbound University Medical Center,
Nijmegan, The Netherlands: Cell biological consequences
of human complex-1 deficiency.
B.M. Spiegelman, Dana-Farber Cancer Institute, Boston,
SESSION 2: Biochemistry and Physiology
Chairperson: B.N. Ames, University of California, Berkeley
R.A. Capaldi, University of Oregon, Eugene: Measurement of
oxidative damage to OXPHOS proteins in neurodegenera-
tion: Toward identification of biomarker for Alzheimer's and
Parkinson's diseases.
Massachusetts: Regulation of mitochondria biogenesis and
bioenergetics through the PGC-1 coactivators.
R.C. Scarpulla, Northwestern University Medical School,
Chicago, Illinois: PGC-1-related coactivator (PRC): A
potential link between cell proliferation and respiratory
chain expression.
R Giuseppe Pelicci, European Institute of Oncology, Milan,
Italy: Regulation of ROS metabolism by p66Shc.
R Bernardi, University of Padova, Italy: The mitochondrial
permeability transition in degenerative diseases and aging.
SESSION 3: Animal Models
Chairperson: B.M. Spiegelman, Dana-Farber Cancer Institute, Boston, Massachusetts
T Pro Ila, University Wisconsin, Madison: Aging, oxidative
stress, and apoptosis in mitochondrial mutator mice.
C.T. Moraes, University of Miami, Florida: A mouse model of
SESSION 4: Brain Disease and Aging
Chairperson: D.C. Wallace, University of California, Irvine
M.F. Beal, Weill Medical College of Cornell University, New
York: Therapeutic approaches to mitochondrial dysfunction
in neurodegenerative diseases.
B.N. Ames, University of California, Berkeley, Oakland:
COX deficiency in the CNS.
D. Walker, California Institute of Technology, Pasadena:
Mitochondrial dysfunction in Drosophila.
Delaying (or accelerating) the mitochondrial decay of aging.
L.P. Guarente, Massachusetts Institute of Technology,
Cambridge: Function of mitochondrial sirtuin Sirt4.
SESSION 5: Friedreich Ataxia, ALS, and AD
Chairperson: A.D. Roses, GlaxoSmithKline, Research Triangle Park, North Carolina
G. Isaya, Mayo Clinic, Rochester, Minnesota: Anti-oxidant
functions of frataxin: Roles in Friedreich ataxia and other
age-related conditions.
R.B. Wilson, University of Pennsylvania, Philadelphia:
Mitochondrial dysfunction in Friedreich ataxia.
P. Pasinelli, Massachusetts General Hospital, Charlestown:
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SOD1/BCI-2 complex: A role in the regulation of mitochon-
dria cell death.
D.W. Cleveland, University of California, San Diego:
Mitochondrial involvement in familial ALS.
G. Manfredi, Cornell University, New York: Mitochondrial
involvement in SOD1-familial ALS.
A.D. Roses, GlaxoSmithKline, Research Triangle Park, North
Carolina: An apoE4 isoform-specific mechanism for altered
energy metabolism in Alzheimer's disease.
M. Ankarcrona, Karolinska Institutet, Huddinge, Sweden:
Mechanisms of cell death in Alzheimer's disease: Focus on
y-secretase and mitochondria.
A. Kontush, Hopital de la Pitie, Paris, France: Amyloid-p pep-
tide and mitochondria in Alzheimer's disease: Is there a link
mediated by oxidative stress?
D.C. Wallace, University of California, Irvine: A mitochondrial
paradigm for metabolic and degenerative diseases, cancer,
and aging.
SESSION 6: Huntington's Disease and Parkinson's Disease
Chairperson: M.F. Beal, Weill Medical College of Cornell University, New York
G.V.W. Johnson, University of Alabama, Birmingham: Mutant
Huntington compromises mitochondrial function.
R.L. Nussbaum, National Human Genome Research Institute,
Bethesda, Maryland: Role of a-synuclein in lipid metabolism
and mitochondrial function.
A. Abeliovich, Columbia University College of Physicians and
Surgeons, New York: Oxidative stress and dopamine neu-
ron survival: The role of DJ-1.
J.M. Vance, Duke University Medical Center, Durham, North
Carolina: Mitochondria and late-onset Parkinson's disease.
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M. Cookson, National Institutes of Health, Bethesda,
Maryland: PINK1 and DJ-1, associated with recessive
parkinsonism, delineate mitochondrial pathways important
in neuronal survival.
Discussion:
Common Themes
Mitochondria
Neurological Diseases
Microbial Forensics 2005: Sample Management
October 16-19
FUNDED BY U.S. Department of Homeland Security
ARRANGED BY S.E. Schutzer, UMDNJ-New Jersey Medical School
B. Budowle, Federal Bureau of Investigation
J.P. Burans, U.S. Department of Homeland Security
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Overview and Goals: B. Budowle, Federal Bureau of Investigation, Washington, D.C.
SESSION 1: Sampling/Collection Strategies I
Chairperson: B.L. Marrone, Los Alamos National Laboratory, New Mexico
D. Beecher, FBI Laboratory, Quantico, Virginia: Strategies for
collection and sampling (known/unknown pathogen).
J. Fletcher, Oklahoma State University, Stillwater: Sampling
issues for plant pathogens.
L.L. Rodriquez, ARS, USDA Plum Island Animal Disease
Center, Greenport, New York: Sampling issues for
animal pathogens.
J.E. LeClerc, Food and Drug Administration, Laurel,
Maryland: Sampling issues for food pathogens.
SESSION 2: Sampling/Collection Strategies II
Chairperson: J.P. Burans, U.S. Department of Homeland Security, Frederick, Maryland
F.P. Keller, Federal Bureau of Investigation, Quantico, Virginia: N. Valentine, Pacific Northwest National Laboratory, Rich-
land, Washington: Protocols for collecting from substrates.FBI protocols for sample collection.
S. Schutzer, J. Fletcher, B. Budowle, M. Wilson
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SESSION 3: Sampling/Collection Strategies III
Chairperson: B. Budowle, Federal Bureau of Investigation, Washington, D.C.
M. Hale, U.S. Army Medical Research Institute of Infectious
Diseases, Fort Detrick, Maryland: Sampling issues/proto-
cols for toxins.
T.G. Ksiazek, Centers for Disease Control and Prevention,
Atlanta, Georgia: Sampling strategies for BSL3/4 agents.
L. Lind ler, U.S. Department of Homeland Security, Frederick,
Maryland: Sampling strategies for bacteria.
J.P. Burans, U.S. Department of Homeland Security,
Frederick, Maryland: Sampling strategies and impact on
downstream analyses.
SESSION 4: Sampling/Collection Strategies IV
Chairperson: P.T. Pesenti, U.S. Department of Homeland Security, Washington, D.C.
M.A. Heitkamp, Savannah River National Laboratory, Aiken, B.L. Marrone, Los Alamos National Laboratory, New Mexico:
South Carolina: Collecting background controls. The GAO report and beyond anthrax spores.
SESSION 5: Packaging, Shipping, and Storage (Integrity, Preservation, Safety, Regulations)
Chairperson: S.P. Velsko, Lawrence Livermore National Laboratory, California
W.T. Cobb, Cobb Consulting Services, Kennewick,
Washington: Forensic plant issues.
Y.A. Lue, Quest Diagnostics Laboratories, Teterboro, New
Jersey: Preservation of samples during shipping.
M. Hevey, NBFAC Research & Spoke Lab Program,
Frederick, Maryland: Storage and preservation in
the laboratory.
SESSION 6: Extraction/Preparation Strategies (Maintaining Integrity of Signatures) I
Chairperson: M.R. Wilson. FBI Academy, Quantico, Virginia
S.P. Velsko, Lawrence Livermore National Laboratory,
California: Collection and preservation of samples for
chemical and physical analysis.
K.L. Wahl, Pacific Northwest National Laboratory, Richland,
Washington: Extraction strategies for proteins and other
organic molecules.
C.R. Kuske, Los Alamos National Laboratory, New Mexico:
Extraction strategies for nucleic acids.
SESSION 7: Extraction/Preparation Strategies (Maintaining Integrity of Signatures) II
Chairperson: S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
M.R. Wilson, FBI Academy, Quantico, Virginia: Nucleic acid
concentration techniques.
J. Dunbar, Los Alamos National Laboratory, New Mexico:
Removing or neutralizing inhibitors (of nucleic acid analyses).
M. Lipton, Pacific Northwest National Laboratory, Richland,
Washington: Microbial extraction from dirt: Examples and
complete proteomic analysis.
SESSION 8: Wrap-up Sessions
Chairperson: B. Budowle, Federal Bureau of Investigation, Washington, D.C.
M. Eshoo, Isis Pharmaceuticals, Carlsbad, California: Whole-
genome amplification strategies and issues.
T. Cebu la, U.S. Food and Drug Administration, Laurel,
Maryland: Collating methods, value, and preparedness.
P.T. Pesenti, U.S. Department of Homeland Security,
Washington, D.C.: New technologies on the horizon.
B.L. Marrone, Los Alamos National Laboratory, New Mexico:
Research needs.
SESSION 9: Summary and Review
Chairperson: S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
B. Budowle, Federal Bureau of Investigation, Washington, School, Newark: Review of meeting and strategies for
D.C./ S.E. Schutzer, UMDNJ-New Jersey Medical addressing gaps.
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Introduction and Sustainable Use of Vaccines in Developing
Countries
October 19-21
FUNDED BY Albert B. Sabin Vaccine Institute, with the support from the Bill & Melinda Gates Foundation
ARRANGED BY K. Reilly, Sabin Vaccine Institute
F.F. Songane, Ministerio da Saude
Welcome and Introduction of Speaker: H.R. Shepherd, Albert B. Sabin Vaccine Institute, New Canaan, Connecticut
G. Alleyne, Pan American Health Organization. Washington, D.C.: Immunization
for all: A condition for health and development.
K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania and F.F. Songane,
Ministerio da Saude, Maputo, Mozambique: Charge to the Conference.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R.A. MacDougall, Albert B. Sabin Vaccine Institute, Washington, D.C.: Review of Delphi Survey
SESSION 1: Review of Current Immunization Status in Developing Countries
Moderators: K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania, and F.F. Songane,
Ministerio da Saude, Maputo, Mozambique
Panel Immunisation (EPI), Hanoi, Vietnam
J.M. Okwo Bele, World Health Organization, Geneva,
Switzerland Open Discussion and Consensus
N. Antwi Agyei, Ghana Health Service, Accra What lessons can be learned from the current
N. Van Cuong, National Expanded Programme on situation?
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SESSION 2: Financial Resources to Support Immunization: What Is Available, What Is Needed?
Moderators: K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania, and F.F. Songane,
Ministerio da Saude, Maputo, Mozambique
Panel
J. Lob-Levyt, UNICEF, Geneva, Switzerland
I. Makumbi, Ministry of Health, Uganda
R. Levine, Center for Global Development, Washington, D.C.
G. Lamb, World Bank, Washington, D.C.
M. Harvey, USAID, Washington, D.C.
SESSION 3: Procurement and Supply of Existing and New Vaccines
Moderators: K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania, and F.F. Songane,
Ministerio da Saude, Maputo, Mozambique
Panel
S. Jarrett, UNICEF, New York F Valente, Ministry of Health, Angola
J.K. Andrus, Pan American Health Organization, W. Vandermissen, GlaxoSmithKline Biologicals, Rixensart,
Washington, D.C. Belgium
SESSION 4: Review of Discussions and Consensus on Key Points
Moderators: K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania, and F.F. Songane,
Ministerio da Saude, Maputo, Mozambique
SESSION 5: Opportunities and Recommendations for Sustainable Performance Levels in Immunization
Moderators. K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania, and F.F. Songane, Ministerio
da Saude, Maputo, Mozambique
Panel
T. Belaye, Federal Democratic Republic of Ethiopia, Addis
Ababa
G. Aslanyan, Canadian International Development Agency,
Quebec, Canada
H. Sunman, Department of International Development,
London, United Kingdom
A. Mahmoud, Merck & Co., Inc., Whitehouse Station, New
Jersey
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J.-M. Okwo-Bete, World Health Organization, Geneva,
Switzerland
Conference Wrap Up/Next Steps
L.A. Miller, Wentz Miller & Associates, Darien, Connecticut
K. Reilly, Sabin Vaccine Institute, Rosemont, Pennsylvania
F Songane, Ministerio da Saude, Maputo, Mozambique
M. Kitambi, M. Harvey, T. Be laye
Epilepsy Genetics and Pharmacogenetics
October 23-26
FUNDED BY UCB Pharma and the National Society for Epilepsy
ARRANGED BY N. Delanty, Royal College of Surgeons in Ireland
D.B. Goldstein, Duke Institute for Genome Sciences and Policy
L. Sander, University College, London
S.M. Sisodiya, University College, London
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D.B. Goldstein, Duke Institute for Genome Sciences and Policy, Durham, North Carolina
SESSION 1: Epilepsy: Epidemiological and Clinical Context
Chairperson: L. Sander, University College London, United Kingdom
S.M. Sisodiya, University College London, United Kingdom:
Epilepsy: Setting the stage.
L. Sander, University College London, United Kingdom:
Epidemiological considerations.
A. Lascelles, National Society for Epilepsy, London, United
Kingdom: Perspectives from patients and family.
SESSION 2: Phenotyping and Genotyping: Issues
Chairperson: S.M. Sisodiya, University College London, United Kingdom
N. Delanty, Royal College of Surgeons in Ireland, Dublin:
The promise and perils of epilepsy phenotyping?
J. Mulley, Women's and Children's Hospital, North
Adelaide, Australia: The genetics of "simple" and
complex idiopathic epilepsies.
D.H. Lowenstein, University of California, San Francisco:
Large-scale phenotyping of epilepsy.
L. Sander, D. Goldstein, S. Sisodyia
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SESSION 3: Epilepsy Genetics I
Chairperson: L. Sander, University College London, United Kingdom
M. Weale, University College London, United Kingdom:
Representing genetic variation in a large-scale epilepsy
genetic association study.
J. Hirschhorn, Children's Hospital, Boston, Massachusetts:
Performing and interpreting association studies for
complex traits.
J.O. McNamara, Duke University Medical Center, Durham,
North Carolina: Genetic and molecular mechanisms of
epileptogenetics.
J.L. Noebels, Baylor College of Medicine, Houston, Texas:
Large-scale resequencing of ion channels in epilepsy: The
Human Channelopathy Project.
D.L. Burgess, Baylor College of Medicine, Houston, Texas:
Large-scale resequencing of ion channels in epilepsy:
Design, implementation, and progress.
P.B. Crino, University of Pennsylvania Medical Center,
Philadelphia: Somatic mutations during brain development
that lead to sporadic brain malformations associated with
epilepsy.
SESSION 4: Epilepsy Genetics II
Chairperson: N. Delanty, Royal College of Surgeons in Ireland, Dublin
R. Ottman, Columbia University, New York: Genetic epidemi-
ology of the epilepsies.
0. Chiba-Falek, Human Genome Research Institute, NIH,
Bethesda, Maryland: Regulation of a-synuclein (SNCA)
expression in Parkinson's disease: Identification of regulato-
ry polymorphisms.
G. Cavalleri, University College London, United Kingdom:
BRD2 as a risk factor for JME.
C. Depondt, Universite Libre de Bruxelles, Belgium: Role of
SCNIA in sporadic epilepsy and epilepsy pharmacogenetics.
C.P. Doherty, Royal College of Surgeons in Ireland, Dublin:
The potential for endophenotypic description in epilepsy
syndromes.
A. Escayg, Emory University School of Medicine, Atlanta,
Georgia: Role of the voltage-gated sodium channels in
inherited epilepsy.
SESSION 5: Epilepsy Pharmacogenetics I
Chairperson: S.M. Sisodiya, University College London, United Kingdom
D.B. Goldstein, Duke Institute for Genome Sciences and
Policy, Durham, North Carolina: Epilepsy pharmacogenet-
ics: Where are we headed?
D.L. Kroetz, University of California, San Francisco:
Expression of multidrug resistance transporters in human
brain and relationship to MDR polymorphisms.
D. Weinshenker, Emory School of Medicine, Atlanta,
Georgia: Noradrenergic control of seizure susceptibility and
anticonvulsant drug efficacy.
C. Szoeke, The University of Melbourne, Australia:
Pharmacogenetics in anti-epilepsy medications: An
Australian prospective study in newly treated patients.
SESSION 6: Epilepsy Pharmacogenetics II
Chairperson: D.B. Goldstein, Duke Institute for Genome Sciences and Policy, Durham, North
Carolina
M. Pirmohamed, University of Liverpool, United Kingdom:
Epilepsy pharmacogenetics.
R.A. Radtke, Duke University Medical Center, Durham, North
Carolina: Defining treatment response in epilepsy pharma-
cogenetics.
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A.C. Need, Duke Institute for Genome Sciences and Policy,
Durham, North Carolina: Pharmacogenetics of topiramate-
induced cognitive deficits in epilepsy patients.
A. Malhotra, The Zucker Hillside Hospital, Glen Oaks, New
York: Genes for neurocognitive function: Implications for
treatment.
The GABAergic System
October 30-November 2
FUNDED BY Marie Robertson Memorial Fund
ARRANGED BY Z.J. Huang, Cold Spring Harbor Laboratory
G. Buzsaki, Rutgers, The State University of New Jersey
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Z.J. Huang, Cold Spring Harbor Laboratory
SESSION 1: Cell Types: From Genomics (Genotypes) to Phenotypes
Chairperson: B. Connors, Brown University, Providence, Rhode Island
H. Markram, Brain & Mind Institute, Lausanne, Switzerland:
Reconstructing the neocortical microcircuit with a diversity
of GABAergic interneurons.
S. Nelson, Brandeis University, Waltham, Massachusetts:
Physiological genomics of cortical interneurons
SESSION 2: Development
Chairperson: D.A. McCormick, Yale University School of Medicine, New Haven, Connecticut
G.J. Fishell, Skirball Institute, New York: The developmental
origin of cortical interneurons predicts their mature physio-
logical properties.
S.A. Anderson, Weill Medical College of Cornell University,
SESSION 3: GABA Synthesis and Release, Transport
Chairperson: I. Mody, University of California, Los Angeles
Z.J. Huang, Cold Spring Harbor Laboratory: A novel function
of GABA in regulating GABAergic synapse and circuit
development.
K. Behar, Yale University School of Medicine, New Haven,
Connecticut: Measurements of GABA synthesis and
GABA/glutamine cycling in relation to the GAD isoforms in
rat cerebral cortex using magnetic resonance spectroscopy.
New York: Specification of cortical interneurons in the
medial ganglionic eminence.
A. Represa, INMED/INSERM, Marseille, France: GABA is the
pioneering transmitter in developing hippocampus.
Y. Zilberter, Institute de Neurobiologie de la Mediterranee,
Marseille, France: Pyramidal cell and interneurons in layer
2/3 of the juvenile neocortex: Multifaceted relations.
D. Attwell, University College London, United Kingdom:
Reversal of GABA transporters and plasticity of GABA
receptor signaling in brain ischemia.
P. Jonas, G. Buzsaki
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SESSION 4: GABA Receptors I
Chairperson: D. Attwell, University College London, United Kingdom
R.W. Olsen, University of California, Los Angeles: GABA-A
receptors: Identification of the alcohol receptor as an
extrasynaptic subtype of GABA-A receptors.
U. Rudolph, University of Zurich, Switzerland: GABA-A
receptor subtypes: Targets for novel anxiolytic and
antipsychotic drugs.
I. Mody, University of California, Los Angeles: Distinct
modulation of tonic and phasic inhibitions.
SESSION 5: GABA Receptors II
Chairperson: D.M. Kul !man, University College London, United Kingdom
S. Moss, University of Pennsylvania, Philadelphia: Molecular
mechanisms that regulate the membrane trafficking and
function of GABA receptors.
B. Bettler, Universital Basel, Switzerland: Genetic dissociation
of GABA-B functions.
W. Sieghart, Center for Brain Research, Vienna, Austria:
Defining the role of neuronal circuits: Fast and reversible
regulation of selected cell types.
SESSION 6: Cellular Physiology 1
Chairperson: M. Hausser, University College London, United Kingdom
D.A. McCormick, Yale University School of Medicine, New Coordinating GABAergic networks with chemical and elec-
Haven, Connecticut: GABAergic systems critically control trical synapses.
spike rate and timing in cortical networks. A.M. Thomson, University of London, United Kingdom:
B.W. Connors, Brown University, Providence, Rhode Island: Interneurons and inhibitory circuitry in cortical regions.
SESSION 7: Cellular Physiology II
Chairperson: S. Andersen, Weill Medical College of Cornell University, New York
M. Hausser, University College London, United Kingdom: cortical connections.
Functional properties of inhibitory circuits in the cerebellar P. Jonas, Universitat Freiburg, Germany: Fast, strong, and
cortex. shunting inhibitory synapses improve the robustness of
E.M. Callaway, The Salk Institute for Biological Studies, La oscillations in hippocampal interneuron networks.
Jolla: Fine-scale and inhibitory cell-type specificity of
SESSION 8: Plasticity
Chairperson: A. Graybiel, Massachusetts Institute of Technology, Cambridge
M.-M. Poo, University of California, San Diego: Plasticity of
GABAergic transmission.
D.M. Kullmann, University College of London, United
Kingdom: Plasticity of GABAergic inhibition of hippo-
SESSION 9: Network, System, Behavior - Part 1
Chairperson: M.-M. Poo, University of California, San Diego
campal interneurons.
C. Mc Bain, NICHD, Bethesda, Maryland: Plasticity at hip-
pocampal mossy fiber interneuron synapses: What goes
down sometimes must go back up!
G. Buzsaki, Rutgers, The State University of New Jersey, cellular and systems level.
Newark: Functions and cost of inhibition: Questions for the X. Wang, Brandeis University, Waltham, Massachusetts:
future. Interneuron actions in a working memory network: To
H. Monyer, University of Heidelberg, Germany: Molecular inhibit or disinhibit?
approaches to study GABAergic interneurons at the
SESSION 10: Network, System, Behavior: Part 2 (Striatum, Basal Ganglia, and "Other Systems")
Chairperson: K. Behar, Yale University School of Medicine, New Haven, Connecticut
B. Rudy, New York University: Molecular determinants of fast-
spiking cell function.
A. Graybiel, Massachusetts Institute of Technology,
Cambridge: Inhibition in the basal ganglia.
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D.A. Lewis, University of Pittsburgh, Pennsylvania: Cortical
GABA neurons and the pathophysiology of schizophrenia.
G. Buzsaki, Rutgers, The State University of New Jersey,
Newark: Summary.
Barriers and Solutions in the Use of Mouse Models to Develop
Therapeutic Strategies for NF1- and NF2-associated Tumors
November 3-5
FUNDED BY U.S. Department of Defense (through a grant to the Children's Tumor Foundation)
ARRANGED BY K.M. Shannon. University of California
K. Hunter-Schaedle, Children's Tumor Foundation
SESSION 1: Setting the Stage
Chairperson: K.M. Shannon, University of California
K.M. Shannon, University of California, San Francisco:
Overview of meeting purpose and goals: "Throwing down
the gauntlet."
M. Kaime, Congressionally Directed Medical Research
Program, Fort Detrick, Maryland: Plans for the formation of
a Neurofibromatosis Clinical Research Consortium.
S. Lowe, Cold Spring Harbor Laboratory: The use of mouse
models to probe drug sensitivity and resistance.
D.A. Tuveson, University of Pennsylvania School of Medicine,
Philadelphia: A prototype mouse hospital for performing
preclinical trials.
Discussion moderated by K.M. Shannon, University of
California, San Francisco
N. Ratner, A. Bernards
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SESSION 2: NF1- and NF2-associated Tumors: Clinical and Pathologic Features and Current
Treatments
Chairperson: D.W. Clapp, Indiana University School of Medicine, Indianapolis
M. Mac Collin, Massachusetts General Hospital, Charlestown:
Clinical aspects of neurofibromatosis demanding attention.
B. Welling, The Ohio State University, Columbus: Barriers and
solutions in the use of mouse models to develop strategies
for NS1- and NS2-associated tumors.
S. Blaney, Baylor College of Medicine, Houston, Texas:
Challenges in clinical trial development for childhood can-
cers and applicability to neurofibromatosis-related tumors.
A. Stemmer-Rachamimov, Massachusetts General Hospital,
Boston: Of mice and men: Pathology of neurofibromatosis-
associated lesions.
B. Widemann, National Cancer Institute, Bethesda,
Maryland: Endpoints for clinical trials in NE.
Discussion moderated by W. Clapp, Indiana University
School of Medicine, Indianapolis
SESSION 3: Therapeutic Targets and Drug Discovery in NF1: Part 1
Chairperson: M. Mac Collin, Massachusetts General Hospital, Charlestown
A. Bernards, Massachusetts General Hospital Cancer Center,
Harvard Medical School, Charlestown: NF1 drug targets
from a fly's perspective.
N. Ratner, Children's Hospital Medical Center, Cincinnati,
Ohio: Transgenic and cell culture models of NF1.
SESSION 4: Target and Drug Discovery in NF1: Part 2
Chairperson: B. Widemann, National Cancer Institute, Bethesda, Maryland
K. Cichowski, Brigham & Women's Hospital and Harvard
Medical School, Boston, Massachusetts: mTOR as a
potential therapeutic target in NF1.
J. Gibbs, Merck & Co., Inc., Boston, Massachusetts:
Thinking beyond Ras GTPase.
G. Bollag, Plexxikon, Berkeley, California: Kinase inhibitors for
SESSION 5: Therapeutic Targets and Drug Discovery in NF2
Chairperson: B. Welling, The Ohio State University, Columbus
J. Chernoff, Fox Chase Cancer Center, Philadelphia,
Pennsylvania: A search for allosteric inhibitors of p21-acti-
vated kinases.
A. McClatchey, Massachusetts General Hospital Cancer
Center, Harvard Medical School, Charlestown: Preclinical
therapeutics for NF2: Are we ready?
SESSION 6: Mouse Models and Preclinical Data
Chairperson: B.R. Korf, University of Alabama, Birmingham
E. Holland, Memorial Sloan-Kettering Cancer Center, New
York: Gliomas.
D. Gutmann, Washington University School of Medicine, St.
Louis, Missouri: Mouse models of NF-1-associated optic
glioma.
D.W. Clapp, Indiana University School of Medicine,
Indianapolis: The use of PET/CT imaging to detect the
development of plexiform neurofibromas in Krox20;
Nf1flox/-mice.
K. Shannon, University of California, San Francisco: Stage-
specific response of NF1 mutant myeloid malignancies to a
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the potential treatment of NF1.
Discussion moderated by M. Mac Collin, Massachusetts
General Hospital, Charlestown, and B. Widemann,
National Cancer Institute, Bethesda, Maryland
R. Chen, NexGenix Pharmaceuticals, LLC, Burlingame,
California: Small-molecule inhibitors of Pak for the treat-
ment of NF2.
Discussion moderated by B. Welling, The Ohio State
University, Columbus
targeted agent.
M. Giovannini, "Genomique Fonctionnelle des Tumeurs
Solides," Paris, France: Understanding F2: Insights from
mouse models.
Discussion moderated by B.R. Korf, University of
Alabama, Birmingham
K. Hunter-Schaedle, Children's Tumor Foundation, New York:
Children's Tumor Foundation Drug Discovery Partnerships:
A proposed partnering and funding initiative.
SESSION 7: Breakout Sessions
Introduction by Moderators: K.M. Shannon, University of California, San Francisco, and D.H.
Gutmann, Washington, University School of Medicine, St. Louis, Missouri
Each participant was assigned by the organizers to a break-
out session as follows:
Group 1: What additional information do we need to have
regarding drug targets in NF1 and NF2? How can we use
tissues from genetically engineered mice to address this
problem?
Assigned Moderator: A. Bernards, Massachusetts
General Hospital Cancer Center, Charlestown
J. Chernoff, Fox Chase Cancer Center, Philadelphia,
Pennsylvania
K. Chichowski, Brigham & Women's Hospital, Boston,
Massachusetts
A. McClatchey, Massachusetts General Hospital Cancer
Center, Charlestown
N. Ratner, Children's Hospital Medical Center, Cincinnati,
Ohio
Group 2: What are the major barriers to conducting thera-
peutic trials in NF patients?
Assigned Moderator: G. Bol lage, Plexxicon, Berkeley,
California
M. Mac Collin, Massachusetts General Hospital, Charlestown
A. Stemmer-Rachamimov, Massachusetts General Hospital,
Charlestown
P. Bellermann, Children's Tumor Foundation, Sherman, Texas
Group 3: What questions can we address with mouse mod-
els that we cannot address by studying human tumors?
Assigned Moderator: M. Giovannini, "Genomique
SESSION 8: Final Recommendations
Fonctionnelle des Tumeurs Solides," Paris, France
D.H. Gutmann, Washington University School of Medicine,
St. Louis, Missouri
M. McLaughlin, Massachusetts Institute of Technology
Center for Cancer Research, Cambridge
D.W. Clapp, Indiana University School of Medicine,
Indianapolis
Group 4: How can we maximize interactions with industry to
identify and evaluate new therapies for NF?
Assigned Moderator: J.B. Gibbs, Merck & Co., Inc.,
Boston, Massachusetts
R.-H. Chen, NexGenix Pharmaceuticals LLC, Burlingame,
California
E. Holland, Memorial Sloan-Kettering Cancer Center, New
York
C. Marks, National Cancer Institute, Bethesda, Maryland
K. Hunter-Schaedle, Children's Tumor Foundation, New York
Group 5: How can we design preclinical trials to provide
useful information for human clinical trials?
Assigned Moderator: S. Blaney, Baylor College of
Medicine, Houston, Texas
K.M. Shannon, University of California, San Francisco
D.A. Tuveson, University of Pennsylvania School of Medicine,
Philadelphia
B. Widemann, National Cancer Institute, Bethesda, Maryland
J. Heemskerk, NINDS, NIH, Bethesda, Maryland
Open Discussion and Final Recommendations
Moderators: K.M. Shannon, University of California, San Francisco, and D.H. Gutmann,
Washington University School of Medicine, St. Louis, Missouri
A. Bernards, Massachusetts General Hospital Cancer Center,
Charlestown: Group 1 report.
D. Ingram, Indiana University School of Medicine,
Indianapolis: Group 2 report.
M. Giovannini, " Genomique Fonctionnelle des Tumeurs
Solides," Paris, France: Group 3 report,
J.B. Gibbs, Merck & Co., Inc., Boston, Massachusetts:
Group 4 report.
S. Blaney, Baylor College of Medicine, Houston, Texas:
Group 5 report.
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The Biology and Practice of Mammalian Cloning: A Reassessment
November 8-11
FUNDED BY Richard Lounsbery Foundation, Inc.
ARRANGED BY P. Mombaerts, The Rockefeller University
I. Wilmut, University of Edinburgh
Welcome and Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Introduction
S. Willadsen, Saint Barnabas Medical Center, Livingston,
New Jersey: Cloning and interspecific chimeras.
I. Wilmut, University of Edinburgh, United Kingdom: Cells
from cloned embryos: Implications of observations in live-
stock.
A. Trounson, Monash Immunology and Stem Cell
Laboratories, Clayton, Victoria, Australia: Cloning by modifi-
cation of donor cells and cell fusion techniques.
M.E. Westhusin, Texas A&M University, College Station: An
update on cloning at Texas A&M: White-tailed deer and
transgenic goats.
K. Campbell, I. Wilmut
W.-S. Hwang, G. Schatten, X. Yang
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SESSION 2: Human Nuclear Transfer and Embryonic Stem Cells
W.-S. Hwang, Seoul National University, Korea: Human
nuclear transfer I: Background and status.
S.K. Kang, Seoul National University, Korea: Human nuclear
transfer II: Technical advances.
G.E. Schatten, University of Pittsburgh, Pennsylvania:
Scientific frontiers enabled by patient-specific, disease-spe-
cific, and primate-specific stem cells established using
SESSION 3: Mechanisms of Reprogramming
M. Boiani, Max-Planck Institut far Molekulare Biomedizin,
Munich, Germany: Is it all about epigenetics? A look at
nuclear organization, chromosome transmission, and
genetic mutation in clonal mouse embryos.
A. Bortvin, Carnegie Institution of Washington, Baltimore,
Maryland: Development of the next generation of
experimental approaches to the epigenetic regulation
SESSION 4: Mouse and Rat
P. Mombaerts, The Rockefeller University, New York:
Olfaction targeted.
K. Eggan, Harvard University, Cambridge, Massachusetts:
Cloning and stem cells: Interrogating development and
disease by nuclear transplantation.
K. Inoue, RIKEN, Tsukuba, Ibaraki, Japan: Cloning mice from
SESSION 5: Other Species, Ethics
J. Cibelli, Michigan State University, East Lansing: Gene
expression of reprogrammed bovine NT embryos.
C. Galli, Universita Di Bologna, Cremona, Italy:
Reprogramming somatic cells for embryonic, fetal, and off-
spring development in large animals.
X. Yang, University of Connecticut, Storrs: The health status
nuclear transfer: How to accelerate stem cell biomedical
breakthroughs globally.
L. Studer, Memorial Sloan-Kettering Cancer Center, New
York: Human embryonic stem cells and therapeutic
cloning.
A.H. Brivanlou, The Rockefeller University, New York: In vivo
assay of human ES cells.
of the genome.
K. Campbell, University of Nottingham, United Kingdom:
Oocyte kinase and development in ovine nuclear transfer
embryos.
P. Collas, University of Oslo, Norway: In vitro manipulation of
donor nuclei and cells prior to cloning.
differentiated and undifferentiated cells.
T Yagi, Osaka University, Japan: Mouse cloning with neu-
ronal nuclei.
P.M. lannaccone, Northwestern University Medical School,
Chicago, Illinois: The isolation and use of rat ES as poten-
tial nuclear donor cells in NT cloning of the rat.
of our cloned cattle as well as their offspring and their
organ/product compositions.
Y. Hosoi, Kinki University, Naga, Wakayama, Japan: In vitro
development of macaca-rabbit-cloned embryos and trials
of establishment of their cell lines.
D. Spar, Harvard Business School, Boston, Massachusetts:
The business of stem cells.
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The Intracellular Molecular Environment
November 13-16
FUNDED BY
ARRANGED BY D. Spector, Cold Spring Harbor Laboratory
J. Swedlow, University of Dundee
Cold Spring Harbor Laboratory Corporate Sponsor Program
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Nuclear Dynamics and Organization
Chairperson: T. Pederson, University of Massachusetts Medical School, Worcester
J. Gall, Carnegie Institution of Washington, Baltimore,
Maryland: Some physical properties of the nucleoplasm
and nuclear organelles.
T. Cremer, Ludwig-Maximilians-Universitat Munchen,
Germany: Mapping nuclear architecture in space and time.
A. Belmont, University of Illinois, Urbana-Champaign: Large-
scale chromatin structure and dynamics.
D. Spector, Cold Spring Harbor Laboratory: Nuclear
dynamics.
T. Pederson, University of Massachusetts Medical School,
Worcester: Matriculation of mRNA in the nucleus: The
movements are in the medium.
R. Hancock, Laval University, Canada: The crowded nucleus.
SESSION 2: Interpreting Intracellular Movement
Chairperson: K. Luby-Phelps, University of Texas Southwestern Medical Center, Dallas
K. Luby-Phelps, University of Texas Southwestern Medical
Center, Dallas: Physical constraints on the biochemistry
of the cell interior.
M. Saxton, University of California, Davis: A biological inter-
pretation of anomalous subdiffusion.
S. Schnell, Indiana University, Bloomington: Deterministic and
stochastic kinetics of reactions occurring in crowded
intracellular environments.
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M. Weiss, Deutsches Krebsforschungszentrum, Heidelberg,
Germany: Anomalous diffusion caused by molecular
crowding.
A. Elcock, University of Iowa, Iowa City: Molecular simulations
of diffusion and association under pseudocellular conditions.
G. Odell, University of Washington, Seattle: Mathematical/
computer modeling as a tool for comprehending cytoskele-
tal dynamics.
G. Odell, P. Sorger
SESSION 3: Cytoplasmic Dynamics and Signaling
Chairperson: P. Sorger, Massachusetts Institute of Technology, Cambridge
J. Marko, University of Illinois, Chicago: Mechanics of DNA-
protein complexes and whole chromosomes.
M. Engstler, Ludwig-Maximilians-Universitat, Munchen,
Germany: Navigation within a tiny but tidy cell: What can
we learn from trypanosomes?
C. Weijer, University of Dundee, United Kingdom:
Signaling to the cytoskeleton during chemotactic
cell movement.
S. Altschuler, University of Texas Southwestern
Medical Center, Dallas: Creating and maintaining
asymmetries.
P. Sorger, Massachusetts Institute of Technology,
Cambridge: Modeling cell signaling circuits.
SESSION 4: Modeling Dynamic Movements
Chairperson: G. Danuser, Scripps Research Institute, La Jolla, California
D. Eggers, San Jose State University, California: Amplified
hydration effects on binding equilibria in vivo.
E. Siggia, The Rockefeller University, New York: Fluctuations
in the cell cycle in yeast.
K. Schulten, University of Illinois, Urbana-Champaign: In situ
molecular modeling of cellular processes.
G. Danuser, Scripps Research Institute, La Jolla, California:
The dynamic regulation of two colocalized, yet functionally
distinct actin arrays in cell migration.
R. Singer, Albert Einstein College of Medicine, Bronx, New
York: Diffusion vs. transport: Where and when?
SESSION 5: Photons, Electrons, and Protons: Visualizing Intracellular Dynamics
Chairperson: M. Ellisman, University of California, San Diego
G. Dunn, King's College, London, United Kingdom:
Using FLAP to find out how molecules get to where
they are needed.
M. Ellisman, University of California, San Diego: Toward the
visible cell: Collecting and connecting mesoscale data.
G. Pielak, University of North Carolina, Chapel Hill: In-cell
NMR.
J. Swedlow, University of Dundee, United Kingdom:
Mechanistic studies of nuclear and chromosome dynamics.
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The Biology of Neuroendocrine Tumors
November 20-22
FUNDED BY Verto Institute
ARRANGED BY A.J. Levine, Institute for Advanced Study
E. Vosburgh, Verto Institute
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Biology
Chairperson: A.J. Levine, Institute for Advanced Study, Princeton, New Jersey
S.K. Kim, Stanford University School of Medicine, California:
Mechanism of islet tumor suppression by MEN-1.
0. Rosen, Dana Farber Cancer Institute, Boston,
Massachusetts: Chromatin-modifying and RNA processing
complexes of the parafibromin neuroendocrine tumor sup-
pressor protein.
X. Hua, University of Pennsylvania, Philadelphia: Coordinated
regulation of cell proliferation and apoptosis in endocrine
cells by the tumor suppressor menin.
M. Yen, Stanford University Medical Center, California:
Hormonal regulation of menin: Opportunities for therapy?
C.J. Barnstable, Yale University School of Medicine, New
Haven, Connecticut: Therapeutic potential of PEDF in con-
trolling the growth of neural tumors.
J. Tobram-Tink, University of Missouri, Kansas City: PEDF
blocks VEGFR2 signaling and angiogenesis: Potential for
reducing tumor growth and metastasis.
Keynote Speaker: J. Mendelsohn, University of Texas
M.D. Anderson Cancer Center, Houston: EGF receptors: A
target for cancer therapy.
SESSION 2: Genetics
Chairperson: E. Vosbugh, Verto Institute, Stamford, Connecticut
A.J. Levine, Institute for Advanced Study, Princeton, New
Jersey: IAS/CINJ: SNPs in the p53 pathway.
A. Rashid, University of Texas M.D. Anderson Cancer Center,
Houston: Genome-wide SNP allelotyping in carcinoid
tumors and pancreatic endocrine tumors.
E. Freed, Dana-Farber Cancer Institute, Boston,
Massachusetts: Use of SNPs to identify genes in neuroen-
docrine tumor growth and development.
M. Essand, Uppsala University, Sweden: Gene therapy and
SESSION 3: Progress in the Treatment of Carcinoid Tumors
Chairperson: L.K. Kvols, University of South Florida, Tampa
D. Hochhauser, Royal Free & University College Medical
School, London, United Kingdom: Modulation of
chemotherapy by EGFR inhibition,
R.V. Lloyd, Mayo Clinic, Rochester, Minnesota: EGFR
studies in GI carcinoids and pancreatic tumors and
response to therapy.
L.K. Kvols, University of South Florida, Tampa: Clinical
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R. Sack ler, S. Kaufer
immunotherapy of gastrointestinal neuroendocrine tumors.
F. Leu, Verto Institute, Princeton, New Jersey: CINJ: SSTR1-
5 antibodies.
C. Harris, Verto Institute, Princeton, New Jersey: CINJ: LINE
1 retrotransposons and genomic stability, role in neuroen-
docrine tumors?
C. Kuperwasser, Tufts University, Boston, Massachusetts:
Novel xenograft models of human breast cancer.
updates in carcinoid therapy.
J. Yao, Gastrointestinal Medical Oncology, Houston, Texas:
Translational research at M.D. Anderson.
M.N. Kulke, Dana-Farber Cancer Institute, Boston,
Massachusetts: Results of the phase II trial of SU11248 in
metastatic neuroendocrine tumors.
Prion Biology: Puzzles and Paradoxes
November 27-30
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Collinge, University College
C. Weissmann, The Scripps Institute
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: The Species Barrier and Prion Strains
Chairperson: J. Collinge, National Hospital for Neurology & Neurosurgery, London, United Kingdom
K. Wuthrich, The Scripps Research Institute, La Jolla,
California: Structural biology of the cellular form of prion
proteins.
J. Wadsworth, MRC Prion Unit, University College, London,
United Kingdom: Molecular basis of species- and strain-
dependent barriers in transmissibility of mammalian prions.
J. Manson, Institute for Animal Health, Edinburgh, United
Kingdom: Control of TSEs by host PrP.
M.H. Groschup, Friedrich-Loeffler Institute, Greifswald-Insel
Riems, Germany: Atypical scrapie cases in small ruminants
carry abnormal PrP with unusual biochemical features.
W.K. Surewicz, Case Western Reserve University, Cleveland,
Ohio: Molecular basis of species and strain-dependent bar-
riers in transmissibility of mammalian prions.
J. Collinge, C. Weissmann K. Wuthrich, H. Michel
S. Prusiner, C. Beisel
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SESSION 2: How Did Prions Evolve and Epidemics Originate?
Chairperson: C. Weissmann, The Scripps Institute, Jupiter, Florida
S. Mead, MRC Prion Unit, University College, London, United S.L. Lindquist, Whitehead Institute, Cambridge,
Kingdom: The genetic consequences of prion disease epi- Massachusetts: Structural insights into yeast priondemics. conversion.
R.B. Wickner, National Institutes of Health, Bethesda, L.B. Schonberger, DVRD, NCID, CDC, Atlanta, Georgia:
Maryland: Transformation of (URE3) by amyloid from Surveillance of Creutzfeldt-Jakob disease in the
recombinant Ure2p transmits three prion variants. United States.
SESSION 3: Key Issues Arising from the Day
SESSION 4: Synthetic Prions: Have We Made Them?
Chairperson: C. Weissmann, The Scripps Institute, Jupiter, Florida
S.B. Prusiner, University of California, San Francisco: Mouse
synthetic prions I.
G. Legname, University of California, San Francisco: Mouse
synthetic prions II.
I. Baskakov, University of Maryland Biotechnology Institute,
Baltimore: Mechanisms of PrP polymerization into
amyloid fibrills.
G. Jackson, National Hospital for Neurology & Neurosurgery,
London, United Kingdom: Assaying for synthetic prions.
SESSION 5: Key Issues Arising From the Day
G. Telling, University of Kentucky, Lexington: Transgenic stud-
ies of CWD and mechanisms controlling prion transmission.
B. Caughey, NIAID, National Institutes of Health, Hamilton,
Montana: Particle size and infectivity in TSE diseases.
S. Supattapone, Dartmouth Medical School, Hanover,
New Hampshire: Pr Pres formation from purified
substrates in vitro.
C. Soto, University of Texas Medical Branch, Galveston:
Generation of prions, species barrier, and prion strains.
SESSION 6: Neurotoxicity and Therapeutics in Neurodegenerative Disease
Chairperson: J. Collinge, MRC Prion Unit, University College, London, United Kingdom
C.I. Lasmezas, The Scripps Institute, Jupiter, Florida:
Mechanisms of prion-induced neurodegeneration.
D. Caspar, Florida State University, Tallahassee: Prion amyloid
fibrils and cross-0 confusion.
SESSION 7: Key Issues for Future Research
380
D.B. Teplow, David Geffen School of Medicine at UCLA:
Amyloid B-protein asembly and neurodegeneration: When
the core of the problem is not the "core."
Cancer Stem Cells
December 4-7
FUNDED BY
ARRANGED BY M. Wicha, University of Michigan
J. M. Rosen, Baylor College of Medicine
Cold Spring Harbor Laboratory Corporate Sponsor Program
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Key Questions To Be Addressed: J.M. Rosen, Baylor College of Medicine, Houston, Texas
SESSION 1: Key Signaling Pathways and Mechanisms in Stem Cell Self-renewal
Chairperson: T.D. Tlsty, University of California, San Francisco
R. Nusse, Stanford University Medical School, California: Wnt
signaling and stem cell control.
P. Beachy, Johns Hopkins University, Baltimore, Maryland:
Hedgehog signaling in tissue repair, neoplasia, and
metastasis.
P. Polakis, Genentech, Inc., San Francisco: Therapeutic
intervention of Wnt signaling in cancer.
J. Sher ley, Massachusetts Institute of Technology,
Cambridge: Adult stem cells as sites of carcinogenesis.
I.R. Lemischka, Princeton University, New Jersey: Functional
genomics and stem cells.
M. van Lohuizen, The Netherlands Cancer Institute,
Amsterdam: Polycomb repressors controlling stem cell
fate: Implications for cancer and development.
SESSION 2: Role of the Microenvironment and the Stem Cell Niche
Chairperson: R.J. Jones, Johns Hopkins University, Baltimore, Maryland
G.H. Smith, NCl/National Institutes of Health, Bethesda,
Maryland: The influence of the mammary stem cell niche on
borrowed stem cells.
T.D. Tlsty, University of California, San Francisco: Early epige-
netic and genetic events in carcinogenesis.
M. Wicha, J. Chang
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SESSION 3: Hematopoietic Stem Cells, Leukemias, and Myeloma
Chairperson: M. van Lohuizen, The Netherlands Cancer Institute,
M. Goodell, Baylor College of Medicine, Houston, Texas:
Regulation of hematopoietic stem cell self-renewal.
J.E. Dick, Princess Margaret Hospital, Toronto, Canada:
Cancer stem cells: Lessons from leukemia.
S.J. Morrison, University of Michigan Medical School, Ann
Arbor: Role of Pten in the self-renewal of normal and
leukemic stem cells.
G. Morrone, University of Catanzaro, Italy: Dissecting leuke-
mogenesis: Primary leukemic stem cells and gene-transfer-
mediated models of leukemogenesis.
SESSION 4: Solid Cancers 1
Chairperson: J.M. Rosen, Baylor College of Medicine, Houston,
O.N. Witte, University of California, Los Angeles: Prostate
stem cells and prostate cancer.
J.M. Bishop, University of California, San Francisco:
SESSION 5: Clinical Implications
Chairperson: J.M. Rosen, Baylor College of Medicine, Houston,
L. Norton, Memorial Sloan-Kettering Cancer Center, New
York: Is cancer a disease of self-seeding (by cancer stem
cells?).
J. Chang, Baylor College of Medicine, Houston, Texas:
SESSION 6: Solid Cancers 2
Chairperson: M. Wicha, University of Michigan, Ann Arbor
C. Alexander, University of Wisconsin, Madison: Mouse
mammary development and neoplasia.
M.T. Lewis, Baylor College of Medicine, Houston, Texas:
Hedgehog regulation of mammary epithelial stem/progeni-
tor cells in the mouse.
M.F. Clarke, University of Michigan Health System, Ann
Arbor: Identification and molecular characterization of
epithelial cancer stem cells in human and mouse solid
tumors.
F.M. Watt, Cancer Research, United Kingdom, London: Role
of stem cells and differentiated cells in epidermal carcino-
genesis.
Amsterdam
T Look, Dana Farber Cancer Institute, Boston,
Massachusetts: del(5q) and epigenetic suppression of
a-caterin (CTNNA1) in CD34+CD38 human AML-
initiating cells.
C. Jordan, University of Rochester School of Medicine, New
York: Novel strategies for selective eradication of leukemia
stem cells.
R.J. Jones, Johns Hopkins University, Baltimore, Maryland:
Cancer stem cells: Clinical implications.
Texas
Progenitor cells and tumorigenesis in the liver and breast: A
study with mouse models.
P. Dirks, Hospital for Sick Children, Toronto, Canada: Human
brain-tumor-initiating cells.
Texas
Breast cancer stem cells and therapeutic resistance.
G.V. Glinsky, Ordway Research Institute, Inc., Albany, New
York: A death from cancer pathway and stem cell cancer
hypothesis.
M. Wicha, University of Michigan, Ann Arbor: Role of
Hedgehog and Bmi-1 signaling in mammary stem cell self-
renewal.
R. Clarke, Christie Hospital Trust, Manchester, United
Kingdom: Isolation and characterization of human breast
stem cells.
A.A. Dlugosz, University of Michigan, Ann Arbor: Hedgehog
signaling in tumor initiation and maintenance.
R. McKay, NINDS/National Institutes of Health, Bethesda,
Maryland: Stem cell survival mechanisms in regeneration
and cancer.
SESSION 7: Key Issues of the Meeting
Moderators: M. Wicha, University of Michigan, Ann Arbor and J.M. Rosen, Baylor College of Medicine,Houston, Texas
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DOLAN DNA LEARNING CENTER
EXECUTIVE DIRECTOR'S REPORT
Preparing students and families to thrive in the gene age
ADMINISTRATION INSTRUCTION BIOMEDIA TECHNOLOGY
DEVELOPMENT
Nancy Daidola Elna Carrasco John Connolly Adrian Arva
Mary Lamont Jeanette Collette Eun-Sook Jeong Greg Chin
Stacy Leotta David Gundaker Susan Lauter Uwe Hilgert
David Mick los Natalia Hanson Chun-hua Yang Bruce Nash
Karen Orzel Laura Johns
Carolyn Reid Amanda Mc Brien
Erin McKechnie
Danielle Sixsmith
Lauren Weidler
In his book Coming into the Country, John McPhee describes his People in the region of the
experiences in Alaska, in 1976, as people anticipated the opening upper Yukon refer to their part
of oilfields and pipelines in that last great American frontier. of Alaska as "the country"
McPhee's Alaska of 1976 presents an appropriate metaphor for A stranger appearing among
biology in 2006. Like Alaska, the landscapes of genomes laid bare them is said to have
present vistas of limitless promise. Mining living genomes presents
"come into the country"
many of the same logistical and philosophical problems as mining
the Alaskan wilderness. Frontiers of all kinds challenge similar sorts of people-those anxious for
knowledge, fortune, adventure, solitude, or another chance. The desires of those who would exploit
the frontier need to be balanced against those who see it as a holy place for contemplation.
Coming into the gene age also challenges those who teach. DNA sequences from hundreds of
organisms are available to anyone with an Internet connection-as are bioinformatics tools that allow
one to explore sequence data, predict the presence of genes, and compare features shared between
different organisms. These freely available resources hold the promise of making modern biology an
egalitarian pursuit. For the first time in the history of biology, students can work with the same infor-
mation, at the same time, and with the same tools as research scientists.
Working directly with genome data can help students understand
the ever-changing concept of a gene and to conceptualize the "big pic-
1
lure" of a complex, dynamic genome. Evaluating genome evolution and
understanding our shared genetic heritage also may be the best inocu-
I lation against racism.
tunity to involve students in the ever-increasing trove of DNA data that will
to look at their own DNA and use it as an entrée to the genome world.
O
that students become adept in moving between the in vitro and in silico
worlds. Third, we need to develop more intuitive, visually pleasing com-
Second, we need to integrate bioinformatics with biochemistry labs, so
puler tools that engage students and allow them to quickly learn the rudi-
Biology researchers and educators need to seize this unique oppor-
Nchange forever how we think about life. First, we need to allow students
t
ments of gene analysis. Fourth, we need to welcome students as part-
A fictitious cover design ners in the effort to evaluate and annotate the vast number of genes that
based on John McPhee's are known only as predicted computer models.Coming into the Country
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Coming into the Gene Age
During the past year, the Dolan DNALC made significant strides to help students and teachers come into
the gene age. Working directly with CSHL researchers Lincoln Stein and Doreen Ware, we completed
major elements of the Dynamic Gene Internet site. As educational outreach for the National Science
Foundation (NSF)-funded Gramene Comparative Genomics Project, this site helps students learn mod-
ern concepts of gene structure by participating in genome research. The site is essentially an education-
al interface to the Apollo genome annotator, a research tool for editing "gene models" predicted by com-
puter algorithms. Apollo was used to annotate the Drosophila genome, and we are adapting it for use
with grain plants. The site's name emphasizes the gene both as a dynamic structure that changes through
evolutionary time and as a dynamic concept that changes with our increasing knowledge of genome
organization. The design for Dynamic Gene recalls the "streamlining movement" that influenced design
during the middle of the 20th century with ideas borrowed from aviation and automobile design.
e
Students begin with tutorials that illustrate components of genes, and how different kinds of evidence
for gene structure are gathered and compiled into gene models. Narrated videos capture the screen
movements and commentary as an expert uses the Apollo research tool to solve common problems of
gene annotation. Students can then annotate sequences at several levels: (1) Beginners can construct
gene models for individual genes, and then compare their models to a "correct" model provided by an
expert annotator. (2) At the next level, students can tackle a number of genes assembled into an "artificial
contig" and compare their models with curated results. (3) Advanced students, or whole classes, can take
on the project of a contig containing a genome region that has not been hand-curated.
We also worked with the Carolina Biological Supply Company to
develop a new line of DNA Learning Center Kits that stress the mod-
ern synthesis of molecular biology and computation. Each experiment
in the series integrates in vitro experimentation with in silico bioinfor-
matics. The experiments incorporate user-friendly features from the
DNAKITS popular DNA Science lab-text, including flow charts, marginal notes,
Learning Center and extensive instructor information. Exclusive Bio-i Guides allow stu-
dents to follow the recorded screen movements and mouse clicks of
DNALC staff as they solve bioinformatics problems tailored to each experiment. A companion CD-ROM
and Internet site provides exclusive access to the Bio-i Guides and additional e-learning tools that can
be used in class or at home. Complete instructions for each experiment can be accessed as a unique
virtual lab notebook, as well as printable PDF files. Animations on key techniques of molecular genet-
ics and genomic biology are drawn from the DNALC's award-winning Internet site, DNA Interactive.
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Molecular analysis of dumpy (dpy-13) phenotypes in C.
elegans. These photographs illustrate that RNAi pro-
duces the same dumpy (short and fat) phenotype as a
deletion in the dpy-13 gene. The agarose gel compares
PCR products from the dpy-13 gene of a wild-type worm and two worms with the Dpy phenotype. The PCR prod-
ucts from wild-type and RNAi-induced dpy-13 worms are identical, while the dpy-13 mutant shows a shorter PCR
product resulting from a chromosome deletion. This illustrates that RNAi silences gene function and produces a phe-
notype without altering the gene itself.
Bringing Revolutionary Technology into the Classroom
With the complete human DNA sequence "in the bag," ahead lies the task of understanding the func-
tion of each gene and how it interacts with other genes. Such functional studies typically rely on mutat-
ing a particular gene, and then looking for its physical or behavioral effects in a living organism.
Obviously, such studies cannot be carried out on human beings, so biologists rely on "model organ-
isms" to shed light on elements of human physiology and cell biology. Although the microscopic worm
Caenorhabditis elegans might seem an unlikely stand-in, it actually shares quite a lot of cell biochem-
istry with humans and has become a key model system in which to study gene function.
In recent years, the usefulness of the C. elegans model system has been dramatically enhanced
because it is particularly suited to the revolutionary technique of RNA interference (RNAi). This method
allows one to "silence" virtually any gene at will, within the context of a living organism. Amazingly, all that
is required is for the worm to eat or be bathed in double-stranded RNA that is complementary to the
part of the gene to be silenced. C. elegans is inexpensive to maintain, grows quickly (going from egg to
adult in several days), and populates a culture plate with thousands of offspring that can be quickly
screened for RNAi-induced phenotypes. For these reasons, we have invested in developing the RNAi /C.
elegans system to bring functional genome analysis into precollege and beginning college classes.
As 2005 drew to a close, we had working prototypes of key experiments for our NSF-funded cur-
riculum that explores the mechanism and uses of RNAi. With technical support from CSHL researcher
Greg Hannon, a pioneer in RNAi technology, and an Advisory Panellead high school and college fac-
ulty, we are prepared to test experiments at workshops to be held in San Francisco, Oklahoma, and
New York City in summer 2006.
The workshop will include an entire set of techniques for doing RNAi in C. elegans-beginning with
observation of mutant phenotypes (physical and behavioral) and basic worm "husbandry." Participants
then learn simple methods to induce RNAi and observe specific mutant phenotypes in manipulated
worms. The mechanism of RNAi is investigated in two C. elegans strains with identical "dumpy" traits:
one induced by RNAi and one caused by a chromosomal deletion. "Single-worm" polymerase chain
reaction (PCR) is used to amplify DNA from the dumpy locus, and the DNA from wild-type worms is
compared to DNA from RNAi and chromosomal mutants. Gel electrophoresis identifies the deletion in
the mutant, but not in wild-type and RNAi-treated strains, providing evidence that RNAi does not alter
the genetic code. In another experiment, a mutant phenotype is "rescued" (compensated for) by RNAi.
Participants also learn the process needed to silence any gene in the C. elegans genome, providing
the possibility for student-centered research projects. Participants learn to use online sequence data to
design primers to amplify part of a target gene and clone it into a feeding vector. The recombinant vector
is then transformed into Escherichia colt, which, in turn, are fed to C. elegans. In addition, faculty will have
access to the DNALC's own collection of RNAi-feeding strains that can be used to screen for a variety of
mutant phenotypes. The importance of C. elegans as a model for higher organisms is highlighted by bioin-
formatics exercises that show the strong relatedness of worm genes and their human homologs.
387
Building a Revolutionary Internet Site
In 2005, we began development of Genes to Cognition (G2C) Online, a modern Internet site on cur-
rent research on the molecular basis of human thinking and disorders of thinking. The project is revo-
lutionary because it is being built in parallel with a major international research program-its namesake
G2C at the Wellcome Trust Sanger Institute-and because it will employ a nonlinear, network structure
designed to provide a personalized learning experience. Our objective is to build an Internet site that
functions on several "meta" levels in that it:
Reports on and is informed by current neuroscience research.
Embodies a network structure analogous to the gene and cell networks that underlie cognition.
Encourages individuals to reflect on their own thinking and learning.
The project was launched with the first meeting of the G2C Advisory Panel on March 11 at the CSHL
Banbury Center. The 15 participants, from the United States and Europe, brought expertise from a
number of fields that will be important to the success of the project, including neuroscience research,
genetics and ethics issues, precollege and college science education, informal science education, pro-
ject evaluation, and multimedia production. At the meeting, panelists were introduced to the challenges
of producing a network-based Internet site, including building the database/meta-tag system, evaluat-
ing the system, and disseminating the system.
We relied heavily upon concept mapping during the first year of the project. Originally developed by
Advisory Panelist and education pioneer, Joseph Novak, concept maps provide a visual method to con-
dense and represent large bodies of knowledge in a meaningful way. Thus, we worked with Joe to elic-
it expert concept maps from leaders in key knowledge domains of importance to G2C Online. Merging
the individual expert maps will create a master map, whose intersections (nodes) will suggest key con-
cepts for which rich multimedia and inquiry modules will be developed. As part of this effort, we worked
with advisory panelists Laura Maitland, Mary Colvard, and Caren Gough to develop concept maps of
G2C content areas that are of direct relevance to high school/college biology and psychology curricula.
Concept maps will guide the development of the logic system of the knowledge network-a system
of meta-tags to annotate content. Each item of content for G2C Online is being built as a standalone,
independent medium item that occupies a specific space in a larger network of items, or nodes. As
more content is added, and as more visitors use the site, a network engine will dynamically build and
rebuild the network in accordance to the relationships between each node in terms of who uses them,
how they are used, and the topics they encompass. The network structure should facilitate meta-cog-
nition by helping the visitor make connections between concepts.
Concept mapping has suggested a three-dimensional array (below) to guide initial content devel-
opment and meta-tagging. Thus, if site visitors are interested in autism, they will be able to view the
disorder through a number of lenses that represent a continuum of approaches to science and phe-
nomenological levels. Thus, autism is seen not only as a disorder of behavior, but a disorder of the
brain, of neural circuits that make up the brain, of cells that make up these circuits, of proteins that sig-
nal within these cells, and, finally, of genes that encode these proteins.
Cognitive Disorders Approaches to Science Anatomical-Molecular Continuum
ADHD Neuroimaging Behavioral/clinical
Alzheimer's Electrophysiology Anatomical: Brain regions
Autism Psychological/clinical Physiological: Neural circuits
Bipolar disorder Family/epidemiological Cell biological: Signal transduction
Chronic pain Bioinformatics Molecular: DNA and genetic regulation
Depression Historical
Schizophrenia Ethical
Stroke and injury
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Hewlett Grant Completes Funding for G2C in the U.S.
From its compelling premise-to encourage students to think about the biology of thought-to its adap-
tive network architecture, to its strong connections to elite centers of biological research, G2C Online
has the potential to set a high standard for educational technology. However, to prove its real worth as
a model for others, this innovative project demands an equally rigorous evaluation and dissemination
program. Thus, we were pleased when, in October, the William and Flora Hewlett Foundation added
$470,000 to existing funding of $1 million from the Dana Foundation to support the evaluation and dis-
semination of G2C Online. The project is funded under the technology priority of Hewlett's education
program, which aims to "improve access to exemplary postsecondary and K-12 educational content
through a variety of approaches." The Hewlett grant will support several major objectives:
Integrate insights from cognitive and neuroscience research into Internet site construction. As part
of this objective, in Fall 2006 we will convene a high-level workshop at the CSHL Banbury Center
to draw together 30-40 Internet site developers and experts from diverse field to conceptualize fea-
tures of Internet sites of the future.
Determine how concept maps can support Internet site construction and student learning. This objec-
tive supports the construction of expert concept maps to guide creation of the G2C "knowledge net-
work" and classroom studies to determine how concept mapping supports student meta-cognition.
Demonstrate how Internet education materials developed alongside current research efforts can sup-
port and extend syllabus-centered teaching with examples of science process. This objective will offer
insight into how supplementary Internet materials can fit into a school system that is increasingly dri-
ven by standardized testing-with a focus on Advanced Placement biology and psychology courses.
Provide insight into how different audiences interact with multimedia content and how narrative ver-
sus exploratory modes influence understanding of neuroscience concepts. This objective supports
research on how students and teachers make use of the G2C knowledge network.
Distribute G2C Online to biology and psychology educators. This objective will support nationwide
training workshops for 480 biology and psychology teachers, as well as presentations at teacher
professional meetings.
The Hewlett award puts us in the company of other high-level Internet developers. We are current-
ly exploring partnerships with two other Hewlett grantees: public broadcaster WGBH and the Berkeley
Lab's Center for Science & Engineering Education. The strength of both Dana and Hewlett support
puts us in a strong position to realize our goal to obtain funding for a parallel evaluation and dissemi-
nation program in Great Britain.
Internet Collaborations Extend Our Leadership
The DNALC participated in several high-level Internet collaborations in 2005. Key among these was the
announcement in October of a $2.8 million consortium grant from the National Science Digital Library
program of the NSF. Under the grant, the DNALC will receive $250,000 over 4 years to catalog and
make more than 100 hours of its proprietary Internet content available through the BiosciEdNet (BEN)
Collaborative. Headed by the American Association for the Advancement of Science, the BEN
Collaborative is primarily a cooperative of professional societies that are making their content available
through the BEN portal. The DNALC is one of only several independent content producers, among
more than 20 collaborators included in this second phase of the project.
The BEN Collaborative is part of the DNALC's ongoing effort to decompose its narrative content so
that constituent content "molecules" and "atoms" can be searched for and viewed independently. The
DNALC will make available, through the BEN Collaborative, multimedia elements from its eight major
content sites. This will include approximately 200 content molecules (multimedia units, activities,
lesson plans, and laboratories) and 5000 content atoms (individual multimedia items: animations,
video, photographs, and flat art).
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We continued to participate in the development two
Internet sites funded by the National Institutes of Health
(NIH). The Cancer Biomedical Informatics Grid (CaBIG,
https://cabig.nci.nih.gov/) is an Internet resource to share
data and tools among cancer researchers. The DNALC is
lending its expertise to the Training Work Space, which is
creating standards and templates to help collaborators con-
struct a unified knowledge base. We also collaborated with
the Fralin Biotechnology Center at Virginia Tech to design
and program an online platform for their NIH Partnership for
Research and Education in Plants (PREP; www.prep.
biotech.vt.edu). This work was funded through the same
NIH program that funded our Inside Cancer Internet site. The
PREP Online Lab Notebook provides an environment to
support student experiments with the model plant
Arabidopsis. Students grow mutant and wild-type plants
under various conditions, record their observations, and
attempt to understand how mutations affect response to
environmental stimuli. Plant scientists participate in the pro-
ject by providing mutants and offering advice to participating
students and teachers. The PREP Internet site coordinates
with the DNALC's Greenomes site (www.greenomes.org), a
set of molecular genetic experiments with Arabidopsis and
corn.
Real and Virtual Visitors Increase
Real and virtual visitors continued to increase in 2005. During the year, the DNALC had 38,654 visitors,
a 3% increase from the previous year. Key among these were 29,910 students and teachers who con-
ducted lab experiments at the DNALC, in local schools, and at training workshops at sites around the
world. Visits to the DNALC's family of Internet sites rose 13%, to 6.15 million. DNA Interactive, regis-
tered the largest increase (48%), followed by Your Genes, Your Health (32%) and Genetic Origins (28%).
Much of this growth was due to a sophisticated indexing system that makes multimedia content more
"visible" to search engines that are accustomed to html and text documents.
Internet Site
Average visit
length (in minutes) Visits in 2005
Increase from
2004 (%)
Gene Almanac 8:37 2,110,416 -1.20%
DNA from the Beginning 8:58 1,355,681 7.18%
Your Genes, Your Health 7:26 1,139,401 32.40%
DNA Interactive 7:27 964,919 48.43%
Image Archive on the American
Eugenics Movement 8:54 286,403 1.06%
Bioservers 16:03 159,228 15.39%
Genetic Origins 7:38 140,318 28.71%
All Sites 9:18 6,156,366 13.13%
390
Taking into account that 60% of American Internet users now use high-speed connections, the
DNALC updated two of its older Internet sites in Flash MX, the media integration standard for broad-
band. The Internet portal Gene Almanac was entirely reconceived. A scrolling "belt" across the middle
of the screen provides access to nine DNALC Internet sites, and examples of more than 1000 multi-
media items load randomly in a showcase window at top right. A drawing of the DNALC facility anchors
the lower part of the screen along with access to DNALC services, and the correct phase of the moon
plies the deep blue background above. Image Archive on the American Eugenics Movement, original-
ly released in 2000, received a face-lift that gave it enhanced search features and added cross-refer-
encing and interactive images. Users can now sort images by topic, time period, object type, and orig-
inating archive. Quick links allow users to access images from the same topic, time period, or archive.
Image viewing has been simplified by Zoomify, which allows users to seamlessly move between low-
and high-resolution images. (Rather than loading separate "normal" and "detailed" image files, Zoomify
loads a single high-resolution image.) Visitors then interact with the image-panning across the image
and zooming in at any point.
Students participating in camps
during summer 2005
Faculty Fellowships and Training
With the support from NSF and U.S. Department of Agriculture plant research programs, we hosted
five biology faculty and two student fellows in the summer of 2005. Three faculty participated in the
development of the Dynamic Gene Internet site: Robert Wheeler of Pine Creek High School (Colorado
Springs), Dr. Debra Burhans of Canisius College (Buffalo, New York), and Cesar Gutierrez of John H.
Reagan High School (Austin, Texas).
The second program, "Building Leadership to Expand Participation of Underrepresented Minorities
in Plant Genetics and Genomics" is the educational outreach component of genome research con-
ducted by CSHL researcher Dick McCombie. Two pairs of faculty-student fellows who spent 3 weeks
at Cold Spring Harbor were funded by this NSF grant: Dr. Mary Smith and Timothy Raines from North
Carolina Agricultural and Technical State University in Charlotte, North Carolina, and Dr. Muhammad
Mian and Jonathan Gibbs from Rust College in Holly Springs, Mississippi. The student and faculty fel-
lows participated in a mix of activities at the DNALC and the Hazen Genome Sequencing Center.
In 2005, we continued our NSF-funded Greenomes workshops to train college faculty to use our
laboratory- and Internet-based curriculum, bringing students up to date with modern plant research.
The objective is to use plant systems to illustrate major concepts of molecular and genomic biology,
including the relationship between phenotype and molecular genotype, genetic modification of plants
and detection of transgenes in foods, and linkage and bioinformatics methods for gene mapping.
Sixty-two faculty participated at weeklong Greenomes workshops conducted at San Jose State
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University, California (site host Dr. Katy Korsmeyer), Cornell University, Ithaca, New York (site host Dr.
Sharon Mitchell); and Virginia Polytechnic Institute and State University, Blacksburg, Virginia (site host
Dr. Erin Dolan). We also collaborated with 2004 NSF fellows Dr. Javier Gonzalez-Ramos and Dr. Olga
Kopp to conduct regional 3-day plant workshops at at Texas A&M University Agricultural Research and
Extension Center in Weslaco and at the Utah Valley State College in Orem. Thirty-one high school and
college faculty conducted experiments from the Greenomes curriculum.
In 2005 we partnered with Carolina Biological Supply Company (CBSC) to significantly expand our
presence at teacher professional meetings. CBSC has distributed DNALC experiment kits to science
teachers since 1986, so we were pleased when they offered to provide us free space in the large
exhibits they organize for teacher meetings around the United States. Sharing exhibit space with
CBSC-and cosponsoring workshops with them-allowed us to reach 381 educators at 11 mini-
workshops held at five conventions: the National Science Teacher Association (NSTA) National
Convention, Dallas, Texas; the National Association of Biology Teachers (NABT) National Convention,
Milwaukee, Wisconsin; the California Science Teacher Association (CSTA) Annual Convention, Palm
Springs, California; the Texas Science Teacher Association (CAST) Annual Meeting, Houston; and the
National Science Teacher Association (NSTA), regional convention, Nashville, Tennessee.
Cold Spring Harbor Partnership
Since its founding in 1988, the DNALC's interaction with students has been limited to several hours
during academic-year field trips or several days during summer DNA camps. In the fall of 2005, we
realized a long-held goal of having a sustained relationship with students, when we welcomed our first
class of 21 students from neighboring Cold Spring Harbor High School (CSHHS) into the CSH
Partnership Program. The full-year course is cotaught by DNALC staff and CSHHS biology teacher
Scott Renart. On alternating days, students spend their final two periods at the DNALC doing bio-
chemical experiments or bioinformatics.
Under the program, CSHHS students have the opportunity to access experiment and computer
technology developed by the DNALC over the past 20 years with more than $10 million in federal and
foundation support. The students conducted a range of experiments in bacterial, plant, animal, and
human systems that would typically be found in an upper-level biology elective at a major research uni-
versity. Students learned principles of gene manipulation by making and analyzing recombinant DNA
Cold Spring Harbor High School students work with Dave
Mick los in the computer laboratory. Newly installed graphics
depict a DNA sequence from the mitochondrial control region
studied in human genetics programs at the DNALC.
CSHHS biology teacher Scott Renart discusses details of a
molecular genetics laboratory with a student.
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molecules in the bacterium E. coll. The class then moved on to study genome analysis in the model
plants Arabidopsis and corn, to assay for transgenes in genetically modified (GM) food, and to explore
newly sequenced genes in rice. In a unit on human genetics, students looked at variations in their own
DNA, explored human origins, and performed a population study on the molecular basis of taste and
smell. The year ended with the students testing our latest set of experiments using RNAi to silence
genes in the nematode worm C. elegans.
Genetics as a Model for Whole Learning
Our middle school outreach program, Genetics as a Model for Whole Learning (GMWL), continues to
offer a variety of age-appropriate activities and experiments designed to introduce 5-7th grade stu-
dents to genetics. During the academic year, we worked closely with teachers and administrators to
develop sequential programs that include in-school instruction by DNALC instructors, field trips to the
DNALC, and in-service science training for teachers. Despite lean times for education in Long Island
school districts, more than 60 school systems participated in the 2005 program, with 9900 students
participating in lab field trips at the DNALC, and 9500 students receiving in-school instruction from
DNALC staff.
In-school instruction typically included microscopic examination of cells, observing mutations in
Drosophila, making DNA models, and studying the genetics of human traits. Armed with the basics of
cell biology and genetics, students are then prepared for a culminating field trip to the DNALC. As in
years past, the most popular field trip experiences included extracting DNA from bacteria, genetically
engineering bacteria with a gene for bioluminescence, touring our interactive exhibit The Genes We
Share, and solving The Mystery of Anastasia computer lab. A new lab, CSI: Learning Center, taps into
the popular forensics theme of nighttime television. Students bring their enthusiasm for all things CSI,
and we supply them with the DNA science behind crime scene analysis.
Many of the founding GMWL districts-including Syosset, Jericho, Great Neck, Locust Valley, and
Half Hollow Hills-have gone on to develop sequenced genetics instruction at several grade levels
taught by their own staff. These districts serve as models for other districts striving to meet new state
and national teaching mandates in science. To aid in this effort, we now include information on how our
labs align with New York State, Federal, and AAAS standards for science teaching.
Watson School of Biological Sciences
Our collaboration with the Watson School of Biological Sciences provides the CSHL graduate students
with a unique teaching opportunity. Rather than the traditional training of graduate students as
Teaching Assistants, Watson School students complete a spring rotation working with middle and high
school students at the DNALC. During the course of 12 half-day sessions, students work in pairs under
the tutelage of seasoned DNALC instructors.
During the first phase of the training, students observe a DNALC instructor deliver a laboratory to a
visiting class. Postobservation, the students begin to organize a lesson plan, which integrates their own
experience within the context of a specific experiment. The second phase is coteaching, during which
each student is responsible for delivering a specific part of the laboratory. The third phase is indepen-
dent instruction, during which the students work together to present an entire laboratory under the
observation of the DNALC instructor. During each phase, students receive oral and written critiques
aimed at strengthening their presentation and class management skills. After repeating this learning
process at the middle school and high school levels, the students are required to independently teach
an additional three lessons of their choice.
Some students opt to travel to a local school district to deliver instruction to several middle school
classes. Although the CSHL graduate students are well versed in molecular biology, few have ever
attempted to teach these concepts to young students. We believe that the skills required to deliver a
successful lab experience to precollege students-engagement, organization, and time manage-
ment-are the same skills needed to communicate with any audience.
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Saturday DNA!
Saturday DNA! continues to involve families in hands-on, minds-on explorations of advances and
issues in genetics. Each 2-hour program is designed for children 10-13 years of age (with an accom-
panying adult) or groups ages 14 through adult (with chaperone for participants under 15). During the
year, we presented the "Best of Saturday DNA!"-rescheduling previously popular programs such as
"RNAi: The Destroyer" and "Food for Thought."
New programs included "Walking Whales and Genetics Tales," which explored the ancient relation-
ship between whales and hippos. Although these two animals are physically very different, participants
used sequence analysis to show their close genetic connections. "Stem Cells: When Does Life Begin?"
broke free of the traditional lab setting, allowing participants to explore the science behind stem cell
research. Participants then used their newfound knowledge to defend a point of view in a debate on
the social and ethical issues of stem cell research.
Staff and Interns
The management of the DNALC was significantly bolstered in 2005 with a number of high-level
appointments. Uwe Hilgert was named assistant director, a post that had been vacant for several years.
After joining the DNALC in November 2000, Uwe quickly took over bioinformatics instruction of a
Howard Hughes Medical Institute program. He received a Ph.D. from the Max-Planck Institute for Plant
Breeding in Cologne and conducted postdoctoral research at the University of Arizona. Uwe is respon-
sible for managing the instructional staff and interns, for overseeing laboratory operations here and at
DNALC West, and for organizing workshops and presentations at professional meetings.
John Connolly took the reins as lead producer for G2C Online. John recently received his Ph.D. in
neuropsychology from Trinity College, Dublin. His background in neuroscience and sociological
research will facilitate his work with the broad range of G2C collaborators. Bruce Nash and Greg Chin
were specifically recruited to jump-start our effort to popularize C. e/egans and RNAi in biology instruc-
tion. Bruce received his Ph.D. in medical and molecular genetics at the University of Toronto. He did
postdoctoral research on cell division in C. elegans at the University of Oregon. Greg received his Ph.D.
in developmental biology from Stanford University, followed by a postdoctoral period at the DNAX
Research Institute and teaching at the University of California, Los Angeles.
Bruce Nash, Uwe Hilgert, John Connolly, and Greg Chin
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Laura Johns, Stacy Leotta, and David Gundaker
We were also pleased when Danielle Kearns-Sixsmith returned part-time to the DNALC to take on
evaluation of the G2C site as part of her doctoral research in education at the University of Phoenix,
Arizona. Formerly an education manager at the DNALC, she has a B.S. in biological sciences and M.S.
degrees in secondary science education and educational leadership. David Gundaker joined the full-
time staff as laboratory instructor. With a master's degree in teaching and experience in middle schools
in Fort Collins, Colorado and on Long Island, Dave brings depth to the instructional group. In the fall,
Stacy Leotta became a part-time member of the DNALC administrative staff. Laura Johns stepped in
as part-time lab instructor, filling a gap when Elna Carrasco left on maternity leave. Laura has a bach-
elor's degree in genetic engineering, has done graduate work in marine chemistry, and has experience
cloning ion channels at a small biotech company. Another new addition to the DNALC "family" came
in August when middle school educator Erin Maroney was married to James McKechnie.
During the year, we bid farewell to five staff members at the DNALC: Judy Cumella-Korabik, Dr.
Shirley Chan, Dr. Tom Bubulya, Dr. Craig Hinkley, and Tracy Behar. Program Manager since 1993, Judy
instituted many of the successful administrative methods that helped the DNALC prosper over the last
decade. Shirley was the first multimedia producer hired by the embryonic Biomedia Group in 1997 and
did much of the editorial work for four major Internet sites: DNA from the Beginning, DNA Interactive
(DNAO, Your Genes, Your Health (YGYH), and Inside Cancer. She is now director of interactive media
at Anatomical Travelogue in Manhattan. After helping to significantly reorganize the DNALC research
and development component, Tom and Craig left their positions as scientific managers. Tom moved
with his family to Dayton, Ohio, where he is an instructor in the Department of Biological Sciences at
Wright State University. Craig and Tom worked as a team to develop and test new instructional proto-
cols. Craig joined the biology department of Kingsborough Community College, CUNY. Tracy Behar
left her position as laboratory instructor to teach science at Elwood High School.
High school interns continued to provide key support for our teaching labs, and several carried out
independent research projects under the direction of DNALC and CSHL staff. Rachel Stephan (Kings
Park High School), a new addition to the intern team, worked with Bruce Nash on an independent
research project investigating the effect of known cancer genes on RNA interference.
Our sequencing service continued to grow with the help of college interns Alina Duvall (Hofstra
University), Jennifer Aiello (C.W. Post), and newcomer Alexandra Sloane (Loyola College, Maryland). To
process the growing number of requests, we now collaborate with Dr. Dick McCombie's group at the
Woodbury Genome Center, where high-throughput capillary sequencing has greatly reduced the turn-
around time.
Joining the intern program in 2005 were Matthew Giambrone (Walt Whitman High School), Ian
Hogg (Friends Academy), Matthew Levy (Kings Park High School), Ronnie Morasse (Plainedge High
School), Margarita Varer (Huntington High School), Nick Wilken (Kings Park High School), and Janice
Yong (Kings Park High School).
Several interns returned from college to assist with summer workshops: Benjamin Blonde (Amherst
College), Bryn Donovan (University of Delaware), Michelle Louie (George Washington University), Marie
Mizuno (Binghamton University), and Alex Witkowski (SUNY, Albany).
In August, we bid farewell to the following interns as they began their freshman year at college:
Regina Hu (Northport High School) is studying professional pharmacy at St. John's University; Kimberly
Izzo (Kings Park High School) is pursuing a double major in biology and vocal performance at Indiana
University; Andrew Langer (John H. Glenn High School, Elwood) is studying computer engineering at
SUNY Binghamton; and Elena Melius (Oyster Bay High School) is studying business at Washington
University in St. Louis.
David A. Mick los
Executive Director
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2005 Workshops, Meetings, and Collaborations
January 8
January 11
February 3
February 12
February 15
March 3
March 9
March 9
March 10-11
March 11
March 15
March 15-16
March 21
March 22
March 30-April 1
March 31
April 2
April 4
April 5
April 9
April 11
April 14
April 18
April 22
April 29
May 3
May 9-11
May 14
May 23
May 24
May 25
June 2
June 6-8
June 11
June 15-17
June 20-24
June 21
June 21
June 25-July 9
June 26-July 16
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Saturday DNA!, "A Bug's Life," DNALC
Site visit and museum tour for Watson School of Biological Sciences Students
Site visit and tour by Jim Parrish, Roger Phillips, Lisa Darmo, and Lawrence Wallace of
Carolina Biological
Saturday DNA!, "CSI: Learning Center" and "Animal Models: Showing Off Genes,"
DNALC
West Side School Lecture
Site visit by Xiao-ya Chen, Ai-Zhen Zhang, Yu-lian Wu, Qi Qian, Rui Ming, and Gengxin
Chen of Zhejiang University, China
Genetics Education Program for High School Biology Teachers
Site visit by Robert Ballard, Renea Hardwick, Kathy Kegley, and John Cummings of
Clemson University, South Carolina DNALC
G2C Advisory Panel Meeting with Robert Ballard, Renea Hardwick, John Cummings,
John Coffey, Mary Colvard, Seth Grant, Louise Gruenberg, Russ Hodge, Pauline
Lowrie, Joseph D. McInerney, Joseph Novak, Sarah Robinson, Arati Singh, and
Bronwyn Terrill, the Banbury Center
Site visit by WLIW (Channel 21); filming for "Ticket" about the cultural and public offerings
at CSHL
Site visit by Neil Sandler and Darlene Backelman, Symphony Capital, New York
Genetics Education Program for High School Biology Teachers
Site visit by Jean Caron, Abby Demars, Jessica Powell, Gary Johnson, Iry Schloss, and
Dennis Curran of DNA Epicenter, New London, Connecticut
Genetics Education Program for High School Biology Teachers
NSTA National Meeting, Dallas, Texas
West Side School Lecture
Saturday DNA!, "Food for Thought" and "When Dinosaurs Roamed the Earth," DNALC
Great Moments in DNA Science Honors Student Seminar, CSHL
Genetics Education Program for High School Biology Teachers
Saturday DNA!, "It's Not Just Scientists" and "Stem Cells: When Does Life Begin?,"
DNALC
Great Moments in DNA Science Honors Student Seminar, CSHL
Site visit and museum tour for Ed Blaskey, Commerce Bank, Melville, New York
Great Moments in DNA Science Honors Student Seminar, CSHL
Site visit and tour by Jim Chinitz, VP Enzo BioChem, Farmingdale, New York
Site visit by Robert Frehse, Executive Director of The William Randolph Hearst
Foundation, Manhattan, New York
Site visit by Tahashi Hirata, Chairman, and Hirofumi Nakano, Research Fellow of Kyowa
Hakko Biofrontier Laboratories, Tokyo, Japan
Human DNA Variation, Populations, and Medicine Meeting for Novartis Oncology
Saturday DNA!, "Walking Whales and Genetic Tales" and "Is There a Neanderthal in Your
Family Tree?," DNALC
Site visit and tour by Jon Cooper, Suffolk County Legislature, Huntington, New York
Site visit and tour by Janet Jones, Director of Community Affairs at Verizon, Garden City,
New York
Huntington High School Young Professional Group Meeting hosted by Public Affairs
Office
Site visit by Kidgie Williams, diplomats and family members of UN representatives, hospi-
tality committee for United Nations Delegations, Inc., Manhattan, New York
NSF Plant Molecular Genetics and Genomics Workshop, Orem, Texas
Saturday DNA!, "The Fluid of Life" and "RNAi: The Destroyer," DNALC
NSF Plant Molecular Genetics and Genomics Workshop, Weslaco, Texas
NSF Greenomes Workshop, San Jose, California
Site visit by Joe Novak, Institute of Human and Machine Cognition (IHMC), Florida; Laura
Maitland, AP Psychology Consultant; and Mary Colvard, Education Consultant
Site visit by Tom Dolan, Principal; Scott Renart, Science Teacher; and 70 students and
parents from Cold Spring Harbor High School
NSF Faculty Fellowship, Robert Wheeler, Pine Creek High School, Colorado Springs
Site visit by Ai Hoon Soh, Meridian Junior College, and Peow Ming Foo, Victoria Junior
College, Singapore
June 27-June 30 Fun with DNA Workshop, DNALC
Fun with DNA Workshop, DNALC West
World of Enzymes Workshop, DNALC
June 27-July 2 NSF Faculty Fellowship, Dr. Debra Burhans, Canisius College, Buffalo, New York
June 27-July1 Site visit by Judy Holwell, University of Georgia
July 3-16 USDA Faculty Fellowship, Charlie Gutierrez, John H. Reagan High School, Austin, Texas
July 5-8 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC West
Green Genes Workshop, DNALC
July 7 Site visit by William Fair, VP, Monique Salazar, and Dun Wang from East River Science
Park/NYC Economic Development Corporation, Manhattan, New York
July 7 Site visit by Christopher Richie, National Institute for Diabetes and Digestive and Kidney
Diseases, NIH
July 8 G2C Online Interview with Jeffrey Lieberman, Columbia University, New York
July 10 NSF Faculty Fellowship, Mary Smith and Timothy Raines, North Carolina State University,
Greensboro, North Carolina; and Muhammad Mian and Jonathan Gibbs, Rust College,
Holly Springs, Mississippi
July 11 G2C Online Interview with David Porteous, University of Edinburgh,
United Kingdom
July 11-15 World of Enzymes Workshop, DNALC
Genetic Horizons Workshop, DNALC
July 12 G2C Online Interview with Daniel Weinberger, National Institute of Mental Health,
Maryland
July 13 G2C Online Interview with Pat Levitt, Vanderbilt University, Tennessee
July 18 G2C Online Interview with Sukhi Shergill, Kings College London, United Kingdom
July 18-22 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
July 25-29 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
July 25-29 Bioinformatics in the Classroom Workshop, St. Paul, Minnesota
July 26 Site visit by Frank Posillico, President of Rose Racanelli Real Estate, Dolan DNALC
Corporate Advisory Board member
July 27 Site visit and tour by Kaoru Ushijima, Director, Museum Management Division, Chiba
Prefectural Government, Tashiro, Director/Curator of the Japan Science Foundation,
and translator, Chiba, Japan
August 1 G2C Online interview with Karim Nader, McGill University, Canada
August 1 Site visit by Arthur Spiro, CSHL Trustee, and Cary and Lisa Kravat of Kravat Fabrics
August 1-5 NSF Plant Genetics Workshop, Ithaca, New York
August 1-5 Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC West
Genetic Horizons Workshop, DNALC
August 3 G2C Online interview with Earl Miller, Massachusetts Institute of Technology
August 3 G2C Online interview with Howard Eichenbaum, Boston University,
Massachusetts
August 3 Site visit by Doug Sipp, Miki Murase, Naoki Nambi, and Toshitsugu Hirauchi of the
Ricken Center for Developmental Biology, Japan
August 4 G2C Online interview and site visit by Seth Grant, Wellcome Trust Sanger Institute,
Cambridgeshire, United Kingdom, and Joseph Novak, Institute of Human and Machine
Cognition (IHMC), Florida
August 5 G2C Online interview with Ron Davis, Baylor College of Medicine, Texas
August 8-12 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
August 8-12 NSF Plant Genetics Workshop, Blacksburg, Virginia
August 10-12 Site visit by Laura Maitland, AP Psychology consultant, New York
August 15-19 Genomic Biology, PCR, and Bioinformatics Workshop, Aspen, Colorado
August 15-19 Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Genetic Horizons Workshop, DNALC
August 16-19 Site visit by Laura Maitland, AP Psychology consultant, New York
August 22-26 Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
August 25 Site visit and tour by the Champalimaud Foundation, Lisbon, Portugal
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August 29-Sept. 2
August 29-31
August 30
September 12
September 13
September 14
September 28
October 5-9
October 7
October 15
October 17
October 19
October 24
October 25-29
October 27-29
October 27-29
October 30
November 2
November 7
November 8-9
November 9
November 11
November 12
November 16
November 17
Nov. 21-Dec. 9
November 28
Nov. 28-Dec. 10
December 1-3
December 10
December 30
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World of Enzymes Workshop, DNALC
Site visit by Laura Maitland, AP Psychology consultant, New York
Site visit and tour by Marianne Caton, Director of Internal Communications, and James
Cuniglio, Communications Coordinator, Arrow Electronics, Melville, New York
Public Meeting for Long Island ALS families on ALS research
Cold Spring Harbor High School Partnership Program commences
Site visit by Brad Stefanoni, Director of Business Partnerships, and Lisa Blair, Science
Education Center Director from Southeast Kansas Education Service Center,
Greenbush
Site visit by Jane Block, former Dolan DNALC Corporate Advisory Board member
NABT National Convention, Milwaukee, Wisconsin
G2C Online Interview with Davie Van Vactor, Harvard Medical School, Massachusetts
Saturday DNA!, "The Building Block of Life" and "Food for Thought," DNALC
"Building Family Programs" panel presentation by Long Island Museum Association
Site visit by Rob Dickstein of Pall Corporation, Dolan DNALC Corporate Advisory Board
member
West Side School Lecture
ASHG Convention, Salt Lake City, Utah
CAST Convention (Texas Science Teachers), Houston
CSTA Convention (California Science Teachers), Palm Springs
Site visit by Long Island Association (LIA)
Site visit by Christine Leonardis, Manager Business Development from Long Island
Works Coalition
Site visit by Chris Barlow-Stewart from the University of Sydney, Australia
STANYS Conference, Ellenville, New York
Excellence in Science Award Reception for the American Association of University
Women, Huntington Branch
Site visit by Scott Livingston, Managing Partner from Axiom Capital Management,
Manhattan, New York
Saturday DNA!, "CSI, Learning Center" and "Is There a Neandertal in Your Family Tree?,"
DNALC
Site visit by members of the Three of Garden Club of
America, Cold Spring Harbor area
Site visit by Ed Guiliano, President of New York Institute of Technology, and Lexa Logue,
Provost
Teacher Training Workshop, National Institute of Education and Singapore Science
Center, Singapore
Site visit by Dori and Peter Tilles (Doris M. and Peter S. Tilles Foundation) and Pat and
Edward Travaglianti (CSHL Trustee and President of Commerce Bank of Long Island)
Teacher training at the DNALC, Tan Chwee Li, Fengshan Primary School; Ngian Bang
Yee, Seng Kang Primary School; Chua Yen Ling, Monfort Junior School; and Yean Sok
Kheng, Yio Chu Kang Primary School; Singapore
NSTA Southern Area Convention, Nashville, Tennessee
Saturday DNA!, "The Mystery of Anastasia Romanov" and "RNAi: The Destroyer,"
DNALC
Site visit by Janos Posfai from New England BioLabs, Inc.
Sites of Major Faculty Workshops 1985-2005
Key: Middle School College High School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA California State University, Fullerton 2000
Canada College, Redwood City 1997
Contra Costa County Office of Education, Pleasant Hill 2002
Foothill College, Los Altos Hills 1997
Harbor-UCLA Research & Education Institute, Torrance 2003
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001
San Francisco State University 1991
San Jose State University 2005
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
University of Miami School of Medicine 2000
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
National Center for Biotechnology Information, Bethesda 2002
MASSACHUSETTS Beverly High School 1986
Biogen, Cambridge 2002
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MINNESOTA University of Minnesota St. Paul, St. Paul 2005
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990, 1991
MISSOURI Stowers Institute for Medical Research, Kansas City 2002
Washington University, St. Louis 1989
Washington University, St. Louis 1997
NEW HAMPSHIRE New Hampshire Community Technical College, Portsmouth 1999
St. Paul's School, Concord 1986, 1987
NEVADA University of Nevada, Reno 1992
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
NEW YORK Albany High School 1987
Albany UWE 2004
Bronx High School of Science 1987
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Columbia University 1993
Cold Spring Harbor High School 1985, 1987
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Stuyvesant High School 1998-1999
The Rockefeller University 2003
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Lake Saranac 2001
Union College, Schenectady 2004
US Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA Center for Health Research, Triangle Park 2003
North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA Oklahoma City Community College 2000
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Clemson University, Clemson 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS Austin Community College-Rio Grande Campus 2000
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
Virginia Polytechnic Institute and State University, Blacksburg 2005
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001
University of Washington, Seattle 1993, 1998
WASHINGTON, D.0 Howard University 1992, 1996
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999
Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001-2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University, Uppsala 2004
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COLD SPRING HARBOR
LABORATORY PRESS
2005 PUBLICATIONS
SERIALS
Genes and Development, Vol. 19, 1-3128
(www.genesdev.org)
Genome Research, Vol. 15, 1-1858 (www.genome.org)
Learning and Memory, Vol. 12, 1-664
(www.learnmem.org)
Protein Science, Vol. 14, 1-3188
(www.proteinscience.org)
RNA, Vol. 11, 1-1952 (www.rnajournal.org)
Cold Spring Harbor Symposia in Quantitative Biology
Vol. 69: Epigenetics (www.cshl-symposium.org)
LABORATORY MANUALS
Methods in Yeast Genetics: A Cold Spring Harbor
Laboratory Course Manual, 2005 Edition, David C.
Amberg, Daniel J. Burke, and Jeffrey N. Strathern
Protein-Protein Interactions: A Molecular Cloning
Manual, 2nd Edition, Erica A. Golemis and Peter D.
Adams (eds.)
Basic Methods in Light Microscopy David Spector
and Robert D. Goldman (eds.)
HANDBOOKS
Lab Dynamics: Management Skills for Scientists, by
Carl M. Cohen and Suzanne L. Cohen
Laboratory Research Notebook
MONOGRAPHS
RNA World, 3rd Edition, Raymond F. Geste land,
Thomas R. Cech, and John F. Atkins (eds.)
Telomeres, 2nd Edition, Titia de Lange, Vicki Lundblad,
and Elizabeth Blackburn (eds.)
The Dog and Its Genome, Elaine A. Ostrander, Urs
Giger, and Kerstin Lindblad-Toh (eds.)
Cell Biology of Addiction, Bertha K. Madras, Christine
M. Colvis, Jonathan D. Pollock, Joni L. Rutter, David
Shurtleff, and Mark von Zostrow (eds.)
GENERAL INTEREST
The Inside Story: DNA to RNA to Protein, Jan
Witkowski (ed.)
Landmark Papers in Yeast Biology, Patrick Linder,
David Shore, and Michael N. Hall (eds.) (includes CD)
You, Me, and HIV: With Knowledge We Have Hope! by
Fran Balkwill and Mic Rolph. English, Zulu, and
Afrikaans editions. Educator's Guide (in English)
OTHER
CSHL Annual Report 2004: Yearbook Edition
CSHL Annual Report 2004
Banbury Center Annual Report 2004
Watson School of Biological Sciences Annual Report 2004
WEB SITES
www.evolution-textbook.org: Web site to accompany
Evolution (December 2006 pub date)
www.gastrulation.org: Updated with downloadable fig-
ures from Gastrulation
www.proteinsandproteomics.org: Updated with release
of Protein-Protein Interactions: A Molecular Cloning
Manual, 2nd Edition
www.rna.cshl.edu: Web site to accompany RNA World,
3rd Edition. Includes downloadable chapters from the
2nd edition.
www.you-me-and-hiv.org: Web site to accompany You,
Me, and HIV: With Knowledge We Have Hope!
402
A selection of recently published books
The journal publishing program
COLD SPRING HARBOR LABORATORY PRESS
EXECUTIVE DIRECTOR'S REPORT
Cold Spring Harbor Laboratory Press is the largest of the five educational divisions of the Laboratory.
Continued expansion in recent years has resulted in a staff of 55, offices on the Woodbury campus,
marketing operations based in San Diego, California; Oxfordshire, United Kingdom; and Tubingen,
Germany; and distributors in Japan, China, Korea, India, and South America.
The Press has a mission to further and financially support the Laboratory's commitment to the
advance and spread of scientific knowledge. Our research journals, books, and manuals assist the con-
tinuing professional education of working scientists and graduate students, our textbooks help to edu-
cate college undergraduates, and our other books delve into the practice, personalities, and history of
science and its influence on medicine, business, and social policy. Financially, in 2005, for a second con-
secutive year, the Press substantially exceeded its budgeted financial goals, with an operating margin of
more than $670,000 and income of over $9.75 million. Its total contribution to the Laboratory's econo-
my, including support for institutional overhead and depreciation, was over $1,250,000.
Several achievements underpinned this strong performance. Innovative production management,
including the use of off-shore vendors for composition and printing, generated significant cost savings
in book and journal publishing. Income from several sources also improved. Against industry trends,
institutional subscriptions to the five journals increased by 9%, and the number of site licenses sold
increased substantially, assisted by a new contract with the National Science and Technology Library
of China on behalf of a consortium of major centers of scientific research. Advertisement and spon-
sorship sales for all journals improved by more than 10%. The book program released 12 new titles,
bringing the total number of books in print by the end of year to over 200. More than 11,800 book and
multimedia orders were fulfilled and over 65,000 units shipped. A contract in which Cold-Spring-
Harbor-branded protocols were published in the journal income and valuable
book promotion among a wide readership worldwide, and the co-marketing of the online database
MolecularCloning.com with Nature Methods was also financially advantageous. Fees for the provision
of fulfillment and distribution services in the United States for two other publishers generated addition-
al revenue. In addition, BioSupplyNet.com, the online directory of laboratory supplies and suppliers
relaunched in 2004, added more than 500 new product categories and improved its revenue contri-
bution by over 13%.
The 12 newly published titles were a mix of manuals, monographs, reference, and history books.
The best-seller was Basic Methods in Microscopy, a manual by David Spector and Robert Goldman.
There were new editions of monographs on telomeres and RNA biology and a manual on protein-
protein interactions. A monograph on dogs and their value in gene and genome studies was bathed in
the spotlight of widespread press coverage when the sequence of the dog genome was published in
December. Sales were soundly supported by the perennial favorites Molecular Cloning and At the
Bench.
A large proportion of our recent books were chosen for review in the professional scientific press,
invariably receiving warm words for the quality of the contents and the authority of the authors and edi-
tors who created the books. We are extremely fortunate to be able to call on busy scientists of such
distinction as participants in our projects.
Appreciation of the publishing program's value was further evident in the expanded use made of
journal content. Online readers downloaded articles from the five journals on average 140,000 times
per month, 27% more than in the previous year. Over 13,000 journal pages were published, an increase
of 9%, representing 1,115 new articles. Many of these papers were highlighted in the world's major
news media, including the New York Times, Wall Street Journal, and the BBC News. The impact fac-
tors of four journals increased significantly, Genome Research improving 8% to 10.38. The impact
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factor of Genes & Development, at 16.385, although slightly down, remained one of the 20 highest impact fac-
tors among all primary research journals.
The annual Symposium was published online for the second time. Institutional purchasers now have access
to Symposium manuscripts many months ahead of print publication and to other features such as video inter-
views with speakers at the meeting. Thirteen contracts for new books were signed, including innovative text-
books in human biology, neurobiology, and developmental biology. Ten agreements were signed with foreign
publishers for translations into Chinese, Japanese, German, and Korean, and nine contracts were agreed for
foreign reprint rights.
Copies of the Gates-Foundation-supported second edition of the book for teenagers, You, Me, and HIV, and
an associated teacher's guide, were distributed in three provinces of South Africa. A new method of distribution
was developed, a cascade strategy involving workshops in which teachers were trained to use our materials in
the classroom and also to train other teachers in their use. 50,000 copies in English and 20,000 copies in
Afrikaans and Zulu are being made available free through these workshops, which have expanded the horizons
of this initiative from publishing to a community education project with the potential of mainstreaming AIDS edu-
cation in the school curriculum. With the conclusion of the Foundation grant, further financial support for the
project is being sought.
Two thirds of Press income now comes from journal publishing, more than 70% of it from subscription sales.
Throughout the year, debate continued about the validity of an open-access, funder-supported business model
as an alternative to subscriptions for the publication of research results. In this model, reading research results
online is free, and a paper's publication is supported by a fee paid on the author's behalf by the organization that
funded the research. A growing number of science funding bodies, particularly in Europe, are energetically com-
mitted to this alternative, seeing in the Internet the possibility of ending restrictions on public access to newly
published science and freeing up, for research, the large sums currently spent purchasing and maintaining jour-
nal subscriptions in academic institutions.
Although publishers and scholarly societies have talked of little else in the past several years, the commu-
nity of working scientists at large is less engaged. Only a small proportion of authors in Genome Research chose
to make their papers available in this way when the option was introduced for a modest fee in January. Our jour-
nal archives stretching back as much as 10 years are freely accessible online and all back issues are made pub-
licly available no later than 12 months after publication (6 months for Genes & Development and Genome
Research). This openly available material is certainly used heavily, and such access has been made possible
within the framework of the current subscription model. It is unclear if funding bodies will be prepared to pay a
publication fee high enough to sustain a well-regarded, highly selective journal without additional direct grant
support or private underwriting. Such journals have the irreducibly fixed cost of a professional editorial staff that
ensures first-class peer-review, selection, and distribution of papers.
A direct dialog has begun with some of the activist funding bodies about the real costs of publication and a
fee structure that would support the high-quality journals that Cold Spring Harbor and other not-for-profit orga-
nizations publish. Meanwhile, the policy of the dominant American funding body, the National Institutes of Health,
toward the funder-pays model remains in flux-an important uncertainty, since NIH supports well over half the
research that appears in our journals. Not all journals can release papers less than 1 year after publication with-
out risking subscription cancellation. Meanwhile, an effort to create a freely available online archive of NIH-
funded papers that relies on grantees' voluntary deposition of prepublication manuscripts has achieved low
compliance and NIH may be given more teeth by Congress in 2006. Free release of NIH-supported papers with-
in 6 months may soon become mandated.
Clearly, we are still only at the beginning of a period of major turmoil in the economics and ecology of journal
publishing. And with increasing interest on the part of online superstars Google and Amazon in delivering online
book content to readers, both as whole volumes and as single chapters, the strategic aspects of science pub-
lishing have never been more challenging, or intriguing. If merely distributing the work of our distinguished
authors electronically were enough, fulfilling the educational aspects of our mission would be simple. Sustaining
the enterprise financially, however, is less straightforward.
Staff
The staff members of the Press as of December 2005 are listed elsewhere in this volume. Our organization is
fortunate to have the support of such a professional and dedicated group of people.
In 2005 we welcomed four new colleagues: Richard Cavalieri, Phillip LoFaso, Wayne Manos, and Nora Ruth.
We also said goodbye, thanks, and good luck to Colleen Becker and Kathryn Fitzpatrick. The year's encourag-
ing results were a just reward for the whole staff and the talented managers on whom I depend so much: Jan
Argentine, Ingrid Benirschke, Kathy Cirone, David Crotty, Kathryn Fitzpatrick, Alex Gann, Nancy Hodson, Phillip
Lo Faso, Geraldine Jaitin, Bill Keen, Guy Keyes, Marcie Siconolfi, Linda Sussman, and Denise Weiss. The Press
also owes a great deal to the Editors of our successful journals, Terri Grodzicker at Genes & Development and
Hillary Sussman at Genome Research. And it is a pleasure once again to acknowledge the essential contribu-
tion that my executive assistant Elizabeth Powers makes to our organization.
John R. Inglis
Executive Director
Press staff members
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2005
With comparative financial information as of December 31, 2004
2005 2004
Assets:
Cash and cash equivalents $ 48,885,313 40,744,417
Accounts receivable:
Publications 1,206,608 1,308,718
Other 4,528,843 1,179,604
Grants receivable 8,352,217 6,975,455
Contributions receivable, net 47,578,065 12,492,687
Publications inventory 2,979,817 2,945,099
Prepaid expenses and other assets 2,015,019 1,605,707
Investments 232,371,266 211,294,366
Investment in employee residences 5,726,739 4,830,425
Restricted use assets 3,226,538 2,904,923
Land, buildings, and equipment, net 115,851,522 110,757,023
Total assets $ 472,721,947 397,038,424
Liabilities and net assets:
Liabilities:
Accounts payable and accrued expenses $ 10,361,413 7,429,657
Notes payable 73,638 107,775
Deferred revenue 4,237,554 3,878,738
Bonds payable 45,200,000 45,200,000
Total liabilities 59,872,605 56,616,170
Net assets:
Unrestricted 195,431,117 184,397,408
Temporarily restricted 70,289,399 25,419,056
Permanently restricted 147,128,826 130,605,790
Total net assets 412,849,342 340,422,254
Total liabilities and net assets $ 472,721,947 397,038,424
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2005
With summarized financial information for the year ended December 31, 2004
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2005
Total
2004
Total
Revenue and other support:
Public support (contributions and
non-Federal grant awards) $ 22,009,798 49,454,134 12,312,801 83,776,733 30,258,733
Federal grant awards 32,067,800 - - 32,067,800 29,451,302
Indirect cost allowances 19,558,159 - 19,558,159 17,659,458
Program fees 3,583,017 - 3,583,017 3,644,734
Publications sales 9,751,069 9,751,069 9,743,639
Dining services 3,349,002 - 3,349,002 3,183,440
Rooms and apartments 2,703,382 - - 2,703,382 2,632,671
Royalty and licensing fees 2,873,198 2,873,198 926,913
Investment income (interest and
dividends) 4,831,010 - - 4,831,010 3,134,480
Miscellaneous 652,207 - 652,207 514,559
Total revenue 101,378,642 49,454,134 12,312,801 163,145,577 101,149,929
Net assets released from restrictions 4,583,791 (4,583,791)
Total revenue and other support 105,962,433 44,870,343 12,312,801 163,145,577 101,149,929
Expenses:
Research 57,766,809 - 57,766,809 52,049,866
Educational programs 13,207,352 13,207,352 13,238,766
Publications 9,432,319 9,432,319 9,380,833
Banbury Center conferences 1,396,425 1,396,425 1,159,499
Dolan DNA Learning Center programs 1,231,059 1,231,059 1,611,325
Watson School of Biological Sciences
programs 2,848,109 - 2,848,109 2,263,518
General and administrative 13,267,025 13,267,025 12,508,768
Dining services 4,684,031 4,684,031 4,236,535
Total expenses 103,833,129 - - 103,833,129 96,449,110
Excess of revenue and other support
over expenses 2,129,304 44,870,343 12,312,801 59,312,448 4,700,819
Other changes in net assets:
Net appreciation in fair
value of investments 8,904,405 4,210,235 13,114,640 21,815,957
Increase in net assets 11,033,709 44,870,343 16,523,036 72,427,088 26,516,776
Net assets at beginning of year 184,397,408 25,419,056 130,605,790 340,422,254 313,905,478
Net assets at end of year $ 195,431,117 70,289,399 147,128,826 412,849,342 340,422,254
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended December 31, 2005
With comparative financial information for the year ended December 31, 2004
2005 2004
Cash flows from operating activities:
Increase in net assets $ 72,427,088 26,516,776
Adjustments to reconcile increase in net assets
to net cash used in operating activities:
Depreciation and amortization 5,852,278 5,769,622
Net appreciation in fair value of investments (13,009,353) (21,746,064)
Contributions restricted for long-term investment (47,445,268) (13,812,552)
Changes in assets and liabilities:
(Increase) decrease in accounts receivable (3,247,129) 101,178
(Increase) decrease in grants receivable (1,376,762) 92,932
(Increase) decrease in contributions receivable (125,496) 79,666
Increase in publications inventory (34,718) (738,459)
Increase in prepaid expenses and other assets (409,312) (38,716)
Increase in restricted use assets (321,615) (195,347)
Increase in accounts payable and accrued expenses 900,672 1,275,293
Increase (decrease) in deferred revenue 358,816 (189,222)
Net cash provided by (used in) operating activities 13,569,201 (2,884,893)
Cash flows from investing activities:
Capital expenditures (10,946,777) (7,273,237)
Proceeds from sales and maturities of investments 134,357,645 113,998,317
Purchases of investments (142,643,334) (104,850,454)
Net change in investment in employee residences (678,172) (55,591)
Net cash (used in) provided by investing activities (19,910,638) 1,819,035
Cash flows from financing activities:
Permanently restricted contributions 12,312,801 1,159,665
Contributions restricted for investment in land, buildings,
and equipment 35,132,467 12,652,887
Increase in contributions receivable (34,959,882) (1,119,362)
Increase in accounts payable relating to capital expenditures 2,031,084 179,083
Repayment of notes payable (34,137) (33,183)
Net cash provided by financing activities 14,482,333 12,839,090
Net increase in cash and cash equivalents 8,140,896 11,773,232
Cash and cash equivalents at beginning of year 40,744,417 28,971,185
Cash and cash equivalents at end of year $ 48,885,313 40,744,417
Supplemental disclosures:
Interest paid $ 1,134,372 780,758
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the Federal Government and through grants, cap-
ital gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2005.
GRANTS January 1-December 31, 2005
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2005 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Support Dr. Spector 04/01/05 03/31/06 $ 452,121 *
Dr. Stillman 09/01/05 05/31/07 982,065 *
Dr. Tansey 01/01/05 12/31/05 332,500 *
Dr. Townsend 06/01/05 05/31/06 1,985,558 *
Program Project Support Drs. Hannon /Krainer /Lazebnik/Lowe/ 01/01/97 12/31/06 5,192,593
S. Muthuswamy/Myers/Spector/
Stenlund /Stillman/Tansey
Drs. Lowe/Hannon/S. Muthuswamy 04/01/04 03/31/09 928,197
Dr. Stillman-CSHL Cancer Center Core 08/01/05 07/31/10 4,250,000 *
Pioneer Award Support Dr. Cline 09/30/05 07/31/10 847,501 *
Merit Award Support Dr. Malinow 05/01/92 04/30/10 654,807 *
Dr. Tonks 08/01/91 03/31/06 664,827
Contract Support Drs. SebatNVigler 12/06/05 12/05/06 447,352 *
Research Support Dr. Brody 07/01/04 04/30/09 377,574
Dr. Chklovskii 07/08/04 06/30/09 357,347
Dr. Cline 12/01/04 11/30/09 490,018
Dr. Cline 03/01/98 03/31/06 492,545
Dr. Dubnau 09/15/04 06/30/09 423,428
Dr. Hamaguchi 04/01/04 08/31/05 194,925
Dr. Hannon 07/01/00 08/31/05 364,425
Dr. Hirano 07/01/05 06/30/09 355,950
Dr. Hirano 05/01/96 04/30/08 406,800
Dr. Huang 08/01/01 06/30/06 415,000
Dr. Huang 07/15/05 04/30/09 391,969
Dr. Joshua-Tor 05/01/01 03/31/06 373,500
Dr. Joshua-Tor 02/15/02 01/31/07 373,500
Dr. Joshua-Tor 07/01/05 06/30/09 316,973
Dr. Krainer 07/01/03 06/30/07 596,271
Dr. Krainer 06/01/01 05/31/06 408,400
Dr. Lowe 07/01/04 06/30/09 499,371
Dm. Mainen/Brody 09/23/02 08/31/07 376,888
Dr. Malinow 04/01/95 02/29/08 571,969
Dr. Martienssen 08/01/03 07/31/07 339,000
Dr. Mitra 03/04/05 02/28/09 498,976
'Includes direct and indirect costs
*New grants awarded in 2005
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Dr. Mittal 04/01/04 03/31/09 351,887
Dr. S. Muthuswamy 03/01/03 02/28/07 377,138
Drs. Myers/Herr 03/01/02 02/28/07 359,815
Dr. Neuwald 09/30/98 08/31/06 383,788
Dr. Sebat 09/30/05 07/31/10 149,997
Dr. Skowronski 04/01/98 04/30/08 660,694
Dr. Spector 04/01/90 03/31/07 649,246
Dr. Spector 09/01/04 08/31/08 344,113
Dr. Stein 09/01/02 03/31/06 524,999
Drs. Stenlund/Hernandez 07/01/04 06/30/07 253,912
Dr. Stillman 07/01/91 05/31/08 562,401
Dr. Svoboda 12/01/03 11/30/08 255,475
Dr. Svoboda 12/01/02 11/30/07 225,435
Dr. Svoboda 06/01/03 03/31/08 311,966
Dr. Svoboda 03/01/04 02/28/09 343,238
Dr. Tansey 05/01/03 04/30/07 330,525
Dr. Tonks 05/01/97 06/30/05 389,850
Dr. Tully 03/01/03 02/29/08 385,631
Dr. Tully 08/01/03 05/31/07 381,375
Dr. Van Aelst 05/01/03 04/30/08 339,424
Dr. Wig ler 07/15/98 04/30/07 530,945
Dr. Xu 08/01/03 03/31/07 364,425
Dr. Xu 08/01/05 03/31/06 85,881
Dr. Zador 01/23/03 12/31/07 519,615
Dr. Zhang 09/19/03 08/31/06 705,438
Dr. Zhong 07/01/03 06/30/08 347,051
Research Subcontracts
NIH/Affymetrix Consortium Agreement Dr. Stein 08/01/04 05/31/06 118,035
NIH/Arginox Consortium Agreement Dr. Enikolopov 02/16/05 02/15/06 44,655 *
NIH/Baylor College of Medicine Dr. Mills 09/01/01 08/31/06 226,656
Consortium Agreement
NIH/Baylor College of Medicine Dr. S. Muthuswamy 03/01/04 12/31/04 67,800
Consortium Agreement
NIH/Booz Allen Hamilton caBIG Dr. Stein 08/01/04 02/28/05 264,365
Consortium Agreement
NIH/Booz Allen Hamilton caBIG Dr. Stein 09/01/04 08/31/06 200,209 *
Consortium Agreement
NIH/Caltech Consortium Agreement Dr. Stein 09/01/03 08/31/08 729,272 *
NIH/Caltech Consortium Agreement Dr. Svoboda 04/04/03 02/29/08 148,391
NIH/Columbia University Consortium Dr. Lowe 09/30/00 01/31/06 533,621
Agreement
NIH/Evanston Northwestern Dr. Zhang 07/01/03 06/30/06 132,261
Consortium Agreement
NIH/Massachusetts Institute of Dr. Stein 09/15/04 08/31/06 199,709
Technology Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Mittal 04/01/04 03/31/09 136,686
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Van Aelst 07/10/03 06/30/08 336,324
Consortium Agreement
NIH/Nanoprobes, Inc. Dr. Spector 10/15/05 04/16/06 17,053 *
NIH/Rutgers University Consortium Dr. Mitra 12/08/04 11/30/08 140,504
Agreement
NIH/Stony Brook University Dr. McCombie 11/01/05 08/31/06 55,000 *
NIH/Washington University Dr. Stein 09/01/03 08/31/08 56,199
Consortium Agreement
NIH/Washington University Dr. Stein 11/01/03 10/31/06 56,199
Consortium Agreement
*Includes direct and indirect costs
*New grants awarded in 2005
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NIH/VVeill Cornell Medical Center Dr. Mitra 02/01/04 01/31/06 46,711
Consortium Agreement
NIH/University of Wisconsin Dr. Stein 01/01/04 12/31/07 198,171
Consortium Agreement
Fellowship Support Dr. Lucito 06/01/02 05/31/07 143,473
Dr. Weimer 07/01/05 06/30/08 49,928 *
Dr. Wilbrecht 07/01/05 06/30/08 43,976 *
Course Support Cellular Biology of Addiction 07/15/05 06/30/08 46,250 *
Cell and Developmental Biology of 04/01/93 03/31/09 20,023
Xenopus
DNA Microarray Applications 05/01/99 04/30/07 57,072
Neurobiology of Drosophila 07/01/01 06/30/06 46,189
Advanced Techniques in Molecular 07/01/01 06/30/06 60,990
Neuroscience
Imaging Structure and Function in the 07/01/01 06/30/06 53,348
Nervous System
C. elegans 08/01/98 07/31/06 71,736
Proteomics 07/01/03 06/30/06 68,483
Advanced Bioinformatics 09/01/05 08/31/06 52,000
Computational and Comparative Genomics 09/01/05 08/31/07 47,605
lmmunocytochemistry, In Situ Hybridization,
and Live Cell Imaging
07/01/98 08/31/10 77,962
Meeting Support Learning and Memory 2005 6,627
The Ubiquitin Family 2005 9,000
Telomeres and Telomerase 2005 22,275
The Biology of Genomes 2005 30,470
Protein Phosphorylation and Cell 2005 7,000
Signaling
70th Symposium: Molecular Approaches
to Controlling Cancer
2005 5,000 *
Eukaryotic mRNA Processing 2005 11,373
Mechanisms of Eukaryotic Transcription 2005 8,000
Eukaryotic DNA Replication 2005 5,229
Microbial Pathogenesis and Host Response 2005 13,386
Programmed Cell Death 2005 12,000
Neurobiology of Drosophila 2005 23,000
Genome Informatics 2005 22,000
Rat Genomics and Models 2005 15,000
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Jackson 07/01/05 06/30/10 870,780 *
Dr. McCombie 09/01/03 08/31/06 1,312,408
Dr. Stein 12/15/03 11/30/07 2,407,499
Research Support Dr. Hannon 09/01/04 02/28/06 72,263
Dr. Jackson 03/01/04 02/28/07 145,000
Dr. Lukowitz 04/01/05 03/31/08 116,770 *
Dr. Martienssen 08/31/05 02/28/07 100,000 *
Drs. McCombie/Jackson/Myers 06/15/04 11/30/05 71,984
Dr. Stein 09/01/03 08/31/06 895,615
Dr. Timmermans 09/01/03 08/31/06 123,802
Dr. Van Aelst 08/15/05 07/31/08 131,112 *
Dr. Ware 09/01/03 08/31/08 553,484
*Includes direct and indirect costs
*New grants awarded in 2005
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Research Subcontract Support
NSF/National Center for Genome Dr. Stein 09/01/05 08/31/08 54,497 *
Research Consortium Agreement
NSF/New York University Drs. Mc Combie/Martienssen 10/01/04 09/30/09 256,404
Consortium Agreement
NSF/North Carolina State University Dr. Martienssen 10/01/04 09/30/09 198,945
Consortium Agreement
NSF/University of Arizona Dr. Stein 10/01/03 09/30/07 254,320
Consortium Agreement
NSF/University of California- Drs. Jackson/Martienssen 10/01/01 09/30/06 292,580
Berkeley Consortium Agreement
NSF/University of Florida Consortium Dr. Martienssen 09/15/05 08/31/07 50,747 *
Agreement
NSF/University of Georgia Consortium Dr. Timmermans 09/01/03 12/31/05 85,279
Agreement
NSF/University of Washington Dr. Martienssen 09/01/05 08/31/10 249,080 *
Consortium Agreement
Undergraduate Training Support URP5: REU Site in Bioinformatics and 04/15/05 03/31/06 107,350 *
Computational Biology
Meeting Support Learning and Memory 2005 8,000
Telomeres and Telomerase 2005 4,000
Eukaryotic mRNA Processing 2005 5,000
Eukaryotic DNA Replication 2005 5,000
Neurobiology of Drosophila 2005 10,000
Course Support Advanced Bacterial Genetics 07/15/04 06/30/06 73,721
Advanced Techniques in Plant Science 07/01/03 06/30/06 81,271
Cell and Developmental Biology of 09/01/98 08/31/06 23,503
Xenopus
The Gramene Community Curation 01/15/03 12/31/06 241,616
Network
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/03 08/31/06 76,802
Dr. Jackson 09/01/05 08/31/08 115,187 *
Dr. McCombie 09/15/04 09/14/09 37,812
Drs. McCombie/Martienssen 02/01/04 01/31/07 202,567
Dr. Stein 09/22/03 09/14/08 740,591
Research Subcontract Support
USDA/Oregon State University Dr. Martienssen 12/01/04 11 / 3 0 /0 7 13,023
Consortium Agreement
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 04/01/02 03/31/06 769,317
Drs. Kamalakaran/Dubnau 11/16/05 11/15/06 100,000
Drs. Lucito/Wigler 02/01/05 01/31/07 894,579
Dr. Mainen 04/01/04 03/31/06 101,522
Drs. Wigler/Lucito 04/01/04 03/31/06 2,266,100
Dr. Zhong 12/15/04 12/14/08 334,511
Fellowship Support T. Haire 10/01/04 12/31/06 46,191
A. Lucs 04/01/03 03/31/06 34,108
'Includes direct and indirect costs
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M. Moore 08/16/04 08/15/06 33,694
E. Murchison 02/16/05 02/15/08 30,000
S. Nunez 02/27/04 02/28/07 30,469
A. Rosenberg 02/28/05 02/28/08 30,000
D. Siolas 07/01/04 06/30/06 39,248
K. Siddiqui 04/01/03 03/31/06 36,015
Dr. Smith 04/01/04 03/31/07 122,984
Dr. Xiang 06/01/03 05/31/06 58,664
Research Subcontract Support
U.S. Army/New York University Dr. Lucito 09/27/04 09/26/09 119,785
Consortium Agreement
MISCELLANEOUS
Equipment Support
Breast Cancer Help, Inc. Dr. Stillman 2005 20,000
Breast Cancer Help, Inc./West Islip Dr. Stillman 2005 1,553 *
Youth Enrichment
Program Project Support
DART Neurogenomics Project Drs. Tully/Cline/Dubnau/Henry/Mitra/ 10/01/04 09/30/07 4,420,060
Zhang/Zhong
The Thomas Hartman Foundation for Drs. Cline/Enikolopov/Mainen/Sebat/ 05/01/05 04/30/10 1,200,000 *
Parkinson Research Partnership Tonks/Tully
The Leukemia & Lymphoma Society Dr. Lowe 10/01/03 09/30/08 1,490,451
The Simons Foundation Dr. Wigler 06/01/06 05/31/08 4,792,700 *
Support
American Cancer Society Dr. Wig ler 01/01/96 12/31/05 10,000
American Cancer Society Dr. Wig ler 01/01/01 12/31/05 70,000
Arginox, Inc. Dr. Enikolopov 02/01/05 01/31/06 147,345
Benefit for the Brain Dr. Cline 01/01/05 12/31/05 185,648
Breast Cancer Research Foundation Dr. Wig ler 10/01/05 09/30/06 250,000
Lavinia & Landon Clay Dr. Brody 12/01/05 11/30/06 200,000
CSH Main Street Association Dr. Powers 06/01/05 05/31/06 8,000
Coyle-DeVita Dr. Powers 07/01/05 06/30/06 25,000
De Matteis Family Foundation Dr. Powers 10/01/04 09/30/06 450,000
Den Haag Foundation Dr. Stillman 07/01/03 12/31/05 206,400
Diaz Estate Dr. Stillman 01/01/05 12/31/05 158,591
Dunkin Brands Dr. Powers 11/01/05 10/31/06 5,000
ELJI/SUSB Consortium Agreement Dr. Huang 01/15/04 01/14/07 79,420
Eppley Foundation Dr. Enikolopov 05/01/05 04/30/06 28,000
Find A Cure Today (F.A.C.T.) Dr. S. Muthuswamy 07/01/03 07/31/06 37,595
Samuel & Hillary Fox Dm. S. Muthuswamy/Hicks 07/01/05 06/30/06 2,225
FSMA Dr. Krainer 07/15/04 07/14/05 13,333
Gerber Foundation Dr. Hatchwell 01/01/05 07/31/06 83,300
Irving Hansen Foundation Dr. Tansey 08/01/04 07/31/05 49,413
Harrison's Heart Foundation Dr. Hatchwell 12/21/04 12/31/05 72,500
Ira Hazan Dr. Enikolopov 12/01/03 11/30/05 200,000
James R. Hudson, Jr. Dr. Hannon 06/01/05 05/31/06 50,004
Human Frontier of Science Program Dr. Spector 06/01/03 05/31/06 113,815
Organization (HFSPO)
Human Frontier of Science Program Dr. Mitra 06/15/03 06/14/06 96,500
Organization (HFSPO)
Includes direct and indirect costs
*New grants awarded in 2005
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Town of Islip Breast Cancer Coalition Dr. Powers 08/01/05 07/31/06 5,000 *
Karches Foundation Dr. Wig ler 07/01/05 06/30/10 439,388 *
Kids Care Dr. Powers 04/01/05 03/31/06 3,704 *
The Forrest & Francis Lattner Dr. Sebat 12/16/05 12/16/07 500,000 *
Foundation in honor of
Andrew Harris
The Charles Leach Foundation Dr. Enikolopov 01/01/05 12/31/05 10,000 *
Lehman Brothers Foundation, Inc. Dr. Powers 11/01/05 10/31/06 25,000 *
LI 2-Day Walk to Fight Breast Cancer Dr. S. Muthuswamy 08/01/04 07/31/06 25,000
LIABC (Long Islanders Against Breast Dr. Wig ler 01/01/00 12/31/06 46,027 *
Cancer)
Long Beach Breast Cancer Coalition Dr. S. Muthuswamy 07/15/04 07/14/06 2,000
Manhasset Women's Coalition Dr. Powers 05/01/05 04/30/06 20,000 *
Against Breast Cancer
March of Dimes Dr. Huang 06/01/04 05/31/07 95,409
March of Dimes Dr. Mills 06/01/03 05/31/06 68,686
The G. Harold & Leila Y. Mathers Dr. Zador 07/01/03 06/30/06 170,275
Charitable Trust
The Elizabeth McFarland Breast Dr. Wig ler 03/01/04 02/28/06 35,001
Cancer Fund
Michael's Haven Dr. Lowe 02/01/05 01/31/06 2,000 *
Miracle Foundation Dr. Wig ler 01/01/05 12/31/05 100,000 *
Louis Morin Charitable Trust Dr. Spector 12/01/05 11/30/06 75,000 *
NAAR Dr. Van Aelst 07/01/05 06/30/07 60,000 *
NARSAD Dr. Mainen 09/15/04 09/14/06 50,795
NARSAD Dr. Enikolopov 09/15/04 09/14/05 50,000
Manyu Oga le Dr. Wig ler 07/01/05 06/30/06 50,000 *
Omidyar Foundation Drs. S. Muthuswamy/Powers 07/01/05 06/30/06 200,000 *
Open Biosystems Dr. Hannon 06/01/05 05/31/07 83,300 *
Philip Morris USA Dr. Mittal 07/01/05 06/30/06 423,750 *
Philips Research Dr. Zhang 12/01/05 11/30/06 5,000 *
The Fannie E. Rippel Foundation Drs. Lucito/Tonks 12/01/05 11/30/07 350,000 *
Joan's Legacy: The Joan Scarangelo Dr. Mu 11/01/05 10/31/07 50,000 *
Foundation to Conquer Lung Cancer
The Seraph Foundation Dr. Enikolopov 01/01/01 09/30/06 74,000 *
SMA Foundation Dr. Krainer 06/01/04 05/31/07 65,936
Theodore & Vada Stanley Foundation Dr. Watson 2005 5,000,000 *
Schizophrenia Research
Strelkowski Estate Dr. Stillman 2005 12,500 *
Waldbaum's Foundation Dr. Wigler 03/01/05 02/28/05 10,000 *
WALK for Women Breast Cancer Fund Dr. S. Muthuswamy 2005 6,390 *
West Islip Breast Cancer Coalition
of LI, Inc.
Dr. Wig ler 11/01/05 10/31/06 10,000 *
Women In Science Program Dr. Stillman 01/01/05 12/31/05 30,342 *
Fellowship Support
Rita Allen Foundation Dr. S. Muthuswamy 08/01/04 07/31/05 50,000
Arnold and Mabel Beckman Dr. Dubnau 09/01/05 08/31/08 88,000
Foundation
Burroughs Wellcome Dr. Karpova 09/01/05 08/31/07 58,000 *
Burroughs Wellcome Dr. Zito 08/01/04 06/30/06 60,200
Jane Coffin Childs Foundation Dr. Rivas 07/01/04 06/30/07 43,500
Cody Center/Stony Brook University Dr. Enikolopov 04/01/05 03/31/06 50,000 *
Cody Center/Stony Brook University Dr. Hatchwell 10/01/04 09/30/07 40,000 *
CSHL Association Fellowship Dr. Boivin 2005 51,919 *
CSHL Association Fellowship Dr. Felsen 2005 51,919 *
CSHL Association Fellowship Dr. Gallavotti 2005 51,919 *
CSHL Association Fellowship Dr. Lima 2005 51,919 *
'Includes direct and indirect costs
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CSHL Association Fellowship Dr. Nogueira 2005 49,664
Damon Runyon Cancer Research Dr. Hu 08/01/05 07/31/08 45,000
Foundation
Damon Runyon Cancer Research Dr. Zu 04/01/03 03/31/06 45,000 *
Foundation
DFG German Science Foundation Dr. Bayer 09/01/05 08/31/07 13,450
European Molecular Biology Dr. De Paola 07/01/04 06/30/06 34,500
Organization (EMBO) Long-term
Fellowship
European Molecular Biology Dr. Da Silva 01/15/05 01/14/06 35,000 *
Organization (EMBO) Long-term
Fellowship
Fraxa Research Foundation Dr. Bureau 01/01/05 12/31/05 40,000
Francis Goelet Fellowship in Dr. Wigler 10/01/05 09/30/08 70,672
Biomathematics
Goldring Fellowship Dr. Stillman 09/01/00 08/31/06 75,000
Hereditary Disease Foundation Dr. lijima 05/01/05 04/30/06 58,000
Klingenstein Foundation Dr. Chklovskii 07/01/04 06/30/07 74,376
Leukemia Research Foundation Dr. Ceparo 07/01/05 06/30/07 30,000
The Leukemia & Lymphoma Society Dr. Buckley 11/01/03 10/31/06 40,000
The Leukemia & Lymphoma Society Dr. Gangadharan 07/01/05 06/30/08 55,000
The Leukemia & Lymphoma Society Dr. Liu 07/01/05 06/30/08 55,000
The Leukemia & Lymphoma Society Dr. Wendel 07/01/05 06/30/08 55,000
The Leukemia & Lymphoma Society Dr. Tansey 07/01/01 06/30/06 100,000
Life Sciences Research Foundation/ Dr. Goto 06/01/04 08/31/05 9,837
DOE-Energy Biosciences
Research Fellowship
Maxfield Foundation Dr. Lazebnik 12/01/04 11/30/06 5,000
McKnight Endowment Dr. Huang 07/01/04 06/30/07 75,000
Ministerio de Educacion y Cienia of Spain Dr. Encinas 05/01/04 04/30/06 32,000
National Parkinson's Foundation Dr. Sebat 07/01/05 06/30/06 40,000
NARSAD Dr. Ango 07/01/05 06/30/07
NARSAD Dr. Dicristo 07/01/04 06/30/06 30,000
NARSAD Dr. Takahashi 07/01/05 06/30/07 30,000
NARSAD Dr. Zhong 07/01/05 06/30/07 30,000
Pew Charitable Trust Dr. Huang 07/01/02 06/30/06 60,000
The Andrew Seligson Memorial Dr. Zender 05/01/05 04/30/06 82,300
Clinical Fellowship for Cancer
Research
Alfred P. Sloan Foundation Dr. Brody 09/16/04 09/15/06 24,888
Lauri Strauss Leukemia Foundation Dr. Ceparo 04/01/05 03/31/06 15,000
Swartz Foundation Dr. Kepecs 01/01/05 12/31/05 54,822
Swartz Foundation Dr. Machens 01/01/05 12/31/05 50,000
Swartz Foundation Dr. Chklovskii 01/01/05 12/31/05 50,000
Swartz Foundation Dr. Chklovskii/Wen 01/01/05 12/31/05 50,000
Swartz Foundation Dr. Uchida 01/01/05 12/31/05 50,000
Wellcome Trust Dr. Khoo 04/01/05 03/31/06 20,000
Helen Hay Whitney Foundation Dr. He 04/01/04 03/31/07 45,000
Helen Hay Whitney Foundation Dr. Hemann 09/01/03 08/31/06 46,500
Training Support
William Townsend Porter Foundation Undergraduate Research Program 2005 10,000 *
Steamboat Foundation Undergraduate Research Program 2005 12,000 *
Course Support
Applied Biosystems Workshop on Chicken Genomics 2005 1,000 *
ARK-Genomics-Roslyn Institute Workshop on Chicken Genomics 2005 6,000 *
Cobb-Vantress, Inc. Workshop on Chicken Genomics 2005 2,000 *
Includes direct and indirect costs
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Developmental Dynamics, University
of Utah
Workshop on Chicken Genomics 2005 500 *
Essel Foundation Schizophrenia Workshop 2005 10,000 *
Genesis Workshop on Chicken Genomics 2005 3,000 *
HHMI Neurobiology Courses 2005 410,000 *
Medical Research Council Schizophrenia Workshop 2005 18,182 *
Society For Neuroscience/IBRO Summer courses travel fellowships 2005 17,250 *
Fellowships
Meeting Support
Amersham Biosciences Structural Biology Meeting 2005 1,000 *
BIOGEN IDEC Target Definition and Vector Design for
Molecular Medicine 2005 2,500 *
Bruker Biospin Corp. Structural Biology Meeting 2005 500 *
Cell Genesys Target Definition and Vector Design for
Molecular Medicine 2005 1,500 *
CGT Corporation Target Definition and Vector Design for
Molecular Medicine 2005 500 *
Fluidigm Corporation Structural Biology Meeting 2005 1,200 *
GenVec, Inc. Target Definition and Vector Design for
Molecular Medicine 2005 2,000 *
Hampton Research Corp. Structural Biology Meeting 2005 1,000 *
Health Research, Inc. Northeast Biodefense Center Meeting 2005 58,370 *
Introgen Therapeutics, Inc. Target Definition and Vector Design for
Molecular Medicine 2005 1,000 *
Louisiana Gene Therapy Research Target Definition and Vector Design for
Consortium, Inc. Molecular Medicine 2005 2,000 *
Merck & Company, Inc. Structural Biology Meeting 2005 1,500 *
New England BioLabs Advanced Bacterial Genetics Reunion 2005 1,000 *
Rigaku MSC Structural Biology Meeting 2005 1,000 *
Vector Logics Target Definition and Vector Design for
Molecular Medicine 2005 2,000 *
Wyeth Holding Corporation Target Definition and Vector Design for
Molecular Medicine 2005 2,000 *
Library Support
Josiah Macy, Jr. Foundation 05/01/05 05/31/07 285,247 *
Andrew W. Mellon Fund 05/01/05 09/30/05 23,785 *
New York State 07/01/05 06/30/06 6,588 *
The Rockefeller Foundation and History of Science 2005 20,000 *
The Rockefeller Archives
*Includes direct and indirect costs
*New grants awarded in 2005
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DOLAN DNA LEARNING CENTER GRANTS
Grantor Program/Principal Investigator Duration of Grant 2005 Funding*
FEDERAL GRANTS
National Science Foundation Developing and Disseminating New Laboratories
in RNAi and Functional Genomics
06/04-06/06 $ 234,536
National Science Foundation VCA: Finishing the Rice Genome 09/04-08/06 84,041
National Science Foundation VCA: Gramene: A Platform for Comparative 12/04-11/06 113,118
Genomics
National Institutes of Health Inside Cancer, Multimedia Education Resources
for Cancer
01/03-12/05 43,642
Virginia Tech/NIH Partnership for Research and Education in Plants 09/04-10/05 40,501
U.S.D.A. Systematic Determination of the Gene Set 02/04-01/06 636
NONFEDERAL GRANTS
Carolina Biological Supply Company Research Support 2005 $ 75,000
Clemson University License, training, and development 2005 50,000
Dana Foundation Genes to Cognition (G2C) Online: A Network-
driven Internet Site on Modern Brain Research
10/04-09/06 243,912
Dialog Gentechnik License, training, and development 2005 12,475
Hewlett Foundation Genes to Cognition (G20) Online 10/05-10/06 12,922
North Shore-LIJ Health System DNALC West support 2005 50,000
Singapore Ministry of Education License, training, and development 2005 100,000
The following schools each awarded a grant of $1000 or more for the Curriculum Study Program:
Bellmore-Merrick Central High School District $ 1,250 Long Beach City School District $1,250
Commack Union Free School District 1,250 North Shore Central School District 1,250
East Meadow Union Free School District 2,500 Oceanside Union Free School District 2,500
Elwood Union Free School District 1,250 Oyster Bay-East Norwich Central School District 1,250
Great Neck Union Free School District 1,250 Plainedge Union Free School District 2,500
Green Vale School 2,500 Plainview-Old Bethpage Central School District 1,250
Half Hollow Hills Central School District 2,500 Port Washington Union Free School District 2,500
Harborfields Central School District 1,250 Port ledge School 1,250
Herricks Union Free School District 1,250 Ramaz Upper School 2,500
Island Trees Union Free School District 1,250 Roslyn Union Free School District 1,250
Jericho Union Free School District 1,250 Sachem Central School District 1,250
Kings Park Central School District 2,500 Syosset Central School District 2,500
Levittown Union Free School District 1,250 West Hempstead Union Free School District 2,500
Locust Valley Central School District 1,250 Yeshiva University High School for Girls 1,750
The following schools each awarded a grant of $1000 or more for the Genetics as a Model for Whole Learning Program:
Baldwin Union Free School District $ 1,200 Lynbrook Union Free School District $ 1,360
Bayshore Union Free School District 2,160 Mattituck-Cutchogue Union Free School District 1,700
Bellmore Union Free School District 3,100 Merrick Union Free School District 1,100
Bellmore-Merrick Central School District 6,900 Middle Country Central School District 1,660
Bethpage Union Free School District 1,800 North Bellmore Union Free School District 1,070
Brandeis School 1,375 Old Westbury School of the Holy Child 2,165
East Meadow Union Free School District 2,180 Oyster Bay-East Norwich Central School District 2,357
Elwood Union Free School District 3,750 Port Washington Union Free School District 19,505
Floral Park-Bellerose Union Free School District 5,150 PS 175, Region 3 15,000
Friends Academy 2,030 Rockville Centre Union Free School District 4,695
Green Vale School 1,527 Scarsdale Union Free School District 2,100
Half Hollow Hills Central School District 6,300 South Huntington Union Free School District 7,225
Harborfields Central School District 12,360 St. Dominic Elementary School 3,630
Herricks Union Free School District 1,920 St. Edward the Confessor School 1,650
Huntington Union Free School District 5,827 Syosset Union Free School District 27,260
Lawrence Union Free School District 7,618 Three Village Central School District 2,665
Locust Valley Central School District 1,560
'Includes direct and indirect costs
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BANBURY CENTER GRANTS
Grantor Program/Principal Investigator Duration of Grant 2005 Funding'
FEDERAL SUPPORT
Centers for Disease Control and
Prevention (CDC)
NIH-National Institute of Mental Health
(through a grant to University
of Illinois)
U.S. Department of Defense (through a
grant to Children's Tumor Foundation)
U.S. Department of Defense (through a
grant to Institute of Comparative
Genomics)
U.S. Department of Homeland Security
(through a grant to UMDNJ-New
Jersey Medical School)
NONFEDERAL SUPPORT
Meeting Support
Agencourt Bioscience Corporation
The ALS Association
CFIDS Association of America
Chiron Corporation
The Thomas Hartman Foundation for
Parkinson's Research
Ann L. and Herbert J. Siegel Fund of
the Jewish Communal Fund
The Karches Foundation
Richard Lounsbery Foundation, Inc.
Melanoma Research Foundation
PICO Atlantic
Marie Robertson Memorial Fund
Albert B. Sabin Vaccine Institute, with
support of the Bill & Melinda Gates
Foundation
Spinal Muscular Atrophy Foundation
The Swartz Foundation
National Society for Epilepsy, with
support of UCB Pharma
Verto Institute, LLC
*Includes direct and indirect costs
*New grants awarded in 2005
420
From Markers to Models: Integrating Data to
Make Sense of Biologic Systems
Translational Approaches to Fragile-X Syndrome:
Turning Basic Research Findings into
Therapeutic Targets
Barriers and Solutions in the Use of Mouse
Models to Develop Therapeutic Strategies
for NF1- and NF2-associated Tumors
Pathogenesis and Early Events in Viral Infection 2005
2005 $ 30,000*
2005 36,802'
2005 20,573*
Microbial Forensics 2005: Sample Management 2005
A Critical Review of Melanoma: Genomic
Approaches with Therapeutic Promise
Stem Cells and Axonal Regeneration:
Strategies for the Treatment of ALS
From Markers to Models: Integrating Data to
A Critical Review of Melanoma: Genomic
Approaches with Therapeutic Promise
Parkinson's Disease: Basic Mechanisms and
Therapies
A Critical Review of Melanoma: Genomic
Approaches with Therapeutic Promise
Chronic Lymphocytic Leukemia
The Biology and Practice of Mammalian
Cloning: A Reassessment
A Critical Review of Melanoma: Genomic
Approaches with Therapeutic Promise
A Critical Review of Melanoma: Genomic
Approaches with Therapeutic Promise
The GABAergic System
Introduction and Sustainable Use of Vaccines
in Developing Countries
Spinal Muscular Atrophy: Neuronal Rescue
and Repair from Laboratory to Clinic
Neurobiology of Decision-making
Epilepsy Genetics and Pharmacogenetics
Recent Advances in Neuroendocrine Tumor
Biology
45,878*
37,500*
2005 1,000*
2005 42,174*
2005 5,000*
2005 5,000*
2005 28,907*
2005 25,000*
2005 34,301*
2005 54,040*
2005 15,000*
2005 1,500*
2005 20,000
2005 28,287*
2005 42,448*
2005 48,032*
2005 44,647*
2005 28,121*
DEVELOPMENT
As you have probably read, 2005 was an exceptional year for Cold Spring Harbor Laboratory. Advances made at the Lab in
developing genetic tools that can be applied to the treatment of disease have led to ever-increasing collaborations with clini-
cians at Memorial Sloan-Kettering Cancer Center and North Shore-Long Island Jewish Health System in New York and as far
away as the Karolinska Institute in Sweden. Because the Lab does not have a hospital affiliation, this enables us to work with
the best clinicians in the world in a given area of expertise, such as prostate cancer, leukemia, autism, or Parkinson's disease.
This growth has created a need to expand the Laboratory. By adding six new buildings, scientists will have the space and
research support to focus more on clinical applications and delve further into tough questions that need complex computer
models to decipher. The research and capital required for the Lab to take such a leadership position in designing and apply-
ing these genetic tools for patient care are extremely costly. The Laboratory is indebted to our supporters who have invest-
ed in our dynamic and enthusiastic scientists as they continue on the frontline in the war against debilitating genetic diseases.
The development office has the pleasure of working with smart donors who are optimistic about the future of health care and
view the research at this institution as critically important to them and their families.
Lab donors not only take pride in this important work but also know that their gifts are being well spent. For the fifth con-
secutive year, the philanthropic evaluator Charity Navigator has bestowed their highest four-star rating on Cold Spring Harbor
Laboratory for its sound financial practices. This distinction ranks the Lab among the most responsible of more than 1.5 mil-
lion philanthropic organizations that exist in America to date. Less than 12% of the charities rated have received at least two
consecutive four-star evaluations, indicating that Cold Spring Harbor Laboratory outperforms most charities in America in its
efforts to operate in the most fiscally responsible may possible.
On behalf of the development office, I cannot thank our donors enough for including the Lab in their philanthropic plans
and spreading the word about our work. Cold Spring Harbor Laboratory has always been an institution that has taken on
great challenges and it will continue this way in 2006 and beyond.
Charles V. Prizzi, Chief Development Officer
Cold Spring Harbor Laboratory is a nonprofit research and educational institution, chartered by the State of New York. Less than
half of the Laboratory's annual revenues are derived from Federal grants and contracts, and thus, we rely heavily on support from
the private sector: foundations, corporations, and individuals. Contributions from the private sector are tax exempt under the
provisions of Section 501(c)(3) of the Internal Revenue Code. In addition, the Laboratory is designated a "public charity" and,
therefore, is enabled to receive funds resulting from the termination of "private foundations."
Foundations, corporations, and individuals can give to Cold Spring Harbor through a variety of methods:
Gifts of Money can be made directly to Cold Spring Harbor
Laboratory.
Securities: Stock certificates may be reassigned directly or
transferred through your broker. Appreciated securities should be
given outright, which will avoid capital gains taxes on the appre-
ciated value. Securities that have decreased in value should be
sold, and the proceeds donated. In this way, a donor will receive
a deduction for both the loss and the charitable contribution.
Life Insurance: You may designate the Laboratory as the ben-
eficiary of an existing or new policy, or irrevocably assign owner-
ship of the policy. There are estate tax benefits in either case. If
ownership is assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors
in a pool for attractive investment and tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax
benefits can result from such donations; the Laboratory can use
some in its programs and can sell others.
Charitable Remainder Trusts can be structured to suit the
donor's specific desires as to extent, timing, and tax needs.
Bequests: Designating Cold Spring Harbor Laboratory as benefi-
ciary ensures that a bequest will be utilized as specified.
Conversion of Private Foundation to "Public" Status on
Termination: This may be done by creating a separate fund
within Cold Spring Harbor Laboratory whereby the assets of the
private foundation are accounted for as a separate fund and
used for the purposes specified by the donor. Alternatively, the
private foundation can be established as a supporting organiza-
tion of Cold Spring Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring
Harbor Laboratory and/or the Watson School of Biological
Sciences. Please check with your employer to augment your gift.
For additional information, please contact the Chief Development Officer, Cold Spring Harbor Laboratory, One Bungtown Road,
Cold Spring Harbor, New York 11724. Phone number: 516-367-6865.
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CAPITAL AND ENDOWMENT CONTRIBUTIONS
January 1-December 31, 2005
In 2005, Cold Spring Harbor Laboratory received significant support in the form of capital, program,
and gifts-in-kind contributions from individuals, foundations, and corporations.
GIFTS $100,000 AND ABOVE
Anonymous*
Mr. and Mrs. Donald Everett Minn
The Bristol-Myers Squibb
Pharmaceutical Research Institute
Edward A. Chernoff*
Landon and Lavinia Clay*
Mr. and Mrs. John P. Cleary*
Shelby Cullom Davis Foundation
The 2001 Frederick & Nancy De Matteis
Family Charitable Trust*
GIFTS $5,000499,999
Drs. Giovanna Ferro-Luzzi and Bruce
Ames
Anonymous
Dr. Sydney Brenner*
Drs. Joan E. Brooks and James I.
Garrels
Mrs. and Mrs. Thomas J. Calabrese, Jr.
Total
WOMEN'S PARTNERSHIP
June 26, 2005
Committee Cochairs
Kristina Perkin Davison
Kate Seligson Friedman
Blair Husain
Cristina Mariani-May
Deborah Norville
Nancy Tilghman
Supporters ($1,000+)
Robert de Rothschild
Kate Seligson Friedman
Michelle Gerwin-Carlson
Cristina Mariani-May
Gail McDonnell
Brenda Morey
Louise Parent
Debbie Stevenson
Karen Thorson
Total
*New pledges awarded in 2005
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The William Stamps Farish Fund*
Francis Goelet Trust*
Dr. and Mrs. Philip Goelet*
Gladys and Roland Harrimon Foundation
Strauss-Hawkins Trust*
The Lita Annenberg Hazen Foundation
William Randolph Hearst Foundation*
The Koshland Foundation
Laurie J. Landeau, V.M.D.*
The Lehrman Institute
Cedar Hill Foundation
Robert J. Glaser, M.D.
Dr. Alfred Goldberg
Harrison Family Foundation
Thomas P. Maniatis, Ph.D.
The Rathmann Family Foundation*
$45,286,506.00
FOR SCIENCE
Mr. and Mrs. Robert D. Lindsay and
Family
Mrs. George N. Lindsay
Mrs. Edwin S. Marks*
Gillian and Eduardo Mestre*
Mrs. Leslie N. Quick, Jr.
Herbert J. Siegel*
The Simons Foundation
The Starr Foundation
Mr. and Mrs. Henry Wendt, Ill
Mr. and Mrs. John J. Reese
David Rockefeller
John and Arthur M. Spiro
The Textor Family Foundation
Mr. and Mrs. Richard H. Witmer, Jr.
Karen and Mark Zoller
Women's Partnership cochairs Cristina Mariani-May, Blair Husain, Kate Seligson
Friedman, Kristina Perkin Davison, Nancy Tilghman, and Deborah Norville
$30,367.00
BENEFIT FOR THE BRAIN
November 5, 2005
Committee Cochairs
Monique and Doug Morris
Sandy and Howard Tytel
Benefit Underwriter
Mr. and Mrs. Douglas P. Morris
Platinum Benefactors
William S. Robertson-Banbury Fund
Richard A. Rosenbaum-Greenberg
Traurig, LLP
Mr. and Mrs. Robert Sillerman-The
Tomorrow Foundation
Mr. and Mrs. Howard Tytel
Gold Benefactors
Mr. and Mrs. Joseph Amella-Accretive
Solutions, Inc.
Baker & McKenzie LLP
Mr. and Mrs. John S. Friedman
Mr. and Mrs. Francis J. Ingrassia
Mr. and Mrs. Sanjay Kumar
Mr. and Mrs. Robert D. Lindsay
Mr. and Mrs. David L. Luke III
Mrs. Edwin S. Marks
Total
Dr. Gillian Shepherd Mestre and Mr.
Eduardo G. Mestre
Mr. and Mrs. William R. Miller
Pall Corporation
Mr. and Mrs. Wiltried Witthuhn
Benefactors
Ashner Family Evergreen Foundation
Mr. Michael Burrows
Deloitte & Touche USA, LLP
Mr. and Mrs. Jack Di Maio, Jr.
Mr. and Mrs. Patrik L. Edsparr
Mr. and Mrs. John S. Grace
Mr. and Mrs. James Greene-David J.
Greene Foundation
Mr. and Mrs. Mitchell Jacobson
The Christopher D. Smithers Foundation
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. Roger Tilles
Troutman Sanders LLP
Mr. and Mrs. Seth Zachary-Paul,
Hastings, Janofsky & Walker, LLP
Sponsors
The Americana at Manhasset
Mr. and Mrs. D. Arne Arnesen
Mr. and Mrs. Jay Bernstein
$297,170.00
Mr. and Mrs. Hans E.R. Bosch
Mr. and Mrs. Howard Butnick
Mr. and Mrs. Thomas J. Calabrese, Jr.
Ms. Louise Parent and Mr. John Casa ly
Mr. and Mrs. John D'Addario
Mr. Ron Delsener
Mr. and Mrs. Charles F Dolan
Mr. and Mrs. Michael G. Ferrel
Mr. and Mrs. Stephen A. Garofalo
James I. Garrels, Ph.D.
Mr. and Mrs. Cary A. Kravet
Mr. and Mrs. Andrew M. Levine
Dr. Margaret Cuomo-Maier and Mr.
Howard Maier
Mr. and Mrs David B. Miller
Mr. and Mrs. Ronald J. Morey
Mr. and Mrs. David R. Rogol
Mr. and Mrs. Robert Rosenthal
Mr. and Mrs. Eric A. Rothfeld
Wendy Vander Poel Russell
Mr. and Mrs. James W. Schubauer II
Mr. and Mrs. Mitchell Slater
Mr. and Mrs. James F. Stebbins
Mr. and Mrs. Alan Trautwig
United Healthcare
Mr. and Mrs. Robert von Stade
Mr. and Mrs. Warren T. Wasp
Dr. and Mrs. Richard R. Weiss
Benefit cochairs Howard and Sandy Tytel and Monique and Doug Morris
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PROGRAM CONTRIBUTIONS
January 1-December 31, 2005
Contributions of $5000 and above, exclusive of Annual Fund
GIFTS $100,000 AND ABOVE
The Amgen Foundation, Inc.
The Arnold and Mabel Beckman
Foundation*
The Breast Cancer Research
Foundation*
The Dana Foundation
Curt Engelhorn
The 2001 Frederick & Nancy De Matteis
Family Charitable Trust
The Gerber Foundation*
Francis Goelet Trust*
The Thomas Hartman Foundation for
Parkinson's Research, Inc.
Jo-Ellen and Ira Hazan
The William and Flora Hewlett
Foundation*
Joan's Legacy: The Joan Scarangello
Foundation to Conquer Lung Cancer*
The Karches Foundation*
David H. Koch
The Forrest C. Lattner Foundation*
Mr. and Mrs. Gerard Leeds
Josiah Macy, Jr. Foundation*
The G. Harold and Leila Y. Mathers
Charitable Foundation
The Miracle Foundation
Manyu Oga le
The Pierre and Pamela Omidyar Fund*
Total
Peninsula Community Foundation
Fannie E. Rippel Foundation*
The Seraph Foundation
The Simons Foundation*
St. Giles Foundation
Mr. and Mrs. Theodore R. Stanley
The Swartz Foundation*
GIFTS $5,000499,999
Dunkin Brands
Breast Cancer Help, Inc.
The New York Community Trust-Cashin
Family Fund
Cold Spring Harbor Main Street
Association
Mr. and Mrs. George Cutting, Jr."
Denise and Daniel De Vita
Dr Lester Dubnick
The Eppley Foundation for Research,
Inc.
Find A Cure Today (FACT.)
The Joseph G. Goldring Foundation
The Irving A. Hansen Memorial
Foundation
Harrison's Heart Foundation
James R. Hudson, Jr.
Town of Islip Breast Cancer Coalition
The Charles Henry Leach II Foundation
$27,100,613.00
Total Capital, Endowment,
and Program Contributions
*New pledges awarded in 2005
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$72,714,656.00
The Lehman Brothers Foundation
Long Island 2-Day Walk to Fight Breast
Cancer, Inc.
Long Islanders Against Breast Cancer
(L.I.A.B.C.)
The Manhasset Women's Coalition
Against Breast Cancer*
The Maxfield Foundation
Breast Cancer Awareness Day in
Memory of Elizabeth McFarland
The Andrew W. Mellon Foundation
Louis Morin Charitable Trust
National Parkinson Foundation*
Philips Research
The William Townsend Porter Foundation
The Rathmann Family Foundation*
Roslyn Savings Foundation
The Seligson Foundation
Linda and Hank Spire
Lauri Strauss Leukemia Foundation
Estate of Florence Strelkowski
Peter and Mary Tobin Foundation
UPS Foundation
Waldbaum Foundation
Dr. and Mrs. James D. Watson
West Islip Breast Cancer Coalition for LI,
Inc.
Roy J. Zuckerberg Family Foundation
ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory
campus or at the Banbury Center. Without the strong foundation provided by the Program, we could
neither plan with confidence for the year's meetings nor introduce new and unusual topics.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for 16 representatives of the Corporate Benefactors and for 8 representatives
of the Corporate Sponsors at our meetings. Six and three scientists, respectively, from Benefactors and
Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by invita-
tion of the organizers. Member companies receive gratis copies of Cold Spring Harbor Laboratory
Press publications, including the journals Genes & Development, Learning & Memory Protein Science,
Genome Research, and RNA. We acknowledge our Sponsors in all relevant publications, including the
books of abstracts given to each of the 7,000 participants who come to the meetings each year. The
names of the sponsoring companies are listed on the poster describing the meetings, and this is mailed
to approximately 17,000 scientists throughout the world. In addition, the companies are listed on the
Cold Spring Harbor Laboratory Web site on the Meetings Office and Banbury Center pages. Members
for 2005 were:
CORPORATE BENEFACTORS
Amgen Inc.
Bristol-Myers Squibb Company
GlaxoSmithKline
Novartis Institutes for BioMedical Research
CORPORATE SPONSORS
Applied Biosystems
AstraZeneca
BioVentures, Inc.
Diagnostic Products Corporation
Forest Laboratories, Inc.
Genentech, Inc.
Hoffmann-La Roche Inc.
Johnson & Johnson Pharmaceutical Research
Development, L.L.C.
Kyowa Hakko Kogyo Co., Ltd.
Lexicon Genetics Inc.
Merck Research Laboratories
New England BioLabs, Inc.
OSI Pharmaceuticals, Inc.
Pall Corporation
Sanofi-Aventis
Schering-Plough Research Institute
Wyeth Research
PLANT CORPORATE ASSOCIATES
Arbor Gen
Monsanto Company
CORPORATE AFFILIATES
Affymetrix, Inc.
Agencourt Biosciences
CORPORATE CONTRIBUTORS
Aviva Systems Biology
Biogen Idec, Inc.
Cell Signaling Technology
Illumina
Integrated DNA Technologies
IRx Therapeutics, Inc.
Qiagen
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
Hudson-Alpha Institute for Biotechnology
Total $709,000.00
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President's Council
The President's Council was formed 12 years ago to bring together leaders from business, research, and
biotechnology who share an interest in science and Cold Spring Harbor Laboratory's research.
President's Council members contribute $25,000 or more annually to support the Laboratory's Cold
Spring Harbor Fellows-exceptional young Ph.D. and M.D.s who are making great strides toward inde-
pendent and important research. This year, the President's Council raised more than $400,000, estab-
lishing a new record for the annual contributions to the Cold Spring Harbor Laboratory Fellows program.
The 2005 meeting focused on a topic to which CSHL President Bruce Stillman has dedicated his
own research career: cancer. During the 2-day annual meeting, held October 21 and 22, President's
Council members had the opportunity to hear presentations from leading scientists, physicians, policy
makers, and pharmaceutical companies. Together, these talks and workshops provided a compre-
hensive understanding of the state of the science in 2005 and a clear vision of what the future holds.
The following were members of the 2005 President's Council:
Mr. and Mrs. Abraham Appel
Mr. and Mrs. Donald Everett Axinn
Ms. Karen H. Bechtel
Mr. and Mrs. Daniel J. Cahill
Mr. Michel David-Weill
Mr. and Mrs. John H. Friedman
Dr. and Mrs. Leo A. Guthart
Mr. and Mrs. Charles E. Harris II
Dr. William A. Haseltine
Mr. and Mrs. J. Tomilson Hill Ill
Mr. and Mrs. Walter B. Kissinger
Total
Mr. and Mrs. Thomas J. McGrath
Dr. Gerald Chan and The Morningside Foundation
Ms. Wendy Keys and Mr. Donald Pels
Mr. Roderick N. Reed
Mr. and Mrs. Luis E. Rinaldini
Dr. and Mrs. James H. Simons
Mr. and Mrs. Kenneth I. Starr
Mrs. Cynthia R. Stebbins
Dr. and Mrs. James M. Stone
Dr. and Mrs. Charles L. Stone, Jr.
Mr. and Mrs. Raymond Wong
$466,312.00
President's Council members getting a lesson in X-ray
crystallography
John Friedman, Don Axinn, and Dr. Peter Scardino
Bill Haseltine and Jim and Cathy Stone
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Ken Avanzino, Bruce Stillman, and Robert and Anne James
Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Joseph T. Donohue, President
John S. Grace, Vice President
Lynn M. Gray, Vice President
Henry E. Salzhauer, Treasurer
Cathy Cyphers Soref, Secretary
Directors
David L. Banker
Joyce Bertoldo
Pien Bosch
Maria L. Brisbane
Timothy S. Broadbent
Barbara Candee
George W. Cutting, Jr.
E. Richard Droesch
Linda Ferrante
Kate Seligson Friedman
Lori Garofalo
William F. Gerry
Michael S. O'Brien
Jay C. Plourde
Honorary Directors
John P. Cleary, Esq.
Mary D. Lindsay
Anne R. Meier
Association President's Report
Raymond G. Schuville
John C. Stevenson, Ph.D.
Bruce Stillman, Ph.D.
Lynn McGrath Tone
Sandy Tytel
James D. Watson, Ph.D.
It is my distinct pleasure to report that 2005 marked the third year in a row that members of the Association
raised more than $1 million for the annual fund. We surpassed our highest goal ever, $1,100,000, and
brought in $1,132,475.00 for unrestricted spending for research and programs. The Association annual
fund is a crucial source of financing for start-up research projects, purchasing equipment, and providing fel-
lowships for top young researchers. In fact, our supporters are so generous that the Association instituted
a new membership level in 2005 for annual gifts of $20,000 and above: "Nobelist."
Once again the Laboratory earned a four-star rating from Charity Navigator-a designation awarded by
this independent rating service for efficient use of donor funds-joining 1% of the charities rated by the
service for earning four stars for five consecutive years in a row.
Not only did we raise more money than ever in 2005, but we made more friends. Thanks to our dedi-
cated board of directors, 40 new members joined the Association in 2005, an important step in our mis-
sion to increase awareness of the Laboratory to people beyond our immediate communities.
After 6 years of service, we bid farewell to retiring directors-Alan Kisner, Mary Alice Kolodner, and
Larry Remmel-all of whom continue to be active in Laboratory events and outreach. Trudy Calabrese,
who retired as the Association President this year after serving for 8 years on the Board, left very large
shoes for me to fill. Her enthusiasm, creativity, energy, and particularly her lovefor the Laboratory were felt
by everyone who had the privilege to work with her. Joining the board in 2005 were Joyce Bertoldo, Dick
Droesch, Linda Ferrante, and Sandy Tytel.
Our seventh annual Jazz benefit broke all records for attendance and net profits ($110,000 raised). The
event, chaired by Joanne and Jay Andrea and Pien and Hans Bosch, drew more than 400 guests who
were treated to an extraordinary performance by the multi-Grammy award winning vibraphonist, Gary
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2005 CSHLA Directors
Burton. The concert by Burton and guitarist Julian Lage, pianist Vadim Neselovskyi, and bassist Luques
Curtis completely raised the bar for entertainment at future Laboratory benefits.
Other successful happenings during 2005 included our annual meeting on February 13 with CSHL sci-
entist Dr. James Hicks. Jim described the powerful new technology developed at the Laboratory, ROMA,
or representational oligonucleotide microarray analysis, that analyzes genes and tissue samples for prog-
nosis and diagnosis in breast and other cancers. The technology is evolving rapidly and is now being uti-
lized in the launching of research programs to understand the genetic bases of some neurological disor-
ders, particularly autism.
A wonderful gathering on September 11 for major donors was held on a Sundayafternoon at the home
of CSHL friends Nancy and Patrik Edsparr. It was gratifying to hear former Watson School graduate stu-
dent and current CSHL Fellow Patrick Paddison describe with warmth and good humor his experiences
while a student at the Laboratory and his avid devotion to his current project in cancer research.
A number of our members enjoy personal relationships with Laboratory scientists and their families,
and our directors hosted a "Partnership Picnic" on Sunday, September 18 to encourage more of these
friendships. Director George Cutting, long a champion of promoting friendships with the people who
devote their careers to our health, again provided this year fresh Alaskan salmon for the party, caught by
him and his family over the summer, We are lucky to have the opportunity to get to know scientists from
many different countries, and our partners include these scientists in gatherings of families and friends, a
richly rewarding experience.
The Laboratory's annual Symposium's Dorcas Cummings Memorial Lecture and dinner parties
occurred on Saturday, June 5. Our keynote speaker, Dr. Charles Sawyers of the University of California at
Los Angeles, heads the prostate cancer program there, and he described hiscontribution to the progress
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JAZZ AT THE LAB 2005
April 9, 2005
Lead Sponsors
Centerbrook Architects
Pien and Hans Bosch
Joanne and Jay Andrea
Neisloss Family Foundation
Sponsors
Joseph V. Amelia, Accretive Solutions
Jennifer and Peter Bliven
Maureen and Dan Cahill
Daniel Gale Real Estate
Kelly and Mark DeGennaro
Jamie and David Deming
Kathy and Jack Di Maio
Helen and Charles Dolan
Mary Beth and Joe Donohue
Dvirka and Bartilucci, Consulting
Engineers
Lori and Stephen Garofalo
Deborah and Mitchell Hauser
Elizabeth and Frank Ingrassia
Jay Andrea, Bruce Stillman, and Pien Bosch at Jazz at the Lab
Lorraine and Peter Janssen
Ginny and David Knott
Eugenia and Thomas Korossy
The Marcus Organization
Gillian and Eduardo Mestre
Bowen and John Miller
William & Joyce O'Neil Charitable
Trust
Julie and Luis Rinaldini
Howard Solomon
Cathy and Douglas Soref
Kathleen and Jim Szymanski
Sandy and Howard Tytel
U.S. Trust
Contributors
Barbara and Paul Amoruso, Oxford &
Simpson Realty, Inc.
Trudy and Tom Calabrese
Barbara and Jim Hoover
Mary D. Lindsay
Suzanne and Richard Leeds
The Litwin Foundation
Nancy Marks
Elena Melius Foundation
Robert de Rothschild
Emily and Jerry Spiegel (front) and Alison and Jim Neisloss at Jazz at the Lab
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being made in developing molecularly targeted cancer therapies. More than 20 of our members hosted
dinner parties for their friends and Laboratory and visiting scientists afterward.
Marion and Frank Ahmed
Erica and Henry Babcock
M.L. Blair
Barbara and Bill Candee
Pat and Dick Droesch
Kate and John Friedman
Lola and John Grace
Lynn and Towny Gray
Libby and Rex Hubbard
Lorraine and Peter Janssen
Mary Lindsay
Marcia Kramer Mayer
Noelle and Robert O'Connor
Nancy and Jim Pirtle
Susan and Hank Salzhauer
Debby Solbert
Cathy and Douglas Soref
Jane and Jim Spingarn
A visit with Goose Hill Elementary School Students
430
Janet and John Stevenson
Val and Warren Titus
Lynn and Pat Tone
Maureen and Alfred Vachris
Jennie and Tom Vandeventer
Robin and Paul Vermylen
Ingrid and Nik Vetsch
Terry and Bob Walton
Andree and Jack Welsh
The annual visit from first graders at the Goose Hill
School in Cold Spring Harbor is now in its fourth year. For
two mornings in May, the children come classroom by
classroom to a specially organized science fair given by
enthusiastic young scientists who, with hands-on activi-
ties, teach the children about the work they do to under-
stand the brain, cancer, and plants.
New in 2005 was the Laboratory Association's invita-
tion in early December to participate in the Americana at
Manhasset's annual Champions for Charity shopping ben-
efit. Thanks to chairwomen Pien Bosch, Kate Friedman,
Cathy Soref, and Sandy Tytel, many Association members
and friends turned out to shop and enjoyed a kick-off
cocktail party given by London Jewelers owners Candi
and Mark Udell. Results of the shopping spree will be
announced in March 2006.
In closing, I could not be more pleased with the achieve-
ments of the dedicated members of the Association and the
efforts of my fellow Directors. The fund-raising environment
in general will not get any easier in 2006. However, we are
affiliated with an amazing institution that is making signifi-
cant advances in basic research at every turn. I believe that
we are up for the challenges that lay ahead. I know that I
speak for all of the members of the Association who look
forward to meeting them head on!
Joseph T. Donohue
President
Members of the Cold Spring Harbor Laboratory Association
NOBELISTS
Contributions of $20,000 or more
The Honorable Denise De Vita and
Mr. Daniel De Vita
Mr. Robert B. Gardner, Jr.
Mrs. George N. Lindsay
Dr. Marcia Kramer Mayer and Mr.
Michael Eisenbud
Dr. Gillian Shepherd Mestre and Mr.
Eduardo G. Mestre
Mr. Thomas C. Quick
Mr. David M. Rubenstein
Mr. and Mrs. James F. Stebbins
Dr. and Mrs. James D. Watson
ANGELS
Contributions of $10,000 or more
Mr. and Mrs. Roger L. Bahnik
Ms. Joyce Bertoldo and Mr. Michael
Griffin
Mr. and Mrs. John P. Campbell
Centerbrook Architects and
Planners LLC
Mr. and Mrs. Roderick H. Cushman
Mr. and Mrs. E. Richard Droesch
Dr. R. Brandon Fradd
Mr. and Mrs. Stephen A. Garofalo
Mr. and Mrs. John S. Grace
Mrs. Oliver R. Grace
Mr. and Mrs. Austen T Gray, Jr.
Mr. and Mrs. Joseph Gregory
The Korein Foundation
Jeannette and H. Peter Kriendler
Charitable Trust
Mr. and Mrs. Stephen M. Lessing
Mr. and Mrs. David L. Luke III
Mrs. William L. Matheson
Mr. and Mrs. William Ft. Miller
Mr. and Mrs. Hugh O'Kane, Jr.
Mrs. Gerald D. Olin
Mr. E. John Rosenwald, Jr.
Dr. and Mrs. James H. Simons
Mr. Alan C. Stephenson
Tester Family Foundation
BENEFACTORS
Contributions of $5,000 or more
Anonymous (2)
Mr. and Mrs. Lee S. Ainslie III
Mr. and Mrs. Joseph V Amelia
Mr. and Mrs. W. Dillaway Ayres, Jr
Mr. and Mrs. Hans E.R. Bosch
Mrs. Harry A. Brooks
Ms. Louise Parent and Mr. John
Casaly
Mr. and Mrs. Richard T. Cunniff
Mr. and Mrs. Norris Darrell, Jr.
Mr. and Mrs. Christopher Cullom
Davis
Mr. and Mrs. Joseph T. Donohue
Mr. Theodore J. Forstmann
Mr. and Mrs. Robert A. Gay
Mr. William F. Gerry
Robert J. Glaser, M.D.
Mr. and Mrs. Robert M. Grace
Mrs. John W. Hadley
Ms. Maria L Brisbane and Mr.
Wallace Henderson
Ms. Ruth Grace Jervis
The Kapp Family Foundation
Mr. and Mrs. John D. Kousi
Mr. and Mrs. Robert L Marcus
Mr. and Mrs. Michael S. O'Brien
Mrs. Richardson Pratt, Jr.
Mr. Preston V Pumphrey
Mr. and Mrs. Peter J. Quick
Mr. Daniel J. Rubano
Mr. and Mrs. Henry E. Salzhauer
Mr. and Mrs. Enrique F. Senior
Judi Shesh Memorial Foundation
Mrs. Peter 0. A. Solbert
Mr. and Mrs. Bart T Tiernan
Mr. and Mrs. Richard H. Witmer, Jr.
Robert E. Wittes, M.D.
PATRONS
Contributions of $2,500 or more
Mr. and Mrs. John N. Andrea
Mr. and Mrs. Robert H.B. Baldwin
Mr. and Mrs. Nicholas J. Bartilucci
Dr. and Mrs. Arthur M. Bernhang
Mr. Richard A. Bernstein
Mr. and Mrs. Timothy S. Broadbent
Mr. and Mrs. Thomas J. Calabrese, Jr.
Mr. and Mrs. Peter B. Cumuli
Mrs. Thomas H. Choate
Mr. and Mrs. John P. Cleary
The Craigmyle Foundation
Mr. and Mrs. George W. Cutting, Jr.
Wand Mrs. David H. Deming
Mr. and Mrs. Robert W. Fagiola
Mr. and Mrs. Desmond G.
FitzGerald
Mr. and Mrs. John S. Friedman
Mrs. Edward H. Gerry
Mr. and Mrs. Thomas S.T. Gimbel
Mr. and Mrs. William H. Grover
Mr. Colin F. Hannaway
Mr. and Mrs. Gordon S. Hargraves
Mr. Richard C. Hazlewood
Mr. and Mrs. Christopher G.G. Hogg
Mr. and Mrs. Barclay G. Jones III
Mr. and Mrs. Peter D. Klein
Mr. and Mrs. Townsend J. Knight
Laurie J. Landeau, V.M.D.
Mr. and Mrs. Richard Leeds
Mr. and Mrs. Eugene J. Levitt
Dr. David M. Livingston
Mr. and Mrs. John Ma.skill
Mr. and Mrs. Keith M. Moffat
Nastech Pharmaceutical Company,
Inc.
Mr. and Mrs. James Neisloss
Abby & George O'Neill Trust
Mr. and Mrs. Howard Phipps, Jr.
Susan L. Rose, Ph.D.
Mr. and Mrs. Philip M. Satow
Mr. and Mrs. Raymond G. Schuville
Mr. and Mrs. Douglas S. Soref
Sovereign Volkswagen, Ltd.
Estate of Georgette A. Spingarn
Mr. and Mrs. Erwin P. Staller
Dr. and Mrs. Bruce W. Stillman
Mr. and Mrs. Pascal Franchot Tone
U.S. Trust Company of New York
The Diane and Howard Wohl Family
Foundation, Inc.
The Roy J. Zuckerberg Family
Foundation
ASSOCIATES
Contributions $1,000 or more
Aegis
Anonymous
Mr. and Mrs. Robert F. Albertson
Mr and Mrs. Paul F. Amoruso
Mr. and Mrs. Thomas M. Bancroft, Jr
Mr. and Mrs. David L Banker
Mr. Edmund Bartlett
Mr. and Mrs. Rodney B. Berens
Berger, Torquato & Davis LLP
Mr. and Mrs. Gene M. Bernstein
Mr. and Mrs. Peter Bliven
Mr. and Mm. Allen L. Boorstein
Drs. David Botstein and Renee A.
Fitts
Dr. William Braden III
Mr. and Mrs. Douglas Braff
Mr. and Mrs. Arthur F. Brings
Mr. John D. Britton II
Mr. Frank Brunckhorst
Mr. and Mrs. Daniel J. Cahill
Mr. and Mrs. Daniel J. Callahan, Jr.
Dr. and Mrs. Rolla D. Campbell
Mr. and Mrs. William J. Candee III
Mr. and Mrs. Vincent F. Carosella
Mr. Robert B. Catell
Dr. and Mrs. Leon I. Charash
Mr. and Mrs. Harry G. Charlston
Mr. and Mrs. Gerald L. Chasin
Ms. Ann K. Thompson and Mr.
James C. Childress
Mr. and Mrs. David C. Clark
Mrs. Robert L Clarkson, Jr.
Mr. James W. Cleary
Drs. Joan and Peter F. Cohn
Mr. and Mrs. John H. Coleman
Mr. and Mrs. Curtis Cushman
Pat Petersen/Daniel Gale Agency, Inc.
The Davidson Family Foundation
Mr. Robert de Rothschild
Mr. and Mrs. Mark DeGennaro
Mr. and Mrs. Donald L Deming
Mr. and Mrs. Jack DiMaio, Jr.
Mr. and Mrs. Michael J. DiMaio
Mr. and Mrs. Charles F. Dolan
Dr. Lester Dubnick
Mr. and Mrs. William T. Dunn, Jr.
Dvirka & Bartilucci Consulting
Engineers
Mrs. James A. Eisenman
Mrs. Duncan Elder
Mr. and Mrs. Johnston L Evans
Mr. and Mrs. Donald M. Eversoll
Dr. and Mrs. Robert J. Feeney
Mr. and Mrs. Patrick J. Foye
Mr. and Mrs. Roger Fradin
Mr. and Mrs. E. Maxwell Geddes, Jr.
Dr. and Mrs. Charles B. Goodwin
Ms. Rosalyn C. Gordon
Mr. and Mrs. Mitchell Hauser
Mr. Walter H. Haydock
Mr. and Mrs. Joseph Heyenoort
James Hicks, Ph.D.
Mr. and Mrs. James B. Hoover
Mr. and Mrs. Garfield Horn
Mr. Frederic B. Ingraham
Mr. and Mrs. Francis J. Ingrassia
Walter B. James Fund No. 2
Mr. and Mrs. Peter Janssen
Mr. and Mrs. David M. Knott
Mr. and Mrs. Thomas Korossy
Mr. Abraham Krasnoff
Mr. and Mrs. Gordon E. Lamb
Mr. and Mrs. Edward M. Lamont
Mr. and Mrs. James M. Large, Jr.
Mr. and Mrs. Leonard A. Lauder
Mr. and Mrs. Gerald LeBoff
Mrs. Lois A. Lenahan
Mrs. Henry Lewis III
Mr. and Mrs. Lawrence M. Liman
The Litwin Foundation
Mr. and Mrs. Luke D. Lynch, Jr.
Mr. and Mrs. Patrick H. Mackay
Mrs. David Mahoney
Mrs. Norton W. Mailman
Marcus Property Management Corp.
Mrs. Edwin S. Marks
Robert A. Martienssen, Ph.D.
Mr. and Mrs. Gerald M. Mayer, Jr.
Mrs. James A. McCurdy Jr.
The Elena Mel. Foundation
Mr. and Mrs. Clarence F. Michalis
Mr. and Mrs. John Robinson Miller IV
Mr. and Mrs. Sidney A. Miller
The Leo Model Foundation
Ms. Kathleen A. Mooney
Mr. and Mrs. Francis W. Murray III
Mr. and Mrs. Howard Olian
Mr. and Mrs. Frank J. Olt, Jr.
Orion Consultants
Mr. and Mrs. Richard S. Overton
Oxford & Simpson Realty Services
Mr. and Mrs. Douglas L Paul
Mr. and Mrs. Nichol. B. Paumgarten
Mr. David P. Pearson
Mr. and Mrs. David Peikon
Mr. and Mrs. John J. Phelan, Jr.
Dr. and Mrs. Anthony Piazza
Mr. and Mrs. Robert A. Pilkington
Mr. and Mrs. Thomas L. Pulling
Drs. Marjorie J. van de Stouwe and
Scott J. Ratner
Mr. and Mrs. John R. Reese
Mr. and Mrs. Lawrence Remmel
Mr. William S. Robertson
Mr. and Mrs. Arthur M. Rogers, Jr.
Mr. and Mrs. Steven Roth
Mrs. Miriam K. Rothenberg
Mr. and Mrs. J. Wright Rumbough, Jr.
Mr. and Mrs. Hollis F. Russell
Mrs. William F. Russell
Mr. and Mrs. Anthony L. Sbarro
Mr. and Mrs. Peter G. Schiff
Mr. and Mrs. Thomas L Seifert
Mr. and Mrs. David M. Silfen
Mr. Herbert A. Slater
Mr. and Mrs. H. Brooks Smith
Mr. and Mrs. Owen T. Smith
Mr. and Mrs. Howard Solomon
Mr. and Mrs. Jerry Spiegel
Mr. and Mrs. James L. Spingarn
Dr. and Mrs. John C. Stevenson
Mr. and Mrs. Christopher D. Suozzi
Mr. and Mrs. James Szymanski
Mr. and Mrs. Irwin Tantleff
Mr. and Mrs. Peter S. Tilles
Mrs. Robert W. Tilney
Mr. and Mrs. Stanley S. Trotman, Jr.
Mr. and Mrs. Howard Tytel
Mr. and Mrs. Robert Valdes-Rodriguez
Mrs. Helene P Victor
Dr. and Mrs. Robert Vizza
Mr. and Mrs. Douglas A. Warner III
Mr. and Mrs. Richard C. Webel
Drs. Mary Ann Cardile and Gerald
Weber
Mr. Gerald I. White
Mrs. Eunice Johnson Winslow
Mr. Mayer Wolf
NEIGHBORS
Contributions of $500 or more
Atkinson Koven Feinberg, LLP
Van and Gerri Ayvazian
Mr. and Mrs. Henry D. Babcock
Kendra D. Block
Peter and Sabina Blohm
Rosemary Bourne
Stephen Brand
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Donald and Jadwiga Brown
Margarite Burns
Mr. and Mrs. Gilbert W. Chapman, Jr
Dr. Eleanor Chernick
Mr. and Mrs. Barry Cosel-Pieper
Mr. and Mrs. Frederic R. Coudert III
Brooke and Stefan Cushman
Mr. and Mrs. Christoph Cushman
Mr. and Mrs. Harry P. Davison II
Rosamond A. Dean
Nancy and Kostas Douzinas
Mr. and Mrs. William F. Downey
Mr. and Mrs. John Durkin
Julie C. Eichenberger
Fort Hill Animal Hospital
Dolores Fredrich and Jeff Keller
Kellogg and Kerry Gaines
Mrs. Charles S. Gay
Mr. and Mrs. Elbridge T. Gerry, Jr.
Kevin Gersh
Kerry and Andrew Glanz
Mr. and Mrs. Frank Gundersen
Nancy Hargraves
C. Scott Hartz
Barbara and Murray Hazan
Mr. and Mrs. Dieter Holterbosch
The lovino Family Foundation
Mr. and Mrs. Bernard Kaplan
Steven M. Kaplan
Mr. and Mrs. Saul Katz
Mr. and Mrs. Jeffrey E. Keller
Charles & Lucille King Family
Foundation
Patti and Roy Klein
Suzanne and Richard Kleinknecht
Mr. and Mrs. John Klingenstein
Dr. and Mrs. Jim Jung-Ching Lin
Mr. and Mrs. Robert V Lindsay
William B. Matteson
Nancy Mazarin
Lisa and Charles McCurdy
Mr. and Mrs. John J. McGlinchey
Randall P. McIntyre
Nancy Metz and George Lindsay, Jr.
Rosemary and David Miller
Karen and Walter Morris
Dr. and Mrs. Allan Orenstein
Martha M. Osterhus
Mr. and Mrs. Gilbert R. Ott, Jr.
Pall Corporation
Jeanne and Whitney Pidot
Mrs. Leila C. Pile
Mr. and Mrs. James Pirtle
Jay Plourde
Richard M. Powers, Ph.D.
Mr. and Mrs. George C. Pratt
Nicole and Charlie V Prizzi
Rita Chang and Bill Quinlan
Mr. and Mrs. Luis Rinaldini
Richard and Pamela Rubinstein
Caroline M. and Arthur J. Saladino
Ambassador and Mrs. Arnold
Saltzman
Carol and Jon Santemma
Mr. and Mrs. Marvin H. Schein
Ivy and Francis Scricco
Catherine and John Sebastian
Mr. and Mrs. Howard Simpson
Mr. and Mrs. Clifford B. Sondock
Rena and Paul Stallings
Shirley Steam
Ethel M. Woolverton and Peter H.
Stehli
Mr. and Mrs. Walter C. Teagle III
Mr. and Mrs. George H. Tilghman
Catherine and Alexander Traykovski
Heidi H. Wang
Lisa and Lewis Warren
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Andrea and Jack Welsh
Mr. and Mrs. Peter White
Mr. and Mrs. Douglas Williams
Mr. and Mrs. Samuel H. Wolcott III
FRIENDS
Contributions of $300 or more
Mr. Michael Aboff
Albrecht, Viggiano, Zureck & Co., P.C.
Margaret M. Ames, D.D.S.
Aqua Car Wash
Van J. Ayvazian
Doris and Henry Doris Bachman
Rebecca and Ted Bahr
Dr. Marion and Jens Bakke
Barrier's, Inc. Fine Jewlry & Gifts
Caroline and Fred Bazzini
Mrs. George de B. Bell
Dr. Diane Moriarty and Mr. John
Berejka
Bladykas Engineering, P.C.
M.L. Blair
Blanchfield, King, Kober & Rizzo, LLP
Mr. and Mrs. G.H. Bostwick, Jr.
Scott A. Broadbent, Jr.
Dr. and Mrs. Gerard X. Brogan, Jr.
Mr. and Mrs. James L Brundige
Mr. and Mrs. Newton J. Burkett III
Mr. and Mrs. Joseph Burns
Dr. and Mrs. Walter T. Carpenter
Anna M. Ceraulo
Kevin Clowe
Mary C. Crary
Geraldine McKey Crofoot
Lucy Cutting
Mr. and Mrs. Edward P Dolido
Mr. and Mrs. Mark Donohue
Mr. and Mrs. Benjamin Duke
Lee MacCormick Edwards, Ph.D.
Mr. and Mrs. William Everdell
Mary Anne and Ken Ewald
F.A.C.T. Long Island Foundation
John Falk
Noelle and Burt Faure
Lynn and Saul Federman
Risa and Noah Finkel
Friedlander Group Inc.
Mr. and Mrs. David C. Fuchs
Mr. and Mrs. William C. Gay, Jr.
Dr. and Mrs. Larry E. Gellman
Dr. and Mrs. Morton Glantz
Joseph L. Goldstein
Gondelman Foundation
Mr. and Mrs. Pierre A. Gonthier
George and Harriet Gorelick
Dr. and Mrs. Maurice Green
Mr. and Mrs. Ira Greschler
Tracy and William Hamilton
Carol and David Harrington
Jacquelyn Harvey
Mr. and Mrs. Harold W. Hawkey
Helene Herzig
Charles A. Hickmann
Mr. and Mrs. Charles R. Holcomb
Howard Gaber Designs, Inc.
Nancy E. Hussey
Lesley and John Inglis
Laura J. Ingraham
Mr. and Mrs. Fredd H. Isaksen
Mr. and Mrs. Valdernar F. Jacobsen
Barbara Knowles and Davor Solter
Neil Koenig
Mr. and Mrs. Michael L. Kolodner
Mr. and Mrs. Harry P. Koumas
Lemon Auto Sales, Inc.
Christie and Don Lemp
PJ and Walter Lemp
Mr. and Mrs. Anthony V Leness
Mr. and Mrs. Daniel Leon
Mr. and Mrs. Robert D. Lindsay
Irene N. Llovera, MD
Mr. and Mrs. Jerome D. Lucas
Henry Luce III
Robin and Wayne Manos
Alecia and Elliot Mayrock
Linda H. McLaughlin
Mary H. McLaughlin
Mr. and Mrs. Edward M. Minicozzi
Mr. and Mrs. James D. Mooney, Jr.
Richard K. Moore
Tess Mullarkey
Andrea and Barry Newburger
Lili and John Noesen
Mr. and Mrs. Matthew M. O'Connell
Barry M. Osborn
Lauryl and Robert Palatnick
Mr. and Mrs. Scott L Paterson
Patricia Patterson
Nicole and George Perry
Mr. and Mrs. Howard Phillips
Cynthia Phipps
Mr. and Mrs. R. Stuyvesant Pierrepont
Mr. and Mrs. Richard Pisano, Jr.
Mr. and Mrs. Damen A. Rathkopf
Regency International Business Corp.
Relide Realty Co.
Drs. Anya Hurlbert and Matt Ridley
Kathy and Doug Robinson
Sara and Mario Rodriguez
Mr. and Mrs. Michael Saffran
Dr. Marilyn Moffat Salant
Ilene and Peter Schapero
Schwartz & Blumert LLP
Mrs. Peter Shea
Mrs. Edward M. Shepard
Dr. and Mrs. Peter W. Sherwood
Dr. and Mrs. Walter Shropshire, Jr.
Mary and Bob Sibert
John and Marcella Specce
Arnold Steinberg
Drs. Joan and Thomas Steitz
Frances R. Storrs
Mrs. David S. Taylor
Three Harbors Garden Club
R. Michael Townsend, Ph.D.
John R. Vermylen
Claudia and Don Vogel
Mr. and Mrs. Colton P. Wagner
Mr. and Mrs. Thomas J. Walsh
Mr. and Mrs. Earl Weatherford
Diana Collins and Townsend U.
Weekes, Jr.
Wendy and David Wenger
Mr. and Mrs. R. Paul Wickes
Mr. and Mrs. Malcolm D. Widenor
Kim and Joe Willen
Dr. Charles Yanofsky
Susan and Dave Yeager
Mr. and Mrs. Mark Uoyd Zusy
BASIC
Contributions of $100 or more
Mr. and Mrs. Alan M. Ades
Bruce Alberts
Mr. and Mrs. Charles 0. Ames
Jean E. Andersen
Dr. and Mrs. Carl W. Anderson
Marilyn and Bryan Anthony
Mrs. S. Reed Anthony
Mr. and Mrs. Robert Appel
Mr. and Mrs. Donald Bady
Mr. and Mrs. Robert A. Bailenson
Mr. and Mrs. Benjamin H. Balkind
Daniel P. Barbiero
Joyce and William Baroniunas
Mr. and Mrs. Stephen Benjamin
Maureen and Tony Berejka
Dr. Barbara Bergman
Mr. and Mrs. Irwin Bernstein
Joseph C. Betz
Marjorie and Ashok Bhavnani
Elizabeth Borden
The Bressler Family
Charles A. Brisbane
Terry and Scott Broadbent
Randy and Douglas Brooks
Catherine D. Brown
Kurt, Laura, Lindsay, Brooke and
Nick Brown
Gloria and Sed Browne
Walter J. Buckley
Ward C. Campbell
Dorothea and Bill Cappadona
Kitty Carlisle Hart
Jean Cattier
Marie F. Chiang
Mr. and Mrs. Paul Chisholm
Laurie and Chris Christiansen
Cold Spring Harbor Village Imprvmt.
Society Library
Ann J. Miles and Peter B. Colgrove
Cornelius E. Colley
Colonial Jewelers
Maryda S. Colowick
Janet and Leonard Connolly
Gerald Cordani, M.D.
Claudia Costa
Mr. and Mrs. Thomas M. Craft
Lola Lee Cronacher
Georgiana Crowley
Robert L. Cummings III
Joseph Curry
Mane and Claus Dannasch
Dapper Dan Auto Sales
Katya Davey
Dr. Martin Davis
Robert B. Deans, Jr.
Jean and Curt DeForest
Steve Del Vecchio
Marilyn H. DeLalio
Edward F. DelFoe III
Mrs. Suzanne V Dillenbeck
Thomas L Dillmann
Bryan N. Doherty
Mr. and Mrs. Jack W. Dolce
Melvin J. Draftz
Clementina V Durkes
Mr. and Mrs. William M. Duryea
Elisha Dyer, Jr.
Mr. and Mrs. John E. Eckelberry
Dr. and Mrs. Jerry L. Ellstein
Stephen Ely
Mary English
Dr. and Mrs. N. Dennis Eryou
Mary Ellen Fahs
Elizabeth and Larry Feldman
Mrs. John Fennebresque
J. Barry Ferguson
Fred R. Fertik
Lucy and Pete Fetterolf
Mr. and M.. Seymour Fliegel
Seth E. Frank
Natalie and Lee Friedman
Mr. and Mrs. Lowell J. Friedman
Irwin and Mine Frish
Ellen V Futter
Susie and Jeff Futter
Charles R. Gabalis
Glenn Gallo, D.C.
Mel Ganz
Martin Gellert
Laurie and John Genovese
Mr. and Mrs. Roger M. Gerber
Hugh Jay Gershon
Helen and Monte Get ler
Barbara Gettinger
Mr. and Mrs. Bill Gibson
Zari Ginsburg
Mr. and Mrs. Paul G. Girolamo
Maxine B. Glenn
Drs. Risa and Ken Gold
Alan Goldberg
Richard L. Golden, M.D.
Dr. and Mrs. Lewis A. Goldfinger
Judi Goldhand and Asher B. Dann
Dr. and Mrs. Barry Golub
Gary A. Goodman
Mrs. J. Peter Grace
Mr. and Mrs. Scott H. Greenfield
Mr. and Mrs. Donald B. Gregory
Alain R. Grumberg
Susan Gunduz M.D.
Edie and Allan Haack
Marilyn and Herbert A. Haft
U. Greene and Richard Hamburger
Hamilton, Levy, Miller & Company, Inc.
William H. Hamilton
Mary and John Hardiman
Louisa Thomas Hargrave
Eric P Harkleroad
Dennis E. Harms
Mrs. Chester Hartenstein
Cynthia W. Haueter
Huy ler C. Held
Anthony S. Hendrick
Gilbert Henoch
Dr. and Mm. Stephen M. Hershowitz
Mr. and Mrs. Lawrence P. Hilbert
Deming P Holleran
Karl B. Holtzschue
Mrs. Bruce Duff Hooton
Mr. and Mrs. Richard K. Hyman
Dr. and Mrs. Pavel Illner
Mr. and Mrs. Herbert S. Ingham
Joseph J. Israel
Mr. and Mrs. Richard Jackson
Maurice Jaget
Kathleen and Stuart James
Mrs. Robert D. Jay
Rosalie Joannou
Nicholas Johnnidis, DMD
Miani Johnson
Mr. and Mrs. John F. Johnston II
Winifred Jolly
Mr. and Mrs. Herbert A. Joseph
Paul Kabbabe
Sandra and Wendy Kane
Linda and Avner Kant
Bonnie J. Kansler
Leah R. Karpen
Dr. and Mrs. Richard Kaufman
Ann C. Kazak
Spencer Kellogg II
Joan T. Kelly
Victoria Reese and Gregory Kennedy
CSHLA Annual Fund
Doris Ketcham
Mr. and Mrs. Robert J. King
Dr. and Mrs. Evan Klass
Edward W. Kozlik
John L. Kubacki
Mr. and Mrs. Morton Kunst ler
Mitsuko T. Kurahara
Mrs. John W. Laps ley
George Lawrence
Jared E. Lee
Jong Pil Lee
Mrs. Richard H. Leeds
Mr. Richard B. Lenchus
Jodi and Stephen Lerner
Randy Levinson
Dr. Robert V. Lewis
Maureen and Frank Liantonio
Locust Valley Rotary Club Foundation
Mr. and Mrs. Alan J. Long
Mr. and Mrs. John B. Lo Russo
Mr. and Mrs. John J. Lyons
Anna Maass
Janet I. Mac Innes
Cynthia J. MacKay
Elizabeth J. Mackay, Esq.
Wilfred G. Mackey
Sayre MacLeod III
Mrs. Henry R. Macy
Dr. Helen T. Madden
Jane and Philip Mallinson
Dr. Michael S. Mamakos
Mr. and Mrs. P Mandelik
Jane and Earl Matchett
Joseph E. May
Malcolm S. McClintock
Diana Mcllvaine
Barbara and Angus McIntyre
Mr. and Mrs. Robert M. McLane
Mr. and Mrs. Gregory McMahon
Stephen E. Mermelstein
Elizabeth Meyer
Mr. and Mrs. William Milanese
Kathy Hill Miller and Frederic Miller
Louise G. Miller
Dorothy and Elihu Mod lin
Mr. and Mrs. Walter Mondschein
Mr. and Mrs. George G.
Montgomery, Jr.
Mr. and Mrs. Jesse A. Moore
Pat and Warren Moore
Barbara Ann Moriarty, M.D.
Valerie Wilson Morris
Mr. and Mrs. John G. Morrison
Cynthia and Donald Morrongiello
Jane and Charles Morton
Brent M. Mowery
Marjorie W. Mowery
Ross S. Mowery
Gail and Joseph Muscatel lo
Ann Scolnick and Bernard Musso
Mariko Nakamura
Mm. Mary Helen Neuendorffer-Pfeifer
Mrs. William S. Niven
Mr. and Mrs. Francis E. O'Connor
Noe Ile and Robert O'Connor
Mr. and Mrs. Christopher P O'Hara
Innis O'Rourke, Jr.
Mr. and Mrs. Robert C. Palermo
Nancy and Michael Paloian
The Paniagua Family
Mr. and Mrs. Robert Pascucci
Pebble Hill Building Corp.
Edith Peg ler
Anne and Nathaniel Peirce
Christine and Peter Pell
Mr. and Mrs. William A. Perlmuth
Jan Pero and Rick Losick
Mrs. Ted Peters
Jane M. Pflug
Mr. and Mrs. James Phillips
The Honorable and Mrs.
Thomas C. Platt
Sarah Plimpton
Robert Pol let
Mi la Pollock
Mr. and Mrs. Philip B. Pool, Jr.
Ann Mowery and Allan Powers
Robert Racusin
Pat Ramsay
Mr. and Mrs. Dominic Ranaldo
William Rand
Susan E. Rau
Arthur G. Reid
Ingrid Schneider and David Reiger
Mrs. Ewing W. Reilley
Charles J. Reina
Marcel le and Bernard Reverdin
The Richard Foundation
Corinne Richards
Mr. and Mrs. Barry Richter
Robert J. Riedy
Maud W. Robertson
Elizabeth E. Roosevelt
Mr. and Mrs. Peter Roth
Mrs. Walter N. Rothschild, Jr.
Drs. Maria and Charles Ryan
Mrs. Harold P Salembier
Patricia P Sands
Phyllis Satz
Mr. and Mrs. T.V. Schiavoni
Howard Schliff
Dr. Axel Schmidt
Deborah Schwartz
Paul E. Seidel
Dr. Peter and Lois Ann Sepez
Mr. and Mrs. Frank T Sesti
Dr. and Mrs. George Sheehan
Mrs. Paul C. Sheeline
Joseph Shenker, Ed.D.
Col. and Mrs. R.E. Sheridan
Linda L. Shoemaker
Edward E. Shorin
"CSHLA Membership Support $1,117,423.00
Nonmember Support $ 4,830.00
Endowment Income 10,222.00
Total $1,132,475.00
'Jazz expenses deducted
Scott A. Siegel, M.D.
Eliot N. Silverman
John D. Simpson
Leonard Siper
Suzanne Slocum
Herbert L. Smith III
Mr. and Mrs. John C. Smith
Mr. and Mrs. Stanley R. Smith
Mrs. William S. Smoot
Drs. Made Ion and Carl Solowey
Joan and James Sommermeyer
Frank Stahl
Lydia and Bernard Starr
Steve's Custom Collision
Mr. and Mrs. Byam K. Stevens, Jr.
Pat and Jim Stewart
St. John's Church
Iris H. Sutz
Laura and Brian Swiggett
Mr. and Mrs. Keshav Talwar
Mr. and Mrs. Aldo Tarantini
Janine Tatzel
John W. Taylor
Mr. and Mrs. Marc Tell
Ten Haagen Financial Group
Mr. and Mrs. Edward M. Thomas
George M. Thomas
Jean Thompson
Stanford W. Ting
Top Notch Auto Details
Mr. and Mrs. John M. Townsend
Mr. and Mrs. Francis Trotta
Mr. and Mrs. Edward W. Truslow
Ira J. Udell, M.D.
Mr. and Mrs. Cornelius M. Ulman
Mr. and Mrs. Stephen Van R. Ulman
Beverly S. Vander Poel
Dr. and Mrs. Thornton A. Vandersall
Patricia V Vernam
Ingrid and Niklaus Vetsch
Hattie and Arthur Vogel
F Skiddy von Stade Ill
Dr. and Mrs. Peter Walker
Deborah and Robert Walley
Sarah T. Wardwell
Carley and Carl Weather ley-White
Janina and Richard Weghorn
Mr. and Mrs. L.B. Wehle, Jr.
Jakob J. Westra
Vicky and Stephen Wexler
Sally and Chris White
Mr. and Mrs. Harrison M. Wilson
Dr. and Mrs. Eckard Wimmer
Ann M. Winston
Mr. and Mrs. Frederick C. Witsell, Jr.
Deirdre Woods
Margaret W. Wright
Dr. Keith R. Yamamoto
Mr. and Mrs. Irwin Young
Joan C. Zulch
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CORPORATE AND FOUNDATION MATCHING CONTRIBUTORS
Amgen
Astoria Federal Savings
Bank of America Matching Gifts
Biogen Idec Foundation
Bristol-Myers Squibb Foundation, Inc.
Computer Associates International, Inc.
The Dana Foundation
Florence Corporation
Forest Laboratories, Inc. Matching Gift
Program
iStar Financial, Inc.
The Henry Luce Foundation, Inc
MEMORIAL AND GIFTS-IN-HONOR CONTRIBUTORS
David and Lucile Packard Foundation
Select Equity Group, Inc.
The Sun Microsystems Foundation
United Way of New York City
Verizon Foundation
Anonymous of Friedman's Fine Jewelry The Forrest C. Lattner Foundation Mr. and Mrs. Jim Robbins
Mr. and Mrs. Alan M. Ades Mr. and Mrs. Robert Gal Keung Lau Roberts Jewelers
Mr. and Mrs. Robert Appel Beverley Gasner Sandra Laykind Mr. and Mrs. Stan Robin
Mr. and Mrs. William R. Appleby Mr. and Mrs. Morris W. Geller Mr. and Mrs. Gerald LeBoff Mr. and Mrs. Howard Rosenberg
Esteban Araya Mr. and Mrs. Bill V Gibson Mr. and Mrs. Robert Leffler Mr. and Mrs. Peter Roth
Mr. and Mrs. Nelson Auge Zari Ginsburg Lefrak Organization Financial Department Mr. and Mrs. Steven Roth
Joseph Azznara Berta Gleizer Christie and Don Lemp Mr. and Mrs. Milton Rubien
Mn. and Mrs. Donald Bady Judi Goldhand and Asher B. Dann PJ and Walter Lamp Daniel C. Sager
Rukhsana Bari Beverly F. Goldman Richard B. Lenchus John Saliba
Ambassador and Mrs. Arnold SaltzmanBarrier's Inc.
Lisa Banker
Ann Golick
Mr. and Mrs. Robert M. Grace
Dr. Pamela Lennox
Lesser, Leff & Company LLP Elaine S. Sands, Ph.D.
Ann Berger Mr. and Mrs. Steven Greenhouse Benjamin Levine Barbara Santos
Mr. and Mrs. Irwin Bernstein Mr. and Mrs. Ira Greschler Randy Levinson Mr. and Mrs. Gary Schechter
Mr. and Mrs. Xerxes K. Bhote Gale and Maxine Grossman Mr. and Mrs. Lawrence M. Liman Deborah Schwartz
Mr. and Mrs. Peter Blitzer Alain R. Grumberg Long Island Science Education Schwartz & Blumert LIP
Howard L. Boris, P.C. Mr. and Mrs. Herbert A. Haft Leadership Association The Seligson Foundation
Dr. Stephen R. Brand Alexander Halstein Mr. and Mrs. John J. Lyons Dr. and Mrs. Peter V Sepez
Mary Brillante Hamilton, Levy, Miller & Co., Inc. Anna Maass Mr. and Mrs. Sheldon Shaktman
Randy and Douglas Brooks Ted Hamstra Dr. Helen T. Madden Dr. and Mrs. Roy M. Shanon
Brown Family Cohn F. Hannaway Andrea Malley Patricia Sharkey
Mr. and Mrs. Donald Brown Mr. and Mrs. Gordon S. Hargraves Laura Maitland Edward B. Sheridan
Bruce Electric Equipment Corp. Eric P. Harkleroad Mr. and Mrs. John A. Mangano Joyce L. Shields
Cheryl L. Buffo Dennis E. Harms Mr. and Mrs. Robert L. Marcus Linda L. Shoemaker
Margarita L. Burns Brendan S. Harris Mr. and Mrs. Bruce A. Matthews Burton Siedman
Alson Chan Mrs. Chester Hartenstein Mr. and Mrs. Brian T. McCarthy Mr. and Mrs. David M. Silfen
Rob Chase Cynthia W. Haunter Mr. and Mrs. Thomas McGovern Mr. and Mrs. David W Silverstein
Mr. and Mrs. Robert J. Chemtob Mr. and Mrs. William D. Hecht Mr. and Mrs. Jack McOuair Mr. and Mrs. Jerry Spiegel
Mr. and Mrs. Christopher Christiansen Joanne Heiligman Michael's Jewelers Mr. and Mrs. Fred S. Steiner
Mr. and Mrs. John P. Cleary Mrs. Philip R. Herzig Louise G. Miller Mr. and Mrs. Jeffery Stem
Colonial Jewelers
Claudia Costa
W. Allan Herzog
Dacia Horowitz
Mr. and Mrs. Walter Mondschein
Mr. and Mrs. Sung Moon
Andrea, Joel, and Jessica Stillman
David R Stockert
Mr. and Mrs. Eugene Cummings Mr. and Mrs. William S. Howe Kathleen A. Mooney Iris H. Sure
Marilyn H. DeLalio Mr. and Mrs. Richard Hyman Ann Mowery and Allan Powers Mr. and Mrs. Mathew J. Tedesco
Mr. and Mrs. Herbert M. Deutsch Mr. and Mrs. Harris L Insley Marjorie W. Mowery Thomas Jefferson High School for
Mr. and Mrs. Warren K. Dictor Mr. and Mrs. Jeremy G. Isaacs Ross S. Mowery Science and Technology
Mr. and Mrs. Louis P. Di Gennaro
Mr. and Mrs. Carolyn and Nelson Dittmar
Joseph J. Israel
Gail Jacob
David Nadel
Jerry A. Nigro
Ted and Lisa Tieff
Dr. Nicholas Tanks
Barbara Dougherty Mr. and Mrs. Charles Jones Mr. and Mrs. Basil F. Northam Mr. and Mrs. Francis Trotta
Melvin J. Draftz Mr. and Mrs. Herbert A Joseph Mr. and Mrs. Dennis M. O'Donnell Mr. and Mrs. Craig Truer
Mr. and Mrs. William M. Duryea Mr. and Mrs. James J. Juliano Mr. and Mrs. Howard Olian Valentina Varshayskaya
Mr. and Mrs. Kenneth J. Dzurilla Paul Kabbabe Dr. and Mrs. Allan Orenstein VPK Enterprises
Mr. and Mrs. Una and Solomon Ellma.n Mr. and Mrs. Avner Kanfi Rafael Ortiz Holly M. Warshaw
Dr. and Mrs. N. Dennis Eryou Abby and Rick Kaplan Beth Pandolpho Marian S. Wanner
Hugh H. Evans III Mr. and Mrs. Bernard Kaplan Melvin Paradise Dorothy Weintraub
Janie Faulds Steven M. Kaplan Dominic Paul Mr. and Mrs. Stanley Weintraub
Debra A. Fenton Mr. and Mrs. Mark Katz Mr. and Mrs. William A. Perlmuth Jody Berger Wenig
Dr. and Mrs. Albert Fine, DDS Mr. and Mrs. Saul Katz Mr. and Mrs. Harvey Perm. Phyllis Wilk
Thelma Fisher Dr. and Mrs. Donald S. Kent Shellie G. Phillips Mr. and Mrs. Alan H. Wilson
Dr. and Mrs. Glen Frtterman, M.D. Sara F. Kibbey Mr. and Mrs. Jeffrey J. Picarello Ann. M. Winston
Mr. and Mrs. Seymour Fliegd Patricia C. Kiley Judith S. Pollack Mr. and Mrs. Aaron H. Wolff
Carolyn R. Fostel Kimco Realty Corp. Mr. and Mrs. Dominic Ranaldo Deirdre Woods
Katharine Fournier Mr. and Mrs. Michael B. Kidd Susan E. Rau Mr. and Mrs. Joel Wortsmann
Seth E. Frank Mr. and Mrs. Ira Kramer Mr. and Mrs. Richard Rauch Mr. and Mrs. Jiunhong and Ching Yang
Mr. and Mrs. Walter A Frank Jeannette and H. Peter Krtendler Corinne Richards Mr. and Mrs. David M. Yeager
Mr. and Mrs. Lowell J. Friedman Charitable Trust Mr. and Mrs. Barry Richter Mr. and Mrs. Irwin Young
Billy J. Walker, Don Johnson, and the Staff
IN HONOR OF IN MEMORY OF
Dr. and Mrs. Morton Abend Nancy Marks Diane C. Azznara Mr. Ruhser Hurbas Mr. Jack Richards
Dr. Arnold Bank Karen Orzel John Banks Mr. Wayne Jervis Pat Robinson
Steven Braunstein Mrs. Wendy Russell Dr. Box Boxer Eugene Kirschenbaum Barbara Rosen
Susan and Steven Braunstein Henry Salzhauer Mrs. Freda Burd Denise Konrad Christopher Rung
Brandon Halstein Ethel and Henry Schulman Mr. Joseph D'Amato Judith Landwehr Lillian Schechter
Andrew Harris Alan Seligson Mark Davison Margaret Tenke Lisberg Samuel Schechter
Ms. Nicole Leffler Cathy Soref Frank Delgrosso Mr. Arthur Magasis Rolene Schliff
Zelda Lessne Arthur Spiro Mrs. Leona Dubnick Shirty Maley Andrew Seligson
Mrs. Mary D. Lindsay Trudy Woods R. Duncan Elder Carol Marcincuk Helen Ruth Shurman
Cindy and John Mangano Irwin Epstein
Helen B. Fink
Margaret McGahy
Rose M. Mooney
Cassie Stern
Barbara Burkitt Sussman
Peter J. Hannaway Monica Mower,/ Lois Tenke
George W. Hemstead M.D. Julian Pabon Ronnie Wacker
Goldie Hoffman
Dolan DNALC Corporate Advisory Board Annual Fund
The Corporate Advisory Board, established in 1992, serves the Dolan DNA Learning Center as a liai-
son to the corporate community and assists in securing unrestricted support. As a means of raising
support and awareness, the Corporate Advisory Board conducts the annual Golf Tournament and the
Annual Fund.
Chairman: Edward A. Chernoff, Motors & Armatures, Inc.
CSHL Trustee Liaison: Arthur M. Spiro
Michael Aboff, Aboff's Inc
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, Commerce Bank
Thomas W. Bogue, Signature Bank
Thomas J. Calabrese, Daniel Gale Sothebys
International Realty
Richard A. Catalano, KPMG, LLP
James Chinitz
Robert Dickstein, Ph.D., Pall Corporation
Robert E. Diller, Brinkman Instruments
Candido E. Fuentes-Felix, M.D., F.A.C.S.
ANNUAL FUND CONTRIBUTIONS
GENOME SUPPORTERS
Contributions of $10,000 or more
Arrow Electronics, Inc.
Edward A. Chernoff, Motors & Armatures, Inc.
CHROMOSOME SUPPORTERS
Contributions of $5,000 or more
Beverley Gasner/The Henlopen Foundation
Laurie J. Landeau, V.M.D.
Luitpold Pharmaceuticals Inc.
The Elena Melius Foundation
Newsday
OSI Pharmaceuticals, Inc.
Pall Corporation
E. John Rosenwald, Jr.
Topspin Partners, LP
GENE SUPPORTERS
Contributions of $2,500 or more
Mr. and Mrs. Thomas Calabrese, Jr.
Dilworth & Barrese, LLP
Daniel Gale Sothebys International Realty
Mr. and Mrs. Richard R Kleinknecht
Patricia Petersen
EXON SUPPORTERS
Contributions of $1,000 or more
A.C. Israel Foundation, Inc.
Aboff's Inc.
Aegis
Joseph Azznara
Brinkmann Instruments, Inc.
Commerce Bank
Festo Corporation
Harweb Foundation
David Garbus, Huntington Business Products
Centre
Lawrence Goodman, Curtis, Mallet-Prevost,
Colt & Mosle LLP
Arthur D. Herman, Herman Development
Corporation
Neil M. Kaufman, Davidoff, Malito & Hutcher
John C. Kean Ill, Kean Development
Corporation
Laurie J. Landeau, V.M.D.
James E. Mattutat, Ingleside Investors, Inc.
Arthur D. Herman
Kaufman & Associates, LLC
Wendy Vander Poel Russell
Dr. and Mm. Bruce W. Stillman
The Schiff Foundation
INTRON SUPPORTERS
Contributions of $500 or more
Mr. and Mrs. Richard Catalano
Crest Hollow Country Club at Woodbury,
Inc./Richard Monti
Enzo Life Sciences, Inc.
Mr. and Mrs. Patrick J. Foye
Mr. and Mrs. John S. Friedman
W. Allan Herzog
Mr. and Mrs. Gerard Justvig
Mr. and Mrs. Sean McAuley
Mr. and Mrs. David Micklos
Mr. and Mrs. Frank Posillico
Nicole and Charles V. Prizzi
Mr. and Mrs. Christian B. Reynolds
Mr. and Mrs. William D. Roche
Mr. and Mrs. Peter S. Tilles
Mr. and Mrs. Roger Tilles
Mr. and Mrs. Yichwan Wang
TRIPLE GODON SUPPORTERS
Contributions of $250 or more
Jane S. Block
Mr. and Mrs. Alain C. Borczuk
Concorde Real Estate Co, Inc.
Curtis, Mallet-Prevost, Colt & Mosle LLP
Kean Development Company, Inc.
Alan and Mary Marks
Mr. and Mrs. William K. Oelsner
Mr. and Mrs. John J. Pufahl
Mr. and Mrs. Francis Scricco
Jeffrey K. Tupper
Total $125,340.00
Patricia Petersen, Daniel Gale Sothebys
International Realty
Frank Posillico, Rose Racanelli Realty/Aireco
Christiaan B. Reynolds, Fimat U.S.A.
William D. Roche
Wendy Vander Peel Russell
Charles R. Schueler, Cablevision
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of New York
Robert Van Nostrand, OSI Pharmaceuticals, Inc.
Tony Wills, Newsday
NUCLEOTIDE PAIR SUPPORTERS
Contributions of $100 or more
James A. Attwood, Jr.
Berger's Wholesale Meats Inc.
Mr. and Mrs. Piero Casalicchio
Andrew Ceraulo, Esq.
Executive Realty, Inc.
Danielle and Joe Faria
Fogarty
Drs. Eileen M.K. Fontanetta and John B.
Amodio
Dr. and Mrs. Candido E. Fuentes-Felix
Mr. and Mrs. Gregory Gavin
Dr. and Mrs. Steven M. Goldberg
Mr. and Mrs. Alexander Halstein
Mr. and Mrs. Stephen Hannan
Michael G. Hardial
Magdalen E. Hull, M.D./Huntington
Reproductive Med., PC
Dr. and Mrs. Ron Israeli
Paula and Richard Kniffin
Mr. and Mrs. Denny Kupferman
Warren B. Lane
Mr. and Mrs. Joseph A. LoCicero
Cynthia and Donald Morrongiello
Karen H. Orzel
The Paniagua Family
Mr. and Mrs. Howard Phipps III
Dr. and Mrs. Robert J. Rosati
Mr. and Mrs. Bret E. Russell
Mr. and Mm. Jeffrey Schwartz
Mr. and Mrs. Christopher Seniuk
Mr. and Mrs. H. Brooks Smith
Penny Stern, M.D.
Laura and Brian Swiggett
Kurt Timmel
Mei-Ya and Cheng-Jen Tsai
Mr. and Mrs. John E. Welsh III
Norma Whitley
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TWELFTH ANNUAL GOLF TOURNAMENT SPONSORS
FOUNDING TOURNAMENT SPONSOR
JPMorgan Chase & Co.
MAJOR CORPORATE SPONSORS
Cablevision Systems Corporation
Fortunato Sons, Inc.
Marsh, Inc.
Motors & Armatures, Inc.
Thomas C. Quick
CORPORATE SPONSORS
Commerce Bank
Mr. and Mrs. Charles F. Dolan
KPMG LLP
National Maintenance Supplies Inc.
OSI Pharmaceuticals, Inc.
Pall Corporation
United Healthcare
BREAKFAST SPONSOR
Bank of America
PRIZE SPONSOR
Fisher Scientific International Inc.
REGISTRATION TABLE SPONSOR
U.S. Trust Company of New York
DRIVING RANGE SPONSOR
Crest Hollow Country Club at Woodbury, Inc.
TEE/GREEN SPONSORS
Mr. and Mrs. Michael J. Bertuch
Electronix Systems Central Station Alarms, Inc.
Saul Ewing LLP
Jostens Printing and Publishing
Newsday
Royal Healthcare of Long Island
Mr. and Mrs. Arthur J. Saladino
The Sheridan Press
State Bank of Long Island
GOLF CART SPONSORS
A Partymaker, Inc.
The Appliance Home Center
Berger's Wholesale Meats Inc.
D. Reis Furniture Mfg. Corp.
Mr. and Mrs. Joseph A. Feria
Landscapes by Jeffco, Inc.
Lewisy Fuel Oil, Inc.
New York Biotechnology Association, Inc.
Seafood Emporium Fish Market
HOLE-IN-ONE SPONSOR
Competition BMW of Smithtown
Total (net)
GOLD PACKAGE SPONSORS
All Pro Carpet Co., Inc.
Berger Raft Design Associates
Brinkmann Instruments/Eppendorf
Brownstone Agency, Inc.
Mr. and Mrs. Thomas J. Calabrese, Jr.
Curtis, Mallet-Prevost, Colt & Mos le LLP
Daniel Gale Agency, Inc.
Davidoff Malito & Hutcher LLP
Dilworth & Barrese
Herman Development Corporation
Huntington Business Products Centre, Inc.
OSI Pharmaceuticals, Inc.
Oxford & Simpson Realty Svcs., Inc.
John G. Passarelli, M.D.
PricewaterhouseCoopers, LLP
RBC Capital Markets
Mr. and Mrs. Bernard F. Reynolds
Schwartzapfel, Novich, Truhowsky &
Marcus, PC
The Seligson Foundation
Mr. and Mrs. Peter S. Titles
U.S. Trust Company of New York
SILVER PACKAGE SPONSORS
Advantage Title Agency, Inc.
Corte! Business Solutions, Inc.
Enzo Life Sciences, Inc.
Ingleside Investors
Met Life
Mintz Levin Cohn Ferris Glovsky & Popeo
Rose Racanelli Real Estate
BRONZE PACKAGE SPONSORS
Aboff's Inc.
Burt Building Materials Corp.
Callan, Koster, Brady & Brennan, LLP
DONATIONS
Mr. W. Allan Herzog
Mr. And Mrs. Richard R Kleinknecht
RAFFLE AND LIVE AUCTION SPONSORS
Aboff's
American Girl
American Museum of Natural History
The Appliance Home Center
Audio Command Systems
Austin Travel
Dill Ayres
Barney's
Bedlam Street Restaurant
Blue Honu Restaurant
Bon Bons Chocolatier
Bryant & Cooper
Suzanne Christensen Interiors
Cold Spring Harbor Laboratory
$144,818.00
Total Dolan DNALC Annual Fund
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Cole's House Restaurant
Commerce Bank
Competition BMW
Cradle of Aviation Museum
Dragons Arena Football
Frassanito Jewelers
Dr. Candido Fuentes-Felix
Garden City Hotel
Golf Magazine
Jeff Hawkins
Huntington Indoor Tennis
Huntington Village Sports
Island Green Golf Center
Jonathan's Restaurant
Suzanne and Richard Kleinknecht
Laurie J. Landeau, V.M.D.
Madame Tussaud's Museum
Marsh's
Medieval Times
Mill River Inn
Mim's Restaurant
New York Knicks
New York Rangers
Oheka Castle
Rexer Parkes
Thomas C. Quick
Sbarro, Inc.
Southwest Airlines
Splish Splash
St. Andrews Restaurant
Stephen Steinthahl
Syosset Limousine
Titleist
Vineyard Vines
FAVOR BAG SUPPLIERS
Commerce Bank
Curtis, Mallet-Prevost, Cott & Mos le LLP
Daniel Gale Agency, Inc.
Golf Magazine
Golfsmith
Huntington Business Products Centre
Met Life
Titleist
GOLF COCHAIRMEN
Richard Catalano, KPMG
Robert Van Nostrand, OSI Pharmaceuticals,
Inc.
AUCTIONEER
Scott Miller, SB Capital
THANK YOU
Cold Spring Harbor Laboratory Volunteers
Dolan DNA Learning Center Volunteers
Piping Rock Club Staff
$270,158.00
The Harbor Society
Individuals who inform us of their intention to make a gift to Cold Spring Harbor Laboratory from their
estate are invited to become members of The Harbor Society, with benefits that include invitations to
special events and personal research updates. Helping to build a bigger and stronger endowment
through an estate gift ensures that CSHL will continue to pursue its mission for years to come.
In 2005, we increased our efforts to show donors the benefits of including CSHL in their estate plan
by running a large campaign entitled "Our Future Is in Your Hands." Our children, grandchildren, and
all future generations will benefit from the advances our scientists are able to make in understanding
the exact working of each cell in our bodies, and private philanthropy is the foundation of this work.
At present, more than 40 individuals or families have informed us of their plans to give a portion of
their estates to CSHL. We are also aware of a number of people who may decide to include the Lab
in their wills but prefer not to divulge their final philanthropic decisions. Through creative planned giv-
ing arrangements, thoughtful donors can minimize the after-tax cost of their contributions while secur-
ing allowable benefits for themselves and their families. The nearly annual revisions of the nation's tax
code in recent years have made it imperative to make informed choices in financial and tax planning,
and our Development Department continued throughout 2005 to help donors understand the ramifi-
cations of the constantly changing planned giving environment.
Undergraduate Research Program Sponsors
Founded in 1959, the Undergraduate Research Program allows college students from around the
world to participate in hands-on, inquiry-based avenues of exploration. This educational approach
increases students' understanding of science, nurtures their enthusiasm about science, exposes them
to the excitement of scientific discovery, and stimulates their curiosities while interesting them in pur-
suing research careers or other science careers. Twenty-five national and international participants
spent 10 weeks during the summer at Cold Spring Harbor Laboratory conducting research under the
guidance of staff scientists.
CONTRIBUTORS
The Cornelius N. Bliss Memorial Fund
Robert Cummings/Dorcas Cummings Endowment
Dr. Alfred Goldberg
Reverend Linda P. Hancock
Hunter College
The Joe Lewis Jefferson Foundation
Dr. Randi Leavitt
National Science Foundation
The William Townsend Porter Foundation
Mr. and Mrs. William S. Post
Dr. Philip Starr
The Steamboat Foundation
Mr. Joel N.H. Stern
Mrs. Robert W. Tilney, Jr.
ENDOWMENTS
Emanuel Ax Fund
Burroughs Wellcome Fund
Garfield Fellowship
H. Bentley Glass Fellowship
Libby Fellowship
Robert H.P. Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
Total $269,518.00
Total Private Contribution $75,562,119.00
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LABORATORY STAFF
Bruce W. Stillman, President
James D. Watson, Chancellor
Hollis Cline, Director of Research
W. Dil laway Ayres, Jr., Chief Operating Officer
Lilian Clark Gann, Dean, Watson School of Biological Sciences
Lari C. Russo, Comptroller
John P. Maroney, Director, Office of Technology Transfer/
In-House Counsel
Terri I. Grodzicker, Assistant Director of Academic
Affairs
Jan A. Witkowski, Executive Director, Banbury Center
David A. Mick los, Executive Director, Dolan DNA
Learning Center
John R. Inglis, Executive Director, CSHL Press
David J. Stewart, Executive Director, Meetings and
Courses
RESEARCH
Professors
Gregory Hannon*
Tatsuya Hirano
Leemor Joshua-Tor
Adrian Krainer
Yuri Lazebnik
Scott Lowe*
Roberto Malinow
Robert Martienssen
W. Richard McCombie
Partha Mitra
David Spector
Lincoln Stein
Karel Svoboda'
William Tansey
Nicholas Tonks
Timothy Tully
Michael Wig ler
Rui-Ming Xu
Michael Zhang
Yi Zhong
Associate Professors
Carlos Brody
Dmitri Chklovskii
Grigori Enikolopov
Z. Josh Huang
David Jackson
Zachary Mainen
Alea Mills
Andrew Neuwald
Scott Powers
Jacek Skowronski
Area Stenlund
Marja Timmermans
Linda Van Aelst
Anthony Zador
Assistant Professors
Joshua Dubnau
Alexei Koulakov
Robert Lucito
Wolfgang Lukowitz
Vivek Mittal
Senthil Muthuswamy
Michael Myers
Jonathan Sebat
Investigator
Eli Hatchwell
Senior Computer Scientists
Alexander Krasnitz
Lakshmi Muthuswamy
Ravi Sachidanandam
Boris Yamrom
Cold Spring Harbor Fellows
Ira Hall
Gilbert Henry
Patrick Paddison
Senior Research Investigator
James Hicks
Research Investigators
Kenneth Chang
Eric Enemark
Diane Esposito
Antonius Holtmaat
Tatyana Michurina
David Mu
Natalia Peunova
Cordula Schulz
Mona Spector
Doreen Ware
Zhenyu Xuan
Adjunct Associate Professor
Roussoudan Bourtchouladze
Adjunct Assistant Professor
Mirjana Maletic-Savatic
Visiting Professors
illiam Benjamin
Frances Hannan
Matthew Ridley
Visiting Scientists/
Collaborative Scientists
Nevenka Dimitrova
Paulo Ferreira
Adriana Hemerly
Julie Kan
Bernard Khoo
Tetsuya Nakamura
Maxim Nikitchenko
Filippo Petti
Aman Saleem
David Tegay
Senior Fellows
Jannik Andersen
Jidong Liu
Masashi Narita
Clinical Fellow
Lars Zender
Postdoctoral Fellows
Eric Allemand
Amy Altick
Nobuki Aono
Victoria Aranda Calleja
Anindya Bagchi
Martin Bayer
Yoselin Benitez Alfonso
Jennifer Bestman
Jannic Boehm
Benjamin Boettner
Benoit Boivin
Hemant Bokil
Peter Bommert
Anka Brie
Deirdre Buckley
Ingrid Bureau
Michelle Carmell
Enrique Cepero
Shuaili Chen
Agustin Chicas
Stephanie Chow
Anne Daulny
James Demas
Laurence Denis
Vincenzo De Paola
Michael Deweese
Graziella Di Cristo
Ross Dickins"
Dominik Duelli
Ingrid Ehrlich
Juan Encinas
Yuda Fang
Gidon Felsen
Tristan Fiedler
Rita Gandhi
Supriya Gangadharan
DingCheng Gao
Damien Garcia
Fuqiang Geng
Michael Golding
Naira Gorovits
Noah Gray
Vladimir Grubor
Mengjuan Guo
Xuecui Guo
Michelle Hastings
Hongzhen He
Lin He
Michael Hemann
Shanta Hinton
Yoshitaka Hippo
Maarten Hoek
Hao-Chi Hsu
Hailan Hu
Yimin Hua
Ying Huang
Daniel Huber
Michael Huebner
Kanae lijima
Koichi lijima
Employee of the Howard Hughes Medical Institute
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Danielle Irvine Richard Slotkin Magdalena Gierszewska Oliver Tam
Vijay lyer Andrew Smith Angelique Girard Dougal Tervo
Sitharthan Kamalakaran Philip Smith Teresa Haire Kathryn Tworkowski
Prasanth Kumar Christian Speck Md Aftabul Hague Wei Wei
Kannanganattu Takuya Takahashi Christopher Harvey Quan Wen
Fedor Karginov* Hiroki Taniguchi Xingyue He Jeremy Wilusz
Rotem Karni Milos Tanurdzic Jill Hemish Xiaoyun Wu
Alla Karpova Vatsala Thirumalai Shun Ho Wen Xue
Adam Kepecs Niraj Tolia Ikuko Hotta Yan Yang
Helmut Kessels Dmitry Tsigankov Katarzyna Hrecka Yu-Ting Yang
William Keyes Mitsuko Uchida Tomas Hromadka Seungtai Yoon
Valery Krizhanovsky Naoshige Uchida Helen Hsieh Min Yu
Sandra Kuhlman Santhosh Vadivelu Ingrid lbarra Chih-Chi Yuan
Prakash Kumar Caroline van der Meijden Justyna Janas Hatim Zariwala
John Kurland Liang Wang Kendall Jensen Chao lin Zhang
Byeong Ha Lee Yalin Wang Keisha John Zhen Zhao
Yoon-Ha Lee Robby Weimer Danny Khalil
Bo Li Hans Guido Wendel Anna Kloc
Jianli Li Linda Wilbrecht Rebecca Kohnz Research Programmers
Susana Lima Caizhi Wu Charles Kopec
Christian Machens Shouzhen Xia Jonathan Kui Peter Andrews
Alexis Maizel Bin Xiang Cern Kuscu Shulamit Avraham
Dheeraj Malhotra Hong Yang Michael Kwofie Scott Cain
Akira Mamiya Zhong Yao Jane Lee Payan Canaran
Louis Manganas Miguel Zaratiegui Biurrun Amy Leung Gengxin Chen
Anthony Mazurek Lixing Zhan Guang Lin Nansheng Chen
Albert Mel lick Zuo Zhang Pei-Chun Lin Maoyen Chi
Yuriy Mishchenko Xiaoyue Zhao Shih-Chieh Lin Benjamin Faga
Sylvain Mitelheiser Haining Zhong Xiaofei Liu Gopalakrishnan Gopinathrao
Arnitabh Mohanty Jack Zilfou Sarahjane Locke Todd Harris
Nael Nadif Kasri Karen Zito Alexandra Lucs Jude Kendall
Namiko Nagasawa Johannes Zuber Christopher Maher
Tal Nawy Hiroshi Makino Lalitha Krishnan
Fabio Nogueira Marco Mangone Anthony Leotta
Itay Onn Graduate Students Anagha Matapurkar Chengzhi Liang
Gonzalo Hugo Otazu Aldana Katherine McJunkin Hiren Maniar
Hysell Oviedo Hiroki Asari Elizabeth Murchison Sheldon McKay
Mario Pagani Rebecca Bish Nicholas Navin Timothy O'Connor
Dhruv Pant Allison Blum Daniel Nolan Andrew Olson
June Hee Park Francois Bolduc Marissa Nolan Deepa Pal
Leopoldo Petreanu* Darren Burgess Sabrina Nunez Shiran Pasternak
Tara Phelps-Durr Kasandra Burgos Hazeem Okunola Liya Ren
Antonella Piccini Abhishek Chakraborty Shraddha Pai Theodore Roeder
Yijun Qi Santanu Chakraborty Cristian Papazoglu-Statescu Nihar Sheth
Michael Quirk Cindy Chang Prem Premsrirut Xiaodong Tao
Ileng Ramachandran Sihem Cheloufi Sachin Ranade Marcella Tello-Ruiz
Kandasamy Ravi Beth Chen Frederick Rollins Matthew Vaughn
Michael Regulski Yi-Chun Chen Jasmin Roohi Xuehong Wei
Fabiola Rivas Hsueh-Cheng Chiang MI Rosenberg Guanming Wu
Francesc Roca Daniel Chitwood Mar lies Rossmann Charles Youens-Clark
Michael Ronemus Shu-Ling Chiu Dustin Schones Wei Zhao
Simon Rumpel Galen Collins Stephanie Shaw
Jorge Santos Da Silva Catherine Cormier Khalid Siddiqui
Angshuman Sarkar Ahmet Den li David Simpson Research Associates
Takashi Sato Monica Dus Rahul Sinha
Volker Scheuss Rebecca Ewald Despina Siolas Vtvekanand Balija
Mayilvahanan Shanmugam Claudia Feierstein Aleksander Sobczyk Carmelita Bautista
Pranav Sharma Patrick Finigan Smita Srivastava Lisa Manche
Yi-Jun Sheu Oliver Fregoso Shuying Sun Mila McCurrach
Keishi Shintomi Elvin Garcia Hongjae Sunwoo Ken Nguyen
Jose Silva James Gergel Lung-Hao Tai Linda Rodgers
Employee of the Howard Hughes Medical Institute
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Simone Salghetti
Patricia Wendel
Laboratory Facility Managers
Stephen Hearn
Christopher Johns
Sang Yong Kim
Pamela Moody
Timothy Mulligan
Joseph Simorowski
Spencer Tep lin
Jennifer Troge
Ming Wang
Regina Whitaker
Laboratory Managers
Martha Daddario
Joseph Simorowski
Scientific Administrators
Paloma Anderson
Sadie Arana
Christine Bedell
Patricia Bird
Lynn Boss
Jo Leonardo*
Idea Mallardi
Anita Matthes*
Barbara Matusik
Sandra Michelsen
Denise Moller
Carol Sekunda*
Lyzette Williams
Madeline Wisnewski
Laboratory Technicians
Deborah Aufiero
Theresa Auletta
Amal Bak leh
Kathryn Bambino
Jody Barditch
Kenneth Bergami
Sabrina Boettcher*
Kimberly Bronson
Barry Burbach*
Matthew Camiolo
Chih-Ming Chen
Nancy Dawkins-Pisani
Stephanie Dennison
Kristin Diggins*
Christopher Egan
Margaret Falkowski
John Giudicessi
Elena Glushenkova
Inessa Hakker
Michiko Hirano
Lisa Hufnagel
Taneisha James
Frederick Katzenberger
So Young Kim
Erik Kockenmeister
Melissa Kramer
Karen Kuntz
Evan Leibu
Zhi Zhong Li
Wen Wen Lin
Joanna Lloyd
Beicong Ma*
Shahinez Madi
Jennifer Meth
Beth Miller
Barbara Mish
Stephanie Muller
Masako Narita
Lidia Nascimento
Peter O'Brien
Ronnie Packer
Daniel Perkowski
Umamaheswari Ramu
Michael Riggs
Patricia Roccanova
Dongyon Roh
Christine Rosenthal*
Use Lotte Schmidt
Stephen Schuck
Maria Siddiqui
Nishi Sinha
Stephanie Smith
Lori Spiegel
Hua Tang
Ann Marie Torres
Hong Wang
Huaien Wang
Jing Wang
Yue Wang
Jeanne Wiggins
Jason Williams
Scilla Wu
Ying Wu
Miao-Miao Yang
Mianjia Ye
Lifang Zhang
Xiaoqun Zhang*
Media Makers/Laboratory
Aides
Maria Andrade
June Blanchford
Patricia Brady
Florinda Chaves
Terrance Chisum
Christopher Danielski
Salvador Henriquez
Hong Jie Shen
Marcela Lara
" Employee of the Howard Hughes Medical Institute
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Vincent Meschan
Maria Mosquera
Kenny Rojas
Rulan Shen
Richard Suen
Amy Tang-Qiu
Margaret Wallace
Research Administration
Maureen Bell
Denise Roberts
Watson School of
Biological Sciences
Lilian Clark Gann, Dean
Alyson Kass-Eisler
Dawn Meehan
Eva Radeck
DEPARTMENTS
Comptroller's Office and
Accounting
Lad C. Russo, Comptroller
Sharon Bense
Karine Boyce
Helen Chase
Damian Desiderio
Karen Filasky
Mary Ellen Goldstein
Laura Guterman
Elizabeth Janow
Patricia Maroney
Alison McDermott
Mary Ann Miceli
Kari Pavlovsky
Patricia Penner
Grace Tomasi
Patricia Urena
Noreen Vance
Banbury Center
Jan A. Witkowski, Executive
Director
Sydney Gary
Barbara Polakowski
Eleanor Sidorenko
Beatrice To liver
Central Administration
Maureen Berejka
Delia King
Susan Pagano
Judith Smith
CSHL Press
John R. Inglis, Executive Director
Director's Office
Elizabeth Powers
Acquisitions
Alexander Gann
David Crotty
Finance
William Keen
Richard Cavalieri
Nancy Hodson
Books: Editorial
Janet Argentine
Mary Cozza
Judith Cuddihy
Maryliz Dickerson
Joan Ebert
Maria Fairchild
Kaaren Janssen
Inez Sialiano
Books: Production
Denise Weiss
Patricia Barker
Kathleen Bubbeo
Daniel deBruin
Katherine Kelly
Ma la Mazzullo
Susan Schaefer
Rena Steuer
Journals: Editorial
Terri Grodzicker
Hillary Sussman
Margaret Calicchia
Laureen Connell
Heather Cosel-Pieper
Bibiane Garite
Roberta Salant
Maria Smit
Journals: Production
Linda Sussman
Debra Banninger
Cynthia Blaut
Pauline Henick
Mary Mulligan
Nora Ruth
Rita Wallace
Advertising
Marcie Siconolfi
Alexis Moed
Corrisa Salzman
Marketing and Sales
Phillip Lo Faso
Marketing
Kathryn Fitzpatrick
Wayne Manos
Ingrid Benirschke Perkins
Sales
Katya Gurbeloshvili
Guy Keyes
Customer Service and
Distribution
Geraldine Jaitin
Kathleen Cirone
Victor Manchiso
Jacqueline Matura
Mary Saba la
Sharon Story
Christopher Vacca
Development
Charles Prizzi, Chief
Development Officer
Jean De Forest
Alicia DeRosalia
Jan Eisenman
Diane Fagiola
Kiryn Has linger
Karen Orzel
Wendy Schneps
Paula Smith
Jill Stone
Dolan DNA Learning Center
David A. Mick los, Executive
Director
Adrian Arva
Elna Carrasco
Gregpru Chin
Jeanette Collette
John Connolly
Nancy Daidola
David Gundaker
Uwe Hilgert
Eun-Sook Jeong
Laura Johns
Mary Lamont
Susan Lauter
Stacy Leotta
Amanda Mc Brien
Colleen McKechnie
Eric Nash
Carolyn Reid
Danielle Sixsmith
Lauren Weidler
Chun-hua Yang
Facilities
Arthur Brings, Chief Facilities
Officer
Facilities Administration
Christopher Hubert
Frank Russo
Peter Stahl
Leslie Allen
Danielle Ferreira Cunha
Christine Hurson
Randal Jones
Elizabeth Parisi
Marlene Rubino
Charles Schneider
Jenna Williams
Building Services
Poh Sim Koh
Dessie Carter
Ming-Kai Chan
Gabriela Cruz
Diogenes Ferrer
Leo Franz
Angela Garcia
Wilman Garcia
Erick Greene
Leo Greene
Adriana Hincapie
Joseph Houser
Louis Hunter
Oscar Lastra
Patricia McAdams
Dora Merlino
Mary Muno
Wayne Pay
Teodosio Perez
Manuel Ramones
Ronald Romani
Jose Rosario
Claudia Schmid
Cesar Sisalima
Danuta Slodkowska
Steven Tang
Yew Teo
Carpentry and Painting
Peter Schwind
Edwin Bennett
Rafael Estrella
Romulo Estrella
John Meyer
Louis Muno
Wilson Ramones
Steven Randall
John Schindler
Benjamin Veneable III
Harry Wozniak
Employee of the Howard Hughes Medical Institute
Electrical
James Decker
Jerry Armstrong
Paul Edwards
Louis Jagoda
Environmental Health and
Safety
John Pisciotta
Steven Sallese
Graham Wildt
Equipment Design and Repair
Clifford Sutkevich
Robert Eifert
Patrick Flynn
George Newell III
James Robey
Grounds
Daniel Miller
Robert Albinson
Edward Anderson
Santo Bel lino
Daniel Chapman
Drew Comer
Joseph Ellis
Evan Harmon
Matthew Hoyer
Walter Leute
Christopher McEvoy
Michael Peluso
Stanley Schwarz
Eric Vazquez
Laboratory Animal Resources
Lisa Bianco
Amy Burrows
Michael Cahn
Jodi Coblentz
Justin Cohen
Charlene DePoto
Jared Downing
Eileen Earl
Lauren Glenz
Courtney Hakker
Michael Liclican
Lea Manzella
Tsepo Morris
Gustavo Munoz
Aigoul Nourjanova
Wenbo Yang
Mechanical Services
Robert Collins
William Bishop
Robert Dickerson
Wesley Dreusike
Craig Hubbs
Jeffrey Klaverweiden
Lane Smith
John Sundman
Christopher Sutkevich
Security
Gerard Holler
Richard Abreu
John Benson
Keith Brown
Gerard Brush
Frank Carberry
Christopher Clark
Peter Dale
Douglas Dervay II
Robert Gensel
Jeffrey Goldblum
Stephen Gregorovic
Kim Gronachan
William Jantzen
James Knott Jr.
Michael Lynch
Michael Murphy
Kenneth Nastri
Federico Santiago
Herbert Schulz
Leigh Tyrrel
Shipping and Receiving
Daniel Jusino
Moises Abreu
Kevin Donohue
Wayne Hamilton
Leslie Wenzel
Curtis Williams
Food and Beverage Service
James Hope, Director
Alexander Aguilera
Andres Alarcon
Xiomara Alfaro
Nicholas Algios
Jeannette Amato
Gloria Blanco
Jaime Bonilla
Francis Bowdren
Vanessa Cancilla
Guiditta Carino
William Carmona
Julio Carrasco
Eladio Castro
Rosa Ciurleo
Joan Doxey
Piedad Echeverri
Julie Ehrlich
Suzanne Esposito
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Lucy Figueroa
Carolyn Fuchs
Ingrid Gomez
Andres Gonzalez
Barbara Gordon
Jennifer Gordon
Hartley Griffith
Pierre Jean-Baptiste
Jesus Magana
Thomas Mcllvaine
Jorge Medina
Laurie Moller
Frederik Munter
Jorge Ramirez
Jose Reyes
Susana Roman
Maria Salazar
Faustino Vargas
Jose Vasquez
Ramon Vasquez
Keith Wieczorek
Jennifer Ziegler
Grants
Susan Schultz, Director
Wendy Crowley
Maureen Davies
Carol DuPree
Diane Errico
Joanne Janelli
Karen McKeon
Kathleen Wall-Rooney
Human Resources
Katherine Raftery, Director
Patricia Crawford
Christie DeRosalia
Sarah Ingraham
Lisa Kubasky
Sandra Neuwald
Barbara Purcell
Marjorie Ryan
Theresa Saia
Rashmi Sinha
Rita Wienclaw
Information Technology
R. Michael Townsend,
Director
James Bense
Gregg Evans
Salvatore Fabozzi
Kelvin Flores
Juan Carlos Gomez
Eric Hansen
Vsevolod Ilyushchenko
Derek Johnson
Juan Carlos Leon
Michael Ma lave
Louis Malfi
Bartholomew Mallio
Matthew Newhall
Barbara Peters
Salvatore Serafino
Russell Strine
David Trimboli
Peter Van Buren
Christian Velicu
Steven Zielinski
Media Arts and Visualization
Philip Renna, Supervisor
James Duffy
Catherine Eberstark
Michael Skuthan
Library
Ludmila Pollock, Director
Paula Abisognio
Ellen Brenner
Clare Bunce
Angela Cornwell
Jay Datema
Anthony Dellureficio
Charles Egleston
Helena Johnson
Marisa Macari
Gail Sherman
Rhonda Veros
Carlos Viteri
Claudia Zago
Meetings and Courses
David J. Stewart, Executive
Director
Mark Beavers
Edward Campodonico
Joseph Carried
William Dickerson
Andrew Mendelsohn
Maureen Morrow
Andrea Newell
Kenneth Orff
Valerie Pakaluk
Jonathan Parsons
Lauren Postyn
Richard Schriefer
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Mary Smith
Margaret Stellabotte
Andrea Stephenson
Barbara Zane
Public Affairs
Jeffrey J. Picarello, Director
Lisa Becker
Margot Bennett
Miriam Chua
Lynn Hardin
Laura Hyman
Peter Sherwood
John Verity
Special Events
Elizabeth Panagot
Joan Lui
Purchasing
Philip Lembo, Director
Margaret Brock
Carol Brower
Susan De Angelo
Jeffrey DuPree
Bruce Fahlbusch
Christopher Oravitz
Krystyna Rzonca
Barbara Santos
Leonard Sposato
Wanda Stolen
Technology Transfer
John P. Maroney, Director and
In-House Council
Elizabeth Cherian-Samuel
Edward Fenn
Lorraine Mclnerny
Limin Wen
RESEARCH STAFF
DEPARTURES DURING
2005
Professors
Nouns Hernandez*
Winship Herr Kiran Kumar Ratnapu
Senior Computer Scientist
Andrew Reiner
Computer Scientist
John Healy
Clinical Fellow
Clare Scott
Postdoctoral Fellows
Andres Barria-Roman
Carine Becamel
Paula Bubulya
Hsu Hsin Chen
Debopriya Das
Rajdeep Das
Robert Del Vecchio
Haiyuan Ding
Farida Emran
Peter Gillespie
Derek Goto
Eve-Ellen Govek
Hui-Fu Guo
Susan Janicki
Cizhong Jiang
Natarajan Kannan
Zachary Lippman
Carla Margulies
Jinrong Min
Masafumi Muratani
Pol O'Fearghail
Lance Palmer
Vijay Patankar
Amandine Penel
Emiliano Rial Verde
Jose Roig
Kalpana Samudre*
Gordon Shepherd*
Pavel Sumazhin
Shweta Tyagi
Erwann Vieu*
Michael Wehr
Ryohei Yasuda
Maria Yuneva
Qing-Shuo Zhang
Fang Zhao
Ming Ming Zhao
Research Programmer
Assistant Professor
Masaaki Hamaguchi
Research Associate
Joan Alexander


